data_1s6u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s6u _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.05 135.83 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.72 132.47 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.639 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 135.24 54.05 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 166.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -111.94 122.07 46.77 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.6 ptp -123.64 120.5 32.95 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.106 1.362 . . . . 0.0 109.533 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.2 mptp? -71.01 134.53 47.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.655 -1.164 . . . . 0.0 108.079 173.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -116.91 150.35 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -113.61 150.35 33.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.36 -35.06 2.42 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.52 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.6 mtm -65.82 85.72 0.08 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.607 1.204 . . . . 0.0 111.603 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 m -122.96 51.08 1.46 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 109.116 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 p -158.32 167.88 28.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 165.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.77 -22.24 50.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.321 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -65.62 -62.0 1.76 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.047 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -52.21 -51.22 59.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.013 0.911 . . . . 0.0 110.235 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 p -57.58 -56.07 26.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.295 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -54.98 -48.34 73.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.776 0.717 . . . . 0.0 111.623 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.2 m -52.85 -51.96 59.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.534 0.734 . . . . 0.0 110.283 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -60.92 -44.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.19 -48.12 71.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.231 0.612 . . . . 0.0 111.087 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.82 28.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.663 0.649 . . . . 0.0 111.624 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -56.96 -47.11 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.109 -0.642 . . . . 0.0 110.945 -174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 mm -66.34 -48.02 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.241 1.016 . . . . 0.0 109.478 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.76 -39.26 31.34 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.533 0.587 . . . . 0.0 112.235 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -60.54 -29.17 68.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.492 0.646 . . . . 0.0 112.489 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -75.04 135.29 41.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.039 0.923 . . . . 0.0 112.088 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -70.72 86.96 0.68 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.917 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.66 0.51 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 115.227 0.851 . . . . 0.0 115.227 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -86.95 149.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 117.844 0.822 . . . . 0.0 109.287 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -120.8 -34.72 3.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -156.53 164.32 38.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -158.29 140.28 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -140.99 82.7 1.85 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.233 1.013 . . . . 0.0 111.222 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -84.47 110.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -89.29 172.16 9.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -48.15 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.461 1.104 . . . . 0.0 109.48 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.11 -61.15 1.89 Allowed 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.389 1.876 . . . . 0.0 110.392 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.17 19.52 7.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.143 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.33 63.87 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.759 2.824 . . . . 0.0 113.462 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 35.2 tt0 -146.6 146.24 30.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.14 124.71 42.39 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.613 1.165 . . . . 0.0 109.596 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -98.05 129.54 44.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.82 1.648 . . . . 0.0 107.23 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.8 123.19 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 104.55 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 118.821 0.737 . . . . 0.0 110.025 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -133.4 167.98 19.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.335 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.42 112.79 63.14 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.233 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.45 78.25 2.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.024 3.149 . . . . 0.0 110.985 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -179.25 -52.95 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.781 1.632 . . . . 0.0 106.919 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.78 -46.06 16.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.155 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 169.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.552 1.541 . . . . 0.0 108.27 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -139.64 162.03 36.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.982 0.913 . . . . 0.0 111.202 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -43.65 -48.28 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.202 1.001 . . . . 0.0 111.15 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.89 -45.66 88.36 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.488 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -50.93 -57.28 8.93 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.231 1.378 . . . . 0.0 108.702 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.9 mmt -46.49 -65.43 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -59.7 5.02 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 121.284 -0.885 . . . . 0.0 112.611 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -44.76 -48.63 10.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.203 0.911 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -40.8 90.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.99 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -67.52 -65.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.077 0.551 . . . . 0.0 110.619 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -43.38 -42.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.38 0.672 . . . . 0.0 112.18 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.42 -32.86 58.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.139 0.882 . . . . 0.0 113.149 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.3 mmt -59.39 -40.26 85.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.68 0.673 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.93 -17.74 2.77 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.372 0.986 . . . . 0.0 111.197 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -84.23 110.53 27.03 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 123.913 0.885 . . . . 0.0 109.581 -171.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -65.89 141.58 65.53 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.33 136.18 32.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.444 0.298 . . . . 0.0 111.779 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.81 78.74 1.22 Allowed 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.16 101.52 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.844 1.657 . . . . 0.0 112.083 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -156.77 56.8 0.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -158.03 130.06 6.96 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 167.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.5 mt . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.245 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.94 134.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.43 134.61 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.09 147.02 43.69 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 163.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -118.04 117.06 28.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -118.28 119.64 35.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.619 1.568 . . . . 0.0 108.275 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.47 140.74 54.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -127.94 146.4 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -105.97 148.15 28.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.32 -31.68 2.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.459 -0.776 . . . . 0.0 114.056 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.5 mtp -61.99 92.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.987 0.893 . . . . 0.0 110.242 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 m -144.46 48.67 1.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.894 1.277 . . . . 0.0 109.724 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -77.26 44.27 0.41 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.668 0.787 . . . . 0.0 111.46 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -129.54 -59.76 1.07 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.392 1.077 . . . . 0.0 108.425 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -54.66 -58.53 7.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.471 0.578 . . . . 0.0 110.655 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 t -51.95 -57.3 9.84 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.271 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 t -57.71 -40.33 79.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.809 0.844 . . . . 0.0 110.557 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -60.85 -49.26 78.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.934 -0.479 . . . . 0.0 110.082 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -51.29 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.5 -51.19 65.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.201 1.0 . . . . 0.0 110.142 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.01 -51.21 57.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.813 0.72 . . . . 0.0 112.059 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.3 -59.58 5.07 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.195 0.997 . . . . 0.0 110.572 -175.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.9 mm -57.67 -38.07 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.264 1.026 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.32 -36.15 7.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.033 0.825 . . . . 0.0 113.676 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.62 -7.01 59.59 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.171 0.986 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.64 149.7 32.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.12 0.873 . . . . 0.0 111.835 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.71 126.53 36.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.194 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.0 -21.06 7.51 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -86.98 151.64 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -118.51 -40.82 2.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.836 1.254 . . . . 0.0 110.726 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -159.13 170.84 21.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -158.48 140.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -143.87 84.73 1.79 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.685 0.794 . . . . 0.0 110.718 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.45 102.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.84 0.856 . . . . 0.0 109.149 -172.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -78.53 177.21 8.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 -48.85 0.41 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 109.054 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -61.43 1.96 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.423 1.489 . . . . 0.0 110.39 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -91.52 19.46 6.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.625 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 37.29 62.27 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.155 2.182 . . . . 0.0 113.603 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.29 149.48 33.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 130.64 46.95 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.332 1.053 . . . . 0.0 110.147 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -102.06 129.3 48.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 107.234 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.6 mm -123.88 127.81 73.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.34 107.36 21.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 110.005 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -145.86 173.24 12.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.498 -0.751 . . . . 0.0 111.813 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -98.65 104.3 23.71 Favored Pre-proline 0 N--CA 1.439 -1.024 0 C-N-CA 124.932 1.293 . . . . 0.0 108.713 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.12 -24.4 73.55 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.836 2.357 . . . . 0.0 112.4 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -22.76 63.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.594 0.758 . . . . 0.0 112.894 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.8 mt -107.97 -64.71 1.18 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.827 0.74 . . . . 0.0 111.474 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -116.5 161.3 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.644 1.177 . . . . 0.0 108.277 -175.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -127.72 165.45 20.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.514 0.726 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.62 -44.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 C-N-CA 124.133 0.973 . . . . 0.0 110.236 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 25.0 tp10 -60.59 -38.19 83.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.135 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.86 -53.63 25.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 mmt -45.21 -59.74 2.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 122.863 0.465 . . . . 0.0 111.634 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -64.01 -53.82 44.02 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.284 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -50.37 -47.05 56.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 120.702 1.592 . . . . 0.0 109.201 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -59.63 -48.96 79.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.704 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -69.74 -63.94 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 122.931 0.492 . . . . 0.0 110.583 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -47.69 -36.47 11.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.318 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.43 -32.82 63.04 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.726 1.148 . . . . 0.0 112.955 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.5 mmt -60.89 -30.39 70.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.437 0.562 . . . . 0.0 110.885 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.54 7.79 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.455 1.503 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -82.5 116.07 61.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.375 1.07 . . . . 0.0 109.524 -171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.76 144.08 64.09 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.611 1.541 . . . . 0.0 108.75 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.27 141.22 35.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.929 0.492 . . . . 0.0 111.179 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -114.49 78.3 1.14 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.88 0.872 . . . . 0.0 110.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.13 103.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.097 1.359 . . . . 0.0 111.2 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -155.41 57.09 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.34 0.59 . . . . 0.0 112.16 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.01 158.17 32.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 122.061 0.934 . . . . 0.0 109.767 179.344 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.58 129.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -91.15 119.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -100.81 133.73 44.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -118.22 115.37 24.62 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.42 126.86 53.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.151 1.38 . . . . 0.0 108.572 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -70.31 140.72 52.33 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 168.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -130.93 143.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.6 159.11 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.84 -39.01 2.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.756 -0.59 . . . . 0.0 114.566 161.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.53 102.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.7 1.25 . . . . 0.0 110.681 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -134.75 34.4 3.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.097 1.359 . . . . 0.0 109.772 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 165.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -72.01 -25.5 61.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.613 0.244 . . . . 0.0 111.316 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -58.52 -56.1 26.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.214 0.606 . . . . 0.0 111.485 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 m -59.12 -55.77 30.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.64 0.654 . . . . 0.0 110.692 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -49.37 -57.47 6.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.22 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -59.73 -42.23 92.68 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.321 0.51 . . . . 0.0 111.206 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.8 m -57.38 -48.83 78.03 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.603 -0.686 . . . . 0.0 110.199 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.63 -49.08 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.253 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -45.16 -53.78 7.69 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.278 1.031 . . . . 0.0 109.546 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.75 -57.41 19.93 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.344 0.973 . . . . 0.0 112.316 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -58.25 -54.38 47.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.868 0.834 . . . . 0.0 109.874 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.0 mm -70.32 -35.95 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.575 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.7 -30.76 9.08 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.733 -0.604 . . . . 0.0 112.688 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.7 -14.81 60.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 118.178 0.989 . . . . 0.0 113.448 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 147.66 51.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.639 1.563 . . . . 0.0 112.746 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.68 97.51 7.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.74 -10.1 1.87 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-O 119.725 -0.486 . . . . 0.0 114.271 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.91 137.82 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -31.66 10.49 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.079 0.551 . . . . 0.0 111.381 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -152.72 159.64 43.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.19 140.92 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.93 136.78 25.67 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.845 0.858 . . . . 0.0 110.53 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -132.96 104.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 120.628 1.558 . . . . 0.0 111.349 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.1 m -83.28 105.34 14.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.685 1.994 . . . . 0.0 110.125 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -44.75 95.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.486 -0.133 . . . . 0.0 110.849 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.48 -57.34 7.2 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.396 1.478 . . . . 0.0 111.287 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.08 11.66 20.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.576 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 1.4 mt-30 33.61 62.93 0.39 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.601 2.36 . . . . 0.0 112.605 -168.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.23 136.25 39.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.971 0.908 . . . . 0.0 110.618 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.34 135.23 53.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.797 1.639 . . . . 0.0 110.168 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.6 m -111.77 124.47 52.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 131.281 3.832 . . . . 0.0 106.438 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mm -125.88 117.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.46 95.42 3.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -123.88 169.52 11.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.22 0.533 . . . . 0.0 111.951 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -108.06 109.81 62.02 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.345 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.86 79.76 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.504 2.803 . . . . 0.0 111.298 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m170 177.13 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 128.07 2.548 . . . . 0.0 108.075 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.95 -46.67 17.87 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.398 -0.189 . . . . 0.0 111.258 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -140.2 170.76 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.375 1.47 . . . . 0.0 107.741 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.8 p -130.53 155.91 45.71 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.128 0.971 . . . . 0.0 111.443 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -46.44 -43.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.638 0.775 . . . . 0.0 110.974 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.68 -45.4 94.33 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.706 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.58 -55.98 27.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.66 1.184 . . . . 0.0 107.814 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.7 mmt -46.16 -59.05 3.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -51.18 70.5 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 121.148 -0.97 . . . . 0.0 111.927 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -52.66 -49.31 65.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.78 -48.19 82.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.373 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.58 -66.8 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.057 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -48.94 -33.95 11.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.428 -0.796 . . . . 0.0 113.003 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.937 1.244 . . . . 0.0 112.937 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.8 mmt -55.47 -42.28 74.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 110.547 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.76 -25.0 2.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.011 0.815 . . . . 0.0 111.326 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -73.86 113.19 20.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.928 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -64.84 143.69 80.75 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.669 1.579 . . . . 0.0 108.857 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.26 40.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -104.78 76.89 1.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 p -52.58 108.0 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 109.828 162.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -155.38 59.79 0.63 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.601 0.715 . . . . 0.0 112.402 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -157.16 168.06 28.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.445 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.81 144.51 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.786 1.634 . . . . 0.0 107.551 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.33 131.76 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.524 1.53 . . . . 0.0 107.546 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.3 122.09 40.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -113.56 118.8 35.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.2 ptp -117.0 128.96 55.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.292 1.037 . . . . 0.0 109.935 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 125.28 28.6 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.19 154.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 119.318 0.963 . . . . 0.0 108.88 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -115.28 154.53 28.94 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 109.74 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.93 -47.54 3.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.691 0.662 . . . . 0.0 112.347 171.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.4 mtm -64.59 86.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.568 0.684 . . . . 0.0 111.82 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 m -135.65 50.7 2.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.476 1.51 . . . . 0.0 109.738 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 p -161.17 167.95 25.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -65.46 177.2 1.21 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.803 0.811 . . . . 0.0 109.837 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t 73.74 -65.73 0.34 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 121.309 -0.869 . . . . 0.0 108.774 -170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.3 m -47.64 -63.47 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.036 0.835 . . . . 0.0 111.317 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -56.03 -55.72 29.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.264 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -58.98 -45.91 89.4 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.137 0.975 . . . . 0.0 111.65 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.5 m -53.64 -50.5 65.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.499 0.719 . . . . 0.0 110.281 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -44.04 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.568 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.5 -51.87 57.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 109.749 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.78 -54.47 34.78 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.259 0.933 . . . . 0.0 112.112 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -60.6 -54.51 44.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.012 -0.699 . . . . 0.0 110.897 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.57 -42.36 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.54 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.55 -23.52 14.26 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.325 -0.708 . . . . 0.0 113.718 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -81.91 -18.87 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.966 1.383 . . . . 0.0 112.283 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.94 131.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.781 1.628 . . . . 0.0 111.292 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -68.68 91.71 0.45 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.37 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.28 -18.34 1.52 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.329 -171.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.91 146.05 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 117.858 0.829 . . . . 0.0 109.587 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -106.21 -44.99 4.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.811 1.645 . . . . 0.0 110.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.58 168.69 26.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 tt -158.35 139.36 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -136.72 86.82 2.24 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.634 1.574 . . . . 0.0 111.039 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.62 97.19 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 109.366 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.0 m -75.66 165.46 25.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.56 -46.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.849 0.859 . . . . 0.0 109.622 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.42 -57.21 12.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.044 1.338 . . . . 0.0 109.423 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -88.05 12.77 12.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.088 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 35.98 58.41 0.94 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.355 2.262 . . . . 0.0 113.19 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.78 140.02 31.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.479 -0.763 . . . . 0.0 108.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.71 112.72 18.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.882 1.273 . . . . 0.0 109.793 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.6 m -87.94 126.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 107.873 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.87 127.97 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.1 110.46 32.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -138.83 167.66 21.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -168.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -103.46 108.87 60.64 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 123.901 0.881 . . . . 0.0 111.01 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.35 76.84 2.18 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.043 3.162 . . . . 0.0 110.674 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -179.09 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.161 2.184 . . . . 0.0 107.846 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.04 -49.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.35 162.28 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.708 1.603 . . . . 0.0 108.244 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -124.67 163.2 22.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 111.973 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.9 t -47.79 -41.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 C-N-CA 123.368 0.667 . . . . 0.0 111.079 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.04 -43.28 87.99 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.21 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -53.23 -51.32 62.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.925 1.239 . . . . 0.0 109.043 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.1 mmt -51.28 -67.28 0.26 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.09 -55.82 26.78 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.06 -1.025 . . . . 0.0 112.876 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -49.76 -49.39 48.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.2 -41.86 94.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 118.619 -1.233 . . . . 0.0 112.674 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.5 -65.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 O-C-N 121.669 -0.644 . . . . 0.0 110.431 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -49.41 -34.65 16.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.458 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.34 -32.63 62.68 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.939 1.245 . . . . 0.0 112.621 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 16.9 mmt -58.96 -41.92 88.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.473 0.579 . . . . 0.0 110.706 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.37 -19.45 3.61 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.634 1.111 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -75.41 114.95 40.9 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.955 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.61 144.88 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.507 1.471 . . . . 0.0 108.969 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.76 135.02 25.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.021 0.438 . . . . 0.0 111.91 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -108.21 78.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.873 1.669 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.08 109.36 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.207 1.803 . . . . 0.0 110.335 165.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -155.82 55.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.72 137.78 13.59 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.976 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.74 140.14 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 125.744 1.618 . . . . 0.0 107.932 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.45 119.35 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.306 1.042 . . . . 0.0 108.404 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.07 125.1 39.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.84 120.21 41.13 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mtt -118.17 127.0 53.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.419 1.088 . . . . 0.0 108.59 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.11 130.57 36.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.62 138.42 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -104.81 146.58 28.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.967 0.507 . . . . 0.0 109.703 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.3 -36.68 3.97 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.586 0.612 . . . . 0.0 113.346 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 mtp -65.92 94.72 0.23 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.822 0.811 . . . . 0.0 110.357 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -119.72 53.92 1.03 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.267 1.427 . . . . 0.0 108.42 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -171.31 157.49 5.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.453 0.701 . . . . 0.0 109.114 -169.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -27.62 60.6 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.664 167.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -57.16 -69.87 0.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.272 0.629 . . . . 0.0 112.025 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -59.11 -48.08 82.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.159 0.436 . . . . 0.0 110.736 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -50.27 -56.72 9.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.824 0.85 . . . . 0.0 110.621 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 t -57.82 -47.18 83.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.602 0.761 . . . . 0.0 111.454 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.7 m -55.2 -48.06 74.38 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 110.944 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.41 -49.42 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 124.194 0.998 . . . . 0.0 108.993 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -46.71 -50.39 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.058 0.943 . . . . 0.0 109.979 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.29 -59.11 11.4 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.022 0.82 . . . . 0.0 112.125 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.79 -57.78 10.98 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.681 0.753 . . . . 0.0 109.776 -174.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.99 -32.03 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.88 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.82 -32.45 25.94 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.754 -0.591 . . . . 0.0 112.419 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.07 4.53 41.72 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 117.906 0.853 . . . . 0.0 112.208 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 152.87 44.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 120.522 1.51 . . . . 0.0 110.102 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -83.45 134.69 34.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 18.87 11.13 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.99 0.805 . . . . 0.0 112.559 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.3 t -122.94 143.93 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.173 1.389 . . . . 0.0 109.757 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.87 -30.42 9.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.286 0.634 . . . . 0.0 112.016 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -160.55 167.27 27.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.874 1.269 . . . . 0.0 108.07 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 tt -155.07 142.13 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.73 151.4 45.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.633 1.573 . . . . 0.0 109.245 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.0 t -140.56 143.51 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.089 0.859 . . . . 0.0 109.546 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 m -112.59 167.99 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.515 1.926 . . . . 0.0 109.297 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.82 -56.98 1.92 Allowed 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.282 1.033 . . . . 0.0 109.239 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.4 -58.2 3.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.977 1.311 . . . . 0.0 111.118 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -91.72 13.38 18.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.277 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 32.15 68.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.795 3.238 . . . . 0.0 112.723 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -136.86 147.85 46.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.067 0.947 . . . . 0.0 109.842 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.34 133.92 50.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.331 1.852 . . . . 0.0 109.665 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -112.4 114.28 26.92 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 128.672 2.789 . . . . 0.0 108.66 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.87 113.57 42.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.04 91.5 2.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.04 13.62 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.717 0.807 . . . . 0.0 113.033 -166.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -102.28 111.14 64.15 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.044 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.9 67.57 3.17 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.974 3.116 . . . . 0.0 109.969 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.43 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.145 1.378 . . . . 0.0 108.702 -173.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.4 -42.18 37.24 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.33 0.252 . . . . 0.0 110.846 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.7 165.15 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 124.402 1.081 . . . . 0.0 108.474 -175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -110.49 158.31 18.65 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.024 1.329 . . . . 0.0 112.056 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -51.09 -46.16 31.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 C-N-CA 124.069 0.948 . . . . 0.0 111.506 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.68 -38.21 84.18 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.174 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -52.0 65.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 120.739 1.609 . . . . 0.0 108.176 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.0 mmt -49.8 -63.14 1.2 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -59.05 -56.19 25.47 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.066 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -43.04 -52.46 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.539 1.135 . . . . 0.0 109.727 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -63.26 -42.19 99.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.39 -62.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 O-C-N 121.838 -0.539 . . . . 0.0 110.174 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -42.77 -41.96 3.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 112.273 171.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.79 -31.9 50.6 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.027 0.831 . . . . 0.0 113.215 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.43 -41.73 90.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.408 0.549 . . . . 0.0 110.84 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.19 -17.89 3.34 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.784 1.183 . . . . 0.0 111.202 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -80.78 113.3 39.08 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.77 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.32 149.6 90.81 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 108.682 -1.315 . . . . 0.0 108.682 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.91 137.32 26.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.281 0.233 . . . . 0.0 111.052 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -107.28 74.9 0.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 103.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.107 1.363 . . . . 0.0 110.298 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -154.57 55.65 0.68 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.458 0.647 . . . . 0.0 112.125 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -158.14 149.78 21.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 175.389 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 m -107.61 129.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -170.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.7 122.63 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.31 130.35 54.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -115.78 119.43 35.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.1 122.4 35.65 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.081 1.352 . . . . 0.0 108.804 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -70.07 138.6 52.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 172.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.86 143.7 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.26 152.0 19.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.31 -37.0 1.99 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.419 0.533 . . . . 0.0 114.268 166.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.5 mtp -70.6 80.47 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.274 1.037 . . . . 0.0 111.319 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.63 24.51 12.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.771 1.228 . . . . 0.0 111.924 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 p -161.03 166.68 27.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.162 0.982 . . . . 0.0 111.45 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -63.79 168.93 4.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.362 168.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 80.05 -64.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.646 1.178 . . . . 0.0 109.864 -172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 m -60.11 -59.01 6.1 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.995 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 p -49.61 -63.15 1.19 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.665 1.186 . . . . 0.0 110.287 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -53.22 -40.74 64.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 111.51 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.7 m -59.98 -49.27 78.34 Favored 'General case' 0 N--CA 1.457 -0.086 0 O-C-N 121.621 -0.675 . . . . 0.0 109.837 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.58 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.99 -53.9 36.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.641 0.776 . . . . 0.0 110.506 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -52.23 52.62 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.219 0.914 . . . . 0.0 111.788 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.17 -58.33 8.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -66.26 -29.37 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.887 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.83 -30.84 7.22 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.736 0.684 . . . . 0.0 113.236 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -89.93 6.95 39.79 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.515 1.158 . . . . 0.0 112.354 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.16 152.35 44.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.516 -1.365 . . . . 0.0 111.982 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -96.28 84.87 3.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.114 1.365 . . . . 0.0 109.575 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.69 -4.87 0.8 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 115.407 0.923 . . . . 0.0 115.407 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.23 134.68 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.058 0.943 . . . . 0.0 108.876 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.64 -34.14 12.71 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 111.319 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.3 165.95 32.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.91 145.44 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 103.233 -2.877 . . . . 0.0 103.233 -171.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -142.34 150.72 41.13 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.886 1.274 . . . . 0.0 109.589 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.39 106.72 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.977 0.808 . . . . 0.0 110.181 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -94.73 80.88 3.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.12 1.368 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -48.01 -41.05 24.5 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.574 0.75 . . . . 0.0 112.371 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.31 -56.33 5.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.093 1.757 . . . . 0.0 110.692 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -100.27 22.83 10.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.955 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 34.19 57.65 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.043 2.537 . . . . 0.0 113.285 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 39.2 tt0 -138.06 131.18 30.23 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.24 147.26 28.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.514 1.526 . . . . 0.0 110.031 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.3 m -124.68 120.12 30.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.307 2.643 . . . . 0.0 106.985 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -121.04 124.92 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.98 97.31 5.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 118.298 0.499 . . . . 0.0 110.443 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -117.75 169.02 9.92 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.341 0.657 . . . . 0.0 112.682 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.91 114.17 61.88 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.209 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.57 77.08 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.532 2.821 . . . . 0.0 111.57 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -177.23 -43.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 127.66 2.384 . . . . 0.0 108.279 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.15 -47.59 27.77 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.4 176.27 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.33 1.452 . . . . 0.0 107.749 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.2 p -143.12 165.99 25.9 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.894 0.77 . . . . 0.0 111.114 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.53 -34.26 28.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 C-N-CA 122.964 0.506 . . . . 0.0 111.953 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -62.06 -42.6 99.36 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.662 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.71 -52.8 62.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.1 mtp -47.34 -59.9 2.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.176 0.591 . . . . 0.0 111.626 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -62.09 -52.88 62.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -47.92 -50.06 28.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.806 0.73 . . . . 0.0 109.241 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -61.4 -49.27 77.58 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.28 -63.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.805 -0.56 . . . . 0.0 110.514 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -45.94 -39.15 8.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.754 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.63 60.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.736 1.153 . . . . 0.0 113.044 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.0 mmt -56.61 -39.43 73.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.51 0.596 . . . . 0.0 110.843 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.87 -17.98 4.33 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.333 1.444 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -78.47 115.22 49.73 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 123.856 0.862 . . . . 0.0 110.213 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -66.83 141.55 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.07 138.03 39.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.646 0.378 . . . . 0.0 111.506 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.09 78.73 1.2 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.733 0.813 . . . . 0.0 109.276 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.07 104.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.841 1.656 . . . . 0.0 110.42 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -156.18 58.48 0.58 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.634 0.731 . . . . 0.0 112.524 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.36 132.06 9.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 tp . . . . . 0 C--N 1.332 -0.16 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.746 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.303 0.097 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.91 131.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.91 0.884 . . . . 0.0 109.771 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.24 123.64 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.584 1.554 . . . . 0.0 106.888 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.08 128.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 159.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -110.24 127.65 55.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.455 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 13.1 ptm -140.71 132.06 26.73 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -75.87 138.84 41.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 m -124.85 150.7 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.39 150.04 31.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.203 0.456 . . . . 0.0 110.339 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.37 -33.1 1.57 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.666 0.651 . . . . 0.0 113.865 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.9 mtp -67.3 78.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.932 0.893 . . . . 0.0 111.916 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -134.07 43.55 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.392 1.077 . . . . 0.0 110.16 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -161.25 151.25 17.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.476 1.11 . . . . 0.0 108.752 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -75.03 55.83 0.74 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.893 1.277 . . . . 0.0 111.427 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.8 m -136.77 -64.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -60.43 -54.24 47.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.751 0.821 . . . . 0.0 109.737 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 t -45.8 -62.94 1.09 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.535 1.134 . . . . 0.0 110.006 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 t -63.77 -39.13 93.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.989 0.516 . . . . 0.0 109.937 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.0 m -58.82 -49.59 77.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.772 -0.58 . . . . 0.0 110.076 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.6 -50.73 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.258 0.481 . . . . 0.0 109.939 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -44.41 -54.57 5.77 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.499 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.68 -57.39 20.12 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.796 0.712 . . . . 0.0 112.04 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -58.63 -54.46 46.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.42 0.628 . . . . 0.0 110.155 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.72 -38.29 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.99 0.916 . . . . 0.0 110.159 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.73 18.94 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.856 -0.527 . . . . 0.0 112.24 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -73.47 -13.82 61.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.18 140.78 47.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 120.266 1.394 . . . . 0.0 112.31 -169.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -69.51 80.17 0.4 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.015 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.31 -19.32 0.23 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.43 133.55 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -31.17 13.01 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.042 0.537 . . . . 0.0 111.485 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -154.36 161.05 41.97 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -156.07 137.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -138.51 153.13 48.75 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.289 1.036 . . . . 0.0 110.148 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.0 t -138.18 111.74 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -87.7 69.54 9.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -42.49 31.49 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.498 0.499 . . . . 0.0 110.624 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -56.33 5.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.711 2.004 . . . . 0.0 111.102 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -98.56 22.35 9.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.062 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 44.13 53.74 6.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.706 2.002 . . . . 0.0 112.782 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.28 147.79 49.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.453 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 148.93 48.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.383 1.873 . . . . 0.0 109.626 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -129.36 116.69 19.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.461 2.704 . . . . 0.0 107.064 -171.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 mm -123.17 110.41 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.57 94.64 3.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -171.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -111.91 167.8 10.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.311 0.577 . . . . 0.0 112.084 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -110.12 113.64 56.62 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.671 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.13 77.11 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.434 2.756 . . . . 0.0 111.176 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -177.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 128.018 2.527 . . . . 0.0 107.954 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.13 -48.55 17.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.39 176.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.514 1.526 . . . . 0.0 108.316 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.1 p -142.62 162.0 36.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.544 0.738 . . . . 0.0 111.502 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -44.08 -45.61 2.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 125.452 1.501 . . . . 0.0 111.681 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -54.99 39.0 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-O 117.146 -1.407 . . . . 0.0 109.035 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -46.47 -55.33 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 110.437 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.0 mmt -46.21 -56.92 5.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.814 0.734 . . . . 0.0 111.713 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -62.84 -61.57 2.31 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.212 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -40.35 -52.14 2.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.961 1.704 . . . . 0.0 109.156 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -61.98 -47.37 85.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.98 -64.73 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.83 -0.544 . . . . 0.0 111.089 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -43.98 -40.05 4.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.69 0.796 . . . . 0.0 112.692 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.72 -32.41 59.62 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.326 0.966 . . . . 0.0 112.861 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.8 mmt -57.81 -41.81 82.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.368 0.531 . . . . 0.0 110.293 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.53 -19.05 2.81 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.622 1.106 . . . . 0.0 111.093 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -78.08 119.27 76.71 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.008 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.91 145.51 80.31 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.575 -1.356 . . . . 0.0 108.575 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.69 135.99 26.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.609 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -99.18 82.82 2.76 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HA ' ' CB ' ' A' ' 7' ' ' MET . 2.4 p -70.07 105.58 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.069 1.347 . . . . 0.0 110.444 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -155.31 58.98 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -153.71 154.01 33.31 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 159.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 163.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.99 136.29 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.933 0.893 . . . . 0.0 109.23 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.76 134.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.322 1.449 . . . . 0.0 108.655 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.15 151.63 40.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -120.24 123.03 42.22 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -124.01 129.53 51.07 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.138 1.375 . . . . 0.0 108.345 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 120.85 29.47 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.389 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.86 125.12 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 124.228 0.955 . . . . 0.0 109.347 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -87.64 152.49 22.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.394 0.677 . . . . 0.0 109.264 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.82 -46.18 1.23 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.518 0.58 . . . . 0.0 112.87 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mtp -70.01 82.64 0.49 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.807 0.804 . . . . 0.0 111.924 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.8 m -133.61 -9.07 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.703 1.601 . . . . 0.0 112.22 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 p -80.8 -17.38 51.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.444 1.498 . . . . 0.0 113.55 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 m80 84.45 -31.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.267 2.227 . . . . 0.0 112.262 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -62.26 -65.76 0.64 Allowed 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -50.88 -48.5 60.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 111.83 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -48.0 -62.32 1.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 109.754 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -59.35 -47.17 86.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.486 1.114 . . . . 0.0 110.84 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.9 m -52.15 -50.09 62.44 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.706 0.803 . . . . 0.0 110.877 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.9 -47.8 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 123.807 0.843 . . . . 0.0 109.447 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -44.67 -52.73 7.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.038 0.935 . . . . 0.0 110.079 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.54 8.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.979 0.8 . . . . 0.0 112.683 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -50.71 70.76 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 121.508 0.67 . . . . 0.0 109.984 -171.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.36 -41.22 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.774 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.78 -34.46 21.87 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.319 0.485 . . . . 0.0 112.518 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -71.14 -7.93 50.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.796 0.838 . . . . 0.0 113.095 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.6 144.77 45.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 120.656 1.571 . . . . 0.0 111.689 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -81.73 61.19 5.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.16 22.45 0.02 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.57 150.52 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -111.77 -40.35 4.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.02 0.928 . . . . 0.0 109.387 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -159.97 164.86 32.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 tt -157.67 141.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 103.903 -2.628 . . . . 0.0 103.903 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -143.04 144.72 32.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.628 1.171 . . . . 0.0 110.119 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.64 131.74 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.174 0.897 . . . . 0.0 110.505 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -113.88 94.28 4.76 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.227 1.811 . . . . 0.0 109.733 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.32 91.22 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.058 -0.401 . . . . 0.0 112.075 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.83 -57.18 6.8 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.791 1.237 . . . . 0.0 111.049 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -95.2 20.62 8.92 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.742 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 30.81 67.35 0.12 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.776 2.43 . . . . 0.0 113.185 -169.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -131.35 157.64 42.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.626 1.17 . . . . 0.0 109.742 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.17 149.88 50.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.663 1.185 . . . . 0.0 109.698 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 m -127.66 121.3 30.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.424 2.689 . . . . 0.0 106.463 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 mm -128.4 118.87 48.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 105.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.202 -170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -137.58 176.18 8.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.549 -0.72 . . . . 0.0 112.122 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.7 108.26 61.14 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.307 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.82 71.89 4.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 3.307 . . . . 0.0 110.264 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -173.23 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.559 1.944 . . . . 0.0 108.656 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.09 -42.05 11.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.497 0.319 . . . . 0.0 111.297 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.23 160.62 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 125.334 1.453 . . . . 0.0 108.211 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -119.93 168.83 10.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.191 0.996 . . . . 0.0 112.153 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.82 -42.5 18.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.842 0.457 . . . . 0.0 110.699 166.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.95 -46.58 71.03 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.747 -171.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.35 -58.09 4.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.779 1.172 . . . . 0.0 109.359 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.0 mmt -48.17 -66.79 0.34 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.801 0.441 . . . . 0.0 111.746 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -60.41 -58.94 6.35 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 121.129 -0.982 . . . . 0.0 112.263 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -41.44 -50.23 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.45 1.023 . . . . 0.0 109.353 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -65.65 -42.64 91.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.17 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.79 -62.8 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 119.067 0.849 . . . . 0.0 110.883 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -41.67 -40.74 2.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.934 0.894 . . . . 0.0 112.372 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -31.46 44.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.9 -39.63 78.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.371 0.668 . . . . 0.0 110.631 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.6 3.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.823 1.201 . . . . 0.0 111.307 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.06 112.08 42.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.478 1.111 . . . . 0.0 110.393 -169.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.47 128.05 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.795 1.663 . . . . 0.0 109.699 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.7 139.04 53.61 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.864 0.866 . . . . 0.0 111.687 -174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -111.7 76.83 1.0 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.514 0.726 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.76 103.15 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.8 1.64 . . . . 0.0 110.73 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.09 57.0 0.59 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 112.787 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -158.7 139.79 13.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.149 0.499 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -136.82 140.49 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.502 1.521 . . . . 0.0 107.729 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.22 129.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.57 142.82 43.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -128.69 116.76 20.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 ptp -113.42 131.71 55.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.524 0.729 . . . . 0.0 109.566 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -68.01 137.84 55.4 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 165.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 m -121.74 151.96 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -118.22 145.7 44.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.2 -41.45 2.41 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.813 0.721 . . . . 0.0 112.554 171.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -56.56 115.19 2.38 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.12 0.96 . . . . 0.0 110.498 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 m -148.33 39.35 0.9 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.248 1.019 . . . . 0.0 108.362 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -152.53 158.03 41.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -67.19 -19.21 65.53 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.456 0.473 . . . . 0.0 111.928 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.89 -58.1 9.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.34 -52.53 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.675 0.39 . . . . 0.0 110.879 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -54.83 -55.94 24.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -57.05 -45.14 83.42 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.467 0.707 . . . . 0.0 111.196 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -54.6 -50.48 67.95 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.277 -0.889 . . . . 0.0 110.915 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.43 -48.23 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -46.16 -53.59 10.17 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.013 1.325 . . . . 0.0 109.804 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.77 -59.34 9.93 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.102 0.858 . . . . 0.0 111.286 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -55.6 -61.22 2.49 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.601 0.7 . . . . 0.0 110.884 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.69 -47.46 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.752 0.821 . . . . 0.0 109.365 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.41 -40.92 39.68 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -73.68 -9.6 58.83 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.858 0.863 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mt -85.52 132.18 34.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.942 1.246 . . . . 0.0 110.198 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.33 134.95 55.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.62 -20.41 4.9 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.421 0.534 . . . . 0.0 112.466 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.3 141.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.876 1.271 . . . . 0.0 110.392 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -30.77 10.62 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 111.707 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -164.52 168.81 17.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -158.5 143.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -144.85 93.69 2.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 0.0 112.014 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.2 105.36 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.246 0.618 . . . . 0.0 111.188 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -96.68 125.39 41.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.218 1.007 . . . . 0.0 111.402 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -44.64 18.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.978 0.511 . . . . 0.0 110.25 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -61.58 2.06 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 126.142 1.777 . . . . 0.0 110.622 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -91.87 18.61 7.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.863 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.2 62.7 0.29 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.371 2.668 . . . . 0.0 112.234 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.91 124.33 18.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.64 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.38 112.84 25.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.31 1.444 . . . . 0.0 109.839 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -83.76 132.01 34.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.007 1.323 . . . . 0.0 107.753 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -131.07 124.98 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.6 109.02 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.448 0.567 . . . . 0.0 110.442 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -129.67 166.8 19.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -165.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -101.3 106.4 45.21 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 109.758 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.61 81.32 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.625 2.884 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 175.21 -42.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.493 2.317 . . . . 0.0 107.802 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.26 -56.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 167.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.171 1.389 . . . . 0.0 110.167 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -130.01 166.45 20.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.095 1.358 . . . . 0.0 110.091 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -46.85 -45.44 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.621 1.169 . . . . 0.0 111.536 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.71 -39.06 87.14 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 118.942 -0.551 . . . . 0.0 111.171 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.4 -46.95 88.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.6 mtt -51.78 -60.62 2.96 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 122.521 0.329 . . . . 0.0 111.7 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -55.51 33.05 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.064 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -45.56 -53.56 8.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 109.284 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -59.18 -49.02 79.44 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -71.99 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 110.793 -172.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.96 -37.1 13.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.89 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.44 64.75 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.782 1.174 . . . . 0.0 112.73 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.1 mmt -60.39 -43.72 96.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 110.189 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.93 -17.56 3.63 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.96 1.267 . . . . 0.0 110.953 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -72.26 115.55 40.03 Favored Pre-proline 0 N--CA 1.453 -0.318 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.112 -173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -69.2 139.48 42.28 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.527 -1.374 . . . . 0.0 108.527 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.23 138.2 41.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.778 0.431 . . . . 0.0 112.04 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -113.22 78.56 1.15 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.442 1.497 . . . . 0.0 109.512 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -50.71 112.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.597 1.159 . . . . 0.0 108.983 161.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.47 59.7 0.63 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 112.398 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.25 159.18 37.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.8 pm0 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -117.34 132.51 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 127.36 2.264 . . . . 0.0 106.374 162.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.41 130.11 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.56 143.39 46.8 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 170.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -123.73 117.83 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.9 ptp -123.19 131.76 53.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.283 1.033 . . . . 0.0 109.187 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -83.76 116.22 22.59 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.21 144.69 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -56.94 148.68 20.48 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.399 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.31 40.12 1.72 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.159 0.885 . . . . 0.0 113.527 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 45.4 -140.33 0.37 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 113.205 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -124.64 -41.27 2.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.178 1.391 . . . . 0.0 110.267 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.15 165.47 24.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -55.23 -26.08 37.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.536 0.734 . . . . 0.0 112.623 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.4 m -50.59 -44.21 56.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.756 -0.59 . . . . 0.0 110.465 171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -66.64 -55.22 16.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.317 0.647 . . . . 0.0 110.09 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.8 p -53.97 -54.38 39.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.4 t -57.41 -45.98 83.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.942 0.897 . . . . 0.0 110.942 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.6 m -57.09 -49.32 76.23 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.632 -0.668 . . . . 0.0 109.974 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.9 mt -56.07 -48.45 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 118.466 0.575 . . . . 0.0 109.756 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -55.83 -50.44 70.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.803 0.841 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -54.94 33.79 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.648 0.642 . . . . 0.0 112.083 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -53.67 -50.63 65.39 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.256 1.022 . . . . 0.0 110.241 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.29 -49.13 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 109.75 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.37 -36.15 10.71 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 117.989 0.358 . . . . 0.0 112.314 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -69.06 -15.43 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.29 145.01 35.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.693 1.133 . . . . 0.0 111.736 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.18 65.13 4.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.28 13.67 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -170.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.97 143.71 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 119.456 1.628 . . . . 0.0 110.41 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -108.33 -45.05 3.98 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.503 1.521 . . . . 0.0 109.817 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -163.19 171.12 16.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 tt -159.57 144.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -141.84 84.73 1.9 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.671 0.788 . . . . 0.0 110.742 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.19 105.72 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.573 0.749 . . . . 0.0 110.78 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 m -108.48 135.08 50.36 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.824 0.85 . . . . 0.0 111.031 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -48.05 6.52 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.915 0.486 . . . . 0.0 109.764 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -54.39 27.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.636 1.574 . . . . 0.0 110.25 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -79.23 -0.98 34.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.946 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 49.23 58.09 5.76 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.407 1.883 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.4 130.69 8.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.047 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -110.21 115.53 29.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.258 1.423 . . . . 0.0 108.996 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.4 m -90.14 133.85 34.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 107.309 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.66 129.93 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -117.92 106.6 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -127.16 165.22 19.98 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 122.062 -0.399 . . . . 0.0 111.564 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.65 123.05 62.9 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.36 145.67 92.88 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.609 1.539 . . . . 0.0 108.676 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 87.27 -23.02 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.693 1.597 . . . . 0.0 111.824 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.46 -47.36 8.4 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.719 1.145 . . . . 0.0 110.929 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -137.91 158.02 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.639 1.576 . . . . 0.0 108.448 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -114.24 169.92 8.68 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.854 0.862 . . . . 0.0 111.053 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.92 -41.1 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.481 0.712 . . . . 0.0 111.482 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.46 -53.21 51.86 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -171.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -37.3 -60.47 0.66 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.079 1.752 . . . . 0.0 111.486 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 15.4 mtm -48.77 -64.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -59.05 5.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.869 -173.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -36.12 -55.35 0.78 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.006 1.323 . . . . 0.0 111.11 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -60.85 -43.01 98.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.363 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -65.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -37.62 -46.26 0.84 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.177 0.991 . . . . 0.0 112.363 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.87 -32.04 60.4 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.6 mmt -60.32 -39.91 88.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.366 0.53 . . . . 0.0 110.643 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.66 -11.63 3.44 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.512 1.053 . . . . 0.0 111.281 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -90.14 110.47 40.6 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.039 0.936 . . . . 0.0 109.151 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.61 132.82 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.844 1.696 . . . . 0.0 109.301 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.28 49.08 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.003 0.921 . . . . 0.0 111.423 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -117.38 79.07 1.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.845 0.858 . . . . 0.0 109.438 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.62 108.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.025 1.73 . . . . 0.0 110.95 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -154.29 59.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.203 1.002 . . . . 0.0 113.239 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 159.86 34.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 120.803 -1.186 . . . . 0.0 108.166 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.1 tp . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 122.29 1.043 . . . . 0.0 109.377 -177.53 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.31 141.46 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 125.467 1.507 . . . . 0.0 107.889 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.42 122.62 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.0 mt -100.09 141.83 32.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -119.12 125.49 49.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -124.34 119.12 28.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.378 1.471 . . . . 0.0 108.955 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 120.76 22.95 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m -105.68 152.56 7.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -116.12 150.48 37.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.168 0.44 . . . . 0.0 110.786 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.97 -30.23 2.07 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.533 0.587 . . . . 0.0 114.079 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtp -68.93 85.38 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.016 0.908 . . . . 0.0 111.669 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -114.92 6.97 15.52 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.761 1.224 . . . . 0.0 112.232 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -129.12 139.74 51.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.317 0.962 . . . . 0.0 111.236 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -31.51 54.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.363 1.065 . . . . 0.0 111.962 -171.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -45.81 -55.1 7.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.329 1.052 . . . . 0.0 111.709 170.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.86 -54.6 28.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.315 0.507 . . . . 0.0 109.847 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -51.68 -54.96 22.42 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.637 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.6 t -57.85 -46.09 85.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.473 0.579 . . . . 0.0 111.346 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.8 m -56.81 -50.91 70.95 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.368 -0.833 . . . . 0.0 110.843 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.77 -43.9 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.97 -47.88 76.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.917 0.887 . . . . 0.0 110.658 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.88 41.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.825 0.726 . . . . 0.0 111.321 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -65.62 -59.91 3.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.433 0.635 . . . . 0.0 110.946 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.75 -30.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.009 0.924 . . . . 0.0 110.388 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.69 -29.31 7.71 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.498 -0.612 . . . . 0.0 112.764 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -92.43 7.9 41.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.494 1.147 . . . . 0.0 112.77 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.44 159.5 33.13 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.413 1.46 . . . . 0.0 111.656 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.36 82.97 2.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.471 1.508 . . . . 0.0 109.725 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.08 11.79 0.26 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.4 128.6 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 109.599 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -86.22 -36.63 19.32 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -154.23 168.24 27.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 122.201 1.0 . . . . 0.0 108.656 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -157.42 141.6 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -140.61 82.49 1.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 0.0 110.432 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.13 116.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.515 0.726 . . . . 0.0 109.111 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -97.33 -174.23 2.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.52 -47.8 0.17 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.23 1.012 . . . . 0.0 109.533 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.59 -55.83 7.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.514 1.525 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -94.04 19.19 9.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.56 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 36.52 61.48 0.82 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.35 2.26 . . . . 0.0 112.445 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.14 154.55 37.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.184 -0.947 . . . . 0.0 108.758 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.64 130.04 31.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.104 0.962 . . . . 0.0 109.877 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.8 m -92.85 132.75 36.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.743 1.617 . . . . 0.0 107.038 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.3 125.56 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 170.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.33 119.42 50.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.98 161.04 38.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -98.91 116.17 65.42 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.531 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.94 73.13 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.583 2.855 . . . . 0.0 110.546 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -174.73 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 109.744 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.27 -42.88 18.26 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.146 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.27 159.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -119.57 168.68 10.77 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.113 0.869 . . . . 0.0 112.139 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -44.03 -50.33 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.289 1.435 . . . . 0.0 111.209 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -42.68 86.92 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.71 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -48.6 -52.7 21.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.512 1.505 . . . . 0.0 108.663 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -61.64 2.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 121.38 -0.128 . . . . 0.0 111.236 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -58.24 9.14 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.569 -0.707 . . . . 0.0 112.266 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.43 -49.83 24.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.103 0.961 . . . . 0.0 109.458 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.28 -44.28 96.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.896 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.03 -63.87 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 123.166 0.587 . . . . 0.0 110.538 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -43.23 -41.41 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.468 0.707 . . . . 0.0 112.671 172.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.97 -31.26 50.12 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.044 0.838 . . . . 0.0 113.007 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.1 mmt -57.02 -41.65 78.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.372 0.533 . . . . 0.0 111.064 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 -20.79 2.53 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.531 1.062 . . . . 0.0 111.057 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -84.77 110.51 28.32 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 124.24 1.016 . . . . 0.0 110.068 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.82 139.21 61.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.78 134.58 26.82 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.6 72.14 1.54 Allowed 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.172 0.589 . . . . 0.0 110.371 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.55 94.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.012 1.325 . . . . 0.0 112.548 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -158.51 84.32 0.84 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.005 -0.434 . . . . 0.0 110.083 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.16 160.43 37.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 158.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 167.308 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 140.91 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.59 127.45 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.274 1.43 . . . . 0.0 107.473 171.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 pp -112.23 152.02 28.92 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -122.0 121.36 36.85 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.0 mtt -102.31 139.46 37.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -83.93 134.5 34.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 163.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.89 143.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 119.581 1.082 . . . . 0.0 108.819 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -114.58 140.87 48.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.82 -34.61 5.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.83 1.205 . . . . 0.0 112.922 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.0 mtm -69.19 95.33 0.75 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.059 0.93 . . . . 0.0 111.527 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -111.05 27.24 9.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.376 1.07 . . . . 0.0 112.886 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -151.04 159.74 44.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.282 0.947 . . . . 0.0 109.219 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -76.1 -12.66 60.15 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 m -62.76 -54.46 38.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.23 -51.68 65.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.771 0.26 . . . . 0.0 110.775 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p -52.69 -59.34 4.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 109.912 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -57.52 -44.3 84.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.938 0.895 . . . . 0.0 111.258 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.6 m -55.45 -48.69 74.1 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.364 -0.835 . . . . 0.0 110.751 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.34 -50.03 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 122.003 -0.435 . . . . 0.0 109.989 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -46.6 -49.56 18.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.511 1.124 . . . . 0.0 109.684 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -59.11 11.34 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.348 0.975 . . . . 0.0 112.398 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -55.23 37.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.725 0.763 . . . . 0.0 110.294 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.3 mm -70.83 -32.48 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.76 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.19 20.3 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.46 -0.775 . . . . 0.0 112.792 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -79.13 -3.6 46.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.312 1.056 . . . . 0.0 112.552 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.76 134.08 48.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.302 1.41 . . . . 0.0 111.265 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -77.26 115.71 17.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.29 -9.19 5.93 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.21 0.91 . . . . 0.0 111.904 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.45 150.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.28 0.632 . . . . 0.0 109.818 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -109.54 -40.4 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.647 1.579 . . . . 0.0 109.081 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -162.31 172.25 15.97 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.32 1.057 . . . . 0.0 108.741 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -156.46 143.23 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -142.61 146.76 34.86 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.659 1.583 . . . . 0.0 109.419 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -136.23 146.22 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.616 1.098 . . . . 0.0 109.793 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 m -124.68 148.46 47.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 127.494 2.318 . . . . 0.0 109.636 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.0 -56.91 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.87 1.668 . . . . 0.0 110.946 -171.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.03 -58.68 4.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.682 1.593 . . . . 0.0 110.484 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -85.15 0.29 52.19 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 41.23 70.99 0.22 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.737 2.815 . . . . 0.0 110.762 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -140.29 145.61 37.48 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.984 -163.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.75 113.15 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.628 1.571 . . . . 0.0 109.721 -168.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.7 m -89.2 118.7 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.505 2.722 . . . . 0.0 109.574 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -121.71 124.71 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.27 104.78 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -138.05 167.52 21.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 111.797 -167.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -101.79 107.82 53.53 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 123.931 0.892 . . . . 0.0 109.377 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.68 83.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.153 2.569 . . . . 0.0 110.51 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.3 m80 176.54 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 128.132 2.573 . . . . 0.0 107.765 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.65 -51.46 10.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.595 0.236 . . . . 0.0 110.756 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tp -134.34 177.13 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.471 1.509 . . . . 0.0 107.648 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.1 p -136.57 171.97 13.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.602 0.637 . . . . 0.0 110.609 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.2 t -48.33 -35.28 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.043 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -47.41 62.62 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.934 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.95 -51.34 70.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.693 1.197 . . . . 0.0 108.241 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.9 mmt -47.27 -59.81 2.93 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.23 -58.98 6.07 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.14 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 -50.91 9.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.424 1.09 . . . . 0.0 108.692 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -63.44 -45.63 90.01 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.166 0.291 . . . . 0.0 111.311 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.1 -66.62 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.149 0.58 . . . . 0.0 111.213 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -45.3 -38.79 5.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.941 0.791 . . . . 0.0 111.918 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.71 62.14 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.629 1.104 . . . . 0.0 113.123 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.5 mmt -54.93 -41.03 70.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.544 0.611 . . . . 0.0 110.546 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -18.86 3.28 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.52 1.057 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.14 113.58 34.73 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.998 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.37 136.78 44.71 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 N-CA-C 108.965 -1.206 . . . . 0.0 108.965 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 131.71 45.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.875 0.845 . . . . 0.0 112.088 -176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -103.81 77.51 1.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.836 2.054 . . . . 0.0 109.115 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.61 107.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.738 0.815 . . . . 0.0 110.634 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -155.58 55.46 0.62 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -157.35 157.32 33.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.861 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p -87.36 112.99 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.83 128.13 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.82 123.11 46.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -100.15 118.61 36.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -118.0 125.14 49.81 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.361 1.464 . . . . 0.0 108.654 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -70.83 138.08 50.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.1 m -129.74 139.2 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -101.26 150.31 23.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 -40.54 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.327 -0.707 . . . . 0.0 113.779 166.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.4 mtm -62.79 86.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.393 1.097 . . . . 0.0 110.934 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 m -148.19 47.75 1.06 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.732 1.613 . . . . 0.0 108.243 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 p -128.74 -4.66 5.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.093 1.757 . . . . 0.0 111.578 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 66.08 -25.69 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.431 1.493 . . . . 0.0 114.082 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -67.5 -75.15 0.1 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.075 -1.015 . . . . 0.0 111.181 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -44.02 -53.9 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.156 1.783 . . . . 0.0 112.254 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -50.54 -50.7 52.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.688 0.795 . . . . 0.0 111.025 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -65.74 -44.1 86.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.143 0.577 . . . . 0.0 110.494 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 m -50.87 -52.63 39.83 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.696 -0.628 . . . . 0.0 110.313 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -44.74 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 119.196 -0.431 . . . . 0.0 110.665 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.13 -49.05 75.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.327 0.512 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.64 -54.49 30.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.593 0.615 . . . . 0.0 111.806 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -60.72 -55.03 38.04 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.97 -0.724 . . . . 0.0 110.769 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.16 -43.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.143 1.377 . . . . 0.0 109.804 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.07 -29.78 6.9 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.773 0.701 . . . . 0.0 113.961 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -87.87 -12.95 43.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.802 1.301 . . . . 0.0 112.532 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.34 130.78 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.394 1.452 . . . . 0.0 111.866 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.66 90.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.587 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.24 -26.01 0.88 Allowed Glycine 0 C--N 1.331 0.296 0 O-C-N 121.996 -0.44 . . . . 0.0 112.617 -173.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.92 147.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 117.573 0.686 . . . . 0.0 110.249 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -125.19 -31.98 3.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.335 1.054 . . . . 0.0 111.688 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.41 163.43 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -158.85 140.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -144.42 85.31 1.78 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.006 0.922 . . . . 0.0 110.49 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.75 114.99 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -94.53 165.24 12.63 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -47.67 2.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.601 0.76 . . . . 0.0 109.945 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -55.95 13.3 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.178 1.391 . . . . 0.0 110.852 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -90.56 13.37 16.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.873 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 38.5 58.67 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.964 2.105 . . . . 0.0 112.685 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 30.9 tt0 -145.95 142.28 28.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.46 123.7 34.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.522 1.129 . . . . 0.0 110.193 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 m -94.89 127.68 41.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.152 1.381 . . . . 0.0 107.687 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.41 126.11 70.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.9 112.03 34.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.345 0.52 . . . . 0.0 110.659 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -132.56 168.99 17.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.423 0.63 . . . . 0.0 112.155 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -90.97 113.06 56.84 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 124.629 1.172 . . . . 0.0 109.203 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -74.71 76.89 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.821 2.347 . . . . 0.0 110.873 -170.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -176.01 -47.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.158 2.183 . . . . 0.0 108.305 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.15 -43.83 41.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.334 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.71 169.49 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 108.002 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -138.37 164.79 28.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 111.14 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -43.33 -47.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 124.34 1.056 . . . . 0.0 110.899 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -60.81 -49.48 77.32 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.745 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.23 -49.55 73.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.1 1.318 . . . . 0.0 109.415 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.2 -60.95 2.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.132 0.424 . . . . 0.0 111.421 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -57.08 -64.08 1.0 Allowed 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.758 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -40.26 -52.29 2.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.818 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.61 -39.03 88.16 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.89 -63.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 O-C-N 121.734 -0.604 . . . . 0.0 111.056 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -43.8 -39.26 3.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.56 0.744 . . . . 0.0 112.16 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.06 42.18 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.212 0.915 . . . . 0.0 113.164 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -61.7 -36.44 80.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.466 0.575 . . . . 0.0 111.107 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.26 -11.19 5.85 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.862 1.22 . . . . 0.0 111.263 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -84.65 114.76 57.21 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.274 1.029 . . . . 0.0 109.455 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -67.96 140.21 49.54 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.327 1.351 . . . . 0.0 108.598 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.66 140.12 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.696 0.399 . . . . 0.0 111.377 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -112.89 73.93 0.84 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.683 1.193 . . . . 0.0 110.185 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.98 103.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.329 1.852 . . . . 0.0 111.813 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -157.29 54.62 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -159.05 80.71 0.77 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.963 -1.085 . . . . 0.0 111.075 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 124.725 1.21 . . . . 0.0 109.409 -172.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.95 143.79 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.777 1.631 . . . . 0.0 107.722 163.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.14 143.91 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 124.551 1.14 . . . . 0.0 108.125 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.08 117.49 20.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -100.28 125.17 46.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mtt -121.05 119.93 33.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.202 1.001 . . . . 0.0 109.141 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.1 mptp? -73.4 121.96 21.31 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.23 149.66 13.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -114.76 148.01 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.86 -33.02 3.6 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.541 1.067 . . . . 0.0 113.048 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.7 mtp -69.09 75.69 0.33 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 112.91 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 m -142.26 58.2 1.46 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.588 1.155 . . . . 0.0 111.096 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.85 16.83 0.77 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.07 0.548 . . . . 0.0 111.832 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.7 m80 68.8 -35.39 0.3 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.928 1.691 . . . . 0.0 113.357 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -59.84 -51.76 68.36 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.399 1.479 . . . . 0.0 110.874 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -63.56 -60.3 3.51 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.114 0.566 . . . . 0.0 110.655 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -43.8 -58.14 2.89 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.399 1.08 . . . . 0.0 110.327 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -67.04 -43.46 82.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -55.34 -47.07 76.27 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.635 -0.666 . . . . 0.0 110.516 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.75 -48.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.74 -51.32 22.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.292 0.637 . . . . 0.0 109.835 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.24 -58.8 12.64 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.551 0.595 . . . . 0.0 112.334 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -61.28 -60.25 4.03 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.763 0.792 . . . . 0.0 109.741 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -66.37 -27.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.542 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -44.92 -37.35 5.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.59 0.614 . . . . 0.0 112.84 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -88.09 4.13 46.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.989 0.895 . . . . 0.0 112.719 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.28 153.09 43.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 120.292 -1.505 . . . . 0.0 110.374 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -87.07 141.11 28.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.77 11.5 55.02 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.017 0.817 . . . . 0.0 112.783 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -104.59 147.39 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.112 1.365 . . . . 0.0 109.541 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -109.73 -46.47 3.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.615 1.566 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.47 169.62 21.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.0 133.84 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -137.76 154.46 49.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.154 1.381 . . . . 0.0 108.456 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.23 110.32 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -82.01 75.78 8.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 0.0 108.659 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.48 -41.72 9.83 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.476 0.71 . . . . 0.0 110.606 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.42 -56.75 4.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.441 1.497 . . . . 0.0 111.378 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.92 13.71 25.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.008 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.22 60.74 3.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.74 2.016 . . . . 0.0 111.288 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 10.2 tt0 -143.92 132.5 22.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.486 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.16 135.14 40.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.87 1.668 . . . . 0.0 109.465 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.4 m -114.12 81.9 1.61 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.169 2.588 . . . . 0.0 107.684 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.08 127.82 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.26 107.63 20.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 110.416 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -134.57 173.46 11.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.656 -0.652 . . . . 0.0 111.925 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -106.76 106.98 59.5 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.629 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.32 76.28 1.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.202 3.268 . . . . 0.0 110.937 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.74 -43.21 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.627 1.971 . . . . 0.0 108.295 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.62 -42.34 18.35 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.21 169.39 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -120.24 155.54 33.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.461 1.104 . . . . 0.0 111.068 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 t -39.03 -49.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.469 1.108 . . . . 0.0 110.958 164.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -62.75 -46.75 86.6 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.788 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.11 -49.41 73.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.904 1.684 . . . . 0.0 108.53 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.26 -60.27 3.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -59.78 -56.94 15.55 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.82 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.73 -51.09 16.95 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.751 0.82 . . . . 0.0 108.947 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -60.52 -44.66 95.79 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.617 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.94 -65.15 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 122.979 0.512 . . . . 0.0 110.508 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -44.34 -40.21 5.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 118.929 0.786 . . . . 0.0 112.557 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.2 60.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.276 0.944 . . . . 0.0 113.336 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.6 mmt -52.04 -41.76 62.57 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.583 0.629 . . . . 0.0 110.513 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.38 -19.31 2.45 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.45 1.024 . . . . 0.0 111.085 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -83.73 117.52 68.89 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.052 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.84 137.32 52.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 108.721 -1.299 . . . . 0.0 108.721 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.28 47.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.733 0.813 . . . . 0.0 110.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.93 86.22 2.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.45 107.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.98 1.312 . . . . 0.0 109.825 165.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -159.02 56.87 0.42 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 143.23 14.79 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.262 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.43 130.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.134 1.374 . . . . 0.0 107.805 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.14 115.82 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 125.14 1.376 . . . . 0.0 109.274 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -90.51 138.39 31.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -113.85 126.08 54.79 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.7 ptm -132.24 128.24 37.46 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.922 0.889 . . . . 0.0 110.115 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.0 mptp? -78.13 131.15 37.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 148.08 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.431 1.014 . . . . 0.0 109.011 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -105.97 146.52 29.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -32.52 7.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.692 1.139 . . . . 0.0 113.227 169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.9 mtt -75.46 74.25 2.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.501 1.15 . . . . 0.0 112.442 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.2 m -106.44 39.94 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.789 1.236 . . . . 0.0 109.8 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.0 p -160.0 168.68 25.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.06 -8.06 57.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.104 0.561 . . . . 0.0 112.026 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -73.71 -64.6 0.96 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.734 0.697 . . . . 0.0 110.894 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 m -55.41 -55.27 33.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.419 0.628 . . . . 0.0 110.306 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -48.58 -56.0 9.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.818 1.247 . . . . 0.0 110.346 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.4 t -63.58 -45.19 91.55 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.982 0.513 . . . . 0.0 110.7 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -53.66 -49.47 67.87 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.815 -0.553 . . . . 0.0 110.419 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -62.78 -48.07 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 O-C-N 121.99 -0.444 . . . . 0.0 110.116 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.85 -47.64 64.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.18 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.35 25.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.489 1.042 . . . . 0.0 111.741 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -58.32 -57.29 13.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.776 0.798 . . . . 0.0 110.166 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.32 -30.38 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.13 0.972 . . . . 0.0 110.389 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.04 -31.92 8.67 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.62 0.629 . . . . 0.0 112.704 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -84.82 -1.85 56.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.192 0.996 . . . . 0.0 112.733 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.44 149.83 46.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 120.724 1.602 . . . . 0.0 110.346 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -87.29 127.86 35.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.04 14.81 9.65 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.331 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.94 137.96 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.615 1.166 . . . . 0.0 109.452 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 -31.52 10.16 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.106 0.562 . . . . 0.0 111.88 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.99 162.27 40.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 tt -155.9 138.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -140.78 136.18 32.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.437 1.095 . . . . 0.0 110.132 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.17 139.87 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.5 1.046 . . . . 0.0 110.289 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -128.5 127.38 42.33 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.134 1.774 . . . . 0.0 109.644 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.05 -47.1 12.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.933 0.893 . . . . 0.0 111.881 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.48 -58.51 6.87 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.994 1.317 . . . . 0.0 110.356 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.11 4.97 27.92 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.594 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 0.2 OUTLIER 36.22 67.34 0.31 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.317 2.647 . . . . 0.0 113.561 -177.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 3.0 tt0 -143.51 141.19 30.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.758 -170.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.33 148.57 43.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 109.752 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -128.14 118.92 24.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.964 3.306 . . . . 0.0 105.43 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -121.99 120.46 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.85 96.14 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 123.789 0.68 . . . . 0.0 109.227 -174.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -123.42 160.74 26.2 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.651 0.781 . . . . 0.0 111.724 -166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -99.92 116.24 64.85 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.505 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.92 75.56 2.18 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.663 2.909 . . . . 0.0 111.66 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -176.08 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 127.08 2.152 . . . . 0.0 108.238 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.94 -47.09 26.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.86 172.66 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.976 1.31 . . . . 0.0 108.191 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -138.44 158.61 43.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.608 1.163 . . . . 0.0 110.274 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -41.09 -47.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 111.02 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -40.88 94.4 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.818 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -50.74 72.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 61.9 mmm -54.02 -62.98 1.3 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.408 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -55.79 -56.07 24.85 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.342 -0.849 . . . . 0.0 111.817 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -52.81 -46.13 67.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -42.23 93.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.789 177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.01 -64.95 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 O-C-N 121.679 -0.638 . . . . 0.0 109.929 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -46.62 -37.76 8.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 119.003 0.82 . . . . 0.0 113.16 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.22 57.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.611 1.096 . . . . 0.0 113.004 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.0 mmt -53.52 -43.7 68.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.434 0.561 . . . . 0.0 110.577 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.82 -23.84 2.13 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.232 0.92 . . . . 0.0 111.289 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -75.39 113.38 25.41 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.033 -171.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.99 138.58 53.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.244 1.296 . . . . 0.0 109.081 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 140.41 43.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.299 0.571 . . . . 0.0 111.812 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -112.19 76.21 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.01 109.38 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.293 1.037 . . . . 0.0 108.227 168.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.58 53.66 0.67 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -155.53 162.87 40.6 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.551 1.54 . . . . 0.0 107.122 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 124.574 1.149 . . . . 0.0 108.02 -174.311 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.7 t -141.25 146.96 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.419 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.05 141.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.615 1.166 . . . . 0.0 108.28 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.16 120.73 27.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.61 127.25 54.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptp -119.36 124.57 46.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 127.312 2.245 . . . . 0.0 108.837 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -72.66 136.56 45.67 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 m -121.11 157.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.075 0.852 . . . . 0.0 110.48 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -116.71 153.73 31.85 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.853 0.461 . . . . 0.0 110.572 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 -38.91 2.25 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.125 0.869 . . . . 0.0 112.866 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -58.97 93.36 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.049 0.94 . . . . 0.0 110.739 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -141.84 47.45 1.64 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.832 1.253 . . . . 0.0 108.901 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.5 p -155.16 159.46 40.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 164.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -24.81 64.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 123.108 0.255 . . . . 0.0 111.46 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -57.43 -54.94 41.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.417 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.9 m -56.41 -57.16 13.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.117 0.417 . . . . 0.0 110.244 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -55.61 -53.77 52.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.936 0.495 . . . . 0.0 110.318 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 t -61.38 -41.03 96.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.521 0.728 . . . . 0.0 111.288 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 m -59.87 -48.11 83.02 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.109 -0.995 . . . . 0.0 110.445 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.0 mt -59.31 -52.25 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 123.849 0.859 . . . . 0.0 108.72 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.99 -46.08 71.63 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.598 0.759 . . . . 0.0 110.705 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.87 -49.28 72.14 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.24 0.924 . . . . 0.0 111.874 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -59.31 5.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.087 0.943 . . . . 0.0 110.759 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 mm -63.65 -30.38 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.78 1.232 . . . . 0.0 110.755 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.29 -31.66 4.79 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.738 0.685 . . . . 0.0 113.001 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -91.21 2.94 55.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.156 0.982 . . . . 0.0 112.453 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.64 133.11 46.38 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 120.549 1.522 . . . . 0.0 111.201 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -77.55 65.14 3.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 22.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 116.547 1.379 . . . . 0.0 116.547 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.4 154.41 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 117.77 0.785 . . . . 0.0 110.31 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -115.75 -42.21 3.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.616 1.567 . . . . 0.0 109.771 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.06 172.35 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.41 140.59 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -141.56 86.2 1.99 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.0 0.92 . . . . 0.0 112.38 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -89.71 112.63 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.528 -0.733 . . . . 0.0 109.944 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -91.55 176.02 6.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.933 0.893 . . . . 0.0 109.456 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 -47.25 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.247 1.019 . . . . 0.0 110.292 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.43 -59.27 3.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.895 1.678 . . . . 0.0 110.442 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -88.6 9.5 23.82 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.82 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.58 64.93 1.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.532 1.933 . . . . 0.0 111.034 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.73 152.21 39.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.763 0.825 . . . . 0.0 109.044 -165.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.77 123.65 15.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.387 0.613 . . . . 0.0 110.427 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.46 132.5 43.85 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.274 1.83 . . . . 0.0 107.847 171.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mm -129.62 127.49 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.65 118.4 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -141.04 174.81 10.16 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -165.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -109.17 109.02 60.69 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.875 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.48 77.62 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.833 3.022 . . . . 0.0 110.92 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -178.17 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.299 2.64 . . . . 0.0 107.74 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.4 mt -77.98 -46.6 20.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.688 0.222 . . . . 0.0 111.348 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.44 161.45 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -125.61 162.56 24.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.019 0.928 . . . . 0.0 111.181 -171.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 t -50.03 -43.96 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.232 1.013 . . . . 0.0 111.286 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.452 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 2.3 tm-20 -65.47 -37.7 87.62 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.139 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.54 -58.42 8.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.368 1.44 . . . . 0.0 108.387 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.9 mtt -43.55 -60.13 1.88 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER -64.16 -53.61 46.74 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.132 -175.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.452 ' HZ1' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -42.0 -55.68 3.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.434 1.47 . . . . 0.0 109.576 172.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -59.86 -47.73 84.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.923 0.392 . . . . 0.0 111.243 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.07 -63.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.452 0.701 . . . . 0.0 111.086 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -45.29 -39.24 6.36 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.879 0.763 . . . . 0.0 111.915 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.75 56.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.529 1.059 . . . . 0.0 112.84 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.4 mmt -57.56 -44.38 85.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.321 0.51 . . . . 0.0 110.812 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.44 -16.67 4.07 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.842 1.21 . . . . 0.0 111.023 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -77.42 115.83 52.73 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.547 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.47 144.67 80.38 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.39 132.47 24.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.896 0.855 . . . . 0.0 110.943 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.02 69.94 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.944 2.498 . . . . 0.0 108.851 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -62.01 107.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.831 0.852 . . . . 0.0 110.118 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -156.8 54.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.34 67.44 0.46 Allowed 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.235 -0.915 . . . . 0.0 111.092 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.236 0.614 . . . . 0.0 109.439 179.405 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.03 130.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.717 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.0 124.74 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 108.112 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -115.83 127.87 55.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -113.18 126.21 55.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.8 mtt -113.54 125.9 54.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.278 1.831 . . . . 0.0 107.895 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 126.14 30.21 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.57 154.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -120.09 153.47 36.08 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.373 0.669 . . . . 0.0 109.723 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.67 47.83 65.79 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.703 168.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.9 mtm -143.46 109.64 5.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.12 26.36 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.164 1.386 . . . . 0.0 110.859 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -112.66 -4.97 14.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.535 1.534 . . . . 0.0 112.101 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 72.71 -46.99 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.52 1.528 . . . . 0.0 111.625 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -49.61 -55.64 12.86 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.617 0.767 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.83 -54.53 40.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.637 0.653 . . . . 0.0 111.374 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -53.34 -54.6 34.18 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.661 0.384 . . . . 0.0 110.084 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.64 -44.18 93.59 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.083 0.553 . . . . 0.0 111.222 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.6 m -59.81 -46.58 88.8 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.446 -0.784 . . . . 0.0 110.197 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.86 -50.78 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.03 -49.98 59.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.325 0.65 . . . . 0.0 110.832 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.6 -53.64 40.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.685 0.659 . . . . 0.0 111.693 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -64.67 -56.39 14.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.624 0.726 . . . . 0.0 110.288 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -68.86 -34.69 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.704 0.802 . . . . 0.0 110.339 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.45 -27.88 26.83 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.83 -0.544 . . . . 0.0 112.6 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -90.38 3.45 53.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.117 0.959 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.84 142.76 49.6 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.223 1.374 . . . . 0.0 110.211 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.2 133.5 37.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.92 -8.37 36.38 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 123.594 0.616 . . . . 0.0 112.146 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.18 149.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.578 0.751 . . . . 0.0 109.596 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -108.16 -48.24 3.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.623 1.569 . . . . 0.0 109.467 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -157.66 169.53 24.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.6 137.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -140.81 92.46 2.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.783 0.833 . . . . 0.0 111.64 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.6 t -97.1 105.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.649 -0.657 . . . . 0.0 110.037 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m -85.06 161.76 19.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.15 0.98 . . . . 0.0 110.16 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.69 -48.16 2.59 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.015 0.526 . . . . 0.0 111.211 172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.83 -57.68 5.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.507 1.523 . . . . 0.0 110.51 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 22.56 6.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.466 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.286 0.0 OUTLIER 28.15 70.72 0.06 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.143 2.977 . . . . 0.0 113.815 -174.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -138.16 142.34 40.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.204 1.402 . . . . 0.0 108.856 -168.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.06 111.8 15.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.52 1.128 . . . . 0.0 108.99 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -85.62 125.85 33.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mm -124.86 127.62 72.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.19 113.59 43.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -129.94 172.26 11.89 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.09 111.33 62.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 124.69 1.196 . . . . 0.0 108.581 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.82 73.83 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.419 2.746 . . . . 0.0 110.517 -173.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -46.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.74 2.016 . . . . 0.0 109.241 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.27 -44.69 21.21 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 122.602 -0.061 . . . . 0.0 111.136 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -136.09 172.12 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.1 p -133.99 159.28 41.24 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.392 1.077 . . . . 0.0 110.511 -172.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 t -41.93 -48.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 124.671 1.188 . . . . 0.0 111.611 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.05 -44.23 96.44 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.341 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.53 -53.19 55.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.769 1.168 . . . . 0.0 108.803 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 12.5 mtm -51.3 -60.3 3.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.23 0.468 . . . . 0.0 112.204 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.36 -55.29 36.92 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.391 -0.818 . . . . 0.0 111.939 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -45.93 -51.47 13.21 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.917 1.287 . . . . 0.0 109.158 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -60.35 -46.52 89.64 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.663 0.21 . . . . 0.0 111.306 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.35 -66.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.757 0.823 . . . . 0.0 110.491 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -46.56 -37.94 8.74 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.594 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.25 61.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.575 1.079 . . . . 0.0 112.692 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.7 -45.53 85.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.426 0.557 . . . . 0.0 110.523 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.94 -20.42 2.51 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.349 0.976 . . . . 0.0 111.209 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.21 113.75 33.85 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 118.223 -0.894 . . . . 0.0 109.803 -172.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 137.15 41.37 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.26 1.307 . . . . 0.0 108.714 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.91 132.87 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.264 0.554 . . . . 0.0 111.156 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.41 75.04 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.923 1.289 . . . . 0.0 108.718 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.22 103.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.952 1.301 . . . . 0.0 110.796 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -157.13 58.51 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -155.82 136.69 13.54 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.928 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.26 124.51 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -169.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.88 126.0 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.22 116.53 32.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -98.41 110.12 22.77 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -108.84 123.37 48.95 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.977 0.911 . . . . 0.0 108.748 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.33 151.12 46.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 167.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.1 157.06 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.0 145.94 47.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.87 -30.62 8.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.379 0.99 . . . . 0.0 112.956 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.0 94.14 0.47 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.086 0.943 . . . . 0.0 110.399 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.8 m -128.67 44.5 2.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.976 0.91 . . . . 0.0 109.011 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.41 155.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 107.865 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -72.92 -21.97 60.81 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -53.42 -61.02 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.149 0.979 . . . . 0.0 111.708 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.5 m -59.75 -51.57 69.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.649 0.738 . . . . 0.0 109.966 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -53.72 -56.35 18.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.971 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 t -56.11 -46.35 79.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.931 0.892 . . . . 0.0 111.824 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 m -54.73 -50.66 67.82 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.24 -46.44 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.07 -45.76 71.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.474 0.71 . . . . 0.0 111.191 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.18 -56.7 22.86 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.804 0.716 . . . . 0.0 111.673 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.97 -57.34 13.27 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.094 -0.651 . . . . 0.0 111.146 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.45 -43.5 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.068 0.947 . . . . 0.0 110.468 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.94 -33.7 21.48 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 117.985 0.357 . . . . 0.0 112.403 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.85 -4.13 59.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.281 1.032 . . . . 0.0 112.74 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.99 137.51 34.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 120.201 1.364 . . . . 0.0 111.104 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -71.76 123.2 22.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.297 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.23 -2.39 9.7 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.11 0.862 . . . . 0.0 112.592 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.52 159.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.457 0.703 . . . . 0.0 110.796 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -117.58 -47.6 2.62 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -165.26 168.66 16.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 tt -156.78 143.12 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -142.06 98.3 3.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.875 1.67 . . . . 0.0 111.586 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.72 126.76 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.169 0.587 . . . . 0.0 111.534 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -117.04 140.14 49.85 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.676 1.19 . . . . 0.0 110.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 -45.53 9.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.037 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.16 -62.35 1.69 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.687 1.595 . . . . 0.0 110.439 -171.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.78 14.75 11.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.426 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.4 58.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.743 2.817 . . . . 0.0 113.746 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 28.4 tt0 -132.1 138.26 48.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.081 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.51 119.17 32.18 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.824 1.65 . . . . 0.0 109.233 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 m -96.28 112.88 24.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.551 1.54 . . . . 0.0 108.712 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.23 119.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.43 117.79 54.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.54 165.42 27.53 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -94.32 111.65 54.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 126.949 2.099 . . . . 0.0 110.947 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.73 73.84 3.46 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.183 2.588 . . . . 0.0 111.995 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -173.98 -46.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.144 2.178 . . . . 0.0 108.525 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.26 -42.46 68.75 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -176.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -142.4 153.01 43.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.379 0.672 . . . . 0.0 109.948 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -38.1 -49.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 124.987 1.315 . . . . 0.0 111.028 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.37 -46.64 87.74 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.059 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -50.71 66.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.976 1.716 . . . . 0.0 108.056 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -53.14 -59.08 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.07 -0.394 . . . . 0.0 111.005 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . 0.506 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 2.4 ttmm -60.15 -55.71 30.49 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 120.888 -1.132 . . . . 0.0 112.88 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 -42.43 25.73 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.354 1.062 . . . . 0.0 109.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -66.45 -53.48 35.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.599 0.562 . . . . 0.0 111.944 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.43 -62.71 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.069 -1.019 . . . . 0.0 110.897 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.506 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 2.5 mt-10 -52.51 -26.17 12.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.04 62.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.961 1.255 . . . . 0.0 112.496 171.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.39 -35.74 72.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.118 0.567 . . . . 0.0 110.656 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.17 -22.18 5.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.683 1.135 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -70.03 116.26 42.34 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 117.283 -1.342 . . . . 0.0 110.276 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.52 151.18 86.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.356 1.371 . . . . 0.0 109.261 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.13 140.49 28.04 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.42 82.23 1.57 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.326 1.051 . . . . 0.0 110.132 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.14 104.66 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.583 1.553 . . . . 0.0 110.946 173.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -157.73 54.16 0.47 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -158.67 104.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.76 133.34 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 123.574 0.75 . . . . 0.0 109.218 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.1 116.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.304 1.442 . . . . 0.0 108.094 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -96.86 120.56 37.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.35 118.76 34.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -113.77 138.92 49.59 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.403 1.481 . . . . 0.0 108.746 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.43 155.47 40.09 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 155.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -138.13 142.64 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -97.75 151.5 20.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.88 -34.78 2.11 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.707 -0.621 . . . . 0.0 114.209 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.33 91.49 0.08 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.007 0.903 . . . . 0.0 111.746 -173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 m -146.38 61.22 1.23 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.421 1.488 . . . . 0.0 109.587 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.6 p -162.04 157.41 23.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 166.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -78.27 54.44 1.39 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.703 0.401 . . . . 0.0 110.103 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.89 -64.07 0.59 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -56.19 -56.67 18.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.052 0.387 . . . . 0.0 110.79 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -51.53 -55.36 19.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.006 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.87 -42.84 94.58 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.77 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.1 m -56.01 -52.01 65.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -48.27 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.229 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -55.63 -48.87 74.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.117 0.871 . . . . 0.0 110.582 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.47 -52.97 37.82 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.516 0.579 . . . . 0.0 111.665 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -65.95 -61.24 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.548 0.689 . . . . 0.0 110.655 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.69 -32.68 59.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 124.589 1.156 . . . . 0.0 110.422 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.89 -30.67 9.42 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.867 -0.521 . . . . 0.0 112.6 169.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -93.77 10.4 33.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.314 1.046 . . . . 0.0 112.217 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.03 151.87 44.14 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.243 1.383 . . . . 0.0 111.623 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -92.56 81.66 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.949 1.3 . . . . 0.0 110.614 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.93 -13.59 1.13 Allowed Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.914 -0.491 . . . . 0.0 113.899 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.65 151.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -119.08 -35.1 3.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.628 1.171 . . . . 0.0 111.137 173.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -155.42 169.19 24.82 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -156.98 139.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -139.85 90.66 2.41 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.422 1.489 . . . . 0.0 110.534 172.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.86 106.93 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 O-C-N 121.457 -0.777 . . . . 0.0 110.167 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -80.43 178.98 7.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.44 -47.37 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 109.534 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.05 -59.03 3.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.903 1.681 . . . . 0.0 110.541 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.14 12.58 17.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.319 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 43.77 62.72 1.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.659 1.984 . . . . 0.0 112.522 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -145.88 151.11 37.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.511 -0.743 . . . . 0.0 109.345 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.92 125.81 18.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 111.149 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -107.55 120.69 42.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.803 2.041 . . . . 0.0 107.964 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 116.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.82 109.13 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -135.14 170.33 16.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.479 0.657 . . . . 0.0 112.367 -166.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -97.8 110.68 56.45 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.132 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.51 67.06 7.23 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.139 2.56 . . . . 0.0 111.506 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.66 -47.07 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.809 1.244 . . . . 0.0 108.37 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.37 -48.23 73.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.633 0.197 . . . . 0.0 111.198 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tp -134.25 162.83 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.802 1.241 . . . . 0.0 108.196 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 p -121.87 158.64 28.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.747 1.219 . . . . 0.0 110.891 -172.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.73 -48.99 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.386 0 C-N-CA 124.1 0.96 . . . . 0.0 110.881 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.97 -54.13 50.46 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.766 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -45.03 -54.74 6.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.952 1.251 . . . . 0.0 109.365 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -63.11 1.26 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.501 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.39 -61.27 2.45 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -43.07 -51.45 5.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.718 1.207 . . . . 0.0 109.703 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.08 -43.33 95.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.083 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.01 -65.85 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.445 0.698 . . . . 0.0 110.278 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -43.79 -39.27 3.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.507 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.798 1.181 . . . . 0.0 112.958 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.6 mmt -55.37 -40.8 71.76 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.317 0.508 . . . . 0.0 110.841 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.08 -20.16 3.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.587 1.089 . . . . 0.0 110.954 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -75.57 115.7 48.18 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.255 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -66.55 138.48 50.05 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.31 -1.458 . . . . 0.0 108.31 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.47 138.39 38.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.045 0.538 . . . . 0.0 110.595 -175.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -107.05 71.39 0.83 Allowed 'General case' 0 C--N 1.334 -0.066 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.45 105.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 169.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -155.58 55.31 0.62 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 141.26 16.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 170.731 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.09 116.0 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.91 124.4 43.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.85 131.86 56.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.06 117.09 30.3 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.3 mtt -116.82 123.57 47.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.913 0.885 . . . . 0.0 110.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.87 129.47 37.95 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.93 151.36 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.032 0.833 . . . . 0.0 109.668 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 140.67 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.28 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.1 -16.06 45.24 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.266 0.936 . . . . 0.0 114.206 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.2 mtp -76.62 75.7 3.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.3 1.05 . . . . 0.0 110.866 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.4 34.42 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.464 1.505 . . . . 0.0 111.334 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 p -154.1 158.7 40.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.516 -0.74 . . . . 0.0 110.404 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -74.9 61.36 1.03 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.306 167.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -145.88 -63.38 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 167.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 m -52.96 -53.59 47.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.298 0.571 . . . . 0.0 109.952 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.4 p -53.04 -70.16 0.1 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.725 1.21 . . . . 0.0 110.742 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 t -51.3 -45.52 62.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.679 1.592 . . . . 0.0 111.506 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -60.26 -44.93 94.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.889 -0.507 . . . . 0.0 109.944 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -49.22 85.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 118.617 0.644 . . . . 0.0 110.189 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -48.58 -51.67 26.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.656 0.662 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.61 -58.33 15.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.87 0.748 . . . . 0.0 112.614 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -64.36 -52.44 58.3 Favored 'General case' 0 C--N 1.338 0.109 0 O-C-N 121.651 -0.911 . . . . 0.0 109.953 -170.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.02 -27.19 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.308 1.043 . . . . 0.0 109.751 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.72 -32.55 32.89 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.986 -1.071 . . . . 0.0 112.492 166.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -84.74 -1.36 56.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.97 154.12 42.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.435 1.471 . . . . 0.0 112.326 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.91 69.4 9.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.01 18.72 0.02 OUTLIER Glycine 0 N--CA 1.467 0.756 0 N-CA-C 115.373 0.909 . . . . 0.0 115.373 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.17 141.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.852 1.326 . . . . 0.0 108.664 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -111.85 -45.06 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.363 0.665 . . . . 0.0 109.94 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.21 166.99 25.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.71 131.86 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -139.24 129.79 25.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.572 1.149 . . . . 0.0 109.695 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.43 98.4 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 119.234 0.925 . . . . 0.0 110.011 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -72.7 74.03 1.09 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.224 1.41 . . . . 0.0 109.464 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -37.39 -49.22 0.99 Allowed 'General case' 0 C--O 1.227 -0.091 0 C-N-CA 126.351 1.86 . . . . 0.0 111.664 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.87 -55.94 8.67 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.103 1.361 . . . . 0.0 111.562 -174.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.65 -2.99 58.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.654 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.29 54.62 9.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.814 2.446 . . . . 0.0 110.443 -173.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.19 136.34 54.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 109.543 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.61 106.88 17.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.53 1.932 . . . . 0.0 109.742 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -81.45 87.26 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 129.007 2.923 . . . . 0.0 109.382 170.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.61 125.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.74 99.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.417 0 CA-C-N 119.659 1.118 . . . . 0.0 110.333 -173.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.24 159.97 22.42 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.98 131.04 55.2 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.44 163.6 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.18 1.253 . . . . 0.0 109.091 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 73.62 -42.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -48.93 55.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.609 1.095 . . . . 0.0 111.499 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.78 179.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.412 1.485 . . . . 0.0 108.338 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.0 p -148.8 164.16 35.24 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.527 0.603 . . . . 0.0 111.519 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.9 t -46.15 -45.48 5.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 123.768 0.827 . . . . 0.0 111.284 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -62.53 -42.64 99.65 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.488 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.84 -54.42 45.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.1 mmt -45.27 -65.08 0.58 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -56.64 -57.2 13.4 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.312 -0.868 . . . . 0.0 111.761 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -46.32 -47.44 18.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.956 0.798 . . . . 0.0 109.635 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.32 -42.63 87.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.15 -65.02 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 124.409 1.084 . . . . 0.0 110.044 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.36 -39.83 7.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.304 0.642 . . . . 0.0 111.833 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.5 -33.02 59.08 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.398 0.999 . . . . 0.0 113.344 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmt -58.03 -41.73 83.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.6 0.636 . . . . 0.0 110.506 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.87 -16.68 3.48 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.62 1.105 . . . . 0.0 111.06 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.05 117.01 66.79 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.542 -173.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.68 151.56 85.21 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 N-CA-C 108.901 -1.231 . . . . 0.0 108.901 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.04 139.11 28.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.944 0.498 . . . . 0.0 110.517 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.43 75.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.885 0.874 . . . . 0.0 108.758 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.03 105.54 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.081 0.952 . . . . 0.0 110.756 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -155.74 56.71 0.61 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.44 144.35 20.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 174.895 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.1 128.27 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 124.252 1.021 . . . . 0.0 108.755 174.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.14 110.94 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.099 1.76 . . . . 0.0 109.816 -178.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.91 117.97 29.93 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -84.42 126.87 33.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 28.4 mtp -128.51 128.05 43.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.9 25.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.283 0.947 . . . . 0.0 108.553 172.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -90.97 165.44 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -121.07 152.24 38.88 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.18 -33.04 2.24 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.57 -0.706 . . . . 0.0 114.143 165.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.1 mtp -65.14 82.74 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.935 0.867 . . . . 0.0 112.024 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -114.34 48.89 1.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.062 1.345 . . . . 0.0 110.482 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -159.4 163.97 35.02 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.571 -0.706 . . . . 0.0 110.834 169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.91 -35.41 80.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.979 174.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -58.33 -58.04 10.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.576 0.625 . . . . 0.0 111.487 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.2 m -57.76 -57.66 11.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -51.85 -57.1 10.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 110.196 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -59.53 -44.48 93.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.823 0.849 . . . . 0.0 111.302 179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.9 m -57.26 -48.45 78.85 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.435 -0.791 . . . . 0.0 110.243 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.46 -48.86 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 123.031 0.532 . . . . 0.0 109.578 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.69 -49.73 56.66 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.251 0.62 . . . . 0.0 110.36 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.15 -55.41 28.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.96 0.791 . . . . 0.0 111.532 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -64.0 -55.02 25.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.016 -0.696 . . . . 0.0 110.963 -173.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -67.39 -33.76 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 123.61 0.764 . . . . 0.0 110.13 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.44 -35.63 7.25 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.361 0.505 . . . . 0.0 112.399 171.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -83.48 4.27 28.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.76 139.72 47.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.735 1.607 . . . . 0.0 112.06 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.93 81.83 5.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.726 0.81 . . . . 0.0 111.612 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.19 -8.54 0.79 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.07 152.15 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 117.726 0.763 . . . . 0.0 110.244 175.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -113.58 -37.22 4.67 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.246 1.419 . . . . 0.0 110.333 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -160.57 159.16 30.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 tt -152.8 137.25 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -175.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -143.13 150.83 39.98 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.569 1.148 . . . . 0.0 109.754 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.65 128.96 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.613 0.642 . . . . 0.0 109.419 171.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -110.69 79.8 1.24 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.739 1.615 . . . . 0.0 108.271 -177.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -41.7 66.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.044 0.537 . . . . 0.0 110.575 -175.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.7 -54.72 5.94 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 111.054 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.76 16.62 21.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.029 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 35.66 53.82 0.84 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.354 2.662 . . . . 0.0 113.12 -169.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.72 149.27 37.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.586 1.154 . . . . 0.0 109.704 -177.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.4 134.77 49.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.294 1.438 . . . . 0.0 108.823 171.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.8 m -117.34 109.77 17.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.668 2.787 . . . . 0.0 107.011 -173.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mm -119.32 102.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -176.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.02 107.96 21.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -174.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.9 167.3 17.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -100.25 112.17 63.73 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.554 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 69.47 5.84 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.924 3.083 . . . . 0.0 111.533 -170.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.86 -40.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.854 2.462 . . . . 0.0 108.158 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 -45.46 13.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -140.46 158.2 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 107.573 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -106.28 161.97 14.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 112.479 -173.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.17 -39.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 163.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -47.86 81.62 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.15 -178.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.41 -55.14 17.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.022 1.283 . . . . 0.0 109.762 173.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 17.5 mmt -48.5 -63.47 1.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -57.95 -57.86 10.96 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 121.259 -0.9 . . . . 0.0 112.329 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -46.76 -50.76 17.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.225 1.01 . . . . 0.0 108.31 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -57.92 -48.12 80.85 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.987 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.81 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 118.562 -0.733 . . . . 0.0 111.467 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.87 -35.78 6.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.003 1.274 . . . . 0.0 112.381 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.2 -31.61 61.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.736 1.153 . . . . 0.0 113.155 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.6 mmt -55.05 -41.52 71.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.396 0.544 . . . . 0.0 110.585 172.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.47 -18.95 3.85 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.886 1.232 . . . . 0.0 110.95 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -75.53 117.92 67.01 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.979 -173.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.32 140.21 57.58 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.495 -1.386 . . . . 0.0 108.495 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.9 27.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.813 0.816 . . . . 0.0 112.469 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.84 75.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.331 1.052 . . . . 0.0 108.553 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -42.69 104.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 125.029 1.456 . . . . 0.0 109.261 158.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -93.67 -179.51 5.04 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 168.08 20.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.882 170.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.3 pt . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 123.681 0.792 . . . . 0.0 110.106 178.358 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.61 123.83 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 109.865 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 p -80.82 105.9 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.808 1.643 . . . . 0.0 109.82 -178.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 109.09 20.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -87.1 113.16 22.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.18 125.18 47.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.4 mptp? -81.02 125.41 30.13 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.78 148.04 11.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -109.9 155.0 22.28 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.37 -46.67 3.59 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.765 -0.584 . . . . 0.0 112.587 169.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.5 mtp -55.26 96.25 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.914 1.286 . . . . 0.0 110.96 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 p -136.6 31.79 2.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 111.776 -174.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.16 149.62 26.21 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.668 -0.645 . . . . 0.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -72.33 60.26 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.435 1.494 . . . . 0.0 110.722 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.4 m -142.45 -59.96 0.45 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.3 m -58.83 -60.94 3.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 110.025 -177.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -53.5 -49.06 68.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.935 -179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.2 t -66.75 -41.12 88.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 111.104 -175.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 m -59.28 -47.85 83.82 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 176.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -52.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.738 175.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.88 -49.06 63.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.228 0.922 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.85 -47.06 91.29 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.865 0.745 . . . . 0.0 112.054 176.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -60.59 2.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.245 1.023 . . . . 0.0 110.178 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.93 -33.79 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.654 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.0 -30.59 9.58 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.812 0.72 . . . . 0.0 112.99 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -91.33 6.81 43.84 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.279 1.04 . . . . 0.0 112.359 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.33 151.81 34.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.522 -1.361 . . . . 0.0 112.746 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.62 82.57 4.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 0.0 111.493 -174.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.61 -10.31 1.68 Allowed Glycine 0 N--CA 1.462 0.368 0 O-C-N 121.947 -0.47 . . . . 0.0 113.722 -175.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.4 t -78.99 142.43 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -102.58 -42.75 5.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.011 1.324 . . . . 0.0 109.524 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 ttm-85 -155.79 165.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.88 135.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -137.88 88.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.189 1.396 . . . . 0.0 111.051 168.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.91 115.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -87.46 -163.16 0.89 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.33 -48.79 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.33 1.052 . . . . 0.0 109.451 173.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -59.07 4.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 110.339 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.82 11.54 15.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.471 -177.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 39.65 61.82 1.33 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.121 1.768 . . . . 0.0 112.788 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 26.5 tt0 -139.78 153.03 47.04 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 126.23 38.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.728 1.211 . . . . 0.0 109.061 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.0 m -101.33 117.8 35.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.794 1.637 . . . . 0.0 106.983 174.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -119.72 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.34 102.94 14.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -124.33 173.02 8.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -104.27 111.41 65.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 123.941 0.896 . . . . 0.0 109.92 -177.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.2 76.76 2.97 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.709 2.939 . . . . 0.0 110.321 -172.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.54 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.395 1.878 . . . . 0.0 108.369 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.8 -44.12 15.91 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.975 -177.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.2 154.17 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.888 1.275 . . . . 0.0 108.47 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -108.59 162.96 13.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.36 1.064 . . . . 0.0 112.244 -173.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -48.22 -45.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.481 0.712 . . . . 0.0 110.373 165.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -44.02 92.51 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.878 -175.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -54.59 26.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.529 1.513 . . . . 0.0 109.807 171.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.9 mmt -48.13 -62.53 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.918 0.781 . . . . 0.0 111.868 175.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -62.07 -57.61 10.95 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -176.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -47.43 -48.13 26.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 109.25 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -59.39 -48.23 82.45 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.71 174.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.13 -65.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.726 -176.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.98 -30.22 24.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.423 1.01 . . . . 0.0 112.573 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.05 62.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 120.014 1.279 . . . . 0.0 112.845 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.3 mmt -58.44 -40.73 83.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.541 0.609 . . . . 0.0 110.578 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.01 -21.62 3.32 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.537 1.065 . . . . 0.0 110.914 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -73.09 116.76 53.93 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-O 118.345 -0.835 . . . . 0.0 110.14 -173.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.02 141.89 59.74 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.463 1.442 . . . . 0.0 108.679 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.55 134.98 32.93 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -98.29 74.71 2.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.472 1.109 . . . . 0.0 108.309 175.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -36.03 106.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.297 1.623 . . . . 0.0 108.775 154.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 179.93 4.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 168.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -78.91 166.42 22.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.267 176.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 177.754 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.77 0.319 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.29 142.29 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 126.15 1.78 . . . . 0.0 108.195 172.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.27 132.58 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.024 1.73 . . . . 0.0 107.915 175.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.61 129.56 56.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 169.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -117.96 127.2 53.6 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.444 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 12.5 ptm -139.43 129.3 24.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.117 0.567 . . . . 0.0 109.865 -173.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.06 133.88 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.3 m -118.86 150.53 21.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -116.15 151.23 36.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.145 0.498 . . . . 0.0 110.761 177.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.03 -34.3 3.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.094 0.854 . . . . 0.0 112.816 173.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -66.53 94.65 0.29 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.633 0.717 . . . . 0.0 111.6 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 p -126.2 53.28 1.63 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.107 0.963 . . . . 0.0 111.465 -178.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.12 167.51 30.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.697 0.799 . . . . 0.0 109.044 -175.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -84.28 -6.02 59.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.667 0.387 . . . . 0.0 111.486 169.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.1 -74.75 0.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -172.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -51.39 -45.24 62.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.097 1.359 . . . . 0.0 111.589 -177.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -49.38 -63.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.485 1.514 . . . . 0.0 110.511 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -55.33 -45.37 76.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.906 0.882 . . . . 0.0 111.123 177.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -55.3 -47.94 74.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.244 -0.91 . . . . 0.0 110.994 177.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.23 -50.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.139 0.976 . . . . 0.0 109.201 177.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -45.39 -53.05 9.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.566 1.146 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.31 -58.32 15.03 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.793 0.711 . . . . 0.0 112.672 174.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -56.94 -48.19 78.88 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 121.936 -0.744 . . . . 0.0 110.846 -171.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.73 -42.04 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.283 0.633 . . . . 0.0 109.441 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.68 -35.41 23.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.248 0.451 . . . . 0.0 112.412 172.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -63.28 -18.0 63.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.97 142.5 29.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.207 0.912 . . . . 0.0 112.544 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.89 101.43 4.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.364 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.97 -21.54 1.43 Allowed Glycine 0 C--N 1.335 0.511 0 O-C-N 121.554 -0.716 . . . . 0.0 113.274 176.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.96 132.77 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -102.59 -29.55 11.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.995 0.361 . . . . 0.0 111.403 175.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -154.08 164.63 38.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 tt -157.92 144.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 103.914 -2.624 . . . . 0.0 103.914 -176.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -144.13 132.41 21.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.893 0.877 . . . . 0.0 111.254 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -125.76 136.55 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.935 1.243 . . . . 0.0 111.701 175.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -122.12 124.36 43.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.204 1.801 . . . . 0.0 110.147 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -51.23 9.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.65 0.78 . . . . 0.0 110.723 -177.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -53.03 45.8 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.557 1.143 . . . . 0.0 110.557 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.61 4.11 37.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.48 -177.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 38.86 61.56 1.21 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.273 2.629 . . . . 0.0 111.371 -174.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -141.85 138.14 31.92 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.734 -0.604 . . . . 0.0 110.903 -173.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.98 30.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.556 1.542 . . . . 0.0 110.003 172.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.6 m -121.71 125.51 46.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.706 3.602 . . . . 0.0 104.928 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.44 119.71 54.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.81 96.68 4.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -172.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.64 168.47 12.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.709 0.766 . . . . 0.0 111.989 -170.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -97.02 115.29 65.68 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.048 1.339 . . . . 0.0 108.514 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.9 72.3 3.94 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.879 2.386 . . . . 0.0 111.909 -174.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -46.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.304 1.442 . . . . 0.0 108.295 172.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.32 -48.92 66.17 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 119.643 -0.218 . . . . 0.0 111.36 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 177.81 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.825 1.25 . . . . 0.0 109.334 -174.205 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.1 p -141.51 160.12 40.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.347 1.059 . . . . 0.0 111.244 -174.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.22 -49.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.705 1.202 . . . . 0.0 111.771 171.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -58.53 -52.09 67.13 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 118.255 -0.878 . . . . 0.0 108.937 -171.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -46.47 -53.13 11.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.939 1.696 . . . . 0.0 109.799 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.2 mmt -51.17 -58.32 6.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.951 -0.468 . . . . 0.0 111.823 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -59.4 -60.32 4.04 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.082 -1.011 . . . . 0.0 112.455 177.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.97 -40.5 4.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 109.252 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -52.9 15.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 170.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -62.9 -60.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 120.095 1.316 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.91 -36.52 5.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.893 0.77 . . . . 0.0 112.081 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.92 65.85 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.249 0.931 . . . . 0.0 113.368 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -55.51 -38.95 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.965 0.348 . . . . 0.0 110.331 173.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.26 -16.06 4.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.822 1.201 . . . . 0.0 110.805 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -75.55 114.35 35.28 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.492 -174.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.01 141.75 65.48 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 108.266 -1.475 . . . . 0.0 108.266 176.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.28 35.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.44 80.1 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 7' ' ' MET . 0.7 OUTLIER -65.18 107.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.061 1.744 . . . . 0.0 109.694 168.011 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -157.09 59.7 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.12 153.02 30.19 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 163.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.436 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.73 131.36 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 109.01 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.82 120.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 125.277 1.431 . . . . 0.0 110.119 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.73 125.39 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -108.13 115.62 30.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -175.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.0 mtt -115.16 119.28 35.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.45 1.1 . . . . 0.0 108.458 -174.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -72.03 126.52 29.98 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.63 150.45 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.07 153.05 28.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.651 0.594 . . . . 0.0 109.795 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.46 3.43 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.631 -0.539 . . . . 0.0 112.401 172.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.5 mtm -55.06 96.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.703 0.752 . . . . 0.0 111.665 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 p -132.03 18.35 4.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 110.978 -177.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -137.87 163.07 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -72.61 -17.2 61.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.461 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -60.24 3.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.3 0.5 . . . . 0.0 109.779 -177.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.5 m -57.86 -55.02 40.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -57.97 -50.03 74.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.215 -174.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -57.85 -46.15 85.22 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.911 0.778 . . . . 0.0 110.988 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.5 m -54.37 -51.28 65.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.638 0.654 . . . . 0.0 110.336 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.08 -47.61 80.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.251 0.932 . . . . 0.0 110.319 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.49 -55.4 27.16 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 172.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -66.85 -57.47 6.93 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 117.595 0.697 . . . . 0.0 111.281 -173.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.0 -34.58 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 110.079 -177.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.97 -28.34 7.39 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.674 -0.641 . . . . 0.0 112.891 169.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -102.39 18.58 20.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.776 1.23 . . . . 0.0 111.831 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.23 163.17 27.02 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.573 -1.329 . . . . 0.0 111.208 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -100.35 84.83 2.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.004 1.322 . . . . 0.0 110.273 -175.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.07 1.17 3.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.321 0.486 . . . . 0.0 113.725 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.13 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 117.641 0.721 . . . . 0.0 109.975 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -124.55 -41.81 2.13 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.131 1.372 . . . . 0.0 111.001 -176.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -156.93 171.3 20.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -157.14 138.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.051 -2.204 . . . . 0.0 105.051 -174.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -137.47 81.12 1.85 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.192 1.797 . . . . 0.0 110.488 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.06 122.52 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 O-C-N 120.729 -1.232 . . . . 0.0 109.302 -177.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -103.08 168.05 9.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.97 -45.53 2.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.792 0.837 . . . . 0.0 109.786 174.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.06 -57.03 5.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 110.943 -174.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.14 19.7 10.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.456 -175.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 36.44 62.28 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.6 2.36 . . . . 0.0 112.332 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.134 -0.979 . . . . 0.0 108.983 -174.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.04 119.86 34.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.936 1.694 . . . . 0.0 108.581 -175.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.1 m -96.82 125.99 41.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.53 128.91 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.13 117.71 55.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.166 0.986 . . . . 0.0 109.476 -174.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -139.9 175.36 9.65 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -104.81 107.21 57.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.106 1.362 . . . . 0.0 110.392 -177.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.13 77.7 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.378 2.719 . . . . 0.0 110.26 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.53 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 127.084 2.154 . . . . 0.0 108.04 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.02 -45.6 56.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.942 0.401 . . . . 0.0 110.548 -178.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.95 168.61 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -135.57 157.78 46.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.145 0.978 . . . . 0.0 110.18 -171.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -37.71 -47.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.83 1.652 . . . . 0.0 111.497 173.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -50.69 73.07 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.776 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -52.72 -48.7 66.46 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 120.916 1.689 . . . . 0.0 109.406 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mtp -49.97 -62.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -57.74 11.48 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 121.355 -0.841 . . . . 0.0 112.093 -178.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -41.18 -52.75 3.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.614 1.566 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -60.19 -47.69 84.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.445 0.566 . . . . 0.0 111.824 176.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.89 -66.03 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.83 -0.543 . . . . 0.0 111.067 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.34 -37.71 7.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.079 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.44 63.24 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.901 1.228 . . . . 0.0 112.694 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.1 mmt -58.83 -43.61 90.73 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.412 0.551 . . . . 0.0 110.438 174.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.15 3.76 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.541 1.067 . . . . 0.0 111.207 178.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -81.39 118.85 73.95 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.243 -173.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -66.81 137.48 45.48 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 N-CA-C 108.443 -1.406 . . . . 0.0 108.443 174.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.08 140.87 42.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.439 0.696 . . . . 0.0 109.903 178.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -112.28 85.3 2.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 98.18 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.838 2.055 . . . . 0.0 111.402 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.66 60.99 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 141.2 16.42 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.528 0.117 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.022 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.96 133.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -163.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.07 116.0 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 125.127 1.371 . . . . 0.0 110.305 -174.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.55 136.82 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -114.2 114.78 26.47 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.0 ptp -118.24 130.2 55.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.302 1.041 . . . . 0.0 109.831 178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -80.03 125.27 29.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.404 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.25 140.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -103.42 156.58 17.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.82 -32.7 1.69 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.378 0.513 . . . . 0.0 114.199 172.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.7 mtp -67.31 80.84 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.253 1.026 . . . . 0.0 111.721 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -118.67 65.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.123 1.769 . . . . 0.0 109.095 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.24 169.25 9.33 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.92 5.17 52.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.839 0.456 . . . . 0.0 111.749 169.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.5 t -85.57 -65.81 0.97 Allowed 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.801 -0.562 . . . . 0.0 109.69 -174.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.23 -46.81 82.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.49 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -52.09 -60.95 2.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 109.968 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 t -52.12 -44.37 64.44 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.754 1.222 . . . . 0.0 111.231 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -58.07 -50.78 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.486 -0.758 . . . . 0.0 110.592 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.29 -45.78 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.54 -51.6 53.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.689 1.196 . . . . 0.0 110.721 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.63 -54.56 36.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.352 0.501 . . . . 0.0 111.92 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -52.17 66.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.638 -0.919 . . . . 0.0 111.462 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -63.83 -41.38 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.299 0.639 . . . . 0.0 109.709 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.96 19.76 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.448 0.547 . . . . 0.0 112.563 170.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -62.64 -24.93 67.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.724 0.762 . . . . 0.0 112.958 178.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mt -70.75 129.82 40.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.426 1.012 . . . . 0.0 112.825 -171.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.42 87.87 0.12 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.221 174.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -25.0 0.62 Allowed Glycine 0 C--N 1.332 0.343 0 O-C-N 122.035 -0.416 . . . . 0.0 113.406 -177.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.97 151.39 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -112.98 -53.98 2.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.967 0.907 . . . . 0.0 110.276 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.0 165.8 26.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -158.81 139.42 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -175.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -141.51 84.72 1.92 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.648 1.579 . . . . 0.0 110.254 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.43 106.34 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.056 -173.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -92.49 155.12 18.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -47.73 3.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.201 1.0 . . . . 0.0 108.619 177.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.03 -60.1 3.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.36 1.864 . . . . 0.0 110.567 -171.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -94.42 19.57 9.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.192 -175.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.83 49.44 0.57 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.048 2.539 . . . . 0.0 113.662 -177.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 4.7 tp10 -126.94 126.18 42.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.912 -169.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.03 113.25 23.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 110.155 -177.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -91.7 124.93 36.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 108.668 175.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.09 132.64 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 167.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.25 107.05 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.57 1.148 . . . . 0.0 109.665 -174.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.73 159.98 40.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -171.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -81.72 114.1 47.54 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.49 74.59 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.297 2.665 . . . . 0.0 110.791 -171.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -49.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.073 2.149 . . . . 0.0 108.02 173.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.17 -43.63 70.43 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.357 -173.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.23 169.58 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -142.63 165.64 26.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.455 -170.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.0 t -43.96 -45.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.266 1.026 . . . . 0.0 111.391 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.29 -56.9 15.86 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.277 -178.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.56 -48.21 69.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.462 1.483 . . . . 0.0 109.929 -177.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.1 mtm -46.68 -61.8 1.67 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 118.813 0.733 . . . . 0.0 112.54 169.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -60.34 -59.89 4.68 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.326 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -37.8 -54.77 1.23 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.679 1.592 . . . . 0.0 109.614 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.69 -46.86 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.503 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -68.06 -64.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 O-C-N 121.527 -0.733 . . . . 0.0 110.716 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.14 -34.63 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.17 175.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.99 -33.72 65.11 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 120.218 1.372 . . . . 0.0 112.846 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.6 mmt -59.03 -40.14 84.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.536 0.607 . . . . 0.0 110.443 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.95 -20.17 3.43 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.621 1.105 . . . . 0.0 110.989 178.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.62 112.99 19.91 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.183 -173.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -66.21 141.08 61.53 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.6 135.08 34.59 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.759 0.314 . . . . 0.0 111.628 -177.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -108.15 72.6 0.85 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.569 -171.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.83 103.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.637 1.575 . . . . 0.0 111.002 174.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -156.1 56.52 0.59 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.772 0.796 . . . . 0.0 111.925 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -157.13 162.11 39.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 173.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.21 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.44 127.66 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.566 1.146 . . . . 0.0 109.202 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -90.99 116.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 126.295 1.838 . . . . 0.0 109.254 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.08 118.56 37.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -97.0 119.05 34.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -121.42 124.3 44.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.759 1.224 . . . . 0.0 109.203 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -82.53 119.25 24.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.23 122.59 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.98 0.512 . . . . 0.0 110.244 -170.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.11 157.49 20.68 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.474 0.309 . . . . 0.0 111.119 -174.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.03 -44.63 1.46 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.947 0.784 . . . . 0.0 112.119 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 mtm -60.28 109.19 0.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.202 0.501 . . . . 0.0 109.809 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -146.51 19.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.851 1.26 . . . . 0.0 110.014 -177.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.0 148.89 22.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -81.14 42.38 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.094 0.557 . . . . 0.0 112.288 -167.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -122.42 -69.11 0.85 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.253 1.421 . . . . 0.0 107.491 177.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -49.76 -53.36 25.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.201 1.4 . . . . 0.0 110.443 -176.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -51.18 -55.75 16.37 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.173 177.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -60.97 -45.69 93.73 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.349 1.06 . . . . 0.0 110.307 -175.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -55.26 -51.36 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.646 -0.659 . . . . 0.0 110.76 176.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.64 -48.02 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.971 0.509 . . . . 0.0 110.002 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -48.96 -51.72 28.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.447 1.499 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -59.91 9.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 172.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -48.87 79.06 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 122.002 -0.705 . . . . 0.0 110.851 -170.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.3 mm -71.08 -47.79 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.074 0.55 . . . . 0.0 109.96 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.95 -35.26 31.96 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.325 0.488 . . . . 0.0 112.228 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -68.87 -16.38 63.75 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.868 0.867 . . . . 0.0 113.324 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mt -73.91 139.6 45.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.488 1.495 . . . . 0.0 112.106 -176.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -70.1 97.38 1.18 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.062 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.91 -12.87 1.12 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-O 118.662 -1.077 . . . . 0.0 114.181 -175.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.3 t -102.85 139.43 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 118.145 0.973 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 -31.68 14.39 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.881 0.472 . . . . 0.0 111.801 175.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -171.57 164.55 6.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -156.04 138.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 104.022 -2.584 . . . . 0.0 104.022 -172.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -137.78 92.42 2.68 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.79 1.636 . . . . 0.0 111.239 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.41 115.24 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -104.9 103.4 12.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.984 1.713 . . . . 0.0 108.723 -173.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -48.83 71.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.77 0.428 . . . . 0.0 110.628 -179.262 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.17 -54.48 30.21 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.883 1.273 . . . . 0.0 110.24 -176.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.63 5.56 27.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.828 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 35.19 60.21 0.71 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 128.428 2.691 . . . . 0.0 113.081 -175.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -138.79 149.1 44.61 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.154 1.381 . . . . 0.0 108.586 -175.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.37 119.61 27.73 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.634 1.174 . . . . 0.0 110.269 -179.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -103.03 114.44 28.75 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.975 1.71 . . . . 0.0 109.025 -179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.37 115.44 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.76 105.52 18.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.749 0.704 . . . . 0.0 109.927 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -128.61 169.68 14.14 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -166.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.02 111.0 64.74 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 124.554 1.142 . . . . 0.0 110.461 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.58 78.35 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.144 2.563 . . . . 0.0 111.431 -175.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.7 m80 178.97 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.447 2.699 . . . . 0.0 108.624 173.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 -50.21 11.99 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.01 -178.32 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.095 1.358 . . . . 0.0 107.718 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.8 p -142.85 155.22 44.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.358 -174.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.45 -42.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 124.199 1.0 . . . . 0.0 111.07 173.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.15 -39.36 94.43 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.046 -177.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.73 -51.46 64.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.853 1.206 . . . . 0.0 107.748 176.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.0 mmt -47.63 -61.22 2.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 122.447 0.299 . . . . 0.0 111.775 176.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -57.56 -59.45 5.16 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 120.967 -1.083 . . . . 0.0 111.077 177.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 119.312 0.96 . . . . 0.0 109.249 -170.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -57.95 -50.02 74.8 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.85 173.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -69.5 -64.79 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 111.046 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -45.02 -39.51 5.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.791 0.723 . . . . 0.0 112.262 174.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.59 55.74 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.513 1.051 . . . . 0.0 113.293 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -56.27 -39.52 72.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.403 0.547 . . . . 0.0 110.534 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.05 -19.61 2.88 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.714 1.149 . . . . 0.0 111.181 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.33 112.35 40.86 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.359 1.064 . . . . 0.0 110.384 -169.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.22 127.91 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.766 1.644 . . . . 0.0 109.651 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.57 133.03 55.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.618 0.767 . . . . 0.0 111.84 -173.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -105.51 76.02 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.286 1.034 . . . . 0.0 109.493 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.49 109.4 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.076 0.95 . . . . 0.0 110.077 170.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -156.98 53.8 0.51 Allowed 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 178.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 81.47 0.78 Allowed 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.931 -0.481 . . . . 0.0 110.127 -177.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 123.683 0.793 . . . . 0.0 109.565 -179.199 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.5 t -133.9 140.78 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.26 129.13 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 126.049 1.74 . . . . 0.0 110.725 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.31 145.61 46.93 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -122.98 125.96 46.25 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mtt -115.79 129.67 56.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.412 1.885 . . . . 0.0 108.026 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.45 126.29 31.47 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.05 157.04 9.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 119.329 0.968 . . . . 0.0 109.723 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -123.75 143.56 50.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.366 0.603 . . . . 0.0 109.743 170.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.61 -31.51 8.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.005 1.765 . . . . 0.0 112.794 174.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.7 mtt -66.36 99.14 0.53 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.09 0.945 . . . . 0.0 111.02 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.0 m -143.78 56.52 1.34 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.936 -1.102 . . . . 0.0 109.477 174.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.4 p -161.62 159.85 28.07 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 165.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -80.58 44.68 0.73 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.271 0.487 . . . . 0.0 111.222 179.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -123.17 -60.33 1.51 Allowed 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -47.2 -59.89 2.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.488 0.715 . . . . 0.0 110.807 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -52.92 -59.26 4.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.572 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 t -60.38 -45.27 94.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.756 0.822 . . . . 0.0 111.331 -170.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -54.19 -49.97 68.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.56 -0.713 . . . . 0.0 110.462 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.23 -43.9 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -53.58 -50.07 66.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.139 0.976 . . . . 0.0 110.682 177.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.58 -58.25 14.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 171.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -56.32 -52.3 65.05 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.169 -0.607 . . . . 0.0 111.14 -172.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.02 -47.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.907 1.283 . . . . 0.0 109.911 178.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.98 -39.71 26.35 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 172.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -70.48 -13.92 62.32 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mt -82.23 133.37 35.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 120.031 1.287 . . . . 0.0 112.345 -174.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -68.67 91.17 0.42 Allowed 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.532 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.59 -20.87 0.92 Allowed Glycine 0 C--N 1.334 0.433 0 O-C-N 121.859 -0.525 . . . . 0.0 113.752 -177.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -85.93 151.16 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -120.43 -38.29 2.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.873 1.269 . . . . 0.0 111.013 -179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -152.78 171.05 18.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -158.56 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -143.78 88.03 1.96 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.074 1.75 . . . . 0.0 111.298 175.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.83 88.61 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.124 -0.985 . . . . 0.0 111.263 -178.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.04 121.36 21.87 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.675 1.99 . . . . 0.0 110.919 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -46.56 43.22 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.261 -0.899 . . . . 0.0 111.366 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.3 -59.58 3.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.724 1.21 . . . . 0.0 111.211 -170.121 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.35 24.92 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.524 -176.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 24.89 74.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.346 2.659 . . . . 0.0 113.934 -169.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -127.94 136.58 51.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 108.222 -173.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.8 102.38 9.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.53 1.132 . . . . 0.0 108.427 171.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -88.95 125.72 35.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.0 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -118.96 103.59 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.487 1.115 . . . . 0.0 108.067 -174.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -138.78 164.59 29.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -166.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -96.71 110.64 54.26 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.975 -173.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.05 76.57 2.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.894 3.062 . . . . 0.0 110.684 -172.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.407 1.883 . . . . 0.0 107.357 -175.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.51 -46.35 13.51 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.476 0.485 . . . . 0.0 110.48 -171.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.54 155.51 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 107.136 -176.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 p -123.18 161.84 23.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.786 1.234 . . . . 0.0 110.392 -173.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.6 t -45.47 -45.52 4.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 123.831 0.852 . . . . 0.0 111.843 175.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.49 -56.65 17.8 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.038 -175.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -38.82 -59.67 0.93 Allowed 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.015 1.726 . . . . 0.0 110.144 170.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.4 mtm -49.67 -62.79 1.36 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -59.2 -62.64 1.73 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.41 -177.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -38.82 -49.37 1.62 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 120.013 1.278 . . . . 0.0 110.376 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -37.2 78.67 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -72.08 -66.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 124.37 1.068 . . . . 0.0 110.81 175.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -38.0 -40.16 0.45 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.034 1.334 . . . . 0.0 112.403 171.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.38 -35.43 8.29 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 113.514 176.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.83 81.71 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.666 0.787 . . . . 0.0 110.613 178.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.23 -14.66 4.55 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.877 1.227 . . . . 0.0 111.172 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -85.48 115.93 63.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 123.849 0.86 . . . . 0.0 109.866 -171.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.5 142.1 63.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 175.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.4 135.81 44.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.094 0.558 . . . . 0.0 111.401 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -105.7 76.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.577 1.151 . . . . 0.0 109.437 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.41 104.52 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.079 1.352 . . . . 0.0 110.859 171.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -155.73 60.01 0.61 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.71 0.767 . . . . 0.0 112.875 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.31 162.33 40.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.821 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -116.78 128.61 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 124.731 1.212 . . . . 0.0 109.499 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.3 104.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.345 1.458 . . . . 0.0 110.129 -176.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.33 101.89 14.38 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 8.0 mmtp -79.19 120.95 24.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.079 0.952 . . . . 0.0 108.6 174.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.72 119.14 29.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 115.55 19.41 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.43 154.49 5.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -174.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -111.54 156.91 21.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.45 -43.44 3.22 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.261 -0.9 . . . . 0.0 114.043 161.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.5 mtm -61.01 86.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.374 1.087 . . . . 0.0 111.507 -178.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -116.49 38.08 3.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.744 1.618 . . . . 0.0 109.902 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -154.81 162.96 40.92 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -76.74 -21.61 55.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.429 0.456 . . . . 0.0 111.402 -177.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -58.16 -58.91 6.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.752 0.421 . . . . 0.0 110.214 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.1 m -54.5 -53.37 55.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -58.9 -54.2 49.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.075 -175.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -58.74 -45.91 88.6 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.818 0.847 . . . . 0.0 111.229 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.6 m -56.2 -48.46 76.35 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.371 -0.83 . . . . 0.0 110.5 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -59.44 -47.89 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -55.81 -45.0 78.38 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.635 . . . . 0.0 110.764 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.1 -53.26 45.94 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.063 0.84 . . . . 0.0 111.527 173.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -63.0 -59.77 4.36 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.93 0.871 . . . . 0.0 109.834 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.59 -32.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.167 1.387 . . . . 0.0 111.043 -175.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.16 -31.49 6.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.313 0.482 . . . . 0.0 112.447 172.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -80.74 -4.08 53.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.74 139.35 45.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 120.104 1.32 . . . . 0.0 112.524 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -81.18 84.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.136 177.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.04 -13.96 0.86 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 178.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.33 145.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -115.13 -37.33 4.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.249 1.419 . . . . 0.0 111.037 -176.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.66 44.42 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -155.06 126.6 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.253 16.2 mmtm -135.08 102.16 5.11 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 171.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.33 98.58 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.584 -0.697 . . . . 0.0 110.095 -177.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.1 m -89.14 126.84 35.64 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.14 1.376 . . . . 0.0 110.808 -176.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 -42.96 14.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.832 0.853 . . . . 0.0 109.96 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -59.11 4.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.938 1.695 . . . . 0.0 110.376 -173.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -86.58 9.0 19.83 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.001 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 0.1 OUTLIER 32.85 66.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.209 2.604 . . . . 0.0 112.208 -169.548 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 6' ' ' LYS . 2.0 mt-10 -144.5 141.99 29.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.556 1.142 . . . . 0.0 110.685 -173.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.95 120.19 39.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.38 1.472 . . . . 0.0 109.682 -178.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -94.46 78.27 3.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.942 2.497 . . . . 0.0 107.934 175.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.28 103.8 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.54 108.24 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -131.41 175.05 9.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -106.88 109.91 63.35 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.268 1.027 . . . . 0.0 110.187 -175.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 73.74 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.153 3.235 . . . . 0.0 111.216 -170.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -177.91 -39.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.372 2.269 . . . . 0.0 108.368 178.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.75 -46.13 13.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.778 -175.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -135.62 149.08 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -100.58 158.74 15.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.052 0.941 . . . . 0.0 111.676 -173.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.71 -42.97 18.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.939 0.496 . . . . 0.0 110.357 166.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.52 -53.92 50.04 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -176.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -46.14 -54.1 9.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.312 1.045 . . . . 0.0 110.528 172.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.9 mmm -48.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 173.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -56.9 -64.57 0.83 Allowed 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.808 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -37.11 -52.76 1.01 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.907 1.683 . . . . 0.0 109.954 178.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -66.11 -47.26 74.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.081 177.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.61 -62.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.655 0.661 . . . . 0.0 110.453 -178.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.39 -44.08 3.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 112.223 171.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.2 62.3 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.126 0.875 . . . . 0.0 113.065 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.1 -42.29 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.499 0.59 . . . . 0.0 110.467 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.28 -18.71 2.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.596 1.093 . . . . 0.0 111.299 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -81.23 118.31 71.77 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-O 118.417 -0.801 . . . . 0.0 110.373 -169.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.1 140.05 52.77 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 N-CA-C 108.445 -1.406 . . . . 0.0 108.445 173.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.21 132.33 37.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.392 0.615 . . . . 0.0 111.045 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.26 81.24 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -42.02 107.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 125.15 1.531 . . . . 0.0 108.818 160.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -101.87 179.8 4.23 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.121 1.768 . . . . 0.0 106.611 170.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 161.87 18.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.05 -175.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 123.003 0.521 . . . . 0.0 109.709 -178.786 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -105.6 132.45 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.854 0.862 . . . . 0.0 109.161 -176.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.2 115.52 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.646 1.578 . . . . 0.0 109.813 179.435 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.0 124.43 33.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 170.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.48 109.39 21.34 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.3 ptp -119.64 144.64 47.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.094 0.958 . . . . 0.0 109.142 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.85 46.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.922 173.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.92 96.48 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 124.661 1.226 . . . . 0.0 109.448 -166.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -68.3 142.76 55.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.946 -0.471 . . . . 0.0 110.668 -172.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 -47.72 1.0 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.286 0.946 . . . . 0.0 112.525 174.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.7 82.47 2.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.929 0.864 . . . . 0.0 111.899 -171.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -111.35 33.63 4.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.537 1.535 . . . . 0.0 110.545 -178.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -155.37 160.55 40.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -78.0 -1.5 32.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -174.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -76.7 -61.36 1.99 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.49 -0.756 . . . . 0.0 109.629 175.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -56.13 -48.59 75.93 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.717 0.407 . . . . 0.0 110.809 -174.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.9 p -52.03 -60.39 3.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.383 0.673 . . . . 0.0 109.415 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -50.7 -48.21 58.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.786 1.234 . . . . 0.0 111.692 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -54.42 -51.91 63.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.315 -0.866 . . . . 0.0 110.948 176.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.9 mt -62.14 -40.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.97 0.508 . . . . 0.0 109.989 178.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.99 -48.58 78.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.661 1.184 . . . . 0.0 110.599 176.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.82 -56.31 24.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 172.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -56.18 -52.63 63.71 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -174.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.06 -45.81 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.244 1.018 . . . . 0.0 110.299 -175.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.57 -37.61 26.86 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.402 0.525 . . . . 0.0 112.012 175.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -72.99 -9.28 58.56 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.135 0.974 . . . . 0.0 113.5 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mt -81.45 128.45 33.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.431 1.468 . . . . 0.0 111.408 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -66.8 108.87 2.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.097 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.52 -16.28 3.58 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 124.489 1.042 . . . . 0.0 112.613 -178.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.5 152.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 117.053 0.426 . . . . 0.0 110.249 173.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.14 -46.08 2.21 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.31 -178.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.42 165.57 30.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 178.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -156.5 137.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -141.66 90.85 2.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.253 1.021 . . . . 0.0 111.495 179.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.76 90.91 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.512 -0.742 . . . . 0.0 110.194 -177.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 m -84.45 110.21 18.48 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.583 1.153 . . . . 0.0 111.247 -173.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.33 -49.6 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.356 0.663 . . . . 0.0 112.368 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.86 -59.58 3.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.074 1.349 . . . . 0.0 111.095 -170.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -92.57 18.91 7.93 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.438 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 28.9 60.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 129.028 2.931 . . . . 0.0 113.609 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.12 132.46 32.04 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 110.26 -175.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.22 112.5 25.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.451 1.9 . . . . 0.0 109.498 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.0 m -90.56 84.57 5.95 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 127.845 2.458 . . . . 0.0 107.575 173.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.25 113.06 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -107.47 111.76 37.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.957 0.799 . . . . 0.0 110.128 -171.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -129.75 170.89 13.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.762 0.792 . . . . 0.0 112.328 -169.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -106.42 109.25 63.0 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.906 -177.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.36 77.99 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.177 2.584 . . . . 0.0 110.906 -172.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -177.09 -41.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 127.885 2.474 . . . . 0.0 107.926 174.382 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -77.96 -53.84 6.98 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 117.966 0.348 . . . . 0.0 110.974 -177.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.27 179.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.88 1.272 . . . . 0.0 108.84 -176.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -146.37 159.6 43.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.574 0.749 . . . . 0.0 110.992 -172.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -39.28 -48.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.813 1.645 . . . . 0.0 111.159 173.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.78 -50.46 73.37 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.14 -50.64 66.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 120.401 1.455 . . . . 0.0 108.442 176.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.66 -55.96 16.44 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.499 0.19 . . . . 0.0 111.011 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.87 -62.26 1.92 Allowed 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.583 177.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -50.34 5.29 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.446 1.099 . . . . 0.0 109.495 -177.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -60.1 -49.84 76.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 177.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -70.17 -63.76 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.744 -0.597 . . . . 0.0 111.301 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.8 -37.91 6.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 112.548 174.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.78 56.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.779 1.172 . . . . 0.0 113.06 176.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 mmt -56.89 -39.88 75.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.507 0.594 . . . . 0.0 110.625 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.41 -18.96 3.23 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.639 1.114 . . . . 0.0 110.932 176.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -80.94 114.03 45.33 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.48 -172.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.99 141.63 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.663 1.575 . . . . 0.0 108.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.37 134.57 46.41 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.335 0.97 . . . . 0.0 112.956 -177.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -106.47 71.74 0.88 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.14 107.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.8 170.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -150.89 55.19 0.89 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 176.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 159.45 41.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 173.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.013 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 . . . . . 0 N--CA 1.447 -0.622 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.57 141.18 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.082 0.953 . . . . 0.0 109.343 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -104.96 127.01 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 126.462 1.905 . . . . 0.0 110.663 -177.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.21 127.89 54.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.1 111.27 23.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 178.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.4 ptp -113.66 122.23 46.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.698 1.199 . . . . 0.0 109.152 179.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -74.46 130.85 40.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.44 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.15 153.7 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -117.08 146.85 42.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.72 -38.91 2.97 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.267 0.937 . . . . 0.0 113.077 170.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.0 mtt -62.72 137.06 58.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.457 1.129 . . . . 0.0 110.575 -174.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -143.4 -56.99 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.733 -0.605 . . . . 0.0 110.226 176.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.8 p -72.07 156.47 39.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.724 0.693 . . . . 0.0 110.098 -179.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -65.16 -18.71 65.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.295 177.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 m -64.54 -50.18 68.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.422 -0.799 . . . . 0.0 110.665 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -54.62 -57.85 9.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.787 0.721 . . . . 0.0 109.73 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -55.49 -55.31 33.25 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.539 -176.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -56.55 -45.89 80.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.9 m -58.0 -49.48 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.487 -0.758 . . . . 0.0 109.942 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.14 -47.01 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 122.936 0.494 . . . . 0.0 109.912 176.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.56 -50.26 60.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.553 0.741 . . . . 0.0 109.551 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.86 -56.79 22.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.68 0.657 . . . . 0.0 111.817 173.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -60.63 -59.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.198 -0.589 . . . . 0.0 110.948 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.58 -34.25 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.954 -177.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.43 -33.79 6.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.58 168.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -92.42 12.19 23.6 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 117.966 0.883 . . . . 0.0 112.353 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.61 151.24 47.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 120.404 -1.435 . . . . 0.0 109.886 167.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.17 130.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.37 -0.88 29.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.557 1.075 . . . . 0.0 111.909 176.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -95.48 154.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 124.691 1.196 . . . . 0.0 109.658 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -122.1 -41.57 2.42 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.168 0.987 . . . . 0.0 110.055 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -150.66 164.37 36.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -156.97 139.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -172.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -145.49 147.76 32.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.55 0.74 . . . . 0.0 110.027 172.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.32 140.76 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.863 1.211 . . . . 0.0 110.825 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -124.08 132.57 53.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.971 1.708 . . . . 0.0 110.569 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -54.73 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 112.151 176.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.61 -56.73 16.01 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 110.112 -166.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.22 11.58 16.08 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.845 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.37 62.69 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.857 2.863 . . . . 0.0 113.042 -178.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 3.8 tt0 -131.39 142.32 50.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.342 -175.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.72 133.88 55.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.298 1.439 . . . . 0.0 108.659 175.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -109.94 117.18 33.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.518 3.127 . . . . 0.0 106.648 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -126.23 119.29 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.17 108.59 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -168.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.192 0.52 . . . . 0.0 112.008 -165.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -89.31 108.58 25.45 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.714 1.606 . . . . 0.0 109.431 -174.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.2 73.14 2.69 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.02 2.48 . . . . 0.0 111.036 -176.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -168.22 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.413 1.885 . . . . 0.0 108.756 177.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.67 -43.17 63.48 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.36 177.9 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -135.05 162.34 32.75 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.153 0.888 . . . . 0.0 110.215 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.09 -46.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 110.995 169.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -61.14 -57.77 11.11 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.184 -174.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -38.57 -56.85 1.24 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.763 1.625 . . . . 0.0 110.665 172.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.45 -63.01 1.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 122.163 -0.336 . . . . 0.0 111.57 175.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -58.64 7.53 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.714 -0.616 . . . . 0.0 111.964 -177.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -36.88 -54.97 0.92 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.844 1.658 . . . . 0.0 110.491 172.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -41.8 94.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.094 -1.043 . . . . 0.0 113.388 176.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.74 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.174 -0.954 . . . . 0.0 109.98 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -43.42 -40.96 4.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.957 169.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.23 61.16 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.617 1.099 . . . . 0.0 113.222 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.82 -43.79 81.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.593 0.633 . . . . 0.0 110.777 171.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.02 -15.31 4.02 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.047 1.308 . . . . 0.0 111.287 -179.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -80.89 116.89 65.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.91 -173.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.9 140.04 49.27 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 108.397 -1.424 . . . . 0.0 108.397 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.71 140.25 42.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.351 0.66 . . . . 0.0 110.48 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -114.66 79.03 1.21 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.939 0.896 . . . . 0.0 109.152 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 105.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.012 1.325 . . . . 0.0 109.691 169.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -152.98 54.72 0.77 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.735 0.778 . . . . 0.0 112.42 176.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 132.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 175.684 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -80.44 -178.27 6.59 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.05 135.83 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.72 132.47 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.639 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -113.25 135.24 54.05 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 166.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -111.94 122.07 46.77 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.6 ptp -123.64 120.5 32.95 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.106 1.362 . . . . 0.0 109.533 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.2 mptp? -71.01 134.53 47.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.655 -1.164 . . . . 0.0 108.079 173.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -116.91 150.35 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -113.61 150.35 33.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.36 -35.06 2.42 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.52 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.6 mtm -65.82 85.72 0.08 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.607 1.204 . . . . 0.0 111.603 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 m -122.96 51.08 1.46 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 109.116 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 p -158.32 167.88 28.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 165.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.77 -22.24 50.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.321 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -65.62 -62.0 1.76 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.047 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -52.21 -51.22 59.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.013 0.911 . . . . 0.0 110.235 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 p -57.58 -56.07 26.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.295 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -54.98 -48.34 73.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.776 0.717 . . . . 0.0 111.623 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.2 m -52.85 -51.96 59.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.534 0.734 . . . . 0.0 110.283 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -60.92 -44.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.19 -48.12 71.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.231 0.612 . . . . 0.0 111.087 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.82 28.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.663 0.649 . . . . 0.0 111.624 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -56.96 -47.11 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.109 -0.642 . . . . 0.0 110.945 -174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 mm -66.34 -48.02 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.241 1.016 . . . . 0.0 109.478 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.76 -39.26 31.34 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.533 0.587 . . . . 0.0 112.235 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -60.54 -29.17 68.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.492 0.646 . . . . 0.0 112.489 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -75.04 135.29 41.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.039 0.923 . . . . 0.0 112.088 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -70.72 86.96 0.68 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.917 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.66 0.51 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 115.227 0.851 . . . . 0.0 115.227 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -86.95 149.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 117.844 0.822 . . . . 0.0 109.287 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -120.8 -34.72 3.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -156.53 164.32 38.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -158.29 140.28 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -140.99 82.7 1.85 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.233 1.013 . . . . 0.0 111.222 176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -84.47 110.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -89.29 172.16 9.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.58 -48.15 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.461 1.104 . . . . 0.0 109.48 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.11 -61.15 1.89 Allowed 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.389 1.876 . . . . 0.0 110.392 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.17 19.52 7.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.143 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.33 63.87 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.759 2.824 . . . . 0.0 113.462 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 35.2 tt0 -146.6 146.24 30.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -177.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.14 124.71 42.39 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.613 1.165 . . . . 0.0 109.596 -175.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -98.05 129.54 44.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.82 1.648 . . . . 0.0 107.23 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.8 123.19 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 104.55 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 118.821 0.737 . . . . 0.0 110.025 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -133.4 167.98 19.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.335 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.42 112.79 63.14 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.233 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.45 78.25 2.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.024 3.149 . . . . 0.0 110.985 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -179.25 -52.95 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.781 1.632 . . . . 0.0 106.919 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.78 -46.06 16.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.155 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 169.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.552 1.541 . . . . 0.0 108.27 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -139.64 162.03 36.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.982 0.913 . . . . 0.0 111.202 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 86.9 t -43.65 -48.28 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.202 1.001 . . . . 0.0 111.15 172.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.89 -45.66 88.36 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.488 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -50.93 -57.28 8.93 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.231 1.378 . . . . 0.0 108.702 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.9 mmt -46.49 -65.43 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -59.7 5.02 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 121.284 -0.885 . . . . 0.0 112.611 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -44.76 -48.63 10.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.203 0.911 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -40.8 90.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.99 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -67.52 -65.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.077 0.551 . . . . 0.0 110.619 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -43.38 -42.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.38 0.672 . . . . 0.0 112.18 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.42 -32.86 58.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.139 0.882 . . . . 0.0 113.149 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.3 mmt -59.39 -40.26 85.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.68 0.673 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.93 -17.74 2.77 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.372 0.986 . . . . 0.0 111.197 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -84.23 110.53 27.03 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 123.913 0.885 . . . . 0.0 109.581 -171.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -65.89 141.58 65.53 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.33 136.18 32.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.444 0.298 . . . . 0.0 111.779 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.81 78.74 1.22 Allowed 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.16 101.52 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.844 1.657 . . . . 0.0 112.083 176.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -156.77 56.8 0.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -158.03 130.06 6.96 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 167.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.85 63.01 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 59.5 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.867 0.867 . . . . 0.0 109.569 -171.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.94 164.1 51.84 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.611 -0.681 . . . . 0.0 111.788 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? . . . . . 0 C--O 1.25 1.121 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.198 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.666 0 N-CA-C 106.53 -2.628 . . . . 0.0 106.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -170.62 156.19 5.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.94 134.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.43 134.61 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.09 147.02 43.69 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 163.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -118.04 117.06 28.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -118.28 119.64 35.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.619 1.568 . . . . 0.0 108.275 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.47 140.74 54.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -127.94 146.4 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -105.97 148.15 28.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.32 -31.68 2.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.459 -0.776 . . . . 0.0 114.056 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.5 mtp -61.99 92.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.987 0.893 . . . . 0.0 110.242 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 m -144.46 48.67 1.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.894 1.277 . . . . 0.0 109.724 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -77.26 44.27 0.41 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.668 0.787 . . . . 0.0 111.46 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -129.54 -59.76 1.07 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.392 1.077 . . . . 0.0 108.425 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -54.66 -58.53 7.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.471 0.578 . . . . 0.0 110.655 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 t -51.95 -57.3 9.84 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.271 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 t -57.71 -40.33 79.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.809 0.844 . . . . 0.0 110.557 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -60.85 -49.26 78.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.934 -0.479 . . . . 0.0 110.082 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -51.29 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.5 -51.19 65.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.201 1.0 . . . . 0.0 110.142 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.01 -51.21 57.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.813 0.72 . . . . 0.0 112.059 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.3 -59.58 5.07 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.195 0.997 . . . . 0.0 110.572 -175.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.9 mm -57.67 -38.07 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.264 1.026 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.32 -36.15 7.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.033 0.825 . . . . 0.0 113.676 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.62 -7.01 59.59 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.171 0.986 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.64 149.7 32.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.12 0.873 . . . . 0.0 111.835 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.71 126.53 36.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.194 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.0 -21.06 7.51 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -86.98 151.64 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -118.51 -40.82 2.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.836 1.254 . . . . 0.0 110.726 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -159.13 170.84 21.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -158.48 140.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -143.87 84.73 1.79 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.685 0.794 . . . . 0.0 110.718 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.45 102.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.84 0.856 . . . . 0.0 109.149 -172.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -78.53 177.21 8.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.09 -48.85 0.41 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 109.054 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -61.43 1.96 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.423 1.489 . . . . 0.0 110.39 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -91.52 19.46 6.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.625 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 37.29 62.27 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.155 2.182 . . . . 0.0 113.603 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.29 149.48 33.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 130.64 46.95 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.332 1.053 . . . . 0.0 110.147 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -102.06 129.3 48.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 107.234 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.6 mm -123.88 127.81 73.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.34 107.36 21.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 110.005 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -145.86 173.24 12.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.498 -0.751 . . . . 0.0 111.813 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -98.65 104.3 23.71 Favored Pre-proline 0 N--CA 1.439 -1.024 0 C-N-CA 124.932 1.293 . . . . 0.0 108.713 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.12 -24.4 73.55 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.836 2.357 . . . . 0.0 112.4 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -22.76 63.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.594 0.758 . . . . 0.0 112.894 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.8 mt -107.97 -64.71 1.18 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.827 0.74 . . . . 0.0 111.474 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -116.5 161.3 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.644 1.177 . . . . 0.0 108.277 -175.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -127.72 165.45 20.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.514 0.726 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.62 -44.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 C-N-CA 124.133 0.973 . . . . 0.0 110.236 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.411 ' CD ' ' HZ3' ' A' ' 58' ' ' LYS . 25.0 tp10 -60.59 -38.19 83.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.135 -176.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.86 -53.63 25.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 mmt -45.21 -59.74 2.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 122.863 0.465 . . . . 0.0 111.634 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.411 ' HZ3' ' CD ' ' A' ' 55' ' ' GLU . 0.4 OUTLIER -64.01 -53.82 44.02 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.284 -177.679 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -50.37 -47.05 56.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 120.702 1.592 . . . . 0.0 109.201 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -59.63 -48.96 79.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.704 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -69.74 -63.94 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 122.931 0.492 . . . . 0.0 110.583 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -47.69 -36.47 11.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.318 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.43 -32.82 63.04 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.726 1.148 . . . . 0.0 112.955 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.5 mmt -60.89 -30.39 70.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.437 0.562 . . . . 0.0 110.885 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.54 7.79 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.455 1.503 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -82.5 116.07 61.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.375 1.07 . . . . 0.0 109.524 -171.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.76 144.08 64.09 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.611 1.541 . . . . 0.0 108.75 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.27 141.22 35.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.929 0.492 . . . . 0.0 111.179 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -114.49 78.3 1.14 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.88 0.872 . . . . 0.0 110.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.13 103.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.097 1.359 . . . . 0.0 111.2 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -155.41 57.09 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.34 0.59 . . . . 0.0 112.16 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.01 158.17 32.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -153.04 65.19 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.061 0.934 . . . . 0.0 109.767 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.3 93.34 5.27 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.93 -100.97 0.13 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.993 1.317 . . . . 0.0 110.309 -178.33 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.109 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.85 160.04 0.21 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.762 1.225 . . . . 0.0 109.663 157.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.58 129.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.7 t -91.15 119.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -100.81 133.73 44.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -118.22 115.37 24.62 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.42 126.86 53.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.151 1.38 . . . . 0.0 108.572 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -70.31 140.72 52.33 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 168.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -130.93 143.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.6 159.11 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.84 -39.01 2.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.756 -0.59 . . . . 0.0 114.566 161.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.53 102.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.7 1.25 . . . . 0.0 110.681 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -134.75 34.4 3.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.097 1.359 . . . . 0.0 109.772 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 165.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -72.01 -25.5 61.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.613 0.244 . . . . 0.0 111.316 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -58.52 -56.1 26.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.214 0.606 . . . . 0.0 111.485 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 m -59.12 -55.77 30.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.64 0.654 . . . . 0.0 110.692 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -49.37 -57.47 6.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.22 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -59.73 -42.23 92.68 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.321 0.51 . . . . 0.0 111.206 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.8 m -57.38 -48.83 78.03 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.603 -0.686 . . . . 0.0 110.199 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.63 -49.08 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.253 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -45.16 -53.78 7.69 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.278 1.031 . . . . 0.0 109.546 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.75 -57.41 19.93 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.344 0.973 . . . . 0.0 112.316 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -58.25 -54.38 47.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.868 0.834 . . . . 0.0 109.874 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.0 mm -70.32 -35.95 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.575 -173.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.7 -30.76 9.08 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.733 -0.604 . . . . 0.0 112.688 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.7 -14.81 60.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 118.178 0.989 . . . . 0.0 113.448 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -68.71 147.66 51.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.639 1.563 . . . . 0.0 112.746 -178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.68 97.51 7.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.74 -10.1 1.87 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-O 119.725 -0.486 . . . . 0.0 114.271 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.91 137.82 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -31.66 10.49 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.079 0.551 . . . . 0.0 111.381 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -152.72 159.64 43.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.19 140.92 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.93 136.78 25.67 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.845 0.858 . . . . 0.0 110.53 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -132.96 104.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 120.628 1.558 . . . . 0.0 111.349 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.1 m -83.28 105.34 14.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.685 1.994 . . . . 0.0 110.125 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.26 -44.75 95.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.486 -0.133 . . . . 0.0 110.849 176.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.48 -57.34 7.2 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.396 1.478 . . . . 0.0 111.287 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.08 11.66 20.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.576 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 1.4 mt-30 33.61 62.93 0.39 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.601 2.36 . . . . 0.0 112.605 -168.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.23 136.25 39.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.971 0.908 . . . . 0.0 110.618 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.34 135.23 53.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.797 1.639 . . . . 0.0 110.168 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.6 m -111.77 124.47 52.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 131.281 3.832 . . . . 0.0 106.438 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mm -125.88 117.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.46 95.42 3.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -175.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -123.88 169.52 11.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.22 0.533 . . . . 0.0 111.951 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -108.06 109.81 62.02 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.345 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.86 79.76 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.504 2.803 . . . . 0.0 111.298 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m170 177.13 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 128.07 2.548 . . . . 0.0 108.075 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.95 -46.67 17.87 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.398 -0.189 . . . . 0.0 111.258 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -140.2 170.76 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.375 1.47 . . . . 0.0 107.741 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.8 p -130.53 155.91 45.71 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.128 0.971 . . . . 0.0 111.443 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -46.44 -43.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.638 0.775 . . . . 0.0 110.974 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -60.68 -45.4 94.33 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.706 -176.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.58 -55.98 27.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.66 1.184 . . . . 0.0 107.814 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.7 mmt -46.16 -59.05 3.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -60.66 -51.18 70.5 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 121.148 -0.97 . . . . 0.0 111.927 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -52.66 -49.31 65.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.78 -48.19 82.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.373 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.58 -66.8 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.057 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -48.94 -33.95 11.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.428 -0.796 . . . . 0.0 113.003 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.937 1.244 . . . . 0.0 112.937 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.8 mmt -55.47 -42.28 74.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 110.547 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.76 -25.0 2.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.011 0.815 . . . . 0.0 111.326 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -73.86 113.19 20.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.928 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -64.84 143.69 80.75 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.669 1.579 . . . . 0.0 108.857 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.26 40.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -104.78 76.89 1.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 p -52.58 108.0 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 109.828 162.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -155.38 59.79 0.63 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.601 0.715 . . . . 0.0 112.402 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -157.16 168.06 28.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 tp -152.36 65.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.19 59.78 4.63 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.34 146.93 16.22 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.259 1.558 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -61.1 170.41 1.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.017 0.909 . . . . 0.0 112.713 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.81 144.51 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.786 1.634 . . . . 0.0 107.551 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.33 131.76 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.524 1.53 . . . . 0.0 107.546 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -120.3 122.09 40.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -113.56 118.8 35.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 8.2 ptp -117.0 128.96 55.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.292 1.037 . . . . 0.0 109.935 175.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 125.28 28.6 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.19 154.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 119.318 0.963 . . . . 0.0 108.88 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -115.28 154.53 28.94 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 109.74 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.93 -47.54 3.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.691 0.662 . . . . 0.0 112.347 171.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.4 mtm -64.59 86.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.568 0.684 . . . . 0.0 111.82 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 m -135.65 50.7 2.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.476 1.51 . . . . 0.0 109.738 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 p -161.17 167.95 25.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -65.46 177.2 1.21 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.803 0.811 . . . . 0.0 109.837 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t 73.74 -65.73 0.34 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 121.309 -0.869 . . . . 0.0 108.774 -170.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.3 m -47.64 -63.47 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.036 0.835 . . . . 0.0 111.317 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -56.03 -55.72 29.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.264 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -58.98 -45.91 89.4 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.137 0.975 . . . . 0.0 111.65 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.5 m -53.64 -50.5 65.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.499 0.719 . . . . 0.0 110.281 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -44.04 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.568 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.5 -51.87 57.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 109.749 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.78 -54.47 34.78 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.259 0.933 . . . . 0.0 112.112 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -60.6 -54.51 44.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.012 -0.699 . . . . 0.0 110.897 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.57 -42.36 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.54 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.55 -23.52 14.26 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.325 -0.708 . . . . 0.0 113.718 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -81.91 -18.87 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.966 1.383 . . . . 0.0 112.283 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.94 131.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.781 1.628 . . . . 0.0 111.292 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -68.68 91.71 0.45 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.37 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.28 -18.34 1.52 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.329 -171.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.91 146.05 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 117.858 0.829 . . . . 0.0 109.587 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -106.21 -44.99 4.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.811 1.645 . . . . 0.0 110.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.58 168.69 26.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 tt -158.35 139.36 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -136.72 86.82 2.24 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.634 1.574 . . . . 0.0 111.039 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.62 97.19 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 109.366 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.0 m -75.66 165.46 25.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.56 -46.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.849 0.859 . . . . 0.0 109.622 -173.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.42 -57.21 12.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.044 1.338 . . . . 0.0 109.423 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -88.05 12.77 12.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.088 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 35.98 58.41 0.94 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.355 2.262 . . . . 0.0 113.19 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.78 140.02 31.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.479 -0.763 . . . . 0.0 108.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -121.71 112.72 18.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.882 1.273 . . . . 0.0 109.793 -175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 31.6 m -87.94 126.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 107.873 171.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.5 mp -121.87 127.97 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.1 110.46 32.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -138.83 167.66 21.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -168.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -103.46 108.87 60.64 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 123.901 0.881 . . . . 0.0 111.01 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.35 76.84 2.18 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.043 3.162 . . . . 0.0 110.674 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -179.09 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.161 2.184 . . . . 0.0 107.846 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.04 -49.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.35 162.28 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.708 1.603 . . . . 0.0 108.244 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -124.67 163.2 22.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 111.973 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.9 t -47.79 -41.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 C-N-CA 123.368 0.667 . . . . 0.0 111.079 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.04 -43.28 87.99 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.21 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -53.23 -51.32 62.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.925 1.239 . . . . 0.0 109.043 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.1 mmt -51.28 -67.28 0.26 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.09 -55.82 26.78 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.06 -1.025 . . . . 0.0 112.876 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -49.76 -49.39 48.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.2 -41.86 94.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 118.619 -1.233 . . . . 0.0 112.674 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.5 -65.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 O-C-N 121.669 -0.644 . . . . 0.0 110.431 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -49.41 -34.65 16.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.458 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.34 -32.63 62.68 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.939 1.245 . . . . 0.0 112.621 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 16.9 mmt -58.96 -41.92 88.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.473 0.579 . . . . 0.0 110.706 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.37 -19.45 3.61 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.634 1.111 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -75.41 114.95 40.9 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.955 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.61 144.88 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.507 1.471 . . . . 0.0 108.969 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.76 135.02 25.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.021 0.438 . . . . 0.0 111.91 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -108.21 78.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.873 1.669 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -56.08 109.36 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.207 1.803 . . . . 0.0 110.335 165.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -155.82 55.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.72 137.78 13.59 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.04 78.72 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -103.53 174.54 5.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.505 0.722 . . . . 0.0 109.564 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.32 140.53 6.91 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.182 0 C-N-CA 128.058 2.543 . . . . 0.0 105.347 -174.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -133.78 176.18 8.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 108.882 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.74 140.14 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 125.744 1.618 . . . . 0.0 107.932 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.3 t -89.45 119.35 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.306 1.042 . . . . 0.0 108.404 174.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -95.07 125.1 39.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.84 120.21 41.13 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mtt -118.17 127.0 53.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.419 1.088 . . . . 0.0 108.59 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.11 130.57 36.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.62 138.42 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -104.81 146.58 28.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.967 0.507 . . . . 0.0 109.703 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.3 -36.68 3.97 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.586 0.612 . . . . 0.0 113.346 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 mtp -65.92 94.72 0.23 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.822 0.811 . . . . 0.0 110.357 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -119.72 53.92 1.03 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.267 1.427 . . . . 0.0 108.42 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -171.31 157.49 5.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.453 0.701 . . . . 0.0 109.114 -169.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -27.62 60.6 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.664 167.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -57.16 -69.87 0.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.272 0.629 . . . . 0.0 112.025 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -59.11 -48.08 82.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.159 0.436 . . . . 0.0 110.736 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -50.27 -56.72 9.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.824 0.85 . . . . 0.0 110.621 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 t -57.82 -47.18 83.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.602 0.761 . . . . 0.0 111.454 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.7 m -55.2 -48.06 74.38 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 110.944 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 27.5 mt -62.41 -49.42 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 124.194 0.998 . . . . 0.0 108.993 178.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -46.71 -50.39 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.058 0.943 . . . . 0.0 109.979 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.29 -59.11 11.4 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.022 0.82 . . . . 0.0 112.125 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.79 -57.78 10.98 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.681 0.753 . . . . 0.0 109.776 -174.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.99 -32.03 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.88 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.82 -32.45 25.94 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.754 -0.591 . . . . 0.0 112.419 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.07 4.53 41.72 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 117.906 0.853 . . . . 0.0 112.208 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 152.87 44.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 120.522 1.51 . . . . 0.0 110.102 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -83.45 134.69 34.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 18.87 11.13 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.99 0.805 . . . . 0.0 112.559 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.3 t -122.94 143.93 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.173 1.389 . . . . 0.0 109.757 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.87 -30.42 9.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.286 0.634 . . . . 0.0 112.016 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -160.55 167.27 27.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.874 1.269 . . . . 0.0 108.07 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 tt -155.07 142.13 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.73 151.4 45.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.633 1.573 . . . . 0.0 109.245 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.0 t -140.56 143.51 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.089 0.859 . . . . 0.0 109.546 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 m -112.59 167.99 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.515 1.926 . . . . 0.0 109.297 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.82 -56.98 1.92 Allowed 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.282 1.033 . . . . 0.0 109.239 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.4 -58.2 3.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.977 1.311 . . . . 0.0 111.118 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -91.72 13.38 18.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.277 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 32.15 68.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.795 3.238 . . . . 0.0 112.723 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -136.86 147.85 46.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.067 0.947 . . . . 0.0 109.842 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.34 133.92 50.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.331 1.852 . . . . 0.0 109.665 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 38.4 m -112.4 114.28 26.92 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 128.672 2.789 . . . . 0.0 108.66 -176.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -118.87 113.57 42.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.0 t -100.04 91.5 2.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -171.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.04 13.62 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.717 0.807 . . . . 0.0 113.033 -166.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -102.28 111.14 64.15 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.044 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.9 67.57 3.17 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.974 3.116 . . . . 0.0 109.969 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.43 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.145 1.378 . . . . 0.0 108.702 -173.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.4 -42.18 37.24 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.33 0.252 . . . . 0.0 110.846 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.7 165.15 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 124.402 1.081 . . . . 0.0 108.474 -175.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -110.49 158.31 18.65 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.024 1.329 . . . . 0.0 112.056 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -51.09 -46.16 31.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 C-N-CA 124.069 0.948 . . . . 0.0 111.506 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.68 -38.21 84.18 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.174 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -52.0 65.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 120.739 1.609 . . . . 0.0 108.176 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.0 mmt -49.8 -63.14 1.2 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -59.05 -56.19 25.47 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.066 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -43.04 -52.46 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.539 1.135 . . . . 0.0 109.727 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -63.26 -42.19 99.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.39 -62.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 O-C-N 121.838 -0.539 . . . . 0.0 110.174 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -42.77 -41.96 3.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 112.273 171.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.79 -31.9 50.6 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.027 0.831 . . . . 0.0 113.215 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.43 -41.73 90.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.408 0.549 . . . . 0.0 110.84 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.19 -17.89 3.34 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.784 1.183 . . . . 0.0 111.202 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -80.78 113.3 39.08 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.77 -173.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.32 149.6 90.81 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 108.682 -1.315 . . . . 0.0 108.682 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.91 137.32 26.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.281 0.233 . . . . 0.0 111.052 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -107.28 74.9 0.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.7 p -62.57 103.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.107 1.363 . . . . 0.0 110.298 171.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -154.57 55.65 0.68 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.458 0.647 . . . . 0.0 112.125 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -158.14 149.78 21.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.19 81.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.29 90.06 4.95 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 170.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.52 35.0 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.764 1.626 . . . . 0.0 109.501 -173.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.451 ' N ' ' OE2' ' A' ' 2' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.92 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.451 ' OE2' ' N ' ' A' ' 1' ' ' GLY . 14.9 mm-40 -110.51 145.41 37.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -162.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 m -107.61 129.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -170.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.7 122.63 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -107.31 130.35 54.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -115.78 119.43 35.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.1 122.4 35.65 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.081 1.352 . . . . 0.0 108.804 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -70.07 138.6 52.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 172.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.86 143.7 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.26 152.0 19.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.31 -37.0 1.99 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.419 0.533 . . . . 0.0 114.268 166.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.5 mtp -70.6 80.47 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.274 1.037 . . . . 0.0 111.319 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.63 24.51 12.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.771 1.228 . . . . 0.0 111.924 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 p -161.03 166.68 27.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.162 0.982 . . . . 0.0 111.45 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -63.79 168.93 4.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.362 168.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 80.05 -64.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.646 1.178 . . . . 0.0 109.864 -172.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 m -60.11 -59.01 6.1 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.995 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.5 p -49.61 -63.15 1.19 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.665 1.186 . . . . 0.0 110.287 173.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -53.22 -40.74 64.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 111.51 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.7 m -59.98 -49.27 78.34 Favored 'General case' 0 N--CA 1.457 -0.086 0 O-C-N 121.621 -0.675 . . . . 0.0 109.837 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.58 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.99 -53.9 36.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.641 0.776 . . . . 0.0 110.506 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -52.23 52.62 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.219 0.914 . . . . 0.0 111.788 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.17 -58.33 8.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -66.26 -29.37 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.887 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.83 -30.84 7.22 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.736 0.684 . . . . 0.0 113.236 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -89.93 6.95 39.79 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.515 1.158 . . . . 0.0 112.354 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.16 152.35 44.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.516 -1.365 . . . . 0.0 111.982 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -96.28 84.87 3.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.114 1.365 . . . . 0.0 109.575 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.69 -4.87 0.8 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 115.407 0.923 . . . . 0.0 115.407 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.23 134.68 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.058 0.943 . . . . 0.0 108.876 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -94.64 -34.14 12.71 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 111.319 175.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.3 165.95 32.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.91 145.44 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 103.233 -2.877 . . . . 0.0 103.233 -171.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -142.34 150.72 41.13 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.886 1.274 . . . . 0.0 109.589 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.9 t -140.39 106.72 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.977 0.808 . . . . 0.0 110.181 178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -94.73 80.88 3.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.12 1.368 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -48.01 -41.05 24.5 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.574 0.75 . . . . 0.0 112.371 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.31 -56.33 5.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.093 1.757 . . . . 0.0 110.692 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -100.27 22.83 10.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.955 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 34.19 57.65 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.043 2.537 . . . . 0.0 113.285 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 39.2 tt0 -138.06 131.18 30.23 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.24 147.26 28.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.514 1.526 . . . . 0.0 110.031 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.3 m -124.68 120.12 30.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.307 2.643 . . . . 0.0 106.985 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -121.04 124.92 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.98 97.31 5.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 118.298 0.499 . . . . 0.0 110.443 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -117.75 169.02 9.92 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.341 0.657 . . . . 0.0 112.682 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.91 114.17 61.88 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.209 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.57 77.08 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.532 2.821 . . . . 0.0 111.57 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -177.23 -43.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 127.66 2.384 . . . . 0.0 108.279 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.15 -47.59 27.77 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.4 176.27 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.33 1.452 . . . . 0.0 107.749 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.2 p -143.12 165.99 25.9 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.894 0.77 . . . . 0.0 111.114 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.53 -34.26 28.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 C-N-CA 122.964 0.506 . . . . 0.0 111.953 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -62.06 -42.6 99.36 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.662 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.71 -52.8 62.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.1 mtp -47.34 -59.9 2.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.176 0.591 . . . . 0.0 111.626 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -62.09 -52.88 62.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -47.92 -50.06 28.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.806 0.73 . . . . 0.0 109.241 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -61.4 -49.27 77.58 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.28 -63.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.805 -0.56 . . . . 0.0 110.514 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -45.94 -39.15 8.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.754 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.63 60.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.736 1.153 . . . . 0.0 113.044 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.0 mmt -56.61 -39.43 73.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.51 0.596 . . . . 0.0 110.843 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.87 -17.98 4.33 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.333 1.444 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -78.47 115.22 49.73 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 123.856 0.862 . . . . 0.0 110.213 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -66.83 141.55 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.07 138.03 39.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.646 0.378 . . . . 0.0 111.506 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.09 78.73 1.2 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.733 0.813 . . . . 0.0 109.276 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.6 p -65.07 104.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.841 1.656 . . . . 0.0 110.42 170.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -156.18 58.48 0.58 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.634 0.731 . . . . 0.0 112.524 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -156.36 132.06 9.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 tp -130.89 63.98 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -84.47 127.69 34.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.607 0.717 . . . . 0.0 109.098 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.06 81.97 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.249 1.028 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 163.151 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.25 160.65 0.76 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.108 1.763 . . . . 0.0 110.91 164.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.91 131.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.91 0.884 . . . . 0.0 109.771 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.24 123.64 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.584 1.554 . . . . 0.0 106.888 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 19.7 mt -93.08 128.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 159.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -110.24 127.65 55.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.455 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 13.1 ptm -140.71 132.06 26.73 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -75.87 138.84 41.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 m -124.85 150.7 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.39 150.04 31.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.203 0.456 . . . . 0.0 110.339 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.37 -33.1 1.57 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.666 0.651 . . . . 0.0 113.865 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.9 mtp -67.3 78.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.932 0.893 . . . . 0.0 111.916 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -134.07 43.55 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.392 1.077 . . . . 0.0 110.16 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -161.25 151.25 17.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.476 1.11 . . . . 0.0 108.752 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -75.03 55.83 0.74 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.893 1.277 . . . . 0.0 111.427 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.8 m -136.77 -64.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -60.43 -54.24 47.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.751 0.821 . . . . 0.0 109.737 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 t -45.8 -62.94 1.09 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.535 1.134 . . . . 0.0 110.006 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 t -63.77 -39.13 93.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.989 0.516 . . . . 0.0 109.937 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.0 m -58.82 -49.59 77.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.772 -0.58 . . . . 0.0 110.076 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.6 -50.73 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.258 0.481 . . . . 0.0 109.939 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -44.41 -54.57 5.77 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.499 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.68 -57.39 20.12 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.796 0.712 . . . . 0.0 112.04 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -58.63 -54.46 46.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.42 0.628 . . . . 0.0 110.155 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.72 -38.29 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.99 0.916 . . . . 0.0 110.159 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.73 18.94 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.856 -0.527 . . . . 0.0 112.24 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -73.47 -13.82 61.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.18 140.78 47.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 120.266 1.394 . . . . 0.0 112.31 -169.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -69.51 80.17 0.4 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.015 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.31 -19.32 0.23 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.43 133.55 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -31.17 13.01 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.042 0.537 . . . . 0.0 111.485 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -154.36 161.05 41.97 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -156.07 137.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -138.51 153.13 48.75 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.289 1.036 . . . . 0.0 110.148 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.0 t -138.18 111.74 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -87.7 69.54 9.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -42.49 31.49 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.498 0.499 . . . . 0.0 110.624 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -56.33 5.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.711 2.004 . . . . 0.0 111.102 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -98.56 22.35 9.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.062 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 44.13 53.74 6.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.706 2.002 . . . . 0.0 112.782 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.28 147.79 49.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.453 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 148.93 48.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.383 1.873 . . . . 0.0 109.626 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -129.36 116.69 19.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.461 2.704 . . . . 0.0 107.064 -171.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 mm -123.17 110.41 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.57 94.64 3.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -171.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -111.91 167.8 10.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.311 0.577 . . . . 0.0 112.084 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -110.12 113.64 56.62 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.671 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.13 77.11 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.434 2.756 . . . . 0.0 111.176 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -177.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 128.018 2.527 . . . . 0.0 107.954 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.13 -48.55 17.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.39 176.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.514 1.526 . . . . 0.0 108.316 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.1 p -142.62 162.0 36.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.544 0.738 . . . . 0.0 111.502 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.1 t -44.08 -45.61 2.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 125.452 1.501 . . . . 0.0 111.681 175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -54.99 39.0 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-O 117.146 -1.407 . . . . 0.0 109.035 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -46.47 -55.33 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 110.437 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.0 mmt -46.21 -56.92 5.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.814 0.734 . . . . 0.0 111.713 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -62.84 -61.57 2.31 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.212 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -40.35 -52.14 2.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.961 1.704 . . . . 0.0 109.156 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -61.98 -47.37 85.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.98 -64.73 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.83 -0.544 . . . . 0.0 111.089 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -43.98 -40.05 4.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.69 0.796 . . . . 0.0 112.692 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.72 -32.41 59.62 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.326 0.966 . . . . 0.0 112.861 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.8 mmt -57.81 -41.81 82.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.368 0.531 . . . . 0.0 110.293 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.53 -19.05 2.81 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.622 1.106 . . . . 0.0 111.093 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -78.08 119.27 76.71 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.008 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.91 145.51 80.31 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.575 -1.356 . . . . 0.0 108.575 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.69 135.99 26.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.609 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -99.18 82.82 2.76 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.455 ' HA ' ' CB ' ' A' ' 7' ' ' MET . 2.4 p -70.07 105.58 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.069 1.347 . . . . 0.0 110.444 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -155.31 58.98 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 mttm -153.71 154.01 33.31 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 159.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.59 78.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 163.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -92.33 114.74 27.37 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.06 -155.14 15.32 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 129.772 3.229 . . . . 0.0 107.909 168.762 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.174 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 78.69 108.85 0.07 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.977 1.711 . . . . 0.0 109.728 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.99 136.29 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.933 0.893 . . . . 0.0 109.23 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -90.76 134.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.322 1.449 . . . . 0.0 108.655 178.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 mp -122.15 151.63 40.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 165.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -120.24 123.03 42.22 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -124.01 129.53 51.07 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.138 1.375 . . . . 0.0 108.345 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 120.85 29.47 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.389 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.86 125.12 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 124.228 0.955 . . . . 0.0 109.347 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -87.64 152.49 22.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.394 0.677 . . . . 0.0 109.264 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.82 -46.18 1.23 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.518 0.58 . . . . 0.0 112.87 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mtp -70.01 82.64 0.49 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.807 0.804 . . . . 0.0 111.924 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.8 m -133.61 -9.07 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.703 1.601 . . . . 0.0 112.22 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 p -80.8 -17.38 51.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.444 1.498 . . . . 0.0 113.55 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 m80 84.45 -31.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.267 2.227 . . . . 0.0 112.262 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -62.26 -65.76 0.64 Allowed 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -50.88 -48.5 60.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 111.83 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -48.0 -62.32 1.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 109.754 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -59.35 -47.17 86.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.486 1.114 . . . . 0.0 110.84 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.9 m -52.15 -50.09 62.44 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.706 0.803 . . . . 0.0 110.877 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.9 -47.8 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 123.807 0.843 . . . . 0.0 109.447 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -44.67 -52.73 7.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.038 0.935 . . . . 0.0 110.079 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.54 8.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.979 0.8 . . . . 0.0 112.683 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -50.71 70.76 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 121.508 0.67 . . . . 0.0 109.984 -171.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.36 -41.22 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.774 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.78 -34.46 21.87 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.319 0.485 . . . . 0.0 112.518 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -71.14 -7.93 50.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.796 0.838 . . . . 0.0 113.095 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.6 144.77 45.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 120.656 1.571 . . . . 0.0 111.689 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -81.73 61.19 5.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.16 22.45 0.02 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.57 150.52 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -111.77 -40.35 4.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.02 0.928 . . . . 0.0 109.387 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -159.97 164.86 32.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 tt -157.67 141.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 103.903 -2.628 . . . . 0.0 103.903 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -143.04 144.72 32.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.628 1.171 . . . . 0.0 110.119 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.64 131.74 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.174 0.897 . . . . 0.0 110.505 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -113.88 94.28 4.76 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.227 1.811 . . . . 0.0 109.733 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.32 91.22 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.058 -0.401 . . . . 0.0 112.075 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.83 -57.18 6.8 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.791 1.237 . . . . 0.0 111.049 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -95.2 20.62 8.92 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.742 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 30.81 67.35 0.12 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.776 2.43 . . . . 0.0 113.185 -169.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -131.35 157.64 42.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.626 1.17 . . . . 0.0 109.742 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.17 149.88 50.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.663 1.185 . . . . 0.0 109.698 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 m -127.66 121.3 30.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.424 2.689 . . . . 0.0 106.463 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 mm -128.4 118.87 48.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.7 t -121.66 105.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.202 -170.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -137.58 176.18 8.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.549 -0.72 . . . . 0.0 112.122 -168.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.7 108.26 61.14 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.307 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.82 71.89 4.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 3.307 . . . . 0.0 110.264 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -173.23 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.559 1.944 . . . . 0.0 108.656 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.09 -42.05 11.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.497 0.319 . . . . 0.0 111.297 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.23 160.62 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 125.334 1.453 . . . . 0.0 108.211 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -119.93 168.83 10.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.191 0.996 . . . . 0.0 112.153 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.82 -42.5 18.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.842 0.457 . . . . 0.0 110.699 166.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.95 -46.58 71.03 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.747 -171.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.35 -58.09 4.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.779 1.172 . . . . 0.0 109.359 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.0 mmt -48.17 -66.79 0.34 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.801 0.441 . . . . 0.0 111.746 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -60.41 -58.94 6.35 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 121.129 -0.982 . . . . 0.0 112.263 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -41.44 -50.23 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.45 1.023 . . . . 0.0 109.353 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -65.65 -42.64 91.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.17 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.79 -62.8 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 119.067 0.849 . . . . 0.0 110.883 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -41.67 -40.74 2.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.934 0.894 . . . . 0.0 112.372 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -31.46 44.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.9 -39.63 78.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.371 0.668 . . . . 0.0 110.631 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.6 3.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.823 1.201 . . . . 0.0 111.307 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.06 112.08 42.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.478 1.111 . . . . 0.0 110.393 -169.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.47 128.05 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.795 1.663 . . . . 0.0 109.699 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.7 139.04 53.61 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.864 0.866 . . . . 0.0 111.687 -174.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -111.7 76.83 1.0 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.514 0.726 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.5 p -68.76 103.15 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.8 1.64 . . . . 0.0 110.73 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.09 57.0 0.59 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 112.787 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 74' ' ' GLU . 1.3 mmtt -158.7 139.79 13.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -137.88 80.93 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.496 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -85.13 175.88 8.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.281 0.562 . . . . 0.0 110.666 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.41 -78.89 1.42 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.691 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.862 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -120.07 169.14 10.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.091 2.156 . . . . 0.0 111.03 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -136.82 140.49 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.502 1.521 . . . . 0.0 107.729 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.22 129.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.57 142.82 43.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -128.69 116.76 20.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 7.1 ptp -113.42 131.71 55.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.524 0.729 . . . . 0.0 109.566 173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -68.01 137.84 55.4 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 165.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 m -121.74 151.96 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -118.22 145.7 44.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.2 -41.45 2.41 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.813 0.721 . . . . 0.0 112.554 171.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -56.56 115.19 2.38 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.12 0.96 . . . . 0.0 110.498 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 17.9 m -148.33 39.35 0.9 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.248 1.019 . . . . 0.0 108.362 178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -152.53 158.03 41.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -67.19 -19.21 65.53 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.456 0.473 . . . . 0.0 111.928 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.89 -58.1 9.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.34 -52.53 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.675 0.39 . . . . 0.0 110.879 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -54.83 -55.94 24.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -57.05 -45.14 83.42 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.467 0.707 . . . . 0.0 111.196 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -54.6 -50.48 67.95 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.277 -0.889 . . . . 0.0 110.915 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.43 -48.23 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -46.16 -53.59 10.17 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.013 1.325 . . . . 0.0 109.804 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.77 -59.34 9.93 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.102 0.858 . . . . 0.0 111.286 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -55.6 -61.22 2.49 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.601 0.7 . . . . 0.0 110.884 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.69 -47.46 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.752 0.821 . . . . 0.0 109.365 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.41 -40.92 39.68 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -73.68 -9.6 58.83 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.858 0.863 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mt -85.52 132.18 34.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.942 1.246 . . . . 0.0 110.198 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.33 134.95 55.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.62 -20.41 4.9 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.421 0.534 . . . . 0.0 112.466 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.3 141.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.876 1.271 . . . . 0.0 110.392 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -30.77 10.62 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 111.707 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -164.52 168.81 17.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -158.5 143.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -144.85 93.69 2.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 0.0 112.014 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.2 105.36 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.246 0.618 . . . . 0.0 111.188 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -96.68 125.39 41.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.218 1.007 . . . . 0.0 111.402 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -44.64 18.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.978 0.511 . . . . 0.0 110.25 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -61.58 2.06 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 126.142 1.777 . . . . 0.0 110.622 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -91.87 18.61 7.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.863 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.2 62.7 0.29 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.371 2.668 . . . . 0.0 112.234 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.91 124.33 18.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.64 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.38 112.84 25.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.31 1.444 . . . . 0.0 109.839 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -83.76 132.01 34.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.007 1.323 . . . . 0.0 107.753 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -131.07 124.98 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.6 109.02 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.448 0.567 . . . . 0.0 110.442 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -129.67 166.8 19.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -165.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -101.3 106.4 45.21 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 109.758 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.61 81.32 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.625 2.884 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 175.21 -42.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.493 2.317 . . . . 0.0 107.802 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.26 -56.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 167.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.171 1.389 . . . . 0.0 110.167 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -130.01 166.45 20.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.095 1.358 . . . . 0.0 110.091 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -46.85 -45.44 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.621 1.169 . . . . 0.0 111.536 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.71 -39.06 87.14 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 118.942 -0.551 . . . . 0.0 111.171 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.4 -46.95 88.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.6 mtt -51.78 -60.62 2.96 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 122.521 0.329 . . . . 0.0 111.7 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -55.51 33.05 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.064 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -45.56 -53.56 8.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 109.284 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -59.18 -49.02 79.44 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -71.99 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 110.793 -172.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.96 -37.1 13.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.89 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.44 64.75 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.782 1.174 . . . . 0.0 112.73 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.1 mmt -60.39 -43.72 96.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 110.189 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.93 -17.56 3.63 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.96 1.267 . . . . 0.0 110.953 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -72.26 115.55 40.03 Favored Pre-proline 0 N--CA 1.453 -0.318 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.112 -173.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -69.2 139.48 42.28 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.527 -1.374 . . . . 0.0 108.527 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.23 138.2 41.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.778 0.431 . . . . 0.0 112.04 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -113.22 78.56 1.15 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.442 1.497 . . . . 0.0 109.512 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -50.71 112.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.597 1.159 . . . . 0.0 108.983 161.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.47 59.7 0.63 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 112.398 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.25 159.18 37.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -151.56 55.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.28 67.41 9.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.772 0.829 . . . . 0.0 109.423 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.0 156.7 43.89 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 113.684 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 128.122 2.569 . . . . 0.0 112.25 171.603 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.8 pm0 -66.24 173.92 2.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.571 0.748 . . . . 0.0 110.341 160.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -117.34 132.51 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 127.36 2.264 . . . . 0.0 106.374 162.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.41 130.11 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -118.56 143.39 46.8 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 170.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -123.73 117.83 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.9 ptp -123.19 131.76 53.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.283 1.033 . . . . 0.0 109.187 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -83.76 116.22 22.59 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.21 144.69 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -56.94 148.68 20.48 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.399 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.31 40.12 1.72 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.159 0.885 . . . . 0.0 113.527 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 45.4 -140.33 0.37 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 113.205 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -124.64 -41.27 2.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.178 1.391 . . . . 0.0 110.267 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.15 165.47 24.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -55.23 -26.08 37.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.536 0.734 . . . . 0.0 112.623 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.4 m -50.59 -44.21 56.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.756 -0.59 . . . . 0.0 110.465 171.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -66.64 -55.22 16.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.317 0.647 . . . . 0.0 110.09 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.8 p -53.97 -54.38 39.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.4 t -57.41 -45.98 83.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.942 0.897 . . . . 0.0 110.942 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.6 m -57.09 -49.32 76.23 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.632 -0.668 . . . . 0.0 109.974 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.9 mt -56.07 -48.45 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 118.466 0.575 . . . . 0.0 109.756 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -55.83 -50.44 70.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.803 0.841 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -54.94 33.79 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.648 0.642 . . . . 0.0 112.083 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -53.67 -50.63 65.39 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.256 1.022 . . . . 0.0 110.241 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -63.29 -49.13 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 109.75 177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.37 -36.15 10.71 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 117.989 0.358 . . . . 0.0 112.314 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -69.06 -15.43 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.29 145.01 35.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.693 1.133 . . . . 0.0 111.736 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.18 65.13 4.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.28 13.67 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -170.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.97 143.71 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 119.456 1.628 . . . . 0.0 110.41 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -108.33 -45.05 3.98 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.503 1.521 . . . . 0.0 109.817 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -163.19 171.12 16.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.2 tt -159.57 144.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -176.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.3 mmtt -141.84 84.73 1.9 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.671 0.788 . . . . 0.0 110.742 -179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.19 105.72 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.573 0.749 . . . . 0.0 110.78 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 m -108.48 135.08 50.36 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.824 0.85 . . . . 0.0 111.031 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -48.05 6.52 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.915 0.486 . . . . 0.0 109.764 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -54.39 27.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.636 1.574 . . . . 0.0 110.25 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -79.23 -0.98 34.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.946 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 49.23 58.09 5.76 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.407 1.883 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.4 130.69 8.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.047 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -110.21 115.53 29.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.258 1.423 . . . . 0.0 108.996 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 53.4 m -90.14 133.85 34.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 107.309 169.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.66 129.93 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -117.92 106.6 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -127.16 165.22 19.98 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 122.062 -0.399 . . . . 0.0 111.564 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.65 123.05 62.9 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.36 145.67 92.88 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.609 1.539 . . . . 0.0 108.676 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 87.27 -23.02 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.693 1.597 . . . . 0.0 111.824 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.46 -47.36 8.4 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.719 1.145 . . . . 0.0 110.929 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -137.91 158.02 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.639 1.576 . . . . 0.0 108.448 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -114.24 169.92 8.68 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.854 0.862 . . . . 0.0 111.053 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.92 -41.1 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.481 0.712 . . . . 0.0 111.482 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.46 -53.21 51.86 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -171.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -37.3 -60.47 0.66 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.079 1.752 . . . . 0.0 111.486 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 15.4 mtm -48.77 -64.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -59.05 5.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.869 -173.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -36.12 -55.35 0.78 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.006 1.323 . . . . 0.0 111.11 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -60.85 -43.01 98.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.363 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -65.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -37.62 -46.26 0.84 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.177 0.991 . . . . 0.0 112.363 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.87 -32.04 60.4 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.6 mmt -60.32 -39.91 88.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.366 0.53 . . . . 0.0 110.643 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.66 -11.63 3.44 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.512 1.053 . . . . 0.0 111.281 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -90.14 110.47 40.6 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.039 0.936 . . . . 0.0 109.151 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.61 132.82 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.844 1.696 . . . . 0.0 109.301 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.28 49.08 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.003 0.921 . . . . 0.0 111.423 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -117.38 79.07 1.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.845 0.858 . . . . 0.0 109.438 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.1 p -63.62 108.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.025 1.73 . . . . 0.0 110.95 175.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -154.29 59.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.203 1.002 . . . . 0.0 113.239 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.23 159.86 34.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 120.803 -1.186 . . . . 0.0 108.166 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.1 tp -155.46 55.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 122.29 1.043 . . . . 0.0 109.377 -177.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.33 69.93 10.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -172.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.9 17.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.854 1.216 . . . . 0.0 113.503 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 165.055 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.127 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.94 179.3 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.613 0.706 . . . . 0.0 110.592 172.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.31 141.46 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 125.467 1.507 . . . . 0.0 107.889 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.42 122.62 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 15.0 mt -100.09 141.83 32.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.8 tptt -119.12 125.49 49.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -124.34 119.12 28.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.378 1.471 . . . . 0.0 108.955 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 120.76 22.95 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m -105.68 152.56 7.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -116.12 150.48 37.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.168 0.44 . . . . 0.0 110.786 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.97 -30.23 2.07 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.533 0.587 . . . . 0.0 114.079 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtp -68.93 85.38 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.016 0.908 . . . . 0.0 111.669 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -114.92 6.97 15.52 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.761 1.224 . . . . 0.0 112.232 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -129.12 139.74 51.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.317 0.962 . . . . 0.0 111.236 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -31.51 54.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.363 1.065 . . . . 0.0 111.962 -171.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -45.81 -55.1 7.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.329 1.052 . . . . 0.0 111.709 170.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.86 -54.6 28.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.315 0.507 . . . . 0.0 109.847 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -51.68 -54.96 22.42 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.637 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.6 t -57.85 -46.09 85.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.473 0.579 . . . . 0.0 111.346 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.8 m -56.81 -50.91 70.95 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.368 -0.833 . . . . 0.0 110.843 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.77 -43.9 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.97 -47.88 76.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.917 0.887 . . . . 0.0 110.658 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.88 41.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.825 0.726 . . . . 0.0 111.321 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -65.62 -59.91 3.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.433 0.635 . . . . 0.0 110.946 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.75 -30.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.009 0.924 . . . . 0.0 110.388 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.69 -29.31 7.71 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.498 -0.612 . . . . 0.0 112.764 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -92.43 7.9 41.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.494 1.147 . . . . 0.0 112.77 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.44 159.5 33.13 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.413 1.46 . . . . 0.0 111.656 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.36 82.97 2.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.471 1.508 . . . . 0.0 109.725 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.08 11.79 0.26 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.4 128.6 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 109.599 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -86.22 -36.63 19.32 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -154.23 168.24 27.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 122.201 1.0 . . . . 0.0 108.656 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -157.42 141.6 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -140.61 82.49 1.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 0.0 110.432 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.13 116.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.515 0.726 . . . . 0.0 109.111 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -97.33 -174.23 2.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -147.52 -47.8 0.17 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.23 1.012 . . . . 0.0 109.533 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.59 -55.83 7.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.514 1.525 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -94.04 19.19 9.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.56 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 36.52 61.48 0.82 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.35 2.26 . . . . 0.0 112.445 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.14 154.55 37.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.184 -0.947 . . . . 0.0 108.758 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.64 130.04 31.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.104 0.962 . . . . 0.0 109.877 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.8 m -92.85 132.75 36.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.743 1.617 . . . . 0.0 107.038 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.3 125.56 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 170.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.33 119.42 50.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.98 161.04 38.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -98.91 116.17 65.42 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.531 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.94 73.13 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.583 2.855 . . . . 0.0 110.546 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -174.73 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 109.744 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.27 -42.88 18.26 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.146 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.27 159.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -119.57 168.68 10.77 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.113 0.869 . . . . 0.0 112.139 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -44.03 -50.33 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.289 1.435 . . . . 0.0 111.209 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -42.68 86.92 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.71 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -48.6 -52.7 21.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.512 1.505 . . . . 0.0 108.663 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -61.64 2.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 121.38 -0.128 . . . . 0.0 111.236 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -58.24 9.14 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.569 -0.707 . . . . 0.0 112.266 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.43 -49.83 24.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.103 0.961 . . . . 0.0 109.458 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.28 -44.28 96.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.896 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.03 -63.87 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 123.166 0.587 . . . . 0.0 110.538 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -43.23 -41.41 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.468 0.707 . . . . 0.0 112.671 172.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.97 -31.26 50.12 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.044 0.838 . . . . 0.0 113.007 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.1 mmt -57.02 -41.65 78.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.372 0.533 . . . . 0.0 111.064 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 -20.79 2.53 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.531 1.062 . . . . 0.0 111.057 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -84.77 110.51 28.32 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 124.24 1.016 . . . . 0.0 110.068 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.82 139.21 61.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.78 134.58 26.82 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.6 72.14 1.54 Allowed 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.172 0.589 . . . . 0.0 110.371 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.55 94.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.012 1.325 . . . . 0.0 112.548 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -158.51 84.32 0.84 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.005 -0.434 . . . . 0.0 110.083 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.16 160.43 37.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 158.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mp -139.09 73.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.8 176.08 6.77 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.73 157.74 27.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.233 -1.841 . . . . 0.0 107.017 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.75 -173.95 1.65 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.326 1.45 . . . . 0.0 109.29 158.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 140.91 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.4 t -103.59 127.45 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.274 1.43 . . . . 0.0 107.473 171.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 pp -112.23 152.02 28.92 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -122.0 121.36 36.85 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.0 mtt -102.31 139.46 37.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -83.93 134.5 34.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 163.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.89 143.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 119.581 1.082 . . . . 0.0 108.819 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -114.58 140.87 48.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.82 -34.61 5.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.83 1.205 . . . . 0.0 112.922 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.0 mtm -69.19 95.33 0.75 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.059 0.93 . . . . 0.0 111.527 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -111.05 27.24 9.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.376 1.07 . . . . 0.0 112.886 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -151.04 159.74 44.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.282 0.947 . . . . 0.0 109.219 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -76.1 -12.66 60.15 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 m -62.76 -54.46 38.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.23 -51.68 65.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.771 0.26 . . . . 0.0 110.775 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p -52.69 -59.34 4.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 109.912 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -57.52 -44.3 84.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.938 0.895 . . . . 0.0 111.258 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.6 m -55.45 -48.69 74.1 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.364 -0.835 . . . . 0.0 110.751 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.34 -50.03 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 122.003 -0.435 . . . . 0.0 109.989 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -46.6 -49.56 18.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.511 1.124 . . . . 0.0 109.684 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -59.11 11.34 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.348 0.975 . . . . 0.0 112.398 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -55.23 37.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.725 0.763 . . . . 0.0 110.294 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.3 mm -70.83 -32.48 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.76 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.19 20.3 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.46 -0.775 . . . . 0.0 112.792 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -79.13 -3.6 46.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.312 1.056 . . . . 0.0 112.552 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.76 134.08 48.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.302 1.41 . . . . 0.0 111.265 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -77.26 115.71 17.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.29 -9.19 5.93 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.21 0.91 . . . . 0.0 111.904 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.45 150.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.28 0.632 . . . . 0.0 109.818 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -109.54 -40.4 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.647 1.579 . . . . 0.0 109.081 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -162.31 172.25 15.97 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.32 1.057 . . . . 0.0 108.741 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -156.46 143.23 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -142.61 146.76 34.86 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.659 1.583 . . . . 0.0 109.419 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -136.23 146.22 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.616 1.098 . . . . 0.0 109.793 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 m -124.68 148.46 47.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 127.494 2.318 . . . . 0.0 109.636 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.0 -56.91 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.87 1.668 . . . . 0.0 110.946 -171.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.03 -58.68 4.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.682 1.593 . . . . 0.0 110.484 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -85.15 0.29 52.19 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 41.23 70.99 0.22 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.737 2.815 . . . . 0.0 110.762 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -140.29 145.61 37.48 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.984 -163.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.75 113.15 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.628 1.571 . . . . 0.0 109.721 -168.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 39.7 m -89.2 118.7 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.505 2.722 . . . . 0.0 109.574 176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -121.71 124.71 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 6.5 t -118.27 104.78 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -138.05 167.52 21.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 111.797 -167.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -101.79 107.82 53.53 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 123.931 0.892 . . . . 0.0 109.377 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.68 83.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.153 2.569 . . . . 0.0 110.51 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.3 m80 176.54 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 128.132 2.573 . . . . 0.0 107.765 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.65 -51.46 10.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.595 0.236 . . . . 0.0 110.756 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tp -134.34 177.13 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.471 1.509 . . . . 0.0 107.648 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.1 p -136.57 171.97 13.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.602 0.637 . . . . 0.0 110.609 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.2 t -48.33 -35.28 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.043 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -47.41 62.62 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.934 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.95 -51.34 70.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.693 1.197 . . . . 0.0 108.241 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.9 mmt -47.27 -59.81 2.93 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.23 -58.98 6.07 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.14 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 -50.91 9.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.424 1.09 . . . . 0.0 108.692 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -63.44 -45.63 90.01 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.166 0.291 . . . . 0.0 111.311 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.1 -66.62 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.149 0.58 . . . . 0.0 111.213 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -45.3 -38.79 5.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.941 0.791 . . . . 0.0 111.918 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.71 62.14 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.629 1.104 . . . . 0.0 113.123 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.5 mmt -54.93 -41.03 70.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.544 0.611 . . . . 0.0 110.546 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -18.86 3.28 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.52 1.057 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.14 113.58 34.73 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.998 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.37 136.78 44.71 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 N-CA-C 108.965 -1.206 . . . . 0.0 108.965 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 131.71 45.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.875 0.845 . . . . 0.0 112.088 -176.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -103.81 77.51 1.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.836 2.054 . . . . 0.0 109.115 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.4 p -62.61 107.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.738 0.815 . . . . 0.0 110.634 171.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -155.58 55.46 0.62 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -157.35 157.32 33.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 tp -147.69 56.88 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -82.51 60.4 5.13 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.235 -0.915 . . . . 0.0 109.806 -172.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -46.96 108.72 0.3 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.015 -0.993 . . . . 0.0 111.771 -160.215 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -154.68 176.56 12.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.876 0.87 . . . . 0.0 108.737 -152.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.9 p -87.36 112.99 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -176.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.83 128.13 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -116.82 123.11 46.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 167.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -100.15 118.61 36.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -118.0 125.14 49.81 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.361 1.464 . . . . 0.0 108.654 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -70.83 138.08 50.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.1 m -129.74 139.2 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -101.26 150.31 23.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 -40.54 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.327 -0.707 . . . . 0.0 113.779 166.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.4 mtm -62.79 86.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.393 1.097 . . . . 0.0 110.934 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 m -148.19 47.75 1.06 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.732 1.613 . . . . 0.0 108.243 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 p -128.74 -4.66 5.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.093 1.757 . . . . 0.0 111.578 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 66.08 -25.69 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.431 1.493 . . . . 0.0 114.082 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -67.5 -75.15 0.1 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.075 -1.015 . . . . 0.0 111.181 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -44.02 -53.9 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.156 1.783 . . . . 0.0 112.254 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -50.54 -50.7 52.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.688 0.795 . . . . 0.0 111.025 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -65.74 -44.1 86.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.143 0.577 . . . . 0.0 110.494 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 m -50.87 -52.63 39.83 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.696 -0.628 . . . . 0.0 110.313 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -44.74 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 119.196 -0.431 . . . . 0.0 110.665 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.13 -49.05 75.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.327 0.512 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.64 -54.49 30.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.593 0.615 . . . . 0.0 111.806 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -60.72 -55.03 38.04 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.97 -0.724 . . . . 0.0 110.769 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.16 -43.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.143 1.377 . . . . 0.0 109.804 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.07 -29.78 6.9 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.773 0.701 . . . . 0.0 113.961 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -87.87 -12.95 43.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.802 1.301 . . . . 0.0 112.532 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.34 130.78 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.394 1.452 . . . . 0.0 111.866 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.66 90.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.587 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.24 -26.01 0.88 Allowed Glycine 0 C--N 1.331 0.296 0 O-C-N 121.996 -0.44 . . . . 0.0 112.617 -173.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.92 147.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 117.573 0.686 . . . . 0.0 110.249 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -125.19 -31.98 3.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.335 1.054 . . . . 0.0 111.688 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.41 163.43 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -158.85 140.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -144.42 85.31 1.78 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.006 0.922 . . . . 0.0 110.49 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.75 114.99 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -94.53 165.24 12.63 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -47.67 2.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.601 0.76 . . . . 0.0 109.945 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -55.95 13.3 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.178 1.391 . . . . 0.0 110.852 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -90.56 13.37 16.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.873 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 38.5 58.67 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.964 2.105 . . . . 0.0 112.685 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 30.9 tt0 -145.95 142.28 28.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.46 123.7 34.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.522 1.129 . . . . 0.0 110.193 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 m -94.89 127.68 41.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.152 1.381 . . . . 0.0 107.687 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.41 126.11 70.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.9 112.03 34.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.345 0.52 . . . . 0.0 110.659 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -132.56 168.99 17.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.423 0.63 . . . . 0.0 112.155 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -90.97 113.06 56.84 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 124.629 1.172 . . . . 0.0 109.203 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -74.71 76.89 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.821 2.347 . . . . 0.0 110.873 -170.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -176.01 -47.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.158 2.183 . . . . 0.0 108.305 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.15 -43.83 41.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.334 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.71 169.49 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 108.002 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -138.37 164.79 28.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 111.14 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 93.9 t -43.33 -47.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 124.34 1.056 . . . . 0.0 110.899 170.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.409 ' OE1' ' NZ ' ' A' ' 59' ' ' LYS . 0.0 OUTLIER -60.81 -49.48 77.32 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.745 -175.206 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.23 -49.55 73.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.1 1.318 . . . . 0.0 109.415 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.2 -60.95 2.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.132 0.424 . . . . 0.0 111.421 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -57.08 -64.08 1.0 Allowed 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.758 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' NZ ' ' OE1' ' A' ' 55' ' ' GLU . 0.0 OUTLIER -40.26 -52.29 2.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.818 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.61 -39.03 88.16 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.89 -63.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 O-C-N 121.734 -0.604 . . . . 0.0 111.056 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -43.8 -39.26 3.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.56 0.744 . . . . 0.0 112.16 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.06 42.18 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.212 0.915 . . . . 0.0 113.164 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -61.7 -36.44 80.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.466 0.575 . . . . 0.0 111.107 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.26 -11.19 5.85 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.862 1.22 . . . . 0.0 111.263 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -84.65 114.76 57.21 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.274 1.029 . . . . 0.0 109.455 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -67.96 140.21 49.54 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.327 1.351 . . . . 0.0 108.598 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.66 140.12 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.696 0.399 . . . . 0.0 111.377 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -112.89 73.93 0.84 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.683 1.193 . . . . 0.0 110.185 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -65.98 103.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.329 1.852 . . . . 0.0 111.813 175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -157.29 54.62 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -159.05 80.71 0.77 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.963 -1.085 . . . . 0.0 111.075 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 59.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.725 1.21 . . . . 0.0 109.409 -172.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.85 64.28 5.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 135.69 50.25 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.632 -0.667 . . . . 0.0 112.637 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.721 -1.133 . . . . 0.0 109.391 -178.107 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 0.0 OUTLIER -65.69 158.74 26.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.806 1.642 . . . . 0.0 109.568 152.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.95 143.79 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.777 1.631 . . . . 0.0 107.722 163.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.14 143.91 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 124.551 1.14 . . . . 0.0 108.125 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -129.08 117.49 20.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -100.28 125.17 46.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mtt -121.05 119.93 33.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.202 1.001 . . . . 0.0 109.141 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.1 mptp? -73.4 121.96 21.31 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.23 149.66 13.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -114.76 148.01 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.86 -33.02 3.6 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.541 1.067 . . . . 0.0 113.048 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.7 mtp -69.09 75.69 0.33 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 112.91 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 m -142.26 58.2 1.46 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.588 1.155 . . . . 0.0 111.096 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.85 16.83 0.77 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.07 0.548 . . . . 0.0 111.832 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.7 m80 68.8 -35.39 0.3 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.928 1.691 . . . . 0.0 113.357 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -59.84 -51.76 68.36 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.399 1.479 . . . . 0.0 110.874 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -63.56 -60.3 3.51 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.114 0.566 . . . . 0.0 110.655 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -43.8 -58.14 2.89 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.399 1.08 . . . . 0.0 110.327 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -67.04 -43.46 82.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -55.34 -47.07 76.27 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.635 -0.666 . . . . 0.0 110.516 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.75 -48.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.74 -51.32 22.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.292 0.637 . . . . 0.0 109.835 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.24 -58.8 12.64 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.551 0.595 . . . . 0.0 112.334 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -61.28 -60.25 4.03 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.763 0.792 . . . . 0.0 109.741 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -66.37 -27.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.542 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -44.92 -37.35 5.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.59 0.614 . . . . 0.0 112.84 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -88.09 4.13 46.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.989 0.895 . . . . 0.0 112.719 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.28 153.09 43.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 120.292 -1.505 . . . . 0.0 110.374 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -87.07 141.11 28.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.77 11.5 55.02 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.017 0.817 . . . . 0.0 112.783 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -104.59 147.39 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.112 1.365 . . . . 0.0 109.541 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -109.73 -46.47 3.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.615 1.566 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.47 169.62 21.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.0 133.84 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.3 mmtt -137.76 154.46 49.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.154 1.381 . . . . 0.0 108.456 175.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.23 110.32 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -82.01 75.78 8.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 0.0 108.659 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.48 -41.72 9.83 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.476 0.71 . . . . 0.0 110.606 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.42 -56.75 4.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.441 1.497 . . . . 0.0 111.378 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.92 13.71 25.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.008 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.22 60.74 3.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.74 2.016 . . . . 0.0 111.288 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 10.2 tt0 -143.92 132.5 22.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.486 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.16 135.14 40.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.87 1.668 . . . . 0.0 109.465 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.4 m -114.12 81.9 1.61 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.169 2.588 . . . . 0.0 107.684 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.08 127.82 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.26 107.63 20.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 110.416 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -134.57 173.46 11.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.656 -0.652 . . . . 0.0 111.925 -169.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -106.76 106.98 59.5 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.629 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.32 76.28 1.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.202 3.268 . . . . 0.0 110.937 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.74 -43.21 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.627 1.971 . . . . 0.0 108.295 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.62 -42.34 18.35 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.21 169.39 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -120.24 155.54 33.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.461 1.104 . . . . 0.0 111.068 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 3.5 t -39.03 -49.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.469 1.108 . . . . 0.0 110.958 164.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -62.75 -46.75 86.6 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.788 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.11 -49.41 73.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.904 1.684 . . . . 0.0 108.53 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.26 -60.27 3.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -59.78 -56.94 15.55 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.82 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.73 -51.09 16.95 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.751 0.82 . . . . 0.0 108.947 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -60.52 -44.66 95.79 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.617 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.94 -65.15 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 122.979 0.512 . . . . 0.0 110.508 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -44.34 -40.21 5.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 118.929 0.786 . . . . 0.0 112.557 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.2 60.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.276 0.944 . . . . 0.0 113.336 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.6 mmt -52.04 -41.76 62.57 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.583 0.629 . . . . 0.0 110.513 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.38 -19.31 2.45 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.45 1.024 . . . . 0.0 111.085 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -83.73 117.52 68.89 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.052 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.84 137.32 52.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 108.721 -1.299 . . . . 0.0 108.721 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.28 47.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.733 0.813 . . . . 0.0 110.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.93 86.22 2.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.1 t -58.45 107.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.98 1.312 . . . . 0.0 109.825 165.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -159.02 56.87 0.42 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 143.23 14.79 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.72 69.25 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -81.62 101.2 9.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.17 -61.24 4.36 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.236 -173.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.068 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -53.64 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.615 2.366 . . . . 0.0 113.423 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.43 130.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.134 1.374 . . . . 0.0 107.805 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.14 115.82 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 125.14 1.376 . . . . 0.0 109.274 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 pp -90.51 138.39 31.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 171.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -113.85 126.08 54.79 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 13.7 ptm -132.24 128.24 37.46 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.922 0.889 . . . . 0.0 110.115 -177.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.0 mptp? -78.13 131.15 37.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 148.08 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.431 1.014 . . . . 0.0 109.011 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -105.97 146.52 29.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -32.52 7.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.692 1.139 . . . . 0.0 113.227 169.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.9 mtt -75.46 74.25 2.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.501 1.15 . . . . 0.0 112.442 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.2 m -106.44 39.94 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.789 1.236 . . . . 0.0 109.8 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.0 p -160.0 168.68 25.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.06 -8.06 57.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.104 0.561 . . . . 0.0 112.026 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -73.71 -64.6 0.96 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.734 0.697 . . . . 0.0 110.894 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 m -55.41 -55.27 33.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.419 0.628 . . . . 0.0 110.306 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -48.58 -56.0 9.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.818 1.247 . . . . 0.0 110.346 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.4 t -63.58 -45.19 91.55 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.982 0.513 . . . . 0.0 110.7 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -53.66 -49.47 67.87 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.815 -0.553 . . . . 0.0 110.419 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -62.78 -48.07 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 O-C-N 121.99 -0.444 . . . . 0.0 110.116 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.85 -47.64 64.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.18 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.35 25.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.489 1.042 . . . . 0.0 111.741 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -58.32 -57.29 13.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.776 0.798 . . . . 0.0 110.166 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.32 -30.38 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.13 0.972 . . . . 0.0 110.389 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.04 -31.92 8.67 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.62 0.629 . . . . 0.0 112.704 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -84.82 -1.85 56.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.192 0.996 . . . . 0.0 112.733 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.44 149.83 46.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 120.724 1.602 . . . . 0.0 110.346 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -87.29 127.86 35.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.04 14.81 9.65 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.331 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.94 137.96 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.615 1.166 . . . . 0.0 109.452 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 -31.52 10.16 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.106 0.562 . . . . 0.0 111.88 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.99 162.27 40.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 tt -155.9 138.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -140.78 136.18 32.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.437 1.095 . . . . 0.0 110.132 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.17 139.87 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.5 1.046 . . . . 0.0 110.289 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -128.5 127.38 42.33 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.134 1.774 . . . . 0.0 109.644 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.05 -47.1 12.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.933 0.893 . . . . 0.0 111.881 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.48 -58.51 6.87 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.994 1.317 . . . . 0.0 110.356 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.11 4.97 27.92 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.594 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 0.2 OUTLIER 36.22 67.34 0.31 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.317 2.647 . . . . 0.0 113.561 -177.515 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 3.0 tt0 -143.51 141.19 30.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.758 -170.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.33 148.57 43.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 109.752 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -128.14 118.92 24.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.964 3.306 . . . . 0.0 105.43 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -121.99 120.46 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.85 96.14 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 123.789 0.68 . . . . 0.0 109.227 -174.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -123.42 160.74 26.2 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.651 0.781 . . . . 0.0 111.724 -166.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -99.92 116.24 64.85 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.505 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.92 75.56 2.18 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.663 2.909 . . . . 0.0 111.66 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -176.08 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 127.08 2.152 . . . . 0.0 108.238 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.94 -47.09 26.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.86 172.66 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.976 1.31 . . . . 0.0 108.191 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -138.44 158.61 43.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.608 1.163 . . . . 0.0 110.274 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -41.09 -47.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 111.02 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -40.88 94.4 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.818 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -50.74 72.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 61.9 mmm -54.02 -62.98 1.3 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.408 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -55.79 -56.07 24.85 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.342 -0.849 . . . . 0.0 111.817 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -52.81 -46.13 67.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -42.23 93.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.789 177.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.01 -64.95 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 O-C-N 121.679 -0.638 . . . . 0.0 109.929 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -46.62 -37.76 8.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 119.003 0.82 . . . . 0.0 113.16 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.22 57.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.611 1.096 . . . . 0.0 113.004 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.0 mmt -53.52 -43.7 68.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.434 0.561 . . . . 0.0 110.577 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.82 -23.84 2.13 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.232 0.92 . . . . 0.0 111.289 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -75.39 113.38 25.41 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.033 -171.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.99 138.58 53.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.244 1.296 . . . . 0.0 109.081 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 140.41 43.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.299 0.571 . . . . 0.0 111.812 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -112.19 76.21 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 p -62.01 109.38 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.293 1.037 . . . . 0.0 108.227 168.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.58 53.66 0.67 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 3.7 mtpt -155.53 162.87 40.6 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.551 1.54 . . . . 0.0 107.122 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.1 tp -153.82 60.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.574 1.149 . . . . 0.0 108.02 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -80.0 175.47 10.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.02 160.95 24.79 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 0.0 110.048 -178.471 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.03 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.2 158.15 29.53 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.428 1.114 . . . . 0.0 108.161 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.7 t -141.25 146.96 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.419 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.05 141.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.615 1.166 . . . . 0.0 108.28 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -128.16 120.73 27.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.61 127.25 54.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptp -119.36 124.57 46.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 127.312 2.245 . . . . 0.0 108.837 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.6 tptt -72.66 136.56 45.67 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.3 m -121.11 157.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.075 0.852 . . . . 0.0 110.48 176.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -116.71 153.73 31.85 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.853 0.461 . . . . 0.0 110.572 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 -38.91 2.25 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.125 0.869 . . . . 0.0 112.866 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -58.97 93.36 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.049 0.94 . . . . 0.0 110.739 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -141.84 47.45 1.64 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.832 1.253 . . . . 0.0 108.901 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.5 p -155.16 159.46 40.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 164.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -24.81 64.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 123.108 0.255 . . . . 0.0 111.46 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -57.43 -54.94 41.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.417 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.9 m -56.41 -57.16 13.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.117 0.417 . . . . 0.0 110.244 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -55.61 -53.77 52.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.936 0.495 . . . . 0.0 110.318 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 t -61.38 -41.03 96.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.521 0.728 . . . . 0.0 111.288 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 m -59.87 -48.11 83.02 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.109 -0.995 . . . . 0.0 110.445 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.0 mt -59.31 -52.25 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 123.849 0.859 . . . . 0.0 108.72 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.99 -46.08 71.63 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.598 0.759 . . . . 0.0 110.705 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.87 -49.28 72.14 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.24 0.924 . . . . 0.0 111.874 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -59.31 5.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.087 0.943 . . . . 0.0 110.759 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 mm -63.65 -30.38 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.78 1.232 . . . . 0.0 110.755 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.29 -31.66 4.79 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.738 0.685 . . . . 0.0 113.001 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -91.21 2.94 55.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.156 0.982 . . . . 0.0 112.453 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.64 133.11 46.38 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 120.549 1.522 . . . . 0.0 111.201 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -77.55 65.14 3.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 22.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 116.547 1.379 . . . . 0.0 116.547 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.4 154.41 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 117.77 0.785 . . . . 0.0 110.31 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -115.75 -42.21 3.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.616 1.567 . . . . 0.0 109.771 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.06 172.35 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.41 140.59 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -141.56 86.2 1.99 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.0 0.92 . . . . 0.0 112.38 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -89.71 112.63 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.528 -0.733 . . . . 0.0 109.944 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -91.55 176.02 6.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.933 0.893 . . . . 0.0 109.456 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -139.05 -47.25 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.247 1.019 . . . . 0.0 110.292 179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.43 -59.27 3.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.895 1.678 . . . . 0.0 110.442 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -88.6 9.5 23.82 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.82 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.58 64.93 1.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.532 1.933 . . . . 0.0 111.034 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.73 152.21 39.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.763 0.825 . . . . 0.0 109.044 -165.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.77 123.65 15.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.387 0.613 . . . . 0.0 110.427 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.46 132.5 43.85 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.274 1.83 . . . . 0.0 107.847 171.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mm -129.62 127.49 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.65 118.4 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -141.04 174.81 10.16 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -165.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -109.17 109.02 60.69 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.875 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.48 77.62 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.833 3.022 . . . . 0.0 110.92 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -178.17 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.299 2.64 . . . . 0.0 107.74 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.4 mt -77.98 -46.6 20.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.688 0.222 . . . . 0.0 111.348 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.44 161.45 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -125.61 162.56 24.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.019 0.928 . . . . 0.0 111.181 -171.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 30.7 t -50.03 -43.96 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.232 1.013 . . . . 0.0 111.286 173.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.452 ' CD ' ' HZ1' ' A' ' 59' ' ' LYS . 2.3 tm-20 -65.47 -37.7 87.62 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.139 -176.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.54 -58.42 8.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.368 1.44 . . . . 0.0 108.387 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.9 mtt -43.55 -60.13 1.88 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER -64.16 -53.61 46.74 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.132 -175.22 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.452 ' HZ1' ' CD ' ' A' ' 55' ' ' GLU . 0.2 OUTLIER -42.0 -55.68 3.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.434 1.47 . . . . 0.0 109.576 172.666 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -59.86 -47.73 84.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.923 0.392 . . . . 0.0 111.243 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.07 -63.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.452 0.701 . . . . 0.0 111.086 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -45.29 -39.24 6.36 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.879 0.763 . . . . 0.0 111.915 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.75 56.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.529 1.059 . . . . 0.0 112.84 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.4 mmt -57.56 -44.38 85.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.321 0.51 . . . . 0.0 110.812 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.44 -16.67 4.07 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.842 1.21 . . . . 0.0 111.023 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -77.42 115.83 52.73 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.547 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.47 144.67 80.38 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.39 132.47 24.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.896 0.855 . . . . 0.0 110.943 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.02 69.94 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.944 2.498 . . . . 0.0 108.851 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -62.01 107.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.831 0.852 . . . . 0.0 110.118 172.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -156.8 54.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.34 67.44 0.46 Allowed 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.235 -0.915 . . . . 0.0 111.092 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.8 tp -78.79 69.22 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.236 0.614 . . . . 0.0 109.439 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.68 132.29 53.49 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.831 . . . . 0.0 110.082 -172.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 164.52 41.71 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 117.253 -1.356 . . . . 0.0 110.682 168.88 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 CA-C-O 118.263 -1.298 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 40.48 78.69 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.054 1.341 . . . . 0.0 113.405 166.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.03 130.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.717 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.0 124.74 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 108.112 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -115.83 127.87 55.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -113.18 126.21 55.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.8 mtt -113.54 125.9 54.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.278 1.831 . . . . 0.0 107.895 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 126.14 30.21 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.57 154.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -120.09 153.47 36.08 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.373 0.669 . . . . 0.0 109.723 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.67 47.83 65.79 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.703 168.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.9 mtm -143.46 109.64 5.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.12 26.36 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.164 1.386 . . . . 0.0 110.859 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -112.66 -4.97 14.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.535 1.534 . . . . 0.0 112.101 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 72.71 -46.99 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.52 1.528 . . . . 0.0 111.625 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -49.61 -55.64 12.86 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.617 0.767 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.83 -54.53 40.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.637 0.653 . . . . 0.0 111.374 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -53.34 -54.6 34.18 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.661 0.384 . . . . 0.0 110.084 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.64 -44.18 93.59 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.083 0.553 . . . . 0.0 111.222 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.6 m -59.81 -46.58 88.8 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.446 -0.784 . . . . 0.0 110.197 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.8 mt -58.86 -50.78 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.03 -49.98 59.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.325 0.65 . . . . 0.0 110.832 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.6 -53.64 40.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.685 0.659 . . . . 0.0 111.693 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -64.67 -56.39 14.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.624 0.726 . . . . 0.0 110.288 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -68.86 -34.69 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.704 0.802 . . . . 0.0 110.339 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.45 -27.88 26.83 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.83 -0.544 . . . . 0.0 112.6 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -90.38 3.45 53.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.117 0.959 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.84 142.76 49.6 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.223 1.374 . . . . 0.0 110.211 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.2 133.5 37.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.92 -8.37 36.38 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 123.594 0.616 . . . . 0.0 112.146 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.18 149.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.578 0.751 . . . . 0.0 109.596 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -108.16 -48.24 3.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.623 1.569 . . . . 0.0 109.467 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -157.66 169.53 24.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.6 137.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -140.81 92.46 2.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.783 0.833 . . . . 0.0 111.64 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.6 t -97.1 105.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.649 -0.657 . . . . 0.0 110.037 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m -85.06 161.76 19.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.15 0.98 . . . . 0.0 110.16 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.69 -48.16 2.59 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.015 0.526 . . . . 0.0 111.211 172.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.83 -57.68 5.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.507 1.523 . . . . 0.0 110.51 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 22.56 6.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.466 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.286 0.0 OUTLIER 28.15 70.72 0.06 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.143 2.977 . . . . 0.0 113.815 -174.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -138.16 142.34 40.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.204 1.402 . . . . 0.0 108.856 -168.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.06 111.8 15.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.52 1.128 . . . . 0.0 108.99 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -85.62 125.85 33.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mm -124.86 127.62 72.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.19 113.59 43.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -129.94 172.26 11.89 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.09 111.33 62.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 124.69 1.196 . . . . 0.0 108.581 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.82 73.83 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.419 2.746 . . . . 0.0 110.517 -173.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -46.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.74 2.016 . . . . 0.0 109.241 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.27 -44.69 21.21 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 122.602 -0.061 . . . . 0.0 111.136 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -136.09 172.12 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.1 p -133.99 159.28 41.24 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.392 1.077 . . . . 0.0 110.511 -172.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 t -41.93 -48.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 124.671 1.188 . . . . 0.0 111.611 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.05 -44.23 96.44 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.341 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.53 -53.19 55.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.769 1.168 . . . . 0.0 108.803 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 12.5 mtm -51.3 -60.3 3.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.23 0.468 . . . . 0.0 112.204 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.36 -55.29 36.92 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.391 -0.818 . . . . 0.0 111.939 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -45.93 -51.47 13.21 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.917 1.287 . . . . 0.0 109.158 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -60.35 -46.52 89.64 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.663 0.21 . . . . 0.0 111.306 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.35 -66.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.757 0.823 . . . . 0.0 110.491 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -46.56 -37.94 8.74 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.594 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.25 61.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.575 1.079 . . . . 0.0 112.692 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.7 -45.53 85.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.426 0.557 . . . . 0.0 110.523 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.94 -20.42 2.51 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.349 0.976 . . . . 0.0 111.209 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 59.8 m-85 -77.21 113.75 33.85 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 118.223 -0.894 . . . . 0.0 109.803 -172.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 137.15 41.37 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.26 1.307 . . . . 0.0 108.714 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.91 132.87 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.264 0.554 . . . . 0.0 111.156 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.41 75.04 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.923 1.289 . . . . 0.0 108.718 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 13.5 p -65.22 103.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.952 1.301 . . . . 0.0 110.796 172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -157.13 58.51 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.4 tptm -155.82 136.69 13.54 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.47 83.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.41 70.26 1.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.355 0.598 . . . . 0.0 109.676 -171.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.1 -172.33 22.82 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.851 -0.531 . . . . 0.0 113.123 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 116.386 -1.768 . . . . 0.0 109.825 164.384 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 106.089 -2.804 . . . . 0.0 106.089 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 56.45 -147.76 0.51 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.095 0.948 . . . . 0.0 112.522 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.26 124.51 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -169.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.88 126.0 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.22 116.53 32.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -98.41 110.12 22.77 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -108.84 123.37 48.95 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.977 0.911 . . . . 0.0 108.748 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.33 151.12 46.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 167.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.1 157.06 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.0 145.94 47.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.87 -30.62 8.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.379 0.99 . . . . 0.0 112.956 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.0 94.14 0.47 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.086 0.943 . . . . 0.0 110.399 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.8 m -128.67 44.5 2.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.976 0.91 . . . . 0.0 109.011 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.41 155.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 107.865 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -72.92 -21.97 60.81 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -53.42 -61.02 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.149 0.979 . . . . 0.0 111.708 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.5 m -59.75 -51.57 69.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.649 0.738 . . . . 0.0 109.966 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -53.72 -56.35 18.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.971 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 t -56.11 -46.35 79.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.931 0.892 . . . . 0.0 111.824 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 m -54.73 -50.66 67.82 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.24 -46.44 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.07 -45.76 71.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.474 0.71 . . . . 0.0 111.191 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.18 -56.7 22.86 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.804 0.716 . . . . 0.0 111.673 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.97 -57.34 13.27 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.094 -0.651 . . . . 0.0 111.146 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 43.5 mm -59.45 -43.5 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.068 0.947 . . . . 0.0 110.468 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.94 -33.7 21.48 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 117.985 0.357 . . . . 0.0 112.403 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.85 -4.13 59.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.281 1.032 . . . . 0.0 112.74 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.99 137.51 34.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 120.201 1.364 . . . . 0.0 111.104 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -71.76 123.2 22.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.297 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.23 -2.39 9.7 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.11 0.862 . . . . 0.0 112.592 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.52 159.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.457 0.703 . . . . 0.0 110.796 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -117.58 -47.6 2.62 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -165.26 168.66 16.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.4 tt -156.78 143.12 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -176.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -142.06 98.3 3.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.875 1.67 . . . . 0.0 111.586 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.72 126.76 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.169 0.587 . . . . 0.0 111.534 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -117.04 140.14 49.85 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.676 1.19 . . . . 0.0 110.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 -45.53 9.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.037 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.16 -62.35 1.69 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.687 1.595 . . . . 0.0 110.439 -171.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.78 14.75 11.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.426 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.4 58.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.743 2.817 . . . . 0.0 113.746 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 28.4 tt0 -132.1 138.26 48.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.081 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.51 119.17 32.18 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.824 1.65 . . . . 0.0 109.233 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.9 m -96.28 112.88 24.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.551 1.54 . . . . 0.0 108.712 179.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -116.23 119.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.43 117.79 54.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.54 165.42 27.53 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -94.32 111.65 54.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 126.949 2.099 . . . . 0.0 110.947 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.73 73.84 3.46 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.183 2.588 . . . . 0.0 111.995 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -173.98 -46.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.144 2.178 . . . . 0.0 108.525 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.26 -42.46 68.75 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -176.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -142.4 153.01 43.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.379 0.672 . . . . 0.0 109.948 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -38.1 -49.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 124.987 1.315 . . . . 0.0 111.028 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.37 -46.64 87.74 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.059 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -50.71 66.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.976 1.716 . . . . 0.0 108.056 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -53.14 -59.08 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.07 -0.394 . . . . 0.0 111.005 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . 0.506 ' HZ1' ' CD ' ' A' ' 62' ' ' GLU . 2.4 ttmm -60.15 -55.71 30.49 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 120.888 -1.132 . . . . 0.0 112.88 178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 -42.43 25.73 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.354 1.062 . . . . 0.0 109.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -66.45 -53.48 35.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.599 0.562 . . . . 0.0 111.944 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.43 -62.71 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.069 -1.019 . . . . 0.0 110.897 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.506 ' CD ' ' HZ1' ' A' ' 58' ' ' LYS . 2.5 mt-10 -52.51 -26.17 12.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.04 62.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.961 1.255 . . . . 0.0 112.496 171.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.39 -35.74 72.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.118 0.567 . . . . 0.0 110.656 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.17 -22.18 5.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.683 1.135 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -70.03 116.26 42.34 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 117.283 -1.342 . . . . 0.0 110.276 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.52 151.18 86.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.356 1.371 . . . . 0.0 109.261 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.13 140.49 28.04 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.42 82.23 1.57 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.326 1.051 . . . . 0.0 110.132 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.14 104.66 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.583 1.553 . . . . 0.0 110.946 173.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -157.73 54.16 0.47 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -158.67 104.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -92.06 68.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -81.25 75.83 8.21 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.55 151.05 17.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 C--O 1.254 1.328 0 CA-C-O 116.017 -1.944 . . . . 0.0 106.056 -178.449 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.008 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -49.38 142.71 7.29 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.647 1.179 . . . . 0.0 109.028 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.76 133.34 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 123.574 0.75 . . . . 0.0 109.218 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.4 p -82.1 116.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.304 1.442 . . . . 0.0 108.094 174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -96.86 120.56 37.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 174.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.35 118.76 34.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -113.77 138.92 49.59 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.403 1.481 . . . . 0.0 108.746 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.43 155.47 40.09 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 155.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -138.13 142.64 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -97.75 151.5 20.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.88 -34.78 2.11 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.707 -0.621 . . . . 0.0 114.209 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.33 91.49 0.08 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.007 0.903 . . . . 0.0 111.746 -173.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 m -146.38 61.22 1.23 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.421 1.488 . . . . 0.0 109.587 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.6 p -162.04 157.41 23.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 166.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -78.27 54.44 1.39 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.703 0.401 . . . . 0.0 110.103 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.89 -64.07 0.59 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -56.19 -56.67 18.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.052 0.387 . . . . 0.0 110.79 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -51.53 -55.36 19.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.006 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.87 -42.84 94.58 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.77 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.1 m -56.01 -52.01 65.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -48.27 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.229 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -55.63 -48.87 74.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.117 0.871 . . . . 0.0 110.582 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.47 -52.97 37.82 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.516 0.579 . . . . 0.0 111.665 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -65.95 -61.24 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.548 0.689 . . . . 0.0 110.655 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.69 -32.68 59.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 124.589 1.156 . . . . 0.0 110.422 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.89 -30.67 9.42 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.867 -0.521 . . . . 0.0 112.6 169.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -93.77 10.4 33.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.314 1.046 . . . . 0.0 112.217 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.03 151.87 44.14 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.243 1.383 . . . . 0.0 111.623 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -92.56 81.66 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.949 1.3 . . . . 0.0 110.614 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.93 -13.59 1.13 Allowed Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.914 -0.491 . . . . 0.0 113.899 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.65 151.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -119.08 -35.1 3.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.628 1.171 . . . . 0.0 111.137 173.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -155.42 169.19 24.82 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -156.98 139.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -139.85 90.66 2.41 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.422 1.489 . . . . 0.0 110.534 172.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.86 106.93 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 O-C-N 121.457 -0.777 . . . . 0.0 110.167 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -80.43 178.98 7.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.44 -47.37 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 109.534 179.407 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.05 -59.03 3.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.903 1.681 . . . . 0.0 110.541 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.14 12.58 17.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.319 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 43.77 62.72 1.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.659 1.984 . . . . 0.0 112.522 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -145.88 151.11 37.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.511 -0.743 . . . . 0.0 109.345 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.92 125.81 18.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 111.149 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 3.4 m -107.55 120.69 42.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.803 2.041 . . . . 0.0 107.964 -178.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mp -122.14 116.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.1 t -104.82 109.13 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -175.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -135.14 170.33 16.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.479 0.657 . . . . 0.0 112.367 -166.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -97.8 110.68 56.45 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.132 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.51 67.06 7.23 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.139 2.56 . . . . 0.0 111.506 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.66 -47.07 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.809 1.244 . . . . 0.0 108.37 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.37 -48.23 73.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.633 0.197 . . . . 0.0 111.198 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tp -134.25 162.83 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.802 1.241 . . . . 0.0 108.196 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 p -121.87 158.64 28.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.747 1.219 . . . . 0.0 110.891 -172.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.73 -48.99 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.386 0 C-N-CA 124.1 0.96 . . . . 0.0 110.881 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.97 -54.13 50.46 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.766 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -45.03 -54.74 6.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.952 1.251 . . . . 0.0 109.365 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -63.11 1.26 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.501 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.39 -61.27 2.45 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -43.07 -51.45 5.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.718 1.207 . . . . 0.0 109.703 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.08 -43.33 95.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.083 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.01 -65.85 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.445 0.698 . . . . 0.0 110.278 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -43.79 -39.27 3.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.507 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.798 1.181 . . . . 0.0 112.958 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.6 mmt -55.37 -40.8 71.76 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.317 0.508 . . . . 0.0 110.841 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.08 -20.16 3.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.587 1.089 . . . . 0.0 110.954 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -75.57 115.7 48.18 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.255 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -66.55 138.48 50.05 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.31 -1.458 . . . . 0.0 108.31 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.47 138.39 38.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.045 0.538 . . . . 0.0 110.595 -175.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -107.05 71.39 0.83 Allowed 'General case' 0 C--N 1.334 -0.066 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.45 105.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 169.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -155.58 55.31 0.62 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 141.26 16.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.43 86.27 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.53 169.47 9.88 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.1 -155.73 15.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.125 0 N-CA-C 102.577 -3.12 . . . . 0.0 102.577 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.77 -176.86 2.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.754 0.822 . . . . 0.0 109.837 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.09 116.0 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.91 124.4 43.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.85 131.86 56.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.06 117.09 30.3 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.3 mtt -116.82 123.57 47.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.913 0.885 . . . . 0.0 110.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.87 129.47 37.95 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.93 151.36 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.032 0.833 . . . . 0.0 109.668 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 140.67 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.28 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.1 -16.06 45.24 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.266 0.936 . . . . 0.0 114.206 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.2 mtp -76.62 75.7 3.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.3 1.05 . . . . 0.0 110.866 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.4 34.42 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.464 1.505 . . . . 0.0 111.334 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 p -154.1 158.7 40.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.516 -0.74 . . . . 0.0 110.404 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -74.9 61.36 1.03 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.306 167.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -145.88 -63.38 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 167.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 m -52.96 -53.59 47.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.298 0.571 . . . . 0.0 109.952 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.4 p -53.04 -70.16 0.1 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.725 1.21 . . . . 0.0 110.742 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 t -51.3 -45.52 62.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.679 1.592 . . . . 0.0 111.506 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -60.26 -44.93 94.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.889 -0.507 . . . . 0.0 109.944 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -49.22 85.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 118.617 0.644 . . . . 0.0 110.189 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -48.58 -51.67 26.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.656 0.662 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.61 -58.33 15.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.87 0.748 . . . . 0.0 112.614 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -64.36 -52.44 58.3 Favored 'General case' 0 C--N 1.338 0.109 0 O-C-N 121.651 -0.911 . . . . 0.0 109.953 -170.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.02 -27.19 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.308 1.043 . . . . 0.0 109.751 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.72 -32.55 32.89 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.986 -1.071 . . . . 0.0 112.492 166.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -84.74 -1.36 56.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.97 154.12 42.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.435 1.471 . . . . 0.0 112.326 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.91 69.4 9.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.01 18.72 0.02 OUTLIER Glycine 0 N--CA 1.467 0.756 0 N-CA-C 115.373 0.909 . . . . 0.0 115.373 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.17 141.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.852 1.326 . . . . 0.0 108.664 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -111.85 -45.06 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.363 0.665 . . . . 0.0 109.94 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.21 166.99 25.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.71 131.86 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.6 mmtt -139.24 129.79 25.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.572 1.149 . . . . 0.0 109.695 -177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.43 98.4 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 119.234 0.925 . . . . 0.0 110.011 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -72.7 74.03 1.09 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.224 1.41 . . . . 0.0 109.464 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -37.39 -49.22 0.99 Allowed 'General case' 0 C--O 1.227 -0.091 0 C-N-CA 126.351 1.86 . . . . 0.0 111.664 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.87 -55.94 8.67 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.103 1.361 . . . . 0.0 111.562 -174.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.65 -2.99 58.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.654 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.29 54.62 9.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.814 2.446 . . . . 0.0 110.443 -173.106 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.19 136.34 54.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 109.543 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.61 106.88 17.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.53 1.932 . . . . 0.0 109.742 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -81.45 87.26 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 129.007 2.923 . . . . 0.0 109.382 170.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.61 125.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.74 99.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.417 0 CA-C-N 119.659 1.118 . . . . 0.0 110.333 -173.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.24 159.97 22.42 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.98 131.04 55.2 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.44 163.6 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.18 1.253 . . . . 0.0 109.091 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 73.62 -42.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -48.93 55.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.609 1.095 . . . . 0.0 111.499 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.78 179.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.412 1.485 . . . . 0.0 108.338 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.0 p -148.8 164.16 35.24 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.527 0.603 . . . . 0.0 111.519 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.9 t -46.15 -45.48 5.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 123.768 0.827 . . . . 0.0 111.284 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -62.53 -42.64 99.65 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.488 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.84 -54.42 45.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.1 mmt -45.27 -65.08 0.58 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -56.64 -57.2 13.4 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.312 -0.868 . . . . 0.0 111.761 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -46.32 -47.44 18.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.956 0.798 . . . . 0.0 109.635 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.32 -42.63 87.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.15 -65.02 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 124.409 1.084 . . . . 0.0 110.044 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.36 -39.83 7.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.304 0.642 . . . . 0.0 111.833 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.5 -33.02 59.08 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.398 0.999 . . . . 0.0 113.344 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmt -58.03 -41.73 83.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.6 0.636 . . . . 0.0 110.506 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.87 -16.68 3.48 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.62 1.105 . . . . 0.0 111.06 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.05 117.01 66.79 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.542 -173.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.68 151.56 85.21 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 N-CA-C 108.901 -1.231 . . . . 0.0 108.901 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.04 139.11 28.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.944 0.498 . . . . 0.0 110.517 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.43 75.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.885 0.874 . . . . 0.0 108.758 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.03 105.54 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.081 0.952 . . . . 0.0 110.756 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -155.74 56.71 0.61 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.44 144.35 20.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.63 64.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.93 91.03 7.5 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.46 -172.09 19.35 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 116.607 -1.664 . . . . 0.0 107.638 173.27 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -177.02 153.3 0.98 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -158.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.1 128.27 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 124.252 1.021 . . . . 0.0 108.755 174.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.14 110.94 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.099 1.76 . . . . 0.0 109.816 -178.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.91 117.97 29.93 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.055 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -84.42 126.87 33.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 28.4 mtp -128.51 128.05 43.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.9 25.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.283 0.947 . . . . 0.0 108.553 172.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -90.97 165.44 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -121.07 152.24 38.88 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.18 -33.04 2.24 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.57 -0.706 . . . . 0.0 114.143 165.139 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.1 mtp -65.14 82.74 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.935 0.867 . . . . 0.0 112.024 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -114.34 48.89 1.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.062 1.345 . . . . 0.0 110.482 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -159.4 163.97 35.02 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.571 -0.706 . . . . 0.0 110.834 169.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.91 -35.41 80.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.979 174.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -58.33 -58.04 10.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.576 0.625 . . . . 0.0 111.487 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.2 m -57.76 -57.66 11.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -51.85 -57.1 10.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 110.196 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -59.53 -44.48 93.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.823 0.849 . . . . 0.0 111.302 179.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.9 m -57.26 -48.45 78.85 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.435 -0.791 . . . . 0.0 110.243 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.46 -48.86 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 123.031 0.532 . . . . 0.0 109.578 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.69 -49.73 56.66 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.251 0.62 . . . . 0.0 110.36 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.15 -55.41 28.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.96 0.791 . . . . 0.0 111.532 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -64.0 -55.02 25.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.016 -0.696 . . . . 0.0 110.963 -173.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -67.39 -33.76 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 123.61 0.764 . . . . 0.0 110.13 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.44 -35.63 7.25 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.361 0.505 . . . . 0.0 112.399 171.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -83.48 4.27 28.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.76 139.72 47.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.735 1.607 . . . . 0.0 112.06 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.93 81.83 5.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.726 0.81 . . . . 0.0 111.612 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.19 -8.54 0.79 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.07 152.15 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 117.726 0.763 . . . . 0.0 110.244 175.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -113.58 -37.22 4.67 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.246 1.419 . . . . 0.0 110.333 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -160.57 159.16 30.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 tt -152.8 137.25 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -175.052 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -143.13 150.83 39.98 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.569 1.148 . . . . 0.0 109.754 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.65 128.96 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.613 0.642 . . . . 0.0 109.419 171.127 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -110.69 79.8 1.24 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.739 1.615 . . . . 0.0 108.271 -177.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -41.7 66.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.044 0.537 . . . . 0.0 110.575 -175.429 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.7 -54.72 5.94 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 111.054 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.76 16.62 21.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.029 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 35.66 53.82 0.84 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.354 2.662 . . . . 0.0 113.12 -169.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.72 149.27 37.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.586 1.154 . . . . 0.0 109.704 -177.133 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.4 134.77 49.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.294 1.438 . . . . 0.0 108.823 171.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.8 m -117.34 109.77 17.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.668 2.787 . . . . 0.0 107.011 -173.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mm -119.32 102.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -176.164 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -99.02 107.96 21.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -174.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.9 167.3 17.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -100.25 112.17 63.73 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.554 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 69.47 5.84 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.924 3.083 . . . . 0.0 111.533 -170.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.86 -40.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.854 2.462 . . . . 0.0 108.158 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 -45.46 13.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -140.46 158.2 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 107.573 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -106.28 161.97 14.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 112.479 -173.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.17 -39.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 163.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -47.86 81.62 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.15 -178.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.41 -55.14 17.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.022 1.283 . . . . 0.0 109.762 173.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 17.5 mmt -48.5 -63.47 1.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.36 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -57.95 -57.86 10.96 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 121.259 -0.9 . . . . 0.0 112.329 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -46.76 -50.76 17.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.225 1.01 . . . . 0.0 108.31 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -57.92 -48.12 80.85 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.987 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.81 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 118.562 -0.733 . . . . 0.0 111.467 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.87 -35.78 6.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.003 1.274 . . . . 0.0 112.381 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.2 -31.61 61.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.736 1.153 . . . . 0.0 113.155 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.6 mmt -55.05 -41.52 71.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.396 0.544 . . . . 0.0 110.585 172.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.47 -18.95 3.85 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.886 1.232 . . . . 0.0 110.95 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -75.53 117.92 67.01 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.979 -173.273 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.32 140.21 57.58 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.495 -1.386 . . . . 0.0 108.495 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.9 27.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.813 0.816 . . . . 0.0 112.469 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.84 75.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.331 1.052 . . . . 0.0 108.553 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -42.69 104.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 125.029 1.456 . . . . 0.0 109.261 158.739 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -93.67 -179.51 5.04 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 168.08 20.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.882 170.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.3 pt -78.39 151.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.681 0.792 . . . . 0.0 110.106 178.358 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -110.29 100.03 8.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.809 0.844 . . . . 0.0 108.819 170.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.22 143.81 21.33 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 164.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 . . . . . 0 C--O 1.254 1.299 0 CA-C-O 115.923 -1.989 . . . . 0.0 106.073 -178.41 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.78 124.88 17.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.61 123.83 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 109.865 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.3 p -80.82 105.9 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.808 1.643 . . . . 0.0 109.82 -178.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 109.09 20.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.565 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -87.1 113.16 22.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.18 125.18 47.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.923 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.479 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.4 mptp? -81.02 125.41 30.13 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.78 148.04 11.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -109.9 155.0 22.28 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.37 -46.67 3.59 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.765 -0.584 . . . . 0.0 112.587 169.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.5 mtp -55.26 96.25 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.914 1.286 . . . . 0.0 110.96 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 p -136.6 31.79 2.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 111.776 -174.093 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.16 149.62 26.21 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.668 -0.645 . . . . 0.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -72.33 60.26 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.435 1.494 . . . . 0.0 110.722 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.4 m -142.45 -59.96 0.45 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.235 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.3 m -58.83 -60.94 3.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 110.025 -177.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -53.5 -49.06 68.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.935 -179.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.2 t -66.75 -41.12 88.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 111.104 -175.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 m -59.28 -47.85 83.82 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 176.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -52.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.738 175.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.88 -49.06 63.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.228 0.922 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.85 -47.06 91.29 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.865 0.745 . . . . 0.0 112.054 176.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -60.59 2.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.245 1.023 . . . . 0.0 110.178 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.93 -33.79 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.654 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.0 -30.59 9.58 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.812 0.72 . . . . 0.0 112.99 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -91.33 6.81 43.84 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.279 1.04 . . . . 0.0 112.359 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.33 151.81 34.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.522 -1.361 . . . . 0.0 112.746 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.62 82.57 4.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 0.0 111.493 -174.474 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.61 -10.31 1.68 Allowed Glycine 0 N--CA 1.462 0.368 0 O-C-N 121.947 -0.47 . . . . 0.0 113.722 -175.571 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.4 t -78.99 142.43 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -102.58 -42.75 5.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.011 1.324 . . . . 0.0 109.524 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 ttm-85 -155.79 165.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.88 135.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -137.88 88.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.189 1.396 . . . . 0.0 111.051 168.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.91 115.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -87.46 -163.16 0.89 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.33 -48.79 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.33 1.052 . . . . 0.0 109.451 173.551 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -59.07 4.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 110.339 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.82 11.54 15.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.471 -177.415 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 39.65 61.82 1.33 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.121 1.768 . . . . 0.0 112.788 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.479 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 26.5 tt0 -139.78 153.03 47.04 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 126.23 38.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.728 1.211 . . . . 0.0 109.061 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.0 m -101.33 117.8 35.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.794 1.637 . . . . 0.0 106.983 174.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -119.72 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.357 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 t -100.34 102.94 14.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.977 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -124.33 173.02 8.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -104.27 111.41 65.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 123.941 0.896 . . . . 0.0 109.92 -177.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.2 76.76 2.97 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.709 2.939 . . . . 0.0 110.321 -172.767 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.54 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.395 1.878 . . . . 0.0 108.369 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.8 -44.12 15.91 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.975 -177.028 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.2 154.17 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.888 1.275 . . . . 0.0 108.47 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -108.59 162.96 13.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.36 1.064 . . . . 0.0 112.244 -173.196 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -48.22 -45.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.481 0.712 . . . . 0.0 110.373 165.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -44.02 92.51 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.878 -175.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -54.59 26.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.529 1.513 . . . . 0.0 109.807 171.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.9 mmt -48.13 -62.53 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.918 0.781 . . . . 0.0 111.868 175.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -62.07 -57.61 10.95 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -176.879 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -47.43 -48.13 26.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 109.25 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -59.39 -48.23 82.45 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.71 174.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.13 -65.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.726 -176.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.98 -30.22 24.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.423 1.01 . . . . 0.0 112.573 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.05 62.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 120.014 1.279 . . . . 0.0 112.845 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.3 mmt -58.44 -40.73 83.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.541 0.609 . . . . 0.0 110.578 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.01 -21.62 3.32 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.537 1.065 . . . . 0.0 110.914 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -73.09 116.76 53.93 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-O 118.345 -0.835 . . . . 0.0 110.14 -173.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.02 141.89 59.74 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.463 1.442 . . . . 0.0 108.679 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.55 134.98 32.93 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -98.29 74.71 2.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.472 1.109 . . . . 0.0 108.309 175.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -36.03 106.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.297 1.623 . . . . 0.0 108.775 154.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 179.93 4.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 168.7 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -78.91 166.42 22.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.267 176.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.21 148.97 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -106.15 166.41 10.53 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 170.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.12 -62.28 0.02 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -164.707 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 143.775 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.423 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.45 171.98 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.823 135.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.29 142.29 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 126.15 1.78 . . . . 0.0 108.195 172.479 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.27 132.58 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.024 1.73 . . . . 0.0 107.915 175.186 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -112.61 129.56 56.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 169.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -117.96 127.2 53.6 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.444 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 12.5 ptm -139.43 129.3 24.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.117 0.567 . . . . 0.0 109.865 -173.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.06 133.88 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.3 m -118.86 150.53 21.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.451 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -116.15 151.23 36.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.145 0.498 . . . . 0.0 110.761 177.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.03 -34.3 3.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.094 0.854 . . . . 0.0 112.816 173.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -66.53 94.65 0.29 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.633 0.717 . . . . 0.0 111.6 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.7 p -126.2 53.28 1.63 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.107 0.963 . . . . 0.0 111.465 -178.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.12 167.51 30.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.697 0.799 . . . . 0.0 109.044 -175.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -84.28 -6.02 59.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.667 0.387 . . . . 0.0 111.486 169.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.1 -74.75 0.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -172.155 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -51.39 -45.24 62.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.097 1.359 . . . . 0.0 111.589 -177.044 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -49.38 -63.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.485 1.514 . . . . 0.0 110.511 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -55.33 -45.37 76.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.906 0.882 . . . . 0.0 111.123 177.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -55.3 -47.94 74.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.244 -0.91 . . . . 0.0 110.994 177.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.23 -50.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.139 0.976 . . . . 0.0 109.201 177.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -45.39 -53.05 9.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.566 1.146 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.31 -58.32 15.03 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.793 0.711 . . . . 0.0 112.672 174.845 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -56.94 -48.19 78.88 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 121.936 -0.744 . . . . 0.0 110.846 -171.277 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.73 -42.04 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.283 0.633 . . . . 0.0 109.441 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.68 -35.41 23.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.248 0.451 . . . . 0.0 112.412 172.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -63.28 -18.0 63.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.97 142.5 29.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.207 0.912 . . . . 0.0 112.544 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.89 101.43 4.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.364 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.97 -21.54 1.43 Allowed Glycine 0 C--N 1.335 0.511 0 O-C-N 121.554 -0.716 . . . . 0.0 113.274 176.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.96 132.77 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -102.59 -29.55 11.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.995 0.361 . . . . 0.0 111.403 175.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -154.08 164.63 38.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 tt -157.92 144.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 103.914 -2.624 . . . . 0.0 103.914 -176.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -144.13 132.41 21.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.893 0.877 . . . . 0.0 111.254 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -125.76 136.55 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.935 1.243 . . . . 0.0 111.701 175.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -122.12 124.36 43.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.204 1.801 . . . . 0.0 110.147 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.01 -51.23 9.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.65 0.78 . . . . 0.0 110.723 -177.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -53.03 45.8 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.557 1.143 . . . . 0.0 110.557 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.61 4.11 37.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.48 -177.778 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 38.86 61.56 1.21 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.273 2.629 . . . . 0.0 111.371 -174.888 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -141.85 138.14 31.92 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.734 -0.604 . . . . 0.0 110.903 -173.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.98 30.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.556 1.542 . . . . 0.0 110.003 172.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.6 m -121.71 125.51 46.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.706 3.602 . . . . 0.0 104.928 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.44 119.71 54.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.81 96.68 4.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -172.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.64 168.47 12.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.709 0.766 . . . . 0.0 111.989 -170.076 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -97.02 115.29 65.68 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.048 1.339 . . . . 0.0 108.514 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.9 72.3 3.94 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.879 2.386 . . . . 0.0 111.909 -174.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -46.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.304 1.442 . . . . 0.0 108.295 172.345 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.32 -48.92 66.17 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 119.643 -0.218 . . . . 0.0 111.36 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 177.81 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.825 1.25 . . . . 0.0 109.334 -174.205 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.1 p -141.51 160.12 40.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.347 1.059 . . . . 0.0 111.244 -174.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 18.4 t -40.22 -49.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.705 1.202 . . . . 0.0 111.771 171.117 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -58.53 -52.09 67.13 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 118.255 -0.878 . . . . 0.0 108.937 -171.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -46.47 -53.13 11.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.939 1.696 . . . . 0.0 109.799 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.2 mmt -51.17 -58.32 6.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.951 -0.468 . . . . 0.0 111.823 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -59.4 -60.32 4.04 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.082 -1.011 . . . . 0.0 112.455 177.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.97 -40.5 4.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 109.252 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -52.9 15.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 170.468 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -62.9 -60.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 120.095 1.316 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.91 -36.52 5.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.893 0.77 . . . . 0.0 112.081 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.92 65.85 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.249 0.931 . . . . 0.0 113.368 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -55.51 -38.95 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.965 0.348 . . . . 0.0 110.331 173.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.26 -16.06 4.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.822 1.201 . . . . 0.0 110.805 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -75.55 114.35 35.28 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.492 -174.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.01 141.75 65.48 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 108.266 -1.475 . . . . 0.0 108.266 176.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.28 35.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.44 80.1 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.215 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.444 ' HA ' ' CB ' ' A' ' 7' ' ' MET . 0.7 OUTLIER -65.18 107.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.061 1.744 . . . . 0.0 109.694 168.011 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -157.09 59.7 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.12 153.02 30.19 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 163.446 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.33 78.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -101.32 179.86 4.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.665 1.186 . . . . 0.0 109.214 177.374 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.19 -124.44 3.09 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.621 0.629 . . . . 0.0 111.563 -175.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 mmt-85 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.922 -1.513 . . . . 0.0 109.728 168.709 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.21 156.48 37.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.593 1.157 . . . . 0.0 109.403 172.112 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.73 131.36 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 109.01 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -90.82 120.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 125.277 1.431 . . . . 0.0 110.119 -177.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.73 125.39 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -108.13 115.62 30.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -175.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.0 mtt -115.16 119.28 35.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.45 1.1 . . . . 0.0 108.458 -174.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -72.03 126.52 29.98 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.63 150.45 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.07 153.05 28.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.651 0.594 . . . . 0.0 109.795 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.46 3.43 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.631 -0.539 . . . . 0.0 112.401 172.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.5 mtm -55.06 96.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.703 0.752 . . . . 0.0 111.665 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 p -132.03 18.35 4.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 110.978 -177.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -137.87 163.07 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -72.61 -17.2 61.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.461 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -60.24 3.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.3 0.5 . . . . 0.0 109.779 -177.205 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.5 m -57.86 -55.02 40.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -57.97 -50.03 74.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.215 -174.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -57.85 -46.15 85.22 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.911 0.778 . . . . 0.0 110.988 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.5 m -54.37 -51.28 65.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.638 0.654 . . . . 0.0 110.336 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.08 -47.61 80.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.251 0.932 . . . . 0.0 110.319 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.49 -55.4 27.16 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 172.416 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -66.85 -57.47 6.93 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 117.595 0.697 . . . . 0.0 111.281 -173.189 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.0 -34.58 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 110.079 -177.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.97 -28.34 7.39 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.674 -0.641 . . . . 0.0 112.891 169.928 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -102.39 18.58 20.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.776 1.23 . . . . 0.0 111.831 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.23 163.17 27.02 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.573 -1.329 . . . . 0.0 111.208 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -100.35 84.83 2.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.004 1.322 . . . . 0.0 110.273 -175.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.07 1.17 3.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.321 0.486 . . . . 0.0 113.725 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.13 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 117.641 0.721 . . . . 0.0 109.975 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -124.55 -41.81 2.13 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.131 1.372 . . . . 0.0 111.001 -176.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -156.93 171.3 20.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -157.14 138.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.051 -2.204 . . . . 0.0 105.051 -174.346 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -137.47 81.12 1.85 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.192 1.797 . . . . 0.0 110.488 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.06 122.52 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 O-C-N 120.729 -1.232 . . . . 0.0 109.302 -177.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -103.08 168.05 9.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.97 -45.53 2.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.792 0.837 . . . . 0.0 109.786 174.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.06 -57.03 5.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 110.943 -174.335 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.14 19.7 10.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.456 -175.284 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 36.44 62.28 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.6 2.36 . . . . 0.0 112.332 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.134 -0.979 . . . . 0.0 108.983 -174.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.04 119.86 34.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.936 1.694 . . . . 0.0 108.581 -175.128 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.1 m -96.82 125.99 41.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.5 mp -125.53 128.91 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.13 117.71 55.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.166 0.986 . . . . 0.0 109.476 -174.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -139.9 175.36 9.65 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -104.81 107.21 57.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.106 1.362 . . . . 0.0 110.392 -177.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.13 77.7 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.378 2.719 . . . . 0.0 110.26 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.53 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 127.084 2.154 . . . . 0.0 108.04 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.02 -45.6 56.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.942 0.401 . . . . 0.0 110.548 -178.467 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.95 168.61 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.985 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -135.57 157.78 46.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.145 0.978 . . . . 0.0 110.18 -171.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -37.71 -47.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.83 1.652 . . . . 0.0 111.497 173.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -50.69 73.07 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.776 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -52.72 -48.7 66.46 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 120.916 1.689 . . . . 0.0 109.406 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mtp -49.97 -62.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -57.74 11.48 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 121.355 -0.841 . . . . 0.0 112.093 -178.182 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -41.18 -52.75 3.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.614 1.566 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -60.19 -47.69 84.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.445 0.566 . . . . 0.0 111.824 176.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.89 -66.03 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.83 -0.543 . . . . 0.0 111.067 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.34 -37.71 7.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.079 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.44 63.24 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.901 1.228 . . . . 0.0 112.694 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.1 mmt -58.83 -43.61 90.73 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.412 0.551 . . . . 0.0 110.438 174.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.15 3.76 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.541 1.067 . . . . 0.0 111.207 178.264 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -81.39 118.85 73.95 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.243 -173.838 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -66.81 137.48 45.48 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 N-CA-C 108.443 -1.406 . . . . 0.0 108.443 174.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.08 140.87 42.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.439 0.696 . . . . 0.0 109.903 178.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -112.28 85.3 2.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.78 98.18 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.838 2.055 . . . . 0.0 111.402 179.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.66 60.99 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.45 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -157.01 141.2 16.42 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.02 77.08 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -83.68 59.59 5.24 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.74 147.65 40.07 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.92 -179.414 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -65.02 -176.3 0.27 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 161.594 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.96 133.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -163.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.07 116.0 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 125.127 1.371 . . . . 0.0 110.305 -174.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.55 136.82 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -114.2 114.78 26.47 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 6.0 ptp -118.24 130.2 55.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.302 1.041 . . . . 0.0 109.831 178.22 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -80.03 125.27 29.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.404 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.25 140.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -103.42 156.58 17.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.82 -32.7 1.69 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.378 0.513 . . . . 0.0 114.199 172.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.7 mtp -67.31 80.84 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.253 1.026 . . . . 0.0 111.721 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -118.67 65.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.123 1.769 . . . . 0.0 109.095 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.24 169.25 9.33 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.92 5.17 52.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.839 0.456 . . . . 0.0 111.749 169.078 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.5 t -85.57 -65.81 0.97 Allowed 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.801 -0.562 . . . . 0.0 109.69 -174.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.23 -46.81 82.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.49 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -52.09 -60.95 2.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 109.968 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 t -52.12 -44.37 64.44 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.754 1.222 . . . . 0.0 111.231 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -58.07 -50.78 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.486 -0.758 . . . . 0.0 110.592 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.29 -45.78 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.54 -51.6 53.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.689 1.196 . . . . 0.0 110.721 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.63 -54.56 36.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.352 0.501 . . . . 0.0 111.92 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -52.17 66.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.638 -0.919 . . . . 0.0 111.462 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -63.83 -41.38 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.299 0.639 . . . . 0.0 109.709 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.96 19.76 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.448 0.547 . . . . 0.0 112.563 170.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -62.64 -24.93 67.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.724 0.762 . . . . 0.0 112.958 178.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mt -70.75 129.82 40.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.426 1.012 . . . . 0.0 112.825 -171.565 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.42 87.87 0.12 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.221 174.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -25.0 0.62 Allowed Glycine 0 C--N 1.332 0.343 0 O-C-N 122.035 -0.416 . . . . 0.0 113.406 -177.559 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.97 151.39 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -112.98 -53.98 2.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.967 0.907 . . . . 0.0 110.276 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.0 165.8 26.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.576 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -158.81 139.42 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -175.289 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -141.51 84.72 1.92 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.648 1.579 . . . . 0.0 110.254 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.43 106.34 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.056 -173.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -92.49 155.12 18.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -47.73 3.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.201 1.0 . . . . 0.0 108.619 177.394 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.03 -60.1 3.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.36 1.864 . . . . 0.0 110.567 -171.925 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -94.42 19.57 9.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.192 -175.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.83 49.44 0.57 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.048 2.539 . . . . 0.0 113.662 -177.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 4.7 tp10 -126.94 126.18 42.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.912 -169.325 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.03 113.25 23.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 110.155 -177.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.7 m -91.7 124.93 36.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 108.668 175.179 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.2 mp -124.09 132.64 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 167.499 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.25 107.05 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.57 1.148 . . . . 0.0 109.665 -174.779 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.73 159.98 40.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -171.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -81.72 114.1 47.54 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.49 74.59 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.297 2.665 . . . . 0.0 110.791 -171.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -49.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.073 2.149 . . . . 0.0 108.02 173.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.17 -43.63 70.43 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.357 -173.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.23 169.58 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -142.63 165.64 26.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.455 -170.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.0 t -43.96 -45.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.266 1.026 . . . . 0.0 111.391 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.29 -56.9 15.86 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.277 -178.349 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.56 -48.21 69.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.462 1.483 . . . . 0.0 109.929 -177.757 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.1 mtm -46.68 -61.8 1.67 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 118.813 0.733 . . . . 0.0 112.54 169.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -60.34 -59.89 4.68 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.326 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -37.8 -54.77 1.23 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.679 1.592 . . . . 0.0 109.614 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.69 -46.86 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.503 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -68.06 -64.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 O-C-N 121.527 -0.733 . . . . 0.0 110.716 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.14 -34.63 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.17 175.095 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.99 -33.72 65.11 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 120.218 1.372 . . . . 0.0 112.846 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.6 mmt -59.03 -40.14 84.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.536 0.607 . . . . 0.0 110.443 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.95 -20.17 3.43 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.621 1.105 . . . . 0.0 110.989 178.928 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.62 112.99 19.91 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.183 -173.345 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -66.21 141.08 61.53 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.6 135.08 34.59 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.759 0.314 . . . . 0.0 111.628 -177.314 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -108.15 72.6 0.85 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.569 -171.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.83 103.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.637 1.575 . . . . 0.0 111.002 174.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -156.1 56.52 0.59 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.772 0.796 . . . . 0.0 111.925 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.511 ' HZ1' ' CD ' ' A' ' 74' ' ' GLU . 8.6 mmtp -157.13 162.11 39.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 173.474 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 tt -155.67 70.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.511 ' CD ' ' HZ1' ' A' ' 72' ' ' LYS . 0.3 OUTLIER -77.89 168.79 19.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.223 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.3 127.89 2.23 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 174.591 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -80.73 156.3 26.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.296 1.038 . . . . 0.0 109.868 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.44 127.66 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.566 1.146 . . . . 0.0 109.202 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -90.99 116.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 126.295 1.838 . . . . 0.0 109.254 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.08 118.56 37.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -97.0 119.05 34.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -121.42 124.3 44.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.759 1.224 . . . . 0.0 109.203 175.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -82.53 119.25 24.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.372 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.23 122.59 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.98 0.512 . . . . 0.0 110.244 -170.75 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.11 157.49 20.68 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.474 0.309 . . . . 0.0 111.119 -174.201 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.03 -44.63 1.46 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.947 0.784 . . . . 0.0 112.119 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 mtm -60.28 109.19 0.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.202 0.501 . . . . 0.0 109.809 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -146.51 19.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.851 1.26 . . . . 0.0 110.014 -177.593 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.0 148.89 22.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.265 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -81.14 42.38 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.094 0.557 . . . . 0.0 112.288 -167.404 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -122.42 -69.11 0.85 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.253 1.421 . . . . 0.0 107.491 177.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -49.76 -53.36 25.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.201 1.4 . . . . 0.0 110.443 -176.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.8 t -51.18 -55.75 16.37 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.173 177.739 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -60.97 -45.69 93.73 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.349 1.06 . . . . 0.0 110.307 -175.985 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -55.26 -51.36 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.646 -0.659 . . . . 0.0 110.76 176.184 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.64 -48.02 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.971 0.509 . . . . 0.0 110.002 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -48.96 -51.72 28.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.447 1.499 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -59.91 9.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 172.921 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -48.87 79.06 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 122.002 -0.705 . . . . 0.0 110.851 -170.607 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.3 mm -71.08 -47.79 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.074 0.55 . . . . 0.0 109.96 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.95 -35.26 31.96 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.325 0.488 . . . . 0.0 112.228 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -68.87 -16.38 63.75 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.868 0.867 . . . . 0.0 113.324 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mt -73.91 139.6 45.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.488 1.495 . . . . 0.0 112.106 -176.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -70.1 97.38 1.18 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.062 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.91 -12.87 1.12 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-O 118.662 -1.077 . . . . 0.0 114.181 -175.703 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.3 t -102.85 139.43 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 118.145 0.973 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 -31.68 14.39 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.881 0.472 . . . . 0.0 111.801 175.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -171.57 164.55 6.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.952 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -156.04 138.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 104.022 -2.584 . . . . 0.0 104.022 -172.888 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -137.78 92.42 2.68 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.79 1.636 . . . . 0.0 111.239 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.41 115.24 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -104.9 103.4 12.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.984 1.713 . . . . 0.0 108.723 -173.811 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -48.83 71.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.77 0.428 . . . . 0.0 110.628 -179.262 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.17 -54.48 30.21 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.883 1.273 . . . . 0.0 110.24 -176.857 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.63 5.56 27.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.828 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 35.19 60.21 0.71 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 128.428 2.691 . . . . 0.0 113.081 -175.882 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -138.79 149.1 44.61 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.154 1.381 . . . . 0.0 108.586 -175.641 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -126.37 119.61 27.73 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.634 1.174 . . . . 0.0 110.269 -179.364 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.0 m -103.03 114.44 28.75 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.975 1.71 . . . . 0.0 109.025 -179.321 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.1 mp -117.37 115.44 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.548 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.76 105.52 18.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.749 0.704 . . . . 0.0 109.927 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -128.61 169.68 14.14 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -166.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.02 111.0 64.74 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 124.554 1.142 . . . . 0.0 110.461 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.58 78.35 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.144 2.563 . . . . 0.0 111.431 -175.72 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.7 m80 178.97 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.447 2.699 . . . . 0.0 108.624 173.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 -50.21 11.99 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.01 -178.32 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.095 1.358 . . . . 0.0 107.718 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.8 p -142.85 155.22 44.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.358 -174.154 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.45 -42.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 124.199 1.0 . . . . 0.0 111.07 173.476 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.15 -39.36 94.43 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.046 -177.638 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.73 -51.46 64.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.853 1.206 . . . . 0.0 107.748 176.216 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.0 mmt -47.63 -61.22 2.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 122.447 0.299 . . . . 0.0 111.775 176.137 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -57.56 -59.45 5.16 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 120.967 -1.083 . . . . 0.0 111.077 177.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 119.312 0.96 . . . . 0.0 109.249 -170.402 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -57.95 -50.02 74.8 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.85 173.262 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -69.5 -64.79 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 111.046 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -45.02 -39.51 5.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.791 0.723 . . . . 0.0 112.262 174.68 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.59 55.74 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.513 1.051 . . . . 0.0 113.293 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -56.27 -39.52 72.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.403 0.547 . . . . 0.0 110.534 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.05 -19.61 2.88 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.714 1.149 . . . . 0.0 111.181 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.33 112.35 40.86 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.359 1.064 . . . . 0.0 110.384 -169.038 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.22 127.91 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.766 1.644 . . . . 0.0 109.651 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.57 133.03 55.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.618 0.767 . . . . 0.0 111.84 -173.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -105.51 76.02 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.286 1.034 . . . . 0.0 109.493 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.49 109.4 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.076 0.95 . . . . 0.0 110.077 170.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -156.98 53.8 0.51 Allowed 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 178.619 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 81.47 0.78 Allowed 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.931 -0.481 . . . . 0.0 110.127 -177.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tp -78.55 59.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.683 0.793 . . . . 0.0 109.565 -179.199 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.24 163.31 19.75 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.393 -0.817 . . . . 0.0 110.208 -177.539 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.7 90.98 0.08 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -172.443 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.964 -1.493 . . . . 0.0 109.549 -176.471 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.922 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 13.7 pm0 -96.65 -166.28 1.39 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.46 2.304 . . . . 0.0 109.994 -176.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.5 t -133.9 140.78 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -101.26 129.13 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 126.049 1.74 . . . . 0.0 110.725 -179.514 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.8 mp -120.31 145.61 46.93 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -122.98 125.96 46.25 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.105 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mtt -115.79 129.67 56.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.412 1.885 . . . . 0.0 108.026 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.45 126.29 31.47 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.05 157.04 9.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 119.329 0.968 . . . . 0.0 109.723 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -123.75 143.56 50.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.366 0.603 . . . . 0.0 109.743 170.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.61 -31.51 8.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.005 1.765 . . . . 0.0 112.794 174.745 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.7 mtt -66.36 99.14 0.53 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.09 0.945 . . . . 0.0 111.02 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.0 m -143.78 56.52 1.34 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.936 -1.102 . . . . 0.0 109.477 174.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.4 p -161.62 159.85 28.07 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 165.152 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -80.58 44.68 0.73 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.271 0.487 . . . . 0.0 111.222 179.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -123.17 -60.33 1.51 Allowed 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.756 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -47.2 -59.89 2.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.488 0.715 . . . . 0.0 110.807 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -52.92 -59.26 4.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.572 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 t -60.38 -45.27 94.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.756 0.822 . . . . 0.0 111.331 -170.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -54.19 -49.97 68.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.56 -0.713 . . . . 0.0 110.462 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.23 -43.9 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -53.58 -50.07 66.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.139 0.976 . . . . 0.0 110.682 177.527 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.58 -58.25 14.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 171.136 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -56.32 -52.3 65.05 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.169 -0.607 . . . . 0.0 111.14 -172.349 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.8 mm -62.02 -47.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.907 1.283 . . . . 0.0 109.911 178.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.98 -39.71 26.35 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 172.23 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -70.48 -13.92 62.32 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.664 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mt -82.23 133.37 35.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 120.031 1.287 . . . . 0.0 112.345 -174.547 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -68.67 91.17 0.42 Allowed 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.532 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.59 -20.87 0.92 Allowed Glycine 0 C--N 1.334 0.433 0 O-C-N 121.859 -0.525 . . . . 0.0 113.752 -177.115 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -85.93 151.16 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -120.43 -38.29 2.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.873 1.269 . . . . 0.0 111.013 -179.545 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -152.78 171.05 18.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.8 tt -158.56 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.323 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -143.78 88.03 1.96 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.074 1.75 . . . . 0.0 111.298 175.367 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.83 88.61 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.124 -0.985 . . . . 0.0 111.263 -178.425 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.04 121.36 21.87 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.675 1.99 . . . . 0.0 110.919 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -46.56 43.22 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.261 -0.899 . . . . 0.0 111.366 179.312 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.3 -59.58 3.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.724 1.21 . . . . 0.0 111.211 -170.121 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.35 24.92 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.524 -176.216 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 24.89 74.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.346 2.659 . . . . 0.0 113.934 -169.021 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -127.94 136.58 51.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 108.222 -173.214 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.8 102.38 9.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.53 1.132 . . . . 0.0 108.427 171.374 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 8.2 m -88.95 125.72 35.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 2.6 mp -123.0 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.516 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -118.96 103.59 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.487 1.115 . . . . 0.0 108.067 -174.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -138.78 164.59 29.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -166.766 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -96.71 110.64 54.26 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.975 -173.112 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.05 76.57 2.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.894 3.062 . . . . 0.0 110.684 -172.285 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.407 1.883 . . . . 0.0 107.357 -175.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.51 -46.35 13.51 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.476 0.485 . . . . 0.0 110.48 -171.394 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.54 155.51 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 107.136 -176.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 p -123.18 161.84 23.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.786 1.234 . . . . 0.0 110.392 -173.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.6 t -45.47 -45.52 4.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 123.831 0.852 . . . . 0.0 111.843 175.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.49 -56.65 17.8 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.038 -175.427 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -38.82 -59.67 0.93 Allowed 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.015 1.726 . . . . 0.0 110.144 170.618 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.4 mtm -49.67 -62.79 1.36 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -59.2 -62.64 1.73 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.41 -177.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -38.82 -49.37 1.62 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 120.013 1.278 . . . . 0.0 110.376 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -37.2 78.67 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.693 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -72.08 -66.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 124.37 1.068 . . . . 0.0 110.81 175.489 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -38.0 -40.16 0.45 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.034 1.334 . . . . 0.0 112.403 171.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.38 -35.43 8.29 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 113.514 176.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.83 81.71 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.666 0.787 . . . . 0.0 110.613 178.626 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.23 -14.66 4.55 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.877 1.227 . . . . 0.0 111.172 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -85.48 115.93 63.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 123.849 0.86 . . . . 0.0 109.866 -171.107 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.5 142.1 63.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 175.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.4 135.81 44.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.094 0.558 . . . . 0.0 111.401 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -105.7 76.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.577 1.151 . . . . 0.0 109.437 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.41 104.52 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.079 1.352 . . . . 0.0 110.859 171.909 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -155.73 60.01 0.61 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.71 0.767 . . . . 0.0 112.875 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.31 162.33 40.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.455 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 tp -156.88 70.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.09 67.62 8.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.892 0.853 . . . . 0.0 109.253 -173.194 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.87 153.71 33.4 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.202 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -174.898 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.87 150.93 40.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.881 0.841 . . . . 0.0 110.163 171.707 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -116.78 128.61 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 124.731 1.212 . . . . 0.0 109.499 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.3 104.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.345 1.458 . . . . 0.0 110.129 -176.064 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.33 101.89 14.38 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.709 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HZ1' ' CD ' ' A' ' 42' ' ' GLU . 8.0 mmtp -79.19 120.95 24.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.079 0.952 . . . . 0.0 108.6 174.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.72 119.14 29.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.142 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 115.55 19.41 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.45 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.43 154.49 5.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -174.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -111.54 156.91 21.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.174 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.45 -43.44 3.22 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.261 -0.9 . . . . 0.0 114.043 161.907 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.5 mtm -61.01 86.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.374 1.087 . . . . 0.0 111.507 -178.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -116.49 38.08 3.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.744 1.618 . . . . 0.0 109.902 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -154.81 162.96 40.92 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.313 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -76.74 -21.61 55.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.429 0.456 . . . . 0.0 111.402 -177.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -58.16 -58.91 6.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.752 0.421 . . . . 0.0 110.214 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.1 m -54.5 -53.37 55.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -58.9 -54.2 49.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.075 -175.883 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -58.74 -45.91 88.6 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.818 0.847 . . . . 0.0 111.229 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.6 m -56.2 -48.46 76.35 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.371 -0.83 . . . . 0.0 110.5 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -59.44 -47.89 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -55.81 -45.0 78.38 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.635 . . . . 0.0 110.764 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.1 -53.26 45.94 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.063 0.84 . . . . 0.0 111.527 173.226 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -63.0 -59.77 4.36 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.93 0.871 . . . . 0.0 109.834 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.59 -32.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.167 1.387 . . . . 0.0 111.043 -175.166 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.16 -31.49 6.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.313 0.482 . . . . 0.0 112.447 172.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -80.74 -4.08 53.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.74 139.35 45.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 120.104 1.32 . . . . 0.0 112.524 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -81.18 84.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.136 177.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.04 -13.96 0.86 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 178.888 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.33 145.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.673 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -115.13 -37.33 4.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.249 1.419 . . . . 0.0 111.037 -176.001 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.66 44.42 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.67 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -155.06 126.6 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.253 16.2 mmtm -135.08 102.16 5.11 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 171.355 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.33 98.58 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.584 -0.697 . . . . 0.0 110.095 -177.419 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.1 m -89.14 126.84 35.64 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.14 1.376 . . . . 0.0 110.808 -176.417 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.65 -42.96 14.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.832 0.853 . . . . 0.0 109.96 -179.941 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -59.11 4.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.938 1.695 . . . . 0.0 110.376 -173.957 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -86.58 9.0 19.83 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.001 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 0.1 OUTLIER 32.85 66.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.209 2.604 . . . . 0.0 112.208 -169.548 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' CD ' ' HZ1' ' A' ' 6' ' ' LYS . 2.0 mt-10 -144.5 141.99 29.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.556 1.142 . . . . 0.0 110.685 -173.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.95 120.19 39.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.38 1.472 . . . . 0.0 109.682 -178.571 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -94.46 78.27 3.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.942 2.497 . . . . 0.0 107.934 175.132 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.28 103.8 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.54 108.24 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.328 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -131.41 175.05 9.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -106.88 109.91 63.35 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.268 1.027 . . . . 0.0 110.187 -175.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 73.74 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.153 3.235 . . . . 0.0 111.216 -170.138 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -177.91 -39.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.372 2.269 . . . . 0.0 108.368 178.933 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.75 -46.13 13.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.778 -175.606 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -135.62 149.08 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.869 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -100.58 158.74 15.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.052 0.941 . . . . 0.0 111.676 -173.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.71 -42.97 18.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.939 0.496 . . . . 0.0 110.357 166.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.52 -53.92 50.04 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -176.306 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -46.14 -54.1 9.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.312 1.045 . . . . 0.0 110.528 172.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.9 mmm -48.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 173.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 15.0 tttp -56.9 -64.57 0.83 Allowed 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.808 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -37.11 -52.76 1.01 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.907 1.683 . . . . 0.0 109.954 178.106 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -66.11 -47.26 74.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.081 177.428 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.61 -62.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.655 0.661 . . . . 0.0 110.453 -178.136 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -42.39 -44.08 3.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 112.223 171.344 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.2 62.3 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.126 0.875 . . . . 0.0 113.065 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.1 -42.29 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.499 0.59 . . . . 0.0 110.467 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.28 -18.71 2.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.596 1.093 . . . . 0.0 111.299 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -81.23 118.31 71.77 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-O 118.417 -0.801 . . . . 0.0 110.373 -169.302 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.1 140.05 52.77 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 N-CA-C 108.445 -1.406 . . . . 0.0 108.445 173.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.21 132.33 37.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.392 0.615 . . . . 0.0 111.045 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.26 81.24 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.019 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -42.02 107.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 125.15 1.531 . . . . 0.0 108.818 160.961 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -101.87 179.8 4.23 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.121 1.768 . . . . 0.0 106.611 170.813 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 161.87 18.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.05 -175.048 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mt -75.77 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.003 0.521 . . . . 0.0 109.709 -178.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.77 106.49 16.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.157 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.78 164.56 14.05 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.5 ttt-85 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.069 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -47.15 152.84 0.52 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.715 2.006 . . . . 0.0 111.8 167.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -105.6 132.45 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.854 0.862 . . . . 0.0 109.161 -176.197 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.2 115.52 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.646 1.578 . . . . 0.0 109.813 179.435 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.0 124.43 33.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 170.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.48 109.39 21.34 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.432 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 16.3 ptp -119.64 144.64 47.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.094 0.958 . . . . 0.0 109.142 179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.85 46.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.922 173.83 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.92 96.48 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 124.661 1.226 . . . . 0.0 109.448 -166.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -68.3 142.76 55.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.946 -0.471 . . . . 0.0 110.668 -172.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 -47.72 1.0 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.286 0.946 . . . . 0.0 112.525 174.071 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.7 82.47 2.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.929 0.864 . . . . 0.0 111.899 -171.912 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -111.35 33.63 4.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.537 1.535 . . . . 0.0 110.545 -178.776 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -155.37 160.55 40.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.288 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -78.0 -1.5 32.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -174.754 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -76.7 -61.36 1.99 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.49 -0.756 . . . . 0.0 109.629 175.087 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -56.13 -48.59 75.93 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.717 0.407 . . . . 0.0 110.809 -174.469 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.9 p -52.03 -60.39 3.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.383 0.673 . . . . 0.0 109.415 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -50.7 -48.21 58.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.786 1.234 . . . . 0.0 111.692 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -54.42 -51.91 63.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.315 -0.866 . . . . 0.0 110.948 176.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.9 mt -62.14 -40.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.97 0.508 . . . . 0.0 109.989 178.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.99 -48.58 78.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.661 1.184 . . . . 0.0 110.599 176.178 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.82 -56.31 24.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 172.499 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -56.18 -52.63 63.71 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -174.584 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.06 -45.81 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.244 1.018 . . . . 0.0 110.299 -175.456 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.57 -37.61 26.86 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.402 0.525 . . . . 0.0 112.012 175.515 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -72.99 -9.28 58.56 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.135 0.974 . . . . 0.0 113.5 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mt -81.45 128.45 33.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.431 1.468 . . . . 0.0 111.408 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -66.8 108.87 2.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.097 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.52 -16.28 3.58 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 124.489 1.042 . . . . 0.0 112.613 -178.287 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.5 152.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 117.053 0.426 . . . . 0.0 110.249 173.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.14 -46.08 2.21 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.31 -178.686 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.42 165.57 30.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 178.601 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -156.5 137.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -141.66 90.85 2.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.253 1.021 . . . . 0.0 111.495 179.091 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.76 90.91 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.512 -0.742 . . . . 0.0 110.194 -177.137 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 m -84.45 110.21 18.48 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.583 1.153 . . . . 0.0 111.247 -173.765 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.33 -49.6 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.356 0.663 . . . . 0.0 112.368 177.892 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.86 -59.58 3.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.074 1.349 . . . . 0.0 111.095 -170.906 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -92.57 18.91 7.93 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.438 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 28.9 60.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 129.028 2.931 . . . . 0.0 113.609 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.12 132.46 32.04 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 110.26 -175.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -102.22 112.5 25.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.451 1.9 . . . . 0.0 109.498 179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.0 m -90.56 84.57 5.95 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 127.845 2.458 . . . . 0.0 107.575 173.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.25 113.06 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -107.47 111.76 37.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.957 0.799 . . . . 0.0 110.128 -171.508 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -129.75 170.89 13.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.762 0.792 . . . . 0.0 112.328 -169.615 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -106.42 109.25 63.0 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.906 -177.28 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.36 77.99 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.177 2.584 . . . . 0.0 110.906 -172.408 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -177.09 -41.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 127.885 2.474 . . . . 0.0 107.926 174.382 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -77.96 -53.84 6.98 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 117.966 0.348 . . . . 0.0 110.974 -177.895 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.27 179.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.88 1.272 . . . . 0.0 108.84 -176.541 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -146.37 159.6 43.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.574 0.749 . . . . 0.0 110.992 -172.701 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -39.28 -48.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.813 1.645 . . . . 0.0 111.159 173.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.78 -50.46 73.37 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.14 -50.64 66.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 120.401 1.455 . . . . 0.0 108.442 176.488 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.66 -55.96 16.44 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.499 0.19 . . . . 0.0 111.011 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.87 -62.26 1.92 Allowed 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.583 177.427 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -50.34 5.29 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.446 1.099 . . . . 0.0 109.495 -177.913 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -60.1 -49.84 76.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 177.176 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -70.17 -63.76 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.744 -0.597 . . . . 0.0 111.301 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.8 -37.91 6.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 112.548 174.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.78 56.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.779 1.172 . . . . 0.0 113.06 176.891 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 mmt -56.89 -39.88 75.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.507 0.594 . . . . 0.0 110.625 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.41 -18.96 3.23 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.639 1.114 . . . . 0.0 110.932 176.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -80.94 114.03 45.33 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.48 -172.092 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.99 141.63 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.663 1.575 . . . . 0.0 108.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.37 134.57 46.41 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.335 0.97 . . . . 0.0 112.956 -177.241 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -106.47 71.74 0.88 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.82 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.14 107.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.8 170.22 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -150.89 55.19 0.89 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 176.156 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 159.45 41.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 173.39 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.57 59.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.013 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -78.47 172.09 14.16 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.725 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.72 166.73 16.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 174.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 171.578 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -82.81 -154.75 0.14 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.799 1.64 . . . . 0.0 111.339 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.57 141.18 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.082 0.953 . . . . 0.0 109.343 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -104.96 127.01 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 126.462 1.905 . . . . 0.0 110.663 -177.723 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.21 127.89 54.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.1 111.27 23.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 178.864 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.4 ptp -113.66 122.23 46.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.698 1.199 . . . . 0.0 109.152 179.477 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -74.46 130.85 40.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.44 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.15 153.7 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -117.08 146.85 42.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.259 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.72 -38.91 2.97 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.267 0.937 . . . . 0.0 113.077 170.756 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 34.0 mtt -62.72 137.06 58.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.457 1.129 . . . . 0.0 110.575 -174.989 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -143.4 -56.99 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.733 -0.605 . . . . 0.0 110.226 176.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.8 p -72.07 156.47 39.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.724 0.693 . . . . 0.0 110.098 -179.33 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -65.16 -18.71 65.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.295 177.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 m -64.54 -50.18 68.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.422 -0.799 . . . . 0.0 110.665 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -54.62 -57.85 9.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.787 0.721 . . . . 0.0 109.73 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -55.49 -55.31 33.25 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.539 -176.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -56.55 -45.89 80.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.9 m -58.0 -49.48 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.487 -0.758 . . . . 0.0 109.942 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.1 mt -61.14 -47.01 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 122.936 0.494 . . . . 0.0 109.912 176.737 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.56 -50.26 60.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.553 0.741 . . . . 0.0 109.551 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.86 -56.79 22.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.68 0.657 . . . . 0.0 111.817 173.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -60.63 -59.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.198 -0.589 . . . . 0.0 110.948 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.6 mp -67.58 -34.25 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.954 -177.376 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.43 -33.79 6.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.58 168.804 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -92.42 12.19 23.6 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 117.966 0.883 . . . . 0.0 112.353 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.61 151.24 47.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 120.404 -1.435 . . . . 0.0 109.886 167.316 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.17 130.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.37 -0.88 29.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.557 1.075 . . . . 0.0 111.909 176.463 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -95.48 154.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 124.691 1.196 . . . . 0.0 109.658 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -122.1 -41.57 2.42 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.168 0.987 . . . . 0.0 110.055 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -150.66 164.37 36.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.603 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.5 tt -156.97 139.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -172.899 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -145.49 147.76 32.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.55 0.74 . . . . 0.0 110.027 172.067 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.32 140.76 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.863 1.211 . . . . 0.0 110.825 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -124.08 132.57 53.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.971 1.708 . . . . 0.0 110.569 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -54.73 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 112.151 176.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.61 -56.73 16.01 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 110.112 -166.195 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.22 11.58 16.08 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.845 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.37 62.69 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.857 2.863 . . . . 0.0 113.042 -178.327 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 3.8 tt0 -131.39 142.32 50.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.342 -175.227 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -118.72 133.88 55.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.298 1.439 . . . . 0.0 108.659 175.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -109.94 117.18 33.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.518 3.127 . . . . 0.0 106.648 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -126.23 119.29 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.927 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.17 108.59 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -168.029 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.192 0.52 . . . . 0.0 112.008 -165.356 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -89.31 108.58 25.45 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.714 1.606 . . . . 0.0 109.431 -174.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.2 73.14 2.69 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.02 2.48 . . . . 0.0 111.036 -176.726 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -168.22 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.413 1.885 . . . . 0.0 108.756 177.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.67 -43.17 63.48 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.36 177.9 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -135.05 162.34 32.75 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.153 0.888 . . . . 0.0 110.215 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.09 -46.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 110.995 169.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -61.14 -57.77 11.11 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.184 -174.719 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -38.57 -56.85 1.24 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.763 1.625 . . . . 0.0 110.665 172.422 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.45 -63.01 1.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 122.163 -0.336 . . . . 0.0 111.57 175.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -58.64 7.53 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.714 -0.616 . . . . 0.0 111.964 -177.443 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -36.88 -54.97 0.92 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.844 1.658 . . . . 0.0 110.491 172.649 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -41.8 94.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.094 -1.043 . . . . 0.0 113.388 176.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.74 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.174 -0.954 . . . . 0.0 109.98 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -43.42 -40.96 4.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.957 169.553 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.23 61.16 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.617 1.099 . . . . 0.0 113.222 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.82 -43.79 81.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.593 0.633 . . . . 0.0 110.777 171.801 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.02 -15.31 4.02 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.047 1.308 . . . . 0.0 111.287 -179.01 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -80.89 116.89 65.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.91 -173.221 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.9 140.04 49.27 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 108.397 -1.424 . . . . 0.0 108.397 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.71 140.25 42.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.351 0.66 . . . . 0.0 110.48 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -114.66 79.03 1.21 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.939 0.896 . . . . 0.0 109.152 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 105.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.012 1.325 . . . . 0.0 109.691 169.796 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -152.98 54.72 0.77 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.735 0.778 . . . . 0.0 112.42 176.282 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 132.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.15 70.59 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 175.81 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.288 0.565 . . . . 0.0 109.613 174.322 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.32 135.98 12.88 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 125.476 1.51 . . . . 0.0 112.692 169.906 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.05 135.83 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.72 132.47 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.639 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 70' ' ' VAL . 4.1 mm? -113.25 135.24 54.05 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 166.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -111.94 122.07 46.77 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.6 ptp -123.64 120.5 32.95 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.106 1.362 . . . . 0.0 109.533 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.2 mptp? -71.01 134.53 47.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.655 -1.164 . . . . 0.0 108.079 173.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -116.91 150.35 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -113.61 150.35 33.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.36 -35.06 2.42 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.52 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.6 mtm -65.82 85.72 0.08 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.607 1.204 . . . . 0.0 111.603 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 m -122.96 51.08 1.46 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 109.116 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 p -158.32 167.88 28.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 165.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.77 -22.24 50.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.321 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -65.62 -62.0 1.76 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.047 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -52.21 -51.22 59.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.013 0.911 . . . . 0.0 110.235 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 p -57.58 -56.07 26.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.295 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -54.98 -48.34 73.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.776 0.717 . . . . 0.0 111.623 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.2 m -52.85 -51.96 59.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.534 0.734 . . . . 0.0 110.283 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -60.92 -44.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.19 -48.12 71.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.231 0.612 . . . . 0.0 111.087 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.82 28.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.663 0.649 . . . . 0.0 111.624 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -56.96 -47.11 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.109 -0.642 . . . . 0.0 110.945 -174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 mm -66.34 -48.02 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.241 1.016 . . . . 0.0 109.478 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.76 -39.26 31.34 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.533 0.587 . . . . 0.0 112.235 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -60.54 -29.17 68.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.492 0.646 . . . . 0.0 112.489 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -75.04 135.29 41.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.039 0.923 . . . . 0.0 112.088 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -70.72 86.96 0.68 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.917 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.66 0.51 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 115.227 0.851 . . . . 0.0 115.227 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -86.95 149.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 117.844 0.822 . . . . 0.0 109.287 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -120.8 -34.72 3.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -156.53 164.32 38.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -158.29 140.28 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.1 mmtm -140.99 82.7 1.85 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.233 1.013 . . . . 0.0 111.222 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -84.47 110.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -89.29 172.16 9.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.58 -48.15 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.461 1.104 . . . . 0.0 109.48 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.11 -61.15 1.89 Allowed 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.389 1.876 . . . . 0.0 110.392 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.17 19.52 7.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.143 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.33 63.87 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.759 2.824 . . . . 0.0 113.462 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.441 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 35.2 tt0 -146.6 146.24 30.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -125.14 124.71 42.39 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.613 1.165 . . . . 0.0 109.596 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -98.05 129.54 44.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.82 1.648 . . . . 0.0 107.23 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.8 123.19 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 104.55 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 118.821 0.737 . . . . 0.0 110.025 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -133.4 167.98 19.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.335 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.42 112.79 63.14 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.233 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.45 78.25 2.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.024 3.149 . . . . 0.0 110.985 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -179.25 -52.95 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.781 1.632 . . . . 0.0 106.919 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.78 -46.06 16.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.155 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 169.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.552 1.541 . . . . 0.0 108.27 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -139.64 162.03 36.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.982 0.913 . . . . 0.0 111.202 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 70' ' ' VAL . 86.9 t -43.65 -48.28 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.202 1.001 . . . . 0.0 111.15 172.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.89 -45.66 88.36 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.488 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -50.93 -57.28 8.93 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.231 1.378 . . . . 0.0 108.702 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.9 mmt -46.49 -65.43 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -59.7 5.02 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 121.284 -0.885 . . . . 0.0 112.611 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -44.76 -48.63 10.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.203 0.911 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -40.8 90.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.99 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -67.52 -65.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.077 0.551 . . . . 0.0 110.619 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -43.38 -42.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.38 0.672 . . . . 0.0 112.18 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.42 -32.86 58.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.139 0.882 . . . . 0.0 113.149 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.3 mmt -59.39 -40.26 85.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.68 0.673 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.93 -17.74 2.77 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.372 0.986 . . . . 0.0 111.197 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -84.23 110.53 27.03 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 123.913 0.885 . . . . 0.0 109.581 -171.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -65.89 141.58 65.53 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.33 136.18 32.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.444 0.298 . . . . 0.0 111.779 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.81 78.74 1.22 Allowed 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 5' ' ' LEU . 10.4 p -66.16 101.52 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.844 1.657 . . . . 0.0 112.083 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -156.77 56.8 0.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -158.03 130.06 6.96 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 167.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.5 mt . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.245 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.94 134.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.43 134.61 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.09 147.02 43.69 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 163.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -118.04 117.06 28.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -118.28 119.64 35.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.619 1.568 . . . . 0.0 108.275 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.47 140.74 54.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -127.94 146.4 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -105.97 148.15 28.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.32 -31.68 2.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.459 -0.776 . . . . 0.0 114.056 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.5 mtp -61.99 92.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.987 0.893 . . . . 0.0 110.242 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 m -144.46 48.67 1.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.894 1.277 . . . . 0.0 109.724 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -77.26 44.27 0.41 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.668 0.787 . . . . 0.0 111.46 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -129.54 -59.76 1.07 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.392 1.077 . . . . 0.0 108.425 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -54.66 -58.53 7.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.471 0.578 . . . . 0.0 110.655 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 t -51.95 -57.3 9.84 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.271 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 t -57.71 -40.33 79.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.809 0.844 . . . . 0.0 110.557 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -60.85 -49.26 78.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.934 -0.479 . . . . 0.0 110.082 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -51.29 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.5 -51.19 65.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.201 1.0 . . . . 0.0 110.142 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.01 -51.21 57.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.813 0.72 . . . . 0.0 112.059 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.3 -59.58 5.07 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.195 0.997 . . . . 0.0 110.572 -175.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.9 mm -57.67 -38.07 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.264 1.026 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.32 -36.15 7.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.033 0.825 . . . . 0.0 113.676 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.62 -7.01 59.59 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.171 0.986 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.64 149.7 32.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.12 0.873 . . . . 0.0 111.835 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.71 126.53 36.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.194 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.0 -21.06 7.51 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -86.98 151.64 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -118.51 -40.82 2.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.836 1.254 . . . . 0.0 110.726 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -159.13 170.84 21.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -158.48 140.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -143.87 84.73 1.79 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.685 0.794 . . . . 0.0 110.718 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.45 102.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.84 0.856 . . . . 0.0 109.149 -172.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -78.53 177.21 8.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -141.09 -48.85 0.41 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 109.054 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -61.43 1.96 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.423 1.489 . . . . 0.0 110.39 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -91.52 19.46 6.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.625 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 37.29 62.27 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.155 2.182 . . . . 0.0 113.603 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.29 149.48 33.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 130.64 46.95 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.332 1.053 . . . . 0.0 110.147 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -102.06 129.3 48.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 107.234 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.6 mm -123.88 127.81 73.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.34 107.36 21.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 110.005 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -145.86 173.24 12.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.498 -0.751 . . . . 0.0 111.813 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -98.65 104.3 23.71 Favored Pre-proline 0 N--CA 1.439 -1.024 0 C-N-CA 124.932 1.293 . . . . 0.0 108.713 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.12 -24.4 73.55 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.836 2.357 . . . . 0.0 112.4 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -22.76 63.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.594 0.758 . . . . 0.0 112.894 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.8 mt -107.97 -64.71 1.18 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.827 0.74 . . . . 0.0 111.474 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -116.5 161.3 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.644 1.177 . . . . 0.0 108.277 -175.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -127.72 165.45 20.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.514 0.726 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.62 -44.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 C-N-CA 124.133 0.973 . . . . 0.0 110.236 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -60.59 -38.19 83.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.135 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.86 -53.63 25.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 mmt -45.21 -59.74 2.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 122.863 0.465 . . . . 0.0 111.634 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -53.82 44.02 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.284 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -50.37 -47.05 56.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 120.702 1.592 . . . . 0.0 109.201 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -59.63 -48.96 79.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.704 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -69.74 -63.94 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 122.931 0.492 . . . . 0.0 110.583 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -47.69 -36.47 11.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.318 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.43 -32.82 63.04 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.726 1.148 . . . . 0.0 112.955 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.5 mmt -60.89 -30.39 70.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.437 0.562 . . . . 0.0 110.885 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.54 7.79 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.455 1.503 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -82.5 116.07 61.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.375 1.07 . . . . 0.0 109.524 -171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.76 144.08 64.09 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.611 1.541 . . . . 0.0 108.75 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.27 141.22 35.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.929 0.492 . . . . 0.0 111.179 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -114.49 78.3 1.14 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.88 0.872 . . . . 0.0 110.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.13 103.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.097 1.359 . . . . 0.0 111.2 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -155.41 57.09 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.34 0.59 . . . . 0.0 112.16 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.01 158.17 32.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 122.061 0.934 . . . . 0.0 109.767 179.344 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.58 129.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 41.7 t -91.15 119.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 70' ' ' VAL . 3.2 tm? -100.81 133.73 44.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -118.22 115.37 24.62 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.42 126.86 53.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.151 1.38 . . . . 0.0 108.572 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -70.31 140.72 52.33 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 168.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -130.93 143.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.6 159.11 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.84 -39.01 2.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.756 -0.59 . . . . 0.0 114.566 161.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.53 102.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.7 1.25 . . . . 0.0 110.681 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -134.75 34.4 3.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.097 1.359 . . . . 0.0 109.772 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 165.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -72.01 -25.5 61.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.613 0.244 . . . . 0.0 111.316 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -58.52 -56.1 26.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.214 0.606 . . . . 0.0 111.485 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 m -59.12 -55.77 30.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.64 0.654 . . . . 0.0 110.692 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -49.37 -57.47 6.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.22 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -59.73 -42.23 92.68 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.321 0.51 . . . . 0.0 111.206 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.8 m -57.38 -48.83 78.03 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.603 -0.686 . . . . 0.0 110.199 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.63 -49.08 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.253 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -45.16 -53.78 7.69 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.278 1.031 . . . . 0.0 109.546 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.75 -57.41 19.93 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.344 0.973 . . . . 0.0 112.316 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -58.25 -54.38 47.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.868 0.834 . . . . 0.0 109.874 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 28' ' ' LEU . 24.0 mm -70.32 -35.95 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.575 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.7 -30.76 9.08 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.733 -0.604 . . . . 0.0 112.688 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.7 -14.81 60.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 118.178 0.989 . . . . 0.0 113.448 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -68.71 147.66 51.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.639 1.563 . . . . 0.0 112.746 -178.729 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.68 97.51 7.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.74 -10.1 1.87 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-O 119.725 -0.486 . . . . 0.0 114.271 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.91 137.82 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -31.66 10.49 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.079 0.551 . . . . 0.0 111.381 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -152.72 159.64 43.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.19 140.92 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.93 136.78 25.67 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.845 0.858 . . . . 0.0 110.53 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -132.96 104.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 120.628 1.558 . . . . 0.0 111.349 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.1 m -83.28 105.34 14.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.685 1.994 . . . . 0.0 110.125 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -62.26 -44.75 95.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.486 -0.133 . . . . 0.0 110.849 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.48 -57.34 7.2 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.396 1.478 . . . . 0.0 111.287 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.08 11.66 20.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.576 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 1.4 mt-30 33.61 62.93 0.39 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.601 2.36 . . . . 0.0 112.605 -168.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.23 136.25 39.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.971 0.908 . . . . 0.0 110.618 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.34 135.23 53.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.797 1.639 . . . . 0.0 110.168 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.6 m -111.77 124.47 52.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 131.281 3.832 . . . . 0.0 106.438 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mm -125.88 117.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -108.46 95.42 3.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -123.88 169.52 11.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.22 0.533 . . . . 0.0 111.951 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -108.06 109.81 62.02 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.345 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.86 79.76 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.504 2.803 . . . . 0.0 111.298 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m170 177.13 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 128.07 2.548 . . . . 0.0 108.075 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.95 -46.67 17.87 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.398 -0.189 . . . . 0.0 111.258 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -140.2 170.76 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.375 1.47 . . . . 0.0 107.741 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.8 p -130.53 155.91 45.71 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.128 0.971 . . . . 0.0 111.443 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -46.44 -43.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.638 0.775 . . . . 0.0 110.974 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 4.1 tm-20 -60.68 -45.4 94.33 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.706 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.58 -55.98 27.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.66 1.184 . . . . 0.0 107.814 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.7 mmt -46.16 -59.05 3.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' NZ ' ' OE2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -60.66 -51.18 70.5 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 121.148 -0.97 . . . . 0.0 111.927 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -52.66 -49.31 65.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.78 -48.19 82.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.373 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.58 -66.8 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.057 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -48.94 -33.95 11.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.428 -0.796 . . . . 0.0 113.003 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.937 1.244 . . . . 0.0 112.937 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.8 mmt -55.47 -42.28 74.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 110.547 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.76 -25.0 2.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.011 0.815 . . . . 0.0 111.326 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -73.86 113.19 20.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.928 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -64.84 143.69 80.75 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.669 1.579 . . . . 0.0 108.857 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.26 40.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -104.78 76.89 1.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 5' ' ' LEU . 1.3 p -52.58 108.0 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 109.828 162.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -155.38 59.79 0.63 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.601 0.715 . . . . 0.0 112.402 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -157.16 168.06 28.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.445 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.81 144.51 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.786 1.634 . . . . 0.0 107.551 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.33 131.76 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.524 1.53 . . . . 0.0 107.546 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 70' ' ' VAL . 3.0 tm? -120.3 122.09 40.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -113.56 118.8 35.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 8.2 ptp -117.0 128.96 55.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.292 1.037 . . . . 0.0 109.935 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 125.28 28.6 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.19 154.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 119.318 0.963 . . . . 0.0 108.88 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -115.28 154.53 28.94 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 109.74 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.93 -47.54 3.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.691 0.662 . . . . 0.0 112.347 171.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.4 mtm -64.59 86.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.568 0.684 . . . . 0.0 111.82 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 m -135.65 50.7 2.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.476 1.51 . . . . 0.0 109.738 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 p -161.17 167.95 25.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -65.46 177.2 1.21 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.803 0.811 . . . . 0.0 109.837 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t 73.74 -65.73 0.34 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 121.309 -0.869 . . . . 0.0 108.774 -170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.3 m -47.64 -63.47 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.036 0.835 . . . . 0.0 111.317 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -56.03 -55.72 29.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.264 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -58.98 -45.91 89.4 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.137 0.975 . . . . 0.0 111.65 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.5 m -53.64 -50.5 65.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.499 0.719 . . . . 0.0 110.281 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -44.04 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.568 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.5 -51.87 57.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 109.749 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.78 -54.47 34.78 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.259 0.933 . . . . 0.0 112.112 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -60.6 -54.51 44.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.012 -0.699 . . . . 0.0 110.897 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.57 -42.36 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.54 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.55 -23.52 14.26 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.325 -0.708 . . . . 0.0 113.718 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -81.91 -18.87 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.966 1.383 . . . . 0.0 112.283 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.94 131.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.781 1.628 . . . . 0.0 111.292 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -68.68 91.71 0.45 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.37 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.28 -18.34 1.52 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.329 -171.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.91 146.05 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 117.858 0.829 . . . . 0.0 109.587 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -106.21 -44.99 4.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.811 1.645 . . . . 0.0 110.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.58 168.69 26.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 tt -158.35 139.36 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -136.72 86.82 2.24 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.634 1.574 . . . . 0.0 111.039 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.62 97.19 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 109.366 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.0 m -75.66 165.46 25.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -131.56 -46.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.849 0.859 . . . . 0.0 109.622 -173.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.42 -57.21 12.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.044 1.338 . . . . 0.0 109.423 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -88.05 12.77 12.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.088 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 35.98 58.41 0.94 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.355 2.262 . . . . 0.0 113.19 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.78 140.02 31.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.479 -0.763 . . . . 0.0 108.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -121.71 112.72 18.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.882 1.273 . . . . 0.0 109.793 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.449 ' C ' HD12 ' A' ' 45' ' ' ILE . 31.6 m -87.94 126.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 107.873 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 44' ' ' THR . 3.5 mp -121.87 127.97 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.1 110.46 32.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -138.83 167.66 21.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -168.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -103.46 108.87 60.64 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 123.901 0.881 . . . . 0.0 111.01 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.35 76.84 2.18 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.043 3.162 . . . . 0.0 110.674 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -179.09 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.161 2.184 . . . . 0.0 107.846 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.04 -49.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.35 162.28 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.708 1.603 . . . . 0.0 108.244 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -124.67 163.2 22.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 111.973 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.9 t -47.79 -41.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 C-N-CA 123.368 0.667 . . . . 0.0 111.079 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.04 -43.28 87.99 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.21 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -53.23 -51.32 62.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.925 1.239 . . . . 0.0 109.043 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.1 mmt -51.28 -67.28 0.26 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.09 -55.82 26.78 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.06 -1.025 . . . . 0.0 112.876 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -49.76 -49.39 48.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.2 -41.86 94.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 118.619 -1.233 . . . . 0.0 112.674 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.5 -65.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 O-C-N 121.669 -0.644 . . . . 0.0 110.431 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -49.41 -34.65 16.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.458 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.34 -32.63 62.68 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.939 1.245 . . . . 0.0 112.621 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 16.9 mmt -58.96 -41.92 88.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.473 0.579 . . . . 0.0 110.706 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.37 -19.45 3.61 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.634 1.111 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -75.41 114.95 40.9 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.955 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.61 144.88 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.507 1.471 . . . . 0.0 108.969 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.76 135.02 25.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.021 0.438 . . . . 0.0 111.91 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -108.21 78.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.873 1.669 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -56.08 109.36 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.207 1.803 . . . . 0.0 110.335 165.039 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -155.82 55.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.72 137.78 13.59 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.976 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.74 140.14 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 125.744 1.618 . . . . 0.0 107.932 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 46' ' ' VAL . 37.3 t -89.45 119.35 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.306 1.042 . . . . 0.0 108.404 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm? -95.07 125.1 39.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.84 120.21 41.13 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mtt -118.17 127.0 53.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.419 1.088 . . . . 0.0 108.59 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.11 130.57 36.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.62 138.42 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -104.81 146.58 28.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.967 0.507 . . . . 0.0 109.703 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.3 -36.68 3.97 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.586 0.612 . . . . 0.0 113.346 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 mtp -65.92 94.72 0.23 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.822 0.811 . . . . 0.0 110.357 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -119.72 53.92 1.03 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.267 1.427 . . . . 0.0 108.42 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -171.31 157.49 5.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.453 0.701 . . . . 0.0 109.114 -169.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -27.62 60.6 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.664 167.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -57.16 -69.87 0.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.272 0.629 . . . . 0.0 112.025 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -59.11 -48.08 82.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.159 0.436 . . . . 0.0 110.736 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -50.27 -56.72 9.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.824 0.85 . . . . 0.0 110.621 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 t -57.82 -47.18 83.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.602 0.761 . . . . 0.0 111.454 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.7 m -55.2 -48.06 74.38 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 110.944 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 66' ' ' PHE . 27.5 mt -62.41 -49.42 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 124.194 0.998 . . . . 0.0 108.993 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -46.71 -50.39 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.058 0.943 . . . . 0.0 109.979 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.29 -59.11 11.4 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.022 0.82 . . . . 0.0 112.125 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.79 -57.78 10.98 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.681 0.753 . . . . 0.0 109.776 -174.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.99 -32.03 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.88 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.82 -32.45 25.94 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.754 -0.591 . . . . 0.0 112.419 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.07 4.53 41.72 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 117.906 0.853 . . . . 0.0 112.208 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 152.87 44.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 120.522 1.51 . . . . 0.0 110.102 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -83.45 134.69 34.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 18.87 11.13 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.99 0.805 . . . . 0.0 112.559 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.3 t -122.94 143.93 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.173 1.389 . . . . 0.0 109.757 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.87 -30.42 9.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.286 0.634 . . . . 0.0 112.016 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -160.55 167.27 27.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.874 1.269 . . . . 0.0 108.07 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 tt -155.07 142.13 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.73 151.4 45.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.633 1.573 . . . . 0.0 109.245 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.0 t -140.56 143.51 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.089 0.859 . . . . 0.0 109.546 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 m -112.59 167.99 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.515 1.926 . . . . 0.0 109.297 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.82 -56.98 1.92 Allowed 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.282 1.033 . . . . 0.0 109.239 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.4 -58.2 3.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.977 1.311 . . . . 0.0 111.118 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -91.72 13.38 18.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.277 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 32.15 68.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.795 3.238 . . . . 0.0 112.723 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -136.86 147.85 46.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.067 0.947 . . . . 0.0 109.842 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.34 133.92 50.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.331 1.852 . . . . 0.0 109.665 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 45' ' ' ILE . 38.4 m -112.4 114.28 26.92 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 128.672 2.789 . . . . 0.0 108.66 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.543 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -118.87 113.57 42.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 4' ' ' VAL . 3.0 t -100.04 91.5 2.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.04 13.62 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.717 0.807 . . . . 0.0 113.033 -166.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -102.28 111.14 64.15 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.044 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.9 67.57 3.17 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.974 3.116 . . . . 0.0 109.969 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.43 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.145 1.378 . . . . 0.0 108.702 -173.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.4 -42.18 37.24 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.33 0.252 . . . . 0.0 110.846 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.7 165.15 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 124.402 1.081 . . . . 0.0 108.474 -175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -110.49 158.31 18.65 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.024 1.329 . . . . 0.0 112.056 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -51.09 -46.16 31.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 C-N-CA 124.069 0.948 . . . . 0.0 111.506 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.68 -38.21 84.18 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.174 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -52.0 65.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 120.739 1.609 . . . . 0.0 108.176 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.0 mmt -49.8 -63.14 1.2 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -59.05 -56.19 25.47 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.066 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -43.04 -52.46 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.539 1.135 . . . . 0.0 109.727 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -63.26 -42.19 99.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.39 -62.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 O-C-N 121.838 -0.539 . . . . 0.0 110.174 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -42.77 -41.96 3.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 112.273 171.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.79 -31.9 50.6 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.027 0.831 . . . . 0.0 113.215 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.43 -41.73 90.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.408 0.549 . . . . 0.0 110.84 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.19 -17.89 3.34 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.784 1.183 . . . . 0.0 111.202 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 21' ' ' ILE . 48.3 m-85 -80.78 113.3 39.08 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.77 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.32 149.6 90.81 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 108.682 -1.315 . . . . 0.0 108.682 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.91 137.32 26.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.281 0.233 . . . . 0.0 111.052 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -107.28 74.9 0.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.7 p -62.57 103.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.107 1.363 . . . . 0.0 110.298 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -154.57 55.65 0.68 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.458 0.647 . . . . 0.0 112.125 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 5' ' ' LEU . 3.2 mmtp -158.14 149.78 21.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 175.389 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 m -107.61 129.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -170.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.7 122.63 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 72' ' ' LYS . 3.3 mm? -107.31 130.35 54.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -115.78 119.43 35.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.1 122.4 35.65 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.081 1.352 . . . . 0.0 108.804 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -70.07 138.6 52.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 172.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.86 143.7 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.26 152.0 19.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.31 -37.0 1.99 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.419 0.533 . . . . 0.0 114.268 166.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.5 mtp -70.6 80.47 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.274 1.037 . . . . 0.0 111.319 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.63 24.51 12.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.771 1.228 . . . . 0.0 111.924 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 p -161.03 166.68 27.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.162 0.982 . . . . 0.0 111.45 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -63.79 168.93 4.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.362 168.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 80.05 -64.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.646 1.178 . . . . 0.0 109.864 -172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 m -60.11 -59.01 6.1 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.995 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CG1' ' A' ' 36' ' ' VAL . 16.5 p -49.61 -63.15 1.19 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.665 1.186 . . . . 0.0 110.287 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -53.22 -40.74 64.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 111.51 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.7 m -59.98 -49.27 78.34 Favored 'General case' 0 N--CA 1.457 -0.086 0 O-C-N 121.621 -0.675 . . . . 0.0 109.837 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.58 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.99 -53.9 36.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.641 0.776 . . . . 0.0 110.506 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -52.23 52.62 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.219 0.914 . . . . 0.0 111.788 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.17 -58.33 8.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -66.26 -29.37 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.887 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.83 -30.84 7.22 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.736 0.684 . . . . 0.0 113.236 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -89.93 6.95 39.79 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.515 1.158 . . . . 0.0 112.354 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.16 152.35 44.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.516 -1.365 . . . . 0.0 111.982 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -96.28 84.87 3.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.114 1.365 . . . . 0.0 109.575 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.69 -4.87 0.8 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 115.407 0.923 . . . . 0.0 115.407 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.23 134.68 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.058 0.943 . . . . 0.0 108.876 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -34.14 12.71 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 111.319 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.3 165.95 32.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.91 145.44 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 103.233 -2.877 . . . . 0.0 103.233 -171.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -142.34 150.72 41.13 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.886 1.274 . . . . 0.0 109.589 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG1' HG22 ' A' ' 18' ' ' THR . 21.9 t -140.39 106.72 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.977 0.808 . . . . 0.0 110.181 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -94.73 80.88 3.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.12 1.368 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -48.01 -41.05 24.5 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.574 0.75 . . . . 0.0 112.371 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.31 -56.33 5.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.093 1.757 . . . . 0.0 110.692 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -100.27 22.83 10.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.955 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 34.19 57.65 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.043 2.537 . . . . 0.0 113.285 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 39.2 tt0 -138.06 131.18 30.23 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.24 147.26 28.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.514 1.526 . . . . 0.0 110.031 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.3 m -124.68 120.12 30.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.307 2.643 . . . . 0.0 106.985 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -121.04 124.92 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.98 97.31 5.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 118.298 0.499 . . . . 0.0 110.443 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -117.75 169.02 9.92 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.341 0.657 . . . . 0.0 112.682 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.91 114.17 61.88 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.209 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.57 77.08 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.532 2.821 . . . . 0.0 111.57 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -177.23 -43.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 127.66 2.384 . . . . 0.0 108.279 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.15 -47.59 27.77 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.4 176.27 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.33 1.452 . . . . 0.0 107.749 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.2 p -143.12 165.99 25.9 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.894 0.77 . . . . 0.0 111.114 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.53 -34.26 28.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 C-N-CA 122.964 0.506 . . . . 0.0 111.953 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -62.06 -42.6 99.36 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.662 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.71 -52.8 62.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.1 mtp -47.34 -59.9 2.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.176 0.591 . . . . 0.0 111.626 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -62.09 -52.88 62.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -47.92 -50.06 28.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.806 0.73 . . . . 0.0 109.241 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -61.4 -49.27 77.58 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.28 -63.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.805 -0.56 . . . . 0.0 110.514 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -45.94 -39.15 8.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.754 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.63 60.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.736 1.153 . . . . 0.0 113.044 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.0 mmt -56.61 -39.43 73.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.51 0.596 . . . . 0.0 110.843 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.87 -17.98 4.33 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.333 1.444 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -78.47 115.22 49.73 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 123.856 0.862 . . . . 0.0 110.213 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -66.83 141.55 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.07 138.03 39.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.646 0.378 . . . . 0.0 111.506 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.09 78.73 1.2 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.733 0.813 . . . . 0.0 109.276 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.6 p -65.07 104.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.841 1.656 . . . . 0.0 110.42 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -156.18 58.48 0.58 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.634 0.731 . . . . 0.0 112.524 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.655 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -156.36 132.06 9.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 tp . . . . . 0 C--N 1.332 -0.16 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.746 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.303 0.097 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.91 131.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.91 0.884 . . . . 0.0 109.771 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.24 123.64 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.584 1.554 . . . . 0.0 106.888 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.563 HD22 ' CG2' ' A' ' 70' ' ' VAL . 19.7 mt -93.08 128.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 159.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -110.24 127.65 55.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.438 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 13.1 ptm -140.71 132.06 26.73 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -75.87 138.84 41.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 m -124.85 150.7 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.39 150.04 31.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.203 0.456 . . . . 0.0 110.339 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.37 -33.1 1.57 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.666 0.651 . . . . 0.0 113.865 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.9 mtp -67.3 78.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.932 0.893 . . . . 0.0 111.916 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -134.07 43.55 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.392 1.077 . . . . 0.0 110.16 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -161.25 151.25 17.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.476 1.11 . . . . 0.0 108.752 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -75.03 55.83 0.74 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.893 1.277 . . . . 0.0 111.427 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.8 m -136.77 -64.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -60.43 -54.24 47.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.751 0.821 . . . . 0.0 109.737 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 t -45.8 -62.94 1.09 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.535 1.134 . . . . 0.0 110.006 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 t -63.77 -39.13 93.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.989 0.516 . . . . 0.0 109.937 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.0 m -58.82 -49.59 77.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.772 -0.58 . . . . 0.0 110.076 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.6 -50.73 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.258 0.481 . . . . 0.0 109.939 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -44.41 -54.57 5.77 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.499 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.68 -57.39 20.12 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.796 0.712 . . . . 0.0 112.04 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -58.63 -54.46 46.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.42 0.628 . . . . 0.0 110.155 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.72 -38.29 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.99 0.916 . . . . 0.0 110.159 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.73 18.94 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.856 -0.527 . . . . 0.0 112.24 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -73.47 -13.82 61.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.18 140.78 47.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 120.266 1.394 . . . . 0.0 112.31 -169.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -69.51 80.17 0.4 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.015 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.31 -19.32 0.23 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.43 133.55 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -31.17 13.01 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.042 0.537 . . . . 0.0 111.485 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -154.36 161.05 41.97 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -156.07 137.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -138.51 153.13 48.75 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.289 1.036 . . . . 0.0 110.148 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.0 t -138.18 111.74 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -87.7 69.54 9.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.658 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -48.34 -42.49 31.49 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.498 0.499 . . . . 0.0 110.624 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -56.33 5.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.711 2.004 . . . . 0.0 111.102 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -98.56 22.35 9.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.062 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 44.13 53.74 6.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.706 2.002 . . . . 0.0 112.782 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.28 147.79 49.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.453 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 148.93 48.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.383 1.873 . . . . 0.0 109.626 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -129.36 116.69 19.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.461 2.704 . . . . 0.0 107.064 -171.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 mm -123.17 110.41 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.57 94.64 3.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -171.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -111.91 167.8 10.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.311 0.577 . . . . 0.0 112.084 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -110.12 113.64 56.62 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.671 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.13 77.11 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.434 2.756 . . . . 0.0 111.176 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -177.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 128.018 2.527 . . . . 0.0 107.954 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.13 -48.55 17.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.39 176.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.514 1.526 . . . . 0.0 108.316 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.1 p -142.62 162.0 36.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.544 0.738 . . . . 0.0 111.502 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG22 HD21 ' A' ' 5' ' ' LEU . 21.1 t -44.08 -45.61 2.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 125.452 1.501 . . . . 0.0 111.681 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -54.99 39.0 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-O 117.146 -1.407 . . . . 0.0 109.035 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -46.47 -55.33 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 110.437 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.0 mmt -46.21 -56.92 5.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.814 0.734 . . . . 0.0 111.713 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -62.84 -61.57 2.31 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.212 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -40.35 -52.14 2.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.961 1.704 . . . . 0.0 109.156 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -61.98 -47.37 85.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.98 -64.73 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.83 -0.544 . . . . 0.0 111.089 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -43.98 -40.05 4.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.69 0.796 . . . . 0.0 112.692 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.72 -32.41 59.62 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.326 0.966 . . . . 0.0 112.861 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.8 mmt -57.81 -41.81 82.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.368 0.531 . . . . 0.0 110.293 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.53 -19.05 2.81 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.622 1.106 . . . . 0.0 111.093 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -78.08 119.27 76.71 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.008 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.91 145.51 80.31 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.575 -1.356 . . . . 0.0 108.575 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.69 135.99 26.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.609 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -99.18 82.82 2.76 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD22 ' A' ' 5' ' ' LEU . 2.4 p -70.07 105.58 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.069 1.347 . . . . 0.0 110.444 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -155.31 58.98 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 5' ' ' LEU . 34.9 mttm -153.71 154.01 33.31 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 159.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 163.933 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.99 136.29 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.933 0.893 . . . . 0.0 109.23 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.485 HG23 HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -90.76 134.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.322 1.449 . . . . 0.0 108.655 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 47' ' ' TYR . 6.1 mp -122.15 151.63 40.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 165.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -120.24 123.03 42.22 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -124.01 129.53 51.07 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.138 1.375 . . . . 0.0 108.345 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 120.85 29.47 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.389 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.86 125.12 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 124.228 0.955 . . . . 0.0 109.347 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -87.64 152.49 22.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.394 0.677 . . . . 0.0 109.264 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.82 -46.18 1.23 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.518 0.58 . . . . 0.0 112.87 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mtp -70.01 82.64 0.49 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.807 0.804 . . . . 0.0 111.924 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.8 m -133.61 -9.07 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.703 1.601 . . . . 0.0 112.22 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 p -80.8 -17.38 51.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.444 1.498 . . . . 0.0 113.55 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 m80 84.45 -31.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.267 2.227 . . . . 0.0 112.262 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -62.26 -65.76 0.64 Allowed 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -50.88 -48.5 60.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 111.83 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -48.0 -62.32 1.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 109.754 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -59.35 -47.17 86.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.486 1.114 . . . . 0.0 110.84 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.9 m -52.15 -50.09 62.44 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.706 0.803 . . . . 0.0 110.877 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.9 -47.8 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 123.807 0.843 . . . . 0.0 109.447 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -44.67 -52.73 7.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.038 0.935 . . . . 0.0 110.079 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.54 8.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.979 0.8 . . . . 0.0 112.683 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -50.71 70.76 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 121.508 0.67 . . . . 0.0 109.984 -171.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.36 -41.22 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.774 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.78 -34.46 21.87 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.319 0.485 . . . . 0.0 112.518 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -71.14 -7.93 50.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.796 0.838 . . . . 0.0 113.095 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.6 144.77 45.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 120.656 1.571 . . . . 0.0 111.689 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -81.73 61.19 5.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.16 22.45 0.02 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.57 150.52 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -111.77 -40.35 4.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.02 0.928 . . . . 0.0 109.387 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -159.97 164.86 32.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 tt -157.67 141.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 103.903 -2.628 . . . . 0.0 103.903 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -143.04 144.72 32.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.628 1.171 . . . . 0.0 110.119 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.64 131.74 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.174 0.897 . . . . 0.0 110.505 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -113.88 94.28 4.76 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.227 1.811 . . . . 0.0 109.733 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.32 91.22 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.058 -0.401 . . . . 0.0 112.075 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.83 -57.18 6.8 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.791 1.237 . . . . 0.0 111.049 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -95.2 20.62 8.92 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.742 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 30.81 67.35 0.12 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.776 2.43 . . . . 0.0 113.185 -169.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -131.35 157.64 42.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.626 1.17 . . . . 0.0 109.742 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.17 149.88 50.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.663 1.185 . . . . 0.0 109.698 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 m -127.66 121.3 30.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.424 2.689 . . . . 0.0 106.463 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 mm -128.4 118.87 48.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 4' ' ' VAL . 1.7 t -121.66 105.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.202 -170.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 5' ' ' LEU . 35.2 p90 -137.58 176.18 8.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.549 -0.72 . . . . 0.0 112.122 -168.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.7 108.26 61.14 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.307 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.82 71.89 4.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 3.307 . . . . 0.0 110.264 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -173.23 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.559 1.944 . . . . 0.0 108.656 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.09 -42.05 11.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.497 0.319 . . . . 0.0 111.297 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.23 160.62 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 125.334 1.453 . . . . 0.0 108.211 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -119.93 168.83 10.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.191 0.996 . . . . 0.0 112.153 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.82 -42.5 18.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.842 0.457 . . . . 0.0 110.699 166.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.95 -46.58 71.03 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.747 -171.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.35 -58.09 4.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.779 1.172 . . . . 0.0 109.359 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.0 mmt -48.17 -66.79 0.34 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.801 0.441 . . . . 0.0 111.746 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -60.41 -58.94 6.35 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 121.129 -0.982 . . . . 0.0 112.263 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -41.44 -50.23 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.45 1.023 . . . . 0.0 109.353 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -65.65 -42.64 91.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.17 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.79 -62.8 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 119.067 0.849 . . . . 0.0 110.883 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -41.67 -40.74 2.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.934 0.894 . . . . 0.0 112.372 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -31.46 44.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.9 -39.63 78.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.371 0.668 . . . . 0.0 110.631 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.6 3.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.823 1.201 . . . . 0.0 111.307 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.06 112.08 42.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.478 1.111 . . . . 0.0 110.393 -169.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.47 128.05 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.795 1.663 . . . . 0.0 109.699 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.7 139.04 53.61 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.864 0.866 . . . . 0.0 111.687 -174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -111.7 76.83 1.0 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.514 0.726 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 70' ' ' VAL . 8.5 p -68.76 103.15 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.8 1.64 . . . . 0.0 110.73 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.09 57.0 0.59 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 112.787 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -158.7 139.79 13.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.149 0.499 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -136.82 140.49 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.502 1.521 . . . . 0.0 107.729 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.22 129.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.57 142.82 43.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -128.69 116.76 20.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.494 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 7.1 ptp -113.42 131.71 55.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.524 0.729 . . . . 0.0 109.566 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -68.01 137.84 55.4 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 165.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 m -121.74 151.96 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -118.22 145.7 44.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.2 -41.45 2.41 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.813 0.721 . . . . 0.0 112.554 171.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -56.56 115.19 2.38 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.12 0.96 . . . . 0.0 110.498 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 13' ' ' THR . 17.9 m -148.33 39.35 0.9 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.248 1.019 . . . . 0.0 108.362 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -152.53 158.03 41.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -67.19 -19.21 65.53 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.456 0.473 . . . . 0.0 111.928 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.89 -58.1 9.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.34 -52.53 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.675 0.39 . . . . 0.0 110.879 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -54.83 -55.94 24.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -57.05 -45.14 83.42 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.467 0.707 . . . . 0.0 111.196 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -54.6 -50.48 67.95 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.277 -0.889 . . . . 0.0 110.915 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.43 -48.23 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -46.16 -53.59 10.17 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.013 1.325 . . . . 0.0 109.804 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.77 -59.34 9.93 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.102 0.858 . . . . 0.0 111.286 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -55.6 -61.22 2.49 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.601 0.7 . . . . 0.0 110.884 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.69 -47.46 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.752 0.821 . . . . 0.0 109.365 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.41 -40.92 39.68 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -73.68 -9.6 58.83 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.858 0.863 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mt -85.52 132.18 34.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.942 1.246 . . . . 0.0 110.198 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.33 134.95 55.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.62 -20.41 4.9 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.421 0.534 . . . . 0.0 112.466 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.3 141.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.876 1.271 . . . . 0.0 110.392 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -30.77 10.62 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 111.707 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -164.52 168.81 17.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -158.5 143.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -144.85 93.69 2.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 0.0 112.014 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.2 105.36 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.246 0.618 . . . . 0.0 111.188 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -96.68 125.39 41.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.218 1.007 . . . . 0.0 111.402 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -44.64 18.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.978 0.511 . . . . 0.0 110.25 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -61.58 2.06 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 126.142 1.777 . . . . 0.0 110.622 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -91.87 18.61 7.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.863 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.2 62.7 0.29 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.371 2.668 . . . . 0.0 112.234 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.91 124.33 18.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.64 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.38 112.84 25.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.31 1.444 . . . . 0.0 109.839 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -83.76 132.01 34.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.007 1.323 . . . . 0.0 107.753 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -131.07 124.98 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.6 109.02 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.448 0.567 . . . . 0.0 110.442 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -129.67 166.8 19.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -165.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -101.3 106.4 45.21 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 109.758 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.61 81.32 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.625 2.884 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 175.21 -42.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.493 2.317 . . . . 0.0 107.802 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.26 -56.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 167.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.171 1.389 . . . . 0.0 110.167 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -130.01 166.45 20.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.095 1.358 . . . . 0.0 110.091 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -46.85 -45.44 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.621 1.169 . . . . 0.0 111.536 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.71 -39.06 87.14 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 118.942 -0.551 . . . . 0.0 111.171 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.4 -46.95 88.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.6 mtt -51.78 -60.62 2.96 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 122.521 0.329 . . . . 0.0 111.7 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -55.51 33.05 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.064 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -45.56 -53.56 8.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 109.284 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -59.18 -49.02 79.44 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -71.99 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 110.793 -172.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.96 -37.1 13.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.89 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.44 64.75 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.782 1.174 . . . . 0.0 112.73 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.1 mmt -60.39 -43.72 96.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 110.189 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.93 -17.56 3.63 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.96 1.267 . . . . 0.0 110.953 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -72.26 115.55 40.03 Favored Pre-proline 0 N--CA 1.453 -0.318 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.112 -173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -69.2 139.48 42.28 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.527 -1.374 . . . . 0.0 108.527 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.23 138.2 41.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.778 0.431 . . . . 0.0 112.04 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -113.22 78.56 1.15 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.442 1.497 . . . . 0.0 109.512 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -50.71 112.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.597 1.159 . . . . 0.0 108.983 161.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.47 59.7 0.63 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 112.398 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.25 159.18 37.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -117.34 132.51 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 127.36 2.264 . . . . 0.0 106.374 162.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.41 130.11 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.646 HD12 ' CG2' ' A' ' 70' ' ' VAL . 2.6 mm? -118.56 143.39 46.8 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 170.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -123.73 117.83 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.9 ptp -123.19 131.76 53.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.283 1.033 . . . . 0.0 109.187 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -83.76 116.22 22.59 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.21 144.69 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -56.94 148.68 20.48 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.399 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.31 40.12 1.72 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.159 0.885 . . . . 0.0 113.527 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 45.4 -140.33 0.37 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 113.205 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -124.64 -41.27 2.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.178 1.391 . . . . 0.0 110.267 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.15 165.47 24.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -55.23 -26.08 37.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.536 0.734 . . . . 0.0 112.623 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.4 m -50.59 -44.21 56.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.756 -0.59 . . . . 0.0 110.465 171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -66.64 -55.22 16.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.317 0.647 . . . . 0.0 110.09 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.8 p -53.97 -54.38 39.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.4 t -57.41 -45.98 83.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.942 0.897 . . . . 0.0 110.942 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.6 m -57.09 -49.32 76.23 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.632 -0.668 . . . . 0.0 109.974 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.9 mt -56.07 -48.45 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 118.466 0.575 . . . . 0.0 109.756 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -55.83 -50.44 70.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.803 0.841 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -54.94 33.79 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.648 0.642 . . . . 0.0 112.083 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -53.67 -50.63 65.39 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.256 1.022 . . . . 0.0 110.241 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 34' ' ' ILE . 14.1 mm -63.29 -49.13 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 109.75 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.37 -36.15 10.71 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 117.989 0.358 . . . . 0.0 112.314 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -69.06 -15.43 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.29 145.01 35.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.693 1.133 . . . . 0.0 111.736 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.18 65.13 4.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.28 13.67 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -170.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.97 143.71 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 119.456 1.628 . . . . 0.0 110.41 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -108.33 -45.05 3.98 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.503 1.521 . . . . 0.0 109.817 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -163.19 171.12 16.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 25' ' ' ILE . 5.2 tt -159.57 144.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 34.3 mmtt -141.84 84.73 1.9 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.671 0.788 . . . . 0.0 110.742 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.19 105.72 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.573 0.749 . . . . 0.0 110.78 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 m -108.48 135.08 50.36 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.824 0.85 . . . . 0.0 111.031 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -48.05 6.52 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.915 0.486 . . . . 0.0 109.764 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -54.39 27.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.636 1.574 . . . . 0.0 110.25 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -79.23 -0.98 34.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.946 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 49.23 58.09 5.76 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.407 1.883 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.4 130.69 8.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.047 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -110.21 115.53 29.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.258 1.423 . . . . 0.0 108.996 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 35' ' ' LYS . 53.4 m -90.14 133.85 34.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 107.309 169.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.66 129.93 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -117.92 106.6 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -127.16 165.22 19.98 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 122.062 -0.399 . . . . 0.0 111.564 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.65 123.05 62.9 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.36 145.67 92.88 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.609 1.539 . . . . 0.0 108.676 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 87.27 -23.02 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.693 1.597 . . . . 0.0 111.824 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.46 -47.36 8.4 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.719 1.145 . . . . 0.0 110.929 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -137.91 158.02 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.639 1.576 . . . . 0.0 108.448 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -114.24 169.92 8.68 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.854 0.862 . . . . 0.0 111.053 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.92 -41.1 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.481 0.712 . . . . 0.0 111.482 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.46 -53.21 51.86 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -171.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -37.3 -60.47 0.66 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.079 1.752 . . . . 0.0 111.486 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 15.4 mtm -48.77 -64.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -59.05 5.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.869 -173.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -36.12 -55.35 0.78 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.006 1.323 . . . . 0.0 111.11 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -60.85 -43.01 98.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.363 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -65.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -37.62 -46.26 0.84 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.177 0.991 . . . . 0.0 112.363 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.87 -32.04 60.4 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.6 mmt -60.32 -39.91 88.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.366 0.53 . . . . 0.0 110.643 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.66 -11.63 3.44 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.512 1.053 . . . . 0.0 111.281 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -90.14 110.47 40.6 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.039 0.936 . . . . 0.0 109.151 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.61 132.82 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.844 1.696 . . . . 0.0 109.301 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.28 49.08 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.003 0.921 . . . . 0.0 111.423 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -117.38 79.07 1.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.845 0.858 . . . . 0.0 109.438 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.646 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.1 p -63.62 108.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.025 1.73 . . . . 0.0 110.95 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -154.29 59.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.203 1.002 . . . . 0.0 113.239 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.525 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -159.23 159.86 34.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 120.803 -1.186 . . . . 0.0 108.166 178.509 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.1 tp . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 122.29 1.043 . . . . 0.0 109.377 -177.53 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.31 141.46 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 125.467 1.507 . . . . 0.0 107.889 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.42 122.62 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 72' ' ' LYS . 15.0 mt -100.09 141.83 32.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 168.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 72' ' ' LYS . 16.8 tptt -119.12 125.49 49.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -124.34 119.12 28.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.378 1.471 . . . . 0.0 108.955 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 120.76 22.95 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m -105.68 152.56 7.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -116.12 150.48 37.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.168 0.44 . . . . 0.0 110.786 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.97 -30.23 2.07 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.533 0.587 . . . . 0.0 114.079 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtp -68.93 85.38 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.016 0.908 . . . . 0.0 111.669 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -114.92 6.97 15.52 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.761 1.224 . . . . 0.0 112.232 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -129.12 139.74 51.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.317 0.962 . . . . 0.0 111.236 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -31.51 54.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.363 1.065 . . . . 0.0 111.962 -171.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -45.81 -55.1 7.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.329 1.052 . . . . 0.0 111.709 170.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.86 -54.6 28.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.315 0.507 . . . . 0.0 109.847 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -51.68 -54.96 22.42 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.637 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.6 t -57.85 -46.09 85.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.473 0.579 . . . . 0.0 111.346 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.8 m -56.81 -50.91 70.95 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.368 -0.833 . . . . 0.0 110.843 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.77 -43.9 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.97 -47.88 76.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.917 0.887 . . . . 0.0 110.658 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.88 41.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.825 0.726 . . . . 0.0 111.321 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -65.62 -59.91 3.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.433 0.635 . . . . 0.0 110.946 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.75 -30.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.009 0.924 . . . . 0.0 110.388 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.69 -29.31 7.71 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.498 -0.612 . . . . 0.0 112.764 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -92.43 7.9 41.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.494 1.147 . . . . 0.0 112.77 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.44 159.5 33.13 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.413 1.46 . . . . 0.0 111.656 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.36 82.97 2.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.471 1.508 . . . . 0.0 109.725 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.08 11.79 0.26 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.4 128.6 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 109.599 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -86.22 -36.63 19.32 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -154.23 168.24 27.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 122.201 1.0 . . . . 0.0 108.656 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -157.42 141.6 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -140.61 82.49 1.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 0.0 110.432 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.13 116.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.515 0.726 . . . . 0.0 109.111 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -97.33 -174.23 2.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -147.52 -47.8 0.17 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.23 1.012 . . . . 0.0 109.533 179.137 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.59 -55.83 7.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.514 1.525 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -94.04 19.19 9.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.56 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 36.52 61.48 0.82 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.35 2.26 . . . . 0.0 112.445 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.14 154.55 37.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.184 -0.947 . . . . 0.0 108.758 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.64 130.04 31.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.104 0.962 . . . . 0.0 109.877 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.8 m -92.85 132.75 36.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.743 1.617 . . . . 0.0 107.038 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.3 125.56 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 170.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.33 119.42 50.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.98 161.04 38.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -98.91 116.17 65.42 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.531 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.94 73.13 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.583 2.855 . . . . 0.0 110.546 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -174.73 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 109.744 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.27 -42.88 18.26 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.146 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.27 159.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -119.57 168.68 10.77 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.113 0.869 . . . . 0.0 112.139 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -44.03 -50.33 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.289 1.435 . . . . 0.0 111.209 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -42.68 86.92 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.71 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -48.6 -52.7 21.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.512 1.505 . . . . 0.0 108.663 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -61.64 2.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 121.38 -0.128 . . . . 0.0 111.236 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -58.24 9.14 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.569 -0.707 . . . . 0.0 112.266 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.43 -49.83 24.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.103 0.961 . . . . 0.0 109.458 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.28 -44.28 96.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.896 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.03 -63.87 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 123.166 0.587 . . . . 0.0 110.538 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -43.23 -41.41 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.468 0.707 . . . . 0.0 112.671 172.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.97 -31.26 50.12 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.044 0.838 . . . . 0.0 113.007 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.1 mmt -57.02 -41.65 78.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.372 0.533 . . . . 0.0 111.064 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 -20.79 2.53 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.531 1.062 . . . . 0.0 111.057 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -84.77 110.51 28.32 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 124.24 1.016 . . . . 0.0 110.068 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.82 139.21 61.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.78 134.58 26.82 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.6 72.14 1.54 Allowed 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.172 0.589 . . . . 0.0 110.371 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.55 94.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.012 1.325 . . . . 0.0 112.548 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -158.51 84.32 0.84 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.005 -0.434 . . . . 0.0 110.083 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -158.16 160.43 37.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 158.69 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 167.308 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 140.91 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 46' ' ' VAL . 18.4 t -103.59 127.45 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.274 1.43 . . . . 0.0 107.473 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 70' ' ' VAL . 1.9 pp -112.23 152.02 28.92 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -122.0 121.36 36.85 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.0 mtt -102.31 139.46 37.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -83.93 134.5 34.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 163.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.89 143.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 119.581 1.082 . . . . 0.0 108.819 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -114.58 140.87 48.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.82 -34.61 5.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.83 1.205 . . . . 0.0 112.922 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.0 mtm -69.19 95.33 0.75 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.059 0.93 . . . . 0.0 111.527 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -111.05 27.24 9.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.376 1.07 . . . . 0.0 112.886 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -151.04 159.74 44.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.282 0.947 . . . . 0.0 109.219 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -76.1 -12.66 60.15 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 m -62.76 -54.46 38.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.23 -51.68 65.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.771 0.26 . . . . 0.0 110.775 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p -52.69 -59.34 4.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 109.912 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -57.52 -44.3 84.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.938 0.895 . . . . 0.0 111.258 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.6 m -55.45 -48.69 74.1 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.364 -0.835 . . . . 0.0 110.751 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.34 -50.03 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 122.003 -0.435 . . . . 0.0 109.989 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -46.6 -49.56 18.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.511 1.124 . . . . 0.0 109.684 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -59.11 11.34 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.348 0.975 . . . . 0.0 112.398 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -55.23 37.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.725 0.763 . . . . 0.0 110.294 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.3 mm -70.83 -32.48 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.76 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.19 20.3 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.46 -0.775 . . . . 0.0 112.792 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -79.13 -3.6 46.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.312 1.056 . . . . 0.0 112.552 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.76 134.08 48.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.302 1.41 . . . . 0.0 111.265 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -77.26 115.71 17.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.29 -9.19 5.93 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.21 0.91 . . . . 0.0 111.904 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.45 150.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.28 0.632 . . . . 0.0 109.818 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -109.54 -40.4 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.647 1.579 . . . . 0.0 109.081 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -162.31 172.25 15.97 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.32 1.057 . . . . 0.0 108.741 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -156.46 143.23 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -142.61 146.76 34.86 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.659 1.583 . . . . 0.0 109.419 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -136.23 146.22 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.616 1.098 . . . . 0.0 109.793 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 m -124.68 148.46 47.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 127.494 2.318 . . . . 0.0 109.636 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.0 -56.91 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.87 1.668 . . . . 0.0 110.946 -171.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.03 -58.68 4.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.682 1.593 . . . . 0.0 110.484 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -85.15 0.29 52.19 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 41.23 70.99 0.22 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.737 2.815 . . . . 0.0 110.762 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -140.29 145.61 37.48 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.984 -163.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.75 113.15 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.628 1.571 . . . . 0.0 109.721 -168.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 45' ' ' ILE . 39.7 m -89.2 118.7 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.505 2.722 . . . . 0.0 109.574 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 ' C ' ' A' ' 44' ' ' THR . 2.9 mp -121.71 124.71 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -118.27 104.78 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -138.05 167.52 21.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 111.797 -167.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -101.79 107.82 53.53 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 123.931 0.892 . . . . 0.0 109.377 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.68 83.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.153 2.569 . . . . 0.0 110.51 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.3 m80 176.54 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 128.132 2.573 . . . . 0.0 107.765 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.65 -51.46 10.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.595 0.236 . . . . 0.0 110.756 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tp -134.34 177.13 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.471 1.509 . . . . 0.0 107.648 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.1 p -136.57 171.97 13.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.602 0.637 . . . . 0.0 110.609 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.2 t -48.33 -35.28 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.043 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -47.41 62.62 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.934 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.95 -51.34 70.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.693 1.197 . . . . 0.0 108.241 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.9 mmt -47.27 -59.81 2.93 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.23 -58.98 6.07 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.14 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 -50.91 9.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.424 1.09 . . . . 0.0 108.692 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -63.44 -45.63 90.01 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.166 0.291 . . . . 0.0 111.311 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.1 -66.62 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.149 0.58 . . . . 0.0 111.213 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -45.3 -38.79 5.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.941 0.791 . . . . 0.0 111.918 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.71 62.14 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.629 1.104 . . . . 0.0 113.123 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.5 mmt -54.93 -41.03 70.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.544 0.611 . . . . 0.0 110.546 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -18.86 3.28 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.52 1.057 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.14 113.58 34.73 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.998 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.37 136.78 44.71 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 N-CA-C 108.965 -1.206 . . . . 0.0 108.965 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 131.71 45.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.875 0.845 . . . . 0.0 112.088 -176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -103.81 77.51 1.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.836 2.054 . . . . 0.0 109.115 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 5' ' ' LEU . 14.4 p -62.61 107.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.738 0.815 . . . . 0.0 110.634 171.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -155.58 55.46 0.62 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -157.35 157.32 33.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.861 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 47' ' ' TYR . 12.9 p -87.36 112.99 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.83 128.13 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 70' ' ' VAL . 3.5 mm? -116.82 123.11 46.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -100.15 118.61 36.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -118.0 125.14 49.81 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.361 1.464 . . . . 0.0 108.654 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -70.83 138.08 50.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.1 m -129.74 139.2 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -101.26 150.31 23.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 -40.54 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.327 -0.707 . . . . 0.0 113.779 166.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.4 mtm -62.79 86.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.393 1.097 . . . . 0.0 110.934 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 m -148.19 47.75 1.06 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.732 1.613 . . . . 0.0 108.243 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 p -128.74 -4.66 5.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.093 1.757 . . . . 0.0 111.578 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 66.08 -25.69 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.431 1.493 . . . . 0.0 114.082 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -67.5 -75.15 0.1 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.075 -1.015 . . . . 0.0 111.181 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -44.02 -53.9 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.156 1.783 . . . . 0.0 112.254 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -50.54 -50.7 52.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.688 0.795 . . . . 0.0 111.025 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -65.74 -44.1 86.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.143 0.577 . . . . 0.0 110.494 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 m -50.87 -52.63 39.83 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.696 -0.628 . . . . 0.0 110.313 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -44.74 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 119.196 -0.431 . . . . 0.0 110.665 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.13 -49.05 75.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.327 0.512 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.64 -54.49 30.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.593 0.615 . . . . 0.0 111.806 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -60.72 -55.03 38.04 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.97 -0.724 . . . . 0.0 110.769 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.16 -43.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.143 1.377 . . . . 0.0 109.804 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.07 -29.78 6.9 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.773 0.701 . . . . 0.0 113.961 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -87.87 -12.95 43.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.802 1.301 . . . . 0.0 112.532 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.34 130.78 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.394 1.452 . . . . 0.0 111.866 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.66 90.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.587 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.24 -26.01 0.88 Allowed Glycine 0 C--N 1.331 0.296 0 O-C-N 121.996 -0.44 . . . . 0.0 112.617 -173.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.92 147.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 117.573 0.686 . . . . 0.0 110.249 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -125.19 -31.98 3.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.335 1.054 . . . . 0.0 111.688 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.41 163.43 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -158.85 140.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -144.42 85.31 1.78 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.006 0.922 . . . . 0.0 110.49 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.75 114.99 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -94.53 165.24 12.63 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -47.67 2.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.601 0.76 . . . . 0.0 109.945 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -55.95 13.3 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.178 1.391 . . . . 0.0 110.852 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -90.56 13.37 16.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.873 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 38.5 58.67 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.964 2.105 . . . . 0.0 112.685 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 30.9 tt0 -145.95 142.28 28.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.46 123.7 34.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.522 1.129 . . . . 0.0 110.193 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 m -94.89 127.68 41.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.152 1.381 . . . . 0.0 107.687 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.41 126.11 70.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.9 112.03 34.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.345 0.52 . . . . 0.0 110.659 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' O ' HG12 ' A' ' 3' ' ' VAL . 32.6 p90 -132.56 168.99 17.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.423 0.63 . . . . 0.0 112.155 -173.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -90.97 113.06 56.84 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 124.629 1.172 . . . . 0.0 109.203 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -74.71 76.89 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.821 2.347 . . . . 0.0 110.873 -170.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -176.01 -47.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.158 2.183 . . . . 0.0 108.305 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.15 -43.83 41.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.334 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.71 169.49 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 108.002 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -138.37 164.79 28.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 111.14 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 70' ' ' VAL . 93.9 t -43.33 -47.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 124.34 1.056 . . . . 0.0 110.899 170.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -49.48 77.32 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.745 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.23 -49.55 73.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.1 1.318 . . . . 0.0 109.415 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.2 -60.95 2.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.132 0.424 . . . . 0.0 111.421 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -57.08 -64.08 1.0 Allowed 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.758 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.26 -52.29 2.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.818 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.61 -39.03 88.16 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.89 -63.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 O-C-N 121.734 -0.604 . . . . 0.0 111.056 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -43.8 -39.26 3.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.56 0.744 . . . . 0.0 112.16 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.06 42.18 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.212 0.915 . . . . 0.0 113.164 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -61.7 -36.44 80.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.466 0.575 . . . . 0.0 111.107 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.26 -11.19 5.85 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.862 1.22 . . . . 0.0 111.263 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -84.65 114.76 57.21 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.274 1.029 . . . . 0.0 109.455 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -67.96 140.21 49.54 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.327 1.351 . . . . 0.0 108.598 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.66 140.12 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.696 0.399 . . . . 0.0 111.377 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -112.89 73.93 0.84 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.683 1.193 . . . . 0.0 110.185 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 5' ' ' LEU . 8.9 p -65.98 103.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.329 1.852 . . . . 0.0 111.813 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -157.29 54.62 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -159.05 80.71 0.77 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.963 -1.085 . . . . 0.0 111.075 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 124.725 1.21 . . . . 0.0 109.409 -172.859 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.95 143.79 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.777 1.631 . . . . 0.0 107.722 163.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.14 143.91 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 124.551 1.14 . . . . 0.0 108.125 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.406 ' CD1' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -129.08 117.49 20.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -100.28 125.17 46.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mtt -121.05 119.93 33.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.202 1.001 . . . . 0.0 109.141 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.1 mptp? -73.4 121.96 21.31 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.23 149.66 13.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -114.76 148.01 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.86 -33.02 3.6 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.541 1.067 . . . . 0.0 113.048 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.7 mtp -69.09 75.69 0.33 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 112.91 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 m -142.26 58.2 1.46 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.588 1.155 . . . . 0.0 111.096 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.85 16.83 0.77 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.07 0.548 . . . . 0.0 111.832 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.7 m80 68.8 -35.39 0.3 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.928 1.691 . . . . 0.0 113.357 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -59.84 -51.76 68.36 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.399 1.479 . . . . 0.0 110.874 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -63.56 -60.3 3.51 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.114 0.566 . . . . 0.0 110.655 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -43.8 -58.14 2.89 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.399 1.08 . . . . 0.0 110.327 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -67.04 -43.46 82.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -55.34 -47.07 76.27 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.635 -0.666 . . . . 0.0 110.516 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.75 -48.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.74 -51.32 22.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.292 0.637 . . . . 0.0 109.835 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.24 -58.8 12.64 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.551 0.595 . . . . 0.0 112.334 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -61.28 -60.25 4.03 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.763 0.792 . . . . 0.0 109.741 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -66.37 -27.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.542 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -44.92 -37.35 5.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.59 0.614 . . . . 0.0 112.84 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -88.09 4.13 46.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.989 0.895 . . . . 0.0 112.719 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.28 153.09 43.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 120.292 -1.505 . . . . 0.0 110.374 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -87.07 141.11 28.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.77 11.5 55.02 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.017 0.817 . . . . 0.0 112.783 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -104.59 147.39 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.112 1.365 . . . . 0.0 109.541 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -109.73 -46.47 3.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.615 1.566 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.47 169.62 21.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.0 133.84 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 48.3 mmtt -137.76 154.46 49.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.154 1.381 . . . . 0.0 108.456 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.23 110.32 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -82.01 75.78 8.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 0.0 108.659 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.48 -41.72 9.83 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.476 0.71 . . . . 0.0 110.606 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.42 -56.75 4.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.441 1.497 . . . . 0.0 111.378 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.92 13.71 25.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.008 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.22 60.74 3.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.74 2.016 . . . . 0.0 111.288 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 10.2 tt0 -143.92 132.5 22.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.486 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.16 135.14 40.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.87 1.668 . . . . 0.0 109.465 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.4 m -114.12 81.9 1.61 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.169 2.588 . . . . 0.0 107.684 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.08 127.82 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.26 107.63 20.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 110.416 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' HG23 ' A' ' 54' ' ' VAL . 12.9 p90 -134.57 173.46 11.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.656 -0.652 . . . . 0.0 111.925 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -106.76 106.98 59.5 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.629 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.32 76.28 1.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.202 3.268 . . . . 0.0 110.937 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.74 -43.21 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.627 1.971 . . . . 0.0 108.295 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.62 -42.34 18.35 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.21 169.39 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -120.24 155.54 33.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.461 1.104 . . . . 0.0 111.068 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG23 ' OH ' ' A' ' 47' ' ' TYR . 3.5 t -39.03 -49.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.469 1.108 . . . . 0.0 110.958 164.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -62.75 -46.75 86.6 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.788 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.11 -49.41 73.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.904 1.684 . . . . 0.0 108.53 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.26 -60.27 3.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -59.78 -56.94 15.55 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.82 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.73 -51.09 16.95 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.751 0.82 . . . . 0.0 108.947 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -60.52 -44.66 95.79 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.617 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.94 -65.15 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 122.979 0.512 . . . . 0.0 110.508 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -44.34 -40.21 5.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 118.929 0.786 . . . . 0.0 112.557 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.2 60.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.276 0.944 . . . . 0.0 113.336 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.6 mmt -52.04 -41.76 62.57 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.583 0.629 . . . . 0.0 110.513 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.38 -19.31 2.45 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.45 1.024 . . . . 0.0 111.085 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -83.73 117.52 68.89 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.052 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.84 137.32 52.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 108.721 -1.299 . . . . 0.0 108.721 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.28 47.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.733 0.813 . . . . 0.0 110.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.93 86.22 2.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 5' ' ' LEU . 3.1 t -58.45 107.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.98 1.312 . . . . 0.0 109.825 165.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -159.02 56.87 0.42 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 143.23 14.79 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.262 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.43 130.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.134 1.374 . . . . 0.0 107.805 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.14 115.82 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 125.14 1.376 . . . . 0.0 109.274 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' LEU . 1.7 pp -90.51 138.39 31.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -113.85 126.08 54.79 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.41 ' SD ' HD11 ' A' ' 5' ' ' LEU . 13.7 ptm -132.24 128.24 37.46 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.922 0.889 . . . . 0.0 110.115 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.0 mptp? -78.13 131.15 37.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 148.08 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.431 1.014 . . . . 0.0 109.011 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -105.97 146.52 29.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -32.52 7.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.692 1.139 . . . . 0.0 113.227 169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.9 mtt -75.46 74.25 2.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.501 1.15 . . . . 0.0 112.442 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.2 m -106.44 39.94 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.789 1.236 . . . . 0.0 109.8 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.0 p -160.0 168.68 25.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.06 -8.06 57.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.104 0.561 . . . . 0.0 112.026 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -73.71 -64.6 0.96 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.734 0.697 . . . . 0.0 110.894 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 m -55.41 -55.27 33.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.419 0.628 . . . . 0.0 110.306 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -48.58 -56.0 9.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.818 1.247 . . . . 0.0 110.346 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.4 t -63.58 -45.19 91.55 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.982 0.513 . . . . 0.0 110.7 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -53.66 -49.47 67.87 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.815 -0.553 . . . . 0.0 110.419 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -62.78 -48.07 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 O-C-N 121.99 -0.444 . . . . 0.0 110.116 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.85 -47.64 64.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.18 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.35 25.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.489 1.042 . . . . 0.0 111.741 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -58.32 -57.29 13.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.776 0.798 . . . . 0.0 110.166 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.32 -30.38 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.13 0.972 . . . . 0.0 110.389 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.04 -31.92 8.67 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.62 0.629 . . . . 0.0 112.704 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -84.82 -1.85 56.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.192 0.996 . . . . 0.0 112.733 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.44 149.83 46.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 120.724 1.602 . . . . 0.0 110.346 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -87.29 127.86 35.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.04 14.81 9.65 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.331 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.94 137.96 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.615 1.166 . . . . 0.0 109.452 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 -31.52 10.16 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.106 0.562 . . . . 0.0 111.88 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.99 162.27 40.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 tt -155.9 138.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -140.78 136.18 32.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.437 1.095 . . . . 0.0 110.132 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.17 139.87 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.5 1.046 . . . . 0.0 110.289 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -128.5 127.38 42.33 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.134 1.774 . . . . 0.0 109.644 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.05 -47.1 12.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.933 0.893 . . . . 0.0 111.881 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.48 -58.51 6.87 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.994 1.317 . . . . 0.0 110.356 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.11 4.97 27.92 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.594 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 0.2 OUTLIER 36.22 67.34 0.31 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.317 2.647 . . . . 0.0 113.561 -177.515 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 3.0 tt0 -143.51 141.19 30.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.758 -170.469 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.33 148.57 43.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 109.752 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -128.14 118.92 24.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.964 3.306 . . . . 0.0 105.43 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -121.99 120.46 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.85 96.14 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 123.789 0.68 . . . . 0.0 109.227 -174.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -123.42 160.74 26.2 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.651 0.781 . . . . 0.0 111.724 -166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -99.92 116.24 64.85 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.505 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.92 75.56 2.18 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.663 2.909 . . . . 0.0 111.66 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -176.08 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 127.08 2.152 . . . . 0.0 108.238 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.94 -47.09 26.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.86 172.66 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.976 1.31 . . . . 0.0 108.191 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -138.44 158.61 43.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.608 1.163 . . . . 0.0 110.274 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -41.09 -47.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 111.02 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -40.88 94.4 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.818 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -50.74 72.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 61.9 mmm -54.02 -62.98 1.3 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.408 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -55.79 -56.07 24.85 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.342 -0.849 . . . . 0.0 111.817 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -52.81 -46.13 67.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -42.23 93.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.789 177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.01 -64.95 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 O-C-N 121.679 -0.638 . . . . 0.0 109.929 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -46.62 -37.76 8.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 119.003 0.82 . . . . 0.0 113.16 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.22 57.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.611 1.096 . . . . 0.0 113.004 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.0 mmt -53.52 -43.7 68.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.434 0.561 . . . . 0.0 110.577 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.82 -23.84 2.13 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.232 0.92 . . . . 0.0 111.289 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -75.39 113.38 25.41 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.033 -171.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.99 138.58 53.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.244 1.296 . . . . 0.0 109.081 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 140.41 43.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.299 0.571 . . . . 0.0 111.812 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -112.19 76.21 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.406 ' HA ' ' HB3' ' A' ' 7' ' ' MET . 1.9 p -62.01 109.38 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.293 1.037 . . . . 0.0 108.227 168.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.58 53.66 0.67 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -155.53 162.87 40.6 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.551 1.54 . . . . 0.0 107.122 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 124.574 1.149 . . . . 0.0 108.02 -174.311 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.7 t -141.25 146.96 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.419 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.05 141.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.615 1.166 . . . . 0.0 108.28 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 70' ' ' VAL . 3.1 tm? -128.16 120.73 27.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.61 127.25 54.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptp -119.36 124.57 46.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 127.312 2.245 . . . . 0.0 108.837 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 4.6 tptt -72.66 136.56 45.67 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 9.3 m -121.11 157.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.075 0.852 . . . . 0.0 110.48 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -116.71 153.73 31.85 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.853 0.461 . . . . 0.0 110.572 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 -38.91 2.25 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.125 0.869 . . . . 0.0 112.866 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -58.97 93.36 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.049 0.94 . . . . 0.0 110.739 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -141.84 47.45 1.64 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.832 1.253 . . . . 0.0 108.901 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.5 p -155.16 159.46 40.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 164.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -24.81 64.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 123.108 0.255 . . . . 0.0 111.46 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -57.43 -54.94 41.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.417 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.9 m -56.41 -57.16 13.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.117 0.417 . . . . 0.0 110.244 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -55.61 -53.77 52.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.936 0.495 . . . . 0.0 110.318 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 t -61.38 -41.03 96.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.521 0.728 . . . . 0.0 111.288 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 m -59.87 -48.11 83.02 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.109 -0.995 . . . . 0.0 110.445 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.0 mt -59.31 -52.25 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 123.849 0.859 . . . . 0.0 108.72 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.99 -46.08 71.63 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.598 0.759 . . . . 0.0 110.705 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.87 -49.28 72.14 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.24 0.924 . . . . 0.0 111.874 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -59.31 5.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.087 0.943 . . . . 0.0 110.759 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 mm -63.65 -30.38 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.78 1.232 . . . . 0.0 110.755 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.29 -31.66 4.79 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.738 0.685 . . . . 0.0 113.001 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -91.21 2.94 55.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.156 0.982 . . . . 0.0 112.453 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.64 133.11 46.38 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 120.549 1.522 . . . . 0.0 111.201 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -77.55 65.14 3.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 22.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 116.547 1.379 . . . . 0.0 116.547 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.4 154.41 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 117.77 0.785 . . . . 0.0 110.31 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -115.75 -42.21 3.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.616 1.567 . . . . 0.0 109.771 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.06 172.35 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.41 140.59 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -141.56 86.2 1.99 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.0 0.92 . . . . 0.0 112.38 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -89.71 112.63 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.528 -0.733 . . . . 0.0 109.944 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -91.55 176.02 6.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.933 0.893 . . . . 0.0 109.456 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -139.05 -47.25 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.247 1.019 . . . . 0.0 110.292 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.43 -59.27 3.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.895 1.678 . . . . 0.0 110.442 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -88.6 9.5 23.82 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.82 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.58 64.93 1.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.532 1.933 . . . . 0.0 111.034 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.73 152.21 39.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.763 0.825 . . . . 0.0 109.044 -165.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.77 123.65 15.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.387 0.613 . . . . 0.0 110.427 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.46 132.5 43.85 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.274 1.83 . . . . 0.0 107.847 171.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mm -129.62 127.49 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.65 118.4 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -141.04 174.81 10.16 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -165.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -109.17 109.02 60.69 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.875 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.48 77.62 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.833 3.022 . . . . 0.0 110.92 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -178.17 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.299 2.64 . . . . 0.0 107.74 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.4 mt -77.98 -46.6 20.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.688 0.222 . . . . 0.0 111.348 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.44 161.45 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -125.61 162.56 24.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.019 0.928 . . . . 0.0 111.181 -171.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 70' ' ' VAL . 30.7 t -50.03 -43.96 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.232 1.013 . . . . 0.0 111.286 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.47 -37.7 87.62 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.139 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.54 -58.42 8.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.368 1.44 . . . . 0.0 108.387 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.9 mtt -43.55 -60.13 1.88 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER -64.16 -53.61 46.74 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.132 -175.22 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.0 -55.68 3.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.434 1.47 . . . . 0.0 109.576 172.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -59.86 -47.73 84.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.923 0.392 . . . . 0.0 111.243 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.07 -63.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.452 0.701 . . . . 0.0 111.086 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -45.29 -39.24 6.36 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.879 0.763 . . . . 0.0 111.915 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.75 56.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.529 1.059 . . . . 0.0 112.84 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.4 mmt -57.56 -44.38 85.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.321 0.51 . . . . 0.0 110.812 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.44 -16.67 4.07 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.842 1.21 . . . . 0.0 111.023 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -77.42 115.83 52.73 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.547 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.47 144.67 80.38 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.39 132.47 24.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.896 0.855 . . . . 0.0 110.943 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.02 69.94 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.944 2.498 . . . . 0.0 108.851 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -62.01 107.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.831 0.852 . . . . 0.0 110.118 172.07 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -156.8 54.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.34 67.44 0.46 Allowed 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.235 -0.915 . . . . 0.0 111.092 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.236 0.614 . . . . 0.0 109.439 179.405 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.03 130.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.717 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.0 124.74 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 108.112 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.9 mm? -115.83 127.87 55.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -113.18 126.21 55.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.8 mtt -113.54 125.9 54.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.278 1.831 . . . . 0.0 107.895 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 126.14 30.21 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.57 154.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -120.09 153.47 36.08 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.373 0.669 . . . . 0.0 109.723 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.67 47.83 65.79 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.703 168.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.9 mtm -143.46 109.64 5.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.12 26.36 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.164 1.386 . . . . 0.0 110.859 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -112.66 -4.97 14.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.535 1.534 . . . . 0.0 112.101 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 72.71 -46.99 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.52 1.528 . . . . 0.0 111.625 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -49.61 -55.64 12.86 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.617 0.767 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.83 -54.53 40.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.637 0.653 . . . . 0.0 111.374 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -53.34 -54.6 34.18 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.661 0.384 . . . . 0.0 110.084 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.64 -44.18 93.59 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.083 0.553 . . . . 0.0 111.222 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.6 m -59.81 -46.58 88.8 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.446 -0.784 . . . . 0.0 110.197 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 66' ' ' PHE . 3.8 mt -58.86 -50.78 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.094 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.03 -49.98 59.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.325 0.65 . . . . 0.0 110.832 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.6 -53.64 40.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.685 0.659 . . . . 0.0 111.693 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -64.67 -56.39 14.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.624 0.726 . . . . 0.0 110.288 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -68.86 -34.69 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.704 0.802 . . . . 0.0 110.339 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.45 -27.88 26.83 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.83 -0.544 . . . . 0.0 112.6 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -90.38 3.45 53.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.117 0.959 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.84 142.76 49.6 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.223 1.374 . . . . 0.0 110.211 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.2 133.5 37.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.92 -8.37 36.38 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 123.594 0.616 . . . . 0.0 112.146 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.18 149.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.578 0.751 . . . . 0.0 109.596 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -108.16 -48.24 3.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.623 1.569 . . . . 0.0 109.467 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -157.66 169.53 24.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.6 137.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -140.81 92.46 2.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.783 0.833 . . . . 0.0 111.64 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.6 t -97.1 105.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.649 -0.657 . . . . 0.0 110.037 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m -85.06 161.76 19.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.15 0.98 . . . . 0.0 110.16 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.69 -48.16 2.59 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.015 0.526 . . . . 0.0 111.211 172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.83 -57.68 5.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.507 1.523 . . . . 0.0 110.51 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 22.56 6.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.466 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.286 0.0 OUTLIER 28.15 70.72 0.06 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.143 2.977 . . . . 0.0 113.815 -174.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -138.16 142.34 40.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.204 1.402 . . . . 0.0 108.856 -168.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.06 111.8 15.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.52 1.128 . . . . 0.0 108.99 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -85.62 125.85 33.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mm -124.86 127.62 72.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.19 113.59 43.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -129.94 172.26 11.89 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.09 111.33 62.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 124.69 1.196 . . . . 0.0 108.581 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.82 73.83 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.419 2.746 . . . . 0.0 110.517 -173.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -46.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.74 2.016 . . . . 0.0 109.241 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.27 -44.69 21.21 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 122.602 -0.061 . . . . 0.0 111.136 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -136.09 172.12 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.1 p -133.99 159.28 41.24 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.392 1.077 . . . . 0.0 110.511 -172.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 t -41.93 -48.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 124.671 1.188 . . . . 0.0 111.611 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.05 -44.23 96.44 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.341 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.53 -53.19 55.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.769 1.168 . . . . 0.0 108.803 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 12.5 mtm -51.3 -60.3 3.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.23 0.468 . . . . 0.0 112.204 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.36 -55.29 36.92 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.391 -0.818 . . . . 0.0 111.939 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -45.93 -51.47 13.21 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.917 1.287 . . . . 0.0 109.158 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -60.35 -46.52 89.64 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.663 0.21 . . . . 0.0 111.306 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.35 -66.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.757 0.823 . . . . 0.0 110.491 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -46.56 -37.94 8.74 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.594 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.25 61.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.575 1.079 . . . . 0.0 112.692 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.7 -45.53 85.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.426 0.557 . . . . 0.0 110.523 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.94 -20.42 2.51 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.349 0.976 . . . . 0.0 111.209 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 21' ' ' ILE . 59.8 m-85 -77.21 113.75 33.85 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 118.223 -0.894 . . . . 0.0 109.803 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 137.15 41.37 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.26 1.307 . . . . 0.0 108.714 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.91 132.87 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.264 0.554 . . . . 0.0 111.156 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.41 75.04 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.923 1.289 . . . . 0.0 108.718 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 5' ' ' LEU . 13.5 p -65.22 103.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.952 1.301 . . . . 0.0 110.796 172.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -157.13 58.51 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' O ' HD13 ' A' ' 5' ' ' LEU . 4.4 tptm -155.82 136.69 13.54 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.928 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.26 124.51 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -169.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.88 126.0 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.22 116.53 32.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -98.41 110.12 22.77 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' HD13 ' A' ' 45' ' ' ILE . 2.4 ptp -108.84 123.37 48.95 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.977 0.911 . . . . 0.0 108.748 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.33 151.12 46.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 167.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.1 157.06 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.0 145.94 47.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.87 -30.62 8.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.379 0.99 . . . . 0.0 112.956 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.0 94.14 0.47 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.086 0.943 . . . . 0.0 110.399 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.8 m -128.67 44.5 2.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.976 0.91 . . . . 0.0 109.011 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.41 155.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 107.865 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -72.92 -21.97 60.81 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -53.42 -61.02 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.149 0.979 . . . . 0.0 111.708 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.5 m -59.75 -51.57 69.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.649 0.738 . . . . 0.0 109.966 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -53.72 -56.35 18.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.971 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 t -56.11 -46.35 79.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.931 0.892 . . . . 0.0 111.824 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 m -54.73 -50.66 67.82 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.24 -46.44 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.07 -45.76 71.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.474 0.71 . . . . 0.0 111.191 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.18 -56.7 22.86 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.804 0.716 . . . . 0.0 111.673 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.97 -57.34 13.27 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.094 -0.651 . . . . 0.0 111.146 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 34' ' ' ILE . 43.5 mm -59.45 -43.5 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.068 0.947 . . . . 0.0 110.468 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.94 -33.7 21.48 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 117.985 0.357 . . . . 0.0 112.403 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.85 -4.13 59.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.281 1.032 . . . . 0.0 112.74 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.99 137.51 34.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 120.201 1.364 . . . . 0.0 111.104 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -71.76 123.2 22.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.297 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.23 -2.39 9.7 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.11 0.862 . . . . 0.0 112.592 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.52 159.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.457 0.703 . . . . 0.0 110.796 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -117.58 -47.6 2.62 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -165.26 168.66 16.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 25' ' ' ILE . 12.4 tt -156.78 143.12 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -142.06 98.3 3.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.875 1.67 . . . . 0.0 111.586 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.72 126.76 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.169 0.587 . . . . 0.0 111.534 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -117.04 140.14 49.85 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.676 1.19 . . . . 0.0 110.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 -45.53 9.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.037 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.16 -62.35 1.69 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.687 1.595 . . . . 0.0 110.439 -171.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.78 14.75 11.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.426 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.4 58.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.743 2.817 . . . . 0.0 113.746 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 28.4 tt0 -132.1 138.26 48.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.081 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.51 119.17 32.18 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.824 1.65 . . . . 0.0 109.233 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.9 m -96.28 112.88 24.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.551 1.54 . . . . 0.0 108.712 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -116.23 119.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.43 117.79 54.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.54 165.42 27.53 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -94.32 111.65 54.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 126.949 2.099 . . . . 0.0 110.947 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.73 73.84 3.46 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.183 2.588 . . . . 0.0 111.995 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -173.98 -46.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.144 2.178 . . . . 0.0 108.525 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.26 -42.46 68.75 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -176.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -142.4 153.01 43.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.379 0.672 . . . . 0.0 109.948 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -38.1 -49.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 124.987 1.315 . . . . 0.0 111.028 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.37 -46.64 87.74 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.059 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -50.71 66.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.976 1.716 . . . . 0.0 108.056 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -53.14 -59.08 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.07 -0.394 . . . . 0.0 111.005 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.15 -55.71 30.49 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 120.888 -1.132 . . . . 0.0 112.88 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 -42.43 25.73 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.354 1.062 . . . . 0.0 109.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -66.45 -53.48 35.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.599 0.562 . . . . 0.0 111.944 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.43 -62.71 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.069 -1.019 . . . . 0.0 110.897 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -52.51 -26.17 12.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.04 62.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.961 1.255 . . . . 0.0 112.496 171.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.39 -35.74 72.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.118 0.567 . . . . 0.0 110.656 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.17 -22.18 5.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.683 1.135 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -70.03 116.26 42.34 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 117.283 -1.342 . . . . 0.0 110.276 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.52 151.18 86.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.356 1.371 . . . . 0.0 109.261 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.13 140.49 28.04 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.42 82.23 1.57 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.326 1.051 . . . . 0.0 110.132 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.14 104.66 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.583 1.553 . . . . 0.0 110.946 173.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -157.73 54.16 0.47 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -158.67 104.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.76 133.34 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 123.574 0.75 . . . . 0.0 109.218 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 46' ' ' VAL . 1.4 p -82.1 116.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.304 1.442 . . . . 0.0 108.094 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 5' ' ' LEU . 5.0 tt -96.86 120.56 37.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.35 118.76 34.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -113.77 138.92 49.59 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.403 1.481 . . . . 0.0 108.746 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.43 155.47 40.09 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 155.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -138.13 142.64 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -97.75 151.5 20.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.88 -34.78 2.11 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.707 -0.621 . . . . 0.0 114.209 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.33 91.49 0.08 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.007 0.903 . . . . 0.0 111.746 -173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 m -146.38 61.22 1.23 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.421 1.488 . . . . 0.0 109.587 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.6 p -162.04 157.41 23.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 166.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -78.27 54.44 1.39 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.703 0.401 . . . . 0.0 110.103 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.89 -64.07 0.59 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -56.19 -56.67 18.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.052 0.387 . . . . 0.0 110.79 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -51.53 -55.36 19.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.006 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.87 -42.84 94.58 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.77 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.1 m -56.01 -52.01 65.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -48.27 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.229 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -55.63 -48.87 74.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.117 0.871 . . . . 0.0 110.582 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.47 -52.97 37.82 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.516 0.579 . . . . 0.0 111.665 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -65.95 -61.24 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.548 0.689 . . . . 0.0 110.655 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.69 -32.68 59.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 124.589 1.156 . . . . 0.0 110.422 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.89 -30.67 9.42 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.867 -0.521 . . . . 0.0 112.6 169.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -93.77 10.4 33.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.314 1.046 . . . . 0.0 112.217 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.03 151.87 44.14 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.243 1.383 . . . . 0.0 111.623 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -92.56 81.66 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.949 1.3 . . . . 0.0 110.614 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.93 -13.59 1.13 Allowed Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.914 -0.491 . . . . 0.0 113.899 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.65 151.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -119.08 -35.1 3.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.628 1.171 . . . . 0.0 111.137 173.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -155.42 169.19 24.82 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -156.98 139.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -139.85 90.66 2.41 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.422 1.489 . . . . 0.0 110.534 172.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.86 106.93 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 O-C-N 121.457 -0.777 . . . . 0.0 110.167 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -80.43 178.98 7.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -142.44 -47.37 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 109.534 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.05 -59.03 3.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.903 1.681 . . . . 0.0 110.541 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.14 12.58 17.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.319 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 43.77 62.72 1.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.659 1.984 . . . . 0.0 112.522 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -145.88 151.11 37.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.511 -0.743 . . . . 0.0 109.345 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.92 125.81 18.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 111.149 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 3.4 m -107.55 120.69 42.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.803 2.041 . . . . 0.0 107.964 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 44' ' ' THR . 3.8 mp -122.14 116.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 4' ' ' VAL . 2.1 t -104.82 109.13 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -135.14 170.33 16.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.479 0.657 . . . . 0.0 112.367 -166.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -97.8 110.68 56.45 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.132 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.51 67.06 7.23 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.139 2.56 . . . . 0.0 111.506 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.66 -47.07 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.809 1.244 . . . . 0.0 108.37 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.37 -48.23 73.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.633 0.197 . . . . 0.0 111.198 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tp -134.25 162.83 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.802 1.241 . . . . 0.0 108.196 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 p -121.87 158.64 28.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.747 1.219 . . . . 0.0 110.891 -172.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.73 -48.99 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.386 0 C-N-CA 124.1 0.96 . . . . 0.0 110.881 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.97 -54.13 50.46 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.766 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -45.03 -54.74 6.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.952 1.251 . . . . 0.0 109.365 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -63.11 1.26 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.501 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.39 -61.27 2.45 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -43.07 -51.45 5.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.718 1.207 . . . . 0.0 109.703 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.08 -43.33 95.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.083 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.01 -65.85 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.445 0.698 . . . . 0.0 110.278 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -43.79 -39.27 3.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.507 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.798 1.181 . . . . 0.0 112.958 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.6 mmt -55.37 -40.8 71.76 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.317 0.508 . . . . 0.0 110.841 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.08 -20.16 3.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.587 1.089 . . . . 0.0 110.954 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -75.57 115.7 48.18 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.255 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -66.55 138.48 50.05 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.31 -1.458 . . . . 0.0 108.31 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.47 138.39 38.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.045 0.538 . . . . 0.0 110.595 -175.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -107.05 71.39 0.83 Allowed 'General case' 0 C--N 1.334 -0.066 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.45 105.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 169.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -155.58 55.31 0.62 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 141.26 16.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 170.731 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.09 116.0 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.91 124.4 43.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.85 131.86 56.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.06 117.09 30.3 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.3 mtt -116.82 123.57 47.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.913 0.885 . . . . 0.0 110.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.87 129.47 37.95 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.93 151.36 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.032 0.833 . . . . 0.0 109.668 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 140.67 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.28 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.1 -16.06 45.24 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.266 0.936 . . . . 0.0 114.206 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.2 mtp -76.62 75.7 3.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.3 1.05 . . . . 0.0 110.866 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.4 34.42 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.464 1.505 . . . . 0.0 111.334 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 p -154.1 158.7 40.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.516 -0.74 . . . . 0.0 110.404 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -74.9 61.36 1.03 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.306 167.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -145.88 -63.38 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 167.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 m -52.96 -53.59 47.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.298 0.571 . . . . 0.0 109.952 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.4 p -53.04 -70.16 0.1 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.725 1.21 . . . . 0.0 110.742 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 t -51.3 -45.52 62.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.679 1.592 . . . . 0.0 111.506 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -60.26 -44.93 94.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.889 -0.507 . . . . 0.0 109.944 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -49.22 85.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 118.617 0.644 . . . . 0.0 110.189 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -48.58 -51.67 26.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.656 0.662 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.61 -58.33 15.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.87 0.748 . . . . 0.0 112.614 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -64.36 -52.44 58.3 Favored 'General case' 0 C--N 1.338 0.109 0 O-C-N 121.651 -0.911 . . . . 0.0 109.953 -170.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.02 -27.19 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.308 1.043 . . . . 0.0 109.751 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.72 -32.55 32.89 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.986 -1.071 . . . . 0.0 112.492 166.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -84.74 -1.36 56.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.97 154.12 42.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.435 1.471 . . . . 0.0 112.326 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.91 69.4 9.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.01 18.72 0.02 OUTLIER Glycine 0 N--CA 1.467 0.756 0 N-CA-C 115.373 0.909 . . . . 0.0 115.373 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.17 141.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.852 1.326 . . . . 0.0 108.664 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -111.85 -45.06 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.363 0.665 . . . . 0.0 109.94 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.21 166.99 25.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.71 131.86 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 5.6 mmtt -139.24 129.79 25.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.572 1.149 . . . . 0.0 109.695 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.43 98.4 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 119.234 0.925 . . . . 0.0 110.011 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -72.7 74.03 1.09 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.224 1.41 . . . . 0.0 109.464 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -37.39 -49.22 0.99 Allowed 'General case' 0 C--O 1.227 -0.091 0 C-N-CA 126.351 1.86 . . . . 0.0 111.664 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.87 -55.94 8.67 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.103 1.361 . . . . 0.0 111.562 -174.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.65 -2.99 58.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.654 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.29 54.62 9.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.814 2.446 . . . . 0.0 110.443 -173.106 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.19 136.34 54.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 109.543 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.61 106.88 17.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.53 1.932 . . . . 0.0 109.742 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -81.45 87.26 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 129.007 2.923 . . . . 0.0 109.382 170.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.61 125.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.74 99.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.417 0 CA-C-N 119.659 1.118 . . . . 0.0 110.333 -173.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.24 159.97 22.42 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.98 131.04 55.2 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.44 163.6 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.18 1.253 . . . . 0.0 109.091 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 73.62 -42.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -48.93 55.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.609 1.095 . . . . 0.0 111.499 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.78 179.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.412 1.485 . . . . 0.0 108.338 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.0 p -148.8 164.16 35.24 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.527 0.603 . . . . 0.0 111.519 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.9 t -46.15 -45.48 5.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 123.768 0.827 . . . . 0.0 111.284 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -62.53 -42.64 99.65 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.488 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.84 -54.42 45.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.1 mmt -45.27 -65.08 0.58 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -56.64 -57.2 13.4 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.312 -0.868 . . . . 0.0 111.761 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -46.32 -47.44 18.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.956 0.798 . . . . 0.0 109.635 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.32 -42.63 87.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.15 -65.02 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 124.409 1.084 . . . . 0.0 110.044 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.36 -39.83 7.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.304 0.642 . . . . 0.0 111.833 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.5 -33.02 59.08 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.398 0.999 . . . . 0.0 113.344 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmt -58.03 -41.73 83.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.6 0.636 . . . . 0.0 110.506 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.87 -16.68 3.48 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.62 1.105 . . . . 0.0 111.06 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.05 117.01 66.79 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.542 -173.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.68 151.56 85.21 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 N-CA-C 108.901 -1.231 . . . . 0.0 108.901 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.04 139.11 28.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.944 0.498 . . . . 0.0 110.517 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.43 75.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.885 0.874 . . . . 0.0 108.758 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.03 105.54 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.081 0.952 . . . . 0.0 110.756 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -155.74 56.71 0.61 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.44 144.35 20.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 174.895 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.1 128.27 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 124.252 1.021 . . . . 0.0 108.755 174.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.14 110.94 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.099 1.76 . . . . 0.0 109.816 -178.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.91 117.97 29.93 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.055 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -84.42 126.87 33.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 28.4 mtp -128.51 128.05 43.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.9 25.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.283 0.947 . . . . 0.0 108.553 172.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -90.97 165.44 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -121.07 152.24 38.88 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.18 -33.04 2.24 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.57 -0.706 . . . . 0.0 114.143 165.139 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.1 mtp -65.14 82.74 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.935 0.867 . . . . 0.0 112.024 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -114.34 48.89 1.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.062 1.345 . . . . 0.0 110.482 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -159.4 163.97 35.02 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.571 -0.706 . . . . 0.0 110.834 169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.91 -35.41 80.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.979 174.828 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -58.33 -58.04 10.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.576 0.625 . . . . 0.0 111.487 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.2 m -57.76 -57.66 11.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -51.85 -57.1 10.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 110.196 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -59.53 -44.48 93.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.823 0.849 . . . . 0.0 111.302 179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.9 m -57.26 -48.45 78.85 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.435 -0.791 . . . . 0.0 110.243 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.46 -48.86 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 123.031 0.532 . . . . 0.0 109.578 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.69 -49.73 56.66 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.251 0.62 . . . . 0.0 110.36 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.15 -55.41 28.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.96 0.791 . . . . 0.0 111.532 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -64.0 -55.02 25.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.016 -0.696 . . . . 0.0 110.963 -173.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -67.39 -33.76 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 123.61 0.764 . . . . 0.0 110.13 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.44 -35.63 7.25 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.361 0.505 . . . . 0.0 112.399 171.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -83.48 4.27 28.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.76 139.72 47.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.735 1.607 . . . . 0.0 112.06 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.93 81.83 5.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.726 0.81 . . . . 0.0 111.612 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.19 -8.54 0.79 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.07 152.15 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 117.726 0.763 . . . . 0.0 110.244 175.933 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -113.58 -37.22 4.67 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.246 1.419 . . . . 0.0 110.333 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -160.57 159.16 30.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 tt -152.8 137.25 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -175.052 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -143.13 150.83 39.98 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.569 1.148 . . . . 0.0 109.754 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.65 128.96 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.613 0.642 . . . . 0.0 109.419 171.127 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -110.69 79.8 1.24 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.739 1.615 . . . . 0.0 108.271 -177.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -41.7 66.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.044 0.537 . . . . 0.0 110.575 -175.429 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.7 -54.72 5.94 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 111.054 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.76 16.62 21.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.029 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 35.66 53.82 0.84 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.354 2.662 . . . . 0.0 113.12 -169.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.72 149.27 37.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.586 1.154 . . . . 0.0 109.704 -177.133 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.4 134.77 49.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.294 1.438 . . . . 0.0 108.823 171.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.8 m -117.34 109.77 17.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.668 2.787 . . . . 0.0 107.011 -173.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mm -119.32 102.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -176.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' GLU . 2.3 t -99.02 107.96 21.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -174.615 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.9 167.3 17.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -100.25 112.17 63.73 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.554 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 69.47 5.84 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.924 3.083 . . . . 0.0 111.533 -170.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.86 -40.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.854 2.462 . . . . 0.0 108.158 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 -45.46 13.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -140.46 158.2 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 107.573 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -106.28 161.97 14.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 112.479 -173.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.17 -39.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 163.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -47.86 81.62 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.15 -178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.41 -55.14 17.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.022 1.283 . . . . 0.0 109.762 173.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 17.5 mmt -48.5 -63.47 1.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.36 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -57.95 -57.86 10.96 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 121.259 -0.9 . . . . 0.0 112.329 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -46.76 -50.76 17.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.225 1.01 . . . . 0.0 108.31 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -57.92 -48.12 80.85 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.987 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.81 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 118.562 -0.733 . . . . 0.0 111.467 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.87 -35.78 6.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.003 1.274 . . . . 0.0 112.381 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.2 -31.61 61.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.736 1.153 . . . . 0.0 113.155 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.6 mmt -55.05 -41.52 71.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.396 0.544 . . . . 0.0 110.585 172.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.47 -18.95 3.85 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.886 1.232 . . . . 0.0 110.95 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -75.53 117.92 67.01 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.979 -173.273 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.32 140.21 57.58 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.495 -1.386 . . . . 0.0 108.495 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.9 27.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.813 0.816 . . . . 0.0 112.469 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.84 75.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.331 1.052 . . . . 0.0 108.553 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -42.69 104.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 125.029 1.456 . . . . 0.0 109.261 158.739 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -93.67 -179.51 5.04 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 168.08 20.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.882 170.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.3 pt . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 123.681 0.792 . . . . 0.0 110.106 178.358 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.61 123.83 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 109.865 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 46' ' ' VAL . 1.3 p -80.82 105.9 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.808 1.643 . . . . 0.0 109.82 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 109.09 20.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.565 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -87.1 113.16 22.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.18 125.18 47.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.923 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.446 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.4 mptp? -81.02 125.41 30.13 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.78 148.04 11.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -109.9 155.0 22.28 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.593 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.37 -46.67 3.59 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.765 -0.584 . . . . 0.0 112.587 169.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.5 mtp -55.26 96.25 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.914 1.286 . . . . 0.0 110.96 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 p -136.6 31.79 2.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 111.776 -174.093 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.16 149.62 26.21 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.668 -0.645 . . . . 0.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -72.33 60.26 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.435 1.494 . . . . 0.0 110.722 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.4 m -142.45 -59.96 0.45 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.235 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.3 m -58.83 -60.94 3.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 110.025 -177.0 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -53.5 -49.06 68.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.935 -179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.2 t -66.75 -41.12 88.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 111.104 -175.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 m -59.28 -47.85 83.82 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 176.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -52.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.738 175.503 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.88 -49.06 63.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.228 0.922 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.85 -47.06 91.29 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.865 0.745 . . . . 0.0 112.054 176.211 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -60.59 2.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.245 1.023 . . . . 0.0 110.178 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.93 -33.79 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.654 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.0 -30.59 9.58 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.812 0.72 . . . . 0.0 112.99 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -91.33 6.81 43.84 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.279 1.04 . . . . 0.0 112.359 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.33 151.81 34.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.522 -1.361 . . . . 0.0 112.746 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.62 82.57 4.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 0.0 111.493 -174.474 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.61 -10.31 1.68 Allowed Glycine 0 N--CA 1.462 0.368 0 O-C-N 121.947 -0.47 . . . . 0.0 113.722 -175.571 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.4 t -78.99 142.43 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -102.58 -42.75 5.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.011 1.324 . . . . 0.0 109.524 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 ttm-85 -155.79 165.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.88 135.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -137.88 88.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.189 1.396 . . . . 0.0 111.051 168.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.91 115.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -87.46 -163.16 0.89 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 pt? -155.33 -48.79 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.33 1.052 . . . . 0.0 109.451 173.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -59.07 4.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 110.339 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.82 11.54 15.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.471 -177.415 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 39.65 61.82 1.33 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.121 1.768 . . . . 0.0 112.788 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 26.5 tt0 -139.78 153.03 47.04 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 126.23 38.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.728 1.211 . . . . 0.0 109.061 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.0 m -101.33 117.8 35.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.794 1.637 . . . . 0.0 106.983 174.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -119.72 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.357 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -100.34 102.94 14.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -124.33 173.02 8.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -104.27 111.41 65.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 123.941 0.896 . . . . 0.0 109.92 -177.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.2 76.76 2.97 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.709 2.939 . . . . 0.0 110.321 -172.767 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.54 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.395 1.878 . . . . 0.0 108.369 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.8 -44.12 15.91 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.975 -177.028 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.2 154.17 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.888 1.275 . . . . 0.0 108.47 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -108.59 162.96 13.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.36 1.064 . . . . 0.0 112.244 -173.196 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -48.22 -45.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.481 0.712 . . . . 0.0 110.373 165.427 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -44.02 92.51 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.878 -175.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -54.59 26.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.529 1.513 . . . . 0.0 109.807 171.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.9 mmt -48.13 -62.53 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.918 0.781 . . . . 0.0 111.868 175.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -62.07 -57.61 10.95 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -176.879 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -47.43 -48.13 26.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 109.25 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -59.39 -48.23 82.45 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.71 174.823 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.13 -65.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.726 -176.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.98 -30.22 24.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.423 1.01 . . . . 0.0 112.573 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.05 62.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 120.014 1.279 . . . . 0.0 112.845 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.3 mmt -58.44 -40.73 83.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.541 0.609 . . . . 0.0 110.578 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.01 -21.62 3.32 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.537 1.065 . . . . 0.0 110.914 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -73.09 116.76 53.93 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-O 118.345 -0.835 . . . . 0.0 110.14 -173.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.02 141.89 59.74 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.463 1.442 . . . . 0.0 108.679 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.55 134.98 32.93 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -98.29 74.71 2.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.472 1.109 . . . . 0.0 108.309 175.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -36.03 106.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.297 1.623 . . . . 0.0 108.775 154.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 179.93 4.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 168.7 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -78.91 166.42 22.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.267 176.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 177.754 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.77 0.319 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.29 142.29 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 126.15 1.78 . . . . 0.0 108.195 172.479 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.27 132.58 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.024 1.73 . . . . 0.0 107.915 175.186 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.737 HD21 HG23 ' A' ' 70' ' ' VAL . 3.3 tm? -112.61 129.56 56.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 169.099 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -117.96 127.2 53.6 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.433 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 12.5 ptm -139.43 129.3 24.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.117 0.567 . . . . 0.0 109.865 -173.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.06 133.88 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.3 m -118.86 150.53 21.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.451 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -116.15 151.23 36.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.145 0.498 . . . . 0.0 110.761 177.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.03 -34.3 3.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.094 0.854 . . . . 0.0 112.816 173.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -66.53 94.65 0.29 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.633 0.717 . . . . 0.0 111.6 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.692 ' HA ' HD13 ' A' ' 38' ' ' LEU . 36.7 p -126.2 53.28 1.63 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.107 0.963 . . . . 0.0 111.465 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.12 167.51 30.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.697 0.799 . . . . 0.0 109.044 -175.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -84.28 -6.02 59.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.667 0.387 . . . . 0.0 111.486 169.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.1 -74.75 0.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -172.155 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -51.39 -45.24 62.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.097 1.359 . . . . 0.0 111.589 -177.044 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -49.38 -63.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.485 1.514 . . . . 0.0 110.511 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -55.33 -45.37 76.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.906 0.882 . . . . 0.0 111.123 177.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -55.3 -47.94 74.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.244 -0.91 . . . . 0.0 110.994 177.409 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.23 -50.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.139 0.976 . . . . 0.0 109.201 177.059 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -45.39 -53.05 9.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.566 1.146 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.31 -58.32 15.03 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.793 0.711 . . . . 0.0 112.672 174.845 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -56.94 -48.19 78.88 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 121.936 -0.744 . . . . 0.0 110.846 -171.277 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.73 -42.04 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.283 0.633 . . . . 0.0 109.441 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.68 -35.41 23.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.248 0.451 . . . . 0.0 112.412 172.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -63.28 -18.0 63.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.97 142.5 29.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.207 0.912 . . . . 0.0 112.544 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.89 101.43 4.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.364 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.97 -21.54 1.43 Allowed Glycine 0 C--N 1.335 0.511 0 O-C-N 121.554 -0.716 . . . . 0.0 113.274 176.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.96 132.77 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -102.59 -29.55 11.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.995 0.361 . . . . 0.0 111.403 175.808 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -154.08 164.63 38.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 tt -157.92 144.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 103.914 -2.624 . . . . 0.0 103.914 -176.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -144.13 132.41 21.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.893 0.877 . . . . 0.0 111.254 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -125.76 136.55 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.935 1.243 . . . . 0.0 111.701 175.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -122.12 124.36 43.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.204 1.801 . . . . 0.0 110.147 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.01 -51.23 9.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.65 0.78 . . . . 0.0 110.723 -177.557 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -53.03 45.8 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.557 1.143 . . . . 0.0 110.557 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.61 4.11 37.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.48 -177.778 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 38.86 61.56 1.21 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.273 2.629 . . . . 0.0 111.371 -174.888 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -141.85 138.14 31.92 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.734 -0.604 . . . . 0.0 110.903 -173.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.98 30.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.556 1.542 . . . . 0.0 110.003 172.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.6 m -121.71 125.51 46.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.706 3.602 . . . . 0.0 104.928 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.44 119.71 54.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.81 96.68 4.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -172.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.64 168.47 12.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.709 0.766 . . . . 0.0 111.989 -170.076 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -97.02 115.29 65.68 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.048 1.339 . . . . 0.0 108.514 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.9 72.3 3.94 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.879 2.386 . . . . 0.0 111.909 -174.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -46.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.304 1.442 . . . . 0.0 108.295 172.345 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.32 -48.92 66.17 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 119.643 -0.218 . . . . 0.0 111.36 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 177.81 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.825 1.25 . . . . 0.0 109.334 -174.205 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.1 p -141.51 160.12 40.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.347 1.059 . . . . 0.0 111.244 -174.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 5' ' ' LEU . 18.4 t -40.22 -49.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.705 1.202 . . . . 0.0 111.771 171.117 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -58.53 -52.09 67.13 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 118.255 -0.878 . . . . 0.0 108.937 -171.866 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -46.47 -53.13 11.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.939 1.696 . . . . 0.0 109.799 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.2 mmt -51.17 -58.32 6.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.951 -0.468 . . . . 0.0 111.823 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -59.4 -60.32 4.04 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.082 -1.011 . . . . 0.0 112.455 177.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.97 -40.5 4.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 109.252 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -52.9 15.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 170.468 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -62.9 -60.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 120.095 1.316 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.91 -36.52 5.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.893 0.77 . . . . 0.0 112.081 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.92 65.85 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.249 0.931 . . . . 0.0 113.368 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -55.51 -38.95 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.965 0.348 . . . . 0.0 110.331 173.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.26 -16.06 4.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.822 1.201 . . . . 0.0 110.805 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -75.55 114.35 35.28 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.492 -174.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.01 141.75 65.48 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 108.266 -1.475 . . . . 0.0 108.266 176.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.28 35.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.44 80.1 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.215 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.737 HG23 HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -65.18 107.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.061 1.744 . . . . 0.0 109.694 168.011 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -157.09 59.7 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.12 153.02 30.19 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 163.446 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.436 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.73 131.36 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 109.01 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 46' ' ' VAL . 2.6 p -90.82 120.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 125.277 1.431 . . . . 0.0 110.119 -177.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.574 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm? -106.73 125.39 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -108.13 115.62 30.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -175.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.0 mtt -115.16 119.28 35.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.45 1.1 . . . . 0.0 108.458 -174.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -72.03 126.52 29.98 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.63 150.45 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.07 153.05 28.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.651 0.594 . . . . 0.0 109.795 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.46 3.43 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.631 -0.539 . . . . 0.0 112.401 172.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.5 mtm -55.06 96.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.703 0.752 . . . . 0.0 111.665 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 p -132.03 18.35 4.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 110.978 -177.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -137.87 163.07 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -72.61 -17.2 61.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.461 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -60.24 3.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.3 0.5 . . . . 0.0 109.779 -177.205 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.5 m -57.86 -55.02 40.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -57.97 -50.03 74.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.215 -174.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -57.85 -46.15 85.22 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.911 0.778 . . . . 0.0 110.988 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.5 m -54.37 -51.28 65.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.638 0.654 . . . . 0.0 110.336 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.08 -47.61 80.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.251 0.932 . . . . 0.0 110.319 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.49 -55.4 27.16 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 172.416 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -66.85 -57.47 6.93 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 117.595 0.697 . . . . 0.0 111.281 -173.189 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.0 -34.58 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 110.079 -177.202 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.97 -28.34 7.39 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.674 -0.641 . . . . 0.0 112.891 169.928 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -102.39 18.58 20.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.776 1.23 . . . . 0.0 111.831 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.23 163.17 27.02 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.573 -1.329 . . . . 0.0 111.208 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -100.35 84.83 2.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.004 1.322 . . . . 0.0 110.273 -175.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.07 1.17 3.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.321 0.486 . . . . 0.0 113.725 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.13 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 117.641 0.721 . . . . 0.0 109.975 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -124.55 -41.81 2.13 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.131 1.372 . . . . 0.0 111.001 -176.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -156.93 171.3 20.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -157.14 138.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.051 -2.204 . . . . 0.0 105.051 -174.346 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -137.47 81.12 1.85 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.192 1.797 . . . . 0.0 110.488 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.06 122.52 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 O-C-N 120.729 -1.232 . . . . 0.0 109.302 -177.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -103.08 168.05 9.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.97 -45.53 2.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.792 0.837 . . . . 0.0 109.786 174.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.06 -57.03 5.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 110.943 -174.335 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.14 19.7 10.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.456 -175.284 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 36.44 62.28 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.6 2.36 . . . . 0.0 112.332 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.134 -0.979 . . . . 0.0 108.983 -174.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.04 119.86 34.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.936 1.694 . . . . 0.0 108.581 -175.128 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 20.1 m -96.82 125.99 41.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.482 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -125.53 128.91 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.695 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -110.13 117.71 55.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.166 0.986 . . . . 0.0 109.476 -174.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -139.9 175.36 9.65 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -104.81 107.21 57.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.106 1.362 . . . . 0.0 110.392 -177.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.13 77.7 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.378 2.719 . . . . 0.0 110.26 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.53 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 127.084 2.154 . . . . 0.0 108.04 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.02 -45.6 56.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.942 0.401 . . . . 0.0 110.548 -178.467 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.95 168.61 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.985 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -135.57 157.78 46.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.145 0.978 . . . . 0.0 110.18 -171.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -37.71 -47.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.83 1.652 . . . . 0.0 111.497 173.018 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -50.69 73.07 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.776 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -52.72 -48.7 66.46 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 120.916 1.689 . . . . 0.0 109.406 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mtp -49.97 -62.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -57.74 11.48 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 121.355 -0.841 . . . . 0.0 112.093 -178.182 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -41.18 -52.75 3.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.614 1.566 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -60.19 -47.69 84.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.445 0.566 . . . . 0.0 111.824 176.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.89 -66.03 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.83 -0.543 . . . . 0.0 111.067 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.34 -37.71 7.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.079 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.44 63.24 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.901 1.228 . . . . 0.0 112.694 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.1 mmt -58.83 -43.61 90.73 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.412 0.551 . . . . 0.0 110.438 174.066 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.15 3.76 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.541 1.067 . . . . 0.0 111.207 178.264 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -81.39 118.85 73.95 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.243 -173.838 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -66.81 137.48 45.48 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 N-CA-C 108.443 -1.406 . . . . 0.0 108.443 174.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.08 140.87 42.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.439 0.696 . . . . 0.0 109.903 178.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -112.28 85.3 2.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.5 p -74.78 98.18 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.838 2.055 . . . . 0.0 111.402 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.66 60.99 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.45 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -157.01 141.2 16.42 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.876 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.528 0.117 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.022 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.96 133.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -163.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.07 116.0 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 125.127 1.371 . . . . 0.0 110.305 -174.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.55 136.82 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -114.2 114.78 26.47 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 6.0 ptp -118.24 130.2 55.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.302 1.041 . . . . 0.0 109.831 178.22 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -80.03 125.27 29.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.404 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.25 140.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -103.42 156.58 17.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.82 -32.7 1.69 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.378 0.513 . . . . 0.0 114.199 172.863 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.7 mtp -67.31 80.84 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.253 1.026 . . . . 0.0 111.721 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -118.67 65.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.123 1.769 . . . . 0.0 109.095 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.24 169.25 9.33 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.92 5.17 52.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.839 0.456 . . . . 0.0 111.749 169.078 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.5 t -85.57 -65.81 0.97 Allowed 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.801 -0.562 . . . . 0.0 109.69 -174.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.23 -46.81 82.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.49 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -52.09 -60.95 2.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 109.968 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 t -52.12 -44.37 64.44 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.754 1.222 . . . . 0.0 111.231 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -58.07 -50.78 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.486 -0.758 . . . . 0.0 110.592 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.29 -45.78 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.54 -51.6 53.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.689 1.196 . . . . 0.0 110.721 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.63 -54.56 36.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.352 0.501 . . . . 0.0 111.92 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -52.17 66.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.638 -0.919 . . . . 0.0 111.462 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -63.83 -41.38 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.299 0.639 . . . . 0.0 109.709 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.96 19.76 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.448 0.547 . . . . 0.0 112.563 170.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -62.64 -24.93 67.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.724 0.762 . . . . 0.0 112.958 178.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mt -70.75 129.82 40.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.426 1.012 . . . . 0.0 112.825 -171.565 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.42 87.87 0.12 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.221 174.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -25.0 0.62 Allowed Glycine 0 C--N 1.332 0.343 0 O-C-N 122.035 -0.416 . . . . 0.0 113.406 -177.559 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.97 151.39 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -112.98 -53.98 2.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.967 0.907 . . . . 0.0 110.276 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.0 165.8 26.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.576 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -158.81 139.42 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -175.289 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -141.51 84.72 1.92 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.648 1.579 . . . . 0.0 110.254 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.43 106.34 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.056 -173.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -92.49 155.12 18.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -47.73 3.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.201 1.0 . . . . 0.0 108.619 177.394 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.03 -60.1 3.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.36 1.864 . . . . 0.0 110.567 -171.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -94.42 19.57 9.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.192 -175.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.83 49.44 0.57 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.048 2.539 . . . . 0.0 113.662 -177.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 4.7 tp10 -126.94 126.18 42.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.912 -169.325 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -115.03 113.25 23.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 110.155 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.491 ' C ' HD12 ' A' ' 45' ' ' ILE . 5.7 m -91.7 124.93 36.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 108.668 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' C ' ' A' ' 44' ' ' THR . 3.2 mp -124.09 132.64 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 167.499 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.25 107.05 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.57 1.148 . . . . 0.0 109.665 -174.779 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.73 159.98 40.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -171.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -81.72 114.1 47.54 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.49 74.59 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.297 2.665 . . . . 0.0 110.791 -171.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -49.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.073 2.149 . . . . 0.0 108.02 173.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.17 -43.63 70.43 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.357 -173.761 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.23 169.58 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -142.63 165.64 26.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.455 -170.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.0 t -43.96 -45.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.266 1.026 . . . . 0.0 111.391 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.29 -56.9 15.86 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.277 -178.349 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.56 -48.21 69.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.462 1.483 . . . . 0.0 109.929 -177.757 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.1 mtm -46.68 -61.8 1.67 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 118.813 0.733 . . . . 0.0 112.54 169.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -60.34 -59.89 4.68 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.326 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -37.8 -54.77 1.23 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.679 1.592 . . . . 0.0 109.614 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.69 -46.86 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.503 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -68.06 -64.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 O-C-N 121.527 -0.733 . . . . 0.0 110.716 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.14 -34.63 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.17 175.095 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.99 -33.72 65.11 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 120.218 1.372 . . . . 0.0 112.846 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.6 mmt -59.03 -40.14 84.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.536 0.607 . . . . 0.0 110.443 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.95 -20.17 3.43 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.621 1.105 . . . . 0.0 110.989 178.928 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.62 112.99 19.91 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.183 -173.345 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -66.21 141.08 61.53 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.6 135.08 34.59 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.759 0.314 . . . . 0.0 111.628 -177.314 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -108.15 72.6 0.85 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.569 -171.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.83 103.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.637 1.575 . . . . 0.0 111.002 174.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -156.1 56.52 0.59 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.772 0.796 . . . . 0.0 111.925 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -157.13 162.11 39.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 173.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.21 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.44 127.66 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.566 1.146 . . . . 0.0 109.202 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -90.99 116.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 126.295 1.838 . . . . 0.0 109.254 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.08 118.56 37.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -97.0 119.05 34.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.507 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.3 ptp -121.42 124.3 44.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.759 1.224 . . . . 0.0 109.203 175.7 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -82.53 119.25 24.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.372 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.23 122.59 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.98 0.512 . . . . 0.0 110.244 -170.75 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.11 157.49 20.68 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.474 0.309 . . . . 0.0 111.119 -174.201 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.03 -44.63 1.46 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.947 0.784 . . . . 0.0 112.119 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 mtm -60.28 109.19 0.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.202 0.501 . . . . 0.0 109.809 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -146.51 19.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.851 1.26 . . . . 0.0 110.014 -177.593 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.0 148.89 22.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.265 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -81.14 42.38 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.094 0.557 . . . . 0.0 112.288 -167.404 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -122.42 -69.11 0.85 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.253 1.421 . . . . 0.0 107.491 177.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -49.76 -53.36 25.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.201 1.4 . . . . 0.0 110.443 -176.179 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 HG21 HD22 ' A' ' 38' ' ' LEU . 11.8 t -51.18 -55.75 16.37 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.173 177.739 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -60.97 -45.69 93.73 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.349 1.06 . . . . 0.0 110.307 -175.985 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -55.26 -51.36 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.646 -0.659 . . . . 0.0 110.76 176.184 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.64 -48.02 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.971 0.509 . . . . 0.0 110.002 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -48.96 -51.72 28.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.447 1.499 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -59.91 9.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 172.921 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -48.87 79.06 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 122.002 -0.705 . . . . 0.0 110.851 -170.607 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.3 mm -71.08 -47.79 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.074 0.55 . . . . 0.0 109.96 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.95 -35.26 31.96 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.325 0.488 . . . . 0.0 112.228 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -68.87 -16.38 63.75 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.868 0.867 . . . . 0.0 113.324 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mt -73.91 139.6 45.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.488 1.495 . . . . 0.0 112.106 -176.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -70.1 97.38 1.18 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.062 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.91 -12.87 1.12 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-O 118.662 -1.077 . . . . 0.0 114.181 -175.703 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.3 t -102.85 139.43 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 118.145 0.973 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 -31.68 14.39 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.881 0.472 . . . . 0.0 111.801 175.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -171.57 164.55 6.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.952 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -156.04 138.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 104.022 -2.584 . . . . 0.0 104.022 -172.888 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -137.78 92.42 2.68 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.79 1.636 . . . . 0.0 111.239 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.41 115.24 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -104.9 103.4 12.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.984 1.713 . . . . 0.0 108.723 -173.811 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.816 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -65.5 -48.83 71.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.77 0.428 . . . . 0.0 110.628 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.17 -54.48 30.21 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.883 1.273 . . . . 0.0 110.24 -176.857 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.63 5.56 27.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.828 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 35.19 60.21 0.71 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 128.428 2.691 . . . . 0.0 113.081 -175.882 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -138.79 149.1 44.61 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.154 1.381 . . . . 0.0 108.586 -175.641 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -126.37 119.61 27.73 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.634 1.174 . . . . 0.0 110.269 -179.364 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 45' ' ' ILE . 9.0 m -103.03 114.44 28.75 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.975 1.71 . . . . 0.0 109.025 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 44' ' ' THR . 2.1 mp -117.37 115.44 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.76 105.52 18.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.749 0.704 . . . . 0.0 109.927 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -128.61 169.68 14.14 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -166.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.02 111.0 64.74 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 124.554 1.142 . . . . 0.0 110.461 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.58 78.35 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.144 2.563 . . . . 0.0 111.431 -175.72 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.7 m80 178.97 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.447 2.699 . . . . 0.0 108.624 173.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 -50.21 11.99 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.01 -178.32 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.095 1.358 . . . . 0.0 107.718 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.8 p -142.85 155.22 44.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.358 -174.154 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.45 -42.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 124.199 1.0 . . . . 0.0 111.07 173.476 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.15 -39.36 94.43 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.046 -177.638 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.73 -51.46 64.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.853 1.206 . . . . 0.0 107.748 176.216 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.0 mmt -47.63 -61.22 2.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 122.447 0.299 . . . . 0.0 111.775 176.137 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -57.56 -59.45 5.16 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 120.967 -1.083 . . . . 0.0 111.077 177.002 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 119.312 0.96 . . . . 0.0 109.249 -170.402 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -57.95 -50.02 74.8 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.85 173.262 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -69.5 -64.79 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 111.046 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -45.02 -39.51 5.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.791 0.723 . . . . 0.0 112.262 174.68 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.59 55.74 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.513 1.051 . . . . 0.0 113.293 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -56.27 -39.52 72.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.403 0.547 . . . . 0.0 110.534 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.05 -19.61 2.88 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.714 1.149 . . . . 0.0 111.181 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.33 112.35 40.86 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.359 1.064 . . . . 0.0 110.384 -169.038 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.22 127.91 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.766 1.644 . . . . 0.0 109.651 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.57 133.03 55.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.618 0.767 . . . . 0.0 111.84 -173.769 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -105.51 76.02 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.286 1.034 . . . . 0.0 109.493 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.49 109.4 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.076 0.95 . . . . 0.0 110.077 170.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -156.98 53.8 0.51 Allowed 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 178.619 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 81.47 0.78 Allowed 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.931 -0.481 . . . . 0.0 110.127 -177.089 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 123.683 0.793 . . . . 0.0 109.565 -179.199 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.71 ' HG3' HG12 ' A' ' 46' ' ' VAL . 13.7 pm0 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.5 t -133.9 140.78 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' C ' HD12 ' A' ' 5' ' ' LEU . 7.7 p -101.26 129.13 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 126.049 1.74 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 47' ' ' TYR . 10.8 mp -120.31 145.61 46.93 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.988 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -122.98 125.96 46.25 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.105 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mtt -115.79 129.67 56.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.412 1.885 . . . . 0.0 108.026 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.45 126.29 31.47 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.05 157.04 9.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 119.329 0.968 . . . . 0.0 109.723 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -123.75 143.56 50.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.366 0.603 . . . . 0.0 109.743 170.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.61 -31.51 8.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.005 1.765 . . . . 0.0 112.794 174.745 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.7 mtt -66.36 99.14 0.53 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.09 0.945 . . . . 0.0 111.02 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.0 m -143.78 56.52 1.34 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.936 -1.102 . . . . 0.0 109.477 174.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.4 p -161.62 159.85 28.07 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 165.152 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -80.58 44.68 0.73 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.271 0.487 . . . . 0.0 111.222 179.044 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -123.17 -60.33 1.51 Allowed 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.756 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -47.2 -59.89 2.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.488 0.715 . . . . 0.0 110.807 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -52.92 -59.26 4.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.572 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 t -60.38 -45.27 94.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.756 0.822 . . . . 0.0 111.331 -170.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -54.19 -49.97 68.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.56 -0.713 . . . . 0.0 110.462 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.23 -43.9 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.699 ' HA ' HD13 ' A' ' 34' ' ' ILE . 8.1 mt-10 -53.58 -50.07 66.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.139 0.976 . . . . 0.0 110.682 177.527 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.58 -58.25 14.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 171.136 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -56.32 -52.3 65.05 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.169 -0.607 . . . . 0.0 111.14 -172.349 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.587 HG21 HD12 ' A' ' 34' ' ' ILE . 24.8 mm -62.02 -47.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.907 1.283 . . . . 0.0 109.911 178.469 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.98 -39.71 26.35 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 172.23 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -70.48 -13.92 62.32 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.664 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mt -82.23 133.37 35.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 120.031 1.287 . . . . 0.0 112.345 -174.547 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -68.67 91.17 0.42 Allowed 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.532 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.59 -20.87 0.92 Allowed Glycine 0 C--N 1.334 0.433 0 O-C-N 121.859 -0.525 . . . . 0.0 113.752 -177.115 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -85.93 151.16 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -120.43 -38.29 2.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.873 1.269 . . . . 0.0 111.013 -179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -152.78 171.05 18.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 22' ' ' GLU . 14.8 tt -158.56 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -143.78 88.03 1.96 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.074 1.75 . . . . 0.0 111.298 175.367 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.83 88.61 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.124 -0.985 . . . . 0.0 111.263 -178.425 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.04 121.36 21.87 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.675 1.99 . . . . 0.0 110.919 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -73.97 -46.56 43.22 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.261 -0.899 . . . . 0.0 111.366 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 m-20 -47.3 -59.58 3.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.724 1.21 . . . . 0.0 111.211 -170.121 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.35 24.92 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.524 -176.216 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 24.89 74.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.346 2.659 . . . . 0.0 113.934 -169.021 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -127.94 136.58 51.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 108.222 -173.214 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.8 102.38 9.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.53 1.132 . . . . 0.0 108.427 171.374 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.568 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.2 m -88.95 125.72 35.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.348 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -123.0 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.516 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 2' ' ' GLU . 2.6 t -118.96 103.59 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.487 1.115 . . . . 0.0 108.067 -174.081 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HE1' HD13 ' A' ' 5' ' ' LEU . 17.0 p90 -138.78 164.59 29.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -166.766 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -96.71 110.64 54.26 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.975 -173.112 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.05 76.57 2.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.894 3.062 . . . . 0.0 110.684 -172.285 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.407 1.883 . . . . 0.0 107.357 -175.345 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.51 -46.35 13.51 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.476 0.485 . . . . 0.0 110.48 -171.394 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.54 155.51 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 107.136 -176.537 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 p -123.18 161.84 23.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.786 1.234 . . . . 0.0 110.392 -173.619 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.6 t -45.47 -45.52 4.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 123.831 0.852 . . . . 0.0 111.843 175.981 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.49 -56.65 17.8 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.038 -175.427 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -38.82 -59.67 0.93 Allowed 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.015 1.726 . . . . 0.0 110.144 170.618 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.4 mtm -49.67 -62.79 1.36 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -59.2 -62.64 1.73 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.41 -177.698 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -38.82 -49.37 1.62 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 120.013 1.278 . . . . 0.0 110.376 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -37.2 78.67 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.693 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -72.08 -66.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 124.37 1.068 . . . . 0.0 110.81 175.489 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -38.0 -40.16 0.45 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.034 1.334 . . . . 0.0 112.403 171.454 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.38 -35.43 8.29 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 113.514 176.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.83 81.71 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.666 0.787 . . . . 0.0 110.613 178.626 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.23 -14.66 4.55 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.877 1.227 . . . . 0.0 111.172 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -85.48 115.93 63.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 123.849 0.86 . . . . 0.0 109.866 -171.107 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.5 142.1 63.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 175.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.4 135.81 44.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.094 0.558 . . . . 0.0 111.401 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -105.7 76.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.577 1.151 . . . . 0.0 109.437 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.41 104.52 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.079 1.352 . . . . 0.0 110.859 171.909 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -155.73 60.01 0.61 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.71 0.767 . . . . 0.0 112.875 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.31 162.33 40.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.455 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.821 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -116.78 128.61 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 124.731 1.212 . . . . 0.0 109.499 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.3 104.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.345 1.458 . . . . 0.0 110.129 -176.064 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.33 101.89 14.38 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.709 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -79.19 120.95 24.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.079 0.952 . . . . 0.0 108.6 174.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.72 119.14 29.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.142 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 115.55 19.41 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.45 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.43 154.49 5.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -174.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -111.54 156.91 21.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.174 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.45 -43.44 3.22 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.261 -0.9 . . . . 0.0 114.043 161.907 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.5 mtm -61.01 86.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.374 1.087 . . . . 0.0 111.507 -178.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -116.49 38.08 3.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.744 1.618 . . . . 0.0 109.902 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -154.81 162.96 40.92 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.313 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -76.74 -21.61 55.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.429 0.456 . . . . 0.0 111.402 -177.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -58.16 -58.91 6.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.752 0.421 . . . . 0.0 110.214 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.1 m -54.5 -53.37 55.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -58.9 -54.2 49.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.075 -175.883 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -58.74 -45.91 88.6 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.818 0.847 . . . . 0.0 111.229 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.6 m -56.2 -48.46 76.35 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.371 -0.83 . . . . 0.0 110.5 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -59.44 -47.89 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -55.81 -45.0 78.38 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.635 . . . . 0.0 110.764 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.1 -53.26 45.94 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.063 0.84 . . . . 0.0 111.527 173.226 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -63.0 -59.77 4.36 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.93 0.871 . . . . 0.0 109.834 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.59 -32.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.167 1.387 . . . . 0.0 111.043 -175.166 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.16 -31.49 6.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.313 0.482 . . . . 0.0 112.447 172.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -80.74 -4.08 53.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.74 139.35 45.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 120.104 1.32 . . . . 0.0 112.524 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -81.18 84.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.136 177.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.04 -13.96 0.86 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 178.888 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.33 145.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.673 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -115.13 -37.33 4.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.249 1.419 . . . . 0.0 111.037 -176.001 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.66 44.42 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.67 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -155.06 126.6 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' LYS 0.253 16.2 mmtm -135.08 102.16 5.11 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 171.355 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.33 98.58 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.584 -0.697 . . . . 0.0 110.095 -177.419 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.1 m -89.14 126.84 35.64 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.14 1.376 . . . . 0.0 110.808 -176.417 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -84.65 -42.96 14.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.832 0.853 . . . . 0.0 109.96 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -59.11 4.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.938 1.695 . . . . 0.0 110.376 -173.957 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -86.58 9.0 19.83 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.001 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 0.1 OUTLIER 32.85 66.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.209 2.604 . . . . 0.0 112.208 -169.548 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -144.5 141.99 29.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.556 1.142 . . . . 0.0 110.685 -173.458 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.95 120.19 39.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.38 1.472 . . . . 0.0 109.682 -178.571 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -94.46 78.27 3.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.942 2.497 . . . . 0.0 107.934 175.132 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.28 103.8 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.54 108.24 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.328 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -131.41 175.05 9.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.899 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -106.88 109.91 63.35 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.268 1.027 . . . . 0.0 110.187 -175.157 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 73.74 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.153 3.235 . . . . 0.0 111.216 -170.138 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -177.91 -39.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.372 2.269 . . . . 0.0 108.368 178.933 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.75 -46.13 13.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.778 -175.606 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -135.62 149.08 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.869 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -100.58 158.74 15.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.052 0.941 . . . . 0.0 111.676 -173.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.71 -42.97 18.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.939 0.496 . . . . 0.0 110.357 166.095 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.52 -53.92 50.04 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -176.306 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -46.14 -54.1 9.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.312 1.045 . . . . 0.0 110.528 172.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.9 mmm -48.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 173.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 15.0 tttp -56.9 -64.57 0.83 Allowed 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.808 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -37.11 -52.76 1.01 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.907 1.683 . . . . 0.0 109.954 178.106 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -66.11 -47.26 74.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.081 177.428 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.61 -62.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.655 0.661 . . . . 0.0 110.453 -178.136 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 1.8 tt0 -42.39 -44.08 3.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 112.223 171.344 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.2 62.3 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.126 0.875 . . . . 0.0 113.065 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.1 -42.29 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.499 0.59 . . . . 0.0 110.467 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.28 -18.71 2.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.596 1.093 . . . . 0.0 111.299 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -81.23 118.31 71.77 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-O 118.417 -0.801 . . . . 0.0 110.373 -169.302 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.1 140.05 52.77 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 N-CA-C 108.445 -1.406 . . . . 0.0 108.445 173.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.21 132.33 37.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.392 0.615 . . . . 0.0 111.045 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.26 81.24 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.019 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -42.02 107.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 125.15 1.531 . . . . 0.0 108.818 160.961 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -101.87 179.8 4.23 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.121 1.768 . . . . 0.0 106.611 170.813 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 161.87 18.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.05 -175.048 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 123.003 0.521 . . . . 0.0 109.709 -178.786 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -105.6 132.45 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.854 0.862 . . . . 0.0 109.161 -176.197 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.2 115.52 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.646 1.578 . . . . 0.0 109.813 179.435 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.0 124.43 33.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 170.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.48 109.39 21.34 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.432 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.724 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptp -119.64 144.64 47.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.094 0.958 . . . . 0.0 109.142 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.85 46.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.922 173.83 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.92 96.48 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 124.661 1.226 . . . . 0.0 109.448 -166.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -68.3 142.76 55.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.946 -0.471 . . . . 0.0 110.668 -172.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 -47.72 1.0 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.286 0.946 . . . . 0.0 112.525 174.071 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.7 82.47 2.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.929 0.864 . . . . 0.0 111.899 -171.912 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -111.35 33.63 4.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.537 1.535 . . . . 0.0 110.545 -178.776 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -155.37 160.55 40.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.288 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -78.0 -1.5 32.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -174.754 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -76.7 -61.36 1.99 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.49 -0.756 . . . . 0.0 109.629 175.087 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -56.13 -48.59 75.93 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.717 0.407 . . . . 0.0 110.809 -174.469 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.9 p -52.03 -60.39 3.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.383 0.673 . . . . 0.0 109.415 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -50.7 -48.21 58.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.786 1.234 . . . . 0.0 111.692 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -54.42 -51.91 63.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.315 -0.866 . . . . 0.0 110.948 176.68 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.9 mt -62.14 -40.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.97 0.508 . . . . 0.0 109.989 178.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.99 -48.58 78.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.661 1.184 . . . . 0.0 110.599 176.178 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.82 -56.31 24.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 172.499 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -56.18 -52.63 63.71 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -174.584 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.06 -45.81 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.244 1.018 . . . . 0.0 110.299 -175.456 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.57 -37.61 26.86 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.402 0.525 . . . . 0.0 112.012 175.515 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -72.99 -9.28 58.56 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.135 0.974 . . . . 0.0 113.5 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mt -81.45 128.45 33.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.431 1.468 . . . . 0.0 111.408 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -66.8 108.87 2.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.097 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.52 -16.28 3.58 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 124.489 1.042 . . . . 0.0 112.613 -178.287 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.5 152.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 117.053 0.426 . . . . 0.0 110.249 173.043 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.14 -46.08 2.21 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.31 -178.686 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.42 165.57 30.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 178.601 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -156.5 137.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -141.66 90.85 2.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.253 1.021 . . . . 0.0 111.495 179.091 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.76 90.91 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.512 -0.742 . . . . 0.0 110.194 -177.137 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 m -84.45 110.21 18.48 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.583 1.153 . . . . 0.0 111.247 -173.765 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.741 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -63.33 -49.6 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.356 0.663 . . . . 0.0 112.368 177.892 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.86 -59.58 3.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.074 1.349 . . . . 0.0 111.095 -170.906 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -92.57 18.91 7.93 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.438 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 28.9 60.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 129.028 2.931 . . . . 0.0 113.609 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.12 132.46 32.04 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 110.26 -175.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.724 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.22 112.5 25.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.451 1.9 . . . . 0.0 109.498 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.0 m -90.56 84.57 5.95 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 127.845 2.458 . . . . 0.0 107.575 173.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.25 113.06 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -107.47 111.76 37.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.957 0.799 . . . . 0.0 110.128 -171.508 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -129.75 170.89 13.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.762 0.792 . . . . 0.0 112.328 -169.615 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -106.42 109.25 63.0 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.906 -177.28 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.36 77.99 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.177 2.584 . . . . 0.0 110.906 -172.408 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.09 -41.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 127.885 2.474 . . . . 0.0 107.926 174.382 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -77.96 -53.84 6.98 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 117.966 0.348 . . . . 0.0 110.974 -177.895 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.27 179.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.88 1.272 . . . . 0.0 108.84 -176.541 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -146.37 159.6 43.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.574 0.749 . . . . 0.0 110.992 -172.701 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -39.28 -48.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.813 1.645 . . . . 0.0 111.159 173.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.78 -50.46 73.37 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.14 -50.64 66.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 120.401 1.455 . . . . 0.0 108.442 176.488 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.66 -55.96 16.44 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.499 0.19 . . . . 0.0 111.011 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.87 -62.26 1.92 Allowed 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.583 177.427 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -50.34 5.29 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.446 1.099 . . . . 0.0 109.495 -177.913 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -60.1 -49.84 76.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 177.176 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -70.17 -63.76 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.744 -0.597 . . . . 0.0 111.301 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.8 -37.91 6.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 112.548 174.272 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.78 56.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.779 1.172 . . . . 0.0 113.06 176.891 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 mmt -56.89 -39.88 75.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.507 0.594 . . . . 0.0 110.625 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.41 -18.96 3.23 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.639 1.114 . . . . 0.0 110.932 176.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -80.94 114.03 45.33 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.48 -172.092 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.99 141.63 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.663 1.575 . . . . 0.0 108.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.37 134.57 46.41 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.335 0.97 . . . . 0.0 112.956 -177.241 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -106.47 71.74 0.88 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.82 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.14 107.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.8 170.22 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -150.89 55.19 0.89 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 176.156 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 159.45 41.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 173.39 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.013 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 . . . . . 0 N--CA 1.447 -0.622 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.57 141.18 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.082 0.953 . . . . 0.0 109.343 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -104.96 127.01 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 126.462 1.905 . . . . 0.0 110.663 -177.723 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.21 127.89 54.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.1 111.27 23.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 178.864 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.422 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.4 ptp -113.66 122.23 46.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.698 1.199 . . . . 0.0 109.152 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -74.46 130.85 40.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.44 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.15 153.7 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -117.08 146.85 42.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.259 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.72 -38.91 2.97 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.267 0.937 . . . . 0.0 113.077 170.756 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 21' ' ' ILE . 34.0 mtt -62.72 137.06 58.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.457 1.129 . . . . 0.0 110.575 -174.989 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -143.4 -56.99 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.733 -0.605 . . . . 0.0 110.226 176.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.8 p -72.07 156.47 39.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.724 0.693 . . . . 0.0 110.098 -179.33 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -65.16 -18.71 65.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.295 177.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 m -64.54 -50.18 68.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.422 -0.799 . . . . 0.0 110.665 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -54.62 -57.85 9.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.787 0.721 . . . . 0.0 109.73 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -55.49 -55.31 33.25 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.539 -176.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -56.55 -45.89 80.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.9 m -58.0 -49.48 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.487 -0.758 . . . . 0.0 109.942 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CE ' ' A' ' 12' ' ' MET . 3.1 mt -61.14 -47.01 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 122.936 0.494 . . . . 0.0 109.912 176.737 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.56 -50.26 60.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.553 0.741 . . . . 0.0 109.551 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.86 -56.79 22.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.68 0.657 . . . . 0.0 111.817 173.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -60.63 -59.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.198 -0.589 . . . . 0.0 110.948 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -67.58 -34.25 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.954 -177.376 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.43 -33.79 6.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.58 168.804 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -92.42 12.19 23.6 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 117.966 0.883 . . . . 0.0 112.353 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.61 151.24 47.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 120.404 -1.435 . . . . 0.0 109.886 167.316 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.17 130.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.37 -0.88 29.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.557 1.075 . . . . 0.0 111.909 176.463 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -95.48 154.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 124.691 1.196 . . . . 0.0 109.658 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -122.1 -41.57 2.42 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.168 0.987 . . . . 0.0 110.055 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -150.66 164.37 36.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.603 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 25' ' ' ILE . 10.5 tt -156.97 139.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -172.899 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -145.49 147.76 32.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.55 0.74 . . . . 0.0 110.027 172.067 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.32 140.76 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.863 1.211 . . . . 0.0 110.825 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -124.08 132.57 53.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.971 1.708 . . . . 0.0 110.569 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -54.73 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 112.151 176.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.61 -56.73 16.01 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 110.112 -166.195 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.22 11.58 16.08 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.845 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.37 62.69 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.857 2.863 . . . . 0.0 113.042 -178.327 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 3.8 tt0 -131.39 142.32 50.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.342 -175.227 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -118.72 133.88 55.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.298 1.439 . . . . 0.0 108.659 175.71 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -109.94 117.18 33.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.518 3.127 . . . . 0.0 106.648 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -126.23 119.29 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.927 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.17 108.59 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -168.029 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.192 0.52 . . . . 0.0 112.008 -165.356 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -89.31 108.58 25.45 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.714 1.606 . . . . 0.0 109.431 -174.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.2 73.14 2.69 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.02 2.48 . . . . 0.0 111.036 -176.726 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -168.22 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.413 1.885 . . . . 0.0 108.756 177.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.67 -43.17 63.48 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.36 177.9 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -135.05 162.34 32.75 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.153 0.888 . . . . 0.0 110.215 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.09 -46.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 110.995 169.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -61.14 -57.77 11.11 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.184 -174.719 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -38.57 -56.85 1.24 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.763 1.625 . . . . 0.0 110.665 172.422 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.45 -63.01 1.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 122.163 -0.336 . . . . 0.0 111.57 175.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -58.64 7.53 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.714 -0.616 . . . . 0.0 111.964 -177.443 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -36.88 -54.97 0.92 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.844 1.658 . . . . 0.0 110.491 172.649 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -41.8 94.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.094 -1.043 . . . . 0.0 113.388 176.308 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.74 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.174 -0.954 . . . . 0.0 109.98 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -43.42 -40.96 4.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.957 169.553 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.23 61.16 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.617 1.099 . . . . 0.0 113.222 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.82 -43.79 81.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.593 0.633 . . . . 0.0 110.777 171.801 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.02 -15.31 4.02 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.047 1.308 . . . . 0.0 111.287 -179.01 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 21' ' ' ILE . 44.2 m-85 -80.89 116.89 65.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.91 -173.221 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.9 140.04 49.27 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 108.397 -1.424 . . . . 0.0 108.397 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.71 140.25 42.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.351 0.66 . . . . 0.0 110.48 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -114.66 79.03 1.21 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.939 0.896 . . . . 0.0 109.152 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 105.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.012 1.325 . . . . 0.0 109.691 169.796 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -152.98 54.72 0.77 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.735 0.778 . . . . 0.0 112.42 176.282 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 132.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 175.684 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -80.44 -178.27 6.59 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.05 135.83 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.72 132.47 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.639 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 70' ' ' VAL . 4.1 mm? -113.25 135.24 54.05 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 166.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -111.94 122.07 46.77 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.6 ptp -123.64 120.5 32.95 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.106 1.362 . . . . 0.0 109.533 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.2 mptp? -71.01 134.53 47.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.655 -1.164 . . . . 0.0 108.079 173.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -116.91 150.35 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -113.61 150.35 33.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.36 -35.06 2.42 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.52 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.6 mtm -65.82 85.72 0.08 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.607 1.204 . . . . 0.0 111.603 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 m -122.96 51.08 1.46 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 109.116 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 p -158.32 167.88 28.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 165.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.77 -22.24 50.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.321 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -65.62 -62.0 1.76 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.047 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -52.21 -51.22 59.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.013 0.911 . . . . 0.0 110.235 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 p -57.58 -56.07 26.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.295 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -54.98 -48.34 73.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.776 0.717 . . . . 0.0 111.623 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.2 m -52.85 -51.96 59.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.534 0.734 . . . . 0.0 110.283 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -60.92 -44.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.19 -48.12 71.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.231 0.612 . . . . 0.0 111.087 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.82 28.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.663 0.649 . . . . 0.0 111.624 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -56.96 -47.11 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.109 -0.642 . . . . 0.0 110.945 -174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 mm -66.34 -48.02 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.241 1.016 . . . . 0.0 109.478 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.76 -39.26 31.34 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.533 0.587 . . . . 0.0 112.235 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -60.54 -29.17 68.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.492 0.646 . . . . 0.0 112.489 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -75.04 135.29 41.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.039 0.923 . . . . 0.0 112.088 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -70.72 86.96 0.68 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.917 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.66 0.51 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 115.227 0.851 . . . . 0.0 115.227 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -86.95 149.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 117.844 0.822 . . . . 0.0 109.287 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -120.8 -34.72 3.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -156.53 164.32 38.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -158.29 140.28 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.1 mmtm -140.99 82.7 1.85 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.233 1.013 . . . . 0.0 111.222 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -84.47 110.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -89.29 172.16 9.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.58 -48.15 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.461 1.104 . . . . 0.0 109.48 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.11 -61.15 1.89 Allowed 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.389 1.876 . . . . 0.0 110.392 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.17 19.52 7.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.143 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.33 63.87 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.759 2.824 . . . . 0.0 113.462 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.441 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 35.2 tt0 -146.6 146.24 30.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -177.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -125.14 124.71 42.39 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.613 1.165 . . . . 0.0 109.596 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -98.05 129.54 44.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.82 1.648 . . . . 0.0 107.23 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.8 123.19 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 104.55 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 118.821 0.737 . . . . 0.0 110.025 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -133.4 167.98 19.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.335 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.42 112.79 63.14 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.233 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.45 78.25 2.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.024 3.149 . . . . 0.0 110.985 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -179.25 -52.95 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.781 1.632 . . . . 0.0 106.919 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.78 -46.06 16.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.155 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 169.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.552 1.541 . . . . 0.0 108.27 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -139.64 162.03 36.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.982 0.913 . . . . 0.0 111.202 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 70' ' ' VAL . 86.9 t -43.65 -48.28 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.202 1.001 . . . . 0.0 111.15 172.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.89 -45.66 88.36 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.488 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -50.93 -57.28 8.93 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.231 1.378 . . . . 0.0 108.702 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.9 mmt -46.49 -65.43 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -59.7 5.02 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 121.284 -0.885 . . . . 0.0 112.611 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -44.76 -48.63 10.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.203 0.911 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -40.8 90.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.99 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -67.52 -65.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.077 0.551 . . . . 0.0 110.619 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -43.38 -42.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.38 0.672 . . . . 0.0 112.18 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.42 -32.86 58.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.139 0.882 . . . . 0.0 113.149 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.3 mmt -59.39 -40.26 85.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.68 0.673 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.93 -17.74 2.77 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.372 0.986 . . . . 0.0 111.197 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -84.23 110.53 27.03 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 123.913 0.885 . . . . 0.0 109.581 -171.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -65.89 141.58 65.53 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.33 136.18 32.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.444 0.298 . . . . 0.0 111.779 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.81 78.74 1.22 Allowed 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 5' ' ' LEU . 10.4 p -66.16 101.52 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.844 1.657 . . . . 0.0 112.083 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -156.77 56.8 0.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -158.03 130.06 6.96 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 167.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.85 63.01 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 59.5 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.867 0.867 . . . . 0.0 109.569 -171.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.94 164.1 51.84 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.611 -0.681 . . . . 0.0 111.788 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? . . . . . 0 C--O 1.25 1.121 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.198 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.666 0 N-CA-C 106.53 -2.628 . . . . 0.0 106.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -170.62 156.19 5.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.94 134.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.43 134.61 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.09 147.02 43.69 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 163.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -118.04 117.06 28.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -118.28 119.64 35.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.619 1.568 . . . . 0.0 108.275 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.47 140.74 54.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -127.94 146.4 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -105.97 148.15 28.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.32 -31.68 2.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.459 -0.776 . . . . 0.0 114.056 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.5 mtp -61.99 92.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.987 0.893 . . . . 0.0 110.242 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 m -144.46 48.67 1.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.894 1.277 . . . . 0.0 109.724 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -77.26 44.27 0.41 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.668 0.787 . . . . 0.0 111.46 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -129.54 -59.76 1.07 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.392 1.077 . . . . 0.0 108.425 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -54.66 -58.53 7.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.471 0.578 . . . . 0.0 110.655 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 t -51.95 -57.3 9.84 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.271 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 t -57.71 -40.33 79.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.809 0.844 . . . . 0.0 110.557 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -60.85 -49.26 78.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.934 -0.479 . . . . 0.0 110.082 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -51.29 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.5 -51.19 65.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.201 1.0 . . . . 0.0 110.142 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.01 -51.21 57.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.813 0.72 . . . . 0.0 112.059 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.3 -59.58 5.07 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.195 0.997 . . . . 0.0 110.572 -175.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.9 mm -57.67 -38.07 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.264 1.026 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.32 -36.15 7.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.033 0.825 . . . . 0.0 113.676 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.62 -7.01 59.59 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.171 0.986 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.64 149.7 32.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.12 0.873 . . . . 0.0 111.835 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.71 126.53 36.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.194 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.0 -21.06 7.51 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -86.98 151.64 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -118.51 -40.82 2.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.836 1.254 . . . . 0.0 110.726 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -159.13 170.84 21.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -158.48 140.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -143.87 84.73 1.79 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.685 0.794 . . . . 0.0 110.718 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.45 102.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.84 0.856 . . . . 0.0 109.149 -172.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -78.53 177.21 8.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -141.09 -48.85 0.41 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 109.054 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -61.43 1.96 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.423 1.489 . . . . 0.0 110.39 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -91.52 19.46 6.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.625 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 37.29 62.27 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.155 2.182 . . . . 0.0 113.603 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.29 149.48 33.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 130.64 46.95 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.332 1.053 . . . . 0.0 110.147 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -102.06 129.3 48.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 107.234 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.6 mm -123.88 127.81 73.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.34 107.36 21.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 110.005 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -145.86 173.24 12.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.498 -0.751 . . . . 0.0 111.813 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -98.65 104.3 23.71 Favored Pre-proline 0 N--CA 1.439 -1.024 0 C-N-CA 124.932 1.293 . . . . 0.0 108.713 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.12 -24.4 73.55 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.836 2.357 . . . . 0.0 112.4 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -22.76 63.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.594 0.758 . . . . 0.0 112.894 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.8 mt -107.97 -64.71 1.18 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.827 0.74 . . . . 0.0 111.474 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -116.5 161.3 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.644 1.177 . . . . 0.0 108.277 -175.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -127.72 165.45 20.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.514 0.726 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.62 -44.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 C-N-CA 124.133 0.973 . . . . 0.0 110.236 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -60.59 -38.19 83.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.135 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.86 -53.63 25.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 mmt -45.21 -59.74 2.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 122.863 0.465 . . . . 0.0 111.634 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -53.82 44.02 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.284 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -50.37 -47.05 56.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 120.702 1.592 . . . . 0.0 109.201 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -59.63 -48.96 79.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.704 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -69.74 -63.94 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 122.931 0.492 . . . . 0.0 110.583 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -47.69 -36.47 11.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.318 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.43 -32.82 63.04 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.726 1.148 . . . . 0.0 112.955 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.5 mmt -60.89 -30.39 70.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.437 0.562 . . . . 0.0 110.885 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.54 7.79 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.455 1.503 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -82.5 116.07 61.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.375 1.07 . . . . 0.0 109.524 -171.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.76 144.08 64.09 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.611 1.541 . . . . 0.0 108.75 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.27 141.22 35.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.929 0.492 . . . . 0.0 111.179 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -114.49 78.3 1.14 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.88 0.872 . . . . 0.0 110.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.13 103.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.097 1.359 . . . . 0.0 111.2 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -155.41 57.09 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.34 0.59 . . . . 0.0 112.16 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.01 158.17 32.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -153.04 65.19 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.061 0.934 . . . . 0.0 109.767 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.3 93.34 5.27 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.93 -100.97 0.13 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.993 1.317 . . . . 0.0 110.309 -178.33 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.109 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.85 160.04 0.21 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.762 1.225 . . . . 0.0 109.663 157.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.58 129.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 41.7 t -91.15 119.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 70' ' ' VAL . 3.2 tm? -100.81 133.73 44.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -118.22 115.37 24.62 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.42 126.86 53.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.151 1.38 . . . . 0.0 108.572 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -70.31 140.72 52.33 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 168.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -130.93 143.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.6 159.11 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.84 -39.01 2.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.756 -0.59 . . . . 0.0 114.566 161.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.53 102.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.7 1.25 . . . . 0.0 110.681 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -134.75 34.4 3.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.097 1.359 . . . . 0.0 109.772 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 165.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -72.01 -25.5 61.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.613 0.244 . . . . 0.0 111.316 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -58.52 -56.1 26.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.214 0.606 . . . . 0.0 111.485 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 m -59.12 -55.77 30.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.64 0.654 . . . . 0.0 110.692 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -49.37 -57.47 6.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.22 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -59.73 -42.23 92.68 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.321 0.51 . . . . 0.0 111.206 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.8 m -57.38 -48.83 78.03 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.603 -0.686 . . . . 0.0 110.199 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.63 -49.08 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.253 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -45.16 -53.78 7.69 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.278 1.031 . . . . 0.0 109.546 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.75 -57.41 19.93 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.344 0.973 . . . . 0.0 112.316 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -58.25 -54.38 47.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.868 0.834 . . . . 0.0 109.874 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 28' ' ' LEU . 24.0 mm -70.32 -35.95 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.575 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.7 -30.76 9.08 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.733 -0.604 . . . . 0.0 112.688 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.7 -14.81 60.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 118.178 0.989 . . . . 0.0 113.448 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -68.71 147.66 51.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.639 1.563 . . . . 0.0 112.746 -178.729 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.68 97.51 7.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.74 -10.1 1.87 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-O 119.725 -0.486 . . . . 0.0 114.271 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.91 137.82 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -31.66 10.49 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.079 0.551 . . . . 0.0 111.381 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -152.72 159.64 43.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.19 140.92 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.93 136.78 25.67 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.845 0.858 . . . . 0.0 110.53 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -132.96 104.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 120.628 1.558 . . . . 0.0 111.349 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.1 m -83.28 105.34 14.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.685 1.994 . . . . 0.0 110.125 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -62.26 -44.75 95.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.486 -0.133 . . . . 0.0 110.849 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.48 -57.34 7.2 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.396 1.478 . . . . 0.0 111.287 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.08 11.66 20.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.576 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 1.4 mt-30 33.61 62.93 0.39 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.601 2.36 . . . . 0.0 112.605 -168.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.23 136.25 39.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.971 0.908 . . . . 0.0 110.618 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.34 135.23 53.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.797 1.639 . . . . 0.0 110.168 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.6 m -111.77 124.47 52.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 131.281 3.832 . . . . 0.0 106.438 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mm -125.88 117.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -108.46 95.42 3.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -123.88 169.52 11.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.22 0.533 . . . . 0.0 111.951 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -108.06 109.81 62.02 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.345 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.86 79.76 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.504 2.803 . . . . 0.0 111.298 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m170 177.13 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 128.07 2.548 . . . . 0.0 108.075 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.95 -46.67 17.87 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.398 -0.189 . . . . 0.0 111.258 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -140.2 170.76 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.375 1.47 . . . . 0.0 107.741 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.8 p -130.53 155.91 45.71 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.128 0.971 . . . . 0.0 111.443 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -46.44 -43.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.638 0.775 . . . . 0.0 110.974 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 4.1 tm-20 -60.68 -45.4 94.33 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.706 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.58 -55.98 27.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.66 1.184 . . . . 0.0 107.814 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.7 mmt -46.16 -59.05 3.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' NZ ' ' OE2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -60.66 -51.18 70.5 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 121.148 -0.97 . . . . 0.0 111.927 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -52.66 -49.31 65.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.78 -48.19 82.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.373 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.58 -66.8 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.057 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -48.94 -33.95 11.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.428 -0.796 . . . . 0.0 113.003 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.937 1.244 . . . . 0.0 112.937 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.8 mmt -55.47 -42.28 74.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 110.547 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.76 -25.0 2.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.011 0.815 . . . . 0.0 111.326 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -73.86 113.19 20.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.928 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -64.84 143.69 80.75 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.669 1.579 . . . . 0.0 108.857 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.26 40.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -104.78 76.89 1.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 5' ' ' LEU . 1.3 p -52.58 108.0 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 109.828 162.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -155.38 59.79 0.63 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.601 0.715 . . . . 0.0 112.402 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -157.16 168.06 28.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 tp -152.36 65.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.19 59.78 4.63 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.34 146.93 16.22 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.259 1.558 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -61.1 170.41 1.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.017 0.909 . . . . 0.0 112.713 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.81 144.51 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.786 1.634 . . . . 0.0 107.551 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.33 131.76 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.524 1.53 . . . . 0.0 107.546 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 70' ' ' VAL . 3.0 tm? -120.3 122.09 40.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -113.56 118.8 35.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 8.2 ptp -117.0 128.96 55.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.292 1.037 . . . . 0.0 109.935 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 125.28 28.6 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.19 154.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 119.318 0.963 . . . . 0.0 108.88 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -115.28 154.53 28.94 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 109.74 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.93 -47.54 3.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.691 0.662 . . . . 0.0 112.347 171.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.4 mtm -64.59 86.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.568 0.684 . . . . 0.0 111.82 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 m -135.65 50.7 2.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.476 1.51 . . . . 0.0 109.738 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 p -161.17 167.95 25.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -65.46 177.2 1.21 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.803 0.811 . . . . 0.0 109.837 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t 73.74 -65.73 0.34 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 121.309 -0.869 . . . . 0.0 108.774 -170.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.3 m -47.64 -63.47 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.036 0.835 . . . . 0.0 111.317 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -56.03 -55.72 29.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.264 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -58.98 -45.91 89.4 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.137 0.975 . . . . 0.0 111.65 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.5 m -53.64 -50.5 65.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.499 0.719 . . . . 0.0 110.281 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -44.04 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.568 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.5 -51.87 57.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 109.749 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.78 -54.47 34.78 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.259 0.933 . . . . 0.0 112.112 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -60.6 -54.51 44.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.012 -0.699 . . . . 0.0 110.897 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.57 -42.36 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.54 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.55 -23.52 14.26 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.325 -0.708 . . . . 0.0 113.718 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -81.91 -18.87 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.966 1.383 . . . . 0.0 112.283 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.94 131.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.781 1.628 . . . . 0.0 111.292 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -68.68 91.71 0.45 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.37 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.28 -18.34 1.52 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.329 -171.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.91 146.05 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 117.858 0.829 . . . . 0.0 109.587 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -106.21 -44.99 4.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.811 1.645 . . . . 0.0 110.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.58 168.69 26.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 tt -158.35 139.36 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -136.72 86.82 2.24 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.634 1.574 . . . . 0.0 111.039 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.62 97.19 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 109.366 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.0 m -75.66 165.46 25.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -131.56 -46.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.849 0.859 . . . . 0.0 109.622 -173.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.42 -57.21 12.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.044 1.338 . . . . 0.0 109.423 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -88.05 12.77 12.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.088 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 35.98 58.41 0.94 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.355 2.262 . . . . 0.0 113.19 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.78 140.02 31.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.479 -0.763 . . . . 0.0 108.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -121.71 112.72 18.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.882 1.273 . . . . 0.0 109.793 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.449 ' C ' HD12 ' A' ' 45' ' ' ILE . 31.6 m -87.94 126.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 107.873 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 44' ' ' THR . 3.5 mp -121.87 127.97 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.1 110.46 32.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -138.83 167.66 21.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -168.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -103.46 108.87 60.64 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 123.901 0.881 . . . . 0.0 111.01 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.35 76.84 2.18 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.043 3.162 . . . . 0.0 110.674 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -179.09 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.161 2.184 . . . . 0.0 107.846 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.04 -49.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.35 162.28 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.708 1.603 . . . . 0.0 108.244 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -124.67 163.2 22.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 111.973 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.9 t -47.79 -41.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 C-N-CA 123.368 0.667 . . . . 0.0 111.079 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.04 -43.28 87.99 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.21 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -53.23 -51.32 62.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.925 1.239 . . . . 0.0 109.043 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.1 mmt -51.28 -67.28 0.26 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.09 -55.82 26.78 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.06 -1.025 . . . . 0.0 112.876 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -49.76 -49.39 48.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.2 -41.86 94.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 118.619 -1.233 . . . . 0.0 112.674 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.5 -65.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 O-C-N 121.669 -0.644 . . . . 0.0 110.431 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -49.41 -34.65 16.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.458 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.34 -32.63 62.68 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.939 1.245 . . . . 0.0 112.621 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 16.9 mmt -58.96 -41.92 88.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.473 0.579 . . . . 0.0 110.706 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.37 -19.45 3.61 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.634 1.111 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -75.41 114.95 40.9 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.955 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.61 144.88 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.507 1.471 . . . . 0.0 108.969 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.76 135.02 25.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.021 0.438 . . . . 0.0 111.91 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -108.21 78.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.873 1.669 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -56.08 109.36 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.207 1.803 . . . . 0.0 110.335 165.039 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -155.82 55.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.72 137.78 13.59 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.04 78.72 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -103.53 174.54 5.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.505 0.722 . . . . 0.0 109.564 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.32 140.53 6.91 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.443 ' HE ' ' C ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.182 0 C-N-CA 128.058 2.543 . . . . 0.0 105.347 -174.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -133.78 176.18 8.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 108.882 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.74 140.14 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 125.744 1.618 . . . . 0.0 107.932 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 46' ' ' VAL . 37.3 t -89.45 119.35 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.306 1.042 . . . . 0.0 108.404 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm? -95.07 125.1 39.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.84 120.21 41.13 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mtt -118.17 127.0 53.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.419 1.088 . . . . 0.0 108.59 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.11 130.57 36.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.62 138.42 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -104.81 146.58 28.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.967 0.507 . . . . 0.0 109.703 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.3 -36.68 3.97 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.586 0.612 . . . . 0.0 113.346 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 mtp -65.92 94.72 0.23 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.822 0.811 . . . . 0.0 110.357 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -119.72 53.92 1.03 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.267 1.427 . . . . 0.0 108.42 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -171.31 157.49 5.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.453 0.701 . . . . 0.0 109.114 -169.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -27.62 60.6 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.664 167.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -57.16 -69.87 0.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.272 0.629 . . . . 0.0 112.025 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -59.11 -48.08 82.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.159 0.436 . . . . 0.0 110.736 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -50.27 -56.72 9.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.824 0.85 . . . . 0.0 110.621 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 t -57.82 -47.18 83.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.602 0.761 . . . . 0.0 111.454 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.7 m -55.2 -48.06 74.38 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 110.944 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 66' ' ' PHE . 27.5 mt -62.41 -49.42 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 124.194 0.998 . . . . 0.0 108.993 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -46.71 -50.39 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.058 0.943 . . . . 0.0 109.979 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.29 -59.11 11.4 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.022 0.82 . . . . 0.0 112.125 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.79 -57.78 10.98 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.681 0.753 . . . . 0.0 109.776 -174.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.99 -32.03 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.88 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.82 -32.45 25.94 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.754 -0.591 . . . . 0.0 112.419 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.07 4.53 41.72 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 117.906 0.853 . . . . 0.0 112.208 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 152.87 44.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 120.522 1.51 . . . . 0.0 110.102 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -83.45 134.69 34.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 18.87 11.13 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.99 0.805 . . . . 0.0 112.559 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.3 t -122.94 143.93 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.173 1.389 . . . . 0.0 109.757 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.87 -30.42 9.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.286 0.634 . . . . 0.0 112.016 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -160.55 167.27 27.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.874 1.269 . . . . 0.0 108.07 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 tt -155.07 142.13 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.73 151.4 45.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.633 1.573 . . . . 0.0 109.245 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.0 t -140.56 143.51 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.089 0.859 . . . . 0.0 109.546 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 m -112.59 167.99 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.515 1.926 . . . . 0.0 109.297 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.82 -56.98 1.92 Allowed 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.282 1.033 . . . . 0.0 109.239 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.4 -58.2 3.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.977 1.311 . . . . 0.0 111.118 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -91.72 13.38 18.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.277 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 32.15 68.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.795 3.238 . . . . 0.0 112.723 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -136.86 147.85 46.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.067 0.947 . . . . 0.0 109.842 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.34 133.92 50.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.331 1.852 . . . . 0.0 109.665 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 45' ' ' ILE . 38.4 m -112.4 114.28 26.92 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 128.672 2.789 . . . . 0.0 108.66 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.543 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -118.87 113.57 42.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 4' ' ' VAL . 3.0 t -100.04 91.5 2.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.04 13.62 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.717 0.807 . . . . 0.0 113.033 -166.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -102.28 111.14 64.15 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.044 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.9 67.57 3.17 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.974 3.116 . . . . 0.0 109.969 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.43 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.145 1.378 . . . . 0.0 108.702 -173.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.4 -42.18 37.24 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.33 0.252 . . . . 0.0 110.846 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.7 165.15 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 124.402 1.081 . . . . 0.0 108.474 -175.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -110.49 158.31 18.65 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.024 1.329 . . . . 0.0 112.056 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -51.09 -46.16 31.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 C-N-CA 124.069 0.948 . . . . 0.0 111.506 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.68 -38.21 84.18 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.174 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -52.0 65.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 120.739 1.609 . . . . 0.0 108.176 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.0 mmt -49.8 -63.14 1.2 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -59.05 -56.19 25.47 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.066 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -43.04 -52.46 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.539 1.135 . . . . 0.0 109.727 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -63.26 -42.19 99.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.39 -62.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 O-C-N 121.838 -0.539 . . . . 0.0 110.174 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -42.77 -41.96 3.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 112.273 171.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.79 -31.9 50.6 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.027 0.831 . . . . 0.0 113.215 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.43 -41.73 90.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.408 0.549 . . . . 0.0 110.84 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.19 -17.89 3.34 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.784 1.183 . . . . 0.0 111.202 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 21' ' ' ILE . 48.3 m-85 -80.78 113.3 39.08 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.77 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.32 149.6 90.81 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 108.682 -1.315 . . . . 0.0 108.682 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.91 137.32 26.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.281 0.233 . . . . 0.0 111.052 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -107.28 74.9 0.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.7 p -62.57 103.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.107 1.363 . . . . 0.0 110.298 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -154.57 55.65 0.68 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.458 0.647 . . . . 0.0 112.125 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 5' ' ' LEU . 3.2 mmtp -158.14 149.78 21.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.19 81.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.29 90.06 4.95 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 170.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.52 35.0 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.764 1.626 . . . . 0.0 109.501 -173.776 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.92 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.51 145.41 37.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -162.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 m -107.61 129.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -170.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.7 122.63 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 72' ' ' LYS . 3.3 mm? -107.31 130.35 54.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -115.78 119.43 35.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.1 122.4 35.65 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.081 1.352 . . . . 0.0 108.804 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -70.07 138.6 52.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 172.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.86 143.7 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.26 152.0 19.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.31 -37.0 1.99 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.419 0.533 . . . . 0.0 114.268 166.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.5 mtp -70.6 80.47 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.274 1.037 . . . . 0.0 111.319 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.63 24.51 12.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.771 1.228 . . . . 0.0 111.924 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 p -161.03 166.68 27.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.162 0.982 . . . . 0.0 111.45 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -63.79 168.93 4.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.362 168.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 80.05 -64.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.646 1.178 . . . . 0.0 109.864 -172.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 m -60.11 -59.01 6.1 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.995 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CG1' ' A' ' 36' ' ' VAL . 16.5 p -49.61 -63.15 1.19 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.665 1.186 . . . . 0.0 110.287 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -53.22 -40.74 64.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 111.51 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.7 m -59.98 -49.27 78.34 Favored 'General case' 0 N--CA 1.457 -0.086 0 O-C-N 121.621 -0.675 . . . . 0.0 109.837 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.58 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.99 -53.9 36.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.641 0.776 . . . . 0.0 110.506 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -52.23 52.62 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.219 0.914 . . . . 0.0 111.788 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.17 -58.33 8.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -66.26 -29.37 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.887 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.83 -30.84 7.22 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.736 0.684 . . . . 0.0 113.236 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -89.93 6.95 39.79 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.515 1.158 . . . . 0.0 112.354 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.16 152.35 44.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.516 -1.365 . . . . 0.0 111.982 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -96.28 84.87 3.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.114 1.365 . . . . 0.0 109.575 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.69 -4.87 0.8 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 115.407 0.923 . . . . 0.0 115.407 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.23 134.68 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.058 0.943 . . . . 0.0 108.876 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.64 -34.14 12.71 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 111.319 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.3 165.95 32.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.91 145.44 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 103.233 -2.877 . . . . 0.0 103.233 -171.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -142.34 150.72 41.13 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.886 1.274 . . . . 0.0 109.589 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG1' HG22 ' A' ' 18' ' ' THR . 21.9 t -140.39 106.72 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.977 0.808 . . . . 0.0 110.181 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -94.73 80.88 3.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.12 1.368 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -48.01 -41.05 24.5 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.574 0.75 . . . . 0.0 112.371 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.31 -56.33 5.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.093 1.757 . . . . 0.0 110.692 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -100.27 22.83 10.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.955 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 34.19 57.65 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.043 2.537 . . . . 0.0 113.285 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 39.2 tt0 -138.06 131.18 30.23 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.24 147.26 28.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.514 1.526 . . . . 0.0 110.031 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.3 m -124.68 120.12 30.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.307 2.643 . . . . 0.0 106.985 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -121.04 124.92 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.0 t -113.98 97.31 5.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 118.298 0.499 . . . . 0.0 110.443 -176.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -117.75 169.02 9.92 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.341 0.657 . . . . 0.0 112.682 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.91 114.17 61.88 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.209 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.57 77.08 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.532 2.821 . . . . 0.0 111.57 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -177.23 -43.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 127.66 2.384 . . . . 0.0 108.279 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.15 -47.59 27.77 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.4 176.27 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.33 1.452 . . . . 0.0 107.749 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.2 p -143.12 165.99 25.9 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.894 0.77 . . . . 0.0 111.114 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.53 -34.26 28.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 C-N-CA 122.964 0.506 . . . . 0.0 111.953 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -62.06 -42.6 99.36 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.662 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.71 -52.8 62.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.1 mtp -47.34 -59.9 2.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.176 0.591 . . . . 0.0 111.626 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -62.09 -52.88 62.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -47.92 -50.06 28.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.806 0.73 . . . . 0.0 109.241 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -61.4 -49.27 77.58 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.28 -63.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.805 -0.56 . . . . 0.0 110.514 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -45.94 -39.15 8.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.754 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.63 60.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.736 1.153 . . . . 0.0 113.044 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.0 mmt -56.61 -39.43 73.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.51 0.596 . . . . 0.0 110.843 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.87 -17.98 4.33 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.333 1.444 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -78.47 115.22 49.73 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 123.856 0.862 . . . . 0.0 110.213 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -66.83 141.55 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.07 138.03 39.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.646 0.378 . . . . 0.0 111.506 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.09 78.73 1.2 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.733 0.813 . . . . 0.0 109.276 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.6 p -65.07 104.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.841 1.656 . . . . 0.0 110.42 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -156.18 58.48 0.58 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.634 0.731 . . . . 0.0 112.524 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.655 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -156.36 132.06 9.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 tp -130.89 63.98 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -84.47 127.69 34.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.607 0.717 . . . . 0.0 109.098 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.06 81.97 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.249 1.028 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 163.151 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.25 160.65 0.76 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.108 1.763 . . . . 0.0 110.91 164.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.91 131.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.91 0.884 . . . . 0.0 109.771 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.24 123.64 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.584 1.554 . . . . 0.0 106.888 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.563 HD22 ' CG2' ' A' ' 70' ' ' VAL . 19.7 mt -93.08 128.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 159.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -110.24 127.65 55.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.438 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 13.1 ptm -140.71 132.06 26.73 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -75.87 138.84 41.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 m -124.85 150.7 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.39 150.04 31.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.203 0.456 . . . . 0.0 110.339 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.37 -33.1 1.57 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.666 0.651 . . . . 0.0 113.865 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.9 mtp -67.3 78.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.932 0.893 . . . . 0.0 111.916 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -134.07 43.55 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.392 1.077 . . . . 0.0 110.16 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -161.25 151.25 17.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.476 1.11 . . . . 0.0 108.752 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -75.03 55.83 0.74 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.893 1.277 . . . . 0.0 111.427 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.8 m -136.77 -64.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -60.43 -54.24 47.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.751 0.821 . . . . 0.0 109.737 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 t -45.8 -62.94 1.09 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.535 1.134 . . . . 0.0 110.006 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 t -63.77 -39.13 93.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.989 0.516 . . . . 0.0 109.937 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.0 m -58.82 -49.59 77.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.772 -0.58 . . . . 0.0 110.076 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.6 -50.73 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.258 0.481 . . . . 0.0 109.939 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -44.41 -54.57 5.77 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.499 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.68 -57.39 20.12 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.796 0.712 . . . . 0.0 112.04 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -58.63 -54.46 46.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.42 0.628 . . . . 0.0 110.155 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.72 -38.29 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.99 0.916 . . . . 0.0 110.159 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.73 18.94 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.856 -0.527 . . . . 0.0 112.24 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -73.47 -13.82 61.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.18 140.78 47.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 120.266 1.394 . . . . 0.0 112.31 -169.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -69.51 80.17 0.4 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.015 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.31 -19.32 0.23 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.43 133.55 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -31.17 13.01 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.042 0.537 . . . . 0.0 111.485 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -154.36 161.05 41.97 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -156.07 137.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -138.51 153.13 48.75 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.289 1.036 . . . . 0.0 110.148 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.0 t -138.18 111.74 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -87.7 69.54 9.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.658 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -48.34 -42.49 31.49 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.498 0.499 . . . . 0.0 110.624 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -56.33 5.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.711 2.004 . . . . 0.0 111.102 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -98.56 22.35 9.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.062 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 44.13 53.74 6.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.706 2.002 . . . . 0.0 112.782 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.28 147.79 49.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.453 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 148.93 48.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.383 1.873 . . . . 0.0 109.626 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -129.36 116.69 19.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.461 2.704 . . . . 0.0 107.064 -171.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 mm -123.17 110.41 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.57 94.64 3.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -171.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -111.91 167.8 10.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.311 0.577 . . . . 0.0 112.084 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -110.12 113.64 56.62 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.671 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.13 77.11 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.434 2.756 . . . . 0.0 111.176 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -177.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 128.018 2.527 . . . . 0.0 107.954 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.13 -48.55 17.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.39 176.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.514 1.526 . . . . 0.0 108.316 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.1 p -142.62 162.0 36.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.544 0.738 . . . . 0.0 111.502 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG22 HD21 ' A' ' 5' ' ' LEU . 21.1 t -44.08 -45.61 2.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 125.452 1.501 . . . . 0.0 111.681 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -54.99 39.0 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-O 117.146 -1.407 . . . . 0.0 109.035 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -46.47 -55.33 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 110.437 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.0 mmt -46.21 -56.92 5.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.814 0.734 . . . . 0.0 111.713 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -62.84 -61.57 2.31 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.212 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -40.35 -52.14 2.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.961 1.704 . . . . 0.0 109.156 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -61.98 -47.37 85.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.98 -64.73 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.83 -0.544 . . . . 0.0 111.089 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -43.98 -40.05 4.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.69 0.796 . . . . 0.0 112.692 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.72 -32.41 59.62 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.326 0.966 . . . . 0.0 112.861 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.8 mmt -57.81 -41.81 82.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.368 0.531 . . . . 0.0 110.293 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.53 -19.05 2.81 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.622 1.106 . . . . 0.0 111.093 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -78.08 119.27 76.71 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.008 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.91 145.51 80.31 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.575 -1.356 . . . . 0.0 108.575 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.69 135.99 26.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.609 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -99.18 82.82 2.76 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD22 ' A' ' 5' ' ' LEU . 2.4 p -70.07 105.58 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.069 1.347 . . . . 0.0 110.444 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -155.31 58.98 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 5' ' ' LEU . 34.9 mttm -153.71 154.01 33.31 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 159.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.59 78.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 163.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -92.33 114.74 27.37 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.06 -155.14 15.32 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 129.772 3.229 . . . . 0.0 107.909 168.762 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.174 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 78.69 108.85 0.07 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.977 1.711 . . . . 0.0 109.728 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.99 136.29 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.933 0.893 . . . . 0.0 109.23 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.485 HG23 HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -90.76 134.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.322 1.449 . . . . 0.0 108.655 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 47' ' ' TYR . 6.1 mp -122.15 151.63 40.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 165.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -120.24 123.03 42.22 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -124.01 129.53 51.07 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.138 1.375 . . . . 0.0 108.345 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 120.85 29.47 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.389 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.86 125.12 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 124.228 0.955 . . . . 0.0 109.347 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -87.64 152.49 22.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.394 0.677 . . . . 0.0 109.264 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.82 -46.18 1.23 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.518 0.58 . . . . 0.0 112.87 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mtp -70.01 82.64 0.49 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.807 0.804 . . . . 0.0 111.924 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.8 m -133.61 -9.07 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.703 1.601 . . . . 0.0 112.22 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 p -80.8 -17.38 51.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.444 1.498 . . . . 0.0 113.55 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 m80 84.45 -31.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.267 2.227 . . . . 0.0 112.262 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -62.26 -65.76 0.64 Allowed 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -50.88 -48.5 60.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 111.83 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -48.0 -62.32 1.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 109.754 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -59.35 -47.17 86.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.486 1.114 . . . . 0.0 110.84 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.9 m -52.15 -50.09 62.44 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.706 0.803 . . . . 0.0 110.877 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.9 -47.8 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 123.807 0.843 . . . . 0.0 109.447 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -44.67 -52.73 7.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.038 0.935 . . . . 0.0 110.079 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.54 8.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.979 0.8 . . . . 0.0 112.683 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -50.71 70.76 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 121.508 0.67 . . . . 0.0 109.984 -171.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.36 -41.22 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.774 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.78 -34.46 21.87 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.319 0.485 . . . . 0.0 112.518 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -71.14 -7.93 50.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.796 0.838 . . . . 0.0 113.095 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.6 144.77 45.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 120.656 1.571 . . . . 0.0 111.689 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -81.73 61.19 5.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.16 22.45 0.02 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.57 150.52 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -111.77 -40.35 4.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.02 0.928 . . . . 0.0 109.387 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -159.97 164.86 32.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 tt -157.67 141.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 103.903 -2.628 . . . . 0.0 103.903 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -143.04 144.72 32.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.628 1.171 . . . . 0.0 110.119 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.64 131.74 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.174 0.897 . . . . 0.0 110.505 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -113.88 94.28 4.76 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.227 1.811 . . . . 0.0 109.733 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.32 91.22 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.058 -0.401 . . . . 0.0 112.075 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.83 -57.18 6.8 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.791 1.237 . . . . 0.0 111.049 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -95.2 20.62 8.92 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.742 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 30.81 67.35 0.12 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.776 2.43 . . . . 0.0 113.185 -169.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -131.35 157.64 42.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.626 1.17 . . . . 0.0 109.742 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.17 149.88 50.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.663 1.185 . . . . 0.0 109.698 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 m -127.66 121.3 30.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.424 2.689 . . . . 0.0 106.463 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 mm -128.4 118.87 48.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 4' ' ' VAL . 1.7 t -121.66 105.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.202 -170.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 5' ' ' LEU . 35.2 p90 -137.58 176.18 8.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.549 -0.72 . . . . 0.0 112.122 -168.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.7 108.26 61.14 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.307 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.82 71.89 4.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 3.307 . . . . 0.0 110.264 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -173.23 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.559 1.944 . . . . 0.0 108.656 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.09 -42.05 11.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.497 0.319 . . . . 0.0 111.297 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.23 160.62 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 125.334 1.453 . . . . 0.0 108.211 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -119.93 168.83 10.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.191 0.996 . . . . 0.0 112.153 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.82 -42.5 18.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.842 0.457 . . . . 0.0 110.699 166.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.95 -46.58 71.03 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.747 -171.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.35 -58.09 4.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.779 1.172 . . . . 0.0 109.359 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.0 mmt -48.17 -66.79 0.34 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.801 0.441 . . . . 0.0 111.746 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -60.41 -58.94 6.35 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 121.129 -0.982 . . . . 0.0 112.263 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -41.44 -50.23 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.45 1.023 . . . . 0.0 109.353 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -65.65 -42.64 91.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.17 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.79 -62.8 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 119.067 0.849 . . . . 0.0 110.883 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -41.67 -40.74 2.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.934 0.894 . . . . 0.0 112.372 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -31.46 44.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.9 -39.63 78.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.371 0.668 . . . . 0.0 110.631 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.6 3.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.823 1.201 . . . . 0.0 111.307 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.06 112.08 42.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.478 1.111 . . . . 0.0 110.393 -169.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.47 128.05 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.795 1.663 . . . . 0.0 109.699 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.7 139.04 53.61 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.864 0.866 . . . . 0.0 111.687 -174.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -111.7 76.83 1.0 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.514 0.726 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 70' ' ' VAL . 8.5 p -68.76 103.15 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.8 1.64 . . . . 0.0 110.73 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.09 57.0 0.59 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 112.787 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.498 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 1.3 mmtt -158.7 139.79 13.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -137.88 80.93 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -85.13 175.88 8.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.281 0.562 . . . . 0.0 110.666 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.41 -78.89 1.42 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.691 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.862 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -120.07 169.14 10.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.091 2.156 . . . . 0.0 111.03 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -136.82 140.49 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.502 1.521 . . . . 0.0 107.729 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.22 129.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.57 142.82 43.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -128.69 116.76 20.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.494 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 7.1 ptp -113.42 131.71 55.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.524 0.729 . . . . 0.0 109.566 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -68.01 137.84 55.4 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 165.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 m -121.74 151.96 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -118.22 145.7 44.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.2 -41.45 2.41 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.813 0.721 . . . . 0.0 112.554 171.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -56.56 115.19 2.38 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.12 0.96 . . . . 0.0 110.498 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 13' ' ' THR . 17.9 m -148.33 39.35 0.9 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.248 1.019 . . . . 0.0 108.362 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -152.53 158.03 41.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -67.19 -19.21 65.53 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.456 0.473 . . . . 0.0 111.928 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.89 -58.1 9.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.34 -52.53 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.675 0.39 . . . . 0.0 110.879 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -54.83 -55.94 24.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -57.05 -45.14 83.42 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.467 0.707 . . . . 0.0 111.196 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -54.6 -50.48 67.95 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.277 -0.889 . . . . 0.0 110.915 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.43 -48.23 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -46.16 -53.59 10.17 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.013 1.325 . . . . 0.0 109.804 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.77 -59.34 9.93 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.102 0.858 . . . . 0.0 111.286 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -55.6 -61.22 2.49 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.601 0.7 . . . . 0.0 110.884 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.69 -47.46 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.752 0.821 . . . . 0.0 109.365 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.41 -40.92 39.68 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -73.68 -9.6 58.83 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.858 0.863 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mt -85.52 132.18 34.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.942 1.246 . . . . 0.0 110.198 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.33 134.95 55.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.62 -20.41 4.9 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.421 0.534 . . . . 0.0 112.466 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.3 141.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.876 1.271 . . . . 0.0 110.392 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -30.77 10.62 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 111.707 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -164.52 168.81 17.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -158.5 143.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -144.85 93.69 2.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 0.0 112.014 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.2 105.36 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.246 0.618 . . . . 0.0 111.188 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -96.68 125.39 41.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.218 1.007 . . . . 0.0 111.402 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -44.64 18.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.978 0.511 . . . . 0.0 110.25 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -61.58 2.06 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 126.142 1.777 . . . . 0.0 110.622 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -91.87 18.61 7.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.863 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.2 62.7 0.29 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.371 2.668 . . . . 0.0 112.234 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.91 124.33 18.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.64 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.38 112.84 25.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.31 1.444 . . . . 0.0 109.839 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -83.76 132.01 34.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.007 1.323 . . . . 0.0 107.753 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -131.07 124.98 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.6 109.02 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.448 0.567 . . . . 0.0 110.442 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -129.67 166.8 19.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -165.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -101.3 106.4 45.21 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 109.758 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.61 81.32 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.625 2.884 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 175.21 -42.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.493 2.317 . . . . 0.0 107.802 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.26 -56.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 167.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.171 1.389 . . . . 0.0 110.167 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -130.01 166.45 20.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.095 1.358 . . . . 0.0 110.091 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -46.85 -45.44 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.621 1.169 . . . . 0.0 111.536 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.71 -39.06 87.14 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 118.942 -0.551 . . . . 0.0 111.171 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.4 -46.95 88.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.6 mtt -51.78 -60.62 2.96 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 122.521 0.329 . . . . 0.0 111.7 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -55.51 33.05 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.064 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -45.56 -53.56 8.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 109.284 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -59.18 -49.02 79.44 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -71.99 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 110.793 -172.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.96 -37.1 13.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.89 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.44 64.75 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.782 1.174 . . . . 0.0 112.73 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.1 mmt -60.39 -43.72 96.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 110.189 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.93 -17.56 3.63 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.96 1.267 . . . . 0.0 110.953 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -72.26 115.55 40.03 Favored Pre-proline 0 N--CA 1.453 -0.318 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.112 -173.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -69.2 139.48 42.28 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.527 -1.374 . . . . 0.0 108.527 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.23 138.2 41.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.778 0.431 . . . . 0.0 112.04 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -113.22 78.56 1.15 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.442 1.497 . . . . 0.0 109.512 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -50.71 112.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.597 1.159 . . . . 0.0 108.983 161.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.47 59.7 0.63 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 112.398 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.25 159.18 37.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -151.56 55.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.28 67.41 9.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.772 0.829 . . . . 0.0 109.423 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.0 156.7 43.89 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 113.684 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 128.122 2.569 . . . . 0.0 112.25 171.603 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.8 pm0 -66.24 173.92 2.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.571 0.748 . . . . 0.0 110.341 160.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -117.34 132.51 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 127.36 2.264 . . . . 0.0 106.374 162.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.41 130.11 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.646 HD12 ' CG2' ' A' ' 70' ' ' VAL . 2.6 mm? -118.56 143.39 46.8 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 170.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -123.73 117.83 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.9 ptp -123.19 131.76 53.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.283 1.033 . . . . 0.0 109.187 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -83.76 116.22 22.59 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.21 144.69 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -56.94 148.68 20.48 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.399 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.31 40.12 1.72 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.159 0.885 . . . . 0.0 113.527 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 45.4 -140.33 0.37 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 113.205 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -124.64 -41.27 2.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.178 1.391 . . . . 0.0 110.267 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.15 165.47 24.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -55.23 -26.08 37.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.536 0.734 . . . . 0.0 112.623 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.4 m -50.59 -44.21 56.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.756 -0.59 . . . . 0.0 110.465 171.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -66.64 -55.22 16.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.317 0.647 . . . . 0.0 110.09 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.8 p -53.97 -54.38 39.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.4 t -57.41 -45.98 83.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.942 0.897 . . . . 0.0 110.942 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.6 m -57.09 -49.32 76.23 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.632 -0.668 . . . . 0.0 109.974 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.9 mt -56.07 -48.45 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 118.466 0.575 . . . . 0.0 109.756 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -55.83 -50.44 70.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.803 0.841 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -54.94 33.79 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.648 0.642 . . . . 0.0 112.083 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -53.67 -50.63 65.39 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.256 1.022 . . . . 0.0 110.241 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 34' ' ' ILE . 14.1 mm -63.29 -49.13 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 109.75 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.37 -36.15 10.71 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 117.989 0.358 . . . . 0.0 112.314 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -69.06 -15.43 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.29 145.01 35.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.693 1.133 . . . . 0.0 111.736 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.18 65.13 4.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.28 13.67 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -170.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.97 143.71 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 119.456 1.628 . . . . 0.0 110.41 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -108.33 -45.05 3.98 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.503 1.521 . . . . 0.0 109.817 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -163.19 171.12 16.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 25' ' ' ILE . 5.2 tt -159.57 144.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 34.3 mmtt -141.84 84.73 1.9 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.671 0.788 . . . . 0.0 110.742 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.19 105.72 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.573 0.749 . . . . 0.0 110.78 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 m -108.48 135.08 50.36 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.824 0.85 . . . . 0.0 111.031 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -48.05 6.52 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.915 0.486 . . . . 0.0 109.764 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -54.39 27.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.636 1.574 . . . . 0.0 110.25 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -79.23 -0.98 34.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.946 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 49.23 58.09 5.76 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.407 1.883 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.4 130.69 8.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.047 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -110.21 115.53 29.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.258 1.423 . . . . 0.0 108.996 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 35' ' ' LYS . 53.4 m -90.14 133.85 34.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 107.309 169.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.66 129.93 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -117.92 106.6 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -127.16 165.22 19.98 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 122.062 -0.399 . . . . 0.0 111.564 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.65 123.05 62.9 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.36 145.67 92.88 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.609 1.539 . . . . 0.0 108.676 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 87.27 -23.02 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.693 1.597 . . . . 0.0 111.824 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.46 -47.36 8.4 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.719 1.145 . . . . 0.0 110.929 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -137.91 158.02 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.639 1.576 . . . . 0.0 108.448 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -114.24 169.92 8.68 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.854 0.862 . . . . 0.0 111.053 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.92 -41.1 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.481 0.712 . . . . 0.0 111.482 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.46 -53.21 51.86 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -171.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -37.3 -60.47 0.66 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.079 1.752 . . . . 0.0 111.486 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 15.4 mtm -48.77 -64.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -59.05 5.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.869 -173.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -36.12 -55.35 0.78 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.006 1.323 . . . . 0.0 111.11 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -60.85 -43.01 98.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.363 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -65.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -37.62 -46.26 0.84 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.177 0.991 . . . . 0.0 112.363 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.87 -32.04 60.4 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.6 mmt -60.32 -39.91 88.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.366 0.53 . . . . 0.0 110.643 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.66 -11.63 3.44 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.512 1.053 . . . . 0.0 111.281 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -90.14 110.47 40.6 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.039 0.936 . . . . 0.0 109.151 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.61 132.82 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.844 1.696 . . . . 0.0 109.301 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.28 49.08 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.003 0.921 . . . . 0.0 111.423 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -117.38 79.07 1.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.845 0.858 . . . . 0.0 109.438 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.646 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.1 p -63.62 108.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.025 1.73 . . . . 0.0 110.95 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -154.29 59.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.203 1.002 . . . . 0.0 113.239 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.525 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -159.23 159.86 34.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 120.803 -1.186 . . . . 0.0 108.166 178.509 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.1 tp -155.46 55.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 122.29 1.043 . . . . 0.0 109.377 -177.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.33 69.93 10.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -172.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.9 17.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.854 1.216 . . . . 0.0 113.503 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 165.055 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.127 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.94 179.3 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.613 0.706 . . . . 0.0 110.592 172.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.31 141.46 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 125.467 1.507 . . . . 0.0 107.889 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.42 122.62 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 72' ' ' LYS . 15.0 mt -100.09 141.83 32.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 168.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 72' ' ' LYS . 16.8 tptt -119.12 125.49 49.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -124.34 119.12 28.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.378 1.471 . . . . 0.0 108.955 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 120.76 22.95 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m -105.68 152.56 7.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -116.12 150.48 37.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.168 0.44 . . . . 0.0 110.786 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.97 -30.23 2.07 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.533 0.587 . . . . 0.0 114.079 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtp -68.93 85.38 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.016 0.908 . . . . 0.0 111.669 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -114.92 6.97 15.52 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.761 1.224 . . . . 0.0 112.232 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -129.12 139.74 51.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.317 0.962 . . . . 0.0 111.236 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -31.51 54.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.363 1.065 . . . . 0.0 111.962 -171.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -45.81 -55.1 7.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.329 1.052 . . . . 0.0 111.709 170.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.86 -54.6 28.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.315 0.507 . . . . 0.0 109.847 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -51.68 -54.96 22.42 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.637 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.6 t -57.85 -46.09 85.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.473 0.579 . . . . 0.0 111.346 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.8 m -56.81 -50.91 70.95 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.368 -0.833 . . . . 0.0 110.843 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.77 -43.9 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.97 -47.88 76.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.917 0.887 . . . . 0.0 110.658 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.88 41.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.825 0.726 . . . . 0.0 111.321 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -65.62 -59.91 3.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.433 0.635 . . . . 0.0 110.946 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.75 -30.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.009 0.924 . . . . 0.0 110.388 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.69 -29.31 7.71 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.498 -0.612 . . . . 0.0 112.764 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -92.43 7.9 41.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.494 1.147 . . . . 0.0 112.77 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.44 159.5 33.13 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.413 1.46 . . . . 0.0 111.656 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.36 82.97 2.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.471 1.508 . . . . 0.0 109.725 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.08 11.79 0.26 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.4 128.6 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 109.599 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -86.22 -36.63 19.32 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -154.23 168.24 27.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 122.201 1.0 . . . . 0.0 108.656 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -157.42 141.6 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -140.61 82.49 1.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 0.0 110.432 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.13 116.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.515 0.726 . . . . 0.0 109.111 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -97.33 -174.23 2.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -147.52 -47.8 0.17 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.23 1.012 . . . . 0.0 109.533 179.137 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.59 -55.83 7.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.514 1.525 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -94.04 19.19 9.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.56 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 36.52 61.48 0.82 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.35 2.26 . . . . 0.0 112.445 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.14 154.55 37.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.184 -0.947 . . . . 0.0 108.758 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.64 130.04 31.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.104 0.962 . . . . 0.0 109.877 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.8 m -92.85 132.75 36.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.743 1.617 . . . . 0.0 107.038 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.3 125.56 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 170.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.33 119.42 50.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.98 161.04 38.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -98.91 116.17 65.42 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.531 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.94 73.13 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.583 2.855 . . . . 0.0 110.546 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -174.73 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 109.744 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.27 -42.88 18.26 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.146 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.27 159.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -119.57 168.68 10.77 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.113 0.869 . . . . 0.0 112.139 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -44.03 -50.33 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.289 1.435 . . . . 0.0 111.209 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -42.68 86.92 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.71 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -48.6 -52.7 21.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.512 1.505 . . . . 0.0 108.663 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -61.64 2.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 121.38 -0.128 . . . . 0.0 111.236 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -58.24 9.14 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.569 -0.707 . . . . 0.0 112.266 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.43 -49.83 24.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.103 0.961 . . . . 0.0 109.458 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.28 -44.28 96.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.896 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.03 -63.87 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 123.166 0.587 . . . . 0.0 110.538 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -43.23 -41.41 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.468 0.707 . . . . 0.0 112.671 172.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.97 -31.26 50.12 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.044 0.838 . . . . 0.0 113.007 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.1 mmt -57.02 -41.65 78.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.372 0.533 . . . . 0.0 111.064 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 -20.79 2.53 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.531 1.062 . . . . 0.0 111.057 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -84.77 110.51 28.32 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 124.24 1.016 . . . . 0.0 110.068 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.82 139.21 61.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.78 134.58 26.82 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.6 72.14 1.54 Allowed 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.172 0.589 . . . . 0.0 110.371 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.55 94.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.012 1.325 . . . . 0.0 112.548 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -158.51 84.32 0.84 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.005 -0.434 . . . . 0.0 110.083 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -158.16 160.43 37.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 158.69 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mp -139.09 73.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.8 176.08 6.77 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.73 157.74 27.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.233 -1.841 . . . . 0.0 107.017 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.75 -173.95 1.65 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.326 1.45 . . . . 0.0 109.29 158.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 140.91 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 46' ' ' VAL . 18.4 t -103.59 127.45 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.274 1.43 . . . . 0.0 107.473 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 70' ' ' VAL . 1.9 pp -112.23 152.02 28.92 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -122.0 121.36 36.85 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.0 mtt -102.31 139.46 37.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -83.93 134.5 34.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 163.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.89 143.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 119.581 1.082 . . . . 0.0 108.819 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -114.58 140.87 48.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.82 -34.61 5.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.83 1.205 . . . . 0.0 112.922 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.0 mtm -69.19 95.33 0.75 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.059 0.93 . . . . 0.0 111.527 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -111.05 27.24 9.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.376 1.07 . . . . 0.0 112.886 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -151.04 159.74 44.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.282 0.947 . . . . 0.0 109.219 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -76.1 -12.66 60.15 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 m -62.76 -54.46 38.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.23 -51.68 65.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.771 0.26 . . . . 0.0 110.775 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p -52.69 -59.34 4.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 109.912 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -57.52 -44.3 84.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.938 0.895 . . . . 0.0 111.258 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.6 m -55.45 -48.69 74.1 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.364 -0.835 . . . . 0.0 110.751 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.34 -50.03 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 122.003 -0.435 . . . . 0.0 109.989 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -46.6 -49.56 18.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.511 1.124 . . . . 0.0 109.684 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -59.11 11.34 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.348 0.975 . . . . 0.0 112.398 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -55.23 37.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.725 0.763 . . . . 0.0 110.294 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.3 mm -70.83 -32.48 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.76 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.19 20.3 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.46 -0.775 . . . . 0.0 112.792 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -79.13 -3.6 46.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.312 1.056 . . . . 0.0 112.552 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.76 134.08 48.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.302 1.41 . . . . 0.0 111.265 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -77.26 115.71 17.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.29 -9.19 5.93 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.21 0.91 . . . . 0.0 111.904 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.45 150.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.28 0.632 . . . . 0.0 109.818 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -109.54 -40.4 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.647 1.579 . . . . 0.0 109.081 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -162.31 172.25 15.97 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.32 1.057 . . . . 0.0 108.741 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -156.46 143.23 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -142.61 146.76 34.86 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.659 1.583 . . . . 0.0 109.419 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -136.23 146.22 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.616 1.098 . . . . 0.0 109.793 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 m -124.68 148.46 47.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 127.494 2.318 . . . . 0.0 109.636 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.0 -56.91 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.87 1.668 . . . . 0.0 110.946 -171.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.03 -58.68 4.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.682 1.593 . . . . 0.0 110.484 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -85.15 0.29 52.19 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 41.23 70.99 0.22 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.737 2.815 . . . . 0.0 110.762 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -140.29 145.61 37.48 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.984 -163.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.75 113.15 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.628 1.571 . . . . 0.0 109.721 -168.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 45' ' ' ILE . 39.7 m -89.2 118.7 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.505 2.722 . . . . 0.0 109.574 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 ' C ' ' A' ' 44' ' ' THR . 2.9 mp -121.71 124.71 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -118.27 104.78 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -138.05 167.52 21.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 111.797 -167.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -101.79 107.82 53.53 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 123.931 0.892 . . . . 0.0 109.377 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.68 83.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.153 2.569 . . . . 0.0 110.51 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.3 m80 176.54 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 128.132 2.573 . . . . 0.0 107.765 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.65 -51.46 10.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.595 0.236 . . . . 0.0 110.756 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tp -134.34 177.13 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.471 1.509 . . . . 0.0 107.648 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.1 p -136.57 171.97 13.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.602 0.637 . . . . 0.0 110.609 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.2 t -48.33 -35.28 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.043 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -47.41 62.62 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.934 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.95 -51.34 70.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.693 1.197 . . . . 0.0 108.241 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.9 mmt -47.27 -59.81 2.93 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.23 -58.98 6.07 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.14 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 -50.91 9.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.424 1.09 . . . . 0.0 108.692 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -63.44 -45.63 90.01 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.166 0.291 . . . . 0.0 111.311 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.1 -66.62 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.149 0.58 . . . . 0.0 111.213 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -45.3 -38.79 5.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.941 0.791 . . . . 0.0 111.918 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.71 62.14 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.629 1.104 . . . . 0.0 113.123 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.5 mmt -54.93 -41.03 70.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.544 0.611 . . . . 0.0 110.546 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -18.86 3.28 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.52 1.057 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.14 113.58 34.73 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.998 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.37 136.78 44.71 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 N-CA-C 108.965 -1.206 . . . . 0.0 108.965 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 131.71 45.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.875 0.845 . . . . 0.0 112.088 -176.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -103.81 77.51 1.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.836 2.054 . . . . 0.0 109.115 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 5' ' ' LEU . 14.4 p -62.61 107.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.738 0.815 . . . . 0.0 110.634 171.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -155.58 55.46 0.62 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -157.35 157.32 33.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 tp -147.69 56.88 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -82.51 60.4 5.13 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.235 -0.915 . . . . 0.0 109.806 -172.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -46.96 108.72 0.3 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.015 -0.993 . . . . 0.0 111.771 -160.215 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -154.68 176.56 12.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.876 0.87 . . . . 0.0 108.737 -152.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 47' ' ' TYR . 12.9 p -87.36 112.99 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.83 128.13 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 70' ' ' VAL . 3.5 mm? -116.82 123.11 46.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -100.15 118.61 36.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -118.0 125.14 49.81 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.361 1.464 . . . . 0.0 108.654 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -70.83 138.08 50.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.1 m -129.74 139.2 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -101.26 150.31 23.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 -40.54 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.327 -0.707 . . . . 0.0 113.779 166.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.4 mtm -62.79 86.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.393 1.097 . . . . 0.0 110.934 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 m -148.19 47.75 1.06 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.732 1.613 . . . . 0.0 108.243 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 p -128.74 -4.66 5.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.093 1.757 . . . . 0.0 111.578 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 66.08 -25.69 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.431 1.493 . . . . 0.0 114.082 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -67.5 -75.15 0.1 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.075 -1.015 . . . . 0.0 111.181 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -44.02 -53.9 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.156 1.783 . . . . 0.0 112.254 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -50.54 -50.7 52.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.688 0.795 . . . . 0.0 111.025 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -65.74 -44.1 86.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.143 0.577 . . . . 0.0 110.494 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 m -50.87 -52.63 39.83 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.696 -0.628 . . . . 0.0 110.313 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -44.74 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 119.196 -0.431 . . . . 0.0 110.665 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.13 -49.05 75.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.327 0.512 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.64 -54.49 30.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.593 0.615 . . . . 0.0 111.806 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -60.72 -55.03 38.04 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.97 -0.724 . . . . 0.0 110.769 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.16 -43.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.143 1.377 . . . . 0.0 109.804 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.07 -29.78 6.9 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.773 0.701 . . . . 0.0 113.961 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -87.87 -12.95 43.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.802 1.301 . . . . 0.0 112.532 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.34 130.78 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.394 1.452 . . . . 0.0 111.866 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.66 90.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.587 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.24 -26.01 0.88 Allowed Glycine 0 C--N 1.331 0.296 0 O-C-N 121.996 -0.44 . . . . 0.0 112.617 -173.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.92 147.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 117.573 0.686 . . . . 0.0 110.249 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -125.19 -31.98 3.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.335 1.054 . . . . 0.0 111.688 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.41 163.43 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -158.85 140.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -144.42 85.31 1.78 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.006 0.922 . . . . 0.0 110.49 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.75 114.99 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -94.53 165.24 12.63 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -47.67 2.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.601 0.76 . . . . 0.0 109.945 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -55.95 13.3 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.178 1.391 . . . . 0.0 110.852 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -90.56 13.37 16.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.873 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 38.5 58.67 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.964 2.105 . . . . 0.0 112.685 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 30.9 tt0 -145.95 142.28 28.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.46 123.7 34.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.522 1.129 . . . . 0.0 110.193 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 m -94.89 127.68 41.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.152 1.381 . . . . 0.0 107.687 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.41 126.11 70.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.9 112.03 34.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.345 0.52 . . . . 0.0 110.659 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' O ' HG12 ' A' ' 3' ' ' VAL . 32.6 p90 -132.56 168.99 17.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.423 0.63 . . . . 0.0 112.155 -173.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -90.97 113.06 56.84 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 124.629 1.172 . . . . 0.0 109.203 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -74.71 76.89 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.821 2.347 . . . . 0.0 110.873 -170.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -176.01 -47.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.158 2.183 . . . . 0.0 108.305 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.15 -43.83 41.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.334 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.71 169.49 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 108.002 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -138.37 164.79 28.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 111.14 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 70' ' ' VAL . 93.9 t -43.33 -47.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 124.34 1.056 . . . . 0.0 110.899 170.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -49.48 77.32 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.745 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.23 -49.55 73.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.1 1.318 . . . . 0.0 109.415 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.2 -60.95 2.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.132 0.424 . . . . 0.0 111.421 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -57.08 -64.08 1.0 Allowed 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.758 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.26 -52.29 2.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.818 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.61 -39.03 88.16 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.89 -63.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 O-C-N 121.734 -0.604 . . . . 0.0 111.056 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -43.8 -39.26 3.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.56 0.744 . . . . 0.0 112.16 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.06 42.18 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.212 0.915 . . . . 0.0 113.164 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -61.7 -36.44 80.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.466 0.575 . . . . 0.0 111.107 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.26 -11.19 5.85 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.862 1.22 . . . . 0.0 111.263 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -84.65 114.76 57.21 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.274 1.029 . . . . 0.0 109.455 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -67.96 140.21 49.54 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.327 1.351 . . . . 0.0 108.598 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.66 140.12 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.696 0.399 . . . . 0.0 111.377 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -112.89 73.93 0.84 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.683 1.193 . . . . 0.0 110.185 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 5' ' ' LEU . 8.9 p -65.98 103.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.329 1.852 . . . . 0.0 111.813 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -157.29 54.62 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -159.05 80.71 0.77 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.963 -1.085 . . . . 0.0 111.075 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 59.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.725 1.21 . . . . 0.0 109.409 -172.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.85 64.28 5.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 135.69 50.25 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.632 -0.667 . . . . 0.0 112.637 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.721 -1.133 . . . . 0.0 109.391 -178.107 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.69 158.74 26.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.806 1.642 . . . . 0.0 109.568 152.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.95 143.79 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.777 1.631 . . . . 0.0 107.722 163.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.14 143.91 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 124.551 1.14 . . . . 0.0 108.125 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' CD1' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -129.08 117.49 20.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -100.28 125.17 46.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mtt -121.05 119.93 33.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.202 1.001 . . . . 0.0 109.141 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.1 mptp? -73.4 121.96 21.31 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.23 149.66 13.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -114.76 148.01 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.86 -33.02 3.6 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.541 1.067 . . . . 0.0 113.048 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.7 mtp -69.09 75.69 0.33 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 112.91 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 m -142.26 58.2 1.46 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.588 1.155 . . . . 0.0 111.096 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.85 16.83 0.77 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.07 0.548 . . . . 0.0 111.832 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.7 m80 68.8 -35.39 0.3 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.928 1.691 . . . . 0.0 113.357 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -59.84 -51.76 68.36 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.399 1.479 . . . . 0.0 110.874 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -63.56 -60.3 3.51 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.114 0.566 . . . . 0.0 110.655 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -43.8 -58.14 2.89 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.399 1.08 . . . . 0.0 110.327 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -67.04 -43.46 82.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -55.34 -47.07 76.27 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.635 -0.666 . . . . 0.0 110.516 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.75 -48.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.74 -51.32 22.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.292 0.637 . . . . 0.0 109.835 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.24 -58.8 12.64 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.551 0.595 . . . . 0.0 112.334 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -61.28 -60.25 4.03 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.763 0.792 . . . . 0.0 109.741 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -66.37 -27.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.542 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -44.92 -37.35 5.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.59 0.614 . . . . 0.0 112.84 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -88.09 4.13 46.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.989 0.895 . . . . 0.0 112.719 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.28 153.09 43.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 120.292 -1.505 . . . . 0.0 110.374 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -87.07 141.11 28.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.77 11.5 55.02 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.017 0.817 . . . . 0.0 112.783 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -104.59 147.39 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.112 1.365 . . . . 0.0 109.541 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -109.73 -46.47 3.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.615 1.566 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.47 169.62 21.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.0 133.84 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 48.3 mmtt -137.76 154.46 49.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.154 1.381 . . . . 0.0 108.456 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.23 110.32 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -82.01 75.78 8.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 0.0 108.659 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.48 -41.72 9.83 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.476 0.71 . . . . 0.0 110.606 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.42 -56.75 4.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.441 1.497 . . . . 0.0 111.378 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.92 13.71 25.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.008 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.22 60.74 3.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.74 2.016 . . . . 0.0 111.288 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 10.2 tt0 -143.92 132.5 22.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.486 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.16 135.14 40.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.87 1.668 . . . . 0.0 109.465 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.4 m -114.12 81.9 1.61 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.169 2.588 . . . . 0.0 107.684 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.08 127.82 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.26 107.63 20.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 110.416 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' HG23 ' A' ' 54' ' ' VAL . 12.9 p90 -134.57 173.46 11.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.656 -0.652 . . . . 0.0 111.925 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -106.76 106.98 59.5 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.629 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.32 76.28 1.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.202 3.268 . . . . 0.0 110.937 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.74 -43.21 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.627 1.971 . . . . 0.0 108.295 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.62 -42.34 18.35 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.21 169.39 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -120.24 155.54 33.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.461 1.104 . . . . 0.0 111.068 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG23 ' OH ' ' A' ' 47' ' ' TYR . 3.5 t -39.03 -49.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.469 1.108 . . . . 0.0 110.958 164.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -62.75 -46.75 86.6 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.788 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.11 -49.41 73.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.904 1.684 . . . . 0.0 108.53 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.26 -60.27 3.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -59.78 -56.94 15.55 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.82 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.73 -51.09 16.95 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.751 0.82 . . . . 0.0 108.947 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -60.52 -44.66 95.79 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.617 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.94 -65.15 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 122.979 0.512 . . . . 0.0 110.508 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -44.34 -40.21 5.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 118.929 0.786 . . . . 0.0 112.557 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.2 60.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.276 0.944 . . . . 0.0 113.336 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.6 mmt -52.04 -41.76 62.57 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.583 0.629 . . . . 0.0 110.513 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.38 -19.31 2.45 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.45 1.024 . . . . 0.0 111.085 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -83.73 117.52 68.89 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.052 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.84 137.32 52.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 108.721 -1.299 . . . . 0.0 108.721 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.28 47.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.733 0.813 . . . . 0.0 110.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.93 86.22 2.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 5' ' ' LEU . 3.1 t -58.45 107.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.98 1.312 . . . . 0.0 109.825 165.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -159.02 56.87 0.42 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 143.23 14.79 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.72 69.25 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -81.62 101.2 9.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.17 -61.24 4.36 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.236 -173.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.068 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -53.64 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.615 2.366 . . . . 0.0 113.423 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.43 130.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.134 1.374 . . . . 0.0 107.805 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.14 115.82 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 125.14 1.376 . . . . 0.0 109.274 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' LEU . 1.7 pp -90.51 138.39 31.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -113.85 126.08 54.79 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.41 ' SD ' HD11 ' A' ' 5' ' ' LEU . 13.7 ptm -132.24 128.24 37.46 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.922 0.889 . . . . 0.0 110.115 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.0 mptp? -78.13 131.15 37.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 148.08 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.431 1.014 . . . . 0.0 109.011 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -105.97 146.52 29.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -32.52 7.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.692 1.139 . . . . 0.0 113.227 169.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.9 mtt -75.46 74.25 2.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.501 1.15 . . . . 0.0 112.442 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.2 m -106.44 39.94 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.789 1.236 . . . . 0.0 109.8 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.0 p -160.0 168.68 25.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.06 -8.06 57.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.104 0.561 . . . . 0.0 112.026 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -73.71 -64.6 0.96 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.734 0.697 . . . . 0.0 110.894 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 m -55.41 -55.27 33.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.419 0.628 . . . . 0.0 110.306 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -48.58 -56.0 9.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.818 1.247 . . . . 0.0 110.346 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.4 t -63.58 -45.19 91.55 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.982 0.513 . . . . 0.0 110.7 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -53.66 -49.47 67.87 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.815 -0.553 . . . . 0.0 110.419 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -62.78 -48.07 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 O-C-N 121.99 -0.444 . . . . 0.0 110.116 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.85 -47.64 64.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.18 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.35 25.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.489 1.042 . . . . 0.0 111.741 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -58.32 -57.29 13.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.776 0.798 . . . . 0.0 110.166 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.32 -30.38 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.13 0.972 . . . . 0.0 110.389 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.04 -31.92 8.67 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.62 0.629 . . . . 0.0 112.704 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -84.82 -1.85 56.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.192 0.996 . . . . 0.0 112.733 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.44 149.83 46.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 120.724 1.602 . . . . 0.0 110.346 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -87.29 127.86 35.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.04 14.81 9.65 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.331 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.94 137.96 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.615 1.166 . . . . 0.0 109.452 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 -31.52 10.16 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.106 0.562 . . . . 0.0 111.88 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.99 162.27 40.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 tt -155.9 138.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -140.78 136.18 32.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.437 1.095 . . . . 0.0 110.132 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.17 139.87 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.5 1.046 . . . . 0.0 110.289 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -128.5 127.38 42.33 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.134 1.774 . . . . 0.0 109.644 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.05 -47.1 12.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.933 0.893 . . . . 0.0 111.881 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.48 -58.51 6.87 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.994 1.317 . . . . 0.0 110.356 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.11 4.97 27.92 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.594 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 0.2 OUTLIER 36.22 67.34 0.31 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.317 2.647 . . . . 0.0 113.561 -177.515 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 3.0 tt0 -143.51 141.19 30.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.758 -170.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.33 148.57 43.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 109.752 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -128.14 118.92 24.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.964 3.306 . . . . 0.0 105.43 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -121.99 120.46 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.85 96.14 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 123.789 0.68 . . . . 0.0 109.227 -174.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -123.42 160.74 26.2 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.651 0.781 . . . . 0.0 111.724 -166.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -99.92 116.24 64.85 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.505 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.92 75.56 2.18 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.663 2.909 . . . . 0.0 111.66 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -176.08 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 127.08 2.152 . . . . 0.0 108.238 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.94 -47.09 26.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.86 172.66 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.976 1.31 . . . . 0.0 108.191 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -138.44 158.61 43.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.608 1.163 . . . . 0.0 110.274 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -41.09 -47.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 111.02 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -40.88 94.4 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.818 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -50.74 72.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 61.9 mmm -54.02 -62.98 1.3 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.408 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -55.79 -56.07 24.85 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.342 -0.849 . . . . 0.0 111.817 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -52.81 -46.13 67.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -42.23 93.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.789 177.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.01 -64.95 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 O-C-N 121.679 -0.638 . . . . 0.0 109.929 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -46.62 -37.76 8.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 119.003 0.82 . . . . 0.0 113.16 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.22 57.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.611 1.096 . . . . 0.0 113.004 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.0 mmt -53.52 -43.7 68.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.434 0.561 . . . . 0.0 110.577 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.82 -23.84 2.13 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.232 0.92 . . . . 0.0 111.289 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -75.39 113.38 25.41 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.033 -171.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.99 138.58 53.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.244 1.296 . . . . 0.0 109.081 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 140.41 43.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.299 0.571 . . . . 0.0 111.812 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -112.19 76.21 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.406 ' HA ' ' HB3' ' A' ' 7' ' ' MET . 1.9 p -62.01 109.38 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.293 1.037 . . . . 0.0 108.227 168.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.58 53.66 0.67 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 3.7 mtpt -155.53 162.87 40.6 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.551 1.54 . . . . 0.0 107.122 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.1 tp -153.82 60.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.574 1.149 . . . . 0.0 108.02 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -80.0 175.47 10.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.02 160.95 24.79 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 0.0 110.048 -178.471 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.03 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.2 158.15 29.53 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.428 1.114 . . . . 0.0 108.161 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.7 t -141.25 146.96 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.419 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.05 141.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.615 1.166 . . . . 0.0 108.28 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 70' ' ' VAL . 3.1 tm? -128.16 120.73 27.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.61 127.25 54.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptp -119.36 124.57 46.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 127.312 2.245 . . . . 0.0 108.837 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 4.6 tptt -72.66 136.56 45.67 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 9.3 m -121.11 157.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.075 0.852 . . . . 0.0 110.48 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -116.71 153.73 31.85 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.853 0.461 . . . . 0.0 110.572 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 -38.91 2.25 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.125 0.869 . . . . 0.0 112.866 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -58.97 93.36 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.049 0.94 . . . . 0.0 110.739 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -141.84 47.45 1.64 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.832 1.253 . . . . 0.0 108.901 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.5 p -155.16 159.46 40.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 164.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -24.81 64.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 123.108 0.255 . . . . 0.0 111.46 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -57.43 -54.94 41.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.417 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.9 m -56.41 -57.16 13.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.117 0.417 . . . . 0.0 110.244 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -55.61 -53.77 52.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.936 0.495 . . . . 0.0 110.318 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 t -61.38 -41.03 96.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.521 0.728 . . . . 0.0 111.288 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 m -59.87 -48.11 83.02 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.109 -0.995 . . . . 0.0 110.445 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.0 mt -59.31 -52.25 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 123.849 0.859 . . . . 0.0 108.72 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.99 -46.08 71.63 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.598 0.759 . . . . 0.0 110.705 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.87 -49.28 72.14 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.24 0.924 . . . . 0.0 111.874 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -59.31 5.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.087 0.943 . . . . 0.0 110.759 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 mm -63.65 -30.38 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.78 1.232 . . . . 0.0 110.755 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.29 -31.66 4.79 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.738 0.685 . . . . 0.0 113.001 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -91.21 2.94 55.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.156 0.982 . . . . 0.0 112.453 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.64 133.11 46.38 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 120.549 1.522 . . . . 0.0 111.201 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -77.55 65.14 3.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 22.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 116.547 1.379 . . . . 0.0 116.547 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.4 154.41 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 117.77 0.785 . . . . 0.0 110.31 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -115.75 -42.21 3.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.616 1.567 . . . . 0.0 109.771 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.06 172.35 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.41 140.59 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -141.56 86.2 1.99 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.0 0.92 . . . . 0.0 112.38 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -89.71 112.63 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.528 -0.733 . . . . 0.0 109.944 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -91.55 176.02 6.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.933 0.893 . . . . 0.0 109.456 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -139.05 -47.25 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.247 1.019 . . . . 0.0 110.292 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.43 -59.27 3.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.895 1.678 . . . . 0.0 110.442 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -88.6 9.5 23.82 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.82 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.58 64.93 1.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.532 1.933 . . . . 0.0 111.034 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.73 152.21 39.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.763 0.825 . . . . 0.0 109.044 -165.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.77 123.65 15.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.387 0.613 . . . . 0.0 110.427 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.46 132.5 43.85 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.274 1.83 . . . . 0.0 107.847 171.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mm -129.62 127.49 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.65 118.4 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -141.04 174.81 10.16 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -165.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -109.17 109.02 60.69 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.875 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.48 77.62 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.833 3.022 . . . . 0.0 110.92 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -178.17 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.299 2.64 . . . . 0.0 107.74 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.4 mt -77.98 -46.6 20.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.688 0.222 . . . . 0.0 111.348 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.44 161.45 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -125.61 162.56 24.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.019 0.928 . . . . 0.0 111.181 -171.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 70' ' ' VAL . 30.7 t -50.03 -43.96 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.232 1.013 . . . . 0.0 111.286 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.47 -37.7 87.62 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.139 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.54 -58.42 8.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.368 1.44 . . . . 0.0 108.387 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.9 mtt -43.55 -60.13 1.88 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER -64.16 -53.61 46.74 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.132 -175.22 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.0 -55.68 3.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.434 1.47 . . . . 0.0 109.576 172.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -59.86 -47.73 84.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.923 0.392 . . . . 0.0 111.243 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.07 -63.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.452 0.701 . . . . 0.0 111.086 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -45.29 -39.24 6.36 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.879 0.763 . . . . 0.0 111.915 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.75 56.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.529 1.059 . . . . 0.0 112.84 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.4 mmt -57.56 -44.38 85.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.321 0.51 . . . . 0.0 110.812 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.44 -16.67 4.07 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.842 1.21 . . . . 0.0 111.023 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -77.42 115.83 52.73 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.547 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.47 144.67 80.38 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.39 132.47 24.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.896 0.855 . . . . 0.0 110.943 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.02 69.94 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.944 2.498 . . . . 0.0 108.851 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -62.01 107.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.831 0.852 . . . . 0.0 110.118 172.07 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -156.8 54.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.34 67.44 0.46 Allowed 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.235 -0.915 . . . . 0.0 111.092 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.8 tp -78.79 69.22 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.236 0.614 . . . . 0.0 109.439 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.68 132.29 53.49 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.831 . . . . 0.0 110.082 -172.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 164.52 41.71 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 117.253 -1.356 . . . . 0.0 110.682 168.88 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 CA-C-O 118.263 -1.298 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 40.48 78.69 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.054 1.341 . . . . 0.0 113.405 166.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.03 130.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.717 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.0 124.74 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 108.112 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.9 mm? -115.83 127.87 55.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -113.18 126.21 55.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.8 mtt -113.54 125.9 54.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.278 1.831 . . . . 0.0 107.895 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 126.14 30.21 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.57 154.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -120.09 153.47 36.08 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.373 0.669 . . . . 0.0 109.723 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.67 47.83 65.79 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.703 168.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.9 mtm -143.46 109.64 5.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.12 26.36 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.164 1.386 . . . . 0.0 110.859 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -112.66 -4.97 14.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.535 1.534 . . . . 0.0 112.101 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 72.71 -46.99 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.52 1.528 . . . . 0.0 111.625 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -49.61 -55.64 12.86 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.617 0.767 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.83 -54.53 40.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.637 0.653 . . . . 0.0 111.374 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -53.34 -54.6 34.18 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.661 0.384 . . . . 0.0 110.084 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.64 -44.18 93.59 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.083 0.553 . . . . 0.0 111.222 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.6 m -59.81 -46.58 88.8 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.446 -0.784 . . . . 0.0 110.197 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 66' ' ' PHE . 3.8 mt -58.86 -50.78 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.03 -49.98 59.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.325 0.65 . . . . 0.0 110.832 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.6 -53.64 40.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.685 0.659 . . . . 0.0 111.693 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -64.67 -56.39 14.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.624 0.726 . . . . 0.0 110.288 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -68.86 -34.69 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.704 0.802 . . . . 0.0 110.339 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.45 -27.88 26.83 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.83 -0.544 . . . . 0.0 112.6 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -90.38 3.45 53.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.117 0.959 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.84 142.76 49.6 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.223 1.374 . . . . 0.0 110.211 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.2 133.5 37.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.92 -8.37 36.38 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 123.594 0.616 . . . . 0.0 112.146 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.18 149.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.578 0.751 . . . . 0.0 109.596 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -108.16 -48.24 3.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.623 1.569 . . . . 0.0 109.467 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -157.66 169.53 24.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.6 137.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -140.81 92.46 2.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.783 0.833 . . . . 0.0 111.64 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.6 t -97.1 105.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.649 -0.657 . . . . 0.0 110.037 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m -85.06 161.76 19.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.15 0.98 . . . . 0.0 110.16 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.69 -48.16 2.59 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.015 0.526 . . . . 0.0 111.211 172.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.83 -57.68 5.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.507 1.523 . . . . 0.0 110.51 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 22.56 6.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.466 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.286 0.0 OUTLIER 28.15 70.72 0.06 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.143 2.977 . . . . 0.0 113.815 -174.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -138.16 142.34 40.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.204 1.402 . . . . 0.0 108.856 -168.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.06 111.8 15.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.52 1.128 . . . . 0.0 108.99 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -85.62 125.85 33.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mm -124.86 127.62 72.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.19 113.59 43.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -129.94 172.26 11.89 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.09 111.33 62.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 124.69 1.196 . . . . 0.0 108.581 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.82 73.83 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.419 2.746 . . . . 0.0 110.517 -173.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -46.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.74 2.016 . . . . 0.0 109.241 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.27 -44.69 21.21 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 122.602 -0.061 . . . . 0.0 111.136 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -136.09 172.12 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.1 p -133.99 159.28 41.24 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.392 1.077 . . . . 0.0 110.511 -172.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 t -41.93 -48.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 124.671 1.188 . . . . 0.0 111.611 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.05 -44.23 96.44 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.341 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.53 -53.19 55.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.769 1.168 . . . . 0.0 108.803 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 12.5 mtm -51.3 -60.3 3.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.23 0.468 . . . . 0.0 112.204 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.36 -55.29 36.92 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.391 -0.818 . . . . 0.0 111.939 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -45.93 -51.47 13.21 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.917 1.287 . . . . 0.0 109.158 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -60.35 -46.52 89.64 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.663 0.21 . . . . 0.0 111.306 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.35 -66.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.757 0.823 . . . . 0.0 110.491 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -46.56 -37.94 8.74 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.594 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.25 61.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.575 1.079 . . . . 0.0 112.692 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.7 -45.53 85.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.426 0.557 . . . . 0.0 110.523 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.94 -20.42 2.51 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.349 0.976 . . . . 0.0 111.209 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 21' ' ' ILE . 59.8 m-85 -77.21 113.75 33.85 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 118.223 -0.894 . . . . 0.0 109.803 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 137.15 41.37 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.26 1.307 . . . . 0.0 108.714 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.91 132.87 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.264 0.554 . . . . 0.0 111.156 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.41 75.04 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.923 1.289 . . . . 0.0 108.718 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 5' ' ' LEU . 13.5 p -65.22 103.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.952 1.301 . . . . 0.0 110.796 172.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -157.13 58.51 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' O ' HD13 ' A' ' 5' ' ' LEU . 4.4 tptm -155.82 136.69 13.54 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.47 83.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.41 70.26 1.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.355 0.598 . . . . 0.0 109.676 -171.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.1 -172.33 22.82 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.851 -0.531 . . . . 0.0 113.123 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 116.386 -1.768 . . . . 0.0 109.825 164.384 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 106.089 -2.804 . . . . 0.0 106.089 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 56.45 -147.76 0.51 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.095 0.948 . . . . 0.0 112.522 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.26 124.51 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -169.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.88 126.0 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.22 116.53 32.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -98.41 110.12 22.77 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' HD13 ' A' ' 45' ' ' ILE . 2.4 ptp -108.84 123.37 48.95 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.977 0.911 . . . . 0.0 108.748 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.33 151.12 46.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 167.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.1 157.06 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.0 145.94 47.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.87 -30.62 8.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.379 0.99 . . . . 0.0 112.956 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.0 94.14 0.47 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.086 0.943 . . . . 0.0 110.399 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.8 m -128.67 44.5 2.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.976 0.91 . . . . 0.0 109.011 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.41 155.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 107.865 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -72.92 -21.97 60.81 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -53.42 -61.02 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.149 0.979 . . . . 0.0 111.708 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.5 m -59.75 -51.57 69.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.649 0.738 . . . . 0.0 109.966 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -53.72 -56.35 18.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.971 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 t -56.11 -46.35 79.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.931 0.892 . . . . 0.0 111.824 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 m -54.73 -50.66 67.82 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.24 -46.44 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.07 -45.76 71.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.474 0.71 . . . . 0.0 111.191 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.18 -56.7 22.86 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.804 0.716 . . . . 0.0 111.673 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.97 -57.34 13.27 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.094 -0.651 . . . . 0.0 111.146 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 34' ' ' ILE . 43.5 mm -59.45 -43.5 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.068 0.947 . . . . 0.0 110.468 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.94 -33.7 21.48 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 117.985 0.357 . . . . 0.0 112.403 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.85 -4.13 59.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.281 1.032 . . . . 0.0 112.74 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.99 137.51 34.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 120.201 1.364 . . . . 0.0 111.104 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -71.76 123.2 22.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.297 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.23 -2.39 9.7 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.11 0.862 . . . . 0.0 112.592 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.52 159.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.457 0.703 . . . . 0.0 110.796 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -117.58 -47.6 2.62 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -165.26 168.66 16.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 25' ' ' ILE . 12.4 tt -156.78 143.12 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -142.06 98.3 3.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.875 1.67 . . . . 0.0 111.586 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.72 126.76 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.169 0.587 . . . . 0.0 111.534 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -117.04 140.14 49.85 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.676 1.19 . . . . 0.0 110.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 -45.53 9.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.037 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.16 -62.35 1.69 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.687 1.595 . . . . 0.0 110.439 -171.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.78 14.75 11.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.426 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.4 58.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.743 2.817 . . . . 0.0 113.746 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 28.4 tt0 -132.1 138.26 48.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.081 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.51 119.17 32.18 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.824 1.65 . . . . 0.0 109.233 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.9 m -96.28 112.88 24.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.551 1.54 . . . . 0.0 108.712 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -116.23 119.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.43 117.79 54.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.54 165.42 27.53 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -94.32 111.65 54.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 126.949 2.099 . . . . 0.0 110.947 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.73 73.84 3.46 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.183 2.588 . . . . 0.0 111.995 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -173.98 -46.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.144 2.178 . . . . 0.0 108.525 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.26 -42.46 68.75 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -176.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -142.4 153.01 43.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.379 0.672 . . . . 0.0 109.948 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -38.1 -49.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 124.987 1.315 . . . . 0.0 111.028 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.37 -46.64 87.74 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.059 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -50.71 66.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.976 1.716 . . . . 0.0 108.056 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -53.14 -59.08 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.07 -0.394 . . . . 0.0 111.005 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.15 -55.71 30.49 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 120.888 -1.132 . . . . 0.0 112.88 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 -42.43 25.73 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.354 1.062 . . . . 0.0 109.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -66.45 -53.48 35.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.599 0.562 . . . . 0.0 111.944 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.43 -62.71 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.069 -1.019 . . . . 0.0 110.897 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -52.51 -26.17 12.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.04 62.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.961 1.255 . . . . 0.0 112.496 171.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.39 -35.74 72.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.118 0.567 . . . . 0.0 110.656 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.17 -22.18 5.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.683 1.135 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -70.03 116.26 42.34 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 117.283 -1.342 . . . . 0.0 110.276 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.52 151.18 86.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.356 1.371 . . . . 0.0 109.261 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.13 140.49 28.04 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.42 82.23 1.57 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.326 1.051 . . . . 0.0 110.132 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.14 104.66 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.583 1.553 . . . . 0.0 110.946 173.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -157.73 54.16 0.47 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -158.67 104.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -92.06 68.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -81.25 75.83 8.21 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.55 151.05 17.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 C--O 1.254 1.328 0 CA-C-O 116.017 -1.944 . . . . 0.0 106.056 -178.449 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.008 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -49.38 142.71 7.29 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.647 1.179 . . . . 0.0 109.028 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.76 133.34 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 123.574 0.75 . . . . 0.0 109.218 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 46' ' ' VAL . 1.4 p -82.1 116.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.304 1.442 . . . . 0.0 108.094 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 5' ' ' LEU . 5.0 tt -96.86 120.56 37.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.35 118.76 34.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -113.77 138.92 49.59 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.403 1.481 . . . . 0.0 108.746 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.43 155.47 40.09 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 155.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -138.13 142.64 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -97.75 151.5 20.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.88 -34.78 2.11 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.707 -0.621 . . . . 0.0 114.209 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.33 91.49 0.08 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.007 0.903 . . . . 0.0 111.746 -173.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 m -146.38 61.22 1.23 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.421 1.488 . . . . 0.0 109.587 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.6 p -162.04 157.41 23.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 166.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -78.27 54.44 1.39 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.703 0.401 . . . . 0.0 110.103 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.89 -64.07 0.59 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -56.19 -56.67 18.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.052 0.387 . . . . 0.0 110.79 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -51.53 -55.36 19.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.006 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.87 -42.84 94.58 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.77 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.1 m -56.01 -52.01 65.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -48.27 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.229 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -55.63 -48.87 74.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.117 0.871 . . . . 0.0 110.582 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.47 -52.97 37.82 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.516 0.579 . . . . 0.0 111.665 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -65.95 -61.24 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.548 0.689 . . . . 0.0 110.655 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.69 -32.68 59.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 124.589 1.156 . . . . 0.0 110.422 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.89 -30.67 9.42 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.867 -0.521 . . . . 0.0 112.6 169.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -93.77 10.4 33.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.314 1.046 . . . . 0.0 112.217 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.03 151.87 44.14 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.243 1.383 . . . . 0.0 111.623 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -92.56 81.66 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.949 1.3 . . . . 0.0 110.614 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.93 -13.59 1.13 Allowed Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.914 -0.491 . . . . 0.0 113.899 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.65 151.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -119.08 -35.1 3.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.628 1.171 . . . . 0.0 111.137 173.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -155.42 169.19 24.82 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -156.98 139.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -139.85 90.66 2.41 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.422 1.489 . . . . 0.0 110.534 172.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.86 106.93 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 O-C-N 121.457 -0.777 . . . . 0.0 110.167 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -80.43 178.98 7.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -142.44 -47.37 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 109.534 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.05 -59.03 3.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.903 1.681 . . . . 0.0 110.541 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.14 12.58 17.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.319 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 43.77 62.72 1.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.659 1.984 . . . . 0.0 112.522 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -145.88 151.11 37.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.511 -0.743 . . . . 0.0 109.345 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.92 125.81 18.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 111.149 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 3.4 m -107.55 120.69 42.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.803 2.041 . . . . 0.0 107.964 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 44' ' ' THR . 3.8 mp -122.14 116.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 4' ' ' VAL . 2.1 t -104.82 109.13 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -135.14 170.33 16.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.479 0.657 . . . . 0.0 112.367 -166.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -97.8 110.68 56.45 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.132 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.51 67.06 7.23 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.139 2.56 . . . . 0.0 111.506 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.66 -47.07 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.809 1.244 . . . . 0.0 108.37 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.37 -48.23 73.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.633 0.197 . . . . 0.0 111.198 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tp -134.25 162.83 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.802 1.241 . . . . 0.0 108.196 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 p -121.87 158.64 28.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.747 1.219 . . . . 0.0 110.891 -172.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.73 -48.99 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.386 0 C-N-CA 124.1 0.96 . . . . 0.0 110.881 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.97 -54.13 50.46 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.766 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -45.03 -54.74 6.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.952 1.251 . . . . 0.0 109.365 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -63.11 1.26 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.501 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.39 -61.27 2.45 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -43.07 -51.45 5.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.718 1.207 . . . . 0.0 109.703 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.08 -43.33 95.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.083 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.01 -65.85 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.445 0.698 . . . . 0.0 110.278 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -43.79 -39.27 3.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.507 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.798 1.181 . . . . 0.0 112.958 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.6 mmt -55.37 -40.8 71.76 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.317 0.508 . . . . 0.0 110.841 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.08 -20.16 3.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.587 1.089 . . . . 0.0 110.954 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -75.57 115.7 48.18 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.255 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -66.55 138.48 50.05 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.31 -1.458 . . . . 0.0 108.31 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.47 138.39 38.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.045 0.538 . . . . 0.0 110.595 -175.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -107.05 71.39 0.83 Allowed 'General case' 0 C--N 1.334 -0.066 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.45 105.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 169.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -155.58 55.31 0.62 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 141.26 16.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.43 86.27 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.53 169.47 9.88 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.1 -155.73 15.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.125 0 N-CA-C 102.577 -3.12 . . . . 0.0 102.577 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.77 -176.86 2.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.754 0.822 . . . . 0.0 109.837 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.09 116.0 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.91 124.4 43.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.85 131.86 56.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.06 117.09 30.3 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.3 mtt -116.82 123.57 47.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.913 0.885 . . . . 0.0 110.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.87 129.47 37.95 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.93 151.36 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.032 0.833 . . . . 0.0 109.668 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 140.67 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.28 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.1 -16.06 45.24 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.266 0.936 . . . . 0.0 114.206 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.2 mtp -76.62 75.7 3.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.3 1.05 . . . . 0.0 110.866 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.4 34.42 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.464 1.505 . . . . 0.0 111.334 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 p -154.1 158.7 40.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.516 -0.74 . . . . 0.0 110.404 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -74.9 61.36 1.03 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.306 167.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -145.88 -63.38 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 167.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 m -52.96 -53.59 47.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.298 0.571 . . . . 0.0 109.952 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.4 p -53.04 -70.16 0.1 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.725 1.21 . . . . 0.0 110.742 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 t -51.3 -45.52 62.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.679 1.592 . . . . 0.0 111.506 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -60.26 -44.93 94.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.889 -0.507 . . . . 0.0 109.944 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -49.22 85.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 118.617 0.644 . . . . 0.0 110.189 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -48.58 -51.67 26.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.656 0.662 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.61 -58.33 15.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.87 0.748 . . . . 0.0 112.614 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -64.36 -52.44 58.3 Favored 'General case' 0 C--N 1.338 0.109 0 O-C-N 121.651 -0.911 . . . . 0.0 109.953 -170.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.02 -27.19 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.308 1.043 . . . . 0.0 109.751 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.72 -32.55 32.89 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.986 -1.071 . . . . 0.0 112.492 166.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -84.74 -1.36 56.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.97 154.12 42.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.435 1.471 . . . . 0.0 112.326 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.91 69.4 9.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.01 18.72 0.02 OUTLIER Glycine 0 N--CA 1.467 0.756 0 N-CA-C 115.373 0.909 . . . . 0.0 115.373 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.17 141.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.852 1.326 . . . . 0.0 108.664 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -111.85 -45.06 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.363 0.665 . . . . 0.0 109.94 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.21 166.99 25.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.71 131.86 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 5.6 mmtt -139.24 129.79 25.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.572 1.149 . . . . 0.0 109.695 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.43 98.4 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 119.234 0.925 . . . . 0.0 110.011 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -72.7 74.03 1.09 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.224 1.41 . . . . 0.0 109.464 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -37.39 -49.22 0.99 Allowed 'General case' 0 C--O 1.227 -0.091 0 C-N-CA 126.351 1.86 . . . . 0.0 111.664 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.87 -55.94 8.67 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.103 1.361 . . . . 0.0 111.562 -174.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.65 -2.99 58.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.654 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.29 54.62 9.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.814 2.446 . . . . 0.0 110.443 -173.106 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.19 136.34 54.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 109.543 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.61 106.88 17.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.53 1.932 . . . . 0.0 109.742 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -81.45 87.26 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 129.007 2.923 . . . . 0.0 109.382 170.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.61 125.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.74 99.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.417 0 CA-C-N 119.659 1.118 . . . . 0.0 110.333 -173.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.24 159.97 22.42 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.98 131.04 55.2 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.44 163.6 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.18 1.253 . . . . 0.0 109.091 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 73.62 -42.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -48.93 55.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.609 1.095 . . . . 0.0 111.499 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.78 179.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.412 1.485 . . . . 0.0 108.338 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.0 p -148.8 164.16 35.24 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.527 0.603 . . . . 0.0 111.519 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.9 t -46.15 -45.48 5.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 123.768 0.827 . . . . 0.0 111.284 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -62.53 -42.64 99.65 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.488 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.84 -54.42 45.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.1 mmt -45.27 -65.08 0.58 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -56.64 -57.2 13.4 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.312 -0.868 . . . . 0.0 111.761 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -46.32 -47.44 18.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.956 0.798 . . . . 0.0 109.635 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.32 -42.63 87.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.15 -65.02 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 124.409 1.084 . . . . 0.0 110.044 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.36 -39.83 7.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.304 0.642 . . . . 0.0 111.833 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.5 -33.02 59.08 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.398 0.999 . . . . 0.0 113.344 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmt -58.03 -41.73 83.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.6 0.636 . . . . 0.0 110.506 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.87 -16.68 3.48 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.62 1.105 . . . . 0.0 111.06 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.05 117.01 66.79 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.542 -173.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.68 151.56 85.21 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 N-CA-C 108.901 -1.231 . . . . 0.0 108.901 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.04 139.11 28.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.944 0.498 . . . . 0.0 110.517 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.43 75.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.885 0.874 . . . . 0.0 108.758 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.03 105.54 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.081 0.952 . . . . 0.0 110.756 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -155.74 56.71 0.61 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.44 144.35 20.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.63 64.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.93 91.03 7.5 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.46 -172.09 19.35 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 116.607 -1.664 . . . . 0.0 107.638 173.27 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -177.02 153.3 0.98 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -158.02 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.1 128.27 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 124.252 1.021 . . . . 0.0 108.755 174.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.14 110.94 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.099 1.76 . . . . 0.0 109.816 -178.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.91 117.97 29.93 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.055 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -84.42 126.87 33.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 28.4 mtp -128.51 128.05 43.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.9 25.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.283 0.947 . . . . 0.0 108.553 172.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -90.97 165.44 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -121.07 152.24 38.88 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.18 -33.04 2.24 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.57 -0.706 . . . . 0.0 114.143 165.139 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.1 mtp -65.14 82.74 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.935 0.867 . . . . 0.0 112.024 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -114.34 48.89 1.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.062 1.345 . . . . 0.0 110.482 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -159.4 163.97 35.02 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.571 -0.706 . . . . 0.0 110.834 169.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.91 -35.41 80.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.979 174.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -58.33 -58.04 10.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.576 0.625 . . . . 0.0 111.487 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.2 m -57.76 -57.66 11.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -51.85 -57.1 10.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 110.196 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -59.53 -44.48 93.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.823 0.849 . . . . 0.0 111.302 179.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.9 m -57.26 -48.45 78.85 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.435 -0.791 . . . . 0.0 110.243 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.46 -48.86 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 123.031 0.532 . . . . 0.0 109.578 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.69 -49.73 56.66 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.251 0.62 . . . . 0.0 110.36 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.15 -55.41 28.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.96 0.791 . . . . 0.0 111.532 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -64.0 -55.02 25.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.016 -0.696 . . . . 0.0 110.963 -173.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -67.39 -33.76 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 123.61 0.764 . . . . 0.0 110.13 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.44 -35.63 7.25 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.361 0.505 . . . . 0.0 112.399 171.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -83.48 4.27 28.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.76 139.72 47.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.735 1.607 . . . . 0.0 112.06 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.93 81.83 5.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.726 0.81 . . . . 0.0 111.612 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.19 -8.54 0.79 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.07 152.15 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 117.726 0.763 . . . . 0.0 110.244 175.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -113.58 -37.22 4.67 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.246 1.419 . . . . 0.0 110.333 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -160.57 159.16 30.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 tt -152.8 137.25 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -175.052 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -143.13 150.83 39.98 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.569 1.148 . . . . 0.0 109.754 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.65 128.96 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.613 0.642 . . . . 0.0 109.419 171.127 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -110.69 79.8 1.24 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.739 1.615 . . . . 0.0 108.271 -177.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -41.7 66.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.044 0.537 . . . . 0.0 110.575 -175.429 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.7 -54.72 5.94 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 111.054 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.76 16.62 21.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.029 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 35.66 53.82 0.84 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.354 2.662 . . . . 0.0 113.12 -169.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.72 149.27 37.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.586 1.154 . . . . 0.0 109.704 -177.133 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.4 134.77 49.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.294 1.438 . . . . 0.0 108.823 171.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.8 m -117.34 109.77 17.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.668 2.787 . . . . 0.0 107.011 -173.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mm -119.32 102.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -176.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' GLU . 2.3 t -99.02 107.96 21.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -174.615 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.9 167.3 17.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -100.25 112.17 63.73 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.554 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 69.47 5.84 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.924 3.083 . . . . 0.0 111.533 -170.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.86 -40.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.854 2.462 . . . . 0.0 108.158 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 -45.46 13.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -140.46 158.2 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 107.573 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -106.28 161.97 14.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 112.479 -173.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.17 -39.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 163.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -47.86 81.62 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.15 -178.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.41 -55.14 17.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.022 1.283 . . . . 0.0 109.762 173.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 17.5 mmt -48.5 -63.47 1.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.36 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -57.95 -57.86 10.96 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 121.259 -0.9 . . . . 0.0 112.329 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -46.76 -50.76 17.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.225 1.01 . . . . 0.0 108.31 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -57.92 -48.12 80.85 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.987 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.81 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 118.562 -0.733 . . . . 0.0 111.467 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.87 -35.78 6.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.003 1.274 . . . . 0.0 112.381 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.2 -31.61 61.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.736 1.153 . . . . 0.0 113.155 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.6 mmt -55.05 -41.52 71.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.396 0.544 . . . . 0.0 110.585 172.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.47 -18.95 3.85 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.886 1.232 . . . . 0.0 110.95 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -75.53 117.92 67.01 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.979 -173.273 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.32 140.21 57.58 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.495 -1.386 . . . . 0.0 108.495 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.9 27.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.813 0.816 . . . . 0.0 112.469 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.84 75.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.331 1.052 . . . . 0.0 108.553 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -42.69 104.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 125.029 1.456 . . . . 0.0 109.261 158.739 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -93.67 -179.51 5.04 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 168.08 20.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.882 170.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.3 pt -78.39 151.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.681 0.792 . . . . 0.0 110.106 178.358 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -110.29 100.03 8.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.809 0.844 . . . . 0.0 108.819 170.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.22 143.81 21.33 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 164.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 . . . . . 0 C--O 1.254 1.299 0 CA-C-O 115.923 -1.989 . . . . 0.0 106.073 -178.41 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.78 124.88 17.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.61 123.83 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 109.865 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 46' ' ' VAL . 1.3 p -80.82 105.9 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.808 1.643 . . . . 0.0 109.82 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 109.09 20.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.565 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 1.4 mptm? -87.1 113.16 22.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.49 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.18 125.18 47.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.923 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.4 mptp? -81.02 125.41 30.13 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.78 148.04 11.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -109.9 155.0 22.28 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.37 -46.67 3.59 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.765 -0.584 . . . . 0.0 112.587 169.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.5 mtp -55.26 96.25 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.914 1.286 . . . . 0.0 110.96 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 p -136.6 31.79 2.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 111.776 -174.093 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.16 149.62 26.21 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.668 -0.645 . . . . 0.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -72.33 60.26 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.435 1.494 . . . . 0.0 110.722 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.4 m -142.45 -59.96 0.45 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.235 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.3 m -58.83 -60.94 3.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 110.025 -177.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -53.5 -49.06 68.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.935 -179.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.2 t -66.75 -41.12 88.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 111.104 -175.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 m -59.28 -47.85 83.82 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 176.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -52.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.738 175.503 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.88 -49.06 63.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.228 0.922 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.85 -47.06 91.29 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.865 0.745 . . . . 0.0 112.054 176.211 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -60.59 2.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.245 1.023 . . . . 0.0 110.178 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.93 -33.79 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.654 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.0 -30.59 9.58 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.812 0.72 . . . . 0.0 112.99 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -91.33 6.81 43.84 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.279 1.04 . . . . 0.0 112.359 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.33 151.81 34.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.522 -1.361 . . . . 0.0 112.746 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.62 82.57 4.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 0.0 111.493 -174.474 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.61 -10.31 1.68 Allowed Glycine 0 N--CA 1.462 0.368 0 O-C-N 121.947 -0.47 . . . . 0.0 113.722 -175.571 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.4 t -78.99 142.43 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -102.58 -42.75 5.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.011 1.324 . . . . 0.0 109.524 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 ttm-85 -155.79 165.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.88 135.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -137.88 88.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.189 1.396 . . . . 0.0 111.051 168.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.91 115.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -87.46 -163.16 0.89 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 pt? -155.33 -48.79 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.33 1.052 . . . . 0.0 109.451 173.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -59.07 4.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 110.339 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.82 11.54 15.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.471 -177.415 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 39.65 61.82 1.33 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.121 1.768 . . . . 0.0 112.788 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 26.5 tt0 -139.78 153.03 47.04 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 126.23 38.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.728 1.211 . . . . 0.0 109.061 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.0 m -101.33 117.8 35.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.794 1.637 . . . . 0.0 106.983 174.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -119.72 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.357 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -100.34 102.94 14.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -124.33 173.02 8.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -104.27 111.41 65.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 123.941 0.896 . . . . 0.0 109.92 -177.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.2 76.76 2.97 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.709 2.939 . . . . 0.0 110.321 -172.767 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.54 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.395 1.878 . . . . 0.0 108.369 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.8 -44.12 15.91 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.975 -177.028 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.2 154.17 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.888 1.275 . . . . 0.0 108.47 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -108.59 162.96 13.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.36 1.064 . . . . 0.0 112.244 -173.196 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -48.22 -45.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.481 0.712 . . . . 0.0 110.373 165.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -44.02 92.51 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.878 -175.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -54.59 26.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.529 1.513 . . . . 0.0 109.807 171.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.9 mmt -48.13 -62.53 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.918 0.781 . . . . 0.0 111.868 175.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -62.07 -57.61 10.95 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -176.879 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -47.43 -48.13 26.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 109.25 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -59.39 -48.23 82.45 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.71 174.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.13 -65.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.726 -176.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.98 -30.22 24.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.423 1.01 . . . . 0.0 112.573 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.05 62.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 120.014 1.279 . . . . 0.0 112.845 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.3 mmt -58.44 -40.73 83.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.541 0.609 . . . . 0.0 110.578 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.01 -21.62 3.32 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.537 1.065 . . . . 0.0 110.914 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -73.09 116.76 53.93 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-O 118.345 -0.835 . . . . 0.0 110.14 -173.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.02 141.89 59.74 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.463 1.442 . . . . 0.0 108.679 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.55 134.98 32.93 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -98.29 74.71 2.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.472 1.109 . . . . 0.0 108.309 175.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -36.03 106.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.297 1.623 . . . . 0.0 108.775 154.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 179.93 4.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 168.7 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -78.91 166.42 22.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.267 176.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.21 148.97 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 41.8 mt-10 -106.15 166.41 10.53 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 170.083 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.12 -62.28 0.02 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -164.707 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 143.775 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.423 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.45 171.98 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.823 135.369 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.29 142.29 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 126.15 1.78 . . . . 0.0 108.195 172.479 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.27 132.58 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.024 1.73 . . . . 0.0 107.915 175.186 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.737 HD21 HG23 ' A' ' 70' ' ' VAL . 3.3 tm? -112.61 129.56 56.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 169.099 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -117.96 127.2 53.6 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.433 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 12.5 ptm -139.43 129.3 24.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.117 0.567 . . . . 0.0 109.865 -173.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.06 133.88 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.3 m -118.86 150.53 21.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.451 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -116.15 151.23 36.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.145 0.498 . . . . 0.0 110.761 177.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.03 -34.3 3.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.094 0.854 . . . . 0.0 112.816 173.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -66.53 94.65 0.29 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.633 0.717 . . . . 0.0 111.6 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.692 ' HA ' HD13 ' A' ' 38' ' ' LEU . 36.7 p -126.2 53.28 1.63 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.107 0.963 . . . . 0.0 111.465 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.12 167.51 30.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.697 0.799 . . . . 0.0 109.044 -175.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -84.28 -6.02 59.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.667 0.387 . . . . 0.0 111.486 169.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.1 -74.75 0.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -172.155 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -51.39 -45.24 62.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.097 1.359 . . . . 0.0 111.589 -177.044 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -49.38 -63.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.485 1.514 . . . . 0.0 110.511 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -55.33 -45.37 76.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.906 0.882 . . . . 0.0 111.123 177.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -55.3 -47.94 74.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.244 -0.91 . . . . 0.0 110.994 177.409 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.23 -50.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.139 0.976 . . . . 0.0 109.201 177.059 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -45.39 -53.05 9.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.566 1.146 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.31 -58.32 15.03 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.793 0.711 . . . . 0.0 112.672 174.845 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -56.94 -48.19 78.88 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 121.936 -0.744 . . . . 0.0 110.846 -171.277 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.73 -42.04 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.283 0.633 . . . . 0.0 109.441 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.68 -35.41 23.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.248 0.451 . . . . 0.0 112.412 172.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -63.28 -18.0 63.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.97 142.5 29.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.207 0.912 . . . . 0.0 112.544 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.89 101.43 4.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.364 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.97 -21.54 1.43 Allowed Glycine 0 C--N 1.335 0.511 0 O-C-N 121.554 -0.716 . . . . 0.0 113.274 176.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.96 132.77 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -102.59 -29.55 11.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.995 0.361 . . . . 0.0 111.403 175.808 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -154.08 164.63 38.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 tt -157.92 144.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 103.914 -2.624 . . . . 0.0 103.914 -176.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -144.13 132.41 21.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.893 0.877 . . . . 0.0 111.254 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -125.76 136.55 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.935 1.243 . . . . 0.0 111.701 175.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -122.12 124.36 43.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.204 1.801 . . . . 0.0 110.147 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.01 -51.23 9.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.65 0.78 . . . . 0.0 110.723 -177.557 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -53.03 45.8 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.557 1.143 . . . . 0.0 110.557 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.61 4.11 37.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.48 -177.778 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 38.86 61.56 1.21 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.273 2.629 . . . . 0.0 111.371 -174.888 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -141.85 138.14 31.92 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.734 -0.604 . . . . 0.0 110.903 -173.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.98 30.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.556 1.542 . . . . 0.0 110.003 172.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.6 m -121.71 125.51 46.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.706 3.602 . . . . 0.0 104.928 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.44 119.71 54.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.81 96.68 4.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -172.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.64 168.47 12.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.709 0.766 . . . . 0.0 111.989 -170.076 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -97.02 115.29 65.68 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.048 1.339 . . . . 0.0 108.514 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.9 72.3 3.94 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.879 2.386 . . . . 0.0 111.909 -174.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -46.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.304 1.442 . . . . 0.0 108.295 172.345 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.32 -48.92 66.17 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 119.643 -0.218 . . . . 0.0 111.36 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 177.81 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.825 1.25 . . . . 0.0 109.334 -174.205 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.1 p -141.51 160.12 40.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.347 1.059 . . . . 0.0 111.244 -174.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 5' ' ' LEU . 18.4 t -40.22 -49.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.705 1.202 . . . . 0.0 111.771 171.117 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -58.53 -52.09 67.13 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 118.255 -0.878 . . . . 0.0 108.937 -171.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -46.47 -53.13 11.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.939 1.696 . . . . 0.0 109.799 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.2 mmt -51.17 -58.32 6.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.951 -0.468 . . . . 0.0 111.823 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -59.4 -60.32 4.04 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.082 -1.011 . . . . 0.0 112.455 177.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.97 -40.5 4.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 109.252 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -52.9 15.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 170.468 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -62.9 -60.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 120.095 1.316 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.91 -36.52 5.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.893 0.77 . . . . 0.0 112.081 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.92 65.85 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.249 0.931 . . . . 0.0 113.368 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -55.51 -38.95 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.965 0.348 . . . . 0.0 110.331 173.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.26 -16.06 4.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.822 1.201 . . . . 0.0 110.805 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -75.55 114.35 35.28 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.492 -174.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.01 141.75 65.48 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 108.266 -1.475 . . . . 0.0 108.266 176.046 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.28 35.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.44 80.1 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.215 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.737 HG23 HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -65.18 107.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.061 1.744 . . . . 0.0 109.694 168.011 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -157.09 59.7 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.12 153.02 30.19 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 163.446 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.33 78.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -101.32 179.86 4.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.665 1.186 . . . . 0.0 109.214 177.374 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.19 -124.44 3.09 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.621 0.629 . . . . 0.0 111.563 -175.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 mmt-85 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.922 -1.513 . . . . 0.0 109.728 168.709 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.21 156.48 37.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.593 1.157 . . . . 0.0 109.403 172.112 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.73 131.36 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 109.01 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 46' ' ' VAL . 2.6 p -90.82 120.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 125.277 1.431 . . . . 0.0 110.119 -177.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.574 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm? -106.73 125.39 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -108.13 115.62 30.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -175.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.0 mtt -115.16 119.28 35.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.45 1.1 . . . . 0.0 108.458 -174.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -72.03 126.52 29.98 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.63 150.45 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.07 153.05 28.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.651 0.594 . . . . 0.0 109.795 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.46 3.43 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.631 -0.539 . . . . 0.0 112.401 172.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.5 mtm -55.06 96.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.703 0.752 . . . . 0.0 111.665 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 p -132.03 18.35 4.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 110.978 -177.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -137.87 163.07 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -72.61 -17.2 61.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.461 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -60.24 3.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.3 0.5 . . . . 0.0 109.779 -177.205 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.5 m -57.86 -55.02 40.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -57.97 -50.03 74.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.215 -174.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -57.85 -46.15 85.22 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.911 0.778 . . . . 0.0 110.988 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.5 m -54.37 -51.28 65.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.638 0.654 . . . . 0.0 110.336 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.08 -47.61 80.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.251 0.932 . . . . 0.0 110.319 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.49 -55.4 27.16 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 172.416 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -66.85 -57.47 6.93 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 117.595 0.697 . . . . 0.0 111.281 -173.189 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.0 -34.58 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 110.079 -177.202 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.97 -28.34 7.39 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.674 -0.641 . . . . 0.0 112.891 169.928 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -102.39 18.58 20.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.776 1.23 . . . . 0.0 111.831 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.23 163.17 27.02 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.573 -1.329 . . . . 0.0 111.208 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -100.35 84.83 2.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.004 1.322 . . . . 0.0 110.273 -175.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.07 1.17 3.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.321 0.486 . . . . 0.0 113.725 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.13 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 117.641 0.721 . . . . 0.0 109.975 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -124.55 -41.81 2.13 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.131 1.372 . . . . 0.0 111.001 -176.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -156.93 171.3 20.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -157.14 138.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.051 -2.204 . . . . 0.0 105.051 -174.346 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -137.47 81.12 1.85 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.192 1.797 . . . . 0.0 110.488 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.06 122.52 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 O-C-N 120.729 -1.232 . . . . 0.0 109.302 -177.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -103.08 168.05 9.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.97 -45.53 2.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.792 0.837 . . . . 0.0 109.786 174.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.06 -57.03 5.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 110.943 -174.335 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.14 19.7 10.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.456 -175.284 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 36.44 62.28 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.6 2.36 . . . . 0.0 112.332 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.134 -0.979 . . . . 0.0 108.983 -174.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.04 119.86 34.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.936 1.694 . . . . 0.0 108.581 -175.128 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 20.1 m -96.82 125.99 41.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.482 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -125.53 128.91 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.695 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -110.13 117.71 55.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.166 0.986 . . . . 0.0 109.476 -174.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -139.9 175.36 9.65 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -104.81 107.21 57.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.106 1.362 . . . . 0.0 110.392 -177.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.13 77.7 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.378 2.719 . . . . 0.0 110.26 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -177.53 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 127.084 2.154 . . . . 0.0 108.04 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.02 -45.6 56.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.942 0.401 . . . . 0.0 110.548 -178.467 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.95 168.61 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.985 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -135.57 157.78 46.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.145 0.978 . . . . 0.0 110.18 -171.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -37.71 -47.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.83 1.652 . . . . 0.0 111.497 173.018 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -50.69 73.07 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.776 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -52.72 -48.7 66.46 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 120.916 1.689 . . . . 0.0 109.406 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mtp -49.97 -62.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -57.74 11.48 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 121.355 -0.841 . . . . 0.0 112.093 -178.182 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -41.18 -52.75 3.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.614 1.566 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -60.19 -47.69 84.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.445 0.566 . . . . 0.0 111.824 176.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.89 -66.03 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.83 -0.543 . . . . 0.0 111.067 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.34 -37.71 7.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.079 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.44 63.24 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.901 1.228 . . . . 0.0 112.694 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.1 mmt -58.83 -43.61 90.73 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.412 0.551 . . . . 0.0 110.438 174.066 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.15 3.76 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.541 1.067 . . . . 0.0 111.207 178.264 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -81.39 118.85 73.95 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.243 -173.838 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -66.81 137.48 45.48 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 N-CA-C 108.443 -1.406 . . . . 0.0 108.443 174.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.08 140.87 42.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.439 0.696 . . . . 0.0 109.903 178.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -112.28 85.3 2.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.5 p -74.78 98.18 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.838 2.055 . . . . 0.0 111.402 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.66 60.99 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.45 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -157.01 141.2 16.42 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.876 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.02 77.08 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -83.68 59.59 5.24 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.415 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.74 147.65 40.07 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.121 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.92 -179.414 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -65.02 -176.3 0.27 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 161.594 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.96 133.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -163.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.07 116.0 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 125.127 1.371 . . . . 0.0 110.305 -174.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.55 136.82 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -114.2 114.78 26.47 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 6.0 ptp -118.24 130.2 55.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.302 1.041 . . . . 0.0 109.831 178.22 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -80.03 125.27 29.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.404 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.25 140.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -103.42 156.58 17.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.82 -32.7 1.69 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.378 0.513 . . . . 0.0 114.199 172.863 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.7 mtp -67.31 80.84 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.253 1.026 . . . . 0.0 111.721 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -118.67 65.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.123 1.769 . . . . 0.0 109.095 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.24 169.25 9.33 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.92 5.17 52.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.839 0.456 . . . . 0.0 111.749 169.078 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.5 t -85.57 -65.81 0.97 Allowed 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.801 -0.562 . . . . 0.0 109.69 -174.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.23 -46.81 82.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.49 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -52.09 -60.95 2.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 109.968 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 t -52.12 -44.37 64.44 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.754 1.222 . . . . 0.0 111.231 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -58.07 -50.78 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.486 -0.758 . . . . 0.0 110.592 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.29 -45.78 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.54 -51.6 53.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.689 1.196 . . . . 0.0 110.721 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.63 -54.56 36.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.352 0.501 . . . . 0.0 111.92 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -52.17 66.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.638 -0.919 . . . . 0.0 111.462 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -63.83 -41.38 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.299 0.639 . . . . 0.0 109.709 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.96 19.76 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.448 0.547 . . . . 0.0 112.563 170.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -62.64 -24.93 67.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.724 0.762 . . . . 0.0 112.958 178.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mt -70.75 129.82 40.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.426 1.012 . . . . 0.0 112.825 -171.565 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.42 87.87 0.12 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.221 174.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -25.0 0.62 Allowed Glycine 0 C--N 1.332 0.343 0 O-C-N 122.035 -0.416 . . . . 0.0 113.406 -177.559 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.97 151.39 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -112.98 -53.98 2.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.967 0.907 . . . . 0.0 110.276 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.0 165.8 26.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.576 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -158.81 139.42 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -175.289 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -141.51 84.72 1.92 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.648 1.579 . . . . 0.0 110.254 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.43 106.34 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.056 -173.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -92.49 155.12 18.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -47.73 3.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.201 1.0 . . . . 0.0 108.619 177.394 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.03 -60.1 3.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.36 1.864 . . . . 0.0 110.567 -171.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -94.42 19.57 9.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.192 -175.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.83 49.44 0.57 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.048 2.539 . . . . 0.0 113.662 -177.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 4.7 tp10 -126.94 126.18 42.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.912 -169.325 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -115.03 113.25 23.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 110.155 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.491 ' C ' HD12 ' A' ' 45' ' ' ILE . 5.7 m -91.7 124.93 36.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 108.668 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' C ' ' A' ' 44' ' ' THR . 3.2 mp -124.09 132.64 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 167.499 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.25 107.05 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.57 1.148 . . . . 0.0 109.665 -174.779 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.73 159.98 40.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -171.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -81.72 114.1 47.54 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.49 74.59 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.297 2.665 . . . . 0.0 110.791 -171.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -49.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.073 2.149 . . . . 0.0 108.02 173.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.17 -43.63 70.43 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.357 -173.761 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.23 169.58 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -142.63 165.64 26.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.455 -170.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.0 t -43.96 -45.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.266 1.026 . . . . 0.0 111.391 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.29 -56.9 15.86 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.277 -178.349 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.56 -48.21 69.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.462 1.483 . . . . 0.0 109.929 -177.757 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.1 mtm -46.68 -61.8 1.67 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 118.813 0.733 . . . . 0.0 112.54 169.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -60.34 -59.89 4.68 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.326 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -37.8 -54.77 1.23 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.679 1.592 . . . . 0.0 109.614 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.69 -46.86 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.503 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -68.06 -64.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 O-C-N 121.527 -0.733 . . . . 0.0 110.716 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.14 -34.63 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.17 175.095 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.99 -33.72 65.11 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 120.218 1.372 . . . . 0.0 112.846 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.6 mmt -59.03 -40.14 84.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.536 0.607 . . . . 0.0 110.443 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.95 -20.17 3.43 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.621 1.105 . . . . 0.0 110.989 178.928 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.62 112.99 19.91 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.183 -173.345 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -66.21 141.08 61.53 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.6 135.08 34.59 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.759 0.314 . . . . 0.0 111.628 -177.314 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -108.15 72.6 0.85 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.569 -171.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.83 103.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.637 1.575 . . . . 0.0 111.002 174.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -156.1 56.52 0.59 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.772 0.796 . . . . 0.0 111.925 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -157.13 162.11 39.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 173.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 tt -155.67 70.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.89 168.79 19.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.3 127.89 2.23 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 174.591 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -80.73 156.3 26.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.296 1.038 . . . . 0.0 109.868 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.44 127.66 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.566 1.146 . . . . 0.0 109.202 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -90.99 116.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 126.295 1.838 . . . . 0.0 109.254 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.08 118.56 37.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -97.0 119.05 34.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.507 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.3 ptp -121.42 124.3 44.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.759 1.224 . . . . 0.0 109.203 175.7 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -82.53 119.25 24.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.372 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.23 122.59 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.98 0.512 . . . . 0.0 110.244 -170.75 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.11 157.49 20.68 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.474 0.309 . . . . 0.0 111.119 -174.201 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.03 -44.63 1.46 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.947 0.784 . . . . 0.0 112.119 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 mtm -60.28 109.19 0.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.202 0.501 . . . . 0.0 109.809 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -146.51 19.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.851 1.26 . . . . 0.0 110.014 -177.593 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.0 148.89 22.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.265 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -81.14 42.38 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.094 0.557 . . . . 0.0 112.288 -167.404 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -122.42 -69.11 0.85 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.253 1.421 . . . . 0.0 107.491 177.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -49.76 -53.36 25.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.201 1.4 . . . . 0.0 110.443 -176.179 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 HG21 HD22 ' A' ' 38' ' ' LEU . 11.8 t -51.18 -55.75 16.37 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.173 177.739 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -60.97 -45.69 93.73 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.349 1.06 . . . . 0.0 110.307 -175.985 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -55.26 -51.36 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.646 -0.659 . . . . 0.0 110.76 176.184 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.64 -48.02 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.971 0.509 . . . . 0.0 110.002 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -48.96 -51.72 28.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.447 1.499 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -59.91 9.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 172.921 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -48.87 79.06 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 122.002 -0.705 . . . . 0.0 110.851 -170.607 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.3 mm -71.08 -47.79 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.074 0.55 . . . . 0.0 109.96 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.95 -35.26 31.96 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.325 0.488 . . . . 0.0 112.228 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -68.87 -16.38 63.75 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.868 0.867 . . . . 0.0 113.324 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mt -73.91 139.6 45.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.488 1.495 . . . . 0.0 112.106 -176.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -70.1 97.38 1.18 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.062 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.91 -12.87 1.12 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-O 118.662 -1.077 . . . . 0.0 114.181 -175.703 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.3 t -102.85 139.43 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 118.145 0.973 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 -31.68 14.39 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.881 0.472 . . . . 0.0 111.801 175.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -171.57 164.55 6.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.952 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -156.04 138.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 104.022 -2.584 . . . . 0.0 104.022 -172.888 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -137.78 92.42 2.68 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.79 1.636 . . . . 0.0 111.239 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.41 115.24 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -104.9 103.4 12.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.984 1.713 . . . . 0.0 108.723 -173.811 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.816 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -65.5 -48.83 71.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.77 0.428 . . . . 0.0 110.628 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.17 -54.48 30.21 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.883 1.273 . . . . 0.0 110.24 -176.857 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.63 5.56 27.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.828 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 35.19 60.21 0.71 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 128.428 2.691 . . . . 0.0 113.081 -175.882 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -138.79 149.1 44.61 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.154 1.381 . . . . 0.0 108.586 -175.641 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -126.37 119.61 27.73 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.634 1.174 . . . . 0.0 110.269 -179.364 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 45' ' ' ILE . 9.0 m -103.03 114.44 28.75 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.975 1.71 . . . . 0.0 109.025 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 44' ' ' THR . 2.1 mp -117.37 115.44 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.76 105.52 18.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.749 0.704 . . . . 0.0 109.927 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -128.61 169.68 14.14 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -166.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.02 111.0 64.74 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 124.554 1.142 . . . . 0.0 110.461 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.58 78.35 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.144 2.563 . . . . 0.0 111.431 -175.72 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.7 m80 178.97 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.447 2.699 . . . . 0.0 108.624 173.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 -50.21 11.99 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.01 -178.32 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.095 1.358 . . . . 0.0 107.718 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.8 p -142.85 155.22 44.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.358 -174.154 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.45 -42.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 124.199 1.0 . . . . 0.0 111.07 173.476 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.15 -39.36 94.43 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.046 -177.638 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.73 -51.46 64.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.853 1.206 . . . . 0.0 107.748 176.216 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.0 mmt -47.63 -61.22 2.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 122.447 0.299 . . . . 0.0 111.775 176.137 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -57.56 -59.45 5.16 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 120.967 -1.083 . . . . 0.0 111.077 177.002 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 119.312 0.96 . . . . 0.0 109.249 -170.402 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -57.95 -50.02 74.8 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.85 173.262 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -69.5 -64.79 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 111.046 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -45.02 -39.51 5.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.791 0.723 . . . . 0.0 112.262 174.68 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.59 55.74 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.513 1.051 . . . . 0.0 113.293 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -56.27 -39.52 72.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.403 0.547 . . . . 0.0 110.534 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.05 -19.61 2.88 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.714 1.149 . . . . 0.0 111.181 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.33 112.35 40.86 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.359 1.064 . . . . 0.0 110.384 -169.038 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.22 127.91 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.766 1.644 . . . . 0.0 109.651 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.57 133.03 55.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.618 0.767 . . . . 0.0 111.84 -173.769 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -105.51 76.02 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.286 1.034 . . . . 0.0 109.493 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.49 109.4 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.076 0.95 . . . . 0.0 110.077 170.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -156.98 53.8 0.51 Allowed 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 178.619 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 81.47 0.78 Allowed 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.931 -0.481 . . . . 0.0 110.127 -177.089 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tp -78.55 59.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.683 0.793 . . . . 0.0 109.565 -179.199 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.24 163.31 19.75 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.393 -0.817 . . . . 0.0 110.208 -177.539 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.7 90.98 0.08 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -172.443 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.964 -1.493 . . . . 0.0 109.549 -176.471 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.922 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.71 ' HG3' HG12 ' A' ' 46' ' ' VAL . 13.7 pm0 -96.65 -166.28 1.39 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.46 2.304 . . . . 0.0 109.994 -176.093 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.5 t -133.9 140.78 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' C ' HD12 ' A' ' 5' ' ' LEU . 7.7 p -101.26 129.13 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 126.049 1.74 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 47' ' ' TYR . 10.8 mp -120.31 145.61 46.93 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -122.98 125.96 46.25 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.105 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mtt -115.79 129.67 56.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.412 1.885 . . . . 0.0 108.026 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.45 126.29 31.47 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.05 157.04 9.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 119.329 0.968 . . . . 0.0 109.723 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -123.75 143.56 50.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.366 0.603 . . . . 0.0 109.743 170.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.61 -31.51 8.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.005 1.765 . . . . 0.0 112.794 174.745 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.7 mtt -66.36 99.14 0.53 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.09 0.945 . . . . 0.0 111.02 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.0 m -143.78 56.52 1.34 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.936 -1.102 . . . . 0.0 109.477 174.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.4 p -161.62 159.85 28.07 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 165.152 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -80.58 44.68 0.73 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.271 0.487 . . . . 0.0 111.222 179.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -123.17 -60.33 1.51 Allowed 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.756 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -47.2 -59.89 2.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.488 0.715 . . . . 0.0 110.807 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -52.92 -59.26 4.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.572 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 t -60.38 -45.27 94.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.756 0.822 . . . . 0.0 111.331 -170.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -54.19 -49.97 68.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.56 -0.713 . . . . 0.0 110.462 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.23 -43.9 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.699 ' HA ' HD13 ' A' ' 34' ' ' ILE . 8.1 mt-10 -53.58 -50.07 66.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.139 0.976 . . . . 0.0 110.682 177.527 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.58 -58.25 14.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 171.136 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -56.32 -52.3 65.05 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.169 -0.607 . . . . 0.0 111.14 -172.349 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.587 HG21 HD12 ' A' ' 34' ' ' ILE . 24.8 mm -62.02 -47.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.907 1.283 . . . . 0.0 109.911 178.469 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.98 -39.71 26.35 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 172.23 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -70.48 -13.92 62.32 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.664 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mt -82.23 133.37 35.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 120.031 1.287 . . . . 0.0 112.345 -174.547 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -68.67 91.17 0.42 Allowed 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.532 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.59 -20.87 0.92 Allowed Glycine 0 C--N 1.334 0.433 0 O-C-N 121.859 -0.525 . . . . 0.0 113.752 -177.115 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -85.93 151.16 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -120.43 -38.29 2.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.873 1.269 . . . . 0.0 111.013 -179.545 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -152.78 171.05 18.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 22' ' ' GLU . 14.8 tt -158.56 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -143.78 88.03 1.96 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.074 1.75 . . . . 0.0 111.298 175.367 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.83 88.61 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.124 -0.985 . . . . 0.0 111.263 -178.425 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.04 121.36 21.87 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.675 1.99 . . . . 0.0 110.919 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -73.97 -46.56 43.22 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.261 -0.899 . . . . 0.0 111.366 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 m-20 -47.3 -59.58 3.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.724 1.21 . . . . 0.0 111.211 -170.121 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.35 24.92 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.524 -176.216 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 24.89 74.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.346 2.659 . . . . 0.0 113.934 -169.021 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -127.94 136.58 51.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 108.222 -173.214 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.8 102.38 9.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.53 1.132 . . . . 0.0 108.427 171.374 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.568 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.2 m -88.95 125.72 35.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.348 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -123.0 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.516 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 2' ' ' GLU . 2.6 t -118.96 103.59 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.487 1.115 . . . . 0.0 108.067 -174.081 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HE1' HD13 ' A' ' 5' ' ' LEU . 17.0 p90 -138.78 164.59 29.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -166.766 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -96.71 110.64 54.26 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.975 -173.112 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.05 76.57 2.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.894 3.062 . . . . 0.0 110.684 -172.285 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.407 1.883 . . . . 0.0 107.357 -175.345 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.51 -46.35 13.51 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.476 0.485 . . . . 0.0 110.48 -171.394 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.54 155.51 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 107.136 -176.537 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 p -123.18 161.84 23.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.786 1.234 . . . . 0.0 110.392 -173.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.6 t -45.47 -45.52 4.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 123.831 0.852 . . . . 0.0 111.843 175.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.49 -56.65 17.8 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.038 -175.427 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -38.82 -59.67 0.93 Allowed 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.015 1.726 . . . . 0.0 110.144 170.618 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.4 mtm -49.67 -62.79 1.36 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -59.2 -62.64 1.73 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.41 -177.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -38.82 -49.37 1.62 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 120.013 1.278 . . . . 0.0 110.376 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -37.2 78.67 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.693 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -72.08 -66.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 124.37 1.068 . . . . 0.0 110.81 175.489 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -38.0 -40.16 0.45 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.034 1.334 . . . . 0.0 112.403 171.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.38 -35.43 8.29 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 113.514 176.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.83 81.71 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.666 0.787 . . . . 0.0 110.613 178.626 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.23 -14.66 4.55 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.877 1.227 . . . . 0.0 111.172 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -85.48 115.93 63.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 123.849 0.86 . . . . 0.0 109.866 -171.107 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.5 142.1 63.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 175.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.4 135.81 44.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.094 0.558 . . . . 0.0 111.401 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -105.7 76.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.577 1.151 . . . . 0.0 109.437 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.41 104.52 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.079 1.352 . . . . 0.0 110.859 171.909 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -155.73 60.01 0.61 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.71 0.767 . . . . 0.0 112.875 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.31 162.33 40.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.455 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 tp -156.88 70.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.09 67.62 8.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.892 0.853 . . . . 0.0 109.253 -173.194 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.87 153.71 33.4 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.202 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -174.898 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.87 150.93 40.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.881 0.841 . . . . 0.0 110.163 171.707 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -116.78 128.61 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 124.731 1.212 . . . . 0.0 109.499 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.3 104.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.345 1.458 . . . . 0.0 110.129 -176.064 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.33 101.89 14.38 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.709 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -79.19 120.95 24.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.079 0.952 . . . . 0.0 108.6 174.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.72 119.14 29.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.142 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 115.55 19.41 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.45 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.43 154.49 5.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -174.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -111.54 156.91 21.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.174 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.45 -43.44 3.22 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.261 -0.9 . . . . 0.0 114.043 161.907 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.5 mtm -61.01 86.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.374 1.087 . . . . 0.0 111.507 -178.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -116.49 38.08 3.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.744 1.618 . . . . 0.0 109.902 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -154.81 162.96 40.92 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.313 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -76.74 -21.61 55.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.429 0.456 . . . . 0.0 111.402 -177.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -58.16 -58.91 6.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.752 0.421 . . . . 0.0 110.214 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.1 m -54.5 -53.37 55.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -58.9 -54.2 49.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.075 -175.883 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -58.74 -45.91 88.6 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.818 0.847 . . . . 0.0 111.229 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.6 m -56.2 -48.46 76.35 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.371 -0.83 . . . . 0.0 110.5 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -59.44 -47.89 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -55.81 -45.0 78.38 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.635 . . . . 0.0 110.764 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.1 -53.26 45.94 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.063 0.84 . . . . 0.0 111.527 173.226 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -63.0 -59.77 4.36 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.93 0.871 . . . . 0.0 109.834 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.59 -32.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.167 1.387 . . . . 0.0 111.043 -175.166 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.16 -31.49 6.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.313 0.482 . . . . 0.0 112.447 172.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -80.74 -4.08 53.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.74 139.35 45.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 120.104 1.32 . . . . 0.0 112.524 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -81.18 84.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.136 177.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.04 -13.96 0.86 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 178.888 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.33 145.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.673 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -115.13 -37.33 4.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.249 1.419 . . . . 0.0 111.037 -176.001 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.66 44.42 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.67 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -155.06 126.6 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' LYS 0.253 16.2 mmtm -135.08 102.16 5.11 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 171.355 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.33 98.58 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.584 -0.697 . . . . 0.0 110.095 -177.419 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.1 m -89.14 126.84 35.64 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.14 1.376 . . . . 0.0 110.808 -176.417 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.446 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -84.65 -42.96 14.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.832 0.853 . . . . 0.0 109.96 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -59.11 4.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.938 1.695 . . . . 0.0 110.376 -173.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -86.58 9.0 19.83 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.001 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 0.1 OUTLIER 32.85 66.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.209 2.604 . . . . 0.0 112.208 -169.548 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -144.5 141.99 29.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.556 1.142 . . . . 0.0 110.685 -173.458 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.95 120.19 39.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.38 1.472 . . . . 0.0 109.682 -178.571 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -94.46 78.27 3.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.942 2.497 . . . . 0.0 107.934 175.132 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.28 103.8 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.54 108.24 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.328 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -131.41 175.05 9.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -106.88 109.91 63.35 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.268 1.027 . . . . 0.0 110.187 -175.157 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 73.74 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.153 3.235 . . . . 0.0 111.216 -170.138 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -177.91 -39.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.372 2.269 . . . . 0.0 108.368 178.933 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.75 -46.13 13.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.778 -175.606 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -135.62 149.08 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.869 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -100.58 158.74 15.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.052 0.941 . . . . 0.0 111.676 -173.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.71 -42.97 18.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.939 0.496 . . . . 0.0 110.357 166.095 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.52 -53.92 50.04 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -176.306 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -46.14 -54.1 9.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.312 1.045 . . . . 0.0 110.528 172.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.9 mmm -48.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 173.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 15.0 tttp -56.9 -64.57 0.83 Allowed 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.808 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -37.11 -52.76 1.01 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.907 1.683 . . . . 0.0 109.954 178.106 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -66.11 -47.26 74.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.081 177.428 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.61 -62.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.655 0.661 . . . . 0.0 110.453 -178.136 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 1.8 tt0 -42.39 -44.08 3.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 112.223 171.344 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.2 62.3 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.126 0.875 . . . . 0.0 113.065 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.1 -42.29 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.499 0.59 . . . . 0.0 110.467 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.28 -18.71 2.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.596 1.093 . . . . 0.0 111.299 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -81.23 118.31 71.77 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-O 118.417 -0.801 . . . . 0.0 110.373 -169.302 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.1 140.05 52.77 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 N-CA-C 108.445 -1.406 . . . . 0.0 108.445 173.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.21 132.33 37.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.392 0.615 . . . . 0.0 111.045 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.26 81.24 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.019 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -42.02 107.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 125.15 1.531 . . . . 0.0 108.818 160.961 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -101.87 179.8 4.23 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.121 1.768 . . . . 0.0 106.611 170.813 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 161.87 18.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.05 -175.048 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mt -75.77 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.003 0.521 . . . . 0.0 109.709 -178.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.77 106.49 16.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.157 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.78 164.56 14.05 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.5 ttt-85 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.069 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -47.15 152.84 0.52 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.715 2.006 . . . . 0.0 111.8 167.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -105.6 132.45 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.854 0.862 . . . . 0.0 109.161 -176.197 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -94.2 115.52 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.646 1.578 . . . . 0.0 109.813 179.435 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.0 124.43 33.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 170.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.48 109.39 21.34 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.432 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.724 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptp -119.64 144.64 47.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.094 0.958 . . . . 0.0 109.142 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.85 46.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.922 173.83 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.92 96.48 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 124.661 1.226 . . . . 0.0 109.448 -166.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -68.3 142.76 55.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.946 -0.471 . . . . 0.0 110.668 -172.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 -47.72 1.0 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.286 0.946 . . . . 0.0 112.525 174.071 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.7 82.47 2.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.929 0.864 . . . . 0.0 111.899 -171.912 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -111.35 33.63 4.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.537 1.535 . . . . 0.0 110.545 -178.776 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -155.37 160.55 40.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.288 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -78.0 -1.5 32.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -174.754 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -76.7 -61.36 1.99 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.49 -0.756 . . . . 0.0 109.629 175.087 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -56.13 -48.59 75.93 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.717 0.407 . . . . 0.0 110.809 -174.469 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.9 p -52.03 -60.39 3.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.383 0.673 . . . . 0.0 109.415 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -50.7 -48.21 58.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.786 1.234 . . . . 0.0 111.692 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -54.42 -51.91 63.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.315 -0.866 . . . . 0.0 110.948 176.68 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.9 mt -62.14 -40.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.97 0.508 . . . . 0.0 109.989 178.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.99 -48.58 78.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.661 1.184 . . . . 0.0 110.599 176.178 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.82 -56.31 24.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 172.499 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -56.18 -52.63 63.71 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -174.584 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.06 -45.81 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.244 1.018 . . . . 0.0 110.299 -175.456 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.57 -37.61 26.86 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.402 0.525 . . . . 0.0 112.012 175.515 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -72.99 -9.28 58.56 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.135 0.974 . . . . 0.0 113.5 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mt -81.45 128.45 33.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.431 1.468 . . . . 0.0 111.408 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -66.8 108.87 2.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.097 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.52 -16.28 3.58 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 124.489 1.042 . . . . 0.0 112.613 -178.287 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.5 152.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 117.053 0.426 . . . . 0.0 110.249 173.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.14 -46.08 2.21 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.31 -178.686 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.42 165.57 30.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 178.601 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -156.5 137.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -141.66 90.85 2.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.253 1.021 . . . . 0.0 111.495 179.091 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.76 90.91 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.512 -0.742 . . . . 0.0 110.194 -177.137 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 m -84.45 110.21 18.48 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.583 1.153 . . . . 0.0 111.247 -173.765 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.741 ' H ' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -63.33 -49.6 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.356 0.663 . . . . 0.0 112.368 177.892 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.86 -59.58 3.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.074 1.349 . . . . 0.0 111.095 -170.906 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -92.57 18.91 7.93 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.438 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 28.9 60.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 129.028 2.931 . . . . 0.0 113.609 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.12 132.46 32.04 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 110.26 -175.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.724 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.22 112.5 25.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.451 1.9 . . . . 0.0 109.498 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.0 m -90.56 84.57 5.95 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 127.845 2.458 . . . . 0.0 107.575 173.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.25 113.06 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -107.47 111.76 37.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.957 0.799 . . . . 0.0 110.128 -171.508 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -129.75 170.89 13.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.762 0.792 . . . . 0.0 112.328 -169.615 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -106.42 109.25 63.0 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.906 -177.28 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.36 77.99 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.177 2.584 . . . . 0.0 110.906 -172.408 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -177.09 -41.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 127.885 2.474 . . . . 0.0 107.926 174.382 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -77.96 -53.84 6.98 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 117.966 0.348 . . . . 0.0 110.974 -177.895 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.27 179.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.88 1.272 . . . . 0.0 108.84 -176.541 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -146.37 159.6 43.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.574 0.749 . . . . 0.0 110.992 -172.701 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -39.28 -48.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.813 1.645 . . . . 0.0 111.159 173.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.78 -50.46 73.37 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.14 -50.64 66.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 120.401 1.455 . . . . 0.0 108.442 176.488 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.66 -55.96 16.44 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.499 0.19 . . . . 0.0 111.011 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.87 -62.26 1.92 Allowed 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.583 177.427 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -50.34 5.29 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.446 1.099 . . . . 0.0 109.495 -177.913 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -60.1 -49.84 76.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 177.176 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -70.17 -63.76 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.744 -0.597 . . . . 0.0 111.301 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.8 -37.91 6.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 112.548 174.272 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.78 56.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.779 1.172 . . . . 0.0 113.06 176.891 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 mmt -56.89 -39.88 75.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.507 0.594 . . . . 0.0 110.625 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.41 -18.96 3.23 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.639 1.114 . . . . 0.0 110.932 176.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -80.94 114.03 45.33 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.48 -172.092 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.99 141.63 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.663 1.575 . . . . 0.0 108.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.37 134.57 46.41 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.335 0.97 . . . . 0.0 112.956 -177.241 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -106.47 71.74 0.88 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.82 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.14 107.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.8 170.22 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -150.89 55.19 0.89 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 176.156 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 159.45 41.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 173.39 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.57 59.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.013 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.557 ' HB2' HG13 ' A' ' 4' ' ' VAL . 47.4 mt-10 -78.47 172.09 14.16 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.72 166.73 16.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 174.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 171.578 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -82.81 -154.75 0.14 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.799 1.64 . . . . 0.0 111.339 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.57 141.18 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.082 0.953 . . . . 0.0 109.343 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -104.96 127.01 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 126.462 1.905 . . . . 0.0 110.663 -177.723 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.21 127.89 54.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.1 111.27 23.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 178.864 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.422 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.4 ptp -113.66 122.23 46.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.698 1.199 . . . . 0.0 109.152 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -74.46 130.85 40.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.44 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.15 153.7 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -117.08 146.85 42.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.259 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.72 -38.91 2.97 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.267 0.937 . . . . 0.0 113.077 170.756 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 21' ' ' ILE . 34.0 mtt -62.72 137.06 58.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.457 1.129 . . . . 0.0 110.575 -174.989 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -143.4 -56.99 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.733 -0.605 . . . . 0.0 110.226 176.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.8 p -72.07 156.47 39.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.724 0.693 . . . . 0.0 110.098 -179.33 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -65.16 -18.71 65.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.295 177.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 m -64.54 -50.18 68.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.422 -0.799 . . . . 0.0 110.665 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -54.62 -57.85 9.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.787 0.721 . . . . 0.0 109.73 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -55.49 -55.31 33.25 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.539 -176.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -56.55 -45.89 80.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.9 m -58.0 -49.48 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.487 -0.758 . . . . 0.0 109.942 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CE ' ' A' ' 12' ' ' MET . 3.1 mt -61.14 -47.01 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 122.936 0.494 . . . . 0.0 109.912 176.737 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.56 -50.26 60.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.553 0.741 . . . . 0.0 109.551 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.86 -56.79 22.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.68 0.657 . . . . 0.0 111.817 173.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -60.63 -59.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.198 -0.589 . . . . 0.0 110.948 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -67.58 -34.25 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.954 -177.376 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.43 -33.79 6.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.58 168.804 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -92.42 12.19 23.6 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 117.966 0.883 . . . . 0.0 112.353 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.61 151.24 47.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 120.404 -1.435 . . . . 0.0 109.886 167.316 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.17 130.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.37 -0.88 29.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.557 1.075 . . . . 0.0 111.909 176.463 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -95.48 154.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 124.691 1.196 . . . . 0.0 109.658 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -122.1 -41.57 2.42 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.168 0.987 . . . . 0.0 110.055 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -150.66 164.37 36.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.603 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 25' ' ' ILE . 10.5 tt -156.97 139.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -172.899 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -145.49 147.76 32.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.55 0.74 . . . . 0.0 110.027 172.067 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.32 140.76 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.863 1.211 . . . . 0.0 110.825 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -124.08 132.57 53.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.971 1.708 . . . . 0.0 110.569 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -54.73 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 112.151 176.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.61 -56.73 16.01 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 110.112 -166.195 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.22 11.58 16.08 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.845 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.37 62.69 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.857 2.863 . . . . 0.0 113.042 -178.327 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 3.8 tt0 -131.39 142.32 50.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.342 -175.227 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -118.72 133.88 55.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.298 1.439 . . . . 0.0 108.659 175.71 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -109.94 117.18 33.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.518 3.127 . . . . 0.0 106.648 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -126.23 119.29 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.927 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.17 108.59 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -168.029 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.192 0.52 . . . . 0.0 112.008 -165.356 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -89.31 108.58 25.45 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.714 1.606 . . . . 0.0 109.431 -174.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.2 73.14 2.69 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.02 2.48 . . . . 0.0 111.036 -176.726 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -168.22 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.413 1.885 . . . . 0.0 108.756 177.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.67 -43.17 63.48 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.36 177.9 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -135.05 162.34 32.75 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.153 0.888 . . . . 0.0 110.215 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.09 -46.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 110.995 169.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -61.14 -57.77 11.11 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.184 -174.719 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -38.57 -56.85 1.24 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.763 1.625 . . . . 0.0 110.665 172.422 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.45 -63.01 1.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 122.163 -0.336 . . . . 0.0 111.57 175.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -58.64 7.53 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.714 -0.616 . . . . 0.0 111.964 -177.443 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -36.88 -54.97 0.92 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.844 1.658 . . . . 0.0 110.491 172.649 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -41.8 94.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.094 -1.043 . . . . 0.0 113.388 176.308 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.74 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.174 -0.954 . . . . 0.0 109.98 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -43.42 -40.96 4.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.957 169.553 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.23 61.16 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.617 1.099 . . . . 0.0 113.222 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.82 -43.79 81.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.593 0.633 . . . . 0.0 110.777 171.801 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.02 -15.31 4.02 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.047 1.308 . . . . 0.0 111.287 -179.01 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 21' ' ' ILE . 44.2 m-85 -80.89 116.89 65.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.91 -173.221 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.9 140.04 49.27 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 108.397 -1.424 . . . . 0.0 108.397 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.71 140.25 42.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.351 0.66 . . . . 0.0 110.48 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -114.66 79.03 1.21 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.939 0.896 . . . . 0.0 109.152 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 105.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.012 1.325 . . . . 0.0 109.691 169.796 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -152.98 54.72 0.77 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.735 0.778 . . . . 0.0 112.42 176.282 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 132.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.15 70.59 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 175.81 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.288 0.565 . . . . 0.0 109.613 174.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.32 135.98 12.88 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 125.476 1.51 . . . . 0.0 112.692 169.906 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 . . . . . 0 N--CA 1.446 -0.647 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.05 135.83 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.72 132.47 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.639 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 70' ' ' VAL . 4.1 mm? -113.25 135.24 54.05 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 166.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -111.94 122.07 46.77 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.6 ptp -123.64 120.5 32.95 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.106 1.362 . . . . 0.0 109.533 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.441 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.2 mptp? -71.01 134.53 47.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.655 -1.164 . . . . 0.0 108.079 173.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -116.91 150.35 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -113.61 150.35 33.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.36 -35.06 2.42 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.52 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.6 mtm -65.82 85.72 0.08 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.607 1.204 . . . . 0.0 111.603 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 m -122.96 51.08 1.46 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 109.116 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 p -158.32 167.88 28.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 165.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.77 -22.24 50.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.321 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -65.62 -62.0 1.76 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.047 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -52.21 -51.22 59.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.013 0.911 . . . . 0.0 110.235 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 p -57.58 -56.07 26.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.295 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -54.98 -48.34 73.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.776 0.717 . . . . 0.0 111.623 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.2 m -52.85 -51.96 59.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.534 0.734 . . . . 0.0 110.283 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -60.92 -44.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.19 -48.12 71.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.231 0.612 . . . . 0.0 111.087 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.82 28.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.663 0.649 . . . . 0.0 111.624 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -56.96 -47.11 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.109 -0.642 . . . . 0.0 110.945 -174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 mm -66.34 -48.02 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.241 1.016 . . . . 0.0 109.478 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.76 -39.26 31.34 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.533 0.587 . . . . 0.0 112.235 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -60.54 -29.17 68.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.492 0.646 . . . . 0.0 112.489 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -75.04 135.29 41.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.039 0.923 . . . . 0.0 112.088 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -70.72 86.96 0.68 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.917 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.66 0.51 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 115.227 0.851 . . . . 0.0 115.227 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -86.95 149.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 117.844 0.822 . . . . 0.0 109.287 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -120.8 -34.72 3.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -156.53 164.32 38.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -158.29 140.28 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.1 mmtm -140.99 82.7 1.85 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.233 1.013 . . . . 0.0 111.222 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -84.47 110.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -89.29 172.16 9.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.58 -48.15 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.461 1.104 . . . . 0.0 109.48 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.11 -61.15 1.89 Allowed 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.389 1.876 . . . . 0.0 110.392 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.17 19.52 7.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.143 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.33 63.87 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.759 2.824 . . . . 0.0 113.462 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.441 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 35.2 tt0 -146.6 146.24 30.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -125.14 124.71 42.39 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.613 1.165 . . . . 0.0 109.596 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -98.05 129.54 44.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.82 1.648 . . . . 0.0 107.23 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.8 123.19 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 104.55 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 118.821 0.737 . . . . 0.0 110.025 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -133.4 167.98 19.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.335 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.42 112.79 63.14 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.233 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.45 78.25 2.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.024 3.149 . . . . 0.0 110.985 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -179.25 -52.95 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.781 1.632 . . . . 0.0 106.919 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.78 -46.06 16.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.155 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 169.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.552 1.541 . . . . 0.0 108.27 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -139.64 162.03 36.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.982 0.913 . . . . 0.0 111.202 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 70' ' ' VAL . 86.9 t -43.65 -48.28 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.202 1.001 . . . . 0.0 111.15 172.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.89 -45.66 88.36 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.488 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -50.93 -57.28 8.93 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.231 1.378 . . . . 0.0 108.702 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.9 mmt -46.49 -65.43 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -59.7 5.02 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 121.284 -0.885 . . . . 0.0 112.611 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -44.76 -48.63 10.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.203 0.911 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -40.8 90.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.99 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -67.52 -65.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.077 0.551 . . . . 0.0 110.619 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -43.38 -42.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.38 0.672 . . . . 0.0 112.18 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.42 -32.86 58.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.139 0.882 . . . . 0.0 113.149 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.3 mmt -59.39 -40.26 85.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.68 0.673 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.93 -17.74 2.77 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.372 0.986 . . . . 0.0 111.197 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -84.23 110.53 27.03 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 123.913 0.885 . . . . 0.0 109.581 -171.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -65.89 141.58 65.53 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.33 136.18 32.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.444 0.298 . . . . 0.0 111.779 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.81 78.74 1.22 Allowed 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 5' ' ' LEU . 10.4 p -66.16 101.52 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.844 1.657 . . . . 0.0 112.083 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -156.77 56.8 0.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -158.03 130.06 6.96 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 167.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.5 mt . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.245 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 . . . . . 0 N--CA 1.446 -0.646 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.94 134.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.43 134.61 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.09 147.02 43.69 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 163.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -118.04 117.06 28.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -118.28 119.64 35.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.619 1.568 . . . . 0.0 108.275 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.47 140.74 54.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -127.94 146.4 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -105.97 148.15 28.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.32 -31.68 2.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.459 -0.776 . . . . 0.0 114.056 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.5 mtp -61.99 92.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.987 0.893 . . . . 0.0 110.242 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 m -144.46 48.67 1.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.894 1.277 . . . . 0.0 109.724 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -77.26 44.27 0.41 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.668 0.787 . . . . 0.0 111.46 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -129.54 -59.76 1.07 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.392 1.077 . . . . 0.0 108.425 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -54.66 -58.53 7.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.471 0.578 . . . . 0.0 110.655 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 t -51.95 -57.3 9.84 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.271 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 t -57.71 -40.33 79.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.809 0.844 . . . . 0.0 110.557 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -60.85 -49.26 78.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.934 -0.479 . . . . 0.0 110.082 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -51.29 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.5 -51.19 65.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.201 1.0 . . . . 0.0 110.142 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.01 -51.21 57.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.813 0.72 . . . . 0.0 112.059 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.3 -59.58 5.07 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.195 0.997 . . . . 0.0 110.572 -175.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.9 mm -57.67 -38.07 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.264 1.026 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.32 -36.15 7.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.033 0.825 . . . . 0.0 113.676 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.62 -7.01 59.59 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.171 0.986 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.64 149.7 32.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.12 0.873 . . . . 0.0 111.835 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.71 126.53 36.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.194 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.0 -21.06 7.51 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -86.98 151.64 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -118.51 -40.82 2.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.836 1.254 . . . . 0.0 110.726 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -159.13 170.84 21.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -158.48 140.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -143.87 84.73 1.79 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.685 0.794 . . . . 0.0 110.718 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.45 102.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.84 0.856 . . . . 0.0 109.149 -172.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -78.53 177.21 8.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -141.09 -48.85 0.41 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 109.054 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -61.43 1.96 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.423 1.489 . . . . 0.0 110.39 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -91.52 19.46 6.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.625 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 37.29 62.27 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.155 2.182 . . . . 0.0 113.603 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.29 149.48 33.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 130.64 46.95 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.332 1.053 . . . . 0.0 110.147 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -102.06 129.3 48.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 107.234 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.6 mm -123.88 127.81 73.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.34 107.36 21.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 110.005 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -145.86 173.24 12.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.498 -0.751 . . . . 0.0 111.813 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -98.65 104.3 23.71 Favored Pre-proline 0 N--CA 1.439 -1.024 0 C-N-CA 124.932 1.293 . . . . 0.0 108.713 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.12 -24.4 73.55 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.836 2.357 . . . . 0.0 112.4 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -22.76 63.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.594 0.758 . . . . 0.0 112.894 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.8 mt -107.97 -64.71 1.18 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.827 0.74 . . . . 0.0 111.474 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -116.5 161.3 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.644 1.177 . . . . 0.0 108.277 -175.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -127.72 165.45 20.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.514 0.726 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.62 -44.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 C-N-CA 124.133 0.973 . . . . 0.0 110.236 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -60.59 -38.19 83.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.135 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.86 -53.63 25.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 mmt -45.21 -59.74 2.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 122.863 0.465 . . . . 0.0 111.634 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -53.82 44.02 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.284 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -50.37 -47.05 56.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 120.702 1.592 . . . . 0.0 109.201 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -59.63 -48.96 79.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.704 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -69.74 -63.94 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 122.931 0.492 . . . . 0.0 110.583 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -47.69 -36.47 11.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.318 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.43 -32.82 63.04 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.726 1.148 . . . . 0.0 112.955 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.5 mmt -60.89 -30.39 70.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.437 0.562 . . . . 0.0 110.885 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.54 7.79 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.455 1.503 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -82.5 116.07 61.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.375 1.07 . . . . 0.0 109.524 -171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.76 144.08 64.09 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.611 1.541 . . . . 0.0 108.75 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.27 141.22 35.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.929 0.492 . . . . 0.0 111.179 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -114.49 78.3 1.14 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.88 0.872 . . . . 0.0 110.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.13 103.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.097 1.359 . . . . 0.0 111.2 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -155.41 57.09 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.34 0.59 . . . . 0.0 112.16 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.01 158.17 32.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt . . . . . 0 CA--C 1.535 0.388 0 CA-C-O 122.061 0.934 . . . . 0.0 109.767 179.344 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 CA--C 1.535 0.398 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.58 129.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 41.7 t -91.15 119.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 70' ' ' VAL . 3.2 tm? -100.81 133.73 44.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -118.22 115.37 24.62 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.42 126.86 53.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.151 1.38 . . . . 0.0 108.572 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -70.31 140.72 52.33 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 168.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -130.93 143.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.6 159.11 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.84 -39.01 2.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.756 -0.59 . . . . 0.0 114.566 161.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.53 102.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.7 1.25 . . . . 0.0 110.681 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -134.75 34.4 3.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.097 1.359 . . . . 0.0 109.772 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 165.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -72.01 -25.5 61.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.613 0.244 . . . . 0.0 111.316 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -58.52 -56.1 26.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.214 0.606 . . . . 0.0 111.485 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 m -59.12 -55.77 30.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.64 0.654 . . . . 0.0 110.692 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -49.37 -57.47 6.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.22 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -59.73 -42.23 92.68 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.321 0.51 . . . . 0.0 111.206 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.8 m -57.38 -48.83 78.03 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.603 -0.686 . . . . 0.0 110.199 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.63 -49.08 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.253 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -45.16 -53.78 7.69 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.278 1.031 . . . . 0.0 109.546 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.75 -57.41 19.93 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.344 0.973 . . . . 0.0 112.316 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -58.25 -54.38 47.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.868 0.834 . . . . 0.0 109.874 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 28' ' ' LEU . 24.0 mm -70.32 -35.95 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.575 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.7 -30.76 9.08 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.733 -0.604 . . . . 0.0 112.688 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.7 -14.81 60.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 118.178 0.989 . . . . 0.0 113.448 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -68.71 147.66 51.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.639 1.563 . . . . 0.0 112.746 -178.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.68 97.51 7.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.74 -10.1 1.87 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-O 119.725 -0.486 . . . . 0.0 114.271 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.91 137.82 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -31.66 10.49 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.079 0.551 . . . . 0.0 111.381 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -152.72 159.64 43.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.19 140.92 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.93 136.78 25.67 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.845 0.858 . . . . 0.0 110.53 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -132.96 104.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 120.628 1.558 . . . . 0.0 111.349 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.1 m -83.28 105.34 14.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.685 1.994 . . . . 0.0 110.125 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -62.26 -44.75 95.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.486 -0.133 . . . . 0.0 110.849 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.48 -57.34 7.2 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.396 1.478 . . . . 0.0 111.287 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.08 11.66 20.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.576 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 1.4 mt-30 33.61 62.93 0.39 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.601 2.36 . . . . 0.0 112.605 -168.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.23 136.25 39.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.971 0.908 . . . . 0.0 110.618 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.34 135.23 53.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.797 1.639 . . . . 0.0 110.168 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.6 m -111.77 124.47 52.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 131.281 3.832 . . . . 0.0 106.438 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mm -125.88 117.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -108.46 95.42 3.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -123.88 169.52 11.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.22 0.533 . . . . 0.0 111.951 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -108.06 109.81 62.02 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.345 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.86 79.76 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.504 2.803 . . . . 0.0 111.298 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m170 177.13 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 128.07 2.548 . . . . 0.0 108.075 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.95 -46.67 17.87 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.398 -0.189 . . . . 0.0 111.258 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -140.2 170.76 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.375 1.47 . . . . 0.0 107.741 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.8 p -130.53 155.91 45.71 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.128 0.971 . . . . 0.0 111.443 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -46.44 -43.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.638 0.775 . . . . 0.0 110.974 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 4.1 tm-20 -60.68 -45.4 94.33 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.706 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.58 -55.98 27.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.66 1.184 . . . . 0.0 107.814 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.7 mmt -46.16 -59.05 3.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.427 ' NZ ' ' OE2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -60.66 -51.18 70.5 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 121.148 -0.97 . . . . 0.0 111.927 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -52.66 -49.31 65.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.78 -48.19 82.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.373 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.58 -66.8 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.057 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -48.94 -33.95 11.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.428 -0.796 . . . . 0.0 113.003 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.937 1.244 . . . . 0.0 112.937 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.8 mmt -55.47 -42.28 74.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 110.547 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.76 -25.0 2.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.011 0.815 . . . . 0.0 111.326 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -73.86 113.19 20.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.928 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -64.84 143.69 80.75 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.669 1.579 . . . . 0.0 108.857 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.26 40.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -104.78 76.89 1.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 5' ' ' LEU . 1.3 p -52.58 108.0 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 109.828 162.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -155.38 59.79 0.63 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.601 0.715 . . . . 0.0 112.402 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -157.16 168.06 28.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 tp . . . . . 0 N--CA 1.452 -0.335 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.445 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 . . . . . 0 N--CA 1.449 -0.492 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.81 144.51 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.786 1.634 . . . . 0.0 107.551 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.33 131.76 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.524 1.53 . . . . 0.0 107.546 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 70' ' ' VAL . 3.0 tm? -120.3 122.09 40.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -113.56 118.8 35.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 8.2 ptp -117.0 128.96 55.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.292 1.037 . . . . 0.0 109.935 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 125.28 28.6 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.19 154.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 119.318 0.963 . . . . 0.0 108.88 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -115.28 154.53 28.94 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 109.74 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.93 -47.54 3.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.691 0.662 . . . . 0.0 112.347 171.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.4 mtm -64.59 86.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.568 0.684 . . . . 0.0 111.82 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 m -135.65 50.7 2.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.476 1.51 . . . . 0.0 109.738 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 p -161.17 167.95 25.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -65.46 177.2 1.21 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.803 0.811 . . . . 0.0 109.837 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t 73.74 -65.73 0.34 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 121.309 -0.869 . . . . 0.0 108.774 -170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.3 m -47.64 -63.47 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.036 0.835 . . . . 0.0 111.317 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -56.03 -55.72 29.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.264 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -58.98 -45.91 89.4 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.137 0.975 . . . . 0.0 111.65 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.5 m -53.64 -50.5 65.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.499 0.719 . . . . 0.0 110.281 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -44.04 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.568 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.5 -51.87 57.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 109.749 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.78 -54.47 34.78 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.259 0.933 . . . . 0.0 112.112 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -60.6 -54.51 44.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.012 -0.699 . . . . 0.0 110.897 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.57 -42.36 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.54 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.55 -23.52 14.26 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.325 -0.708 . . . . 0.0 113.718 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -81.91 -18.87 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.966 1.383 . . . . 0.0 112.283 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.94 131.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.781 1.628 . . . . 0.0 111.292 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -68.68 91.71 0.45 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.37 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.28 -18.34 1.52 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.329 -171.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.91 146.05 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 117.858 0.829 . . . . 0.0 109.587 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -106.21 -44.99 4.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.811 1.645 . . . . 0.0 110.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.58 168.69 26.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 tt -158.35 139.36 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -136.72 86.82 2.24 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.634 1.574 . . . . 0.0 111.039 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.62 97.19 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 109.366 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.0 m -75.66 165.46 25.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -131.56 -46.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.849 0.859 . . . . 0.0 109.622 -173.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.42 -57.21 12.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.044 1.338 . . . . 0.0 109.423 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -88.05 12.77 12.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.088 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 35.98 58.41 0.94 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.355 2.262 . . . . 0.0 113.19 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.78 140.02 31.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.479 -0.763 . . . . 0.0 108.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -121.71 112.72 18.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.882 1.273 . . . . 0.0 109.793 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.449 ' C ' HD12 ' A' ' 45' ' ' ILE . 31.6 m -87.94 126.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 107.873 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 44' ' ' THR . 3.5 mp -121.87 127.97 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.1 110.46 32.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -138.83 167.66 21.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -168.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -103.46 108.87 60.64 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 123.901 0.881 . . . . 0.0 111.01 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.35 76.84 2.18 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.043 3.162 . . . . 0.0 110.674 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -179.09 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.161 2.184 . . . . 0.0 107.846 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.04 -49.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.35 162.28 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.708 1.603 . . . . 0.0 108.244 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -124.67 163.2 22.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 111.973 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.9 t -47.79 -41.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 C-N-CA 123.368 0.667 . . . . 0.0 111.079 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.04 -43.28 87.99 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.21 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -53.23 -51.32 62.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.925 1.239 . . . . 0.0 109.043 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.1 mmt -51.28 -67.28 0.26 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.09 -55.82 26.78 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.06 -1.025 . . . . 0.0 112.876 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -49.76 -49.39 48.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.2 -41.86 94.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 118.619 -1.233 . . . . 0.0 112.674 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.5 -65.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 O-C-N 121.669 -0.644 . . . . 0.0 110.431 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -49.41 -34.65 16.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.458 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.34 -32.63 62.68 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.939 1.245 . . . . 0.0 112.621 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 16.9 mmt -58.96 -41.92 88.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.473 0.579 . . . . 0.0 110.706 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.37 -19.45 3.61 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.634 1.111 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -75.41 114.95 40.9 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.955 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.61 144.88 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.507 1.471 . . . . 0.0 108.969 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.76 135.02 25.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.021 0.438 . . . . 0.0 111.91 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -108.21 78.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.873 1.669 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -56.08 109.36 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.207 1.803 . . . . 0.0 110.335 165.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -155.82 55.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.72 137.78 13.59 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.976 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.74 140.14 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 125.744 1.618 . . . . 0.0 107.932 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 46' ' ' VAL . 37.3 t -89.45 119.35 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.306 1.042 . . . . 0.0 108.404 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm? -95.07 125.1 39.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.84 120.21 41.13 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mtt -118.17 127.0 53.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.419 1.088 . . . . 0.0 108.59 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.11 130.57 36.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.62 138.42 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -104.81 146.58 28.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.967 0.507 . . . . 0.0 109.703 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.3 -36.68 3.97 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.586 0.612 . . . . 0.0 113.346 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 mtp -65.92 94.72 0.23 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.822 0.811 . . . . 0.0 110.357 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -119.72 53.92 1.03 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.267 1.427 . . . . 0.0 108.42 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -171.31 157.49 5.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.453 0.701 . . . . 0.0 109.114 -169.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -27.62 60.6 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.664 167.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -57.16 -69.87 0.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.272 0.629 . . . . 0.0 112.025 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -59.11 -48.08 82.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.159 0.436 . . . . 0.0 110.736 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -50.27 -56.72 9.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.824 0.85 . . . . 0.0 110.621 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 t -57.82 -47.18 83.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.602 0.761 . . . . 0.0 111.454 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.7 m -55.2 -48.06 74.38 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 110.944 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 66' ' ' PHE . 27.5 mt -62.41 -49.42 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 124.194 0.998 . . . . 0.0 108.993 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -46.71 -50.39 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.058 0.943 . . . . 0.0 109.979 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.29 -59.11 11.4 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.022 0.82 . . . . 0.0 112.125 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.79 -57.78 10.98 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.681 0.753 . . . . 0.0 109.776 -174.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.99 -32.03 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.88 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.82 -32.45 25.94 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.754 -0.591 . . . . 0.0 112.419 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.07 4.53 41.72 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 117.906 0.853 . . . . 0.0 112.208 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 152.87 44.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 120.522 1.51 . . . . 0.0 110.102 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -83.45 134.69 34.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 18.87 11.13 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.99 0.805 . . . . 0.0 112.559 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.3 t -122.94 143.93 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.173 1.389 . . . . 0.0 109.757 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.87 -30.42 9.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.286 0.634 . . . . 0.0 112.016 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -160.55 167.27 27.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.874 1.269 . . . . 0.0 108.07 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 tt -155.07 142.13 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.73 151.4 45.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.633 1.573 . . . . 0.0 109.245 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.0 t -140.56 143.51 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.089 0.859 . . . . 0.0 109.546 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 m -112.59 167.99 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.515 1.926 . . . . 0.0 109.297 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.82 -56.98 1.92 Allowed 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.282 1.033 . . . . 0.0 109.239 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.4 -58.2 3.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.977 1.311 . . . . 0.0 111.118 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -91.72 13.38 18.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.277 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 32.15 68.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.795 3.238 . . . . 0.0 112.723 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -136.86 147.85 46.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.067 0.947 . . . . 0.0 109.842 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.34 133.92 50.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.331 1.852 . . . . 0.0 109.665 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 45' ' ' ILE . 38.4 m -112.4 114.28 26.92 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 128.672 2.789 . . . . 0.0 108.66 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.543 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -118.87 113.57 42.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 4' ' ' VAL . 3.0 t -100.04 91.5 2.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.04 13.62 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.717 0.807 . . . . 0.0 113.033 -166.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -102.28 111.14 64.15 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.044 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.9 67.57 3.17 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.974 3.116 . . . . 0.0 109.969 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.43 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.145 1.378 . . . . 0.0 108.702 -173.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.4 -42.18 37.24 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.33 0.252 . . . . 0.0 110.846 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.7 165.15 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 124.402 1.081 . . . . 0.0 108.474 -175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -110.49 158.31 18.65 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.024 1.329 . . . . 0.0 112.056 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -51.09 -46.16 31.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 C-N-CA 124.069 0.948 . . . . 0.0 111.506 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.68 -38.21 84.18 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.174 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -52.0 65.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 120.739 1.609 . . . . 0.0 108.176 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.0 mmt -49.8 -63.14 1.2 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -59.05 -56.19 25.47 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.066 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -43.04 -52.46 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.539 1.135 . . . . 0.0 109.727 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -63.26 -42.19 99.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.39 -62.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 O-C-N 121.838 -0.539 . . . . 0.0 110.174 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -42.77 -41.96 3.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 112.273 171.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.79 -31.9 50.6 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.027 0.831 . . . . 0.0 113.215 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.43 -41.73 90.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.408 0.549 . . . . 0.0 110.84 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.19 -17.89 3.34 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.784 1.183 . . . . 0.0 111.202 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 21' ' ' ILE . 48.3 m-85 -80.78 113.3 39.08 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.77 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.32 149.6 90.81 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 108.682 -1.315 . . . . 0.0 108.682 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.91 137.32 26.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.281 0.233 . . . . 0.0 111.052 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -107.28 74.9 0.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.7 p -62.57 103.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.107 1.363 . . . . 0.0 110.298 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -154.57 55.65 0.68 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.458 0.647 . . . . 0.0 112.125 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 5' ' ' LEU . 3.2 mmtp -158.14 149.78 21.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mp . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 175.389 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 m -107.61 129.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -170.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.7 122.63 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 72' ' ' LYS . 3.3 mm? -107.31 130.35 54.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -115.78 119.43 35.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.1 122.4 35.65 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.081 1.352 . . . . 0.0 108.804 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -70.07 138.6 52.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 172.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.86 143.7 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.26 152.0 19.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.31 -37.0 1.99 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.419 0.533 . . . . 0.0 114.268 166.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.5 mtp -70.6 80.47 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.274 1.037 . . . . 0.0 111.319 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.63 24.51 12.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.771 1.228 . . . . 0.0 111.924 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 p -161.03 166.68 27.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.162 0.982 . . . . 0.0 111.45 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -63.79 168.93 4.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.362 168.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 80.05 -64.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.646 1.178 . . . . 0.0 109.864 -172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 m -60.11 -59.01 6.1 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.995 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CG1' ' A' ' 36' ' ' VAL . 16.5 p -49.61 -63.15 1.19 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.665 1.186 . . . . 0.0 110.287 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -53.22 -40.74 64.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 111.51 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.7 m -59.98 -49.27 78.34 Favored 'General case' 0 N--CA 1.457 -0.086 0 O-C-N 121.621 -0.675 . . . . 0.0 109.837 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.58 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.99 -53.9 36.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.641 0.776 . . . . 0.0 110.506 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -52.23 52.62 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.219 0.914 . . . . 0.0 111.788 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.17 -58.33 8.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -66.26 -29.37 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.887 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.83 -30.84 7.22 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.736 0.684 . . . . 0.0 113.236 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -89.93 6.95 39.79 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.515 1.158 . . . . 0.0 112.354 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.16 152.35 44.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.516 -1.365 . . . . 0.0 111.982 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -96.28 84.87 3.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.114 1.365 . . . . 0.0 109.575 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.69 -4.87 0.8 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 115.407 0.923 . . . . 0.0 115.407 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.23 134.68 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.058 0.943 . . . . 0.0 108.876 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.414 HE21 HG11 ' A' ' 46' ' ' VAL . 1.4 pt20 -94.64 -34.14 12.71 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 111.319 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.3 165.95 32.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.91 145.44 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 103.233 -2.877 . . . . 0.0 103.233 -171.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -142.34 150.72 41.13 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.886 1.274 . . . . 0.0 109.589 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG1' HG22 ' A' ' 18' ' ' THR . 21.9 t -140.39 106.72 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.977 0.808 . . . . 0.0 110.181 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -94.73 80.88 3.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.12 1.368 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -48.01 -41.05 24.5 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.574 0.75 . . . . 0.0 112.371 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.31 -56.33 5.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.093 1.757 . . . . 0.0 110.692 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -100.27 22.83 10.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.955 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 34.19 57.65 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.043 2.537 . . . . 0.0 113.285 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 39.2 tt0 -138.06 131.18 30.23 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.24 147.26 28.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.514 1.526 . . . . 0.0 110.031 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.3 m -124.68 120.12 30.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.307 2.643 . . . . 0.0 106.985 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -121.04 124.92 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.414 HG11 HE21 ' A' ' 32' ' ' GLN . 2.0 t -113.98 97.31 5.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 118.298 0.499 . . . . 0.0 110.443 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -117.75 169.02 9.92 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.341 0.657 . . . . 0.0 112.682 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.91 114.17 61.88 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.209 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.57 77.08 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.532 2.821 . . . . 0.0 111.57 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -177.23 -43.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 127.66 2.384 . . . . 0.0 108.279 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.15 -47.59 27.77 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.4 176.27 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.33 1.452 . . . . 0.0 107.749 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.2 p -143.12 165.99 25.9 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.894 0.77 . . . . 0.0 111.114 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.53 -34.26 28.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 C-N-CA 122.964 0.506 . . . . 0.0 111.953 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -62.06 -42.6 99.36 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.662 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.71 -52.8 62.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.1 mtp -47.34 -59.9 2.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.176 0.591 . . . . 0.0 111.626 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -62.09 -52.88 62.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -47.92 -50.06 28.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.806 0.73 . . . . 0.0 109.241 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -61.4 -49.27 77.58 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.28 -63.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.805 -0.56 . . . . 0.0 110.514 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -45.94 -39.15 8.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.754 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.63 60.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.736 1.153 . . . . 0.0 113.044 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.0 mmt -56.61 -39.43 73.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.51 0.596 . . . . 0.0 110.843 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.87 -17.98 4.33 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.333 1.444 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -78.47 115.22 49.73 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 123.856 0.862 . . . . 0.0 110.213 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -66.83 141.55 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.07 138.03 39.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.646 0.378 . . . . 0.0 111.506 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.09 78.73 1.2 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.733 0.813 . . . . 0.0 109.276 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.6 p -65.07 104.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.841 1.656 . . . . 0.0 110.42 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -156.18 58.48 0.58 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.634 0.731 . . . . 0.0 112.524 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.655 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -156.36 132.06 9.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 tp . . . . . 0 C--N 1.332 -0.16 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.746 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 . . . . . 0 N--CA 1.45 -0.464 0 CA-C-O 120.303 0.097 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.91 131.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.91 0.884 . . . . 0.0 109.771 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.24 123.64 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.584 1.554 . . . . 0.0 106.888 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.563 HD22 ' CG2' ' A' ' 70' ' ' VAL . 19.7 mt -93.08 128.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 159.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -110.24 127.65 55.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.438 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 13.1 ptm -140.71 132.06 26.73 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -75.87 138.84 41.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 m -124.85 150.7 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.39 150.04 31.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.203 0.456 . . . . 0.0 110.339 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.37 -33.1 1.57 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.666 0.651 . . . . 0.0 113.865 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.9 mtp -67.3 78.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.932 0.893 . . . . 0.0 111.916 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -134.07 43.55 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.392 1.077 . . . . 0.0 110.16 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -161.25 151.25 17.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.476 1.11 . . . . 0.0 108.752 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -75.03 55.83 0.74 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.893 1.277 . . . . 0.0 111.427 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.8 m -136.77 -64.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -60.43 -54.24 47.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.751 0.821 . . . . 0.0 109.737 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 t -45.8 -62.94 1.09 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.535 1.134 . . . . 0.0 110.006 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 t -63.77 -39.13 93.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.989 0.516 . . . . 0.0 109.937 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.0 m -58.82 -49.59 77.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.772 -0.58 . . . . 0.0 110.076 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.6 -50.73 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.258 0.481 . . . . 0.0 109.939 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -44.41 -54.57 5.77 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.499 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.68 -57.39 20.12 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.796 0.712 . . . . 0.0 112.04 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -58.63 -54.46 46.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.42 0.628 . . . . 0.0 110.155 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.72 -38.29 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.99 0.916 . . . . 0.0 110.159 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.73 18.94 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.856 -0.527 . . . . 0.0 112.24 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -73.47 -13.82 61.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.18 140.78 47.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 120.266 1.394 . . . . 0.0 112.31 -169.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -69.51 80.17 0.4 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.015 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.31 -19.32 0.23 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.43 133.55 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -31.17 13.01 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.042 0.537 . . . . 0.0 111.485 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -154.36 161.05 41.97 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -156.07 137.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -138.51 153.13 48.75 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.289 1.036 . . . . 0.0 110.148 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.0 t -138.18 111.74 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -87.7 69.54 9.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.658 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -48.34 -42.49 31.49 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.498 0.499 . . . . 0.0 110.624 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -56.33 5.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.711 2.004 . . . . 0.0 111.102 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -98.56 22.35 9.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.062 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 44.13 53.74 6.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.706 2.002 . . . . 0.0 112.782 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.28 147.79 49.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.453 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 148.93 48.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.383 1.873 . . . . 0.0 109.626 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -129.36 116.69 19.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.461 2.704 . . . . 0.0 107.064 -171.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 mm -123.17 110.41 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.57 94.64 3.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -171.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -111.91 167.8 10.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.311 0.577 . . . . 0.0 112.084 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -110.12 113.64 56.62 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.671 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.13 77.11 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.434 2.756 . . . . 0.0 111.176 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -177.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 128.018 2.527 . . . . 0.0 107.954 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.13 -48.55 17.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.39 176.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.514 1.526 . . . . 0.0 108.316 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.1 p -142.62 162.0 36.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.544 0.738 . . . . 0.0 111.502 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.433 HG22 HD21 ' A' ' 5' ' ' LEU . 21.1 t -44.08 -45.61 2.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 125.452 1.501 . . . . 0.0 111.681 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -54.99 39.0 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-O 117.146 -1.407 . . . . 0.0 109.035 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -46.47 -55.33 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 110.437 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.0 mmt -46.21 -56.92 5.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.814 0.734 . . . . 0.0 111.713 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -62.84 -61.57 2.31 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.212 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -40.35 -52.14 2.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.961 1.704 . . . . 0.0 109.156 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -61.98 -47.37 85.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.98 -64.73 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.83 -0.544 . . . . 0.0 111.089 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -43.98 -40.05 4.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.69 0.796 . . . . 0.0 112.692 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.72 -32.41 59.62 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.326 0.966 . . . . 0.0 112.861 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.8 mmt -57.81 -41.81 82.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.368 0.531 . . . . 0.0 110.293 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.53 -19.05 2.81 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.622 1.106 . . . . 0.0 111.093 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -78.08 119.27 76.71 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.008 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.91 145.51 80.31 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.575 -1.356 . . . . 0.0 108.575 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.69 135.99 26.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.609 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -99.18 82.82 2.76 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD22 ' A' ' 5' ' ' LEU . 2.4 p -70.07 105.58 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.069 1.347 . . . . 0.0 110.444 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -155.31 58.98 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 5' ' ' LEU . 34.9 mttm -153.71 154.01 33.31 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 159.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 163.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 . . . . . 0 CA--C 1.533 0.324 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.99 136.29 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.933 0.893 . . . . 0.0 109.23 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.485 HG23 HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -90.76 134.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.322 1.449 . . . . 0.0 108.655 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 47' ' ' TYR . 6.1 mp -122.15 151.63 40.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 165.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -120.24 123.03 42.22 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -124.01 129.53 51.07 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.138 1.375 . . . . 0.0 108.345 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 120.85 29.47 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.389 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.86 125.12 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 124.228 0.955 . . . . 0.0 109.347 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -87.64 152.49 22.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.394 0.677 . . . . 0.0 109.264 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.82 -46.18 1.23 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.518 0.58 . . . . 0.0 112.87 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mtp -70.01 82.64 0.49 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.807 0.804 . . . . 0.0 111.924 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.8 m -133.61 -9.07 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.703 1.601 . . . . 0.0 112.22 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 p -80.8 -17.38 51.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.444 1.498 . . . . 0.0 113.55 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 m80 84.45 -31.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.267 2.227 . . . . 0.0 112.262 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -62.26 -65.76 0.64 Allowed 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -50.88 -48.5 60.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 111.83 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -48.0 -62.32 1.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 109.754 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -59.35 -47.17 86.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.486 1.114 . . . . 0.0 110.84 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.9 m -52.15 -50.09 62.44 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.706 0.803 . . . . 0.0 110.877 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.9 -47.8 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 123.807 0.843 . . . . 0.0 109.447 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -44.67 -52.73 7.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.038 0.935 . . . . 0.0 110.079 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.54 8.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.979 0.8 . . . . 0.0 112.683 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -50.71 70.76 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 121.508 0.67 . . . . 0.0 109.984 -171.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.36 -41.22 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.774 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.78 -34.46 21.87 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.319 0.485 . . . . 0.0 112.518 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -71.14 -7.93 50.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.796 0.838 . . . . 0.0 113.095 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.6 144.77 45.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 120.656 1.571 . . . . 0.0 111.689 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -81.73 61.19 5.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.16 22.45 0.02 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.57 150.52 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -111.77 -40.35 4.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.02 0.928 . . . . 0.0 109.387 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -159.97 164.86 32.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 tt -157.67 141.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 103.903 -2.628 . . . . 0.0 103.903 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -143.04 144.72 32.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.628 1.171 . . . . 0.0 110.119 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.64 131.74 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.174 0.897 . . . . 0.0 110.505 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -113.88 94.28 4.76 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.227 1.811 . . . . 0.0 109.733 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.32 91.22 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.058 -0.401 . . . . 0.0 112.075 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.83 -57.18 6.8 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.791 1.237 . . . . 0.0 111.049 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -95.2 20.62 8.92 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.742 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 30.81 67.35 0.12 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.776 2.43 . . . . 0.0 113.185 -169.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -131.35 157.64 42.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.626 1.17 . . . . 0.0 109.742 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.17 149.88 50.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.663 1.185 . . . . 0.0 109.698 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 m -127.66 121.3 30.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.424 2.689 . . . . 0.0 106.463 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 mm -128.4 118.87 48.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 4' ' ' VAL . 1.7 t -121.66 105.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.202 -170.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 5' ' ' LEU . 35.2 p90 -137.58 176.18 8.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.549 -0.72 . . . . 0.0 112.122 -168.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.7 108.26 61.14 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.307 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.82 71.89 4.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 3.307 . . . . 0.0 110.264 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -173.23 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.559 1.944 . . . . 0.0 108.656 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.09 -42.05 11.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.497 0.319 . . . . 0.0 111.297 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.23 160.62 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 125.334 1.453 . . . . 0.0 108.211 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -119.93 168.83 10.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.191 0.996 . . . . 0.0 112.153 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.82 -42.5 18.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.842 0.457 . . . . 0.0 110.699 166.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.95 -46.58 71.03 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.747 -171.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.35 -58.09 4.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.779 1.172 . . . . 0.0 109.359 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.0 mmt -48.17 -66.79 0.34 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.801 0.441 . . . . 0.0 111.746 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -60.41 -58.94 6.35 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 121.129 -0.982 . . . . 0.0 112.263 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -41.44 -50.23 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.45 1.023 . . . . 0.0 109.353 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -65.65 -42.64 91.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.17 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.79 -62.8 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 119.067 0.849 . . . . 0.0 110.883 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -41.67 -40.74 2.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.934 0.894 . . . . 0.0 112.372 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -31.46 44.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.9 -39.63 78.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.371 0.668 . . . . 0.0 110.631 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.6 3.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.823 1.201 . . . . 0.0 111.307 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.06 112.08 42.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.478 1.111 . . . . 0.0 110.393 -169.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.47 128.05 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.795 1.663 . . . . 0.0 109.699 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.7 139.04 53.61 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.864 0.866 . . . . 0.0 111.687 -174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -111.7 76.83 1.0 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.514 0.726 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 70' ' ' VAL . 8.5 p -68.76 103.15 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.8 1.64 . . . . 0.0 110.73 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.09 57.0 0.59 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 112.787 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -158.7 139.79 13.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.53 0.21 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 121.149 0.499 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -136.82 140.49 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.502 1.521 . . . . 0.0 107.729 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.22 129.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.57 142.82 43.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -128.69 116.76 20.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.494 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 7.1 ptp -113.42 131.71 55.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.524 0.729 . . . . 0.0 109.566 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -68.01 137.84 55.4 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 165.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 m -121.74 151.96 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -118.22 145.7 44.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.2 -41.45 2.41 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.813 0.721 . . . . 0.0 112.554 171.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -56.56 115.19 2.38 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.12 0.96 . . . . 0.0 110.498 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.439 ' O ' HG22 ' A' ' 13' ' ' THR . 17.9 m -148.33 39.35 0.9 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.248 1.019 . . . . 0.0 108.362 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -152.53 158.03 41.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -67.19 -19.21 65.53 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.456 0.473 . . . . 0.0 111.928 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.89 -58.1 9.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.34 -52.53 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.675 0.39 . . . . 0.0 110.879 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -54.83 -55.94 24.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -57.05 -45.14 83.42 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.467 0.707 . . . . 0.0 111.196 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -54.6 -50.48 67.95 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.277 -0.889 . . . . 0.0 110.915 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.43 -48.23 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -46.16 -53.59 10.17 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.013 1.325 . . . . 0.0 109.804 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.77 -59.34 9.93 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.102 0.858 . . . . 0.0 111.286 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -55.6 -61.22 2.49 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.601 0.7 . . . . 0.0 110.884 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.69 -47.46 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.752 0.821 . . . . 0.0 109.365 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.41 -40.92 39.68 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -73.68 -9.6 58.83 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.858 0.863 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mt -85.52 132.18 34.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.942 1.246 . . . . 0.0 110.198 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.33 134.95 55.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.62 -20.41 4.9 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.421 0.534 . . . . 0.0 112.466 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.3 141.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.876 1.271 . . . . 0.0 110.392 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -30.77 10.62 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 111.707 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -164.52 168.81 17.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -158.5 143.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -144.85 93.69 2.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 0.0 112.014 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.2 105.36 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.246 0.618 . . . . 0.0 111.188 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -96.68 125.39 41.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.218 1.007 . . . . 0.0 111.402 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -44.64 18.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.978 0.511 . . . . 0.0 110.25 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -61.58 2.06 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 126.142 1.777 . . . . 0.0 110.622 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -91.87 18.61 7.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.863 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.2 62.7 0.29 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.371 2.668 . . . . 0.0 112.234 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.91 124.33 18.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.64 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.38 112.84 25.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.31 1.444 . . . . 0.0 109.839 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -83.76 132.01 34.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.007 1.323 . . . . 0.0 107.753 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -131.07 124.98 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.6 109.02 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.448 0.567 . . . . 0.0 110.442 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -129.67 166.8 19.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -165.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -101.3 106.4 45.21 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 109.758 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.61 81.32 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.625 2.884 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 175.21 -42.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.493 2.317 . . . . 0.0 107.802 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.26 -56.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 167.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.171 1.389 . . . . 0.0 110.167 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -130.01 166.45 20.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.095 1.358 . . . . 0.0 110.091 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -46.85 -45.44 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.621 1.169 . . . . 0.0 111.536 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.71 -39.06 87.14 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 118.942 -0.551 . . . . 0.0 111.171 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.4 -46.95 88.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.6 mtt -51.78 -60.62 2.96 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 122.521 0.329 . . . . 0.0 111.7 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -55.51 33.05 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.064 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -45.56 -53.56 8.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 109.284 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -59.18 -49.02 79.44 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -71.99 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 110.793 -172.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.96 -37.1 13.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.89 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.44 64.75 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.782 1.174 . . . . 0.0 112.73 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.1 mmt -60.39 -43.72 96.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 110.189 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.93 -17.56 3.63 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.96 1.267 . . . . 0.0 110.953 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -72.26 115.55 40.03 Favored Pre-proline 0 N--CA 1.453 -0.318 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.112 -173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -69.2 139.48 42.28 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.527 -1.374 . . . . 0.0 108.527 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.23 138.2 41.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.778 0.431 . . . . 0.0 112.04 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -113.22 78.56 1.15 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.442 1.497 . . . . 0.0 109.512 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -50.71 112.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.597 1.159 . . . . 0.0 108.983 161.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.47 59.7 0.63 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 112.398 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.25 159.18 37.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.538 0.505 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 . . . . . 0 N--CA 1.452 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 110.341 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -117.34 132.51 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 127.36 2.264 . . . . 0.0 106.374 162.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.41 130.11 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.646 HD12 ' CG2' ' A' ' 70' ' ' VAL . 2.6 mm? -118.56 143.39 46.8 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 170.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -123.73 117.83 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.9 ptp -123.19 131.76 53.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.283 1.033 . . . . 0.0 109.187 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -83.76 116.22 22.59 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.21 144.69 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -56.94 148.68 20.48 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.399 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.31 40.12 1.72 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.159 0.885 . . . . 0.0 113.527 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 45.4 -140.33 0.37 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 113.205 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -124.64 -41.27 2.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.178 1.391 . . . . 0.0 110.267 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.15 165.47 24.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -55.23 -26.08 37.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.536 0.734 . . . . 0.0 112.623 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.4 m -50.59 -44.21 56.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.756 -0.59 . . . . 0.0 110.465 171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -66.64 -55.22 16.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.317 0.647 . . . . 0.0 110.09 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.8 p -53.97 -54.38 39.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.4 t -57.41 -45.98 83.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.942 0.897 . . . . 0.0 110.942 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.6 m -57.09 -49.32 76.23 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.632 -0.668 . . . . 0.0 109.974 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.9 mt -56.07 -48.45 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 118.466 0.575 . . . . 0.0 109.756 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -55.83 -50.44 70.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.803 0.841 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -54.94 33.79 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.648 0.642 . . . . 0.0 112.083 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -53.67 -50.63 65.39 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.256 1.022 . . . . 0.0 110.241 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 34' ' ' ILE . 14.1 mm -63.29 -49.13 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 109.75 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.37 -36.15 10.71 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 117.989 0.358 . . . . 0.0 112.314 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -69.06 -15.43 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.29 145.01 35.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.693 1.133 . . . . 0.0 111.736 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.18 65.13 4.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.28 13.67 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -170.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.97 143.71 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 119.456 1.628 . . . . 0.0 110.41 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -108.33 -45.05 3.98 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.503 1.521 . . . . 0.0 109.817 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -163.19 171.12 16.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 25' ' ' ILE . 5.2 tt -159.57 144.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 34.3 mmtt -141.84 84.73 1.9 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.671 0.788 . . . . 0.0 110.742 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.19 105.72 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.573 0.749 . . . . 0.0 110.78 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 m -108.48 135.08 50.36 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.824 0.85 . . . . 0.0 111.031 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -48.05 6.52 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.915 0.486 . . . . 0.0 109.764 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -54.39 27.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.636 1.574 . . . . 0.0 110.25 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -79.23 -0.98 34.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.946 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 49.23 58.09 5.76 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.407 1.883 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.4 130.69 8.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.047 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -110.21 115.53 29.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.258 1.423 . . . . 0.0 108.996 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 35' ' ' LYS . 53.4 m -90.14 133.85 34.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 107.309 169.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.66 129.93 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -117.92 106.6 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -127.16 165.22 19.98 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 122.062 -0.399 . . . . 0.0 111.564 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.65 123.05 62.9 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.36 145.67 92.88 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.609 1.539 . . . . 0.0 108.676 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 87.27 -23.02 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.693 1.597 . . . . 0.0 111.824 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.46 -47.36 8.4 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.719 1.145 . . . . 0.0 110.929 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -137.91 158.02 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.639 1.576 . . . . 0.0 108.448 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -114.24 169.92 8.68 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.854 0.862 . . . . 0.0 111.053 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.92 -41.1 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.481 0.712 . . . . 0.0 111.482 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.46 -53.21 51.86 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -171.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -37.3 -60.47 0.66 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.079 1.752 . . . . 0.0 111.486 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 15.4 mtm -48.77 -64.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -59.05 5.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.869 -173.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -36.12 -55.35 0.78 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.006 1.323 . . . . 0.0 111.11 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -60.85 -43.01 98.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.363 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -65.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -37.62 -46.26 0.84 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.177 0.991 . . . . 0.0 112.363 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.87 -32.04 60.4 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.6 mmt -60.32 -39.91 88.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.366 0.53 . . . . 0.0 110.643 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.66 -11.63 3.44 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.512 1.053 . . . . 0.0 111.281 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -90.14 110.47 40.6 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.039 0.936 . . . . 0.0 109.151 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.61 132.82 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.844 1.696 . . . . 0.0 109.301 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.28 49.08 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.003 0.921 . . . . 0.0 111.423 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -117.38 79.07 1.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.845 0.858 . . . . 0.0 109.438 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.646 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.1 p -63.62 108.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.025 1.73 . . . . 0.0 110.95 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -154.29 59.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.203 1.002 . . . . 0.0 113.239 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.525 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -159.23 159.86 34.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 120.803 -1.186 . . . . 0.0 108.166 178.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.1 tp . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 122.29 1.043 . . . . 0.0 109.377 -177.53 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 120.597 0.237 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.31 141.46 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 125.467 1.507 . . . . 0.0 107.889 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.42 122.62 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 72' ' ' LYS . 15.0 mt -100.09 141.83 32.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 168.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 72' ' ' LYS . 16.8 tptt -119.12 125.49 49.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -124.34 119.12 28.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.378 1.471 . . . . 0.0 108.955 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 120.76 22.95 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m -105.68 152.56 7.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -116.12 150.48 37.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.168 0.44 . . . . 0.0 110.786 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.97 -30.23 2.07 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.533 0.587 . . . . 0.0 114.079 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtp -68.93 85.38 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.016 0.908 . . . . 0.0 111.669 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -114.92 6.97 15.52 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.761 1.224 . . . . 0.0 112.232 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -129.12 139.74 51.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.317 0.962 . . . . 0.0 111.236 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -31.51 54.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.363 1.065 . . . . 0.0 111.962 -171.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -45.81 -55.1 7.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.329 1.052 . . . . 0.0 111.709 170.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.86 -54.6 28.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.315 0.507 . . . . 0.0 109.847 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -51.68 -54.96 22.42 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.637 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.6 t -57.85 -46.09 85.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.473 0.579 . . . . 0.0 111.346 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.8 m -56.81 -50.91 70.95 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.368 -0.833 . . . . 0.0 110.843 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.77 -43.9 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.97 -47.88 76.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.917 0.887 . . . . 0.0 110.658 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.88 41.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.825 0.726 . . . . 0.0 111.321 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -65.62 -59.91 3.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.433 0.635 . . . . 0.0 110.946 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.75 -30.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.009 0.924 . . . . 0.0 110.388 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.69 -29.31 7.71 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.498 -0.612 . . . . 0.0 112.764 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -92.43 7.9 41.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.494 1.147 . . . . 0.0 112.77 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.44 159.5 33.13 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.413 1.46 . . . . 0.0 111.656 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.36 82.97 2.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.471 1.508 . . . . 0.0 109.725 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.08 11.79 0.26 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.4 128.6 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 109.599 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -86.22 -36.63 19.32 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -154.23 168.24 27.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 122.201 1.0 . . . . 0.0 108.656 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -157.42 141.6 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -140.61 82.49 1.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 0.0 110.432 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.13 116.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.515 0.726 . . . . 0.0 109.111 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -97.33 -174.23 2.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -147.52 -47.8 0.17 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.23 1.012 . . . . 0.0 109.533 179.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.59 -55.83 7.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.514 1.525 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -94.04 19.19 9.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.56 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 36.52 61.48 0.82 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.35 2.26 . . . . 0.0 112.445 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.14 154.55 37.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.184 -0.947 . . . . 0.0 108.758 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.64 130.04 31.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.104 0.962 . . . . 0.0 109.877 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.8 m -92.85 132.75 36.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.743 1.617 . . . . 0.0 107.038 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.3 125.56 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 170.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.33 119.42 50.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.98 161.04 38.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -98.91 116.17 65.42 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.531 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.94 73.13 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.583 2.855 . . . . 0.0 110.546 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -174.73 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 109.744 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.27 -42.88 18.26 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.146 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.27 159.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -119.57 168.68 10.77 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.113 0.869 . . . . 0.0 112.139 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -44.03 -50.33 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.289 1.435 . . . . 0.0 111.209 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -42.68 86.92 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.71 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -48.6 -52.7 21.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.512 1.505 . . . . 0.0 108.663 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -61.64 2.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 121.38 -0.128 . . . . 0.0 111.236 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -58.24 9.14 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.569 -0.707 . . . . 0.0 112.266 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.43 -49.83 24.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.103 0.961 . . . . 0.0 109.458 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.28 -44.28 96.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.896 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.03 -63.87 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 123.166 0.587 . . . . 0.0 110.538 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -43.23 -41.41 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.468 0.707 . . . . 0.0 112.671 172.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.97 -31.26 50.12 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.044 0.838 . . . . 0.0 113.007 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.1 mmt -57.02 -41.65 78.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.372 0.533 . . . . 0.0 111.064 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 -20.79 2.53 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.531 1.062 . . . . 0.0 111.057 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -84.77 110.51 28.32 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 124.24 1.016 . . . . 0.0 110.068 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.82 139.21 61.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.78 134.58 26.82 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.6 72.14 1.54 Allowed 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.172 0.589 . . . . 0.0 110.371 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.55 94.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.012 1.325 . . . . 0.0 112.548 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -158.51 84.32 0.84 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.005 -0.434 . . . . 0.0 110.083 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -158.16 160.43 37.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 158.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mp . . . . . 0 C--N 1.327 -0.383 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 167.308 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 140.91 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 46' ' ' VAL . 18.4 t -103.59 127.45 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.274 1.43 . . . . 0.0 107.473 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 70' ' ' VAL . 1.9 pp -112.23 152.02 28.92 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -122.0 121.36 36.85 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.0 mtt -102.31 139.46 37.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -83.93 134.5 34.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 163.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.89 143.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 119.581 1.082 . . . . 0.0 108.819 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -114.58 140.87 48.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.82 -34.61 5.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.83 1.205 . . . . 0.0 112.922 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.0 mtm -69.19 95.33 0.75 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.059 0.93 . . . . 0.0 111.527 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -111.05 27.24 9.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.376 1.07 . . . . 0.0 112.886 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -151.04 159.74 44.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.282 0.947 . . . . 0.0 109.219 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -76.1 -12.66 60.15 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 m -62.76 -54.46 38.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.23 -51.68 65.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.771 0.26 . . . . 0.0 110.775 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p -52.69 -59.34 4.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 109.912 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -57.52 -44.3 84.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.938 0.895 . . . . 0.0 111.258 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.6 m -55.45 -48.69 74.1 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.364 -0.835 . . . . 0.0 110.751 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.34 -50.03 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 122.003 -0.435 . . . . 0.0 109.989 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -46.6 -49.56 18.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.511 1.124 . . . . 0.0 109.684 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -59.11 11.34 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.348 0.975 . . . . 0.0 112.398 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -55.23 37.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.725 0.763 . . . . 0.0 110.294 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.3 mm -70.83 -32.48 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.76 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.19 20.3 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.46 -0.775 . . . . 0.0 112.792 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -79.13 -3.6 46.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.312 1.056 . . . . 0.0 112.552 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.76 134.08 48.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.302 1.41 . . . . 0.0 111.265 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -77.26 115.71 17.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.29 -9.19 5.93 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.21 0.91 . . . . 0.0 111.904 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.45 150.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.28 0.632 . . . . 0.0 109.818 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -109.54 -40.4 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.647 1.579 . . . . 0.0 109.081 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -162.31 172.25 15.97 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.32 1.057 . . . . 0.0 108.741 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -156.46 143.23 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -142.61 146.76 34.86 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.659 1.583 . . . . 0.0 109.419 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -136.23 146.22 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.616 1.098 . . . . 0.0 109.793 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 m -124.68 148.46 47.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 127.494 2.318 . . . . 0.0 109.636 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.0 -56.91 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.87 1.668 . . . . 0.0 110.946 -171.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.03 -58.68 4.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.682 1.593 . . . . 0.0 110.484 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -85.15 0.29 52.19 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 41.23 70.99 0.22 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.737 2.815 . . . . 0.0 110.762 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -140.29 145.61 37.48 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.984 -163.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.75 113.15 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.628 1.571 . . . . 0.0 109.721 -168.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 45' ' ' ILE . 39.7 m -89.2 118.7 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.505 2.722 . . . . 0.0 109.574 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 ' C ' ' A' ' 44' ' ' THR . 2.9 mp -121.71 124.71 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -118.27 104.78 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -138.05 167.52 21.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 111.797 -167.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -101.79 107.82 53.53 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 123.931 0.892 . . . . 0.0 109.377 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.68 83.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.153 2.569 . . . . 0.0 110.51 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.3 m80 176.54 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 128.132 2.573 . . . . 0.0 107.765 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.65 -51.46 10.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.595 0.236 . . . . 0.0 110.756 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tp -134.34 177.13 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.471 1.509 . . . . 0.0 107.648 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.1 p -136.57 171.97 13.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.602 0.637 . . . . 0.0 110.609 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.2 t -48.33 -35.28 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.043 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -47.41 62.62 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.934 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.95 -51.34 70.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.693 1.197 . . . . 0.0 108.241 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.9 mmt -47.27 -59.81 2.93 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.23 -58.98 6.07 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.14 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 -50.91 9.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.424 1.09 . . . . 0.0 108.692 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -63.44 -45.63 90.01 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.166 0.291 . . . . 0.0 111.311 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.1 -66.62 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.149 0.58 . . . . 0.0 111.213 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -45.3 -38.79 5.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.941 0.791 . . . . 0.0 111.918 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.71 62.14 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.629 1.104 . . . . 0.0 113.123 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.5 mmt -54.93 -41.03 70.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.544 0.611 . . . . 0.0 110.546 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -18.86 3.28 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.52 1.057 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.14 113.58 34.73 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.998 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.37 136.78 44.71 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 N-CA-C 108.965 -1.206 . . . . 0.0 108.965 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 131.71 45.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.875 0.845 . . . . 0.0 112.088 -176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -103.81 77.51 1.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.836 2.054 . . . . 0.0 109.115 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 5' ' ' LEU . 14.4 p -62.61 107.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.738 0.815 . . . . 0.0 110.634 171.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -155.58 55.46 0.62 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -157.35 157.32 33.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 tp . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.861 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 47' ' ' TYR . 12.9 p -87.36 112.99 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.83 128.13 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 70' ' ' VAL . 3.5 mm? -116.82 123.11 46.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -100.15 118.61 36.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -118.0 125.14 49.81 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.361 1.464 . . . . 0.0 108.654 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -70.83 138.08 50.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.1 m -129.74 139.2 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -101.26 150.31 23.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 -40.54 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.327 -0.707 . . . . 0.0 113.779 166.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.4 mtm -62.79 86.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.393 1.097 . . . . 0.0 110.934 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 m -148.19 47.75 1.06 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.732 1.613 . . . . 0.0 108.243 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 p -128.74 -4.66 5.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.093 1.757 . . . . 0.0 111.578 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 66.08 -25.69 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.431 1.493 . . . . 0.0 114.082 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -67.5 -75.15 0.1 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.075 -1.015 . . . . 0.0 111.181 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -44.02 -53.9 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.156 1.783 . . . . 0.0 112.254 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -50.54 -50.7 52.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.688 0.795 . . . . 0.0 111.025 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -65.74 -44.1 86.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.143 0.577 . . . . 0.0 110.494 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 m -50.87 -52.63 39.83 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.696 -0.628 . . . . 0.0 110.313 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -44.74 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 119.196 -0.431 . . . . 0.0 110.665 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.13 -49.05 75.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.327 0.512 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.64 -54.49 30.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.593 0.615 . . . . 0.0 111.806 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -60.72 -55.03 38.04 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.97 -0.724 . . . . 0.0 110.769 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.16 -43.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.143 1.377 . . . . 0.0 109.804 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.07 -29.78 6.9 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.773 0.701 . . . . 0.0 113.961 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -87.87 -12.95 43.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.802 1.301 . . . . 0.0 112.532 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.34 130.78 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.394 1.452 . . . . 0.0 111.866 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.66 90.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.587 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.24 -26.01 0.88 Allowed Glycine 0 C--N 1.331 0.296 0 O-C-N 121.996 -0.44 . . . . 0.0 112.617 -173.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.92 147.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 117.573 0.686 . . . . 0.0 110.249 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -125.19 -31.98 3.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.335 1.054 . . . . 0.0 111.688 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.41 163.43 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -158.85 140.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -144.42 85.31 1.78 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.006 0.922 . . . . 0.0 110.49 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.75 114.99 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -94.53 165.24 12.63 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -47.67 2.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.601 0.76 . . . . 0.0 109.945 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -55.95 13.3 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.178 1.391 . . . . 0.0 110.852 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -90.56 13.37 16.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.873 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 38.5 58.67 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.964 2.105 . . . . 0.0 112.685 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 30.9 tt0 -145.95 142.28 28.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.46 123.7 34.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.522 1.129 . . . . 0.0 110.193 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 m -94.89 127.68 41.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.152 1.381 . . . . 0.0 107.687 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.41 126.11 70.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.9 112.03 34.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.345 0.52 . . . . 0.0 110.659 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.438 ' O ' HG12 ' A' ' 3' ' ' VAL . 32.6 p90 -132.56 168.99 17.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.423 0.63 . . . . 0.0 112.155 -173.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -90.97 113.06 56.84 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 124.629 1.172 . . . . 0.0 109.203 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -74.71 76.89 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.821 2.347 . . . . 0.0 110.873 -170.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -176.01 -47.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.158 2.183 . . . . 0.0 108.305 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.15 -43.83 41.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.334 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.71 169.49 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 108.002 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -138.37 164.79 28.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 111.14 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 70' ' ' VAL . 93.9 t -43.33 -47.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 124.34 1.056 . . . . 0.0 110.899 170.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -49.48 77.32 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.745 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.23 -49.55 73.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.1 1.318 . . . . 0.0 109.415 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.2 -60.95 2.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.132 0.424 . . . . 0.0 111.421 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -57.08 -64.08 1.0 Allowed 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.758 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.26 -52.29 2.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.818 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.61 -39.03 88.16 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.89 -63.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 O-C-N 121.734 -0.604 . . . . 0.0 111.056 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -43.8 -39.26 3.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.56 0.744 . . . . 0.0 112.16 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.06 42.18 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.212 0.915 . . . . 0.0 113.164 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -61.7 -36.44 80.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.466 0.575 . . . . 0.0 111.107 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.26 -11.19 5.85 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.862 1.22 . . . . 0.0 111.263 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -84.65 114.76 57.21 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.274 1.029 . . . . 0.0 109.455 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -67.96 140.21 49.54 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.327 1.351 . . . . 0.0 108.598 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.66 140.12 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.696 0.399 . . . . 0.0 111.377 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -112.89 73.93 0.84 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.683 1.193 . . . . 0.0 110.185 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 5' ' ' LEU . 8.9 p -65.98 103.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.329 1.852 . . . . 0.0 111.813 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -157.29 54.62 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -159.05 80.71 0.77 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.963 -1.085 . . . . 0.0 111.075 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.8 mt . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 124.725 1.21 . . . . 0.0 109.409 -172.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.95 143.79 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.777 1.631 . . . . 0.0 107.722 163.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.14 143.91 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 124.551 1.14 . . . . 0.0 108.125 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.406 ' CD1' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -129.08 117.49 20.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -100.28 125.17 46.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mtt -121.05 119.93 33.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.202 1.001 . . . . 0.0 109.141 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.1 mptp? -73.4 121.96 21.31 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.23 149.66 13.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -114.76 148.01 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.86 -33.02 3.6 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.541 1.067 . . . . 0.0 113.048 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.7 mtp -69.09 75.69 0.33 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 112.91 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 m -142.26 58.2 1.46 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.588 1.155 . . . . 0.0 111.096 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.85 16.83 0.77 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.07 0.548 . . . . 0.0 111.832 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.7 m80 68.8 -35.39 0.3 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.928 1.691 . . . . 0.0 113.357 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -59.84 -51.76 68.36 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.399 1.479 . . . . 0.0 110.874 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -63.56 -60.3 3.51 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.114 0.566 . . . . 0.0 110.655 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -43.8 -58.14 2.89 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.399 1.08 . . . . 0.0 110.327 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -67.04 -43.46 82.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -55.34 -47.07 76.27 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.635 -0.666 . . . . 0.0 110.516 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.75 -48.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.74 -51.32 22.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.292 0.637 . . . . 0.0 109.835 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.24 -58.8 12.64 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.551 0.595 . . . . 0.0 112.334 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -61.28 -60.25 4.03 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.763 0.792 . . . . 0.0 109.741 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -66.37 -27.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.542 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -44.92 -37.35 5.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.59 0.614 . . . . 0.0 112.84 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -88.09 4.13 46.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.989 0.895 . . . . 0.0 112.719 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.28 153.09 43.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 120.292 -1.505 . . . . 0.0 110.374 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -87.07 141.11 28.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.77 11.5 55.02 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.017 0.817 . . . . 0.0 112.783 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -104.59 147.39 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.112 1.365 . . . . 0.0 109.541 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -109.73 -46.47 3.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.615 1.566 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.47 169.62 21.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.0 133.84 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 48.3 mmtt -137.76 154.46 49.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.154 1.381 . . . . 0.0 108.456 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.23 110.32 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -82.01 75.78 8.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 0.0 108.659 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.48 -41.72 9.83 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.476 0.71 . . . . 0.0 110.606 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.42 -56.75 4.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.441 1.497 . . . . 0.0 111.378 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.92 13.71 25.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.008 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.22 60.74 3.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.74 2.016 . . . . 0.0 111.288 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 10.2 tt0 -143.92 132.5 22.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.486 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.16 135.14 40.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.87 1.668 . . . . 0.0 109.465 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.4 m -114.12 81.9 1.61 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.169 2.588 . . . . 0.0 107.684 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.08 127.82 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.26 107.63 20.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 110.416 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' HG23 ' A' ' 54' ' ' VAL . 12.9 p90 -134.57 173.46 11.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.656 -0.652 . . . . 0.0 111.925 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -106.76 106.98 59.5 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.629 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.32 76.28 1.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.202 3.268 . . . . 0.0 110.937 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.74 -43.21 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.627 1.971 . . . . 0.0 108.295 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.62 -42.34 18.35 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.21 169.39 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -120.24 155.54 33.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.461 1.104 . . . . 0.0 111.068 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.49 HG23 ' OH ' ' A' ' 47' ' ' TYR . 3.5 t -39.03 -49.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.469 1.108 . . . . 0.0 110.958 164.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -62.75 -46.75 86.6 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.788 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.11 -49.41 73.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.904 1.684 . . . . 0.0 108.53 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.26 -60.27 3.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -59.78 -56.94 15.55 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.82 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.73 -51.09 16.95 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.751 0.82 . . . . 0.0 108.947 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -60.52 -44.66 95.79 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.617 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.94 -65.15 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 122.979 0.512 . . . . 0.0 110.508 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -44.34 -40.21 5.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 118.929 0.786 . . . . 0.0 112.557 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.2 60.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.276 0.944 . . . . 0.0 113.336 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.6 mmt -52.04 -41.76 62.57 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.583 0.629 . . . . 0.0 110.513 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.38 -19.31 2.45 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.45 1.024 . . . . 0.0 111.085 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -83.73 117.52 68.89 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.052 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.84 137.32 52.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 108.721 -1.299 . . . . 0.0 108.721 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.28 47.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.733 0.813 . . . . 0.0 110.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.93 86.22 2.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 5' ' ' LEU . 3.1 t -58.45 107.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.98 1.312 . . . . 0.0 109.825 165.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -159.02 56.87 0.42 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 143.23 14.79 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.262 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.447 -0.622 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.43 130.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.134 1.374 . . . . 0.0 107.805 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.14 115.82 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 125.14 1.376 . . . . 0.0 109.274 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' LEU . 1.7 pp -90.51 138.39 31.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -113.85 126.08 54.79 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.41 ' SD ' HD11 ' A' ' 5' ' ' LEU . 13.7 ptm -132.24 128.24 37.46 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.922 0.889 . . . . 0.0 110.115 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.0 mptp? -78.13 131.15 37.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 148.08 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.431 1.014 . . . . 0.0 109.011 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -105.97 146.52 29.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -32.52 7.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.692 1.139 . . . . 0.0 113.227 169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.9 mtt -75.46 74.25 2.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.501 1.15 . . . . 0.0 112.442 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.2 m -106.44 39.94 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.789 1.236 . . . . 0.0 109.8 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.0 p -160.0 168.68 25.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.06 -8.06 57.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.104 0.561 . . . . 0.0 112.026 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -73.71 -64.6 0.96 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.734 0.697 . . . . 0.0 110.894 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 m -55.41 -55.27 33.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.419 0.628 . . . . 0.0 110.306 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -48.58 -56.0 9.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.818 1.247 . . . . 0.0 110.346 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.4 t -63.58 -45.19 91.55 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.982 0.513 . . . . 0.0 110.7 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -53.66 -49.47 67.87 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.815 -0.553 . . . . 0.0 110.419 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -62.78 -48.07 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 O-C-N 121.99 -0.444 . . . . 0.0 110.116 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.85 -47.64 64.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.18 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.35 25.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.489 1.042 . . . . 0.0 111.741 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -58.32 -57.29 13.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.776 0.798 . . . . 0.0 110.166 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.32 -30.38 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.13 0.972 . . . . 0.0 110.389 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.04 -31.92 8.67 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.62 0.629 . . . . 0.0 112.704 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -84.82 -1.85 56.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.192 0.996 . . . . 0.0 112.733 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.44 149.83 46.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 120.724 1.602 . . . . 0.0 110.346 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -87.29 127.86 35.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.04 14.81 9.65 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.331 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.94 137.96 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.615 1.166 . . . . 0.0 109.452 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 -31.52 10.16 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.106 0.562 . . . . 0.0 111.88 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.99 162.27 40.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 tt -155.9 138.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -140.78 136.18 32.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.437 1.095 . . . . 0.0 110.132 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.17 139.87 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.5 1.046 . . . . 0.0 110.289 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -128.5 127.38 42.33 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.134 1.774 . . . . 0.0 109.644 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.05 -47.1 12.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.933 0.893 . . . . 0.0 111.881 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.48 -58.51 6.87 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.994 1.317 . . . . 0.0 110.356 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.11 4.97 27.92 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.594 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 0.2 OUTLIER 36.22 67.34 0.31 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.317 2.647 . . . . 0.0 113.561 -177.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 3.0 tt0 -143.51 141.19 30.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.758 -170.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.33 148.57 43.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 109.752 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -128.14 118.92 24.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.964 3.306 . . . . 0.0 105.43 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -121.99 120.46 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.85 96.14 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 123.789 0.68 . . . . 0.0 109.227 -174.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -123.42 160.74 26.2 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.651 0.781 . . . . 0.0 111.724 -166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -99.92 116.24 64.85 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.505 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.92 75.56 2.18 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.663 2.909 . . . . 0.0 111.66 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -176.08 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 127.08 2.152 . . . . 0.0 108.238 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.94 -47.09 26.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.86 172.66 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.976 1.31 . . . . 0.0 108.191 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -138.44 158.61 43.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.608 1.163 . . . . 0.0 110.274 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -41.09 -47.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 111.02 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -40.88 94.4 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.818 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -50.74 72.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 61.9 mmm -54.02 -62.98 1.3 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.408 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -55.79 -56.07 24.85 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.342 -0.849 . . . . 0.0 111.817 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -52.81 -46.13 67.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -42.23 93.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.789 177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.01 -64.95 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 O-C-N 121.679 -0.638 . . . . 0.0 109.929 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -46.62 -37.76 8.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 119.003 0.82 . . . . 0.0 113.16 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.22 57.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.611 1.096 . . . . 0.0 113.004 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.0 mmt -53.52 -43.7 68.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.434 0.561 . . . . 0.0 110.577 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.82 -23.84 2.13 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.232 0.92 . . . . 0.0 111.289 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -75.39 113.38 25.41 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.033 -171.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.99 138.58 53.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.244 1.296 . . . . 0.0 109.081 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 140.41 43.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.299 0.571 . . . . 0.0 111.812 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -112.19 76.21 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.406 ' HA ' ' HB3' ' A' ' 7' ' ' MET . 1.9 p -62.01 109.38 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.293 1.037 . . . . 0.0 108.227 168.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.58 53.66 0.67 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 3.7 mtpt -155.53 162.87 40.6 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.551 1.54 . . . . 0.0 107.122 173.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 CA--C 1.535 0.367 0 C-N-CA 124.574 1.149 . . . . 0.0 108.02 -174.311 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.398 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.7 t -141.25 146.96 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.419 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.05 141.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.615 1.166 . . . . 0.0 108.28 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 70' ' ' VAL . 3.1 tm? -128.16 120.73 27.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.61 127.25 54.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptp -119.36 124.57 46.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 127.312 2.245 . . . . 0.0 108.837 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 4.6 tptt -72.66 136.56 45.67 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 9.3 m -121.11 157.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.075 0.852 . . . . 0.0 110.48 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -116.71 153.73 31.85 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.853 0.461 . . . . 0.0 110.572 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 -38.91 2.25 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.125 0.869 . . . . 0.0 112.866 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -58.97 93.36 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.049 0.94 . . . . 0.0 110.739 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -141.84 47.45 1.64 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.832 1.253 . . . . 0.0 108.901 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.5 p -155.16 159.46 40.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 164.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -24.81 64.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 123.108 0.255 . . . . 0.0 111.46 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -57.43 -54.94 41.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.417 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.9 m -56.41 -57.16 13.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.117 0.417 . . . . 0.0 110.244 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -55.61 -53.77 52.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.936 0.495 . . . . 0.0 110.318 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 t -61.38 -41.03 96.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.521 0.728 . . . . 0.0 111.288 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 m -59.87 -48.11 83.02 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.109 -0.995 . . . . 0.0 110.445 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.0 mt -59.31 -52.25 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 123.849 0.859 . . . . 0.0 108.72 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.99 -46.08 71.63 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.598 0.759 . . . . 0.0 110.705 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.87 -49.28 72.14 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.24 0.924 . . . . 0.0 111.874 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -59.31 5.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.087 0.943 . . . . 0.0 110.759 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 mm -63.65 -30.38 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.78 1.232 . . . . 0.0 110.755 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.29 -31.66 4.79 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.738 0.685 . . . . 0.0 113.001 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -91.21 2.94 55.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.156 0.982 . . . . 0.0 112.453 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.64 133.11 46.38 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 120.549 1.522 . . . . 0.0 111.201 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -77.55 65.14 3.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 22.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 116.547 1.379 . . . . 0.0 116.547 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.4 154.41 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 117.77 0.785 . . . . 0.0 110.31 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -115.75 -42.21 3.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.616 1.567 . . . . 0.0 109.771 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.06 172.35 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.41 140.59 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -141.56 86.2 1.99 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.0 0.92 . . . . 0.0 112.38 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -89.71 112.63 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.528 -0.733 . . . . 0.0 109.944 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -91.55 176.02 6.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.933 0.893 . . . . 0.0 109.456 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -139.05 -47.25 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.247 1.019 . . . . 0.0 110.292 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.43 -59.27 3.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.895 1.678 . . . . 0.0 110.442 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -88.6 9.5 23.82 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.82 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.58 64.93 1.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.532 1.933 . . . . 0.0 111.034 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.73 152.21 39.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.763 0.825 . . . . 0.0 109.044 -165.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.77 123.65 15.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.387 0.613 . . . . 0.0 110.427 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.46 132.5 43.85 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.274 1.83 . . . . 0.0 107.847 171.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mm -129.62 127.49 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.65 118.4 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -141.04 174.81 10.16 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -165.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -109.17 109.02 60.69 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.875 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.48 77.62 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.833 3.022 . . . . 0.0 110.92 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -178.17 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.299 2.64 . . . . 0.0 107.74 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.4 mt -77.98 -46.6 20.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.688 0.222 . . . . 0.0 111.348 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.44 161.45 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -125.61 162.56 24.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.019 0.928 . . . . 0.0 111.181 -171.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 70' ' ' VAL . 30.7 t -50.03 -43.96 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.232 1.013 . . . . 0.0 111.286 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.47 -37.7 87.62 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.139 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.54 -58.42 8.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.368 1.44 . . . . 0.0 108.387 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.9 mtt -43.55 -60.13 1.88 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER -64.16 -53.61 46.74 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.132 -175.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.0 -55.68 3.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.434 1.47 . . . . 0.0 109.576 172.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -59.86 -47.73 84.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.923 0.392 . . . . 0.0 111.243 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.07 -63.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.452 0.701 . . . . 0.0 111.086 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -45.29 -39.24 6.36 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.879 0.763 . . . . 0.0 111.915 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.75 56.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.529 1.059 . . . . 0.0 112.84 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.4 mmt -57.56 -44.38 85.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.321 0.51 . . . . 0.0 110.812 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.44 -16.67 4.07 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.842 1.21 . . . . 0.0 111.023 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -77.42 115.83 52.73 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.547 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.47 144.67 80.38 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.39 132.47 24.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.896 0.855 . . . . 0.0 110.943 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.02 69.94 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.944 2.498 . . . . 0.0 108.851 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -62.01 107.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.831 0.852 . . . . 0.0 110.118 172.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -156.8 54.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.34 67.44 0.46 Allowed 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.235 -0.915 . . . . 0.0 111.092 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 123.236 0.614 . . . . 0.0 109.439 179.405 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 113.405 0.891 . . . . 0.0 113.405 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.03 130.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.717 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.0 124.74 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 108.112 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.9 mm? -115.83 127.87 55.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -113.18 126.21 55.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.8 mtt -113.54 125.9 54.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.278 1.831 . . . . 0.0 107.895 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 126.14 30.21 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.57 154.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -120.09 153.47 36.08 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.373 0.669 . . . . 0.0 109.723 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.67 47.83 65.79 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.703 168.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.9 mtm -143.46 109.64 5.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.12 26.36 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.164 1.386 . . . . 0.0 110.859 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -112.66 -4.97 14.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.535 1.534 . . . . 0.0 112.101 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 72.71 -46.99 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.52 1.528 . . . . 0.0 111.625 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -49.61 -55.64 12.86 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.617 0.767 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.83 -54.53 40.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.637 0.653 . . . . 0.0 111.374 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -53.34 -54.6 34.18 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.661 0.384 . . . . 0.0 110.084 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.64 -44.18 93.59 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.083 0.553 . . . . 0.0 111.222 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.6 m -59.81 -46.58 88.8 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.446 -0.784 . . . . 0.0 110.197 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 66' ' ' PHE . 3.8 mt -58.86 -50.78 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.03 -49.98 59.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.325 0.65 . . . . 0.0 110.832 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.6 -53.64 40.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.685 0.659 . . . . 0.0 111.693 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -64.67 -56.39 14.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.624 0.726 . . . . 0.0 110.288 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -68.86 -34.69 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.704 0.802 . . . . 0.0 110.339 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.45 -27.88 26.83 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.83 -0.544 . . . . 0.0 112.6 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -90.38 3.45 53.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.117 0.959 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.84 142.76 49.6 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.223 1.374 . . . . 0.0 110.211 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.2 133.5 37.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.92 -8.37 36.38 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 123.594 0.616 . . . . 0.0 112.146 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.18 149.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.578 0.751 . . . . 0.0 109.596 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -108.16 -48.24 3.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.623 1.569 . . . . 0.0 109.467 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -157.66 169.53 24.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.6 137.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -140.81 92.46 2.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.783 0.833 . . . . 0.0 111.64 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.6 t -97.1 105.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.649 -0.657 . . . . 0.0 110.037 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m -85.06 161.76 19.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.15 0.98 . . . . 0.0 110.16 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.69 -48.16 2.59 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.015 0.526 . . . . 0.0 111.211 172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.83 -57.68 5.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.507 1.523 . . . . 0.0 110.51 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 22.56 6.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.466 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.286 0.0 OUTLIER 28.15 70.72 0.06 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.143 2.977 . . . . 0.0 113.815 -174.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -138.16 142.34 40.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.204 1.402 . . . . 0.0 108.856 -168.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.06 111.8 15.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.52 1.128 . . . . 0.0 108.99 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -85.62 125.85 33.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mm -124.86 127.62 72.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.19 113.59 43.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -129.94 172.26 11.89 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.09 111.33 62.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 124.69 1.196 . . . . 0.0 108.581 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.82 73.83 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.419 2.746 . . . . 0.0 110.517 -173.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -46.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.74 2.016 . . . . 0.0 109.241 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.27 -44.69 21.21 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 122.602 -0.061 . . . . 0.0 111.136 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -136.09 172.12 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.1 p -133.99 159.28 41.24 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.392 1.077 . . . . 0.0 110.511 -172.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 t -41.93 -48.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 124.671 1.188 . . . . 0.0 111.611 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.05 -44.23 96.44 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.341 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.53 -53.19 55.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.769 1.168 . . . . 0.0 108.803 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 12.5 mtm -51.3 -60.3 3.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.23 0.468 . . . . 0.0 112.204 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.36 -55.29 36.92 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.391 -0.818 . . . . 0.0 111.939 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -45.93 -51.47 13.21 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.917 1.287 . . . . 0.0 109.158 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -60.35 -46.52 89.64 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.663 0.21 . . . . 0.0 111.306 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.35 -66.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.757 0.823 . . . . 0.0 110.491 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -46.56 -37.94 8.74 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.594 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.25 61.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.575 1.079 . . . . 0.0 112.692 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.7 -45.53 85.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.426 0.557 . . . . 0.0 110.523 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.94 -20.42 2.51 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.349 0.976 . . . . 0.0 111.209 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 21' ' ' ILE . 59.8 m-85 -77.21 113.75 33.85 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 118.223 -0.894 . . . . 0.0 109.803 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 137.15 41.37 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.26 1.307 . . . . 0.0 108.714 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.91 132.87 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.264 0.554 . . . . 0.0 111.156 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.41 75.04 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.923 1.289 . . . . 0.0 108.718 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 5' ' ' LEU . 13.5 p -65.22 103.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.952 1.301 . . . . 0.0 110.796 172.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -157.13 58.51 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.547 ' O ' HD13 ' A' ' 5' ' ' LEU . 4.4 tptm -155.82 136.69 13.54 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.4 mt . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.928 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 N--CA 1.448 -0.554 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.26 124.51 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -169.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.88 126.0 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.22 116.53 32.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -98.41 110.12 22.77 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' HD13 ' A' ' 45' ' ' ILE . 2.4 ptp -108.84 123.37 48.95 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.977 0.911 . . . . 0.0 108.748 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.33 151.12 46.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 167.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.1 157.06 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.0 145.94 47.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.87 -30.62 8.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.379 0.99 . . . . 0.0 112.956 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.0 94.14 0.47 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.086 0.943 . . . . 0.0 110.399 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.8 m -128.67 44.5 2.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.976 0.91 . . . . 0.0 109.011 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.41 155.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 107.865 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -72.92 -21.97 60.81 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -53.42 -61.02 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.149 0.979 . . . . 0.0 111.708 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.5 m -59.75 -51.57 69.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.649 0.738 . . . . 0.0 109.966 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -53.72 -56.35 18.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.971 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 t -56.11 -46.35 79.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.931 0.892 . . . . 0.0 111.824 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 m -54.73 -50.66 67.82 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.24 -46.44 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.07 -45.76 71.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.474 0.71 . . . . 0.0 111.191 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.18 -56.7 22.86 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.804 0.716 . . . . 0.0 111.673 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.97 -57.34 13.27 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.094 -0.651 . . . . 0.0 111.146 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 34' ' ' ILE . 43.5 mm -59.45 -43.5 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.068 0.947 . . . . 0.0 110.468 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.94 -33.7 21.48 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 117.985 0.357 . . . . 0.0 112.403 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.85 -4.13 59.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.281 1.032 . . . . 0.0 112.74 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.99 137.51 34.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 120.201 1.364 . . . . 0.0 111.104 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -71.76 123.2 22.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.297 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.23 -2.39 9.7 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.11 0.862 . . . . 0.0 112.592 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.52 159.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.457 0.703 . . . . 0.0 110.796 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -117.58 -47.6 2.62 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -165.26 168.66 16.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 25' ' ' ILE . 12.4 tt -156.78 143.12 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -142.06 98.3 3.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.875 1.67 . . . . 0.0 111.586 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.72 126.76 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.169 0.587 . . . . 0.0 111.534 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -117.04 140.14 49.85 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.676 1.19 . . . . 0.0 110.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 -45.53 9.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.037 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.16 -62.35 1.69 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.687 1.595 . . . . 0.0 110.439 -171.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.78 14.75 11.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.426 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.4 58.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.743 2.817 . . . . 0.0 113.746 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 28.4 tt0 -132.1 138.26 48.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.081 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.51 119.17 32.18 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.824 1.65 . . . . 0.0 109.233 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.9 m -96.28 112.88 24.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.551 1.54 . . . . 0.0 108.712 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -116.23 119.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.43 117.79 54.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.54 165.42 27.53 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -94.32 111.65 54.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 126.949 2.099 . . . . 0.0 110.947 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.73 73.84 3.46 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.183 2.588 . . . . 0.0 111.995 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -173.98 -46.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.144 2.178 . . . . 0.0 108.525 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.26 -42.46 68.75 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -176.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -142.4 153.01 43.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.379 0.672 . . . . 0.0 109.948 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -38.1 -49.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 124.987 1.315 . . . . 0.0 111.028 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.37 -46.64 87.74 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.059 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -50.71 66.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.976 1.716 . . . . 0.0 108.056 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -53.14 -59.08 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.07 -0.394 . . . . 0.0 111.005 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.15 -55.71 30.49 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 120.888 -1.132 . . . . 0.0 112.88 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 -42.43 25.73 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.354 1.062 . . . . 0.0 109.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -66.45 -53.48 35.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.599 0.562 . . . . 0.0 111.944 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.43 -62.71 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.069 -1.019 . . . . 0.0 110.897 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -52.51 -26.17 12.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.04 62.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.961 1.255 . . . . 0.0 112.496 171.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.39 -35.74 72.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.118 0.567 . . . . 0.0 110.656 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.17 -22.18 5.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.683 1.135 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -70.03 116.26 42.34 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 117.283 -1.342 . . . . 0.0 110.276 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.52 151.18 86.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.356 1.371 . . . . 0.0 109.261 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.13 140.49 28.04 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.42 82.23 1.57 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.326 1.051 . . . . 0.0 110.132 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.14 104.66 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.583 1.553 . . . . 0.0 110.946 173.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -157.73 54.16 0.47 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -158.67 104.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.534 0.335 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.76 133.34 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 123.574 0.75 . . . . 0.0 109.218 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 46' ' ' VAL . 1.4 p -82.1 116.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.304 1.442 . . . . 0.0 108.094 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 5' ' ' LEU . 5.0 tt -96.86 120.56 37.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.35 118.76 34.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -113.77 138.92 49.59 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.403 1.481 . . . . 0.0 108.746 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.43 155.47 40.09 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 155.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -138.13 142.64 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -97.75 151.5 20.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.88 -34.78 2.11 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.707 -0.621 . . . . 0.0 114.209 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.33 91.49 0.08 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.007 0.903 . . . . 0.0 111.746 -173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 m -146.38 61.22 1.23 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.421 1.488 . . . . 0.0 109.587 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.6 p -162.04 157.41 23.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 166.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -78.27 54.44 1.39 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.703 0.401 . . . . 0.0 110.103 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.89 -64.07 0.59 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -56.19 -56.67 18.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.052 0.387 . . . . 0.0 110.79 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -51.53 -55.36 19.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.006 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.87 -42.84 94.58 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.77 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.1 m -56.01 -52.01 65.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -48.27 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.229 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -55.63 -48.87 74.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.117 0.871 . . . . 0.0 110.582 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.47 -52.97 37.82 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.516 0.579 . . . . 0.0 111.665 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -65.95 -61.24 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.548 0.689 . . . . 0.0 110.655 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.69 -32.68 59.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 124.589 1.156 . . . . 0.0 110.422 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.89 -30.67 9.42 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.867 -0.521 . . . . 0.0 112.6 169.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -93.77 10.4 33.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.314 1.046 . . . . 0.0 112.217 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.03 151.87 44.14 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.243 1.383 . . . . 0.0 111.623 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -92.56 81.66 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.949 1.3 . . . . 0.0 110.614 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.93 -13.59 1.13 Allowed Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.914 -0.491 . . . . 0.0 113.899 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.65 151.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -119.08 -35.1 3.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.628 1.171 . . . . 0.0 111.137 173.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -155.42 169.19 24.82 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -156.98 139.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -139.85 90.66 2.41 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.422 1.489 . . . . 0.0 110.534 172.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.86 106.93 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 O-C-N 121.457 -0.777 . . . . 0.0 110.167 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -80.43 178.98 7.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -142.44 -47.37 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 109.534 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.05 -59.03 3.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.903 1.681 . . . . 0.0 110.541 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.14 12.58 17.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.319 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 43.77 62.72 1.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.659 1.984 . . . . 0.0 112.522 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -145.88 151.11 37.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.511 -0.743 . . . . 0.0 109.345 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.92 125.81 18.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 111.149 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 3.4 m -107.55 120.69 42.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.803 2.041 . . . . 0.0 107.964 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 44' ' ' THR . 3.8 mp -122.14 116.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 4' ' ' VAL . 2.1 t -104.82 109.13 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -135.14 170.33 16.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.479 0.657 . . . . 0.0 112.367 -166.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -97.8 110.68 56.45 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.132 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.51 67.06 7.23 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.139 2.56 . . . . 0.0 111.506 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.66 -47.07 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.809 1.244 . . . . 0.0 108.37 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.37 -48.23 73.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.633 0.197 . . . . 0.0 111.198 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tp -134.25 162.83 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.802 1.241 . . . . 0.0 108.196 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 p -121.87 158.64 28.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.747 1.219 . . . . 0.0 110.891 -172.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.73 -48.99 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.386 0 C-N-CA 124.1 0.96 . . . . 0.0 110.881 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.97 -54.13 50.46 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.766 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -45.03 -54.74 6.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.952 1.251 . . . . 0.0 109.365 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -63.11 1.26 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.501 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.39 -61.27 2.45 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -43.07 -51.45 5.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.718 1.207 . . . . 0.0 109.703 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.08 -43.33 95.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.083 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.01 -65.85 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.445 0.698 . . . . 0.0 110.278 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -43.79 -39.27 3.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.507 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.798 1.181 . . . . 0.0 112.958 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.6 mmt -55.37 -40.8 71.76 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.317 0.508 . . . . 0.0 110.841 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.08 -20.16 3.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.587 1.089 . . . . 0.0 110.954 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -75.57 115.7 48.18 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.255 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -66.55 138.48 50.05 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.31 -1.458 . . . . 0.0 108.31 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.47 138.39 38.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.045 0.538 . . . . 0.0 110.595 -175.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -107.05 71.39 0.83 Allowed 'General case' 0 C--N 1.334 -0.066 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.45 105.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 169.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -155.58 55.31 0.62 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 141.26 16.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 170.731 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.09 116.0 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.91 124.4 43.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.85 131.86 56.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.06 117.09 30.3 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.3 mtt -116.82 123.57 47.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.913 0.885 . . . . 0.0 110.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.87 129.47 37.95 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.93 151.36 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.032 0.833 . . . . 0.0 109.668 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 140.67 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.28 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.1 -16.06 45.24 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.266 0.936 . . . . 0.0 114.206 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.2 mtp -76.62 75.7 3.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.3 1.05 . . . . 0.0 110.866 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.4 34.42 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.464 1.505 . . . . 0.0 111.334 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 p -154.1 158.7 40.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.516 -0.74 . . . . 0.0 110.404 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -74.9 61.36 1.03 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.306 167.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -145.88 -63.38 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 167.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 m -52.96 -53.59 47.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.298 0.571 . . . . 0.0 109.952 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.4 p -53.04 -70.16 0.1 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.725 1.21 . . . . 0.0 110.742 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 t -51.3 -45.52 62.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.679 1.592 . . . . 0.0 111.506 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -60.26 -44.93 94.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.889 -0.507 . . . . 0.0 109.944 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -49.22 85.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 118.617 0.644 . . . . 0.0 110.189 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -48.58 -51.67 26.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.656 0.662 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.61 -58.33 15.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.87 0.748 . . . . 0.0 112.614 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -64.36 -52.44 58.3 Favored 'General case' 0 C--N 1.338 0.109 0 O-C-N 121.651 -0.911 . . . . 0.0 109.953 -170.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.02 -27.19 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.308 1.043 . . . . 0.0 109.751 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.72 -32.55 32.89 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.986 -1.071 . . . . 0.0 112.492 166.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -84.74 -1.36 56.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.97 154.12 42.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.435 1.471 . . . . 0.0 112.326 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.91 69.4 9.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.01 18.72 0.02 OUTLIER Glycine 0 N--CA 1.467 0.756 0 N-CA-C 115.373 0.909 . . . . 0.0 115.373 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.17 141.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.852 1.326 . . . . 0.0 108.664 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -111.85 -45.06 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.363 0.665 . . . . 0.0 109.94 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.21 166.99 25.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.71 131.86 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 5.6 mmtt -139.24 129.79 25.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.572 1.149 . . . . 0.0 109.695 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.43 98.4 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 119.234 0.925 . . . . 0.0 110.011 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -72.7 74.03 1.09 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.224 1.41 . . . . 0.0 109.464 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -37.39 -49.22 0.99 Allowed 'General case' 0 C--O 1.227 -0.091 0 C-N-CA 126.351 1.86 . . . . 0.0 111.664 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.87 -55.94 8.67 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.103 1.361 . . . . 0.0 111.562 -174.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.65 -2.99 58.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.654 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.29 54.62 9.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.814 2.446 . . . . 0.0 110.443 -173.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.19 136.34 54.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 109.543 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.61 106.88 17.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.53 1.932 . . . . 0.0 109.742 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -81.45 87.26 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 129.007 2.923 . . . . 0.0 109.382 170.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.61 125.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.74 99.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.417 0 CA-C-N 119.659 1.118 . . . . 0.0 110.333 -173.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.24 159.97 22.42 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.98 131.04 55.2 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.44 163.6 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.18 1.253 . . . . 0.0 109.091 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 73.62 -42.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -48.93 55.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.609 1.095 . . . . 0.0 111.499 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.78 179.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.412 1.485 . . . . 0.0 108.338 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.0 p -148.8 164.16 35.24 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.527 0.603 . . . . 0.0 111.519 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.9 t -46.15 -45.48 5.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 123.768 0.827 . . . . 0.0 111.284 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -62.53 -42.64 99.65 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.488 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.84 -54.42 45.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.1 mmt -45.27 -65.08 0.58 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -56.64 -57.2 13.4 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.312 -0.868 . . . . 0.0 111.761 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -46.32 -47.44 18.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.956 0.798 . . . . 0.0 109.635 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.32 -42.63 87.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.15 -65.02 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 124.409 1.084 . . . . 0.0 110.044 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.36 -39.83 7.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.304 0.642 . . . . 0.0 111.833 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.5 -33.02 59.08 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.398 0.999 . . . . 0.0 113.344 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmt -58.03 -41.73 83.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.6 0.636 . . . . 0.0 110.506 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.87 -16.68 3.48 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.62 1.105 . . . . 0.0 111.06 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.05 117.01 66.79 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.542 -173.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.68 151.56 85.21 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 N-CA-C 108.901 -1.231 . . . . 0.0 108.901 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.04 139.11 28.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.944 0.498 . . . . 0.0 110.517 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.43 75.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.885 0.874 . . . . 0.0 108.758 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.03 105.54 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.081 0.952 . . . . 0.0 110.756 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -155.74 56.71 0.61 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.44 144.35 20.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp . . . . . 0 CA--C 1.533 0.312 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 174.895 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.468 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.1 128.27 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 124.252 1.021 . . . . 0.0 108.755 174.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.14 110.94 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.099 1.76 . . . . 0.0 109.816 -178.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.91 117.97 29.93 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -84.42 126.87 33.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 28.4 mtp -128.51 128.05 43.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.9 25.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.283 0.947 . . . . 0.0 108.553 172.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -90.97 165.44 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -121.07 152.24 38.88 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.18 -33.04 2.24 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.57 -0.706 . . . . 0.0 114.143 165.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.1 mtp -65.14 82.74 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.935 0.867 . . . . 0.0 112.024 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -114.34 48.89 1.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.062 1.345 . . . . 0.0 110.482 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -159.4 163.97 35.02 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.571 -0.706 . . . . 0.0 110.834 169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.91 -35.41 80.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.979 174.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -58.33 -58.04 10.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.576 0.625 . . . . 0.0 111.487 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.2 m -57.76 -57.66 11.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -51.85 -57.1 10.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 110.196 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -59.53 -44.48 93.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.823 0.849 . . . . 0.0 111.302 179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.9 m -57.26 -48.45 78.85 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.435 -0.791 . . . . 0.0 110.243 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.46 -48.86 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 123.031 0.532 . . . . 0.0 109.578 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.69 -49.73 56.66 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.251 0.62 . . . . 0.0 110.36 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.15 -55.41 28.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.96 0.791 . . . . 0.0 111.532 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -64.0 -55.02 25.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.016 -0.696 . . . . 0.0 110.963 -173.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -67.39 -33.76 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 123.61 0.764 . . . . 0.0 110.13 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.44 -35.63 7.25 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.361 0.505 . . . . 0.0 112.399 171.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -83.48 4.27 28.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.76 139.72 47.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.735 1.607 . . . . 0.0 112.06 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.93 81.83 5.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.726 0.81 . . . . 0.0 111.612 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.19 -8.54 0.79 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.07 152.15 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 117.726 0.763 . . . . 0.0 110.244 175.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -113.58 -37.22 4.67 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.246 1.419 . . . . 0.0 110.333 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -160.57 159.16 30.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 tt -152.8 137.25 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -175.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -143.13 150.83 39.98 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.569 1.148 . . . . 0.0 109.754 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.65 128.96 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.613 0.642 . . . . 0.0 109.419 171.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -110.69 79.8 1.24 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.739 1.615 . . . . 0.0 108.271 -177.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -41.7 66.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.044 0.537 . . . . 0.0 110.575 -175.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.7 -54.72 5.94 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 111.054 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.76 16.62 21.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.029 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 35.66 53.82 0.84 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.354 2.662 . . . . 0.0 113.12 -169.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.72 149.27 37.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.586 1.154 . . . . 0.0 109.704 -177.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.4 134.77 49.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.294 1.438 . . . . 0.0 108.823 171.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.8 m -117.34 109.77 17.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.668 2.787 . . . . 0.0 107.011 -173.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mm -119.32 102.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -176.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' GLU . 2.3 t -99.02 107.96 21.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -174.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.9 167.3 17.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -100.25 112.17 63.73 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.554 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 69.47 5.84 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.924 3.083 . . . . 0.0 111.533 -170.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.86 -40.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.854 2.462 . . . . 0.0 108.158 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 -45.46 13.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -140.46 158.2 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 107.573 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -106.28 161.97 14.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 112.479 -173.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.17 -39.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 163.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -47.86 81.62 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.15 -178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.41 -55.14 17.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.022 1.283 . . . . 0.0 109.762 173.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 17.5 mmt -48.5 -63.47 1.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -57.95 -57.86 10.96 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 121.259 -0.9 . . . . 0.0 112.329 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -46.76 -50.76 17.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.225 1.01 . . . . 0.0 108.31 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -57.92 -48.12 80.85 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.987 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.81 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 118.562 -0.733 . . . . 0.0 111.467 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.87 -35.78 6.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.003 1.274 . . . . 0.0 112.381 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.2 -31.61 61.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.736 1.153 . . . . 0.0 113.155 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.6 mmt -55.05 -41.52 71.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.396 0.544 . . . . 0.0 110.585 172.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.47 -18.95 3.85 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.886 1.232 . . . . 0.0 110.95 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -75.53 117.92 67.01 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.979 -173.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.32 140.21 57.58 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.495 -1.386 . . . . 0.0 108.495 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.9 27.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.813 0.816 . . . . 0.0 112.469 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.84 75.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.331 1.052 . . . . 0.0 108.553 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -42.69 104.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 125.029 1.456 . . . . 0.0 109.261 158.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -93.67 -179.51 5.04 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 168.08 20.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.882 170.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.3 pt . . . . . 0 N--CA 1.443 -0.776 0 C-N-CA 123.681 0.792 . . . . 0.0 110.106 178.358 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.331 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.61 123.83 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 109.865 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 46' ' ' VAL . 1.3 p -80.82 105.9 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.808 1.643 . . . . 0.0 109.82 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 109.09 20.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -87.1 113.16 22.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.18 125.18 47.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.446 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.4 mptp? -81.02 125.41 30.13 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.78 148.04 11.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -109.9 155.0 22.28 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.37 -46.67 3.59 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.765 -0.584 . . . . 0.0 112.587 169.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.5 mtp -55.26 96.25 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.914 1.286 . . . . 0.0 110.96 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 p -136.6 31.79 2.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 111.776 -174.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.16 149.62 26.21 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.668 -0.645 . . . . 0.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -72.33 60.26 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.435 1.494 . . . . 0.0 110.722 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.4 m -142.45 -59.96 0.45 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.3 m -58.83 -60.94 3.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 110.025 -177.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -53.5 -49.06 68.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.935 -179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.2 t -66.75 -41.12 88.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 111.104 -175.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 m -59.28 -47.85 83.82 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 176.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -52.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.738 175.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.88 -49.06 63.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.228 0.922 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.85 -47.06 91.29 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.865 0.745 . . . . 0.0 112.054 176.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -60.59 2.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.245 1.023 . . . . 0.0 110.178 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.93 -33.79 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.654 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.0 -30.59 9.58 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.812 0.72 . . . . 0.0 112.99 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -91.33 6.81 43.84 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.279 1.04 . . . . 0.0 112.359 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.33 151.81 34.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.522 -1.361 . . . . 0.0 112.746 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.62 82.57 4.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 0.0 111.493 -174.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.61 -10.31 1.68 Allowed Glycine 0 N--CA 1.462 0.368 0 O-C-N 121.947 -0.47 . . . . 0.0 113.722 -175.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.4 t -78.99 142.43 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -102.58 -42.75 5.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.011 1.324 . . . . 0.0 109.524 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 ttm-85 -155.79 165.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.88 135.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -137.88 88.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.189 1.396 . . . . 0.0 111.051 168.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.91 115.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -87.46 -163.16 0.89 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 pt? -155.33 -48.79 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.33 1.052 . . . . 0.0 109.451 173.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -59.07 4.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 110.339 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.82 11.54 15.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.471 -177.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 39.65 61.82 1.33 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.121 1.768 . . . . 0.0 112.788 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 26.5 tt0 -139.78 153.03 47.04 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 126.23 38.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.728 1.211 . . . . 0.0 109.061 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.0 m -101.33 117.8 35.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.794 1.637 . . . . 0.0 106.983 174.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -119.72 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -100.34 102.94 14.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -124.33 173.02 8.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -104.27 111.41 65.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 123.941 0.896 . . . . 0.0 109.92 -177.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.2 76.76 2.97 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.709 2.939 . . . . 0.0 110.321 -172.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.54 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.395 1.878 . . . . 0.0 108.369 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.8 -44.12 15.91 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.975 -177.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.2 154.17 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.888 1.275 . . . . 0.0 108.47 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -108.59 162.96 13.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.36 1.064 . . . . 0.0 112.244 -173.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -48.22 -45.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.481 0.712 . . . . 0.0 110.373 165.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -44.02 92.51 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.878 -175.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -54.59 26.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.529 1.513 . . . . 0.0 109.807 171.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.9 mmt -48.13 -62.53 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.918 0.781 . . . . 0.0 111.868 175.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -62.07 -57.61 10.95 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -176.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -47.43 -48.13 26.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 109.25 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -59.39 -48.23 82.45 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.71 174.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.13 -65.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.726 -176.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.98 -30.22 24.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.423 1.01 . . . . 0.0 112.573 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.05 62.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 120.014 1.279 . . . . 0.0 112.845 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.3 mmt -58.44 -40.73 83.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.541 0.609 . . . . 0.0 110.578 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.01 -21.62 3.32 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.537 1.065 . . . . 0.0 110.914 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -73.09 116.76 53.93 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-O 118.345 -0.835 . . . . 0.0 110.14 -173.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.02 141.89 59.74 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.463 1.442 . . . . 0.0 108.679 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.55 134.98 32.93 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -98.29 74.71 2.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.472 1.109 . . . . 0.0 108.309 175.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -36.03 106.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.297 1.623 . . . . 0.0 108.775 154.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 179.93 4.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 168.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -78.91 166.42 22.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.267 176.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.5 pt . . . . . 0 N--CA 1.44 -0.934 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 177.754 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 120.77 0.319 . . . . 0.0 110.823 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.29 142.29 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 126.15 1.78 . . . . 0.0 108.195 172.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.27 132.58 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.024 1.73 . . . . 0.0 107.915 175.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.737 HD21 HG23 ' A' ' 70' ' ' VAL . 3.3 tm? -112.61 129.56 56.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 169.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -117.96 127.2 53.6 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.433 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 12.5 ptm -139.43 129.3 24.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.117 0.567 . . . . 0.0 109.865 -173.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.06 133.88 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.3 m -118.86 150.53 21.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -116.15 151.23 36.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.145 0.498 . . . . 0.0 110.761 177.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.03 -34.3 3.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.094 0.854 . . . . 0.0 112.816 173.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -66.53 94.65 0.29 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.633 0.717 . . . . 0.0 111.6 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.692 ' HA ' HD13 ' A' ' 38' ' ' LEU . 36.7 p -126.2 53.28 1.63 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.107 0.963 . . . . 0.0 111.465 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.12 167.51 30.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.697 0.799 . . . . 0.0 109.044 -175.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -84.28 -6.02 59.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.667 0.387 . . . . 0.0 111.486 169.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.1 -74.75 0.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -172.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -51.39 -45.24 62.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.097 1.359 . . . . 0.0 111.589 -177.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -49.38 -63.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.485 1.514 . . . . 0.0 110.511 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -55.33 -45.37 76.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.906 0.882 . . . . 0.0 111.123 177.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -55.3 -47.94 74.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.244 -0.91 . . . . 0.0 110.994 177.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.23 -50.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.139 0.976 . . . . 0.0 109.201 177.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -45.39 -53.05 9.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.566 1.146 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.31 -58.32 15.03 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.793 0.711 . . . . 0.0 112.672 174.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -56.94 -48.19 78.88 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 121.936 -0.744 . . . . 0.0 110.846 -171.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.73 -42.04 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.283 0.633 . . . . 0.0 109.441 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.68 -35.41 23.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.248 0.451 . . . . 0.0 112.412 172.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -63.28 -18.0 63.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.97 142.5 29.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.207 0.912 . . . . 0.0 112.544 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.89 101.43 4.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.364 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.97 -21.54 1.43 Allowed Glycine 0 C--N 1.335 0.511 0 O-C-N 121.554 -0.716 . . . . 0.0 113.274 176.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.96 132.77 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -102.59 -29.55 11.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.995 0.361 . . . . 0.0 111.403 175.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -154.08 164.63 38.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 tt -157.92 144.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 103.914 -2.624 . . . . 0.0 103.914 -176.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -144.13 132.41 21.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.893 0.877 . . . . 0.0 111.254 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -125.76 136.55 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.935 1.243 . . . . 0.0 111.701 175.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -122.12 124.36 43.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.204 1.801 . . . . 0.0 110.147 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.01 -51.23 9.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.65 0.78 . . . . 0.0 110.723 -177.557 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -53.03 45.8 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.557 1.143 . . . . 0.0 110.557 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.61 4.11 37.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.48 -177.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 38.86 61.56 1.21 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.273 2.629 . . . . 0.0 111.371 -174.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -141.85 138.14 31.92 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.734 -0.604 . . . . 0.0 110.903 -173.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.98 30.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.556 1.542 . . . . 0.0 110.003 172.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.6 m -121.71 125.51 46.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.706 3.602 . . . . 0.0 104.928 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.44 119.71 54.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.81 96.68 4.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -172.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.64 168.47 12.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.709 0.766 . . . . 0.0 111.989 -170.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -97.02 115.29 65.68 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.048 1.339 . . . . 0.0 108.514 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.9 72.3 3.94 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.879 2.386 . . . . 0.0 111.909 -174.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -46.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.304 1.442 . . . . 0.0 108.295 172.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.32 -48.92 66.17 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 119.643 -0.218 . . . . 0.0 111.36 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 177.81 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.825 1.25 . . . . 0.0 109.334 -174.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.1 p -141.51 160.12 40.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.347 1.059 . . . . 0.0 111.244 -174.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 5' ' ' LEU . 18.4 t -40.22 -49.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.705 1.202 . . . . 0.0 111.771 171.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -58.53 -52.09 67.13 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 118.255 -0.878 . . . . 0.0 108.937 -171.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -46.47 -53.13 11.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.939 1.696 . . . . 0.0 109.799 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.2 mmt -51.17 -58.32 6.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.951 -0.468 . . . . 0.0 111.823 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -59.4 -60.32 4.04 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.082 -1.011 . . . . 0.0 112.455 177.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.97 -40.5 4.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 109.252 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -52.9 15.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 170.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -62.9 -60.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 120.095 1.316 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.91 -36.52 5.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.893 0.77 . . . . 0.0 112.081 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.92 65.85 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.249 0.931 . . . . 0.0 113.368 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -55.51 -38.95 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.965 0.348 . . . . 0.0 110.331 173.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.26 -16.06 4.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.822 1.201 . . . . 0.0 110.805 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -75.55 114.35 35.28 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.492 -174.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.01 141.75 65.48 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 108.266 -1.475 . . . . 0.0 108.266 176.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.28 35.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.44 80.1 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.737 HG23 HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -65.18 107.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.061 1.744 . . . . 0.0 109.694 168.011 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -157.09 59.7 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.12 153.02 30.19 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 163.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.534 0.347 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.436 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 . . . . . 0 N--CA 1.448 -0.558 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.73 131.36 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 109.01 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 46' ' ' VAL . 2.6 p -90.82 120.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 125.277 1.431 . . . . 0.0 110.119 -177.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 72' ' ' LYS . 1.6 mm? -106.73 125.39 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -108.13 115.62 30.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -175.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.0 mtt -115.16 119.28 35.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.45 1.1 . . . . 0.0 108.458 -174.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -72.03 126.52 29.98 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.63 150.45 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.07 153.05 28.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.651 0.594 . . . . 0.0 109.795 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.46 3.43 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.631 -0.539 . . . . 0.0 112.401 172.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.5 mtm -55.06 96.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.703 0.752 . . . . 0.0 111.665 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 p -132.03 18.35 4.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 110.978 -177.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -137.87 163.07 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -72.61 -17.2 61.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.461 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -60.24 3.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.3 0.5 . . . . 0.0 109.779 -177.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.5 m -57.86 -55.02 40.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -57.97 -50.03 74.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.215 -174.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -57.85 -46.15 85.22 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.911 0.778 . . . . 0.0 110.988 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.5 m -54.37 -51.28 65.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.638 0.654 . . . . 0.0 110.336 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.08 -47.61 80.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.251 0.932 . . . . 0.0 110.319 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.49 -55.4 27.16 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 172.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -66.85 -57.47 6.93 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 117.595 0.697 . . . . 0.0 111.281 -173.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.0 -34.58 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 110.079 -177.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.97 -28.34 7.39 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.674 -0.641 . . . . 0.0 112.891 169.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -102.39 18.58 20.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.776 1.23 . . . . 0.0 111.831 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.23 163.17 27.02 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.573 -1.329 . . . . 0.0 111.208 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -100.35 84.83 2.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.004 1.322 . . . . 0.0 110.273 -175.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.07 1.17 3.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.321 0.486 . . . . 0.0 113.725 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.13 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 117.641 0.721 . . . . 0.0 109.975 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -124.55 -41.81 2.13 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.131 1.372 . . . . 0.0 111.001 -176.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -156.93 171.3 20.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -157.14 138.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.051 -2.204 . . . . 0.0 105.051 -174.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -137.47 81.12 1.85 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.192 1.797 . . . . 0.0 110.488 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.06 122.52 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 O-C-N 120.729 -1.232 . . . . 0.0 109.302 -177.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -103.08 168.05 9.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.97 -45.53 2.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.792 0.837 . . . . 0.0 109.786 174.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.06 -57.03 5.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 110.943 -174.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.14 19.7 10.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.456 -175.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 36.44 62.28 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.6 2.36 . . . . 0.0 112.332 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.134 -0.979 . . . . 0.0 108.983 -174.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.04 119.86 34.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.936 1.694 . . . . 0.0 108.581 -175.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 20.1 m -96.82 125.99 41.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -125.53 128.91 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -110.13 117.71 55.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.166 0.986 . . . . 0.0 109.476 -174.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -139.9 175.36 9.65 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -104.81 107.21 57.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.106 1.362 . . . . 0.0 110.392 -177.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.13 77.7 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.378 2.719 . . . . 0.0 110.26 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.53 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 127.084 2.154 . . . . 0.0 108.04 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.02 -45.6 56.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.942 0.401 . . . . 0.0 110.548 -178.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.95 168.61 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -135.57 157.78 46.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.145 0.978 . . . . 0.0 110.18 -171.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -37.71 -47.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.83 1.652 . . . . 0.0 111.497 173.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -50.69 73.07 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.776 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -52.72 -48.7 66.46 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 120.916 1.689 . . . . 0.0 109.406 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mtp -49.97 -62.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -57.74 11.48 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 121.355 -0.841 . . . . 0.0 112.093 -178.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -41.18 -52.75 3.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.614 1.566 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -60.19 -47.69 84.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.445 0.566 . . . . 0.0 111.824 176.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.89 -66.03 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.83 -0.543 . . . . 0.0 111.067 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.34 -37.71 7.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.079 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.44 63.24 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.901 1.228 . . . . 0.0 112.694 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.1 mmt -58.83 -43.61 90.73 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.412 0.551 . . . . 0.0 110.438 174.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.15 3.76 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.541 1.067 . . . . 0.0 111.207 178.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -81.39 118.85 73.95 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.243 -173.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -66.81 137.48 45.48 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 N-CA-C 108.443 -1.406 . . . . 0.0 108.443 174.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.08 140.87 42.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.439 0.696 . . . . 0.0 109.903 178.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -112.28 85.3 2.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.5 p -74.78 98.18 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.838 2.055 . . . . 0.0 111.402 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.66 60.99 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -157.01 141.2 16.42 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp . . . . . 0 CA--C 1.528 0.117 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.022 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 . . . . . 0 CA--C 1.539 0.548 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.96 133.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -163.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.07 116.0 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 125.127 1.371 . . . . 0.0 110.305 -174.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.55 136.82 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -114.2 114.78 26.47 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 6.0 ptp -118.24 130.2 55.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.302 1.041 . . . . 0.0 109.831 178.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -80.03 125.27 29.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.404 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.25 140.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -103.42 156.58 17.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.82 -32.7 1.69 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.378 0.513 . . . . 0.0 114.199 172.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.7 mtp -67.31 80.84 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.253 1.026 . . . . 0.0 111.721 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -118.67 65.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.123 1.769 . . . . 0.0 109.095 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.24 169.25 9.33 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.92 5.17 52.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.839 0.456 . . . . 0.0 111.749 169.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.5 t -85.57 -65.81 0.97 Allowed 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.801 -0.562 . . . . 0.0 109.69 -174.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.23 -46.81 82.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.49 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -52.09 -60.95 2.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 109.968 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 t -52.12 -44.37 64.44 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.754 1.222 . . . . 0.0 111.231 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -58.07 -50.78 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.486 -0.758 . . . . 0.0 110.592 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.29 -45.78 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.54 -51.6 53.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.689 1.196 . . . . 0.0 110.721 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.63 -54.56 36.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.352 0.501 . . . . 0.0 111.92 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -52.17 66.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.638 -0.919 . . . . 0.0 111.462 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -63.83 -41.38 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.299 0.639 . . . . 0.0 109.709 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.96 19.76 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.448 0.547 . . . . 0.0 112.563 170.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -62.64 -24.93 67.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.724 0.762 . . . . 0.0 112.958 178.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mt -70.75 129.82 40.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.426 1.012 . . . . 0.0 112.825 -171.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.42 87.87 0.12 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.221 174.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -25.0 0.62 Allowed Glycine 0 C--N 1.332 0.343 0 O-C-N 122.035 -0.416 . . . . 0.0 113.406 -177.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.97 151.39 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -112.98 -53.98 2.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.967 0.907 . . . . 0.0 110.276 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.0 165.8 26.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -158.81 139.42 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -175.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -141.51 84.72 1.92 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.648 1.579 . . . . 0.0 110.254 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.43 106.34 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.056 -173.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -92.49 155.12 18.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -47.73 3.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.201 1.0 . . . . 0.0 108.619 177.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.03 -60.1 3.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.36 1.864 . . . . 0.0 110.567 -171.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -94.42 19.57 9.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.192 -175.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.83 49.44 0.57 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.048 2.539 . . . . 0.0 113.662 -177.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 4.7 tp10 -126.94 126.18 42.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.912 -169.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -115.03 113.25 23.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 110.155 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.491 ' C ' HD12 ' A' ' 45' ' ' ILE . 5.7 m -91.7 124.93 36.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 108.668 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' C ' ' A' ' 44' ' ' THR . 3.2 mp -124.09 132.64 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 167.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.25 107.05 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.57 1.148 . . . . 0.0 109.665 -174.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.73 159.98 40.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -171.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -81.72 114.1 47.54 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.49 74.59 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.297 2.665 . . . . 0.0 110.791 -171.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -49.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.073 2.149 . . . . 0.0 108.02 173.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.17 -43.63 70.43 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.357 -173.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.23 169.58 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -142.63 165.64 26.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.455 -170.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.0 t -43.96 -45.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.266 1.026 . . . . 0.0 111.391 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.29 -56.9 15.86 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.277 -178.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.56 -48.21 69.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.462 1.483 . . . . 0.0 109.929 -177.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.1 mtm -46.68 -61.8 1.67 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 118.813 0.733 . . . . 0.0 112.54 169.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -60.34 -59.89 4.68 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.326 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -37.8 -54.77 1.23 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.679 1.592 . . . . 0.0 109.614 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.69 -46.86 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.503 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -68.06 -64.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 O-C-N 121.527 -0.733 . . . . 0.0 110.716 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.14 -34.63 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.17 175.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.99 -33.72 65.11 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 120.218 1.372 . . . . 0.0 112.846 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.6 mmt -59.03 -40.14 84.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.536 0.607 . . . . 0.0 110.443 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.95 -20.17 3.43 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.621 1.105 . . . . 0.0 110.989 178.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.62 112.99 19.91 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.183 -173.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -66.21 141.08 61.53 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.6 135.08 34.59 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.759 0.314 . . . . 0.0 111.628 -177.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -108.15 72.6 0.85 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.569 -171.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.83 103.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.637 1.575 . . . . 0.0 111.002 174.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -156.1 56.52 0.59 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.772 0.796 . . . . 0.0 111.925 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -157.13 162.11 39.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 173.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 tt . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.21 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 . . . . . 0 N--CA 1.451 -0.403 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.44 127.66 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.566 1.146 . . . . 0.0 109.202 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -90.99 116.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 126.295 1.838 . . . . 0.0 109.254 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.08 118.56 37.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -97.0 119.05 34.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.507 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.3 ptp -121.42 124.3 44.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.759 1.224 . . . . 0.0 109.203 175.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -82.53 119.25 24.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.23 122.59 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.98 0.512 . . . . 0.0 110.244 -170.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.11 157.49 20.68 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.474 0.309 . . . . 0.0 111.119 -174.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.03 -44.63 1.46 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.947 0.784 . . . . 0.0 112.119 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 mtm -60.28 109.19 0.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.202 0.501 . . . . 0.0 109.809 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -146.51 19.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.851 1.26 . . . . 0.0 110.014 -177.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.0 148.89 22.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -81.14 42.38 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.094 0.557 . . . . 0.0 112.288 -167.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -122.42 -69.11 0.85 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.253 1.421 . . . . 0.0 107.491 177.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -49.76 -53.36 25.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.201 1.4 . . . . 0.0 110.443 -176.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 HG21 HD22 ' A' ' 38' ' ' LEU . 11.8 t -51.18 -55.75 16.37 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.173 177.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -60.97 -45.69 93.73 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.349 1.06 . . . . 0.0 110.307 -175.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -55.26 -51.36 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.646 -0.659 . . . . 0.0 110.76 176.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.64 -48.02 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.971 0.509 . . . . 0.0 110.002 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -48.96 -51.72 28.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.447 1.499 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -59.91 9.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 172.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -48.87 79.06 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 122.002 -0.705 . . . . 0.0 110.851 -170.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.3 mm -71.08 -47.79 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.074 0.55 . . . . 0.0 109.96 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.95 -35.26 31.96 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.325 0.488 . . . . 0.0 112.228 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -68.87 -16.38 63.75 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.868 0.867 . . . . 0.0 113.324 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mt -73.91 139.6 45.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.488 1.495 . . . . 0.0 112.106 -176.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -70.1 97.38 1.18 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.062 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.91 -12.87 1.12 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-O 118.662 -1.077 . . . . 0.0 114.181 -175.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.3 t -102.85 139.43 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 118.145 0.973 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 -31.68 14.39 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.881 0.472 . . . . 0.0 111.801 175.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -171.57 164.55 6.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -156.04 138.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 104.022 -2.584 . . . . 0.0 104.022 -172.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -137.78 92.42 2.68 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.79 1.636 . . . . 0.0 111.239 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.41 115.24 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -104.9 103.4 12.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.984 1.713 . . . . 0.0 108.723 -173.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.816 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -65.5 -48.83 71.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.77 0.428 . . . . 0.0 110.628 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.17 -54.48 30.21 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.883 1.273 . . . . 0.0 110.24 -176.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.63 5.56 27.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.828 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 35.19 60.21 0.71 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 128.428 2.691 . . . . 0.0 113.081 -175.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -138.79 149.1 44.61 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.154 1.381 . . . . 0.0 108.586 -175.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -126.37 119.61 27.73 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.634 1.174 . . . . 0.0 110.269 -179.364 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 45' ' ' ILE . 9.0 m -103.03 114.44 28.75 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.975 1.71 . . . . 0.0 109.025 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 44' ' ' THR . 2.1 mp -117.37 115.44 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.76 105.52 18.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.749 0.704 . . . . 0.0 109.927 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -128.61 169.68 14.14 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -166.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.02 111.0 64.74 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 124.554 1.142 . . . . 0.0 110.461 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.58 78.35 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.144 2.563 . . . . 0.0 111.431 -175.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.7 m80 178.97 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.447 2.699 . . . . 0.0 108.624 173.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 -50.21 11.99 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.01 -178.32 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.095 1.358 . . . . 0.0 107.718 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.8 p -142.85 155.22 44.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.358 -174.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.45 -42.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 124.199 1.0 . . . . 0.0 111.07 173.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.15 -39.36 94.43 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.046 -177.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.73 -51.46 64.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.853 1.206 . . . . 0.0 107.748 176.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.0 mmt -47.63 -61.22 2.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 122.447 0.299 . . . . 0.0 111.775 176.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -57.56 -59.45 5.16 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 120.967 -1.083 . . . . 0.0 111.077 177.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 119.312 0.96 . . . . 0.0 109.249 -170.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -57.95 -50.02 74.8 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.85 173.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -69.5 -64.79 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 111.046 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -45.02 -39.51 5.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.791 0.723 . . . . 0.0 112.262 174.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.59 55.74 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.513 1.051 . . . . 0.0 113.293 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -56.27 -39.52 72.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.403 0.547 . . . . 0.0 110.534 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.05 -19.61 2.88 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.714 1.149 . . . . 0.0 111.181 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.33 112.35 40.86 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.359 1.064 . . . . 0.0 110.384 -169.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.22 127.91 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.766 1.644 . . . . 0.0 109.651 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.57 133.03 55.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.618 0.767 . . . . 0.0 111.84 -173.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -105.51 76.02 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.286 1.034 . . . . 0.0 109.493 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.49 109.4 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.076 0.95 . . . . 0.0 110.077 170.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -156.98 53.8 0.51 Allowed 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 178.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 81.47 0.78 Allowed 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.931 -0.481 . . . . 0.0 110.127 -177.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tp . . . . . 0 CA--C 1.541 0.613 0 C-N-CA 123.683 0.793 . . . . 0.0 109.565 -179.199 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.71 ' HG3' HG12 ' A' ' 46' ' ' VAL . 13.7 pm0 . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.5 t -133.9 140.78 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.426 ' C ' HD12 ' A' ' 5' ' ' LEU . 7.7 p -101.26 129.13 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 126.049 1.74 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 47' ' ' TYR . 10.8 mp -120.31 145.61 46.93 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -122.98 125.96 46.25 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mtt -115.79 129.67 56.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.412 1.885 . . . . 0.0 108.026 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.45 126.29 31.47 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.05 157.04 9.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 119.329 0.968 . . . . 0.0 109.723 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -123.75 143.56 50.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.366 0.603 . . . . 0.0 109.743 170.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.61 -31.51 8.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.005 1.765 . . . . 0.0 112.794 174.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.7 mtt -66.36 99.14 0.53 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.09 0.945 . . . . 0.0 111.02 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.0 m -143.78 56.52 1.34 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.936 -1.102 . . . . 0.0 109.477 174.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.4 p -161.62 159.85 28.07 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 165.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -80.58 44.68 0.73 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.271 0.487 . . . . 0.0 111.222 179.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -123.17 -60.33 1.51 Allowed 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -47.2 -59.89 2.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.488 0.715 . . . . 0.0 110.807 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -52.92 -59.26 4.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.572 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 t -60.38 -45.27 94.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.756 0.822 . . . . 0.0 111.331 -170.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -54.19 -49.97 68.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.56 -0.713 . . . . 0.0 110.462 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.23 -43.9 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.699 ' HA ' HD13 ' A' ' 34' ' ' ILE . 8.1 mt-10 -53.58 -50.07 66.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.139 0.976 . . . . 0.0 110.682 177.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.58 -58.25 14.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 171.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -56.32 -52.3 65.05 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.169 -0.607 . . . . 0.0 111.14 -172.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.587 HG21 HD12 ' A' ' 34' ' ' ILE . 24.8 mm -62.02 -47.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.907 1.283 . . . . 0.0 109.911 178.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.98 -39.71 26.35 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 172.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -70.48 -13.92 62.32 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mt -82.23 133.37 35.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 120.031 1.287 . . . . 0.0 112.345 -174.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -68.67 91.17 0.42 Allowed 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.532 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.59 -20.87 0.92 Allowed Glycine 0 C--N 1.334 0.433 0 O-C-N 121.859 -0.525 . . . . 0.0 113.752 -177.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -85.93 151.16 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -120.43 -38.29 2.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.873 1.269 . . . . 0.0 111.013 -179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -152.78 171.05 18.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 22' ' ' GLU . 14.8 tt -158.56 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -143.78 88.03 1.96 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.074 1.75 . . . . 0.0 111.298 175.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.83 88.61 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.124 -0.985 . . . . 0.0 111.263 -178.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.04 121.36 21.87 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.675 1.99 . . . . 0.0 110.919 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -73.97 -46.56 43.22 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.261 -0.899 . . . . 0.0 111.366 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 m-20 -47.3 -59.58 3.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.724 1.21 . . . . 0.0 111.211 -170.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.35 24.92 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.524 -176.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 24.89 74.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.346 2.659 . . . . 0.0 113.934 -169.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -127.94 136.58 51.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 108.222 -173.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.8 102.38 9.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.53 1.132 . . . . 0.0 108.427 171.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.568 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.2 m -88.95 125.72 35.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -123.0 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 2' ' ' GLU . 2.6 t -118.96 103.59 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.487 1.115 . . . . 0.0 108.067 -174.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HE1' HD13 ' A' ' 5' ' ' LEU . 17.0 p90 -138.78 164.59 29.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -166.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -96.71 110.64 54.26 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.975 -173.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.05 76.57 2.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.894 3.062 . . . . 0.0 110.684 -172.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.407 1.883 . . . . 0.0 107.357 -175.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.51 -46.35 13.51 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.476 0.485 . . . . 0.0 110.48 -171.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.54 155.51 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 107.136 -176.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 p -123.18 161.84 23.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.786 1.234 . . . . 0.0 110.392 -173.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.6 t -45.47 -45.52 4.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 123.831 0.852 . . . . 0.0 111.843 175.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.49 -56.65 17.8 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.038 -175.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -38.82 -59.67 0.93 Allowed 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.015 1.726 . . . . 0.0 110.144 170.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.4 mtm -49.67 -62.79 1.36 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -59.2 -62.64 1.73 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.41 -177.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -38.82 -49.37 1.62 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 120.013 1.278 . . . . 0.0 110.376 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -37.2 78.67 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -72.08 -66.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 124.37 1.068 . . . . 0.0 110.81 175.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -38.0 -40.16 0.45 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.034 1.334 . . . . 0.0 112.403 171.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.38 -35.43 8.29 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 113.514 176.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.83 81.71 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.666 0.787 . . . . 0.0 110.613 178.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.23 -14.66 4.55 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.877 1.227 . . . . 0.0 111.172 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -85.48 115.93 63.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 123.849 0.86 . . . . 0.0 109.866 -171.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.5 142.1 63.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 175.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.4 135.81 44.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.094 0.558 . . . . 0.0 111.401 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -105.7 76.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.577 1.151 . . . . 0.0 109.437 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.41 104.52 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.079 1.352 . . . . 0.0 110.859 171.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -155.73 60.01 0.61 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.71 0.767 . . . . 0.0 112.875 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.31 162.33 40.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 tp . . . . . 0 CA--C 1.532 0.282 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.821 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 . . . . . 0 CA--C 1.535 0.374 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -116.78 128.61 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 124.731 1.212 . . . . 0.0 109.499 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.3 104.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.345 1.458 . . . . 0.0 110.129 -176.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.33 101.89 14.38 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -79.19 120.95 24.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.079 0.952 . . . . 0.0 108.6 174.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.72 119.14 29.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 115.55 19.41 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.43 154.49 5.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -174.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -111.54 156.91 21.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.45 -43.44 3.22 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.261 -0.9 . . . . 0.0 114.043 161.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.5 mtm -61.01 86.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.374 1.087 . . . . 0.0 111.507 -178.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -116.49 38.08 3.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.744 1.618 . . . . 0.0 109.902 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -154.81 162.96 40.92 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -76.74 -21.61 55.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.429 0.456 . . . . 0.0 111.402 -177.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -58.16 -58.91 6.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.752 0.421 . . . . 0.0 110.214 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.1 m -54.5 -53.37 55.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -58.9 -54.2 49.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.075 -175.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -58.74 -45.91 88.6 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.818 0.847 . . . . 0.0 111.229 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.6 m -56.2 -48.46 76.35 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.371 -0.83 . . . . 0.0 110.5 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -59.44 -47.89 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -55.81 -45.0 78.38 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.635 . . . . 0.0 110.764 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.1 -53.26 45.94 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.063 0.84 . . . . 0.0 111.527 173.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -63.0 -59.77 4.36 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.93 0.871 . . . . 0.0 109.834 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.59 -32.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.167 1.387 . . . . 0.0 111.043 -175.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.16 -31.49 6.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.313 0.482 . . . . 0.0 112.447 172.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -80.74 -4.08 53.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.74 139.35 45.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 120.104 1.32 . . . . 0.0 112.524 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -81.18 84.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.136 177.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.04 -13.96 0.86 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 178.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.33 145.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -115.13 -37.33 4.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.249 1.419 . . . . 0.0 111.037 -176.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.66 44.42 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -155.06 126.6 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' LYS 0.253 16.2 mmtm -135.08 102.16 5.11 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 171.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.33 98.58 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.584 -0.697 . . . . 0.0 110.095 -177.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.1 m -89.14 126.84 35.64 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.14 1.376 . . . . 0.0 110.808 -176.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -84.65 -42.96 14.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.832 0.853 . . . . 0.0 109.96 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -59.11 4.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.938 1.695 . . . . 0.0 110.376 -173.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -86.58 9.0 19.83 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.001 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 0.1 OUTLIER 32.85 66.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.209 2.604 . . . . 0.0 112.208 -169.548 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -144.5 141.99 29.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.556 1.142 . . . . 0.0 110.685 -173.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.95 120.19 39.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.38 1.472 . . . . 0.0 109.682 -178.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -94.46 78.27 3.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.942 2.497 . . . . 0.0 107.934 175.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.28 103.8 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.54 108.24 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -131.41 175.05 9.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -106.88 109.91 63.35 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.268 1.027 . . . . 0.0 110.187 -175.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 73.74 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.153 3.235 . . . . 0.0 111.216 -170.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -177.91 -39.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.372 2.269 . . . . 0.0 108.368 178.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.75 -46.13 13.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.778 -175.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -135.62 149.08 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -100.58 158.74 15.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.052 0.941 . . . . 0.0 111.676 -173.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.71 -42.97 18.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.939 0.496 . . . . 0.0 110.357 166.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.52 -53.92 50.04 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -176.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -46.14 -54.1 9.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.312 1.045 . . . . 0.0 110.528 172.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.9 mmm -48.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 173.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 15.0 tttp -56.9 -64.57 0.83 Allowed 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.808 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -37.11 -52.76 1.01 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.907 1.683 . . . . 0.0 109.954 178.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -66.11 -47.26 74.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.081 177.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.61 -62.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.655 0.661 . . . . 0.0 110.453 -178.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 1.8 tt0 -42.39 -44.08 3.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 112.223 171.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.2 62.3 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.126 0.875 . . . . 0.0 113.065 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.1 -42.29 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.499 0.59 . . . . 0.0 110.467 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.28 -18.71 2.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.596 1.093 . . . . 0.0 111.299 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -81.23 118.31 71.77 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-O 118.417 -0.801 . . . . 0.0 110.373 -169.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.1 140.05 52.77 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 N-CA-C 108.445 -1.406 . . . . 0.0 108.445 173.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.21 132.33 37.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.392 0.615 . . . . 0.0 111.045 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.26 81.24 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -42.02 107.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 125.15 1.531 . . . . 0.0 108.818 160.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -101.87 179.8 4.23 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.121 1.768 . . . . 0.0 106.611 170.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 161.87 18.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.05 -175.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mt . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 123.003 0.521 . . . . 0.0 109.709 -178.786 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 111.8 0.296 . . . . 0.0 111.8 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -105.6 132.45 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.854 0.862 . . . . 0.0 109.161 -176.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -94.2 115.52 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.646 1.578 . . . . 0.0 109.813 179.435 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.0 124.43 33.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 170.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.48 109.39 21.34 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.724 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptp -119.64 144.64 47.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.094 0.958 . . . . 0.0 109.142 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.85 46.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.922 173.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.92 96.48 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 124.661 1.226 . . . . 0.0 109.448 -166.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -68.3 142.76 55.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.946 -0.471 . . . . 0.0 110.668 -172.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 -47.72 1.0 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.286 0.946 . . . . 0.0 112.525 174.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.7 82.47 2.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.929 0.864 . . . . 0.0 111.899 -171.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -111.35 33.63 4.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.537 1.535 . . . . 0.0 110.545 -178.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -155.37 160.55 40.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -78.0 -1.5 32.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -174.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -76.7 -61.36 1.99 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.49 -0.756 . . . . 0.0 109.629 175.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -56.13 -48.59 75.93 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.717 0.407 . . . . 0.0 110.809 -174.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.9 p -52.03 -60.39 3.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.383 0.673 . . . . 0.0 109.415 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -50.7 -48.21 58.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.786 1.234 . . . . 0.0 111.692 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -54.42 -51.91 63.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.315 -0.866 . . . . 0.0 110.948 176.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.9 mt -62.14 -40.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.97 0.508 . . . . 0.0 109.989 178.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.99 -48.58 78.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.661 1.184 . . . . 0.0 110.599 176.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.82 -56.31 24.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 172.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -56.18 -52.63 63.71 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -174.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.06 -45.81 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.244 1.018 . . . . 0.0 110.299 -175.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.57 -37.61 26.86 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.402 0.525 . . . . 0.0 112.012 175.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -72.99 -9.28 58.56 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.135 0.974 . . . . 0.0 113.5 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mt -81.45 128.45 33.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.431 1.468 . . . . 0.0 111.408 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -66.8 108.87 2.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.097 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.52 -16.28 3.58 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 124.489 1.042 . . . . 0.0 112.613 -178.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.5 152.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 117.053 0.426 . . . . 0.0 110.249 173.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.14 -46.08 2.21 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.31 -178.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.42 165.57 30.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 178.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -156.5 137.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -141.66 90.85 2.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.253 1.021 . . . . 0.0 111.495 179.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.76 90.91 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.512 -0.742 . . . . 0.0 110.194 -177.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 m -84.45 110.21 18.48 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.583 1.153 . . . . 0.0 111.247 -173.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -63.33 -49.6 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.356 0.663 . . . . 0.0 112.368 177.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.86 -59.58 3.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.074 1.349 . . . . 0.0 111.095 -170.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -92.57 18.91 7.93 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.438 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 28.9 60.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 129.028 2.931 . . . . 0.0 113.609 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.12 132.46 32.04 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 110.26 -175.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.724 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.22 112.5 25.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.451 1.9 . . . . 0.0 109.498 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.0 m -90.56 84.57 5.95 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 127.845 2.458 . . . . 0.0 107.575 173.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.25 113.06 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -107.47 111.76 37.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.957 0.799 . . . . 0.0 110.128 -171.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -129.75 170.89 13.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.762 0.792 . . . . 0.0 112.328 -169.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -106.42 109.25 63.0 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.906 -177.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.36 77.99 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.177 2.584 . . . . 0.0 110.906 -172.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -177.09 -41.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 127.885 2.474 . . . . 0.0 107.926 174.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -77.96 -53.84 6.98 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 117.966 0.348 . . . . 0.0 110.974 -177.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.27 179.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.88 1.272 . . . . 0.0 108.84 -176.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -146.37 159.6 43.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.574 0.749 . . . . 0.0 110.992 -172.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -39.28 -48.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.813 1.645 . . . . 0.0 111.159 173.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.78 -50.46 73.37 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.14 -50.64 66.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 120.401 1.455 . . . . 0.0 108.442 176.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.66 -55.96 16.44 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.499 0.19 . . . . 0.0 111.011 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.87 -62.26 1.92 Allowed 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.583 177.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -50.34 5.29 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.446 1.099 . . . . 0.0 109.495 -177.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -60.1 -49.84 76.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 177.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -70.17 -63.76 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.744 -0.597 . . . . 0.0 111.301 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.8 -37.91 6.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 112.548 174.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.78 56.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.779 1.172 . . . . 0.0 113.06 176.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 mmt -56.89 -39.88 75.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.507 0.594 . . . . 0.0 110.625 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.41 -18.96 3.23 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.639 1.114 . . . . 0.0 110.932 176.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -80.94 114.03 45.33 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.48 -172.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.99 141.63 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.663 1.575 . . . . 0.0 108.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.37 134.57 46.41 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.335 0.97 . . . . 0.0 112.956 -177.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -106.47 71.74 0.88 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.14 107.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.8 170.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -150.89 55.19 0.89 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 176.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 159.45 41.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 173.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 tp . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.013 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 . . . . . 0 N--CA 1.447 -0.622 0 CA-C-O 119.821 -0.133 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.57 141.18 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.082 0.953 . . . . 0.0 109.343 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -104.96 127.01 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 126.462 1.905 . . . . 0.0 110.663 -177.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.21 127.89 54.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.1 111.27 23.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 178.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.422 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.4 ptp -113.66 122.23 46.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.698 1.199 . . . . 0.0 109.152 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -74.46 130.85 40.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.44 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.15 153.7 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -117.08 146.85 42.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.72 -38.91 2.97 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.267 0.937 . . . . 0.0 113.077 170.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 21' ' ' ILE . 34.0 mtt -62.72 137.06 58.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.457 1.129 . . . . 0.0 110.575 -174.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -143.4 -56.99 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.733 -0.605 . . . . 0.0 110.226 176.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.8 p -72.07 156.47 39.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.724 0.693 . . . . 0.0 110.098 -179.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -65.16 -18.71 65.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.295 177.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 m -64.54 -50.18 68.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.422 -0.799 . . . . 0.0 110.665 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -54.62 -57.85 9.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.787 0.721 . . . . 0.0 109.73 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -55.49 -55.31 33.25 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.539 -176.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -56.55 -45.89 80.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.9 m -58.0 -49.48 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.487 -0.758 . . . . 0.0 109.942 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CE ' ' A' ' 12' ' ' MET . 3.1 mt -61.14 -47.01 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 122.936 0.494 . . . . 0.0 109.912 176.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.56 -50.26 60.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.553 0.741 . . . . 0.0 109.551 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.86 -56.79 22.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.68 0.657 . . . . 0.0 111.817 173.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -60.63 -59.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.198 -0.589 . . . . 0.0 110.948 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -67.58 -34.25 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.954 -177.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.43 -33.79 6.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.58 168.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -92.42 12.19 23.6 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 117.966 0.883 . . . . 0.0 112.353 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.61 151.24 47.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 120.404 -1.435 . . . . 0.0 109.886 167.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.17 130.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.37 -0.88 29.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.557 1.075 . . . . 0.0 111.909 176.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -95.48 154.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 124.691 1.196 . . . . 0.0 109.658 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -122.1 -41.57 2.42 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.168 0.987 . . . . 0.0 110.055 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -150.66 164.37 36.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 25' ' ' ILE . 10.5 tt -156.97 139.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -172.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -145.49 147.76 32.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.55 0.74 . . . . 0.0 110.027 172.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.32 140.76 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.863 1.211 . . . . 0.0 110.825 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -124.08 132.57 53.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.971 1.708 . . . . 0.0 110.569 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -54.73 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 112.151 176.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.61 -56.73 16.01 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 110.112 -166.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.22 11.58 16.08 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.845 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.37 62.69 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.857 2.863 . . . . 0.0 113.042 -178.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 3.8 tt0 -131.39 142.32 50.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.342 -175.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -118.72 133.88 55.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.298 1.439 . . . . 0.0 108.659 175.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -109.94 117.18 33.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.518 3.127 . . . . 0.0 106.648 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -126.23 119.29 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.17 108.59 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -168.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.192 0.52 . . . . 0.0 112.008 -165.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -89.31 108.58 25.45 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.714 1.606 . . . . 0.0 109.431 -174.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.2 73.14 2.69 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.02 2.48 . . . . 0.0 111.036 -176.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -168.22 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.413 1.885 . . . . 0.0 108.756 177.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.67 -43.17 63.48 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.36 177.9 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -135.05 162.34 32.75 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.153 0.888 . . . . 0.0 110.215 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.09 -46.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 110.995 169.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -61.14 -57.77 11.11 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.184 -174.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -38.57 -56.85 1.24 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.763 1.625 . . . . 0.0 110.665 172.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.45 -63.01 1.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 122.163 -0.336 . . . . 0.0 111.57 175.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -58.64 7.53 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.714 -0.616 . . . . 0.0 111.964 -177.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -36.88 -54.97 0.92 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.844 1.658 . . . . 0.0 110.491 172.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -41.8 94.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.094 -1.043 . . . . 0.0 113.388 176.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.74 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.174 -0.954 . . . . 0.0 109.98 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -43.42 -40.96 4.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.957 169.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.23 61.16 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.617 1.099 . . . . 0.0 113.222 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.82 -43.79 81.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.593 0.633 . . . . 0.0 110.777 171.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.02 -15.31 4.02 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.047 1.308 . . . . 0.0 111.287 -179.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 21' ' ' ILE . 44.2 m-85 -80.89 116.89 65.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.91 -173.221 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.9 140.04 49.27 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 108.397 -1.424 . . . . 0.0 108.397 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.71 140.25 42.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.351 0.66 . . . . 0.0 110.48 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -114.66 79.03 1.21 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.939 0.896 . . . . 0.0 109.152 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 105.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.012 1.325 . . . . 0.0 109.691 169.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -152.98 54.72 0.77 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.735 0.778 . . . . 0.0 112.42 176.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 132.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.451 -0.391 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 175.684 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 21.7 mp0 -80.44 -178.27 6.59 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 126.395 1.878 . . . . 0.0 109.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 92.3 t -127.05 135.83 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -89.72 132.47 34.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 C-N-CA 126.351 1.86 . . . . 0.0 107.639 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 70' ' ' VAL . 4.1 mm? -113.25 135.24 54.05 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 166.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 21.1 tptt -111.94 122.07 46.77 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 172.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.6 ptp -123.64 120.5 32.95 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 125.106 1.362 . . . . 0.0 109.533 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.441 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.2 mptp? -71.01 134.53 47.21 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 117.655 -1.164 . . . . 0.0 108.079 173.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 m -116.91 150.35 18.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 178.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -113.61 150.35 33.24 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 81.36 -35.06 2.42 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.548 -0.584 . . . . 0.0 113.52 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 52.6 mtm -65.82 85.72 0.08 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.607 1.204 . . . . 0.0 111.603 178.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.2 m -122.96 51.08 1.46 Allowed 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 126.276 1.83 . . . . 0.0 109.116 176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.7 p -158.32 167.88 28.52 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 165.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -77.77 -22.24 50.49 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.321 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.0 m -65.62 -62.0 1.76 Allowed 'General case' 0 N--CA 1.453 -0.292 0 CA-C-O 118.88 -0.581 . . . . 0.0 111.047 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.1 m -52.21 -51.22 59.5 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 122.013 0.911 . . . . 0.0 110.235 -177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.8 p -57.58 -56.07 26.67 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.326 -1.306 . . . . 0.0 110.295 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.9 t -54.98 -48.34 73.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 118.776 0.717 . . . . 0.0 111.623 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 29.2 m -52.85 -51.96 59.04 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 123.534 0.734 . . . . 0.0 110.283 177.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.7 mt -60.92 -44.26 97.56 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -54.19 -48.12 71.32 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.231 0.612 . . . . 0.0 111.087 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.0 -55.82 28.75 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.663 0.649 . . . . 0.0 111.624 173.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.6 tptt -56.96 -47.11 81.49 Favored 'General case' 0 CA--C 1.529 0.154 0 O-C-N 122.109 -0.642 . . . . 0.0 110.945 -174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.3 mm -66.34 -48.02 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 C-N-CA 124.241 1.016 . . . . 0.0 109.478 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.76 -39.26 31.34 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 123.533 0.587 . . . . 0.0 112.235 174.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -60.54 -29.17 68.97 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 117.492 0.646 . . . . 0.0 112.489 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.4 mt -75.04 135.29 41.26 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 122.039 0.923 . . . . 0.0 112.088 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -70.72 86.96 0.68 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 114.989 -1.005 . . . . 0.0 111.917 -178.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -15.66 0.51 Allowed Glycine 0 C--N 1.334 0.44 0 N-CA-C 115.227 0.851 . . . . 0.0 115.227 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.4 t -86.95 149.69 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 CA-C-N 117.844 0.822 . . . . 0.0 109.287 175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 -120.8 -34.72 3.5 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.434 1.093 . . . . 0.0 111.038 -175.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -156.53 164.32 38.35 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.283 -1.376 . . . . 0.0 107.283 176.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.2 tt -158.29 140.28 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.595 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.414 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 25.1 mmtm -140.99 82.7 1.85 Allowed 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 124.233 1.013 . . . . 0.0 111.222 176.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.3 t -84.47 110.91 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.3 m -89.29 172.16 9.25 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.502 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -133.58 -48.15 0.82 Allowed 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.461 1.104 . . . . 0.0 109.48 179.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -46.11 -61.15 1.89 Allowed 'General case' 0 CA--C 1.515 -0.374 0 C-N-CA 126.389 1.876 . . . . 0.0 110.392 -179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -93.17 19.52 7.93 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.505 -1.225 . . . . 0.0 110.143 -176.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.33 63.87 0.27 Allowed 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 128.759 2.824 . . . . 0.0 113.462 -178.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.441 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 35.2 tt0 -146.6 146.24 30.36 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.239 -1.022 . . . . 0.0 108.239 -177.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.43 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -125.14 124.71 42.39 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.613 1.165 . . . . 0.0 109.596 -175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.0 m -98.05 129.54 44.89 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 125.82 1.648 . . . . 0.0 107.23 175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -128.8 123.19 58.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.433 -1.691 . . . . 0.0 106.433 177.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -117.43 104.55 16.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 CA-C-N 118.821 0.737 . . . . 0.0 110.025 -173.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -133.4 167.98 19.43 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-O 121.183 0.516 . . . . 0.0 112.335 -170.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -98.42 112.79 63.14 Favored Pre-proline 0 N--CA 1.448 -0.56 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.233 -174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -72.45 78.25 2.0 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 124.024 3.149 . . . . 0.0 110.985 -170.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -179.25 -52.95 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.781 1.632 . . . . 0.0 106.919 -173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -80.78 -46.06 16.02 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.155 -173.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.75 169.68 21.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 C-N-CA 125.552 1.541 . . . . 0.0 108.27 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -139.64 162.03 36.08 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.982 0.913 . . . . 0.0 111.202 -170.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.442 HG13 HG21 ' A' ' 70' ' ' VAL . 86.9 t -43.65 -48.28 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.242 0 C-N-CA 124.202 1.001 . . . . 0.0 111.15 172.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -63.89 -45.66 88.36 Favored 'General case' 0 C--O 1.216 -0.669 0 CA-C-O 118.308 -0.853 . . . . 0.0 110.488 -174.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -50.93 -57.28 8.93 Favored 'General case' 0 N--CA 1.456 -0.147 0 CA-C-N 120.231 1.378 . . . . 0.0 108.702 173.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.9 mmt -46.49 -65.43 0.56 Allowed 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 175.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.55 -59.7 5.02 Favored 'General case' 0 C--O 1.216 -0.664 0 O-C-N 121.284 -0.885 . . . . 0.0 112.611 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 14.1 tttt -44.76 -48.63 10.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 119.203 0.911 . . . . 0.0 109.562 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -66.22 -40.8 90.56 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 119.947 -0.701 . . . . 0.0 111.99 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -67.52 -65.12 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.1 0 C-N-CA 123.077 0.551 . . . . 0.0 110.619 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -43.38 -42.07 4.45 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.38 0.672 . . . . 0.0 112.18 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.42 -32.86 58.25 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 119.139 0.882 . . . . 0.0 113.149 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.3 mmt -59.39 -40.26 85.99 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 118.68 0.673 . . . . 0.0 110.681 174.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.93 -17.74 2.77 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.372 0.986 . . . . 0.0 111.197 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -84.23 110.53 27.03 Favored Pre-proline 0 N--CA 1.452 -0.332 0 C-N-CA 123.913 0.885 . . . . 0.0 109.581 -171.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -65.89 141.58 65.53 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 N-CA-C 108.452 -1.403 . . . . 0.0 108.452 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.33 136.18 32.95 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.444 0.298 . . . . 0.0 111.779 -176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -107.81 78.74 1.22 Allowed 'General case' 0 CA--C 1.523 -0.09 0 C-N-CA 124.06 0.944 . . . . 0.0 109.94 -174.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 5' ' ' LEU . 10.4 p -66.16 101.52 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 C-N-CA 125.844 1.657 . . . . 0.0 112.083 176.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.8 pttt -156.77 56.8 0.54 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 2.7 tppt? -158.03 130.06 6.96 Favored 'General case' 0 C--O 1.226 -0.184 0 N-CA-C 106.918 -1.512 . . . . 0.0 106.918 167.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 73.5 mt -120.85 63.01 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.79 59.5 1.73 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.867 0.867 . . . . 0.0 109.569 -171.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.94 164.1 51.84 Favored Glycine 0 CA--C 1.532 1.134 0 O-C-N 121.611 -0.681 . . . . 0.0 111.788 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.0 tmt_? . . . . . 0 C--O 1.25 1.121 0 N-CA-C 105.48 -2.044 . . . . 0.0 105.48 177.198 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.666 0 N-CA-C 106.53 -2.628 . . . . 0.0 106.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -170.62 156.19 5.22 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 -167.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.4 t -125.94 134.78 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 176.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.43 134.61 28.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 N-CA-C 106.288 -1.745 . . . . 0.0 106.288 173.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 61.5 mt -118.09 147.02 43.69 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 163.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -118.04 117.06 28.18 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 177.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.4 ptp -118.28 119.64 35.27 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 125.619 1.568 . . . . 0.0 108.275 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -69.47 140.74 54.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 173.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 m -127.94 146.4 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 -105.97 148.15 28.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -178.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.32 -31.68 2.09 Favored Glycine 0 CA--C 1.533 1.21 0 O-C-N 121.459 -0.776 . . . . 0.0 114.056 169.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 84.5 mtp -61.99 92.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.987 0.893 . . . . 0.0 110.242 179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.1 m -144.46 48.67 1.35 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.894 1.277 . . . . 0.0 109.724 -171.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.7 p -163.12 157.91 21.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 169.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.1 m-70 -77.26 44.27 0.41 Allowed 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.668 0.787 . . . . 0.0 111.46 177.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -129.54 -59.76 1.07 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.392 1.077 . . . . 0.0 108.425 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -54.66 -58.53 7.17 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.471 0.578 . . . . 0.0 110.655 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.6 t -51.95 -57.3 9.84 Favored 'General case' 0 C--O 1.226 -0.174 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.271 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 t -57.71 -40.33 79.3 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.809 0.844 . . . . 0.0 110.557 -172.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.7 m -60.85 -49.26 78.18 Favored 'General case' 0 N--CA 1.453 -0.308 0 O-C-N 121.934 -0.479 . . . . 0.0 110.082 176.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.48 -51.29 73.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 176.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -54.5 -51.19 65.87 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.201 1.0 . . . . 0.0 110.142 -177.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.01 -51.21 57.0 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 123.813 0.72 . . . . 0.0 112.059 173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.3 -59.58 5.07 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.195 0.997 . . . . 0.0 110.572 -175.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.9 mm -57.67 -38.07 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 124.264 1.026 . . . . 0.0 109.713 -179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.32 -36.15 7.36 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.033 0.825 . . . . 0.0 113.676 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.8 ttpt -83.62 -7.01 59.59 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.171 0.986 . . . . 0.0 112.599 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 35.0 mt -78.64 149.7 32.82 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.12 0.873 . . . . 0.0 111.835 -176.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -90.71 126.53 36.01 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.194 178.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.0 -21.06 7.51 Favored Glycine 0 C--N 1.336 0.562 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 86.1 t -86.98 151.64 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 123.478 0.711 . . . . 0.0 110.193 -173.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -118.51 -40.82 2.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.836 1.254 . . . . 0.0 110.726 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttt180 -159.13 170.84 21.09 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -158.48 140.1 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.56 0 N-CA-C 104.085 -2.561 . . . . 0.0 104.085 -174.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -143.87 84.73 1.79 Allowed 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 123.685 0.794 . . . . 0.0 110.718 178.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 67.1 t -94.45 102.26 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.84 0.856 . . . . 0.0 109.149 -172.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -78.53 177.21 8.73 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.741 -0.836 . . . . 0.0 108.741 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.536 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.6 OUTLIER -141.09 -48.85 0.41 Allowed 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.696 0.798 . . . . 0.0 109.054 179.289 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -47.86 -61.43 1.96 Allowed 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 125.423 1.489 . . . . 0.0 110.39 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -91.52 19.46 6.2 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.625 -177.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 37.29 62.27 0.86 Allowed 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.155 2.182 . . . . 0.0 113.603 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -146.29 149.48 33.94 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 -178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.97 130.64 46.95 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 124.332 1.053 . . . . 0.0 110.147 -178.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 5.9 m -102.06 129.3 48.35 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.701 1.601 . . . . 0.0 107.234 174.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.6 mm -123.88 127.81 73.9 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 171.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.34 107.36 21.17 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 110.005 -176.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 50.0 p90 -145.86 173.24 12.3 Favored 'General case' 0 CA--C 1.514 -0.428 0 O-C-N 121.498 -0.751 . . . . 0.0 111.813 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.8 tt0 -98.65 104.3 23.71 Favored Pre-proline 0 N--CA 1.439 -1.024 0 C-N-CA 124.932 1.293 . . . . 0.0 108.713 -178.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -59.12 -24.4 73.55 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.836 2.357 . . . . 0.0 112.4 -176.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -60.09 -22.76 63.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.594 0.758 . . . . 0.0 112.894 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.8 mt -107.97 -64.71 1.18 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.827 0.74 . . . . 0.0 111.474 -177.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -116.5 161.3 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 124.644 1.177 . . . . 0.0 108.277 -175.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.2 p -127.72 165.45 20.03 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 123.514 0.726 . . . . 0.0 111.969 -168.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 78.9 t -46.62 -44.67 6.73 Favored 'Isoleucine or valine' 0 C--N 1.344 0.35 0 C-N-CA 124.133 0.973 . . . . 0.0 110.236 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -60.59 -38.19 83.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 118.423 -0.798 . . . . 0.0 111.135 -176.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -67.86 -53.63 25.26 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 -179.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 26.3 mmt -45.21 -59.74 2.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 122.863 0.465 . . . . 0.0 111.634 173.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -64.01 -53.82 44.02 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.284 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 tppt? -50.37 -47.05 56.29 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 120.702 1.592 . . . . 0.0 109.201 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.2 mm-40 -59.63 -48.96 79.63 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.704 177.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 70.3 mt -69.74 -63.94 0.87 Allowed 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 C-N-CA 122.931 0.492 . . . . 0.0 110.583 -176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -47.69 -36.47 11.26 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.655 -0.688 . . . . 0.0 112.318 175.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.43 -32.82 63.04 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 119.726 1.148 . . . . 0.0 112.955 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.5 mmt -60.89 -30.39 70.13 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.437 0.562 . . . . 0.0 110.885 175.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.54 7.79 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 125.455 1.503 . . . . 0.0 110.716 175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 11.7 m-30 -82.5 116.07 61.69 Favored Pre-proline 0 N--CA 1.449 -0.492 0 C-N-CA 124.375 1.07 . . . . 0.0 109.524 -171.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -67.76 144.08 64.09 Favored 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 121.611 1.541 . . . . 0.0 108.75 178.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -140.27 141.22 35.83 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.929 0.492 . . . . 0.0 111.179 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -114.49 78.3 1.14 Allowed 'General case' 0 C--O 1.232 0.182 0 C-N-CA 123.88 0.872 . . . . 0.0 110.407 -178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 14.8 p -61.13 103.23 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 C-N-CA 125.097 1.359 . . . . 0.0 111.2 171.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.5 pttt -155.41 57.09 0.64 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.34 0.59 . . . . 0.0 112.16 -178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.01 158.17 32.66 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 172.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.4 tt -153.04 65.19 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-O 122.061 0.934 . . . . 0.0 109.767 179.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -79.3 93.34 5.27 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -75.93 -100.97 0.13 Allowed Glycine 0 CA--C 1.53 1.0 0 N-CA-C 108.974 -1.65 . . . . 0.0 108.974 167.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 23.7 ttt180 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 124.993 1.317 . . . . 0.0 110.309 -178.33 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.109 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -48.85 160.04 0.21 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.762 1.225 . . . . 0.0 109.663 157.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.0 m -122.58 129.69 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.964 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 46' ' ' VAL . 41.7 t -91.15 119.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 172.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.586 HD21 HG23 ' A' ' 70' ' ' VAL . 3.2 tm? -100.81 133.73 44.84 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 173.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -118.22 115.37 24.62 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -117.42 126.86 53.35 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.151 1.38 . . . . 0.0 108.572 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -70.31 140.72 52.33 Favored 'General case' 0 C--N 1.332 -0.157 0 N-CA-C 106.852 -1.536 . . . . 0.0 106.852 168.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 m -130.93 143.02 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 178.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -100.6 159.11 15.43 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -176.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.84 -39.01 2.94 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 121.756 -0.59 . . . . 0.0 114.566 161.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.4 mtm -62.53 102.47 0.33 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 118.7 1.25 . . . . 0.0 110.681 179.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -134.75 34.4 3.17 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.097 1.359 . . . . 0.0 109.772 -177.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 16.8 p -147.13 164.41 33.2 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 165.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -72.01 -25.5 61.85 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.613 0.244 . . . . 0.0 111.316 -177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 7.0 m -58.52 -56.1 26.51 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.214 0.606 . . . . 0.0 111.485 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 37.5 m -59.12 -55.77 30.75 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.64 0.654 . . . . 0.0 110.692 -175.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.9 t -49.37 -57.47 6.86 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.648 0.779 . . . . 0.0 110.22 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.3 t -59.73 -42.23 92.68 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.321 0.51 . . . . 0.0 111.206 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 82.8 m -57.38 -48.83 78.03 Favored 'General case' 0 CA--C 1.529 0.151 0 O-C-N 121.603 -0.686 . . . . 0.0 110.199 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -66.63 -49.08 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 CA-C-O 119.213 -0.422 . . . . 0.0 110.253 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -45.16 -53.78 7.69 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.278 1.031 . . . . 0.0 109.546 172.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.75 -57.41 19.93 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.344 0.973 . . . . 0.0 112.316 177.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.5 tptt -58.25 -54.38 47.65 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 117.868 0.834 . . . . 0.0 109.874 -173.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.464 ' HA ' HD12 ' A' ' 28' ' ' LEU . 24.0 mm -70.32 -35.95 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.575 -173.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.7 -30.76 9.08 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.733 -0.604 . . . . 0.0 112.688 172.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.3 tttt -74.7 -14.81 60.78 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 118.178 0.989 . . . . 0.0 113.448 -176.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 25' ' ' ILE . 0.9 OUTLIER -68.71 147.66 51.51 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 120.639 1.563 . . . . 0.0 112.746 -178.729 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -80.68 97.51 7.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-N 114.886 -1.052 . . . . 0.0 111.12 179.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 144.74 -10.1 1.87 Allowed Glycine 0 CA--C 1.522 0.518 0 CA-C-O 119.725 -0.486 . . . . 0.0 114.271 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 59.8 t -94.91 137.82 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 175.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.15 -31.66 10.49 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.079 0.551 . . . . 0.0 111.381 174.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.0 mtt180 -152.72 159.64 43.14 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.5 tt -157.19 140.92 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.278 0 N-CA-C 104.092 -2.559 . . . . 0.0 104.092 -178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 16.0 mmtt -144.93 136.78 25.67 Favored 'General case' 0 C--O 1.219 -0.512 0 C-N-CA 123.845 0.858 . . . . 0.0 110.53 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 92.8 t -132.96 104.69 7.26 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 CA-C-N 120.628 1.558 . . . . 0.0 111.349 178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.1 m -83.28 105.34 14.16 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 126.685 1.994 . . . . 0.0 110.125 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.416 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -62.26 -44.75 95.84 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 122.486 -0.133 . . . . 0.0 110.849 176.294 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -49.48 -57.34 7.2 Favored 'General case' 0 CA--C 1.518 -0.255 0 C-N-CA 125.396 1.478 . . . . 0.0 111.287 -172.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -90.08 11.66 20.1 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.576 -176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.26 1.4 mt-30 33.61 62.93 0.39 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.601 2.36 . . . . 0.0 112.605 -168.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -136.23 136.25 39.74 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.971 0.908 . . . . 0.0 110.618 -172.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -112.34 135.23 53.28 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.797 1.639 . . . . 0.0 110.168 176.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.6 m -111.77 124.47 52.42 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 131.281 3.832 . . . . 0.0 106.438 -178.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.5 mm -125.88 117.74 49.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 105.954 -1.869 . . . . 0.0 105.954 177.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 4' ' ' VAL . 2.9 t -108.46 95.42 3.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -175.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -123.88 169.52 11.5 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-O 121.22 0.533 . . . . 0.0 111.951 -169.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -108.06 109.81 62.02 Favored Pre-proline 0 N--CA 1.447 -0.614 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.345 -174.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.86 79.76 1.58 Allowed 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 123.504 2.803 . . . . 0.0 111.298 -170.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.5 m170 177.13 -41.04 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 128.07 2.548 . . . . 0.0 108.075 176.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 91.7 mt -78.95 -46.67 17.87 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 122.398 -0.189 . . . . 0.0 111.258 -175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -140.2 170.76 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 125.375 1.47 . . . . 0.0 107.741 -176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.8 p -130.53 155.91 45.71 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 124.128 0.971 . . . . 0.0 111.443 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.9 t -46.44 -43.13 5.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 123.638 0.775 . . . . 0.0 110.974 168.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.427 ' OE2' ' NZ ' ' A' ' 58' ' ' LYS . 4.1 tm-20 -60.68 -45.4 94.33 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-O 117.332 -1.318 . . . . 0.0 109.706 -176.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -57.58 -55.98 27.8 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 124.66 1.184 . . . . 0.0 107.814 175.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.7 mmt -46.16 -59.05 3.12 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 177.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.427 ' NZ ' ' OE2' ' A' ' 55' ' ' GLU . 0.3 OUTLIER -60.66 -51.18 70.5 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 121.148 -0.97 . . . . 0.0 111.927 177.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -52.66 -49.31 65.46 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.6 mm-40 -60.78 -48.19 82.91 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 120.772 -0.371 . . . . 0.0 111.373 176.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 78.0 mt -67.58 -66.8 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.196 0 O-C-N 121.849 -0.532 . . . . 0.0 111.057 -177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -48.94 -33.95 11.89 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 118.428 -0.796 . . . . 0.0 113.003 176.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.21 -31.95 61.85 Favored 'General case' 0 C--N 1.345 0.377 0 CA-C-N 119.937 1.244 . . . . 0.0 112.937 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.8 mmt -55.47 -42.28 74.11 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 118.528 0.604 . . . . 0.0 110.547 172.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.76 -25.0 2.28 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.011 0.815 . . . . 0.0 111.326 176.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -73.86 113.19 20.73 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-O 117.686 -1.15 . . . . 0.0 109.928 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -64.84 143.69 80.75 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 121.669 1.579 . . . . 0.0 108.857 178.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.41 132.26 40.96 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 112.991 0.737 . . . . 0.0 112.991 -175.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 -104.78 76.89 1.3 Allowed 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.586 HG23 HD21 ' A' ' 5' ' ' LEU . 1.3 p -52.58 108.0 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 C-N-CA 125.537 1.535 . . . . 0.0 109.828 162.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 47.7 pttt -155.38 59.79 0.63 Allowed 'General case' 0 N--CA 1.452 -0.363 0 CA-C-O 121.601 0.715 . . . . 0.0 112.402 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 tptt -157.16 168.06 28.56 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 170.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.5 tp -152.36 65.05 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -82.19 59.78 4.63 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 -172.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -107.34 146.93 16.22 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 107.841 -2.104 . . . . 0.0 107.841 175.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.259 1.558 0 N-CA-C 105.339 -2.097 . . . . 0.0 105.339 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.88 0 N-CA-C 106.971 -2.452 . . . . 0.0 106.971 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -61.1 170.41 1.64 Allowed 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 118.017 0.909 . . . . 0.0 112.713 170.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.6 t -139.81 144.51 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.786 1.634 . . . . 0.0 107.551 -176.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -95.33 131.76 41.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.524 1.53 . . . . 0.0 107.546 175.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD21 HG23 ' A' ' 70' ' ' VAL . 3.0 tm? -120.3 122.09 40.08 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 105.507 -2.034 . . . . 0.0 105.507 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.7 tptm -113.56 118.8 35.43 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.514 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 8.2 ptp -117.0 128.96 55.7 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.292 1.037 . . . . 0.0 109.935 175.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.1 125.28 28.6 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 106.553 -1.647 . . . . 0.0 106.553 172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.5 m -112.19 154.99 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.135 0 CA-C-N 119.318 0.963 . . . . 0.0 108.88 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -115.28 154.53 28.94 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-O 121.301 0.572 . . . . 0.0 109.74 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.93 -47.54 3.84 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.691 0.662 . . . . 0.0 112.347 171.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 58.4 mtm -64.59 86.39 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.568 0.684 . . . . 0.0 111.82 -177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.0 m -135.65 50.7 2.09 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 125.476 1.51 . . . . 0.0 109.738 177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.7 p -161.17 167.95 25.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 166.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.5 m170 -65.46 177.2 1.21 Allowed 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.803 0.811 . . . . 0.0 109.837 170.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 t 73.74 -65.73 0.34 Allowed 'General case' 0 C--O 1.224 -0.259 0 O-C-N 121.309 -0.869 . . . . 0.0 108.774 -170.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 72.3 m -47.64 -63.47 1.05 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 119.036 0.835 . . . . 0.0 111.317 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -56.03 -55.72 29.43 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.264 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.7 t -58.98 -45.91 89.4 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.137 0.975 . . . . 0.0 111.65 -169.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.5 m -53.64 -50.5 65.6 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.499 0.719 . . . . 0.0 110.281 175.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -65.08 -44.04 95.77 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-O 119.511 -0.28 . . . . 0.0 110.568 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -52.5 -51.87 57.33 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.837 0.855 . . . . 0.0 109.749 176.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.78 -54.47 34.78 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 124.259 0.933 . . . . 0.0 112.112 173.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.5 tptt -60.6 -54.51 44.49 Favored 'General case' 0 N--CA 1.454 -0.232 0 O-C-N 122.012 -0.699 . . . . 0.0 110.897 -172.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 46.2 mm -65.57 -42.36 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.54 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.55 -23.52 14.26 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-O 119.325 -0.708 . . . . 0.0 113.718 174.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 ttmt -81.91 -18.87 42.15 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.966 1.383 . . . . 0.0 112.283 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.0 mt -73.94 131.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 120.781 1.628 . . . . 0.0 111.292 -174.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -68.68 91.71 0.45 Allowed 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.37 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.28 -18.34 1.52 Allowed Glycine 0 C--N 1.334 0.423 0 CA-C-O 119.556 -0.58 . . . . 0.0 113.329 -171.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 82.9 t -79.91 146.05 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 117.858 0.829 . . . . 0.0 109.587 170.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 11.0 mm-40 -106.21 -44.99 4.42 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.811 1.645 . . . . 0.0 110.166 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -157.58 168.69 26.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.4 tt -158.35 139.36 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.427 0 N-CA-C 104.653 -2.351 . . . . 0.0 104.653 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.0 mmtm -136.72 86.82 2.24 Favored 'General case' 0 N--CA 1.443 -0.775 0 C-N-CA 125.634 1.574 . . . . 0.0 111.039 176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.3 t -91.62 97.19 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 C-N-CA 123.345 0.658 . . . . 0.0 109.366 -177.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.0 m -75.66 165.46 25.03 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 175.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.529 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.2 OUTLIER -131.56 -46.08 0.98 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.849 0.859 . . . . 0.0 109.622 -173.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -55.42 -57.21 12.79 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.044 1.338 . . . . 0.0 109.423 176.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -88.05 12.77 12.62 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.088 -174.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 35.98 58.41 0.94 Allowed 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.355 2.262 . . . . 0.0 113.19 -179.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -142.78 140.02 31.21 Favored 'General case' 0 N--CA 1.455 -0.181 0 O-C-N 121.479 -0.763 . . . . 0.0 108.957 -176.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.514 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -121.71 112.72 18.76 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.882 1.273 . . . . 0.0 109.793 -175.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.449 ' C ' HD12 ' A' ' 45' ' ' ILE . 31.6 m -87.94 126.26 34.96 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.24 1.416 . . . . 0.0 107.873 171.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.449 HD12 ' C ' ' A' ' 44' ' ' THR . 3.5 mp -121.87 127.97 75.56 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 106.235 -1.765 . . . . 0.0 106.235 169.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.1 t -114.1 110.46 32.17 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 -178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -138.83 167.66 21.52 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -168.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -103.46 108.87 60.64 Favored Pre-proline 0 N--CA 1.447 -0.614 0 C-N-CA 123.901 0.881 . . . . 0.0 111.01 -174.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -72.35 76.84 2.18 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 124.043 3.162 . . . . 0.0 110.674 -173.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -179.09 -43.25 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 127.161 2.184 . . . . 0.0 107.846 179.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 6.8 mp -84.04 -49.32 9.03 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 -177.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -133.35 162.28 40.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 125.708 1.603 . . . . 0.0 108.244 -176.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.8 p -124.67 163.2 22.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.139 0.976 . . . . 0.0 111.973 -174.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 49.9 t -47.79 -41.53 8.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.151 0 C-N-CA 123.368 0.667 . . . . 0.0 111.079 168.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -66.04 -43.28 87.99 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-O 119.052 -0.499 . . . . 0.0 110.21 -175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -53.23 -51.32 62.55 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 119.925 1.239 . . . . 0.0 109.043 171.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 18.1 mmt -51.28 -67.28 0.26 Allowed 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 111.95 0.352 . . . . 0.0 111.95 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -55.09 -55.82 26.78 Favored 'General case' 0 C--O 1.218 -0.576 0 O-C-N 121.06 -1.025 . . . . 0.0 112.876 -179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -49.76 -49.39 48.46 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -177.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -65.2 -41.86 94.1 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 118.619 -1.233 . . . . 0.0 112.674 176.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.9 mt -65.5 -65.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 O-C-N 121.669 -0.644 . . . . 0.0 110.431 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -49.41 -34.65 16.94 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 118.39 -0.814 . . . . 0.0 112.458 175.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.34 -32.63 62.68 Favored 'General case' 0 C--N 1.345 0.388 0 CA-C-N 119.939 1.245 . . . . 0.0 112.621 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 16.9 mmt -58.96 -41.92 88.63 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-N 118.473 0.579 . . . . 0.0 110.706 173.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.37 -19.45 3.61 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.634 1.111 . . . . 0.0 110.887 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.1 m-85 -75.41 114.95 40.9 Favored Pre-proline 0 N--CA 1.452 -0.371 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.955 -173.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_endo -67.61 144.88 68.11 Favored 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 121.507 1.471 . . . . 0.0 108.969 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.76 135.02 25.82 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.021 0.438 . . . . 0.0 111.91 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -108.21 78.07 1.15 Allowed 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.873 1.669 . . . . 0.0 109.473 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.519 HG23 HD21 ' A' ' 5' ' ' LEU . 0.8 OUTLIER -56.08 109.36 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.207 1.803 . . . . 0.0 110.335 165.039 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.9 pttm -155.82 55.55 0.6 Allowed 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 175.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.72 137.78 13.59 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.9 mp -134.04 78.72 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 170.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -103.53 174.54 5.82 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 123.505 0.722 . . . . 0.0 109.564 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -159.32 140.53 6.91 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 108.044 -2.022 . . . . 0.0 108.044 179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.443 ' HE ' ' C ' ' A' ' 76' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.182 0 C-N-CA 128.058 2.543 . . . . 0.0 105.347 -174.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.7 mp0 -133.78 176.18 8.79 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.3 1.44 . . . . 0.0 108.882 -167.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 76.3 t -126.74 140.14 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 125.744 1.618 . . . . 0.0 107.932 -172.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 46' ' ' VAL . 37.3 t -89.45 119.35 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 C-N-CA 124.306 1.042 . . . . 0.0 108.404 174.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.524 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.6 mm? -95.07 125.1 39.5 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 167.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.84 120.21 41.13 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.2 mtt -118.17 127.0 53.34 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 124.419 1.088 . . . . 0.0 108.59 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -78.11 130.57 36.55 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 168.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.62 138.42 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -104.81 146.58 28.79 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 122.967 0.507 . . . . 0.0 109.703 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 100.3 -36.68 3.97 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.586 0.612 . . . . 0.0 113.346 170.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 13.3 mtp -65.92 94.72 0.23 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.822 0.811 . . . . 0.0 110.357 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.0 m -119.72 53.92 1.03 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.267 1.427 . . . . 0.0 108.42 -178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 6.3 p -171.31 157.49 5.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.453 0.701 . . . . 0.0 109.114 -169.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -74.54 -27.62 60.6 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.664 167.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.9 m -57.16 -69.87 0.14 Allowed 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.272 0.629 . . . . 0.0 112.025 -176.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 79.5 m -59.11 -48.08 82.92 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-N 118.159 0.436 . . . . 0.0 110.736 -174.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.5 p -50.27 -56.72 9.99 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.824 0.85 . . . . 0.0 110.621 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.1 t -57.82 -47.18 83.38 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.602 0.761 . . . . 0.0 111.454 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.7 m -55.2 -48.06 74.38 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 121.247 -0.908 . . . . 0.0 110.944 178.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.419 HD11 ' CD2' ' A' ' 66' ' ' PHE . 27.5 mt -62.41 -49.42 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 C-N-CA 124.194 0.998 . . . . 0.0 108.993 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -46.71 -50.39 18.03 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.058 0.943 . . . . 0.0 109.979 173.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.29 -59.11 11.4 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 124.022 0.82 . . . . 0.0 112.125 176.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -56.79 -57.78 10.98 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 121.681 0.753 . . . . 0.0 109.776 -174.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 38.4 mm -69.99 -32.03 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.88 -174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.82 -32.45 25.94 Favored Glycine 0 CA--C 1.529 0.92 0 O-C-N 121.754 -0.591 . . . . 0.0 112.419 171.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.7 ttmt -87.07 4.53 41.72 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 117.906 0.853 . . . . 0.0 112.208 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.58 152.87 44.25 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 120.522 1.51 . . . . 0.0 110.102 172.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -83.45 134.69 34.85 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 170.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 18.87 11.13 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 123.99 0.805 . . . . 0.0 112.559 174.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.3 t -122.94 143.93 34.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 125.173 1.389 . . . . 0.0 109.757 -176.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.87 -30.42 9.38 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.286 0.634 . . . . 0.0 112.016 172.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.2 mtt85 -160.55 167.27 27.48 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.874 1.269 . . . . 0.0 108.07 -174.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 16.9 tt -155.07 142.13 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.388 0 N-CA-C 103.744 -2.687 . . . . 0.0 103.744 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -139.73 151.4 45.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.633 1.573 . . . . 0.0 109.245 173.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 79.0 t -140.56 143.51 28.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 119.089 0.859 . . . . 0.0 109.546 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.0 m -112.59 167.99 10.02 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.515 1.926 . . . . 0.0 109.297 178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -120.82 -56.98 1.92 Allowed 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 124.282 1.033 . . . . 0.0 109.239 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -46.4 -58.2 3.95 Favored 'General case' 0 CA--C 1.519 -0.218 0 C-N-CA 124.977 1.311 . . . . 0.0 111.118 -174.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -91.72 13.38 18.32 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 114.983 -1.008 . . . . 0.0 111.277 -177.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 32.15 68.33 0.13 Allowed 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 129.795 3.238 . . . . 0.0 112.723 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -136.86 147.85 46.74 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.067 0.947 . . . . 0.0 109.842 -169.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.34 133.92 50.02 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 126.331 1.852 . . . . 0.0 109.665 -173.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.543 ' C ' HD12 ' A' ' 45' ' ' ILE . 38.4 m -112.4 114.28 26.92 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 128.672 2.789 . . . . 0.0 108.66 -176.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.543 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -118.87 113.57 42.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 178.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.445 HG22 HG22 ' A' ' 4' ' ' VAL . 3.0 t -100.04 91.5 2.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -171.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -116.25 165.04 13.62 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 123.717 0.807 . . . . 0.0 113.033 -166.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.5 tt0 -102.28 111.14 64.15 Favored Pre-proline 0 N--CA 1.447 -0.583 0 CA-C-O 118.475 -0.774 . . . . 0.0 109.044 177.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -71.9 67.57 3.17 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.974 3.116 . . . . 0.0 109.969 -179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.43 -46.26 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.145 1.378 . . . . 0.0 108.702 -173.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 73.4 mt -77.4 -42.18 37.24 Favored 'General case' 0 C--N 1.339 0.14 0 C-N-CA 122.33 0.252 . . . . 0.0 110.846 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.4 tp -148.7 165.15 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 C-N-CA 124.402 1.081 . . . . 0.0 108.474 -175.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.3 p -110.49 158.31 18.65 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.024 1.329 . . . . 0.0 112.056 -172.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.7 t -51.09 -46.16 31.01 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 C-N-CA 124.069 0.948 . . . . 0.0 111.506 174.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -60.68 -38.21 84.18 Favored 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.174 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -55.84 -52.0 65.55 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 120.739 1.609 . . . . 0.0 108.176 176.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.0 mmt -49.8 -63.14 1.2 Allowed 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 112.065 0.395 . . . . 0.0 112.065 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -59.05 -56.19 25.47 Favored 'General case' 0 C--O 1.218 -0.582 0 CA-C-O 118.464 -0.779 . . . . 0.0 112.066 -177.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -43.04 -52.46 5.3 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.539 1.135 . . . . 0.0 109.727 175.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 -63.26 -42.19 99.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 178.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.2 mt -70.39 -62.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 O-C-N 121.838 -0.539 . . . . 0.0 110.174 -178.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -42.77 -41.96 3.39 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.802 0.841 . . . . 0.0 112.273 171.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.79 -31.9 50.6 Favored 'General case' 0 C--N 1.343 0.319 0 CA-C-N 119.027 0.831 . . . . 0.0 113.215 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.4 mmt -59.43 -41.73 90.26 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.408 0.549 . . . . 0.0 110.84 173.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.19 -17.89 3.34 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 124.784 1.183 . . . . 0.0 111.202 -178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.419 ' CD2' HD11 ' A' ' 21' ' ' ILE . 48.3 m-85 -80.78 113.3 39.08 Favored Pre-proline 0 N--CA 1.453 -0.28 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.77 -173.576 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -63.32 149.6 90.81 Favored 'Trans proline' 0 N--CA 1.451 -0.988 0 N-CA-C 108.682 -1.315 . . . . 0.0 108.682 173.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.91 137.32 26.14 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.281 0.233 . . . . 0.0 111.052 178.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -107.28 74.9 0.99 Allowed 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.7 p -62.57 103.13 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.107 1.363 . . . . 0.0 110.298 171.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 8.6 pttp -154.57 55.65 0.68 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 121.458 0.647 . . . . 0.0 112.125 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.406 ' O ' HD13 ' A' ' 5' ' ' LEU . 3.2 mmtp -158.14 149.78 21.48 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 177.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.3 mp -135.19 81.45 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 175.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.29 90.06 4.95 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 106.306 -1.739 . . . . 0.0 106.306 170.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 160.46 -165.52 35.0 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 177.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 35.3 ttt180 . . . . . 0 C--O 1.25 1.08 0 C-N-CA 125.764 1.626 . . . . 0.0 109.501 -173.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.92 0 N-CA-C 108.076 -2.01 . . . . 0.0 108.076 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -110.51 145.41 37.78 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -162.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.4 m -107.61 129.8 60.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -170.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -87.7 122.63 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.655 HD13 ' O ' ' A' ' 72' ' ' LYS . 3.3 mm? -107.31 130.35 54.78 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 171.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.1 tptm -115.78 119.43 35.99 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 -178.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.3 ptp -126.1 122.4 35.65 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 125.081 1.352 . . . . 0.0 108.804 -174.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -70.07 138.6 52.19 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 172.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.8 m -126.86 143.7 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 175.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -94.26 152.0 19.01 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.31 -37.0 1.99 Allowed Glycine 0 CA--C 1.532 1.144 0 C-N-CA 123.419 0.533 . . . . 0.0 114.268 166.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.5 mtp -70.6 80.47 0.59 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 118.274 1.037 . . . . 0.0 111.319 -177.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -112.63 24.51 12.4 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.771 1.228 . . . . 0.0 111.924 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 p -161.03 166.68 27.79 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 122.162 0.982 . . . . 0.0 111.45 -173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -63.79 168.93 4.5 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.808 -1.087 . . . . 0.0 109.362 168.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.4 m 80.05 -64.73 0.19 Allowed 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.646 1.178 . . . . 0.0 109.864 -172.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 26.7 m -60.11 -59.01 6.1 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 119.131 0.878 . . . . 0.0 109.995 -176.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.417 HG22 ' CG1' ' A' ' 36' ' ' VAL . 16.5 p -49.61 -63.15 1.19 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.665 1.186 . . . . 0.0 110.287 173.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -53.22 -40.74 64.73 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.364 1.066 . . . . 0.0 111.51 -173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.7 m -59.98 -49.27 78.34 Favored 'General case' 0 N--CA 1.457 -0.086 0 O-C-N 121.621 -0.675 . . . . 0.0 109.837 176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.28 -47.58 89.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 177.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.99 -53.9 36.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.641 0.776 . . . . 0.0 110.506 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.08 -52.23 52.62 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.219 0.914 . . . . 0.0 111.788 177.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.8 tptt -60.17 -58.33 8.99 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 121.562 0.696 . . . . 0.0 109.897 -175.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 27.2 mm -66.26 -29.37 46.47 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.887 -175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.83 -30.84 7.22 Favored Glycine 0 CA--C 1.53 1.013 0 C-N-CA 123.736 0.684 . . . . 0.0 113.236 170.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -89.93 6.95 39.79 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-N 118.515 1.158 . . . . 0.0 112.354 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mt -70.16 152.35 44.39 Favored 'General case' 0 N--CA 1.455 -0.203 0 O-C-N 120.516 -1.365 . . . . 0.0 111.982 175.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -96.28 84.87 3.83 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.114 1.365 . . . . 0.0 109.575 176.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.69 -4.87 0.8 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 115.407 0.923 . . . . 0.0 115.407 -175.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 73.2 t -106.23 134.68 47.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 124.058 0.943 . . . . 0.0 108.876 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.414 HE21 HG11 ' A' ' 46' ' ' VAL . 1.4 pt20 -94.64 -34.14 12.71 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-O 120.638 0.256 . . . . 0.0 111.319 175.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -159.3 165.95 32.29 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.462 -1.311 . . . . 0.0 107.462 -176.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 12.6 tt -156.91 145.44 11.16 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.515 0 N-CA-C 103.233 -2.877 . . . . 0.0 103.233 -171.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -142.34 150.72 41.13 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.886 1.274 . . . . 0.0 109.589 175.044 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.417 ' CG1' HG22 ' A' ' 18' ' ' THR . 21.9 t -140.39 106.72 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 118.977 0.808 . . . . 0.0 110.181 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.6 m -94.73 80.88 3.78 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.12 1.368 . . . . 0.0 109.183 179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.5 pp -48.01 -41.05 24.5 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 123.574 0.75 . . . . 0.0 112.371 173.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.31 -56.33 5.01 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 126.093 1.757 . . . . 0.0 110.692 -177.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -100.27 22.83 10.93 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.955 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 34.19 57.65 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 128.043 2.537 . . . . 0.0 113.285 -173.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.436 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 39.2 tt0 -138.06 131.18 30.23 Favored 'General case' 0 N--CA 1.458 -0.058 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.991 -175.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -105.24 147.26 28.26 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 125.514 1.526 . . . . 0.0 110.031 176.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 99.3 m -124.68 120.12 30.94 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 128.307 2.643 . . . . 0.0 106.985 -174.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -121.04 124.92 73.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.308 -1.738 . . . . 0.0 106.308 177.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.414 HG11 HE21 ' A' ' 32' ' ' GLN . 2.0 t -113.98 97.31 5.51 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 118.298 0.499 . . . . 0.0 110.443 -176.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -117.75 169.02 9.92 Favored 'General case' 0 C--O 1.233 0.231 0 C-N-CA 123.341 0.657 . . . . 0.0 112.682 -170.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -106.91 114.17 61.88 Favored Pre-proline 0 N--CA 1.447 -0.578 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.209 -177.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -72.57 77.08 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.608 0 C-N-CA 123.532 2.821 . . . . 0.0 111.57 -173.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -177.23 -43.79 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 127.66 2.384 . . . . 0.0 108.279 173.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.0 mt -75.15 -47.59 27.77 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 111.295 0.109 . . . . 0.0 111.295 -174.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -139.4 176.27 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 C-N-CA 125.33 1.452 . . . . 0.0 107.749 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.2 p -143.12 165.99 25.9 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-N 118.894 0.77 . . . . 0.0 111.114 -176.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 80.2 t -54.53 -34.26 28.65 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.133 0 C-N-CA 122.964 0.506 . . . . 0.0 111.953 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 12.7 tm-20 -62.06 -42.6 99.36 Favored 'General case' 0 C--O 1.218 -0.573 0 CA-C-O 118.717 -0.659 . . . . 0.0 109.662 179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.71 -52.8 62.8 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 11.1 mtp -47.34 -59.9 2.87 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 123.176 0.591 . . . . 0.0 111.626 176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 29.2 tttm -62.09 -52.88 62.11 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 121.599 -0.688 . . . . 0.0 111.213 -178.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.4 tmtt? -47.92 -50.06 28.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 118.806 0.73 . . . . 0.0 109.241 178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -61.4 -49.27 77.58 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.267 0.469 . . . . 0.0 112.267 176.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.9 mt -68.28 -63.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.805 -0.56 . . . . 0.0 110.514 -175.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -45.94 -39.15 8.45 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-O 118.568 -0.729 . . . . 0.0 112.754 172.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.93 -31.63 60.54 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 119.736 1.153 . . . . 0.0 113.044 178.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.0 mmt -56.61 -39.43 73.58 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.51 0.596 . . . . 0.0 110.843 172.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 133.87 -17.98 4.33 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 125.333 1.444 . . . . 0.0 110.582 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -78.47 115.22 49.73 Favored Pre-proline 0 N--CA 1.451 -0.391 0 C-N-CA 123.856 0.862 . . . . 0.0 110.213 -171.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -66.83 141.55 59.59 Favored 'Trans proline' 0 N--CA 1.452 -0.935 0 N-CA-C 108.363 -1.437 . . . . 0.0 108.363 174.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.07 138.03 39.97 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 122.646 0.378 . . . . 0.0 111.506 -178.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 42.6 m-85 -108.09 78.73 1.2 Allowed 'General case' 0 C--O 1.231 0.102 0 C-N-CA 123.733 0.813 . . . . 0.0 109.276 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.6 p -65.07 104.79 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 125.841 1.656 . . . . 0.0 110.42 170.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 50.1 pttt -156.18 58.48 0.58 Allowed 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.634 0.731 . . . . 0.0 112.524 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.655 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -156.36 132.06 9.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 104.302 -2.481 . . . . 0.0 104.302 175.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 7.3 tp -130.89 63.98 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 71.5 mt-10 -84.47 127.69 34.17 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.607 0.717 . . . . 0.0 109.098 -176.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 168.06 81.97 0.05 OUTLIER Glycine 0 CA--C 1.528 0.859 0 N-CA-C 108.104 -1.998 . . . . 0.0 108.104 -167.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.4 mpt_? . . . . . 0 C--O 1.249 1.028 0 N-CA-C 103.657 -2.72 . . . . 0.0 103.657 163.151 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.194 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.25 160.65 0.76 Allowed 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.108 1.763 . . . . 0.0 110.91 164.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.1 m -127.91 131.86 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 C-N-CA 123.91 0.884 . . . . 0.0 109.771 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.1 t -81.24 123.64 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.584 1.554 . . . . 0.0 106.888 170.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.563 HD22 ' CG2' ' A' ' 70' ' ' VAL . 19.7 mt -93.08 128.96 39.17 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.799 -1.926 . . . . 0.0 105.799 159.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -110.24 127.65 55.09 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 105.615 -1.994 . . . . 0.0 105.615 171.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.438 ' HB3' ' HA ' ' A' ' 70' ' ' VAL . 13.1 ptm -140.71 132.06 26.73 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -75.87 138.84 41.35 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 175.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.7 m -124.85 150.7 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.239 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 174.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -112.39 150.04 31.66 Favored 'General case' 0 N--CA 1.456 -0.132 0 CA-C-N 118.203 0.456 . . . . 0.0 110.339 177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.37 -33.1 1.57 Allowed Glycine 0 CA--C 1.532 1.154 0 C-N-CA 123.666 0.651 . . . . 0.0 113.865 173.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 55.9 mtp -67.3 78.64 0.15 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.932 0.893 . . . . 0.0 111.916 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -134.07 43.55 2.81 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 124.392 1.077 . . . . 0.0 110.16 -169.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -161.25 151.25 17.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.476 1.11 . . . . 0.0 108.752 -178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.3 m-70 -75.03 55.83 0.74 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.893 1.277 . . . . 0.0 111.427 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 63.8 m -136.77 -64.54 0.58 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 171.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.9 m -60.43 -54.24 47.95 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.751 0.821 . . . . 0.0 109.737 -173.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 9.3 t -45.8 -62.94 1.09 Allowed 'General case' 0 C--N 1.338 0.088 0 C-N-CA 124.535 1.134 . . . . 0.0 110.006 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.8 t -63.77 -39.13 93.53 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 122.989 0.516 . . . . 0.0 109.937 -171.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 98.0 m -58.82 -49.59 77.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.772 -0.58 . . . . 0.0 110.076 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.4 mt -63.6 -50.73 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-N 118.258 0.481 . . . . 0.0 109.939 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -44.41 -54.57 5.77 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.268 1.427 . . . . 0.0 110.499 173.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.68 -57.39 20.12 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 123.796 0.712 . . . . 0.0 112.04 177.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.6 tptt -58.63 -54.46 46.77 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-O 121.42 0.628 . . . . 0.0 110.155 -173.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.4 mm -70.72 -38.29 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 C-N-CA 123.99 0.916 . . . . 0.0 110.159 -174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.07 -31.73 18.94 Favored Glycine 0 CA--C 1.529 0.947 0 O-C-N 121.856 -0.527 . . . . 0.0 112.24 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.9 tttt -73.47 -13.82 61.13 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 113.372 0.879 . . . . 0.0 113.372 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -73.18 140.78 47.24 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 120.266 1.394 . . . . 0.0 112.31 -169.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -69.51 80.17 0.4 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.015 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 160.31 -19.32 0.23 Allowed Glycine 0 CA--C 1.52 0.405 0 N-CA-C 115.204 0.842 . . . . 0.0 115.204 -178.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 94.3 t -93.43 133.55 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -178.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.35 -31.17 13.01 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.042 0.537 . . . . 0.0 111.485 178.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -154.36 161.05 41.97 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 -176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.3 tt -156.07 137.67 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.448 0 N-CA-C 104.343 -2.465 . . . . 0.0 104.343 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.9 mmtt -138.51 153.13 48.75 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.289 1.036 . . . . 0.0 110.148 174.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 87.0 t -138.18 111.74 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.6 m -87.7 69.54 9.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 175.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.658 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -48.34 -42.49 31.49 Favored 'General case' 0 CA--C 1.531 0.216 0 O-C-N 123.498 0.499 . . . . 0.0 110.624 -179.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.54 -56.33 5.23 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 126.711 2.004 . . . . 0.0 111.102 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -98.56 22.35 9.99 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.025 -0.988 . . . . 0.0 110.062 -175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 44.13 53.74 6.38 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.706 2.002 . . . . 0.0 112.782 -179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -135.28 147.79 49.34 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.453 179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.55 148.93 48.73 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 126.383 1.873 . . . . 0.0 109.626 178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.4 m -129.36 116.69 19.44 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 128.461 2.704 . . . . 0.0 107.064 -171.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.5 mm -123.17 110.41 26.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.57 94.64 3.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 -171.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -111.91 167.8 10.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-O 121.311 0.577 . . . . 0.0 112.084 -170.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -110.12 113.64 56.62 Favored Pre-proline 0 N--CA 1.447 -0.602 0 CA-C-N 115.124 -0.944 . . . . 0.0 109.671 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -73.13 77.11 2.46 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.434 2.756 . . . . 0.0 111.176 -173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -177.33 -43.93 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 128.018 2.527 . . . . 0.0 107.954 174.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.13 -48.55 17.42 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 111.343 0.127 . . . . 0.0 111.343 -174.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -136.39 176.47 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 125.514 1.526 . . . . 0.0 108.316 -175.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 81.1 p -142.62 162.0 36.6 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.544 0.738 . . . . 0.0 111.502 -173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.433 HG22 HD21 ' A' ' 5' ' ' LEU . 21.1 t -44.08 -45.61 2.15 Favored 'Isoleucine or valine' 0 C--N 1.343 0.311 0 C-N-CA 125.452 1.501 . . . . 0.0 111.681 175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -60.39 -54.99 39.0 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-O 117.146 -1.407 . . . . 0.0 109.035 -172.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -46.47 -55.33 7.63 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.158 1.383 . . . . 0.0 110.437 172.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 16.0 mmt -46.21 -56.92 5.04 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 118.814 0.734 . . . . 0.0 111.713 175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -62.84 -61.57 2.31 Favored 'General case' 0 C--O 1.215 -0.755 0 CA-C-O 118.124 -0.941 . . . . 0.0 112.212 178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.0 tptp -40.35 -52.14 2.73 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 125.961 1.704 . . . . 0.0 109.156 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 55.1 mm-40 -61.98 -47.37 85.13 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 111.782 0.29 . . . . 0.0 111.782 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 53.0 mt -68.98 -64.73 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 O-C-N 121.83 -0.544 . . . . 0.0 111.089 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -43.98 -40.05 4.46 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.69 0.796 . . . . 0.0 112.692 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.72 -32.41 59.62 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 119.326 0.966 . . . . 0.0 112.861 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.8 mmt -57.81 -41.81 82.95 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-N 118.368 0.531 . . . . 0.0 110.293 173.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.53 -19.05 2.81 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.622 1.106 . . . . 0.0 111.093 176.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -78.08 119.27 76.71 Favored Pre-proline 0 N--CA 1.451 -0.408 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.008 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.91 145.51 80.31 Favored 'Trans proline' 0 N--CA 1.452 -0.96 0 N-CA-C 108.575 -1.356 . . . . 0.0 108.575 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -143.69 135.99 26.88 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 120.576 0.227 . . . . 0.0 111.609 177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -99.18 82.82 2.76 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 175.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.563 ' CG2' HD22 ' A' ' 5' ' ' LEU . 2.4 p -70.07 105.58 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.244 0 C-N-CA 125.069 1.347 . . . . 0.0 110.444 172.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 51.8 pttt -155.31 58.98 0.64 Allowed 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.445 ' O ' HD23 ' A' ' 5' ' ' LEU . 34.9 mttm -153.71 154.01 33.31 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.647 -1.612 . . . . 0.0 106.647 159.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.59 78.56 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 104.4 -2.444 . . . . 0.0 104.4 163.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -92.33 114.74 27.37 Favored 'General case' 0 C--O 1.225 -0.219 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -176.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 179.06 -155.14 15.32 Favored Glycine 0 N--CA 1.451 -0.315 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 -172.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? . . . . . 0 C--O 1.254 1.299 0 C-N-CA 129.772 3.229 . . . . 0.0 107.909 168.762 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.174 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 78.69 108.85 0.07 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.977 1.711 . . . . 0.0 109.728 -178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.5 m -119.99 136.29 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 C-N-CA 123.933 0.893 . . . . 0.0 109.23 174.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.485 HG23 HG22 ' A' ' 46' ' ' VAL . 0.4 OUTLIER -90.76 134.48 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 C-N-CA 125.322 1.449 . . . . 0.0 108.655 178.418 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 47' ' ' TYR . 6.1 mp -122.15 151.63 40.77 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 165.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 tptt -120.24 123.03 42.22 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 105.915 -1.884 . . . . 0.0 105.915 -177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.6 ptp -124.01 129.53 51.07 Favored 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 125.138 1.375 . . . . 0.0 108.345 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.74 120.85 29.47 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 117.989 -1.005 . . . . 0.0 108.389 175.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.6 p -136.86 125.12 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 O-C-N 124.228 0.955 . . . . 0.0 109.347 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -87.64 152.49 22.12 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 123.394 0.677 . . . . 0.0 109.264 -174.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 103.82 -46.18 1.23 Allowed Glycine 0 CA--C 1.528 0.852 0 C-N-CA 123.518 0.58 . . . . 0.0 112.87 170.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 3.3 mtp -70.01 82.64 0.49 Allowed 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 117.807 0.804 . . . . 0.0 111.924 -174.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.8 m -133.61 -9.07 2.83 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.703 1.601 . . . . 0.0 112.22 -174.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 18.2 p -80.8 -17.38 51.05 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.444 1.498 . . . . 0.0 113.55 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.4 m80 84.45 -31.17 0.07 Allowed 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.267 2.227 . . . . 0.0 112.262 -175.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 44.5 m -62.26 -65.76 0.64 Allowed 'General case' 0 N--CA 1.454 -0.239 0 O-C-N 121.369 -0.832 . . . . 0.0 109.844 174.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 81.2 m -50.88 -48.5 60.25 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.813 1.245 . . . . 0.0 111.83 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 72.3 p -48.0 -62.32 1.53 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 109.754 177.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -59.35 -47.17 86.44 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.486 1.114 . . . . 0.0 110.84 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.9 m -52.15 -50.09 62.44 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 123.706 0.803 . . . . 0.0 110.877 176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.9 -47.8 84.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.669 0 C-N-CA 123.807 0.843 . . . . 0.0 109.447 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -44.67 -52.73 7.96 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.038 0.935 . . . . 0.0 110.079 172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.34 -60.54 8.63 Favored Glycine 0 CA--C 1.534 1.231 0 C-N-CA 123.979 0.8 . . . . 0.0 112.683 175.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.36 -50.71 70.76 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-O 121.508 0.67 . . . . 0.0 109.984 -171.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 29.8 mm -70.36 -41.22 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.529 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.774 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.78 -34.46 21.87 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 123.319 0.485 . . . . 0.0 112.518 174.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -71.14 -7.93 50.01 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.796 0.838 . . . . 0.0 113.095 -179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.3 mt -73.6 144.77 45.84 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 120.656 1.571 . . . . 0.0 111.689 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.3 pt20 -81.73 61.19 5.0 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 -171.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 173.16 22.45 0.02 OUTLIER Glycine 0 N--CA 1.465 0.588 0 N-CA-C 115.751 1.06 . . . . 0.0 115.751 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 77.4 t -110.57 150.52 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.9 mm-40 -111.77 -40.35 4.32 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.02 0.928 . . . . 0.0 109.387 177.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 26.4 ttm180 -159.97 164.86 32.99 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.8 tt -157.67 141.34 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 N-CA-C 103.903 -2.628 . . . . 0.0 103.903 -175.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.5 mmtp -143.04 144.72 32.38 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.628 1.171 . . . . 0.0 110.119 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.64 131.74 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 119.174 0.897 . . . . 0.0 110.505 171.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.8 m -113.88 94.28 4.76 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 126.227 1.811 . . . . 0.0 109.733 -171.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.01 -46.32 91.22 Favored 'General case' 0 CA--C 1.529 0.169 0 O-C-N 122.058 -0.401 . . . . 0.0 112.075 -177.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.83 -57.18 6.8 Favored 'General case' 0 CA--C 1.516 -0.341 0 C-N-CA 124.791 1.237 . . . . 0.0 111.049 -169.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -95.2 20.62 8.92 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.742 -174.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 30.81 67.35 0.12 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 127.776 2.43 . . . . 0.0 113.185 -169.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -131.35 157.64 42.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.626 1.17 . . . . 0.0 109.742 -176.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -135.17 149.88 50.04 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.663 1.185 . . . . 0.0 109.698 173.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.9 m -127.66 121.3 30.08 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 128.424 2.689 . . . . 0.0 106.463 -170.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.7 mm -128.4 118.87 48.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 -175.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.485 HG22 HG23 ' A' ' 4' ' ' VAL . 1.7 t -121.66 105.58 16.72 Favored 'Isoleucine or valine' 0 C--N 1.342 0.257 0 CA-C-O 121.162 0.506 . . . . 0.0 110.202 -170.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.52 ' CE2' HD13 ' A' ' 5' ' ' LEU . 35.2 p90 -137.58 176.18 8.93 Favored 'General case' 0 CA--C 1.517 -0.297 0 O-C-N 121.549 -0.72 . . . . 0.0 112.122 -168.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 -105.7 108.26 61.14 Favored Pre-proline 0 N--CA 1.448 -0.543 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.307 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -74.82 71.89 4.72 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.261 3.307 . . . . 0.0 110.264 -170.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -173.23 -38.34 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 126.559 1.944 . . . . 0.0 108.656 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 79.9 mt -90.09 -42.05 11.32 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.497 0.319 . . . . 0.0 111.297 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -141.23 160.62 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 C-N-CA 125.334 1.453 . . . . 0.0 108.211 -175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.7 p -119.93 168.83 10.74 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.191 0.996 . . . . 0.0 112.153 -172.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 88.5 t -49.82 -42.5 18.33 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 122.842 0.457 . . . . 0.0 110.699 166.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.95 -46.58 71.03 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-O 118.711 -0.661 . . . . 0.0 109.747 -171.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -46.35 -58.09 4.04 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 119.779 1.172 . . . . 0.0 109.359 171.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 31.0 mmt -48.17 -66.79 0.34 Allowed 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.801 0.441 . . . . 0.0 111.746 175.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.6 ttpt -60.41 -58.94 6.35 Favored 'General case' 0 C--O 1.215 -0.724 0 O-C-N 121.129 -0.982 . . . . 0.0 112.263 -176.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -41.44 -50.23 3.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 119.45 1.023 . . . . 0.0 109.353 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 53.2 mm-40 -65.65 -42.64 91.17 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 119.467 -0.893 . . . . 0.0 113.17 177.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 68.0 mt -68.79 -62.8 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 CA-C-N 119.067 0.849 . . . . 0.0 110.883 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -41.67 -40.74 2.04 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.934 0.894 . . . . 0.0 112.372 173.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -31.46 44.43 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.0 mmt -57.9 -39.63 78.38 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.371 0.668 . . . . 0.0 110.631 174.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.65 -16.6 3.53 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 124.823 1.201 . . . . 0.0 111.307 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -86.06 112.08 42.89 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.478 1.111 . . . . 0.0 110.393 -169.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.47 128.05 14.86 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.795 1.663 . . . . 0.0 109.699 -179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.7 139.04 53.61 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.864 0.866 . . . . 0.0 111.687 -174.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -111.7 76.83 1.0 Allowed 'General case' 0 C--O 1.231 0.124 0 C-N-CA 123.514 0.726 . . . . 0.0 109.979 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.402 HG13 ' O ' ' A' ' 70' ' ' VAL . 8.5 p -68.76 103.15 0.73 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 C-N-CA 125.8 1.64 . . . . 0.0 110.73 175.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.1 pttp -156.09 57.0 0.59 Allowed 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.481 -0.762 . . . . 0.0 112.787 179.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.498 ' HZ3' ' CD ' ' A' ' 74' ' ' GLU . 1.3 mmtt -158.7 139.79 13.04 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -137.88 80.93 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 106.583 -1.636 . . . . 0.0 106.583 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.498 ' CD ' ' HZ3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -85.13 175.88 8.72 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.281 0.562 . . . . 0.0 110.666 174.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -98.41 -78.89 1.42 Allowed Glycine 0 CA--C 1.528 0.899 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 175.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.6 tmm_? . . . . . 0 C--O 1.25 1.129 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.691 179.567 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.862 0 N-CA-C 108.511 -1.835 . . . . 0.0 108.511 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -120.07 169.14 10.49 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.091 2.156 . . . . 0.0 111.03 -170.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.4 t -136.82 140.49 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.502 1.521 . . . . 0.0 107.729 174.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -88.22 129.63 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 169.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 tt -111.57 142.82 43.37 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.987 -1.857 . . . . 0.0 105.987 169.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.6 tptm -128.69 116.76 20.05 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 105.976 -1.861 . . . . 0.0 105.976 178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.494 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 7.1 ptp -113.42 131.71 55.91 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 123.524 0.729 . . . . 0.0 109.566 173.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -68.01 137.84 55.4 Favored 'General case' 0 CA--C 1.516 -0.333 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 165.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.3 m -121.74 151.96 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 171.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -118.22 145.7 44.8 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 96.2 -41.45 2.41 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.813 0.721 . . . . 0.0 112.554 171.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.0 mtt -56.56 115.19 2.38 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.12 0.96 . . . . 0.0 110.498 179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.439 ' O ' HG22 ' A' ' 13' ' ' THR . 17.9 m -148.33 39.35 0.9 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.248 1.019 . . . . 0.0 108.362 178.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -152.53 158.03 41.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 167.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -67.19 -19.21 65.53 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 123.456 0.473 . . . . 0.0 111.928 177.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.89 -58.1 9.85 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 -178.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.5 m -56.34 -52.53 64.2 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 122.675 0.39 . . . . 0.0 110.879 -178.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -54.83 -55.94 24.81 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -178.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 26.2 t -57.05 -45.14 83.42 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.467 0.707 . . . . 0.0 111.196 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -54.6 -50.48 67.95 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.277 -0.889 . . . . 0.0 110.915 175.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.4 mt -63.43 -48.23 88.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 123.01 0.524 . . . . 0.0 109.963 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -46.16 -53.59 10.17 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.013 1.325 . . . . 0.0 109.804 173.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.77 -59.34 9.93 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.102 0.858 . . . . 0.0 111.286 174.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptm -55.6 -61.22 2.49 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 117.601 0.7 . . . . 0.0 110.884 -173.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 1.3 mp -63.69 -47.46 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 C-N-CA 123.752 0.821 . . . . 0.0 109.365 -175.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.41 -40.92 39.68 Favored Glycine 0 CA--C 1.529 0.964 0 N-CA-C 112.106 -0.398 . . . . 0.0 112.106 175.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -73.68 -9.6 58.83 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 123.858 0.863 . . . . 0.0 112.839 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.6 mt -85.52 132.18 34.24 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 119.942 1.246 . . . . 0.0 110.198 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 52.8 tt0 -64.33 134.95 55.66 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 167.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.62 -20.41 4.9 Favored Glycine 0 C--N 1.338 0.667 0 C-N-CA 123.421 0.534 . . . . 0.0 112.466 -178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.9 t -106.3 141.34 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.583 0 C-N-CA 124.876 1.271 . . . . 0.0 110.392 -172.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.88 -30.77 10.62 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.673 0.789 . . . . 0.0 111.707 173.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 31.1 ttm-85 -164.52 168.81 17.92 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.5 tt -158.5 143.19 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 N-CA-C 104.737 -2.32 . . . . 0.0 104.737 -174.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 mmtp -144.85 93.69 2.44 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.999 0.92 . . . . 0.0 112.014 179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.2 105.36 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.246 0.618 . . . . 0.0 111.188 -173.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 4.0 m -96.68 125.39 41.11 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.218 1.007 . . . . 0.0 111.402 -177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -80.83 -44.64 18.14 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.978 0.511 . . . . 0.0 110.25 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -49.96 -61.58 2.06 Favored 'General case' 0 CA--C 1.516 -0.357 0 C-N-CA 126.142 1.777 . . . . 0.0 110.622 -170.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -91.87 18.61 7.53 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.492 -1.231 . . . . 0.0 109.863 -178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.2 62.7 0.29 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 128.371 2.668 . . . . 0.0 112.234 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -139.91 124.33 18.03 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.64 -172.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.38 112.84 25.72 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 125.31 1.444 . . . . 0.0 109.839 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 4.9 m -83.76 132.01 34.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.007 1.323 . . . . 0.0 107.753 169.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -131.07 124.98 56.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 172.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -111.6 109.02 26.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.448 0.567 . . . . 0.0 110.442 -174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -129.67 166.8 19.07 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -165.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -101.3 106.4 45.21 Favored Pre-proline 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 109.758 179.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -70.61 81.32 1.04 Allowed 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.625 2.884 . . . . 0.0 110.31 -177.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER 175.21 -42.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 127.493 2.317 . . . . 0.0 107.802 178.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.8 mt -78.26 -56.13 4.71 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.4 167.43 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 C-N-CA 125.171 1.389 . . . . 0.0 110.167 -177.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -130.01 166.45 20.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.095 1.358 . . . . 0.0 110.091 -176.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 73.9 t -46.85 -45.44 7.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 124.621 1.169 . . . . 0.0 111.536 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -60.71 -39.06 87.14 Favored 'General case' 0 C--O 1.218 -0.589 0 CA-C-O 118.942 -0.551 . . . . 0.0 111.171 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -61.4 -46.95 88.0 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 36.6 mtt -51.78 -60.62 2.96 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 122.521 0.329 . . . . 0.0 111.7 172.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -56.64 -55.51 33.05 Favored 'General case' 0 C--O 1.218 -0.562 0 C-N-CA 120.054 -0.658 . . . . 0.0 111.064 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -45.56 -53.56 8.86 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.953 0.901 . . . . 0.0 109.284 179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 52.9 mm-40 -59.18 -49.02 79.44 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 92.2 mt -71.99 -61.56 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.895 0.878 . . . . 0.0 110.793 -172.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -47.96 -37.1 13.71 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 118.526 -0.75 . . . . 0.0 111.89 172.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.44 64.75 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 119.782 1.174 . . . . 0.0 112.73 176.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.1 mmt -60.39 -43.72 96.35 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.623 0.647 . . . . 0.0 110.189 172.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.93 -17.56 3.63 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.96 1.267 . . . . 0.0 110.953 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.5 m-85 -72.26 115.55 40.03 Favored Pre-proline 0 N--CA 1.453 -0.318 0 CA-C-O 118.49 -0.767 . . . . 0.0 110.112 -173.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -69.2 139.48 42.28 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 N-CA-C 108.527 -1.374 . . . . 0.0 108.527 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.23 138.2 41.6 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.778 0.431 . . . . 0.0 112.04 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -113.22 78.56 1.15 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.442 1.497 . . . . 0.0 109.512 176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -50.71 112.2 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 124.597 1.159 . . . . 0.0 108.983 161.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 32.7 pttt -155.47 59.7 0.63 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 121.197 0.522 . . . . 0.0 112.398 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -157.25 159.18 37.37 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -151.56 55.88 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -83.28 67.41 9.23 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.772 0.829 . . . . 0.0 109.423 -171.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.0 156.7 43.89 Favored Glycine 0 CA--C 1.535 1.285 0 O-C-N 121.852 -0.53 . . . . 0.0 113.684 -176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 . . . . . 0 C--O 1.254 1.339 0 C-N-CA 128.122 2.569 . . . . 0.0 112.25 171.603 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.81 0 N-CA-C 107.088 -2.405 . . . . 0.0 107.088 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.518 ' H ' ' CD ' ' A' ' 2' ' ' GLU . 1.8 pm0 -66.24 173.92 2.91 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 123.571 0.748 . . . . 0.0 110.341 160.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 t -117.34 132.51 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.712 0 C-N-CA 127.36 2.264 . . . . 0.0 106.374 162.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -97.41 130.11 46.54 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.136 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 169.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.646 HD12 ' CG2' ' A' ' 70' ' ' VAL . 2.6 mm? -118.56 143.39 46.8 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 170.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -123.73 117.83 25.84 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.589 -2.004 . . . . 0.0 105.589 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.9 ptp -123.19 131.76 53.8 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 124.283 1.033 . . . . 0.0 109.187 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -83.76 116.22 22.59 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.21 144.69 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -176.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -56.94 148.68 20.48 Favored 'General case' 0 C--O 1.233 0.187 0 C-N-CA 120.046 -0.662 . . . . 0.0 111.399 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.31 40.12 1.72 Allowed Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.159 0.885 . . . . 0.0 113.527 -171.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 1.7 mpt? 45.4 -140.33 0.37 Allowed 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.23 1.812 . . . . 0.0 113.205 170.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 61.1 m -124.64 -41.27 2.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.178 1.391 . . . . 0.0 110.267 174.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -163.15 165.47 24.52 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -170.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.4 p-80 -55.23 -26.08 37.38 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.536 0.734 . . . . 0.0 112.623 -178.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.4 m -50.59 -44.21 56.85 Favored 'General case' 0 N--CA 1.451 -0.398 0 O-C-N 121.756 -0.59 . . . . 0.0 110.465 171.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 38.8 m -66.64 -55.22 16.26 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.317 0.647 . . . . 0.0 110.09 -176.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 67.8 p -53.97 -54.38 39.8 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.4 t -57.41 -45.98 83.98 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.942 0.897 . . . . 0.0 110.942 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 66.6 m -57.09 -49.32 76.23 Favored 'General case' 0 C--N 1.339 0.141 0 O-C-N 121.632 -0.668 . . . . 0.0 109.974 177.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 3.9 mt -56.07 -48.45 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 CA-C-N 118.466 0.575 . . . . 0.0 109.756 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -55.83 -50.44 70.53 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.803 0.841 . . . . 0.0 110.756 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.93 -54.94 33.79 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 123.648 0.642 . . . . 0.0 112.083 173.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.6 tptm -53.67 -50.63 65.39 Favored 'General case' 0 C--N 1.337 0.048 0 C-N-CA 124.256 1.022 . . . . 0.0 110.241 -175.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.416 HG21 HD12 ' A' ' 34' ' ' ILE . 14.1 mm -63.29 -49.13 84.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 123.64 0.776 . . . . 0.0 109.75 177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.37 -36.15 10.71 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 117.989 0.358 . . . . 0.0 112.314 172.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt -69.06 -15.43 63.45 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 mt -78.29 145.01 35.62 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 119.693 1.133 . . . . 0.0 111.736 -175.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -79.18 65.13 4.27 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 -173.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.28 13.67 0.02 OUTLIER Glycine 0 N--CA 1.465 0.582 0 N-CA-C 116.727 1.451 . . . . 0.0 116.727 -170.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 74.8 t -110.97 143.71 20.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 119.456 1.628 . . . . 0.0 110.41 -170.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.8 mm100 -108.33 -45.05 3.98 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 125.503 1.521 . . . . 0.0 109.817 -179.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -163.19 171.12 16.73 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 -175.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.416 HD12 HG21 ' A' ' 25' ' ' ILE . 5.2 tt -159.57 144.55 6.23 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.802 0 N-CA-C 104.957 -2.238 . . . . 0.0 104.957 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.445 ' HB2' ' HB ' ' A' ' 44' ' ' THR . 34.3 mmtt -141.84 84.73 1.9 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.671 0.788 . . . . 0.0 110.742 -179.229 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 89.5 t -96.19 105.72 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 C-N-CA 123.573 0.749 . . . . 0.0 110.78 -173.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 30.8 m -108.48 135.08 50.36 Favored 'General case' 0 C--N 1.341 0.236 0 C-N-CA 123.824 0.85 . . . . 0.0 111.031 -178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -48.05 6.52 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 122.915 0.486 . . . . 0.0 109.764 177.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.41 -54.39 27.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 C-N-CA 125.636 1.574 . . . . 0.0 110.25 -177.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -79.23 -0.98 34.35 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.452 -1.249 . . . . 0.0 111.946 -178.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 49.23 58.09 5.76 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.407 1.883 . . . . 0.0 110.673 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -156.4 130.69 8.69 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.047 -176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -110.21 115.53 29.88 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.258 1.423 . . . . 0.0 108.996 175.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.445 ' HB ' ' HB2' ' A' ' 35' ' ' LYS . 53.4 m -90.14 133.85 34.63 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 125.131 1.373 . . . . 0.0 107.309 169.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 8.3 mm -127.66 129.93 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 106.473 -1.677 . . . . 0.0 106.473 171.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.8 t -117.92 106.6 20.15 Favored 'Isoleucine or valine' 0 C--O 1.232 0.162 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 -175.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -127.16 165.22 19.98 Favored 'General case' 0 CA--C 1.518 -0.272 0 O-C-N 122.062 -0.399 . . . . 0.0 111.564 -170.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -92.65 123.05 62.9 Favored Pre-proline 0 N--CA 1.449 -0.502 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -63.36 145.67 92.88 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 121.609 1.539 . . . . 0.0 108.676 -178.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 87.27 -23.02 0.14 Allowed 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.693 1.597 . . . . 0.0 111.824 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.46 -47.36 8.4 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.719 1.145 . . . . 0.0 110.929 -178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -137.91 158.02 32.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 125.639 1.576 . . . . 0.0 108.448 -174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.2 p -114.24 169.92 8.68 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.854 0.862 . . . . 0.0 111.053 -175.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 21.8 t -52.92 -41.1 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 123.481 0.712 . . . . 0.0 111.482 170.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -64.46 -53.21 51.86 Favored 'General case' 0 C--O 1.215 -0.715 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -171.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -37.3 -60.47 0.66 Allowed 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 126.079 1.752 . . . . 0.0 111.486 169.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 15.4 mtm -48.77 -64.69 0.73 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 172.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -59.05 5.88 Favored 'General case' 0 C--O 1.215 -0.724 0 CA-C-O 118.016 -0.992 . . . . 0.0 111.869 -173.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.1 tptt -36.12 -55.35 0.78 Allowed 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 125.006 1.323 . . . . 0.0 111.11 169.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.6 mm-40 -60.85 -43.01 98.89 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.363 178.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.82 -65.77 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 123.692 0.797 . . . . 0.0 110.577 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -37.62 -46.26 0.84 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.177 0.991 . . . . 0.0 112.363 169.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.87 -32.04 60.4 Favored 'General case' 0 C--N 1.341 0.226 0 N-CA-C 112.932 0.716 . . . . 0.0 112.932 -177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 14.6 mmt -60.32 -39.91 88.72 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 118.366 0.53 . . . . 0.0 110.643 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.66 -11.63 3.44 Favored Glycine 0 CA--C 1.527 0.801 0 C-N-CA 124.512 1.053 . . . . 0.0 111.281 176.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -90.14 110.47 40.6 Favored Pre-proline 0 N--CA 1.45 -0.456 0 C-N-CA 124.039 0.936 . . . . 0.0 109.151 -170.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -69.61 132.82 24.39 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.844 1.696 . . . . 0.0 109.301 -178.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.28 49.08 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 124.003 0.921 . . . . 0.0 111.423 -174.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -117.38 79.07 1.29 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.845 0.858 . . . . 0.0 109.438 -175.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.646 ' CG2' HD12 ' A' ' 5' ' ' LEU . 10.1 p -63.62 108.23 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 C-N-CA 126.025 1.73 . . . . 0.0 110.95 175.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 6.2 pttt -154.29 59.81 0.7 Allowed 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.203 1.002 . . . . 0.0 113.239 178.015 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.525 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -159.23 159.86 34.67 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 120.803 -1.186 . . . . 0.0 108.166 178.509 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 10.1 tp -155.46 55.58 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-O 122.29 1.043 . . . . 0.0 109.377 -177.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.33 69.93 10.47 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 -172.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -54.28 -20.9 17.43 Favored Glycine 0 CA--C 1.531 1.036 0 C-N-CA 124.854 1.216 . . . . 0.0 113.503 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 6.1 ttm180 . . . . . 0 C--O 1.251 1.147 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 165.055 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.127 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.3 mt-10 -79.94 179.3 7.65 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 117.613 0.706 . . . . 0.0 110.592 172.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 70.3 t -107.31 141.46 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 C-N-CA 125.467 1.507 . . . . 0.0 107.889 -178.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -94.42 122.62 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 72' ' ' LYS . 15.0 mt -100.09 141.83 32.39 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 168.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.442 ' CB ' ' HB2' ' A' ' 72' ' ' LYS . 16.8 tptt -119.12 125.49 49.38 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 174.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -124.34 119.12 28.34 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.378 1.471 . . . . 0.0 108.955 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.52 120.76 22.95 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 176.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.2 m -105.68 152.56 7.43 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -178.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -116.12 150.48 37.32 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 118.168 0.44 . . . . 0.0 110.786 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 78.97 -30.23 2.07 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.533 0.587 . . . . 0.0 114.079 174.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 69.9 mtp -68.93 85.38 0.33 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 118.016 0.908 . . . . 0.0 111.669 -178.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.6 m -114.92 6.97 15.52 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.761 1.224 . . . . 0.0 112.232 -176.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.9 p -129.12 139.74 51.84 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 119.317 0.962 . . . . 0.0 111.236 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -54.36 -31.51 54.75 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.363 1.065 . . . . 0.0 111.962 -171.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 5.6 m -45.81 -55.1 7.03 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 124.329 1.052 . . . . 0.0 111.709 170.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 75.5 m -64.86 -54.6 28.47 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 118.315 0.507 . . . . 0.0 109.847 -171.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.4 t -51.68 -54.96 22.42 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.637 178.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 24.6 t -57.85 -46.09 85.3 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 118.473 0.579 . . . . 0.0 111.346 -177.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 42.8 m -56.81 -50.91 70.95 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 121.368 -0.833 . . . . 0.0 110.843 177.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -62.77 -43.9 99.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -55.97 -47.88 76.84 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 123.917 0.887 . . . . 0.0 110.658 176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.24 -52.88 41.09 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 123.825 0.726 . . . . 0.0 111.321 173.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -65.62 -59.91 3.46 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 121.433 0.635 . . . . 0.0 110.946 -175.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 23.1 mm -66.75 -30.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 124.009 0.924 . . . . 0.0 110.388 -173.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.69 -29.31 7.71 Favored Glycine 0 CA--C 1.53 0.982 0 CA-C-O 119.498 -0.612 . . . . 0.0 112.764 169.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.0 tttt -92.43 7.9 41.01 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 118.494 1.147 . . . . 0.0 112.77 -178.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.6 mt -69.44 159.5 33.13 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 120.413 1.46 . . . . 0.0 111.656 176.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -103.36 82.97 2.11 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.471 1.508 . . . . 0.0 109.725 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.08 11.79 0.26 Allowed Glycine 0 CA--C 1.531 1.049 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 -173.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -124.4 128.6 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.31 1.444 . . . . 0.0 109.599 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -86.22 -36.63 19.32 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 171.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.2 mtt180 -154.23 168.24 27.2 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-O 122.201 1.0 . . . . 0.0 108.656 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.9 tt -157.42 141.6 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.683 0 N-CA-C 104.286 -2.487 . . . . 0.0 104.286 -174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.6 mmtp -140.61 82.49 1.85 Allowed 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.275 1.03 . . . . 0.0 110.432 176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 95.7 t -88.13 116.83 30.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 C-N-CA 123.515 0.726 . . . . 0.0 109.111 -174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.0 m -97.33 -174.23 2.88 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.9 OUTLIER -147.52 -47.8 0.17 Allowed 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 124.23 1.012 . . . . 0.0 109.533 179.137 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -46.59 -55.83 7.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 125.514 1.525 . . . . 0.0 110.601 179.376 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -94.04 19.19 9.45 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.56 -175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 36.52 61.48 0.82 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 127.35 2.26 . . . . 0.0 112.445 -177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.14 154.55 37.13 Favored 'General case' 0 N--CA 1.452 -0.367 0 O-C-N 121.184 -0.947 . . . . 0.0 108.758 -174.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -136.64 130.04 31.63 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.104 0.962 . . . . 0.0 109.877 179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.8 m -92.85 132.75 36.72 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.743 1.617 . . . . 0.0 107.038 171.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.5 mm -126.3 125.56 67.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 170.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.4 t -102.33 119.42 50.62 Favored 'Isoleucine or valine' 0 C--N 1.339 0.115 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.98 161.04 38.97 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -98.91 116.17 65.42 Favored Pre-proline 0 N--CA 1.447 -0.613 0 CA-C-N 114.779 -1.101 . . . . 0.0 110.531 -178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.94 73.13 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 123.583 2.855 . . . . 0.0 110.546 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -174.73 -42.15 0.01 OUTLIER 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 125.904 1.682 . . . . 0.0 109.744 178.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.27 -42.88 18.26 Favored 'General case' 0 CA--C 1.527 0.091 0 CA-C-O 119.823 -0.132 . . . . 0.0 111.146 -177.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -145.27 159.8 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 -172.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 59.9 p -119.57 168.68 10.77 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 119.113 0.869 . . . . 0.0 112.139 -174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.6 t -44.03 -50.33 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 C-N-CA 125.289 1.435 . . . . 0.0 111.209 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -42.68 86.92 Favored 'General case' 0 C--O 1.218 -0.576 0 CA-C-O 118.347 -0.835 . . . . 0.0 110.71 -173.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -48.6 -52.7 21.66 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 120.512 1.505 . . . . 0.0 108.663 172.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -55.64 -61.64 2.22 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 121.38 -0.128 . . . . 0.0 111.236 179.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.37 -58.24 9.14 Favored 'General case' 0 C--O 1.218 -0.58 0 O-C-N 121.569 -0.707 . . . . 0.0 112.266 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -47.43 -49.83 24.27 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 124.103 0.961 . . . . 0.0 109.458 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.2 mm100 -62.28 -44.28 96.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 120.095 -0.642 . . . . 0.0 111.896 177.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 81.3 mt -70.03 -63.87 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 C-N-CA 123.166 0.587 . . . . 0.0 110.538 -177.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -43.23 -41.41 3.84 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.468 0.707 . . . . 0.0 112.671 172.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.97 -31.26 50.12 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.044 0.838 . . . . 0.0 113.007 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 6.1 mmt -57.02 -41.65 78.93 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.372 0.533 . . . . 0.0 111.064 173.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.77 -20.79 2.53 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.531 1.062 . . . . 0.0 111.057 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -84.77 110.51 28.32 Favored Pre-proline 0 N--CA 1.453 -0.322 0 C-N-CA 124.24 1.016 . . . . 0.0 110.068 -170.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -64.82 139.21 61.5 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 N-CA-C 108.705 -1.306 . . . . 0.0 108.705 177.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.78 134.58 26.82 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -176.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 -100.6 72.14 1.54 Allowed 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.172 0.589 . . . . 0.0 110.371 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.1 p -57.55 94.91 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 125.012 1.325 . . . . 0.0 112.548 176.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.8 ttmt -158.51 84.32 0.84 Allowed 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 122.005 -0.434 . . . . 0.0 110.083 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.442 ' HB2' ' CB ' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -158.16 160.43 37.23 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 158.69 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.1 mp -139.09 73.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 104.362 -2.459 . . . . 0.0 104.362 167.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -90.8 176.08 6.77 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 172.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -149.73 157.74 27.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 107.244 -2.342 . . . . 0.0 107.244 176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.21 0 CA-C-O 116.233 -1.841 . . . . 0.0 107.017 -172.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.014 0 N-CA-C 108.206 -1.958 . . . . 0.0 108.206 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -73.75 -173.95 1.65 Allowed 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 125.326 1.45 . . . . 0.0 109.29 158.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 53.9 t -130.21 140.91 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 46' ' ' VAL . 18.4 t -103.59 127.45 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 125.274 1.43 . . . . 0.0 107.473 171.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.578 HD13 HG23 ' A' ' 70' ' ' VAL . 1.9 pp -112.23 152.02 28.92 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 169.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 tptm -122.0 121.36 36.85 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.0 mtt -102.31 139.46 37.89 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 30.9 tttt -83.93 134.5 34.66 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 163.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.89 143.76 34.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-N 119.581 1.082 . . . . 0.0 108.819 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mm-40 -114.58 140.87 48.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 -176.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.82 -34.61 5.61 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 124.83 1.205 . . . . 0.0 112.922 171.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 36.0 mtm -69.19 95.33 0.75 Allowed 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.059 0.93 . . . . 0.0 111.527 -177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.8 p -111.05 27.24 9.88 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.376 1.07 . . . . 0.0 112.886 -178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.5 p -151.04 159.74 44.35 Favored 'General case' 0 C--N 1.34 0.185 0 CA-C-N 119.282 0.947 . . . . 0.0 109.219 172.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -76.1 -12.66 60.15 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -177.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.4 m -62.76 -54.46 38.74 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.3 m -55.23 -51.68 65.81 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 117.771 0.26 . . . . 0.0 110.775 179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.9 p -52.69 -59.34 4.6 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 123.154 0.582 . . . . 0.0 109.912 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -57.52 -44.3 84.95 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.938 0.895 . . . . 0.0 111.258 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.6 m -55.45 -48.69 74.1 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 121.364 -0.835 . . . . 0.0 110.751 176.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.9 mt -64.34 -50.03 78.27 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 O-C-N 122.003 -0.435 . . . . 0.0 109.989 178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -46.6 -49.56 18.77 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.511 1.124 . . . . 0.0 109.684 174.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.1 -59.11 11.34 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.348 0.975 . . . . 0.0 112.398 174.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.1 -55.23 37.42 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.725 0.763 . . . . 0.0 110.294 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.3 mm -70.83 -32.48 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 CA-C-N 115.338 -0.847 . . . . 0.0 109.76 -175.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.39 -31.19 20.3 Favored Glycine 0 CA--C 1.532 1.132 0 O-C-N 121.46 -0.775 . . . . 0.0 112.792 171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.4 ttmt -79.13 -3.6 46.3 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 118.312 1.056 . . . . 0.0 112.552 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 mt -69.76 134.08 48.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.302 1.41 . . . . 0.0 111.265 174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -77.26 115.71 17.27 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 172.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.29 -9.19 5.93 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 124.21 0.91 . . . . 0.0 111.904 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.7 p -84.45 150.86 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 C-N-CA 123.28 0.632 . . . . 0.0 109.818 176.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -109.54 -40.4 4.88 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 125.647 1.579 . . . . 0.0 109.081 174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.2 ttt180 -162.31 172.25 15.97 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 122.32 1.057 . . . . 0.0 108.741 177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.4 tt -156.46 143.23 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.423 0 N-CA-C 103.745 -2.687 . . . . 0.0 103.745 179.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.8 mmtp -142.61 146.76 34.86 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 125.659 1.583 . . . . 0.0 109.419 174.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 77.4 t -136.23 146.22 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 119.616 1.098 . . . . 0.0 109.793 173.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.2 m -124.68 148.46 47.97 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 127.494 2.318 . . . . 0.0 109.636 -174.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 33.3 tp -99.0 -56.91 2.3 Favored 'General case' 0 N--CA 1.457 -0.099 0 C-N-CA 125.87 1.668 . . . . 0.0 110.946 -171.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -50.03 -58.68 4.98 Favored 'General case' 0 CA--C 1.518 -0.28 0 C-N-CA 125.682 1.593 . . . . 0.0 110.484 -173.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -85.15 0.29 52.19 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 114.538 -1.21 . . . . 0.0 110.929 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 41.23 70.99 0.22 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 128.737 2.815 . . . . 0.0 110.762 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -140.29 145.61 37.48 Favored 'General case' 0 C--O 1.225 -0.189 0 CA-C-N 115.391 -0.822 . . . . 0.0 108.984 -163.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.75 113.15 14.98 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 125.628 1.571 . . . . 0.0 109.721 -168.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.516 ' C ' HD12 ' A' ' 45' ' ' ILE . 39.7 m -89.2 118.7 29.09 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.505 2.722 . . . . 0.0 109.574 176.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.516 HD12 ' C ' ' A' ' 44' ' ' THR . 2.9 mp -121.71 124.71 72.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 176.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 4' ' ' VAL . 6.5 t -118.27 104.78 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -170.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -138.05 167.52 21.62 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 111.797 -167.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -101.79 107.82 53.53 Favored Pre-proline 0 N--CA 1.443 -0.804 0 C-N-CA 123.931 0.892 . . . . 0.0 109.377 -175.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -70.68 83.84 0.84 Allowed 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 123.153 2.569 . . . . 0.0 110.51 -174.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.3 m80 176.54 -44.22 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 128.132 2.573 . . . . 0.0 107.765 176.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.65 -51.46 10.58 Favored 'General case' 0 N--CA 1.456 -0.142 0 CA-C-O 120.595 0.236 . . . . 0.0 110.756 -175.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.6 tp -134.34 177.13 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 C-N-CA 125.471 1.509 . . . . 0.0 107.648 -178.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 52.1 p -136.57 171.97 13.7 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 118.602 0.637 . . . . 0.0 110.609 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 90.2 t -48.33 -35.28 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.043 165.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -47.41 62.62 Favored 'General case' 0 C--O 1.216 -0.675 0 CA-C-O 118.78 -0.629 . . . . 0.0 109.934 -168.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -57.95 -51.34 70.04 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 124.693 1.197 . . . . 0.0 108.241 174.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.9 mmt -47.27 -59.81 2.93 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 111.923 0.342 . . . . 0.0 111.923 174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.23 -58.98 6.07 Favored 'General case' 0 C--O 1.217 -0.635 0 CA-C-O 118.2 -0.905 . . . . 0.0 111.14 177.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -44.54 -50.91 9.36 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 124.424 1.09 . . . . 0.0 108.692 -176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.7 mm-40 -63.44 -45.63 90.01 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 123.166 0.291 . . . . 0.0 111.311 179.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 94.1 mt -69.1 -66.62 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 C-N-CA 123.149 0.58 . . . . 0.0 111.213 -179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -45.3 -38.79 5.96 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 118.941 0.791 . . . . 0.0 111.918 174.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.06 -32.71 62.14 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.629 1.104 . . . . 0.0 113.123 177.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.5 mmt -54.93 -41.03 70.53 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 118.544 0.611 . . . . 0.0 110.546 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.17 -18.86 3.28 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.52 1.057 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -78.14 113.58 34.73 Favored Pre-proline 0 N--CA 1.452 -0.336 0 CA-C-O 118.282 -0.866 . . . . 0.0 109.998 -172.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -66.37 136.78 44.71 Favored 'Trans proline' 0 N--CA 1.452 -0.962 0 N-CA-C 108.965 -1.206 . . . . 0.0 108.965 178.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -130.37 131.71 45.44 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.875 0.845 . . . . 0.0 112.088 -176.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -103.81 77.51 1.47 Allowed 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.836 2.054 . . . . 0.0 109.115 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.578 HG23 HD13 ' A' ' 5' ' ' LEU . 14.4 p -62.61 107.87 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 C-N-CA 123.738 0.815 . . . . 0.0 110.634 171.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.7 pttt -155.58 55.46 0.62 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 4.1 mmmt -157.35 157.32 33.9 Favored 'General case' 0 C--O 1.231 0.109 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.7 tp -147.69 56.88 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -82.51 60.4 5.13 Favored 'General case' 0 CA--C 1.532 0.262 0 O-C-N 121.235 -0.915 . . . . 0.0 109.806 -172.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -46.96 108.72 0.3 Allowed Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 175.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.3 tpt85 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.015 -0.993 . . . . 0.0 111.771 -160.215 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 105.382 -3.087 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -154.68 176.56 12.28 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 123.876 0.87 . . . . 0.0 108.737 -152.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 47' ' ' TYR . 12.9 p -87.36 112.99 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.85 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 -176.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -80.83 128.13 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 105.761 -1.94 . . . . 0.0 105.761 173.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.547 HD12 HG22 ' A' ' 70' ' ' VAL . 3.5 mm? -116.82 123.11 46.28 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 167.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tptm -100.15 118.61 36.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 171.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 3.7 ptp -118.0 125.14 49.81 Favored 'General case' 0 N--CA 1.443 -0.811 0 C-N-CA 125.361 1.464 . . . . 0.0 108.654 177.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.423 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 0.8 OUTLIER -70.83 138.08 50.0 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 171.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.1 m -129.74 139.2 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -101.26 150.31 23.11 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -176.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.17 -40.54 2.36 Favored Glycine 0 CA--C 1.531 1.035 0 CA-C-O 119.327 -0.707 . . . . 0.0 113.779 166.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.4 mtm -62.79 86.43 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.393 1.097 . . . . 0.0 110.934 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.9 m -148.19 47.75 1.06 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.732 1.613 . . . . 0.0 108.243 -179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.4 p -128.74 -4.66 5.21 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.093 1.757 . . . . 0.0 111.578 -178.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 66.08 -25.69 0.1 Allowed 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.431 1.493 . . . . 0.0 114.082 -170.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 22.7 t -67.5 -75.15 0.1 Allowed 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.075 -1.015 . . . . 0.0 111.181 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.5 m -44.02 -53.9 5.9 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.156 1.783 . . . . 0.0 112.254 -176.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.7 t -50.54 -50.7 52.54 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.688 0.795 . . . . 0.0 111.025 175.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 29.7 t -65.74 -44.1 86.96 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.143 0.577 . . . . 0.0 110.494 -178.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 57.2 m -50.87 -52.63 39.83 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.696 -0.628 . . . . 0.0 110.313 172.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.4 -44.74 93.3 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 CA-C-O 119.196 -0.431 . . . . 0.0 110.665 177.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -56.13 -49.05 75.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-N 118.327 0.512 . . . . 0.0 110.474 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.64 -54.49 30.15 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 123.593 0.615 . . . . 0.0 111.806 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.3 tptp -60.72 -55.03 38.04 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.97 -0.724 . . . . 0.0 110.769 -175.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 12.0 mm -57.16 -43.04 80.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.143 1.377 . . . . 0.0 109.804 -178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.07 -29.78 6.9 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 123.773 0.701 . . . . 0.0 113.961 174.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -87.87 -12.95 43.33 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 118.802 1.301 . . . . 0.0 112.532 -177.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.3 mt -75.34 130.78 39.59 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 120.394 1.452 . . . . 0.0 111.866 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -69.66 90.07 0.56 Allowed 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.587 -173.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.24 -26.01 0.88 Allowed Glycine 0 C--N 1.331 0.296 0 O-C-N 121.996 -0.44 . . . . 0.0 112.617 -173.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.3 t -79.92 147.2 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 117.573 0.686 . . . . 0.0 110.249 -178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -125.19 -31.98 3.02 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.335 1.054 . . . . 0.0 111.688 -177.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -154.41 163.43 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 176.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.4 tt -158.85 140.77 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.483 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.2 mmtp -144.42 85.31 1.78 Allowed 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 124.006 0.922 . . . . 0.0 110.49 172.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -82.75 114.99 24.49 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.6 m -94.53 165.24 12.63 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -47.67 2.58 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.601 0.76 . . . . 0.0 109.945 175.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.3 -55.95 13.3 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 125.178 1.391 . . . . 0.0 110.852 -171.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -90.56 13.37 16.04 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.65 -1.159 . . . . 0.0 110.873 -176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 38.5 58.67 1.61 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.964 2.105 . . . . 0.0 112.685 -175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.423 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 30.9 tt0 -145.95 142.28 28.55 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 -174.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -128.46 123.7 34.31 Favored 'General case' 0 N--CA 1.441 -0.881 0 C-N-CA 124.522 1.129 . . . . 0.0 110.193 -170.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.2 m -94.89 127.68 41.1 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 125.152 1.381 . . . . 0.0 107.687 175.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.6 mm -125.41 126.11 70.05 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 170.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.8 t -120.9 112.03 34.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 118.345 0.52 . . . . 0.0 110.659 -176.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' O ' HG12 ' A' ' 3' ' ' VAL . 32.6 p90 -132.56 168.99 17.25 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.423 0.63 . . . . 0.0 112.155 -173.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -90.97 113.06 56.84 Favored Pre-proline 0 N--CA 1.445 -0.719 0 C-N-CA 124.629 1.172 . . . . 0.0 109.203 -175.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -74.71 76.89 3.15 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.821 2.347 . . . . 0.0 110.873 -170.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -176.01 -47.0 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 127.158 2.183 . . . . 0.0 108.305 174.199 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 50.7 mt -76.15 -43.83 41.1 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 121.172 -0.211 . . . . 0.0 111.334 -173.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -133.71 169.49 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 C-N-CA 125.298 1.439 . . . . 0.0 108.002 -176.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -138.37 164.79 28.42 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.978 0.911 . . . . 0.0 111.14 -172.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.422 HG13 HG21 ' A' ' 70' ' ' VAL . 93.9 t -43.33 -47.42 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 124.34 1.056 . . . . 0.0 110.899 170.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.81 -49.48 77.32 Favored 'General case' 0 C--O 1.218 -0.602 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.745 -175.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -56.23 -49.55 73.81 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 120.1 1.318 . . . . 0.0 109.415 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 19.1 mmt -49.2 -60.95 2.36 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 118.132 0.424 . . . . 0.0 111.421 173.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 ttmt -57.08 -64.08 1.0 Allowed 'General case' 0 C--O 1.217 -0.644 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.758 177.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.26 -52.29 2.66 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.54 1.136 . . . . 0.0 109.818 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -66.61 -39.03 88.16 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 120.607 -0.437 . . . . 0.0 111.918 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.4 mt -70.89 -63.87 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.109 0 O-C-N 121.734 -0.604 . . . . 0.0 111.056 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -43.8 -39.26 3.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 123.56 0.744 . . . . 0.0 112.16 172.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -52.08 -34.06 42.18 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.212 0.915 . . . . 0.0 113.164 177.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -61.7 -36.44 80.92 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.466 0.575 . . . . 0.0 111.107 176.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 130.26 -11.19 5.85 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.862 1.22 . . . . 0.0 111.263 179.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -84.65 114.76 57.21 Favored Pre-proline 0 N--CA 1.45 -0.433 0 C-N-CA 124.274 1.029 . . . . 0.0 109.455 -172.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -67.96 140.21 49.54 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 121.327 1.351 . . . . 0.0 108.598 177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.66 140.12 40.66 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 122.696 0.399 . . . . 0.0 111.377 -178.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -112.89 73.93 0.84 Allowed 'General case' 0 C--N 1.338 0.107 0 C-N-CA 124.683 1.193 . . . . 0.0 110.185 -177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.547 HG22 HD12 ' A' ' 5' ' ' LEU . 8.9 p -65.98 103.64 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 126.329 1.852 . . . . 0.0 111.813 175.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 9.0 pttt -157.29 54.62 0.5 Allowed 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 113.965 1.098 . . . . 0.0 113.965 178.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -159.05 80.71 0.77 Allowed 'General case' 0 CA--C 1.531 0.237 0 O-C-N 120.963 -1.085 . . . . 0.0 111.075 -179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.8 mt -82.06 59.35 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.725 1.21 . . . . 0.0 109.409 -172.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -80.85 64.28 5.56 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.291 -0.881 . . . . 0.0 110.423 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.05 135.69 50.25 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 121.632 -0.667 . . . . 0.0 112.637 -179.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 24.7 ttt85 . . . . . 0 C--O 1.25 1.119 0 CA-C-O 117.721 -1.133 . . . . 0.0 109.391 -178.107 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 108.658 -1.777 . . . . 0.0 108.658 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.69 158.74 26.64 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 125.806 1.642 . . . . 0.0 109.568 152.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 43.8 t -136.95 143.79 33.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 125.777 1.631 . . . . 0.0 107.722 163.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -92.14 143.91 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 124.551 1.14 . . . . 0.0 108.125 176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' CD1' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -129.08 117.49 20.94 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 174.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.7 tptt -100.28 125.17 46.45 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -176.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mtt -121.05 119.93 33.91 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.202 1.001 . . . . 0.0 109.141 179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.422 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.1 mptp? -73.4 121.96 21.31 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 169.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 m -110.23 149.66 13.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.214 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -114.76 148.01 38.96 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 85.86 -33.02 3.6 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.541 1.067 . . . . 0.0 113.048 172.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 50.7 mtp -69.09 75.69 0.33 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.13 0.972 . . . . 0.0 112.91 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.0 m -142.26 58.2 1.46 Allowed 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.588 1.155 . . . . 0.0 111.096 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -150.85 16.83 0.77 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.07 0.548 . . . . 0.0 111.832 175.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 41.7 m80 68.8 -35.39 0.3 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.928 1.691 . . . . 0.0 113.357 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.6 t -59.84 -51.76 68.36 Favored 'General case' 0 N--CA 1.445 -0.684 0 C-N-CA 125.399 1.479 . . . . 0.0 110.874 -178.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -63.56 -60.3 3.51 Favored 'General case' 0 C--N 1.34 0.182 0 C-N-CA 123.114 0.566 . . . . 0.0 110.655 -174.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.5 t -43.8 -58.14 2.89 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 124.399 1.08 . . . . 0.0 110.327 177.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.9 t -67.04 -43.46 82.71 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 110.391 -0.225 . . . . 0.0 110.391 -174.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.1 m -55.34 -47.07 76.27 Favored 'General case' 0 C--N 1.341 0.219 0 O-C-N 121.635 -0.666 . . . . 0.0 110.516 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.7 mt -64.75 -48.37 84.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 CA-C-O 118.905 -0.569 . . . . 0.0 109.601 179.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -47.74 -51.32 22.6 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.292 0.637 . . . . 0.0 109.835 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.24 -58.8 12.64 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 123.551 0.595 . . . . 0.0 112.334 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -61.28 -60.25 4.03 Favored 'General case' 0 N--CA 1.457 -0.109 0 CA-C-O 121.763 0.792 . . . . 0.0 109.741 -171.469 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.1 mm -66.37 -27.91 41.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.542 -176.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -44.92 -37.35 5.38 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 123.59 0.614 . . . . 0.0 112.84 168.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttt -88.09 4.13 46.48 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 117.989 0.895 . . . . 0.0 112.719 -177.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -66.28 153.09 43.5 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 120.292 -1.505 . . . . 0.0 110.374 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -87.07 141.11 28.9 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 172.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.77 11.5 55.02 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 124.017 0.817 . . . . 0.0 112.783 175.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.6 t -104.59 147.39 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 125.112 1.365 . . . . 0.0 109.541 -175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 15.8 mm-40 -109.73 -46.47 3.5 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 125.615 1.566 . . . . 0.0 109.657 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -150.47 169.62 21.05 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.775 -1.194 . . . . 0.0 107.775 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.5 tt -148.0 133.84 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.331 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 172.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 48.3 mmtt -137.76 154.46 49.59 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 125.154 1.381 . . . . 0.0 108.456 175.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.7 t -145.23 110.32 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.4 m -82.01 75.78 8.93 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.408 1.083 . . . . 0.0 108.659 171.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -45.48 -41.72 9.83 Favored 'General case' 0 N--CA 1.462 0.162 0 C-N-CA 123.476 0.71 . . . . 0.0 110.606 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.42 -56.75 4.67 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.441 1.497 . . . . 0.0 111.378 -176.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.92 13.71 25.93 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.008 -176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 50.22 60.74 3.61 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 126.74 2.016 . . . . 0.0 111.288 -176.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 10.2 tt0 -143.92 132.5 22.3 Favored 'General case' 0 C--O 1.226 -0.179 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.486 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -98.16 135.14 40.24 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.87 1.668 . . . . 0.0 109.465 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 94.4 m -114.12 81.9 1.61 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 128.169 2.588 . . . . 0.0 107.684 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 mm -89.08 127.82 41.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -176.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.3 t -121.26 107.63 20.71 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 CA-C-N 119.232 0.924 . . . . 0.0 110.416 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.49 ' OH ' HG23 ' A' ' 54' ' ' VAL . 12.9 p90 -134.57 173.46 11.63 Favored 'General case' 0 CA--C 1.517 -0.31 0 O-C-N 121.656 -0.652 . . . . 0.0 111.925 -169.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -106.76 106.98 59.5 Favored Pre-proline 0 CA--C 1.538 0.497 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.629 -176.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -70.32 76.28 1.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 124.202 3.268 . . . . 0.0 110.937 -173.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -178.74 -43.21 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 126.627 1.971 . . . . 0.0 108.295 -176.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.1 mt -82.62 -42.34 18.35 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 111.36 0.133 . . . . 0.0 111.36 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 tp -143.21 169.39 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 -177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -120.24 155.54 33.01 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 124.461 1.104 . . . . 0.0 111.068 -172.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.49 HG23 ' OH ' ' A' ' 47' ' ' TYR . 3.5 t -39.03 -49.45 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.26 0 C-N-CA 124.469 1.108 . . . . 0.0 110.958 164.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -62.75 -46.75 86.6 Favored 'General case' 0 C--O 1.217 -0.628 0 CA-C-O 117.445 -1.264 . . . . 0.0 110.788 -173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -56.11 -49.41 73.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 120.904 1.684 . . . . 0.0 108.53 175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -52.26 -60.27 3.41 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.007 0.432 . . . . 0.0 110.918 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -59.78 -56.94 15.55 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-O 118.734 -0.65 . . . . 0.0 111.82 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -46.73 -51.09 16.95 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 123.751 0.82 . . . . 0.0 108.947 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -60.52 -44.66 95.79 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 120.876 -0.33 . . . . 0.0 111.617 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 85.7 mt -69.94 -65.15 0.66 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 C-N-CA 122.979 0.512 . . . . 0.0 110.508 -177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -44.34 -40.21 5.17 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 118.929 0.786 . . . . 0.0 112.557 172.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.76 -30.2 60.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.276 0.944 . . . . 0.0 113.336 178.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.6 mmt -52.04 -41.76 62.57 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 118.583 0.629 . . . . 0.0 110.513 171.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 142.38 -19.31 2.45 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.45 1.024 . . . . 0.0 111.085 176.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -83.73 117.52 68.89 Favored Pre-proline 0 N--CA 1.45 -0.457 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.052 -170.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -64.84 137.32 52.96 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 N-CA-C 108.721 -1.299 . . . . 0.0 108.721 175.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -132.72 139.28 47.55 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.733 0.813 . . . . 0.0 110.081 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -104.93 86.22 2.42 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 175.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 5' ' ' LEU . 3.1 t -58.45 107.87 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 124.98 1.312 . . . . 0.0 109.825 165.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -159.02 56.87 0.42 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -159.43 143.23 14.79 Favored 'General case' 0 C--O 1.225 -0.205 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.9 mp -133.72 69.25 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 169.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -81.62 101.2 9.87 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 172.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.17 -61.24 4.36 Favored Glycine 0 CA--C 1.528 0.856 0 O-C-N 121.959 -0.463 . . . . 0.0 112.236 -173.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.068 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 -175.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 107.611 -2.196 . . . . 0.0 107.611 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 24.5 mp0 -53.64 174.83 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 127.615 2.366 . . . . 0.0 113.423 168.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.5 m -100.43 130.73 49.21 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.825 0 C-N-CA 125.134 1.374 . . . . 0.0 107.805 -175.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 p -101.14 115.82 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.237 0 C-N-CA 125.14 1.376 . . . . 0.0 109.274 179.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' C ' HD12 ' A' ' 5' ' ' LEU . 1.7 pp -90.51 138.39 31.59 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 6.2 tptt -113.85 126.08 54.79 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.41 ' SD ' HD11 ' A' ' 5' ' ' LEU . 13.7 ptm -132.24 128.24 37.46 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.922 0.889 . . . . 0.0 110.115 -177.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.429 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 3.0 mptp? -78.13 131.15 37.11 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 176.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.4 m -121.93 148.08 25.65 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 CA-C-N 119.431 1.014 . . . . 0.0 109.011 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -105.97 146.52 29.94 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 176.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.46 -32.52 7.46 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.692 1.139 . . . . 0.0 113.227 169.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 33.9 mtt -75.46 74.25 2.52 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.501 1.15 . . . . 0.0 112.442 -171.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.2 m -106.44 39.94 1.72 Allowed 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.789 1.236 . . . . 0.0 109.8 -178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.0 p -160.0 168.68 25.09 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 175.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -78.06 -8.06 57.73 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.104 0.561 . . . . 0.0 112.026 177.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.1 t -73.71 -64.6 0.96 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.734 0.697 . . . . 0.0 110.894 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 19.4 m -55.41 -55.27 33.57 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.419 0.628 . . . . 0.0 110.306 -173.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 10.0 t -48.58 -56.0 9.59 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.818 1.247 . . . . 0.0 110.346 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.4 t -63.58 -45.19 91.55 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 122.982 0.513 . . . . 0.0 110.7 -176.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 40.4 m -53.66 -49.47 67.87 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 121.815 -0.553 . . . . 0.0 110.419 176.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -62.78 -48.07 89.87 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 O-C-N 121.99 -0.444 . . . . 0.0 110.116 177.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -51.85 -47.64 64.33 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.408 0.683 . . . . 0.0 110.18 178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.67 -56.35 25.77 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.489 1.042 . . . . 0.0 111.741 174.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 15.0 tptt -58.32 -57.29 13.56 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 121.776 0.798 . . . . 0.0 110.166 -175.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 22.8 mm -70.32 -30.38 42.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 C-N-CA 124.13 0.972 . . . . 0.0 110.389 -173.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.04 -31.92 8.67 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 123.62 0.629 . . . . 0.0 112.704 169.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -84.82 -1.85 56.96 Favored 'General case' 0 N--CA 1.445 -0.706 0 CA-C-N 118.192 0.996 . . . . 0.0 112.733 -178.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -70.44 149.83 46.84 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 120.724 1.602 . . . . 0.0 110.346 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 30.5 tt0 -87.29 127.86 35.18 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 172.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 113.04 14.81 9.65 Favored Glycine 0 CA--C 1.524 0.645 0 CA-C-O 119.455 -0.636 . . . . 0.0 113.331 177.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.5 t -122.94 137.96 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 C-N-CA 124.615 1.166 . . . . 0.0 109.452 -176.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.04 -31.52 10.16 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.106 0.562 . . . . 0.0 111.88 175.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.99 162.27 40.36 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.0 tt -155.9 138.39 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.463 0 N-CA-C 103.701 -2.703 . . . . 0.0 103.701 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.9 mmtt -140.78 136.18 32.22 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.437 1.095 . . . . 0.0 110.132 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 38.9 t -137.17 139.87 43.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-N 119.5 1.046 . . . . 0.0 110.289 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.4 m -128.5 127.38 42.33 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 126.134 1.774 . . . . 0.0 109.644 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.05 -47.1 12.05 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.933 0.893 . . . . 0.0 111.881 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -53.48 -58.51 6.87 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.994 1.317 . . . . 0.0 110.356 -175.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -84.11 4.97 27.92 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 114.668 -1.151 . . . . 0.0 110.594 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.279 0.2 OUTLIER 36.22 67.34 0.31 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.317 2.647 . . . . 0.0 113.561 -177.515 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.429 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 3.0 tt0 -143.51 141.19 30.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.758 -170.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -119.33 148.57 43.03 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.515 1.526 . . . . 0.0 109.752 178.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.8 m -128.14 118.92 24.27 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 129.964 3.306 . . . . 0.0 105.43 -174.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -121.99 120.46 61.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 106.691 -1.596 . . . . 0.0 106.691 176.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.85 96.14 4.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 O-C-N 123.789 0.68 . . . . 0.0 109.227 -174.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -123.42 160.74 26.2 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.651 0.781 . . . . 0.0 111.724 -166.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -99.92 116.24 64.85 Favored Pre-proline 0 CA--C 1.537 0.475 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.505 -173.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -71.92 75.56 2.18 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.663 2.909 . . . . 0.0 111.66 -175.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -176.08 -44.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 127.08 2.152 . . . . 0.0 108.238 173.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.6 mt -75.94 -47.09 26.53 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 -178.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.1 tp -141.86 172.66 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.735 0 C-N-CA 124.976 1.31 . . . . 0.0 108.191 -177.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 60.4 p -138.44 158.61 43.94 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.608 1.163 . . . . 0.0 110.274 -175.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.6 t -41.09 -47.51 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.347 0.47 0 C-N-CA 123.976 0.91 . . . . 0.0 111.02 174.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.82 -40.88 94.4 Favored 'General case' 0 C--O 1.217 -0.646 0 CA-C-O 118.987 -0.53 . . . . 0.0 110.818 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -59.07 -50.74 72.92 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.089 -1.449 . . . . 0.0 107.089 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 61.9 mmm -54.02 -62.98 1.3 Allowed 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.408 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -55.79 -56.07 24.85 Favored 'General case' 0 C--O 1.218 -0.596 0 O-C-N 121.342 -0.849 . . . . 0.0 111.817 178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -52.81 -46.13 67.57 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -174.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -65.34 -42.23 93.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 120.454 -0.499 . . . . 0.0 111.789 177.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.7 mt -70.01 -64.95 0.69 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.197 0 O-C-N 121.679 -0.638 . . . . 0.0 109.929 -178.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -46.62 -37.76 8.64 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 119.003 0.82 . . . . 0.0 113.16 173.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.66 -31.22 57.3 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 119.611 1.096 . . . . 0.0 113.004 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 10.0 mmt -53.52 -43.7 68.53 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 118.434 0.561 . . . . 0.0 110.577 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.82 -23.84 2.13 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.232 0.92 . . . . 0.0 111.289 178.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -75.39 113.38 25.41 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-O 117.961 -1.019 . . . . 0.0 110.033 -171.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -65.99 138.58 53.02 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.244 1.296 . . . . 0.0 109.081 178.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.13 140.41 43.64 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 121.299 0.571 . . . . 0.0 111.812 -176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -112.19 76.21 0.96 Allowed 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.406 ' HA ' ' HB3' ' A' ' 7' ' ' MET . 1.9 p -62.01 109.38 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.293 1.037 . . . . 0.0 108.227 168.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 pttp -154.58 53.66 0.67 Allowed 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.413 ' NZ ' ' OE2' ' A' ' 74' ' ' GLU . 3.7 mtpt -155.53 162.87 40.6 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 125.551 1.54 . . . . 0.0 107.122 173.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.1 tp -153.82 60.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 124.574 1.149 . . . . 0.0 108.02 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' OE2' ' NZ ' ' A' ' 72' ' ' LYS . 0.6 OUTLIER -80.0 175.47 10.6 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 176.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.02 160.95 24.79 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 170.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 tmt_? . . . . . 0 C--O 1.25 1.087 0 C-N-CA 125.688 1.595 . . . . 0.0 110.048 -178.471 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.03 0 N-CA-C 107.701 -2.16 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -160.2 158.15 29.53 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.428 1.114 . . . . 0.0 108.161 -179.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 52.7 t -141.25 146.96 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 C-N-CA 125.678 1.591 . . . . 0.0 107.419 176.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -90.05 141.46 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 C-N-CA 124.615 1.166 . . . . 0.0 108.28 175.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.638 HD11 HG23 ' A' ' 70' ' ' VAL . 3.1 tm? -128.16 120.73 27.9 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.61 127.25 54.39 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 176.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.7 ptp -119.36 124.57 46.93 Favored 'General case' 0 N--CA 1.436 -1.14 0 C-N-CA 127.312 2.245 . . . . 0.0 108.837 174.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.427 ' HD2' ' N ' ' A' ' 9' ' ' VAL . 4.6 tptt -72.66 136.56 45.67 Favored 'General case' 0 C--O 1.222 -0.362 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 167.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.427 ' N ' ' HD2' ' A' ' 8' ' ' LYS . 9.3 m -121.11 157.33 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 119.075 0.852 . . . . 0.0 110.48 176.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -116.71 153.73 31.85 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 122.853 0.461 . . . . 0.0 110.572 174.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.28 -38.91 2.25 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.125 0.869 . . . . 0.0 112.866 171.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -58.97 93.36 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.049 0.94 . . . . 0.0 110.739 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.8 m -141.84 47.45 1.64 Allowed 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.832 1.253 . . . . 0.0 108.901 -178.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.5 p -155.16 159.46 40.17 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 164.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -69.23 -24.81 64.06 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 123.108 0.255 . . . . 0.0 111.46 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.9 m -57.43 -54.94 41.18 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 119.111 -0.471 . . . . 0.0 110.417 -178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.9 m -56.41 -57.16 13.49 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 118.117 0.417 . . . . 0.0 110.244 -179.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 63.2 p -55.61 -53.77 52.32 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 122.936 0.495 . . . . 0.0 110.318 -175.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 18.9 t -61.38 -41.03 96.45 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.521 0.728 . . . . 0.0 111.288 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 52.2 m -59.87 -48.11 83.02 Favored 'General case' 0 C--O 1.238 0.45 0 O-C-N 121.109 -0.995 . . . . 0.0 110.445 177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 17.0 mt -59.31 -52.25 63.04 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.984 0 C-N-CA 123.849 0.859 . . . . 0.0 108.72 176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -53.99 -46.08 71.63 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.598 0.759 . . . . 0.0 110.705 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.87 -49.28 72.14 Favored Glycine 0 CA--C 1.529 0.949 0 C-N-CA 124.24 0.924 . . . . 0.0 111.874 174.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -59.31 5.26 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 118.087 0.943 . . . . 0.0 110.759 178.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 mm -63.65 -30.38 49.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 C-N-CA 124.78 1.232 . . . . 0.0 110.755 -172.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.29 -31.66 4.79 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.738 0.685 . . . . 0.0 113.001 170.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -91.21 2.94 55.99 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.156 0.982 . . . . 0.0 112.453 -175.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 mt -70.64 133.11 46.38 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 120.549 1.522 . . . . 0.0 111.201 178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -77.55 65.14 3.01 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 178.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 170.07 22.94 0.02 OUTLIER Glycine 0 CA--C 1.523 0.573 0 N-CA-C 116.547 1.379 . . . . 0.0 116.547 176.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.8 p -111.4 154.41 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 117.77 0.785 . . . . 0.0 110.31 -172.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -115.75 -42.21 3.13 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.616 1.567 . . . . 0.0 109.771 -176.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.06 172.35 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 178.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.41 140.59 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.618 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 -176.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.7 mmtm -141.56 86.2 1.99 Allowed 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.0 0.92 . . . . 0.0 112.38 176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 44.9 t -89.71 112.63 24.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.528 -0.733 . . . . 0.0 109.944 -177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -91.55 176.02 6.7 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.933 0.893 . . . . 0.0 109.456 -178.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -139.05 -47.25 0.48 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.247 1.019 . . . . 0.0 110.292 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.43 -59.27 3.34 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.895 1.678 . . . . 0.0 110.442 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -88.6 9.5 23.82 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 114.819 -1.082 . . . . 0.0 110.82 -177.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER 46.58 64.93 1.34 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.532 1.933 . . . . 0.0 111.034 -177.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.9 mt-10 -145.73 152.21 39.22 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.763 0.825 . . . . 0.0 109.044 -165.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -141.77 123.65 15.29 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 121.387 0.613 . . . . 0.0 110.427 -178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.4 m -98.46 132.5 43.85 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 126.274 1.83 . . . . 0.0 107.847 171.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.9 mm -129.62 127.49 64.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 N-CA-C 104.82 -2.289 . . . . 0.0 104.82 169.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 4.2 t -115.65 118.4 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 -175.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -141.04 174.81 10.16 Favored 'General case' 0 CA--C 1.514 -0.428 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -165.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -109.17 109.02 60.69 Favored Pre-proline 0 N--CA 1.447 -0.604 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.875 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.48 77.62 1.7 Allowed 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 123.833 3.022 . . . . 0.0 110.92 -174.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.2 m170 -178.17 -41.27 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 128.299 2.64 . . . . 0.0 107.74 175.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 93.4 mt -77.98 -46.6 20.61 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.688 0.222 . . . . 0.0 111.348 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.44 161.45 34.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.729 0 N-CA-C 107.297 -1.371 . . . . 0.0 107.297 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 83.8 p -125.61 162.56 24.7 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.019 0.928 . . . . 0.0 111.181 -171.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.485 HG13 HG21 ' A' ' 70' ' ' VAL . 30.7 t -50.03 -43.96 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 124.232 1.013 . . . . 0.0 111.286 173.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -65.47 -37.7 87.62 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 117.821 -1.085 . . . . 0.0 109.139 -176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -56.54 -58.42 8.13 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 120.368 1.44 . . . . 0.0 108.387 173.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 30.9 mtt -43.55 -60.13 1.88 Allowed 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 173.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . 0.259 0.1 OUTLIER -64.16 -53.61 46.74 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-O 117.79 -1.1 . . . . 0.0 112.132 -175.22 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -42.0 -55.68 3.07 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 120.434 1.47 . . . . 0.0 109.576 172.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.6 mm-40 -59.86 -47.73 84.55 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 120.923 0.392 . . . . 0.0 111.243 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 96.9 mt -72.07 -63.7 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.452 0.701 . . . . 0.0 111.086 -175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -45.29 -39.24 6.36 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.879 0.763 . . . . 0.0 111.915 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.75 56.14 Favored 'General case' 0 C--N 1.344 0.352 0 CA-C-N 119.529 1.059 . . . . 0.0 112.84 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.4 mmt -57.56 -44.38 85.19 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.321 0.51 . . . . 0.0 110.812 173.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.44 -16.67 4.07 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.842 1.21 . . . . 0.0 111.023 -176.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -77.42 115.83 52.73 Favored Pre-proline 0 N--CA 1.452 -0.327 0 CA-C-O 118.194 -0.908 . . . . 0.0 109.547 -175.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -65.47 144.67 80.38 Favored 'Trans proline' 0 N--CA 1.45 -1.054 0 N-CA-C 108.117 -1.532 . . . . 0.0 108.117 172.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -142.39 132.47 24.57 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.896 0.855 . . . . 0.0 110.943 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.5 m-85 -98.02 69.94 2.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 127.944 2.498 . . . . 0.0 108.851 -176.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.638 HG23 HD11 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -62.01 107.9 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 123.831 0.852 . . . . 0.0 110.118 172.07 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -156.8 54.74 0.53 Allowed 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.34 67.44 0.46 Allowed 'General case' 0 C--O 1.227 -0.129 0 O-C-N 121.235 -0.915 . . . . 0.0 111.092 176.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 9.8 tp -78.79 69.22 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 123.236 0.614 . . . . 0.0 109.439 179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -107.68 132.29 53.49 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 123.779 0.831 . . . . 0.0 110.082 -172.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.53 164.52 41.71 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 174.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 . . . . . 0 C--O 1.254 1.323 0 CA-C-O 117.253 -1.356 . . . . 0.0 110.682 168.88 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.897 0 CA-C-O 118.263 -1.298 . . . . 0.0 111.387 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 40.48 78.69 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.054 1.341 . . . . 0.0 113.405 166.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.8 p -92.03 130.2 41.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 O-C-N 121.138 -0.976 . . . . 0.0 108.717 179.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -83.0 124.74 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 C-N-CA 124.912 1.285 . . . . 0.0 108.112 174.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.612 HD12 ' CG2' ' A' ' 70' ' ' VAL . 1.9 mm? -115.83 127.87 55.38 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 171.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -113.18 126.21 55.18 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.8 mtt -113.54 125.9 54.71 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 126.278 1.831 . . . . 0.0 107.895 176.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.69 126.14 30.21 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 164.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.4 m -115.57 154.73 16.97 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -120.09 153.47 36.08 Favored 'General case' 0 C--N 1.333 -0.113 0 C-N-CA 123.373 0.669 . . . . 0.0 109.723 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 66.67 47.83 65.79 Favored Glycine 0 CA--C 1.526 0.757 0 CA-C-N 116.34 -0.391 . . . . 0.0 112.703 168.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 66.9 mtm -143.46 109.64 5.34 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.52 1.128 . . . . 0.0 108.281 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -153.12 26.36 0.53 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.164 1.386 . . . . 0.0 110.859 175.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 8.6 p -112.66 -4.97 14.0 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.535 1.534 . . . . 0.0 112.101 -173.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 72.71 -46.99 0.66 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.52 1.528 . . . . 0.0 111.625 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 70.3 m -49.61 -55.64 12.86 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.617 0.767 . . . . 0.0 112.237 178.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 86.9 m -61.83 -54.53 40.94 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-N 118.637 0.653 . . . . 0.0 111.374 -176.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 11.0 p -53.34 -54.6 34.18 Favored 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 122.661 0.384 . . . . 0.0 110.084 178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.64 -44.18 93.59 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.083 0.553 . . . . 0.0 111.222 -179.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 72.6 m -59.81 -46.58 88.8 Favored 'General case' 0 C--O 1.232 0.15 0 O-C-N 121.446 -0.784 . . . . 0.0 110.197 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.683 HD11 ' CD2' ' A' ' 66' ' ' PHE . 3.8 mt -58.86 -50.78 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 176.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -51.03 -49.98 59.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 123.325 0.65 . . . . 0.0 110.832 177.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.6 -53.64 40.09 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 123.685 0.659 . . . . 0.0 111.693 175.249 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 8.1 tptt -64.67 -56.39 14.12 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-O 121.624 0.726 . . . . 0.0 110.288 -174.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 26.3 mm -68.86 -34.69 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 C-N-CA 123.704 0.802 . . . . 0.0 110.339 -173.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -52.45 -27.88 26.83 Favored Glycine 0 CA--C 1.531 1.074 0 O-C-N 121.83 -0.544 . . . . 0.0 112.6 170.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 tttt -90.38 3.45 53.72 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 118.117 0.959 . . . . 0.0 111.843 -178.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.3 mt -71.84 142.76 49.6 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 120.223 1.374 . . . . 0.0 110.211 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -78.2 133.5 37.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 170.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.92 -8.37 36.38 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 123.594 0.616 . . . . 0.0 112.146 177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.18 149.6 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 123.578 0.751 . . . . 0.0 109.596 176.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -108.16 -48.24 3.4 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 125.623 1.569 . . . . 0.0 109.467 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 ttp180 -157.66 169.53 24.44 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 107.343 -1.355 . . . . 0.0 107.343 -176.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.2 tt -157.6 137.73 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.495 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 -173.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 29.2 mmtt -140.81 92.46 2.5 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 123.783 0.833 . . . . 0.0 111.64 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 63.6 t -97.1 105.55 17.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 O-C-N 121.649 -0.657 . . . . 0.0 110.037 -174.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 2.2 m -85.06 161.76 19.58 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 124.15 0.98 . . . . 0.0 110.16 -179.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.3 pp -117.69 -48.16 2.59 Favored 'General case' 0 C--N 1.334 -0.074 0 C-N-CA 123.015 0.526 . . . . 0.0 111.211 172.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.83 -57.68 5.33 Favored 'General case' 0 CA--C 1.517 -0.315 0 C-N-CA 125.507 1.523 . . . . 0.0 110.51 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -95.35 22.56 6.74 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 114.317 -1.311 . . . . 0.0 110.466 -175.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.286 0.0 OUTLIER 28.15 70.72 0.06 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 129.143 2.977 . . . . 0.0 113.815 -174.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -138.16 142.34 40.09 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.204 1.402 . . . . 0.0 108.856 -168.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -125.06 111.8 15.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.52 1.128 . . . . 0.0 108.99 174.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 17.4 m -85.62 125.85 33.46 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.959 -1.497 . . . . 0.0 106.959 166.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 7.4 mm -124.86 127.62 72.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 168.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.19 113.59 43.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -174.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -129.94 172.26 11.89 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -171.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.6 tp-100 -100.09 111.33 62.01 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 124.69 1.196 . . . . 0.0 108.581 -179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.82 73.83 4.1 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.419 2.746 . . . . 0.0 110.517 -173.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.58 -46.51 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.74 2.016 . . . . 0.0 109.241 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.5 mp -79.27 -44.69 21.21 Favored 'General case' 0 C--N 1.338 0.084 0 O-C-N 122.602 -0.061 . . . . 0.0 111.136 -175.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -136.09 172.12 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -176.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 79.1 p -133.99 159.28 41.24 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.392 1.077 . . . . 0.0 110.511 -172.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 8.9 t -41.93 -48.97 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.285 0 C-N-CA 124.671 1.188 . . . . 0.0 111.611 173.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.05 -44.23 96.44 Favored 'General case' 0 C--O 1.212 -0.875 0 CA-C-O 118.28 -0.867 . . . . 0.0 109.341 -173.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -53.53 -53.19 55.09 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 119.769 1.168 . . . . 0.0 108.803 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 12.5 mtm -51.3 -60.3 3.28 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 118.23 0.468 . . . . 0.0 112.204 176.401 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -58.36 -55.29 36.92 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 121.391 -0.818 . . . . 0.0 111.939 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.7 tmtt? -45.93 -51.47 13.21 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 124.917 1.287 . . . . 0.0 109.158 177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.0 mm-40 -60.35 -46.52 89.64 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 117.663 0.21 . . . . 0.0 111.306 177.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.4 mt -68.35 -66.53 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.13 0 C-N-CA 123.757 0.823 . . . . 0.0 110.491 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -46.56 -37.94 8.74 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.667 -0.682 . . . . 0.0 112.594 174.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.16 -32.25 61.99 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 119.575 1.079 . . . . 0.0 112.692 177.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 5.7 mmt -57.7 -45.53 85.56 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 118.426 0.557 . . . . 0.0 110.523 172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 141.94 -20.42 2.51 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.349 0.976 . . . . 0.0 111.209 179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.683 ' CD2' HD11 ' A' ' 21' ' ' ILE . 59.8 m-85 -77.21 113.75 33.85 Favored Pre-proline 0 N--CA 1.453 -0.295 0 CA-C-O 118.223 -0.894 . . . . 0.0 109.803 -172.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.67 137.15 41.37 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 121.26 1.307 . . . . 0.0 108.714 177.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.91 132.87 35.08 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 121.264 0.554 . . . . 0.0 111.156 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -100.41 75.04 1.76 Allowed 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 124.923 1.289 . . . . 0.0 108.718 -179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.612 ' CG2' HD12 ' A' ' 5' ' ' LEU . 13.5 p -65.22 103.85 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 124.952 1.301 . . . . 0.0 110.796 172.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 52.5 pttt -157.13 58.51 0.52 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.547 ' O ' HD13 ' A' ' 5' ' ' LEU . 4.4 tptm -155.82 136.69 13.54 Favored 'General case' 0 C--O 1.225 -0.235 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 172.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.4 mt -135.47 83.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 105.995 -1.854 . . . . 0.0 105.995 177.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -134.41 70.26 1.45 Allowed 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 121.355 0.598 . . . . 0.0 109.676 -171.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -73.1 -172.33 22.82 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 121.851 -0.531 . . . . 0.0 113.123 -179.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 66.3 mtp180 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 116.386 -1.768 . . . . 0.0 109.825 164.384 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.782 0 N-CA-C 106.089 -2.804 . . . . 0.0 106.089 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 56.45 -147.76 0.51 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 118.095 0.948 . . . . 0.0 112.522 168.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.7 m -109.26 124.51 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -169.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -81.88 126.0 39.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 169.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.22 116.53 32.14 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 171.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 tptm -98.41 110.12 22.77 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.434 ' SD ' HD13 ' A' ' 45' ' ' ILE . 2.4 ptp -108.84 123.37 48.95 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 123.977 0.911 . . . . 0.0 108.748 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' NZ ' ' OE1' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -69.33 151.12 46.58 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 167.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.1 157.06 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 174.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -122.0 145.94 47.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 175.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 95.87 -30.62 8.2 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.379 0.99 . . . . 0.0 112.956 173.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 51.4 mtt -68.0 94.14 0.47 Allowed 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 118.086 0.943 . . . . 0.0 110.399 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.8 m -128.67 44.5 2.95 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.976 0.91 . . . . 0.0 109.011 178.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -166.41 155.51 11.15 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.989 1.316 . . . . 0.0 107.865 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -72.92 -21.97 60.81 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.291 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -53.42 -61.02 2.57 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.149 0.979 . . . . 0.0 111.708 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 30.5 m -59.75 -51.57 69.18 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.649 0.738 . . . . 0.0 109.966 -173.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 76.7 p -53.72 -56.35 18.14 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.693 -1.14 . . . . 0.0 109.971 179.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.0 t -56.11 -46.35 79.15 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.931 0.892 . . . . 0.0 111.824 176.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 47.0 m -54.73 -50.66 67.82 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.111 -0.993 . . . . 0.0 110.762 177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -59.24 -46.44 92.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 109.74 -0.466 . . . . 0.0 109.74 175.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -54.07 -45.76 71.82 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.474 0.71 . . . . 0.0 111.191 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.18 -56.7 22.86 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 123.804 0.716 . . . . 0.0 111.673 170.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 32.3 tptt -59.97 -57.34 13.27 Favored 'General case' 0 CA--C 1.529 0.161 0 O-C-N 122.094 -0.651 . . . . 0.0 111.146 -173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.411 HG21 HD12 ' A' ' 34' ' ' ILE . 43.5 mm -59.45 -43.5 90.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 C-N-CA 124.068 0.947 . . . . 0.0 110.468 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.94 -33.7 21.48 Favored Glycine 0 CA--C 1.532 1.106 0 CA-C-N 117.985 0.357 . . . . 0.0 112.403 173.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.3 ttmt -86.85 -4.13 59.14 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.281 1.032 . . . . 0.0 112.74 -177.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 12.3 mt -82.99 137.51 34.13 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 120.201 1.364 . . . . 0.0 111.104 177.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -71.76 123.2 22.09 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.297 174.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.23 -2.39 9.7 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 124.11 0.862 . . . . 0.0 112.592 172.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.4 p -91.52 159.08 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 C-N-CA 123.457 0.703 . . . . 0.0 110.796 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 mm-40 -117.58 -47.6 2.62 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 124.932 1.293 . . . . 0.0 110.835 178.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -165.26 168.66 16.76 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.411 HD12 HG21 ' A' ' 25' ' ' ILE . 12.4 tt -156.78 143.12 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.498 0 N-CA-C 104.562 -2.384 . . . . 0.0 104.562 -176.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -142.06 98.3 3.3 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 125.875 1.67 . . . . 0.0 111.586 173.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.5 t -98.72 126.76 51.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 C-N-CA 123.169 0.587 . . . . 0.0 111.534 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 18.0 m -117.04 140.14 49.85 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.676 1.19 . . . . 0.0 110.685 -178.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.9 -45.53 9.17 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.803 0.841 . . . . 0.0 111.037 -179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.16 -62.35 1.69 Allowed 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 125.687 1.595 . . . . 0.0 110.439 -171.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -89.78 14.75 11.11 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.426 -179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 31.4 58.71 0.29 Allowed 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.743 2.817 . . . . 0.0 113.746 -177.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.476 ' OE1' ' NZ ' ' A' ' 8' ' ' LYS . 28.4 tt0 -132.1 138.26 48.04 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.081 -178.031 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.51 119.17 32.18 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 125.824 1.65 . . . . 0.0 109.233 -173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.9 m -96.28 112.88 24.47 Favored 'General case' 0 CA--C 1.51 -0.584 0 C-N-CA 125.551 1.54 . . . . 0.0 108.712 179.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -116.23 119.46 61.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.5 t -108.43 117.79 54.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -141.54 165.42 27.53 Favored 'General case' 0 C--N 1.339 0.115 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -173.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -94.32 111.65 54.42 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 126.949 2.099 . . . . 0.0 110.947 -175.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -73.73 73.84 3.46 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.183 2.588 . . . . 0.0 111.995 -173.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -173.98 -46.01 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 127.144 2.178 . . . . 0.0 108.525 172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.7 mt -71.26 -42.46 68.75 Favored 'General case' 0 N--CA 1.458 -0.07 0 N-CA-C 111.532 0.197 . . . . 0.0 111.532 -173.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.42 -176.77 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -176.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.3 p -142.4 153.01 43.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.379 0.672 . . . . 0.0 109.948 -175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 42.2 t -38.1 -49.35 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.337 0 C-N-CA 124.987 1.315 . . . . 0.0 111.028 170.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.9 tm-20 -62.37 -46.64 87.74 Favored 'General case' 0 C--O 1.215 -0.717 0 CA-C-O 117.538 -1.22 . . . . 0.0 111.059 -173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -54.33 -50.71 66.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 120.976 1.716 . . . . 0.0 108.056 174.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 1.4 mtp -53.14 -59.08 5.0 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.07 -0.394 . . . . 0.0 111.005 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.4 ttmm -60.15 -55.71 30.49 Favored 'General case' 0 C--O 1.219 -0.506 0 O-C-N 120.888 -1.132 . . . . 0.0 112.88 178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -47.78 -42.43 25.73 Favored 'General case' 0 C--N 1.324 -0.53 0 C-N-CA 124.354 1.062 . . . . 0.0 109.874 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 68.8 mm-40 -66.45 -53.48 35.01 Favored 'General case' 0 CA--C 1.54 0.58 0 O-C-N 123.599 0.562 . . . . 0.0 111.944 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 72.0 mt -59.43 -62.71 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.069 -1.019 . . . . 0.0 110.897 -179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -52.51 -26.17 12.34 Favored 'General case' 0 N--CA 1.444 -0.731 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.39 -35.04 62.42 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.961 1.255 . . . . 0.0 112.496 171.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 22.0 mmt -58.39 -35.74 72.48 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.118 0.567 . . . . 0.0 110.656 175.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 128.17 -22.18 5.39 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.683 1.135 . . . . 0.0 110.462 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -70.03 116.26 42.34 Favored Pre-proline 0 N--CA 1.45 -0.465 0 CA-C-O 117.283 -1.342 . . . . 0.0 110.276 -176.039 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -64.52 151.18 86.55 Favored 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 121.356 1.371 . . . . 0.0 109.261 175.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -145.13 140.49 28.04 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -111.42 82.23 1.57 Allowed 'General case' 0 C--N 1.341 0.214 0 C-N-CA 124.326 1.051 . . . . 0.0 110.132 177.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 6.1 p -70.14 104.66 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 C-N-CA 125.583 1.553 . . . . 0.0 110.946 173.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -157.73 54.16 0.47 Allowed 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.3 mttt -158.67 104.6 1.79 Allowed 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 107.592 -1.262 . . . . 0.0 107.592 167.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -92.06 68.72 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -81.25 75.83 8.21 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 175.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.55 151.05 17.74 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 109.238 -1.545 . . . . 0.0 109.238 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.0 ptt-85 . . . . . 0 C--O 1.254 1.328 0 CA-C-O 116.017 -1.944 . . . . 0.0 106.056 -178.449 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.008 0 N-CA-C 107.711 -2.156 . . . . 0.0 107.711 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -49.38 142.71 7.29 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.647 1.179 . . . . 0.0 109.028 166.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.6 m -118.76 133.34 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.031 0 C-N-CA 123.574 0.75 . . . . 0.0 109.218 -178.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.51 HG23 HG22 ' A' ' 46' ' ' VAL . 1.4 p -82.1 116.72 26.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 C-N-CA 125.304 1.442 . . . . 0.0 108.094 174.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 5' ' ' LEU . 5.0 tt -96.86 120.56 37.42 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 104.054 -2.572 . . . . 0.0 104.054 174.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -114.35 118.76 34.78 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 4.1 ptp -113.77 138.92 49.59 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 125.403 1.481 . . . . 0.0 108.746 169.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -72.43 155.47 40.09 Favored 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 155.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -138.13 142.64 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 170.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -97.75 151.5 20.1 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.88 -34.78 2.11 Favored Glycine 0 CA--C 1.532 1.114 0 O-C-N 121.707 -0.621 . . . . 0.0 114.209 171.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 76.2 mtp -64.33 91.49 0.08 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 118.007 0.903 . . . . 0.0 111.746 -173.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 62.1 m -146.38 61.22 1.23 Allowed 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.421 1.488 . . . . 0.0 109.587 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.6 p -162.04 157.41 23.46 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 166.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 63.8 m80 -78.27 54.44 1.39 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 122.703 0.401 . . . . 0.0 110.103 174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -136.89 -64.07 0.59 Allowed 'General case' 0 N--CA 1.455 -0.193 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 176.004 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 20.1 m -56.19 -56.67 18.06 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.052 0.387 . . . . 0.0 110.79 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.8 t -51.53 -55.36 19.47 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.006 178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.2 t -59.87 -42.84 94.58 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.488 0.715 . . . . 0.0 110.77 -174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 86.1 m -56.01 -52.01 65.73 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -61.05 -48.27 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.229 178.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -55.63 -48.87 74.23 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 119.117 0.871 . . . . 0.0 110.582 -179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -53.47 -52.97 37.82 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 123.516 0.579 . . . . 0.0 111.665 172.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 3.9 tmtp? -65.95 -61.24 2.16 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.548 0.689 . . . . 0.0 110.655 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.8 mm -64.69 -32.68 59.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 124.589 1.156 . . . . 0.0 110.422 -173.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.89 -30.67 9.42 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 121.867 -0.521 . . . . 0.0 112.6 169.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -93.77 10.4 33.19 Favored 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 124.314 1.046 . . . . 0.0 112.217 -177.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 mt -71.03 151.87 44.14 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 120.243 1.383 . . . . 0.0 111.623 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -92.56 81.66 4.82 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.949 1.3 . . . . 0.0 110.614 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.93 -13.59 1.13 Allowed Glycine 0 CA--C 1.526 0.737 0 O-C-N 121.914 -0.491 . . . . 0.0 113.899 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 33.0 t -78.65 151.43 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 173.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 31.6 mm-40 -119.08 -35.1 3.7 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.628 1.171 . . . . 0.0 111.137 173.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 8.7 ttt180 -155.42 169.19 24.82 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 14.9 tt -156.98 139.16 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 N-CA-C 104.639 -2.356 . . . . 0.0 104.639 -174.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -139.85 90.66 2.41 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 125.422 1.489 . . . . 0.0 110.534 172.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 58.2 t -91.86 106.93 18.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 O-C-N 121.457 -0.777 . . . . 0.0 110.167 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.1 m -80.43 178.98 7.95 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.524 ' N ' HD23 ' A' ' 38' ' ' LEU . 0.4 OUTLIER -142.44 -47.37 0.34 Allowed 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.453 0.701 . . . . 0.0 109.534 179.407 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.05 -59.03 3.4 Favored 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 125.903 1.681 . . . . 0.0 110.541 178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -90.14 12.58 17.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.319 -176.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 43.77 62.72 1.82 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 126.659 1.984 . . . . 0.0 112.522 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -145.88 151.11 37.35 Favored 'General case' 0 N--CA 1.452 -0.344 0 O-C-N 121.511 -0.743 . . . . 0.0 109.345 -167.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -140.92 125.81 18.16 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 121.371 0.605 . . . . 0.0 111.149 -172.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.4 ' C ' HD12 ' A' ' 45' ' ' ILE . 3.4 m -107.55 120.69 42.9 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 126.803 2.041 . . . . 0.0 107.964 -178.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 44' ' ' THR . 3.8 mp -122.14 116.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 172.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.51 HG22 HG23 ' A' ' 4' ' ' VAL . 2.1 t -104.82 109.13 26.61 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -175.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -135.14 170.33 16.08 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-O 121.479 0.657 . . . . 0.0 112.367 -166.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -97.8 110.68 56.45 Favored Pre-proline 0 N--CA 1.444 -0.757 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.132 -177.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -76.51 67.06 7.23 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.139 2.56 . . . . 0.0 111.506 -174.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.66 -47.07 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.809 1.244 . . . . 0.0 108.37 177.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 10.3 mp -65.37 -48.23 73.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 117.633 0.197 . . . . 0.0 111.198 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.2 tp -134.25 162.83 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.802 1.241 . . . . 0.0 108.196 -173.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 74.4 p -121.87 158.64 28.52 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.747 1.219 . . . . 0.0 110.891 -172.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 25.3 t -43.73 -48.99 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.345 0.386 0 C-N-CA 124.1 0.96 . . . . 0.0 110.881 171.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -57.97 -54.13 50.46 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-O 118.109 -0.948 . . . . 0.0 110.766 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -45.03 -54.74 6.28 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 119.952 1.251 . . . . 0.0 109.365 175.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -54.59 -63.11 1.26 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.501 178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.2 tttp -55.39 -61.27 2.45 Favored 'General case' 0 C--O 1.215 -0.756 0 O-C-N 121.647 -0.658 . . . . 0.0 111.03 -179.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -43.07 -51.45 5.8 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 124.718 1.207 . . . . 0.0 109.703 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -64.08 -43.33 95.74 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 119.411 -0.916 . . . . 0.0 113.083 176.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.0 mt -69.01 -65.85 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 123.445 0.698 . . . . 0.0 110.278 -178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -43.79 -39.27 3.69 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 118.378 -0.82 . . . . 0.0 112.507 171.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.13 -31.2 61.09 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.798 1.181 . . . . 0.0 112.958 178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.6 mmt -55.37 -40.8 71.76 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.317 0.508 . . . . 0.0 110.841 172.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.08 -20.16 3.22 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 124.587 1.089 . . . . 0.0 110.954 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 53.3 m-85 -75.57 115.7 48.18 Favored Pre-proline 0 N--CA 1.453 -0.297 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.255 -172.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -66.55 138.48 50.05 Favored 'Trans proline' 0 N--CA 1.451 -1.027 0 N-CA-C 108.31 -1.458 . . . . 0.0 108.31 174.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.47 138.39 38.07 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.045 0.538 . . . . 0.0 110.595 -175.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -107.05 71.39 0.83 Allowed 'General case' 0 C--N 1.334 -0.066 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.7 p -59.45 105.4 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 124.288 1.035 . . . . 0.0 110.375 169.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 3.6 pttp -155.58 55.31 0.62 Allowed 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 175.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 141.26 16.77 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 171.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -138.43 86.27 0.52 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 N-CA-C 105.027 -2.212 . . . . 0.0 105.027 170.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.53 169.47 9.88 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 171.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.1 -155.73 15.57 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.652 -0.979 . . . . 0.0 110.652 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.125 0 N-CA-C 102.577 -3.12 . . . . 0.0 102.577 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.14 0 N-CA-C 108.899 -1.681 . . . . 0.0 108.899 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.4 mm-40 -73.77 -176.86 2.56 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.754 0.822 . . . . 0.0 109.837 172.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.6 t -90.09 116.0 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 174.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.2 t -90.91 124.4 43.46 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.85 131.86 56.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 174.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.2 tptt -114.06 117.09 30.3 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 106.745 -1.576 . . . . 0.0 106.745 -178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 2.3 mtt -116.82 123.57 47.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 123.913 0.885 . . . . 0.0 110.505 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.87 129.47 37.95 Favored 'General case' 0 CA--C 1.519 -0.233 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 169.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.3 m -115.93 151.36 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.032 0.833 . . . . 0.0 109.668 177.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -111.85 140.67 46.31 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.354 0.597 . . . . 0.0 110.28 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 86.1 -16.06 45.24 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.266 0.936 . . . . 0.0 114.206 168.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 57.2 mtp -76.62 75.7 3.3 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.3 1.05 . . . . 0.0 110.866 -177.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -112.4 34.42 4.33 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.464 1.505 . . . . 0.0 111.334 -172.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 21.2 p -154.1 158.7 40.85 Favored 'General case' 0 C--O 1.237 0.406 0 O-C-N 121.516 -0.74 . . . . 0.0 110.404 172.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.3 m80 -74.9 61.36 1.03 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.74 0.816 . . . . 0.0 109.306 167.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 13.7 t -145.88 -63.38 0.32 Allowed 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 167.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 22.4 m -52.96 -53.59 47.56 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-O 121.298 0.571 . . . . 0.0 109.952 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.4 p -53.04 -70.16 0.1 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.725 1.21 . . . . 0.0 110.742 177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.0 t -51.3 -45.52 62.2 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.679 1.592 . . . . 0.0 111.506 -175.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 63.2 m -60.26 -44.93 94.87 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 121.889 -0.507 . . . . 0.0 109.944 178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -60.95 -49.22 85.58 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 CA-C-N 118.617 0.644 . . . . 0.0 110.189 173.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -48.58 -51.67 26.65 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.656 0.662 . . . . 0.0 109.882 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.61 -58.33 15.13 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 123.87 0.748 . . . . 0.0 112.614 175.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 6.3 tptm -64.36 -52.44 58.3 Favored 'General case' 0 C--N 1.338 0.109 0 O-C-N 121.651 -0.911 . . . . 0.0 109.953 -170.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 24.6 mm -70.02 -27.19 31.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 C-N-CA 124.308 1.043 . . . . 0.0 109.751 -176.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -51.72 -32.55 32.89 Favored Glycine 0 CA--C 1.534 1.221 0 O-C-N 120.986 -1.071 . . . . 0.0 112.492 166.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -84.74 -1.36 56.16 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 -167.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -69.97 154.12 42.36 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 120.435 1.471 . . . . 0.0 112.326 176.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -82.91 69.4 9.71 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -178.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 169.01 18.72 0.02 OUTLIER Glycine 0 N--CA 1.467 0.756 0 N-CA-C 115.373 0.909 . . . . 0.0 115.373 178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 21.4 t -112.17 141.34 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 118.852 1.326 . . . . 0.0 108.664 -167.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.6 mm100 -111.85 -45.06 3.37 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.363 0.665 . . . . 0.0 109.94 -178.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -147.21 166.99 25.32 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.3 tt -155.71 131.86 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 N-CA-C 104.229 -2.508 . . . . 0.0 104.229 177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.439 ' HD3' ' HA ' ' A' ' 35' ' ' LYS . 5.6 mmtt -139.24 129.79 25.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 124.572 1.149 . . . . 0.0 109.695 -177.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.8 t -119.43 98.4 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-N 119.234 0.925 . . . . 0.0 110.011 177.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.4 m -72.7 74.03 1.09 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 125.224 1.41 . . . . 0.0 109.464 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 1.6 tt -37.39 -49.22 0.99 Allowed 'General case' 0 C--O 1.227 -0.091 0 C-N-CA 126.351 1.86 . . . . 0.0 111.664 173.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.87 -55.94 8.67 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 125.103 1.361 . . . . 0.0 111.562 -174.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.65 -2.99 58.45 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.654 -178.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 54.29 54.62 9.23 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 127.814 2.446 . . . . 0.0 110.443 -173.106 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.19 136.34 54.71 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.762 1.225 . . . . 0.0 109.543 -177.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -108.61 106.88 17.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 126.53 1.932 . . . . 0.0 109.742 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 95.9 m -81.45 87.26 6.21 Favored 'General case' 0 C--N 1.33 -0.262 0 C-N-CA 129.007 2.923 . . . . 0.0 109.382 170.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.1 mm -90.61 125.21 43.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 11.0 t -123.74 99.68 6.8 Favored 'Isoleucine or valine' 0 C--N 1.346 0.417 0 CA-C-N 119.659 1.118 . . . . 0.0 110.333 -173.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.5 p90 -118.24 159.97 22.42 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 -174.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.98 131.04 55.2 Favored Pre-proline 0 N--CA 1.447 -0.576 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 171.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -62.44 163.6 20.33 Favored 'Trans proline' 0 N--CA 1.449 -1.147 0 C-N-CA 121.18 1.253 . . . . 0.0 109.091 174.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 73.62 -42.39 0.52 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.57 1.148 . . . . 0.0 112.477 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.9 mt -70.11 -48.93 55.47 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.609 1.095 . . . . 0.0 111.499 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -141.78 179.68 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 C-N-CA 125.412 1.485 . . . . 0.0 108.338 -176.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.0 p -148.8 164.16 35.24 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 118.527 0.603 . . . . 0.0 111.519 -174.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 50.9 t -46.15 -45.48 5.86 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 C-N-CA 123.768 0.827 . . . . 0.0 111.284 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.6 tp10 -62.53 -42.64 99.65 Favored 'General case' 0 C--O 1.217 -0.617 0 CA-C-O 118.766 -0.635 . . . . 0.0 110.488 -174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.84 -54.42 45.34 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 23.1 mmt -45.27 -65.08 0.58 Allowed 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 112.735 0.643 . . . . 0.0 112.735 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -56.64 -57.2 13.4 Favored 'General case' 0 C--O 1.219 -0.528 0 O-C-N 121.312 -0.868 . . . . 0.0 111.761 -178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 tmtt? -46.32 -47.44 18.43 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 118.956 0.798 . . . . 0.0 109.635 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -66.32 -42.63 87.95 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 177.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 64.6 mt -69.15 -65.02 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.135 0 C-N-CA 124.409 1.084 . . . . 0.0 110.044 -179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -45.36 -39.83 7.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 123.304 0.642 . . . . 0.0 111.833 173.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.5 -33.02 59.08 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 119.398 0.999 . . . . 0.0 113.344 177.687 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.6 mmt -58.03 -41.73 83.81 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.6 0.636 . . . . 0.0 110.506 173.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.87 -16.68 3.48 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 124.62 1.105 . . . . 0.0 111.06 178.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 47.0 m-85 -82.05 117.01 66.79 Favored Pre-proline 0 N--CA 1.45 -0.428 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.542 -173.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -64.68 151.56 85.21 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 N-CA-C 108.901 -1.231 . . . . 0.0 108.901 173.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -144.04 139.11 28.79 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 122.944 0.498 . . . . 0.0 110.517 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -108.43 75.5 0.98 Allowed 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.885 0.874 . . . . 0.0 108.758 179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.3 p -63.03 105.54 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 C-N-CA 124.081 0.952 . . . . 0.0 110.756 171.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 55.9 pttt -155.74 56.71 0.61 Allowed 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 177.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.44 144.35 20.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 168.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.1 mp -132.63 64.13 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 N-CA-C 105.436 -2.061 . . . . 0.0 105.436 174.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -83.93 91.03 7.5 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -175.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.46 -172.09 19.35 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 111.725 -0.55 . . . . 0.0 111.725 -173.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 7.5 mmt180 . . . . . 0 C--O 1.252 1.22 0 CA-C-O 116.607 -1.664 . . . . 0.0 107.638 173.27 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.927 0 N-CA-C 108.115 -1.994 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.443 ' HB2' HG12 ' A' ' 46' ' ' VAL . 0.9 OUTLIER -177.02 153.3 0.98 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -158.02 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 20.4 m -128.1 128.27 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 124.252 1.021 . . . . 0.0 108.755 174.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -84.14 110.94 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 C-N-CA 126.099 1.76 . . . . 0.0 109.816 -178.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.8 tp -90.91 117.97 29.93 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 176.055 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.0 tptt -84.42 126.87 33.64 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 171.713 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 28.4 mtp -128.51 128.05 43.59 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 172.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.66 112.9 25.01 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 119.283 0.947 . . . . 0.0 108.553 172.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 m -90.97 165.44 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 178.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -121.07 152.24 38.88 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 174.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 80.18 -33.04 2.24 Favored Glycine 0 CA--C 1.532 1.147 0 O-C-N 121.57 -0.706 . . . . 0.0 114.143 165.139 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 56.1 mtp -65.14 82.74 0.05 OUTLIER 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 117.935 0.867 . . . . 0.0 112.024 -179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.3 m -114.34 48.89 1.06 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.062 1.345 . . . . 0.0 110.482 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.8 p -159.4 163.97 35.02 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 121.571 -0.706 . . . . 0.0 110.834 169.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -63.91 -35.41 80.55 Favored 'General case' 0 N--CA 1.455 -0.182 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.979 174.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.2 m -58.33 -58.04 10.26 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 118.576 0.625 . . . . 0.0 111.487 -173.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.2 m -57.76 -57.66 11.79 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.254 0.55 . . . . 0.0 110.393 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 40.9 p -51.85 -57.1 10.33 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.622 1.169 . . . . 0.0 110.196 -177.646 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.3 t -59.53 -44.48 93.18 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.823 0.849 . . . . 0.0 111.302 179.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 51.9 m -57.26 -48.45 78.85 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.435 -0.791 . . . . 0.0 110.243 178.642 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.2 mt -61.46 -48.86 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 C-N-CA 123.031 0.532 . . . . 0.0 109.578 178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.69 -49.73 56.66 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.251 0.62 . . . . 0.0 110.36 176.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.15 -55.41 28.38 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 123.96 0.791 . . . . 0.0 111.532 175.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 tttp -64.0 -55.02 25.36 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 122.016 -0.696 . . . . 0.0 110.963 -173.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.1 mm -67.39 -33.76 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 123.61 0.764 . . . . 0.0 110.13 -176.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.44 -35.63 7.25 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 123.361 0.505 . . . . 0.0 112.399 171.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -83.48 4.27 28.57 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 -176.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.1 mt -72.76 139.72 47.3 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.735 1.607 . . . . 0.0 112.06 -178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -78.93 81.83 5.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 123.726 0.81 . . . . 0.0 111.612 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 150.19 -8.54 0.79 Allowed Glycine 0 CA--C 1.525 0.681 0 N-CA-C 114.283 0.473 . . . . 0.0 114.283 -178.516 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.5 p -79.07 152.15 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 117.726 0.763 . . . . 0.0 110.244 175.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -113.58 -37.22 4.67 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 125.246 1.419 . . . . 0.0 110.333 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 21.3 ttm105 -160.57 159.16 30.24 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 15.3 tt -152.8 137.25 9.48 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 104.497 -2.408 . . . . 0.0 104.497 -175.052 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 19.4 mmtp -143.13 150.83 39.98 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.569 1.148 . . . . 0.0 109.754 177.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 53.0 t -134.65 128.96 51.59 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-N 118.613 0.642 . . . . 0.0 109.419 171.127 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.5 m -110.69 79.8 1.24 Allowed 'General case' 0 C--O 1.233 0.22 0 C-N-CA 125.739 1.615 . . . . 0.0 108.271 -177.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.36 -41.7 66.09 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.044 0.537 . . . . 0.0 110.575 -175.429 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.7 -54.72 5.94 Favored 'General case' 0 CA--C 1.515 -0.379 0 C-N-CA 126.659 1.984 . . . . 0.0 111.054 -179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -98.76 16.62 21.62 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.029 -174.774 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 35.66 53.82 0.84 Allowed 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 128.354 2.662 . . . . 0.0 113.12 -169.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -114.72 149.27 37.09 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 124.586 1.154 . . . . 0.0 109.704 -177.133 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -127.4 134.77 49.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 125.294 1.438 . . . . 0.0 108.823 171.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 60.8 m -117.34 109.77 17.23 Favored 'General case' 0 CA--C 1.516 -0.335 0 C-N-CA 128.668 2.787 . . . . 0.0 107.011 -173.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 31.1 mm -119.32 102.86 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -176.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 2' ' ' GLU . 2.3 t -99.02 107.96 21.45 Favored 'Isoleucine or valine' 0 C--O 1.232 0.182 0 N-CA-C 108.731 -0.841 . . . . 0.0 108.731 -174.615 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -128.9 167.3 17.6 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -170.53 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -100.25 112.17 63.73 Favored Pre-proline 0 N--CA 1.449 -0.502 0 CA-C-O 118.761 -0.638 . . . . 0.0 109.554 -178.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.4 69.47 5.84 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 123.924 3.083 . . . . 0.0 111.533 -170.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -169.86 -40.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 127.854 2.462 . . . . 0.0 108.158 179.044 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -83.54 -45.46 13.53 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 111.853 0.316 . . . . 0.0 111.853 -174.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -140.46 158.2 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 C-N-CA 125.203 1.401 . . . . 0.0 107.573 -174.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 91.4 p -106.28 161.97 14.07 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.764 0.826 . . . . 0.0 112.479 -173.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 55.6 t -53.17 -39.7 35.21 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 N-CA-C 109.805 -0.442 . . . . 0.0 109.805 163.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.8 -47.86 81.62 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-O 118.995 -0.526 . . . . 0.0 110.15 -178.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -50.41 -55.14 17.06 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 120.022 1.283 . . . . 0.0 109.762 173.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 17.5 mmt -48.5 -63.47 1.07 Allowed 'General case' 0 N--CA 1.445 -0.707 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.36 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 18.6 tttt -57.95 -57.86 10.96 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 121.259 -0.9 . . . . 0.0 112.329 -178.186 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tttp -46.76 -50.76 17.66 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.225 1.01 . . . . 0.0 108.31 -179.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 12.3 mm-40 -57.92 -48.12 80.85 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 120.169 -0.612 . . . . 0.0 111.987 176.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 47.8 mt -68.81 -65.56 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 CA-C-O 118.562 -0.733 . . . . 0.0 111.467 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -46.87 -35.78 6.77 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 120.003 1.274 . . . . 0.0 112.381 175.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.2 -31.61 61.55 Favored 'General case' 0 C--N 1.345 0.401 0 CA-C-N 119.736 1.153 . . . . 0.0 113.155 177.234 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 17.6 mmt -55.05 -41.52 71.55 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-N 118.396 0.544 . . . . 0.0 110.585 172.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 135.47 -18.95 3.85 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 124.886 1.232 . . . . 0.0 110.95 -179.817 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 44.1 m-85 -75.53 117.92 67.01 Favored Pre-proline 0 N--CA 1.452 -0.364 0 CA-C-O 118.42 -0.8 . . . . 0.0 109.979 -173.273 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -66.32 140.21 57.58 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 N-CA-C 108.495 -1.386 . . . . 0.0 108.495 175.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.2 130.9 27.4 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.813 0.816 . . . . 0.0 112.469 -177.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -88.84 75.82 8.05 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.331 1.052 . . . . 0.0 108.553 176.762 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -42.69 104.18 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 O-C-N 125.029 1.456 . . . . 0.0 109.261 158.739 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.5 mmtp -93.67 -179.51 5.04 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 169.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.24 168.08 20.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.177 -1.374 . . . . 0.0 108.882 170.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 27.3 pt -78.39 151.34 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.681 0.792 . . . . 0.0 110.106 178.358 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -110.29 100.03 8.97 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.809 0.844 . . . . 0.0 108.819 170.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.22 143.81 21.33 Favored Glycine 0 CA--C 1.527 0.817 0 N-CA-C 108.09 -2.004 . . . . 0.0 108.09 164.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.5 tpt180 . . . . . 0 C--O 1.254 1.299 0 CA-C-O 115.923 -1.989 . . . . 0.0 106.073 -178.41 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.417 0 CA-C-O 118.978 -0.901 . . . . 0.0 113.67 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.78 124.88 17.36 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -179.027 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.0 m -125.61 123.83 65.43 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 CA-C-N 119.258 0.935 . . . . 0.0 109.865 174.043 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.447 HG23 HG22 ' A' ' 46' ' ' VAL . 1.3 p -80.82 105.9 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.808 1.643 . . . . 0.0 109.82 -178.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.02 109.09 20.85 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -177.565 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' NZ ' ' OE1' ' A' ' 74' ' ' GLU . 1.4 mptm? -87.1 113.16 22.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 176.49 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -120.18 125.18 47.55 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 172.923 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.446 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.4 mptp? -81.02 125.41 30.13 Favored 'General case' 0 C--O 1.225 -0.189 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 173.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 m -106.78 148.04 11.52 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.243 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 177.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -109.9 155.0 22.28 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.37 -46.67 3.59 Favored Glycine 0 CA--C 1.528 0.866 0 O-C-N 121.765 -0.584 . . . . 0.0 112.587 169.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 83.5 mtp -55.26 96.25 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.914 1.286 . . . . 0.0 110.96 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 p -136.6 31.79 2.8 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.946 0.898 . . . . 0.0 111.776 -174.093 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -155.16 149.62 26.21 Favored 'General case' 0 C--O 1.234 0.286 0 O-C-N 121.668 -0.645 . . . . 0.0 110.673 179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.6 m170 -72.33 60.26 0.44 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.435 1.494 . . . . 0.0 110.722 175.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 24.4 m -142.45 -59.96 0.45 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.235 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.3 m -58.83 -60.94 3.04 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.475 0.71 . . . . 0.0 110.025 -177.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 12.4 t -53.5 -49.06 68.32 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.915 -1.039 . . . . 0.0 109.935 -179.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 13.2 t -66.75 -41.12 88.32 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.022 0.929 . . . . 0.0 111.104 -175.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 64.4 m -59.28 -47.85 83.82 Favored 'General case' 0 C--O 1.237 0.395 0 O-C-N 121.366 -0.834 . . . . 0.0 109.332 176.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.96 -52.95 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 CA-C-O 118.662 -0.685 . . . . 0.0 109.738 175.503 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -51.88 -49.06 63.71 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.228 0.922 . . . . 0.0 111.169 179.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.85 -47.06 91.29 Favored Glycine 0 CA--C 1.529 0.951 0 C-N-CA 123.865 0.745 . . . . 0.0 112.054 176.211 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.97 -60.59 2.69 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 118.245 1.023 . . . . 0.0 110.178 -179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.5 mm -64.93 -33.79 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 C-N-CA 124.077 0.951 . . . . 0.0 110.654 -171.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.0 -30.59 9.58 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 123.812 0.72 . . . . 0.0 112.99 172.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -91.33 6.81 43.84 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 118.279 1.04 . . . . 0.0 112.359 -176.146 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.2 mt -77.33 151.81 34.77 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 120.522 -1.361 . . . . 0.0 112.746 177.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -92.62 82.57 4.81 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.759 1.223 . . . . 0.0 111.493 -174.474 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 145.61 -10.31 1.68 Allowed Glycine 0 N--CA 1.462 0.368 0 O-C-N 121.947 -0.47 . . . . 0.0 113.722 -175.571 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 87.4 t -78.99 142.43 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 169.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mm-40 -102.58 -42.75 5.83 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.011 1.324 . . . . 0.0 109.524 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 23.7 ttm-85 -155.79 165.88 35.19 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 177.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.2 tt -152.88 135.79 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 104.156 -2.535 . . . . 0.0 104.156 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.0 mmtp -137.88 88.01 2.29 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 125.189 1.396 . . . . 0.0 111.051 168.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 25.3 t -87.91 115.98 29.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.387 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 3.2 m -87.46 -163.16 0.89 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.488 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 pt? -155.33 -48.79 0.08 Allowed 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.33 1.052 . . . . 0.0 109.451 173.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.42 -59.07 4.37 Favored 'General case' 0 CA--C 1.517 -0.296 0 C-N-CA 125.116 1.366 . . . . 0.0 110.339 -176.992 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.82 11.54 15.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.471 -177.415 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 39.65 61.82 1.33 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.121 1.768 . . . . 0.0 112.788 -178.354 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 26.5 tt0 -139.78 153.03 47.04 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 175.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -129.16 126.23 38.79 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 124.728 1.211 . . . . 0.0 109.061 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.0 m -101.33 117.8 35.69 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.794 1.637 . . . . 0.0 106.983 174.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 12.5 mm -119.72 106.92 19.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 173.357 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.447 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -100.34 102.94 14.11 Favored 'Isoleucine or valine' 0 C--O 1.231 0.106 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -174.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 29.6 p90 -124.33 173.02 8.66 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -172.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -104.27 111.41 65.17 Favored Pre-proline 0 N--CA 1.448 -0.539 0 C-N-CA 123.941 0.896 . . . . 0.0 109.92 -177.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -74.2 76.76 2.97 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 123.709 2.939 . . . . 0.0 110.321 -172.767 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.54 -42.46 0.01 OUTLIER 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 126.395 1.878 . . . . 0.0 108.369 179.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 5.8 mp -82.8 -44.12 15.91 Favored 'General case' 0 N--CA 1.457 -0.117 0 CA-C-O 119.871 -0.109 . . . . 0.0 110.975 -177.028 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -139.2 154.17 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 124.888 1.275 . . . . 0.0 108.47 -174.133 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.3 p -108.59 162.96 13.66 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.36 1.064 . . . . 0.0 112.244 -173.196 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 47.6 t -48.22 -45.92 13.36 Favored 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 123.481 0.712 . . . . 0.0 110.373 165.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.43 -44.02 92.51 Favored 'General case' 0 C--O 1.216 -0.684 0 CA-C-O 118.627 -0.701 . . . . 0.0 109.878 -175.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -51.6 -54.59 26.14 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 120.529 1.513 . . . . 0.0 109.807 171.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 14.9 mmt -48.13 -62.53 1.43 Allowed 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 118.918 0.781 . . . . 0.0 111.868 175.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 11.9 tttt -62.07 -57.61 10.95 Favored 'General case' 0 C--O 1.22 -0.499 0 O-C-N 121.424 -0.797 . . . . 0.0 113.074 -176.879 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -47.43 -48.13 26.52 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 124.257 1.023 . . . . 0.0 109.25 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.8 mm-40 -59.39 -48.23 82.45 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 119.834 -0.746 . . . . 0.0 111.71 174.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.4 mt -68.13 -65.3 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.12 0 CA-C-O 118.978 -0.534 . . . . 0.0 111.726 -176.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -51.98 -30.22 24.01 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 119.423 1.01 . . . . 0.0 112.573 177.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.05 62.92 Favored 'General case' 0 C--N 1.345 0.38 0 CA-C-N 120.014 1.279 . . . . 0.0 112.845 174.459 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.3 mmt -58.44 -40.73 83.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.541 0.609 . . . . 0.0 110.578 173.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.01 -21.62 3.32 Favored Glycine 0 CA--C 1.526 0.769 0 C-N-CA 124.537 1.065 . . . . 0.0 110.914 177.895 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -73.09 116.76 53.93 Favored Pre-proline 0 N--CA 1.451 -0.388 0 CA-C-O 118.345 -0.835 . . . . 0.0 110.14 -173.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -67.02 141.89 59.74 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 121.463 1.442 . . . . 0.0 108.679 176.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -139.55 134.98 32.93 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -179.631 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -98.29 74.71 2.22 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 124.472 1.109 . . . . 0.0 108.309 175.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -36.03 106.95 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 O-C-N 125.297 1.623 . . . . 0.0 108.775 154.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.49 179.93 4.69 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 168.7 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.0 pttt -78.91 166.42 22.42 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 113.728 -1.578 . . . . 0.0 108.267 176.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 25.5 pt -78.21 148.97 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.934 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.443 177.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.406 ' OE1' ' NZ ' ' A' ' 6' ' ' LYS . 41.8 mt-10 -106.15 166.41 10.53 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 107.059 -1.459 . . . . 0.0 107.059 170.083 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.12 -62.28 0.02 OUTLIER Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 -164.707 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 82.2 mtm180 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 143.775 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.423 0 N-CA-C 108.587 -1.805 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.45 171.98 0.07 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 115.237 -0.481 . . . . 0.0 110.823 135.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.5 m -124.29 142.29 41.58 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.06 0 C-N-CA 126.15 1.78 . . . . 0.0 108.195 172.479 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -99.27 132.58 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 C-N-CA 126.024 1.73 . . . . 0.0 107.915 175.186 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.737 HD21 HG23 ' A' ' 70' ' ' VAL . 3.3 tm? -112.61 129.56 56.34 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.421 -2.066 . . . . 0.0 105.421 169.099 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.8 tptp -117.96 127.2 53.6 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.433 ' CB ' ' HA ' ' A' ' 70' ' ' VAL . 12.5 ptm -139.43 129.3 24.84 Favored 'General case' 0 N--CA 1.44 -0.961 0 C-N-CA 123.117 0.567 . . . . 0.0 109.865 -173.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -73.06 133.88 44.37 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.3 m -118.86 150.53 21.14 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 173.451 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -116.15 151.23 36.07 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 121.145 0.498 . . . . 0.0 110.761 177.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 89.03 -34.3 3.98 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.094 0.854 . . . . 0.0 112.816 173.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 64.4 mtp -66.53 94.65 0.29 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 117.633 0.717 . . . . 0.0 111.6 -178.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.692 ' HA ' HD13 ' A' ' 38' ' ' LEU . 36.7 p -126.2 53.28 1.63 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.107 0.963 . . . . 0.0 111.465 -178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.12 167.51 30.2 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.697 0.799 . . . . 0.0 109.044 -175.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -84.28 -6.02 59.34 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 122.667 0.387 . . . . 0.0 111.486 169.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -81.1 -74.75 0.31 Allowed 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 -172.155 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 62.8 m -51.39 -45.24 62.41 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.097 1.359 . . . . 0.0 111.589 -177.044 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.0 p -49.38 -63.78 1.0 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.485 1.514 . . . . 0.0 110.511 173.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 33.5 t -55.33 -45.37 76.39 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.906 0.882 . . . . 0.0 111.123 177.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.0 m -55.3 -47.94 74.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.244 -0.91 . . . . 0.0 110.994 177.409 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 5.3 mt -61.23 -50.89 78.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 124.139 0.976 . . . . 0.0 109.201 177.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -45.39 -53.05 9.17 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.566 1.146 . . . . 0.0 110.289 174.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.31 -58.32 15.03 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 123.793 0.711 . . . . 0.0 112.672 174.845 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tptt -56.94 -48.19 78.88 Favored 'General case' 0 C--N 1.337 0.062 0 O-C-N 121.936 -0.744 . . . . 0.0 110.846 -171.277 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.3 mm -70.73 -42.04 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.283 0.633 . . . . 0.0 109.441 178.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.68 -35.41 23.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.248 0.451 . . . . 0.0 112.412 172.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.4 ttpt -63.28 -18.0 63.11 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 179.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mt -84.97 142.5 29.59 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 119.207 0.912 . . . . 0.0 112.544 -173.475 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -74.89 101.43 4.41 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.364 -179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 147.97 -21.54 1.43 Allowed Glycine 0 C--N 1.335 0.511 0 O-C-N 121.554 -0.716 . . . . 0.0 113.274 176.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.96 132.77 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.636 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.338 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -102.59 -29.55 11.49 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 117.995 0.361 . . . . 0.0 111.403 175.808 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.1 ttt85 -154.08 164.63 38.17 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 176.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.6 tt -157.92 144.97 9.22 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.49 0 N-CA-C 103.914 -2.624 . . . . 0.0 103.914 -176.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -144.13 132.41 21.92 Favored 'General case' 0 N--CA 1.448 -0.525 0 C-N-CA 123.893 0.877 . . . . 0.0 111.254 179.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 17.6 t -125.76 136.55 60.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 CA-C-N 119.935 1.243 . . . . 0.0 111.701 175.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 41.7 m -122.12 124.36 43.71 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.204 1.801 . . . . 0.0 110.147 -177.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.692 HD13 ' HA ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -79.01 -51.23 9.88 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.65 0.78 . . . . 0.0 110.723 -177.557 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -51.93 -53.03 45.8 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.557 1.143 . . . . 0.0 110.557 -172.112 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -85.61 4.11 37.72 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.48 -177.778 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 38.86 61.56 1.21 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.273 2.629 . . . . 0.0 111.371 -174.888 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -141.85 138.14 31.92 Favored 'General case' 0 C--N 1.34 0.155 0 O-C-N 121.734 -0.604 . . . . 0.0 110.903 -173.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -107.75 147.98 30.08 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 125.556 1.542 . . . . 0.0 110.003 172.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 89.6 m -121.71 125.51 46.77 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 130.706 3.602 . . . . 0.0 104.928 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 5.3 mm -126.44 119.71 54.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.5 t -111.81 96.68 4.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -172.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 15.6 p90 -122.64 168.47 12.14 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-O 121.709 0.766 . . . . 0.0 111.989 -170.076 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 10.9 tm0? -97.02 115.29 65.68 Favored Pre-proline 0 N--CA 1.445 -0.691 0 C-N-CA 125.048 1.339 . . . . 0.0 108.514 -175.101 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.9 72.3 3.94 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.879 2.386 . . . . 0.0 111.909 -174.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.14 -46.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 125.304 1.442 . . . . 0.0 108.295 172.345 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 16.8 mt -67.32 -48.92 66.17 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 119.643 -0.218 . . . . 0.0 111.36 179.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -138.84 177.81 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 124.825 1.25 . . . . 0.0 109.334 -174.205 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.1 p -141.51 160.12 40.8 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.347 1.059 . . . . 0.0 111.244 -174.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 HG22 HD23 ' A' ' 5' ' ' LEU . 18.4 t -40.22 -49.94 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 124.705 1.202 . . . . 0.0 111.771 171.117 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -58.53 -52.09 67.13 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-O 118.255 -0.878 . . . . 0.0 108.937 -171.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -46.47 -53.13 11.78 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.939 1.696 . . . . 0.0 109.799 174.398 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 21.2 mmt -51.17 -58.32 6.44 Favored 'General case' 0 N--CA 1.443 -0.776 0 O-C-N 121.951 -0.468 . . . . 0.0 111.823 175.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -59.4 -60.32 4.04 Favored 'General case' 0 C--O 1.22 -0.497 0 O-C-N 121.082 -1.011 . . . . 0.0 112.455 177.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -43.97 -40.5 4.72 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.472 2.309 . . . . 0.0 109.252 -179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.85 -52.9 15.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 170.468 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 20.8 mt -62.9 -60.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 120.095 1.316 . . . . 0.0 111.401 -177.603 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -45.91 -36.52 5.48 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 118.893 0.77 . . . . 0.0 112.081 175.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.68 -30.92 65.85 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 119.249 0.931 . . . . 0.0 113.368 178.6 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.5 mmt -55.51 -38.95 69.87 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 117.965 0.348 . . . . 0.0 110.331 173.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 132.26 -16.06 4.96 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.822 1.201 . . . . 0.0 110.805 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -75.55 114.35 35.28 Favored Pre-proline 0 N--CA 1.452 -0.345 0 CA-C-O 118.354 -0.831 . . . . 0.0 109.492 -174.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -66.01 141.75 65.48 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 N-CA-C 108.266 -1.475 . . . . 0.0 108.266 176.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.33 132.28 35.43 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -95.44 80.1 3.47 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 169.215 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.737 HG23 HD21 ' A' ' 5' ' ' LEU . 0.7 OUTLIER -65.18 107.54 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 126.061 1.744 . . . . 0.0 109.694 168.011 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -157.09 59.7 0.51 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -179.289 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 35.1 mttm -155.12 153.02 30.19 Favored 'General case' 0 C--N 1.333 -0.148 0 N-CA-C 107.766 -1.198 . . . . 0.0 107.766 163.446 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.3 mp -134.33 78.43 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 105.538 -2.023 . . . . 0.0 105.538 169.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -101.32 179.86 4.24 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.665 1.186 . . . . 0.0 109.214 177.374 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -121.19 -124.44 3.09 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 123.621 0.629 . . . . 0.0 111.563 -175.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 28.3 mmt-85 . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.922 -1.513 . . . . 0.0 109.728 168.709 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.996 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -74.21 156.48 37.23 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 124.593 1.157 . . . . 0.0 109.403 172.112 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.9 m -116.73 131.36 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 109.01 -179.722 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.867 HG23 HG22 ' A' ' 46' ' ' VAL . 2.6 p -90.82 120.04 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 C-N-CA 125.277 1.431 . . . . 0.0 110.119 -177.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.574 HD13 ' O ' ' A' ' 72' ' ' LYS . 1.6 mm? -106.73 125.39 50.94 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.9 tptm -108.13 115.62 30.45 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 106.002 -1.851 . . . . 0.0 106.002 -175.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 9.0 mtt -115.16 119.28 35.86 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.45 1.1 . . . . 0.0 108.458 -174.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 8.4 mptt -72.03 126.52 29.98 Favored 'General case' 0 CA--C 1.514 -0.435 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.63 150.45 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 -179.747 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -113.07 153.05 28.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 123.651 0.594 . . . . 0.0 109.795 -178.711 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 82.86 -45.46 3.43 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.631 -0.539 . . . . 0.0 112.401 172.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 6.5 mtm -55.06 96.95 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 117.703 0.752 . . . . 0.0 111.665 178.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 p -132.03 18.35 4.56 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.889 1.275 . . . . 0.0 110.978 -177.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.4 p -137.87 163.07 32.37 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.101 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -72.61 -17.2 61.7 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.461 178.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -61.95 -60.24 3.93 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.3 0.5 . . . . 0.0 109.779 -177.205 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 27.5 m -57.86 -55.02 40.29 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.0 p -57.97 -50.03 74.78 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 118.631 -0.699 . . . . 0.0 110.215 -174.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 30.7 t -57.85 -46.15 85.22 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 118.911 0.778 . . . . 0.0 110.988 176.864 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 95.5 m -54.37 -51.28 65.3 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 118.638 0.654 . . . . 0.0 110.336 178.677 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -63.66 -42.2 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.363 178.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -57.08 -47.61 80.6 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 119.251 0.932 . . . . 0.0 110.319 178.074 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -54.49 -55.4 27.16 Favored Glycine 0 CA--C 1.528 0.855 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 172.416 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.7 tptt -66.85 -57.47 6.93 Favored 'General case' 0 C--N 1.338 0.1 0 CA-C-N 117.595 0.697 . . . . 0.0 111.281 -173.189 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 37.6 mm -63.0 -34.58 67.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 123.841 0.856 . . . . 0.0 110.079 -177.202 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.97 -28.34 7.39 Favored Glycine 0 CA--C 1.533 1.206 0 O-C-N 121.674 -0.641 . . . . 0.0 112.891 169.928 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -102.39 18.58 20.7 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.776 1.23 . . . . 0.0 111.831 -178.025 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.8 mt -70.23 163.17 27.02 Favored 'General case' 0 CA--C 1.532 0.277 0 O-C-N 120.573 -1.329 . . . . 0.0 111.208 171.291 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 18.8 pt20 -100.35 84.83 2.86 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 125.004 1.322 . . . . 0.0 110.273 -175.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 134.07 1.17 3.7 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 123.321 0.486 . . . . 0.0 113.725 -176.521 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.5 p -88.13 158.56 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.562 0 CA-C-N 117.641 0.721 . . . . 0.0 109.975 178.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -124.55 -41.81 2.13 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.131 1.372 . . . . 0.0 111.001 -176.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 14.9 ttm180 -156.93 171.3 20.68 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 179.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 13.1 tt -157.14 138.5 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.439 0 N-CA-C 105.051 -2.204 . . . . 0.0 105.051 -174.346 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 21.1 mmtp -137.47 81.12 1.85 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 126.192 1.797 . . . . 0.0 110.488 177.5 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 57.4 t -85.06 122.52 38.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 O-C-N 120.729 -1.232 . . . . 0.0 109.302 -177.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.5 m -103.08 168.05 9.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -123.97 -45.53 2.0 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.792 0.837 . . . . 0.0 109.786 174.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -47.06 -57.03 5.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 126.06 1.744 . . . . 0.0 110.943 -174.335 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -95.14 19.7 10.17 Favored 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.456 -175.284 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 36.44 62.28 0.74 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 127.6 2.36 . . . . 0.0 112.332 -176.503 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -148.12 140.49 24.33 Favored 'General case' 0 C--N 1.34 0.193 0 O-C-N 121.134 -0.979 . . . . 0.0 108.983 -174.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -120.04 119.86 34.61 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.936 1.694 . . . . 0.0 108.581 -175.128 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.527 ' C ' HD12 ' A' ' 45' ' ' ILE . 20.1 m -96.82 125.99 41.66 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 175.482 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.527 HD12 ' C ' ' A' ' 44' ' ' THR . 2.5 mp -125.53 128.91 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 169.695 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.867 HG22 HG23 ' A' ' 4' ' ' VAL . 1.8 t -110.13 117.71 55.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 C-N-CA 124.166 0.986 . . . . 0.0 109.476 -174.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -139.9 175.36 9.65 Favored 'General case' 0 C--N 1.339 0.129 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -169.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 13.0 tp60 -104.81 107.21 57.85 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.106 1.362 . . . . 0.0 110.392 -177.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.13 77.7 2.74 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.378 2.719 . . . . 0.0 110.26 -174.801 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -177.53 -48.92 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 C-N-CA 127.084 2.154 . . . . 0.0 108.04 179.387 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.3 mt -73.02 -45.6 56.78 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-O 120.942 0.401 . . . . 0.0 110.548 -178.467 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -134.95 168.61 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.525 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.985 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.9 p -135.57 157.78 46.03 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.145 0.978 . . . . 0.0 110.18 -171.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 16.3 t -37.71 -47.77 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 125.83 1.652 . . . . 0.0 111.497 173.018 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.18 -50.69 73.07 Favored 'General case' 0 C--O 1.214 -0.812 0 CA-C-O 117.935 -1.031 . . . . 0.0 110.776 -178.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -52.72 -48.7 66.46 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 120.916 1.689 . . . . 0.0 109.406 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.6 mtp -49.97 -62.79 1.37 Allowed 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 111.462 0.171 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.43 -57.74 11.48 Favored 'General case' 0 C--O 1.216 -0.707 0 O-C-N 121.355 -0.841 . . . . 0.0 112.093 -178.182 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.0 tmtp? -41.18 -52.75 3.28 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 125.614 1.566 . . . . 0.0 109.581 175.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 39.2 mm-40 -60.19 -47.69 84.88 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 118.445 0.566 . . . . 0.0 111.824 176.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 91.2 mt -67.89 -66.03 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.83 -0.543 . . . . 0.0 111.067 -177.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -46.34 -37.71 7.82 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 118.42 -0.8 . . . . 0.0 112.079 173.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.29 -33.44 63.24 Favored 'General case' 0 C--N 1.344 0.348 0 CA-C-N 119.901 1.228 . . . . 0.0 112.694 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.1 mmt -58.83 -43.61 90.73 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 118.412 0.551 . . . . 0.0 110.438 174.066 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 137.03 -15.15 3.76 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.541 1.067 . . . . 0.0 111.207 178.264 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -81.39 118.85 73.95 Favored Pre-proline 0 N--CA 1.451 -0.394 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.243 -173.838 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -66.81 137.48 45.48 Favored 'Trans proline' 0 N--CA 1.449 -1.107 0 N-CA-C 108.443 -1.406 . . . . 0.0 108.443 174.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -137.08 140.87 42.29 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.439 0.696 . . . . 0.0 109.903 178.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -112.28 85.3 2.13 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' CG2' HD12 ' A' ' 5' ' ' LEU . 2.5 p -74.78 98.18 1.26 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 C-N-CA 126.838 2.055 . . . . 0.0 111.402 179.894 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.66 60.99 0.48 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 -174.45 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.574 ' O ' HD13 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -157.01 141.2 16.42 Favored 'General case' 0 C--O 1.225 -0.23 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 171.876 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.02 77.08 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.117 0 N-CA-C 105.683 -1.969 . . . . 0.0 105.683 172.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.409 ' HB3' ' CG1' ' A' ' 4' ' ' VAL . 0.4 OUTLIER -83.68 59.59 5.24 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -176.415 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -58.74 147.65 40.07 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 111.389 -0.684 . . . . 0.0 111.389 -176.121 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.3 ttt-85 . . . . . 0 C--O 1.25 1.118 0 CA-C-O 117.044 -1.455 . . . . 0.0 109.92 -179.414 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.103 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -65.02 -176.3 0.27 Allowed 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 161.594 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 t -86.96 133.77 29.17 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.213 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -163.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.7 p -105.07 116.0 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 C-N-CA 125.127 1.371 . . . . 0.0 110.305 -174.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -102.55 136.82 41.69 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 106.317 -1.735 . . . . 0.0 106.317 -179.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 12.7 tptt -114.2 114.78 26.47 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 179.605 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 6.0 ptp -118.24 130.2 55.93 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 124.302 1.041 . . . . 0.0 109.831 178.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -80.03 125.27 29.56 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.404 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.5 m -113.25 140.34 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 178.53 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -103.42 156.58 17.64 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 178.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 77.82 -32.7 1.69 Allowed Glycine 0 CA--C 1.533 1.2 0 C-N-CA 123.378 0.513 . . . . 0.0 114.199 172.863 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.7 mtp -67.31 80.84 0.15 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 118.253 1.026 . . . . 0.0 111.721 -179.475 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 16.1 m -118.67 65.01 0.77 Allowed 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 126.123 1.769 . . . . 0.0 109.095 -178.305 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 23.9 p -169.24 169.25 9.33 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 -176.335 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.92 5.17 52.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 122.839 0.456 . . . . 0.0 111.749 169.078 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.5 t -85.57 -65.81 0.97 Allowed 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.801 -0.562 . . . . 0.0 109.69 -174.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.7 m -57.23 -46.81 82.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.261 1.024 . . . . 0.0 110.49 -179.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 70.6 p -52.09 -60.95 2.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 123.294 0.638 . . . . 0.0 109.968 177.689 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 32.0 t -52.12 -44.37 64.44 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.754 1.222 . . . . 0.0 111.231 176.461 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 85.3 m -58.07 -50.78 72.28 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.486 -0.758 . . . . 0.0 110.592 178.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 1.1 mp -61.29 -45.78 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 178.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -51.54 -51.6 53.96 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.689 1.196 . . . . 0.0 110.721 177.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.63 -54.56 36.82 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 123.352 0.501 . . . . 0.0 111.92 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.96 -52.17 66.91 Favored 'General case' 0 N--CA 1.456 -0.148 0 O-C-N 121.638 -0.919 . . . . 0.0 111.462 -174.686 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.2 mm -63.83 -41.38 92.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.299 0.639 . . . . 0.0 109.709 178.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.23 -38.96 19.76 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 123.448 0.547 . . . . 0.0 112.563 170.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.3 tttt -62.64 -24.93 67.86 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-N 117.724 0.762 . . . . 0.0 112.958 178.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mt -70.75 129.82 40.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 119.426 1.012 . . . . 0.0 112.825 -171.565 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -66.42 87.87 0.12 Allowed 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.221 174.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 155.01 -25.0 0.62 Allowed Glycine 0 C--N 1.332 0.343 0 O-C-N 122.035 -0.416 . . . . 0.0 113.406 -177.559 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 79.1 t -79.97 151.39 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 19.8 mm-40 -112.98 -53.98 2.66 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.967 0.907 . . . . 0.0 110.276 174.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -143.0 165.8 26.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 -175.576 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 10.1 tt -158.81 139.42 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 -175.289 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 43.0 mmtt -141.51 84.72 1.92 Allowed 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.648 1.579 . . . . 0.0 110.254 -178.292 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 96.9 t -96.43 106.34 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 C-N-CA 123.326 0.65 . . . . 0.0 110.056 -173.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.9 m -92.49 155.12 18.04 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.19 -47.73 3.9 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.201 1.0 . . . . 0.0 108.619 177.394 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -49.03 -60.1 3.06 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 126.36 1.864 . . . . 0.0 110.567 -171.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -94.42 19.57 9.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 114.371 -1.286 . . . . 0.0 110.192 -175.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 35.83 49.44 0.57 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 128.048 2.539 . . . . 0.0 113.662 -177.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.409 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 4.7 tp10 -126.94 126.18 42.79 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 114.372 -1.285 . . . . 0.0 107.912 -169.325 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -115.03 113.25 23.82 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 110.155 -177.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.491 ' C ' HD12 ' A' ' 45' ' ' ILE . 5.7 m -91.7 124.93 36.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 125.22 1.408 . . . . 0.0 108.668 175.179 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.491 HD12 ' C ' ' A' ' 44' ' ' THR . 3.2 mp -124.09 132.64 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 167.499 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.25 107.05 20.47 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.57 1.148 . . . . 0.0 109.665 -174.779 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 28.7 p90 -138.73 159.98 40.79 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 112.549 0.574 . . . . 0.0 112.549 -171.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -81.72 114.1 47.54 Favored Pre-proline 0 N--CA 1.447 -0.59 0 C-N-CA 125.702 1.601 . . . . 0.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -76.49 74.59 4.68 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.297 2.665 . . . . 0.0 110.791 -171.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -174.22 -49.79 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 127.073 2.149 . . . . 0.0 108.02 173.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.1 mt -70.17 -43.63 70.43 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-N 116.706 -0.225 . . . . 0.0 111.357 -173.761 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -135.23 169.58 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.726 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -177.729 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.4 p -142.63 165.64 26.85 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.477 0.711 . . . . 0.0 110.455 -170.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 54.0 t -43.96 -45.06 2.03 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 C-N-CA 124.266 1.026 . . . . 0.0 111.391 173.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -57.29 -56.9 15.86 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.72 -1.133 . . . . 0.0 110.277 -178.349 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -53.56 -48.21 69.34 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-N 120.462 1.483 . . . . 0.0 109.929 -177.757 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.1 mtm -46.68 -61.8 1.67 Allowed 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 118.813 0.733 . . . . 0.0 112.54 169.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.9 ttmt -60.34 -59.89 4.68 Favored 'General case' 0 C--O 1.216 -0.661 0 CA-C-O 118.713 -0.66 . . . . 0.0 111.326 -178.025 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -37.8 -54.77 1.23 Allowed 'General case' 0 N--CA 1.441 -0.923 0 C-N-CA 125.679 1.592 . . . . 0.0 109.614 176.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 96.7 mm-40 -64.69 -46.86 80.59 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 119.974 -0.69 . . . . 0.0 112.503 178.094 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 75.6 mt -68.06 -64.22 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 O-C-N 121.527 -0.733 . . . . 0.0 110.716 -176.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -50.14 -34.63 22.94 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 118.229 -0.891 . . . . 0.0 112.17 175.095 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.99 -33.72 65.11 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 120.218 1.372 . . . . 0.0 112.846 175.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 18.6 mmt -59.03 -40.14 84.12 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 118.536 0.607 . . . . 0.0 110.443 174.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.95 -20.17 3.43 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.621 1.105 . . . . 0.0 110.989 178.928 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.4 m-85 -74.62 112.99 19.91 Favored Pre-proline 0 N--CA 1.453 -0.286 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.183 -173.345 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -66.21 141.08 61.53 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 N-CA-C 108.054 -1.556 . . . . 0.0 108.054 174.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -138.6 135.08 34.59 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 120.759 0.314 . . . . 0.0 111.628 -177.314 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -108.15 72.6 0.85 Allowed 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.785 0.834 . . . . 0.0 109.569 -171.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -60.83 103.63 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 C-N-CA 125.637 1.575 . . . . 0.0 111.002 174.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 10.9 pttp -156.1 56.52 0.59 Allowed 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.772 0.796 . . . . 0.0 111.925 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 8.6 mmtp -157.13 162.11 39.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 173.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 16.3 tt -155.67 70.73 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.21 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -77.89 168.79 19.35 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.223 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -154.3 127.89 2.23 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 108.179 -1.968 . . . . 0.0 108.179 173.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.5 ttt180 . . . . . 0 C--O 1.247 0.932 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 174.591 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.905 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -80.73 156.3 26.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.296 1.038 . . . . 0.0 109.868 -176.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 24.4 m -114.44 127.66 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 C-N-CA 124.566 1.146 . . . . 0.0 109.202 179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.7 p -90.99 116.75 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 126.295 1.838 . . . . 0.0 109.254 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -101.08 118.56 37.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 179.364 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.3 tptt -97.0 119.05 34.75 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.507 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 4.3 ptp -121.42 124.3 44.16 Favored 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 124.759 1.224 . . . . 0.0 109.203 175.7 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -82.53 119.25 24.0 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.06 -1.83 . . . . 0.0 106.06 176.372 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.8 p -135.23 122.59 36.55 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 122.98 0.512 . . . . 0.0 110.244 -170.75 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -85.11 157.49 20.68 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 122.474 0.309 . . . . 0.0 111.119 -174.201 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 109.03 -44.63 1.46 Allowed Glycine 0 CA--C 1.526 0.773 0 C-N-CA 123.947 0.784 . . . . 0.0 112.119 167.516 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 12.9 mtm -60.28 109.19 0.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.202 0.501 . . . . 0.0 109.809 176.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -146.51 19.39 1.34 Allowed 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 124.851 1.26 . . . . 0.0 110.014 -177.593 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -157.0 148.89 22.68 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.265 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -81.14 42.38 0.65 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.094 0.557 . . . . 0.0 112.288 -167.404 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 74.7 m -122.42 -69.11 0.85 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 125.253 1.421 . . . . 0.0 107.491 177.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 21.7 m -49.76 -53.36 25.45 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.201 1.4 . . . . 0.0 110.443 -176.179 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 HG21 HD22 ' A' ' 38' ' ' LEU . 11.8 t -51.18 -55.75 16.37 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.076 -0.965 . . . . 0.0 110.173 177.739 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 31.7 t -60.97 -45.69 93.73 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.349 1.06 . . . . 0.0 110.307 -175.985 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.8 m -55.26 -51.36 66.89 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 121.646 -0.659 . . . . 0.0 110.76 176.184 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 6.0 mt -60.64 -48.02 90.41 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.971 0.509 . . . . 0.0 110.002 178.833 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -48.96 -51.72 28.78 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.447 1.499 . . . . 0.0 110.414 175.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -59.91 9.71 Favored Glycine 0 CA--C 1.531 1.074 0 N-CA-C 111.789 -0.524 . . . . 0.0 111.789 172.921 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -48.87 79.06 Favored 'General case' 0 C--N 1.339 0.131 0 O-C-N 122.002 -0.705 . . . . 0.0 110.851 -170.607 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.3 mm -71.08 -47.79 59.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.074 0.55 . . . . 0.0 109.96 -178.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -50.95 -35.26 31.96 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.325 0.488 . . . . 0.0 112.228 177.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.4 ttmt -68.87 -16.38 63.75 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.868 0.867 . . . . 0.0 113.324 -179.16 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 mt -73.91 139.6 45.06 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 120.488 1.495 . . . . 0.0 112.106 -176.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -70.1 97.38 1.18 Allowed 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.062 -179.492 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 148.91 -12.87 1.12 Allowed Glycine 0 C--N 1.332 0.359 0 CA-C-O 118.662 -1.077 . . . . 0.0 114.181 -175.703 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 37.3 t -102.85 139.43 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-N 118.145 0.973 . . . . 0.0 110.442 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -93.62 -31.68 14.39 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 122.881 0.472 . . . . 0.0 111.801 175.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -171.57 164.55 6.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 -171.952 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 17.1 tt -156.04 138.59 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.481 0 N-CA-C 104.022 -2.584 . . . . 0.0 104.022 -172.888 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 mmtm -137.78 92.42 2.68 Favored 'General case' 0 N--CA 1.441 -0.924 0 C-N-CA 125.79 1.636 . . . . 0.0 111.239 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -94.41 115.24 32.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 176.841 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.6 m -104.9 103.4 12.97 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.984 1.713 . . . . 0.0 108.723 -173.811 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.816 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.6 OUTLIER -65.5 -48.83 71.23 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.77 0.428 . . . . 0.0 110.628 -179.262 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.17 -54.48 30.21 Favored 'General case' 0 CA--C 1.521 -0.168 0 C-N-CA 124.883 1.273 . . . . 0.0 110.24 -176.857 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -84.63 5.56 27.52 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.828 -177.425 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 35.19 60.21 0.71 Allowed 'General case' 0 N--CA 1.443 -0.789 0 C-N-CA 128.428 2.691 . . . . 0.0 113.081 -175.882 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -138.79 149.1 44.61 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 125.154 1.381 . . . . 0.0 108.586 -175.641 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.507 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -126.37 119.61 27.73 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.634 1.174 . . . . 0.0 110.269 -179.364 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.529 ' C ' HD12 ' A' ' 45' ' ' ILE . 9.0 m -103.03 114.44 28.75 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 125.975 1.71 . . . . 0.0 109.025 -179.321 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.529 HD12 ' C ' ' A' ' 44' ' ' THR . 2.1 mp -117.37 115.44 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -179.548 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.1 t -109.76 105.52 18.97 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.749 0.704 . . . . 0.0 109.927 -173.06 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -128.61 169.68 14.14 Favored 'General case' 0 C--N 1.341 0.224 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -166.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -103.02 111.0 64.74 Favored Pre-proline 0 N--CA 1.447 -0.591 0 C-N-CA 124.554 1.142 . . . . 0.0 110.461 -177.845 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -72.58 78.35 2.04 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.144 2.563 . . . . 0.0 111.431 -175.72 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 2.7 m80 178.97 -38.88 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.447 2.699 . . . . 0.0 108.624 173.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.0 mt -78.52 -50.21 11.99 Favored 'General case' 0 C--N 1.34 0.174 0 N-CA-C 111.613 0.227 . . . . 0.0 111.613 -175.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -131.01 -178.32 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 C-N-CA 125.095 1.358 . . . . 0.0 107.718 -176.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.8 p -142.85 155.22 44.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.858 0.754 . . . . 0.0 111.358 -174.154 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 53.1 t -46.45 -42.81 5.39 Favored 'Isoleucine or valine' 0 C--N 1.341 0.198 0 C-N-CA 124.199 1.0 . . . . 0.0 111.07 173.476 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -63.15 -39.36 94.43 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-O 118.854 -0.593 . . . . 0.0 111.046 -177.638 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -63.73 -51.46 64.83 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.853 1.206 . . . . 0.0 107.748 176.216 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 28.0 mmt -47.63 -61.22 2.04 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 122.447 0.299 . . . . 0.0 111.775 176.137 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 23.8 ttmt -57.56 -59.45 5.16 Favored 'General case' 0 C--O 1.217 -0.64 0 O-C-N 120.967 -1.083 . . . . 0.0 111.077 177.002 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.94 -44.78 64.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 119.312 0.96 . . . . 0.0 109.249 -170.402 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.7 mm-40 -57.95 -50.02 74.8 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.85 173.262 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 84.2 mt -69.5 -64.79 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.528 0.135 0 C-N-CA 122.953 0.501 . . . . 0.0 111.046 -177.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -45.02 -39.51 5.72 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 118.791 0.723 . . . . 0.0 112.262 174.68 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.15 -32.59 55.74 Favored 'General case' 0 C--N 1.343 0.323 0 CA-C-N 119.513 1.051 . . . . 0.0 113.293 177.235 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 23.9 mmt -56.27 -39.52 72.76 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.403 0.547 . . . . 0.0 110.534 174.256 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 140.05 -19.61 2.88 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.714 1.149 . . . . 0.0 111.181 176.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.33 112.35 40.86 Favored Pre-proline 0 N--CA 1.453 -0.318 0 C-N-CA 124.359 1.064 . . . . 0.0 110.384 -169.038 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -67.22 127.91 17.54 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.766 1.644 . . . . 0.0 109.651 -178.508 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -121.57 133.03 55.0 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.618 0.767 . . . . 0.0 111.84 -173.769 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -105.51 76.02 1.18 Allowed 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 124.286 1.034 . . . . 0.0 109.493 -179.851 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.9 p -66.49 109.4 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 124.076 0.95 . . . . 0.0 110.077 170.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.2 pttp -156.98 53.8 0.51 Allowed 'General case' 0 N--CA 1.454 -0.262 0 O-C-N 121.831 -0.543 . . . . 0.0 111.566 178.619 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.04 81.47 0.78 Allowed 'General case' 0 C--O 1.222 -0.394 0 O-C-N 121.931 -0.481 . . . . 0.0 110.127 -177.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.7 tp -78.55 59.8 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 123.683 0.793 . . . . 0.0 109.565 -179.199 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -84.24 163.31 19.75 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.393 -0.817 . . . . 0.0 110.208 -177.539 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 162.7 90.98 0.08 OUTLIER Glycine 0 CA--C 1.523 0.577 0 N-CA-C 107.945 -2.062 . . . . 0.0 107.945 -172.443 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 57.7 ttt-85 . . . . . 0 C--O 1.251 1.17 0 CA-C-O 116.964 -1.493 . . . . 0.0 109.549 -176.471 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.922 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.71 ' HG3' HG12 ' A' ' 46' ' ' VAL . 13.7 pm0 -96.65 -166.28 1.39 Allowed 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 127.46 2.304 . . . . 0.0 109.994 -176.093 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 88.5 t -133.9 140.78 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 178.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.426 ' C ' HD12 ' A' ' 5' ' ' LEU . 7.7 p -101.26 129.13 52.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.967 0 C-N-CA 126.049 1.74 . . . . 0.0 110.725 -179.514 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.513 HD13 ' HE1' ' A' ' 47' ' ' TYR . 10.8 mp -120.31 145.61 46.93 Favored 'General case' 0 N--CA 1.446 -0.671 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 173.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -122.98 125.96 46.25 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 107.316 -1.364 . . . . 0.0 107.316 -178.105 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 5.7 mtt -115.79 129.67 56.53 Favored 'General case' 0 N--CA 1.441 -0.882 0 C-N-CA 126.412 1.885 . . . . 0.0 108.026 179.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.45 126.29 31.47 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 168.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.6 m -109.05 157.04 9.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-N 119.329 0.968 . . . . 0.0 109.723 179.824 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -123.75 143.56 50.22 Favored 'General case' 0 CA--C 1.528 0.107 0 CA-C-O 121.366 0.603 . . . . 0.0 109.743 170.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.61 -31.51 8.27 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 126.005 1.765 . . . . 0.0 112.794 174.745 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 30.7 mtt -66.36 99.14 0.53 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.09 0.945 . . . . 0.0 111.02 -176.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 91.0 m -143.78 56.52 1.34 Allowed 'General case' 0 N--CA 1.448 -0.526 0 O-C-N 120.936 -1.102 . . . . 0.0 109.477 174.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 31.4 p -161.62 159.85 28.07 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 165.152 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 59.0 t60 -80.58 44.68 0.73 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.271 0.487 . . . . 0.0 111.222 179.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 58.7 m -123.17 -60.33 1.51 Allowed 'General case' 0 CA--C 1.52 -0.205 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 173.756 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 34.2 m -47.2 -59.89 2.85 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.488 0.715 . . . . 0.0 110.807 179.624 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.4 t -52.92 -59.26 4.74 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.572 177.488 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.3 t -60.38 -45.27 94.14 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.756 0.822 . . . . 0.0 111.331 -170.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 55.5 m -54.19 -49.97 68.14 Favored 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.56 -0.713 . . . . 0.0 110.462 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.3 mt -63.23 -43.9 98.98 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 110.081 -0.34 . . . . 0.0 110.081 178.748 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.699 ' HA ' HD13 ' A' ' 34' ' ' ILE . 8.1 mt-10 -53.58 -50.07 66.4 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.139 0.976 . . . . 0.0 110.682 177.527 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.58 -58.25 14.86 Favored Glycine 0 CA--C 1.532 1.127 0 N-CA-C 111.692 -0.563 . . . . 0.0 111.692 171.136 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -56.32 -52.3 65.05 Favored 'General case' 0 CA--C 1.53 0.178 0 O-C-N 122.169 -0.607 . . . . 0.0 111.14 -172.349 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.587 HG21 HD12 ' A' ' 34' ' ' ILE . 24.8 mm -62.02 -47.88 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 C-N-CA 124.907 1.283 . . . . 0.0 109.911 178.469 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -48.98 -39.71 26.35 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 111.892 -0.483 . . . . 0.0 111.892 172.23 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.1 ttpt -70.48 -13.92 62.32 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 -178.664 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.4 mt -82.23 133.37 35.25 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 120.031 1.287 . . . . 0.0 112.345 -174.547 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -68.67 91.17 0.42 Allowed 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.532 179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.59 -20.87 0.92 Allowed Glycine 0 C--N 1.334 0.433 0 O-C-N 121.859 -0.525 . . . . 0.0 113.752 -177.115 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.4 t -85.93 151.16 3.71 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 179.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -120.43 -38.29 2.91 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.873 1.269 . . . . 0.0 111.013 -179.545 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.2 ttt85 -152.78 171.05 18.85 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.111 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.699 HD13 ' HA ' ' A' ' 22' ' ' GLU . 14.8 tt -158.56 145.14 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.455 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 -178.323 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 6.2 mmtp -143.78 88.03 1.96 Allowed 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 126.074 1.75 . . . . 0.0 111.298 175.367 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.2 t -96.83 88.61 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 O-C-N 121.124 -0.985 . . . . 0.0 111.263 -178.425 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -75.04 121.36 21.87 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.675 1.99 . . . . 0.0 110.919 -178.381 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.414 HD23 ' N ' ' A' ' 39' ' ' ASP . 0.3 OUTLIER -73.97 -46.56 43.22 Favored 'General case' 0 C--N 1.334 -0.067 0 O-C-N 121.261 -0.899 . . . . 0.0 111.366 179.312 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.414 ' N ' HD23 ' A' ' 38' ' ' LEU . 1.1 m-20 -47.3 -59.58 3.09 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.724 1.21 . . . . 0.0 111.211 -170.121 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -95.35 24.92 4.7 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.845 -1.071 . . . . 0.0 110.524 -176.216 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.1 mt-30 24.89 74.84 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 128.346 2.659 . . . . 0.0 113.934 -169.021 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -127.94 136.58 51.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 108.222 -173.214 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -115.8 102.38 9.66 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.53 1.132 . . . . 0.0 108.427 171.374 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.568 ' C ' HD12 ' A' ' 45' ' ' ILE . 8.2 m -88.95 125.72 35.09 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 170.348 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.568 HD12 ' C ' ' A' ' 44' ' ' THR . 2.6 mp -123.0 132.74 70.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 170.516 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.71 HG12 ' HG3' ' A' ' 2' ' ' GLU . 2.6 t -118.96 103.59 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 124.487 1.115 . . . . 0.0 108.067 -174.081 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.513 ' HE1' HD13 ' A' ' 5' ' ' LEU . 17.0 p90 -138.78 164.59 29.21 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-O 121.213 0.53 . . . . 0.0 111.785 -166.766 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -96.71 110.64 54.26 Favored Pre-proline 0 N--CA 1.444 -0.732 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.975 -173.112 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -72.05 76.57 2.09 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.894 3.062 . . . . 0.0 110.684 -172.285 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -175.32 -50.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 126.407 1.883 . . . . 0.0 107.357 -175.345 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.9 mt -82.51 -46.35 13.51 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 123.476 0.485 . . . . 0.0 110.48 -171.394 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -131.54 155.51 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 125.359 1.464 . . . . 0.0 107.136 -176.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.7 p -123.18 161.84 23.7 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.786 1.234 . . . . 0.0 110.392 -173.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 41.6 t -45.47 -45.52 4.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 C-N-CA 123.831 0.852 . . . . 0.0 111.843 175.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -61.49 -56.65 17.8 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-O 117.815 -1.088 . . . . 0.0 109.038 -175.427 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -38.82 -59.67 0.93 Allowed 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 126.015 1.726 . . . . 0.0 110.144 170.618 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 22.4 mtm -49.67 -62.79 1.36 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 176.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 26.2 ttpt -59.2 -62.64 1.73 Allowed 'General case' 0 C--O 1.212 -0.878 0 CA-C-O 117.873 -1.06 . . . . 0.0 111.41 -177.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.4 tptp -38.82 -49.37 1.62 Allowed 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 120.013 1.278 . . . . 0.0 110.376 177.627 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -68.96 -37.2 78.67 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 177.693 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 86.9 mt -72.08 -66.73 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 C-N-CA 124.37 1.068 . . . . 0.0 110.81 175.489 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -38.0 -40.16 0.45 Allowed 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 125.034 1.334 . . . . 0.0 112.403 171.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -47.38 -35.43 8.29 Favored 'General case' 0 C--N 1.346 0.428 0 CA-C-N 119.323 0.965 . . . . 0.0 113.514 176.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.28 -37.83 81.71 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.666 0.787 . . . . 0.0 110.613 178.626 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.23 -14.66 4.55 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 124.877 1.227 . . . . 0.0 111.172 178.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -85.48 115.93 63.47 Favored Pre-proline 0 N--CA 1.45 -0.447 0 C-N-CA 123.849 0.86 . . . . 0.0 109.866 -171.107 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.5 142.1 63.84 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 N-CA-C 108.72 -1.3 . . . . 0.0 108.72 175.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -133.4 135.81 44.87 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.094 0.558 . . . . 0.0 111.401 179.958 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -105.7 76.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.577 1.151 . . . . 0.0 109.437 -178.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.4 p -60.41 104.52 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 125.079 1.352 . . . . 0.0 110.859 171.909 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 15.8 pttp -155.73 60.01 0.61 Allowed 'General case' 0 CA--C 1.535 0.385 0 CA-C-O 121.71 0.767 . . . . 0.0 112.875 -178.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.31 162.33 40.11 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 173.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.5 tp -156.88 70.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 -179.821 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -82.09 67.62 8.16 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.892 0.853 . . . . 0.0 109.253 -173.194 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -59.87 153.71 33.4 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 177.202 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 21.4 ttt-85 . . . . . 0 C--O 1.254 1.29 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 -174.898 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 1.015 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -62.87 150.93 40.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 117.881 0.841 . . . . 0.0 110.163 171.707 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.2 m -116.78 128.61 74.12 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 124.731 1.212 . . . . 0.0 109.499 -177.748 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.5 p -86.3 104.5 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.642 0 C-N-CA 125.345 1.458 . . . . 0.0 110.129 -176.064 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -92.33 101.89 14.38 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 -176.709 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.0 mmtp -79.19 120.95 24.43 Favored 'General case' 0 N--CA 1.433 -1.302 0 C-N-CA 124.079 0.952 . . . . 0.0 108.6 174.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -122.72 119.14 29.8 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 177.142 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.75 115.55 19.41 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.45 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 m -102.43 154.49 5.2 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.224 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -174.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -111.54 156.91 21.01 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 176.174 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.45 -43.44 3.22 Favored Glycine 0 CA--C 1.528 0.903 0 O-C-N 121.261 -0.9 . . . . 0.0 114.043 161.907 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 72.5 mtm -61.01 86.78 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.374 1.087 . . . . 0.0 111.507 -178.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.8 m -116.49 38.08 3.54 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.744 1.618 . . . . 0.0 109.902 -177.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.3 p -154.81 162.96 40.92 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 170.313 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -76.74 -21.61 55.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 O-C-N 123.429 0.456 . . . . 0.0 111.402 -177.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.3 m -58.16 -58.91 6.38 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.752 0.421 . . . . 0.0 110.214 -178.824 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 50.1 m -54.5 -53.37 55.18 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.896 0.379 . . . . 0.0 110.646 -177.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.9 p -58.9 -54.2 49.77 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.075 -175.883 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.8 t -58.74 -45.91 88.6 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 123.818 0.847 . . . . 0.0 111.229 179.671 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 65.6 m -56.2 -48.46 76.35 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.371 -0.83 . . . . 0.0 110.5 176.291 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.5 mt -59.44 -47.89 89.13 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.744 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -55.81 -45.0 78.38 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.286 0.635 . . . . 0.0 110.764 179.654 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -57.1 -53.26 45.94 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 124.063 0.84 . . . . 0.0 111.527 173.226 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -63.0 -59.77 4.36 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.93 0.871 . . . . 0.0 109.834 -175.633 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 44.2 mm -63.59 -32.83 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 C-N-CA 125.167 1.387 . . . . 0.0 111.043 -175.166 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -47.16 -31.49 6.13 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 123.313 0.482 . . . . 0.0 112.447 172.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.3 tttp -80.74 -4.08 53.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -177.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 mt -73.74 139.35 45.21 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 120.104 1.32 . . . . 0.0 112.524 -175.519 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -81.18 84.27 6.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 115.055 -0.975 . . . . 0.0 111.136 177.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 151.04 -13.96 0.86 Allowed Glycine 0 CA--C 1.522 0.493 0 N-CA-C 114.271 0.468 . . . . 0.0 114.271 178.888 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 91.1 t -81.33 145.61 8.59 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 173.673 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -115.13 -37.33 4.13 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.249 1.419 . . . . 0.0 111.037 -176.001 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.02 159.66 44.42 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 175.67 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.6 tt -155.06 126.6 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 -178.917 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 35' ' ' LYS 0.253 16.2 mmtm -135.08 102.16 5.11 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 113.564 0.949 . . . . 0.0 113.564 171.355 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.0 t -95.33 98.58 8.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 O-C-N 121.584 -0.697 . . . . 0.0 110.095 -177.419 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.1 m -89.14 126.84 35.64 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.14 1.376 . . . . 0.0 110.808 -176.417 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.446 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.2 OUTLIER -84.65 -42.96 14.84 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.832 0.853 . . . . 0.0 109.96 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -59.11 4.61 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 125.938 1.695 . . . . 0.0 110.376 -173.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 26.6 t30 -86.58 9.0 19.83 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.001 -179.388 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . 0.284 0.1 OUTLIER 32.85 66.77 0.19 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 128.209 2.604 . . . . 0.0 112.208 -169.548 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -144.5 141.99 29.93 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.556 1.142 . . . . 0.0 110.685 -173.458 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -114.95 120.19 39.06 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 125.38 1.472 . . . . 0.0 109.682 -178.571 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 28.1 m -94.46 78.27 3.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 127.942 2.497 . . . . 0.0 107.934 175.132 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.0 mm -88.28 103.8 14.03 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 178.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 2.9 t -100.54 108.24 22.68 Favored 'Isoleucine or valine' 0 C--O 1.232 0.142 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 -175.328 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 23.2 p90 -131.41 175.05 9.47 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -170.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -106.88 109.91 63.35 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.268 1.027 . . . . 0.0 110.187 -175.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -74.43 73.74 3.89 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 124.153 3.235 . . . . 0.0 111.216 -170.138 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -177.91 -39.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 127.372 2.269 . . . . 0.0 108.368 178.933 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.75 -46.13 13.52 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-O 119.476 -0.297 . . . . 0.0 111.778 -175.606 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.8 tp -135.62 149.08 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 -174.869 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.6 p -100.58 158.74 15.71 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 124.052 0.941 . . . . 0.0 111.676 -173.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.71 -42.97 18.36 Favored 'Isoleucine or valine' 0 C--N 1.338 0.106 0 C-N-CA 122.939 0.496 . . . . 0.0 110.357 166.095 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -61.52 -53.92 50.04 Favored 'General case' 0 C--O 1.215 -0.749 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -176.306 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -46.14 -54.1 9.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 124.312 1.045 . . . . 0.0 110.528 172.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 32.9 mmm -48.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 112.81 0.671 . . . . 0.0 112.81 173.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . 0.408 ' NZ ' ' OE1' ' A' ' 62' ' ' GLU . 15.0 tttp -56.9 -64.57 0.83 Allowed 'General case' 0 C--O 1.216 -0.685 0 CA-C-O 118.521 -0.752 . . . . 0.0 111.808 179.835 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 tmtt? -37.11 -52.76 1.01 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.907 1.683 . . . . 0.0 109.954 178.106 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.9 mt-30 -66.11 -47.26 74.75 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 119.106 -1.038 . . . . 0.0 113.081 177.428 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 73.3 mt -65.61 -62.41 1.25 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 118.655 0.661 . . . . 0.0 110.453 -178.136 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.408 ' OE1' ' NZ ' ' A' ' 58' ' ' LYS . 1.8 tt0 -42.39 -44.08 3.83 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 123.933 0.893 . . . . 0.0 112.223 171.344 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.73 -31.2 62.3 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 119.126 0.875 . . . . 0.0 113.065 -179.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 19.3 mmt -57.1 -42.29 80.49 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 118.499 0.59 . . . . 0.0 110.467 172.711 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 143.28 -18.71 2.29 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 124.596 1.093 . . . . 0.0 111.299 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 -81.23 118.31 71.77 Favored Pre-proline 0 N--CA 1.452 -0.346 0 CA-C-O 118.417 -0.801 . . . . 0.0 110.373 -169.302 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -67.1 140.05 52.77 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 N-CA-C 108.445 -1.406 . . . . 0.0 108.445 173.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -135.21 132.33 37.77 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 121.392 0.615 . . . . 0.0 111.045 179.48 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -93.26 81.24 4.45 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 175.019 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -42.02 107.85 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 O-C-N 125.15 1.531 . . . . 0.0 108.818 160.961 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 13.3 tttp -101.87 179.8 4.23 Favored 'General case' 0 N--CA 1.434 -1.275 0 C-N-CA 126.121 1.768 . . . . 0.0 106.611 170.813 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.17 161.87 18.63 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.188 -1.369 . . . . 0.0 109.05 -175.048 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 3.6 mt -75.77 134.15 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.003 0.521 . . . . 0.0 109.709 -178.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -107.77 106.49 16.82 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 177.157 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 157.78 164.56 14.05 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 107.935 -2.066 . . . . 0.0 107.935 -177.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 22.5 ttt-85 . . . . . 0 C--O 1.253 1.239 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 176.069 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.333 0 N-CA-C 111.597 -0.601 . . . . 0.0 111.597 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -47.15 152.84 0.52 Allowed 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 126.715 2.006 . . . . 0.0 111.8 167.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.3 m -105.6 132.45 52.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 C-N-CA 123.854 0.862 . . . . 0.0 109.161 -176.197 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.557 HG13 ' HB2' ' A' ' 74' ' ' GLU . 0.8 OUTLIER -94.2 115.52 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.052 0 C-N-CA 125.646 1.578 . . . . 0.0 109.813 179.435 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 93.3 mt -88.0 124.43 33.72 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 105.564 -2.013 . . . . 0.0 105.564 170.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.48 109.39 21.34 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 104.584 -2.376 . . . . 0.0 104.584 175.432 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.724 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 16.3 ptp -119.64 144.64 47.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.094 0.958 . . . . 0.0 109.142 179.189 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.1 123.85 46.69 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.922 173.83 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.5 p -132.92 96.48 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 O-C-N 124.661 1.226 . . . . 0.0 109.448 -166.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -68.3 142.76 55.45 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.946 -0.471 . . . . 0.0 110.668 -172.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 124.81 -47.72 1.0 Allowed Glycine 0 CA--C 1.527 0.825 0 C-N-CA 124.286 0.946 . . . . 0.0 112.525 174.071 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -74.7 82.47 2.08 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.929 0.864 . . . . 0.0 111.899 -171.912 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.7 m -111.35 33.63 4.57 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.537 1.535 . . . . 0.0 110.545 -178.776 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 15.6 p -155.37 160.55 40.78 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 171.288 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -78.0 -1.5 32.44 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -174.754 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 49.9 m -76.7 -61.36 1.99 Allowed 'General case' 0 N--CA 1.455 -0.21 0 O-C-N 121.49 -0.756 . . . . 0.0 109.629 175.087 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 33.7 m -56.13 -48.59 75.93 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 122.717 0.407 . . . . 0.0 110.809 -174.469 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 78.9 p -52.03 -60.39 3.25 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 123.383 0.673 . . . . 0.0 109.415 176.276 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.0 t -50.7 -48.21 58.77 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.786 1.234 . . . . 0.0 111.692 179.313 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 96.5 m -54.42 -51.91 63.44 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.315 -0.866 . . . . 0.0 110.948 176.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 7.9 mt -62.14 -40.42 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 122.97 0.508 . . . . 0.0 109.989 178.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -56.99 -48.58 78.11 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.661 1.184 . . . . 0.0 110.599 176.178 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.82 -56.31 24.53 Favored Glycine 0 CA--C 1.53 1.031 0 N-CA-C 111.053 -0.819 . . . . 0.0 111.053 172.499 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -56.18 -52.63 63.71 Favored 'General case' 0 C--N 1.339 0.149 0 CA-C-O 121.047 0.451 . . . . 0.0 111.138 -174.584 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 mm -71.06 -45.81 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.244 1.018 . . . . 0.0 110.299 -175.456 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -49.57 -37.61 26.86 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 123.402 0.525 . . . . 0.0 112.012 175.515 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.5 tttt -72.99 -9.28 58.56 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.135 0.974 . . . . 0.0 113.5 -178.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.7 mt -81.45 128.45 33.89 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.431 1.468 . . . . 0.0 111.408 178.52 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -66.8 108.87 2.67 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.097 175.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.52 -16.28 3.58 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 124.489 1.042 . . . . 0.0 112.613 -178.287 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.5 t -81.5 152.17 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.413 0 CA-C-N 117.053 0.426 . . . . 0.0 110.249 173.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -122.14 -46.08 2.21 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.31 -178.686 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.42 165.57 30.73 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 178.601 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 7.8 tt -156.5 137.94 5.43 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.585 0 N-CA-C 105.927 -1.879 . . . . 0.0 105.927 179.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -141.66 90.85 2.32 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 124.253 1.021 . . . . 0.0 111.495 179.091 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 23.3 t -92.76 90.91 3.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 O-C-N 121.512 -0.742 . . . . 0.0 110.194 -177.137 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.2 m -84.45 110.21 18.48 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.583 1.153 . . . . 0.0 111.247 -173.765 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.741 HD23 ' H ' ' A' ' 38' ' ' LEU . 0.9 OUTLIER -63.33 -49.6 73.3 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.356 0.663 . . . . 0.0 112.368 177.892 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.86 -59.58 3.46 Favored 'General case' 0 CA--C 1.519 -0.235 0 C-N-CA 125.074 1.349 . . . . 0.0 111.095 -170.906 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 33.7 t-20 -92.57 18.91 7.93 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.744 -1.116 . . . . 0.0 110.438 -177.924 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 28.9 60.9 0.13 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 129.028 2.931 . . . . 0.0 113.609 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -138.12 132.46 32.04 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.928 0.891 . . . . 0.0 110.26 -175.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.724 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -102.22 112.5 25.21 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.451 1.9 . . . . 0.0 109.498 179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 93.0 m -90.56 84.57 5.95 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 127.845 2.458 . . . . 0.0 107.575 173.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 15.8 mm -94.25 113.06 28.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 -177.206 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.4 t -107.47 111.76 37.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-N 118.957 0.799 . . . . 0.0 110.128 -171.508 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -129.75 170.89 13.27 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.762 0.792 . . . . 0.0 112.328 -169.615 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -106.42 109.25 63.0 Favored Pre-proline 0 N--CA 1.444 -0.746 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.906 -177.28 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -74.36 77.99 2.76 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.177 2.584 . . . . 0.0 110.906 -172.408 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 3.9 m170 -177.09 -41.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.187 0 C-N-CA 127.885 2.474 . . . . 0.0 107.926 174.382 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 32.6 mt -77.96 -53.84 6.98 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 117.966 0.348 . . . . 0.0 110.974 -177.895 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -124.27 179.18 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 C-N-CA 124.88 1.272 . . . . 0.0 108.84 -176.541 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.5 p -146.37 159.6 43.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 123.574 0.749 . . . . 0.0 110.992 -172.701 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 13.5 t -39.28 -48.23 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.326 0 C-N-CA 125.813 1.645 . . . . 0.0 111.159 173.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -60.78 -50.46 73.37 Favored 'General case' 0 C--O 1.219 -0.535 0 CA-C-O 118.041 -0.981 . . . . 0.0 111.034 -176.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -54.14 -50.64 66.48 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 120.401 1.455 . . . . 0.0 108.442 176.488 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.66 -55.96 16.44 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 120.499 0.19 . . . . 0.0 111.011 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -61.87 -62.26 1.92 Allowed 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.098 -0.953 . . . . 0.0 111.583 177.427 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -42.52 -50.34 5.29 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 124.446 1.099 . . . . 0.0 109.495 -177.913 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 28.0 mm-40 -60.1 -49.84 76.06 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 177.176 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.7 mt -70.17 -63.76 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 O-C-N 121.744 -0.597 . . . . 0.0 111.301 -178.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -45.8 -37.91 6.59 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 119.208 0.913 . . . . 0.0 112.548 174.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -54.22 -32.78 56.71 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.779 1.172 . . . . 0.0 113.06 176.891 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 20.7 mmt -56.89 -39.88 75.19 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.507 0.594 . . . . 0.0 110.625 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 138.41 -18.96 3.23 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.639 1.114 . . . . 0.0 110.932 176.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -80.94 114.03 45.33 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.48 -172.092 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -62.99 141.63 84.72 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 121.663 1.575 . . . . 0.0 108.514 177.362 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -131.37 134.57 46.41 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.335 0.97 . . . . 0.0 112.956 -177.241 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -106.47 71.74 0.88 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -177.82 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.14 107.16 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.288 1.035 . . . . 0.0 109.8 170.22 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -150.89 55.19 0.89 Allowed 'General case' 0 N--CA 1.456 -0.142 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 176.156 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.22 159.45 41.35 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.332 -1.729 . . . . 0.0 106.332 173.39 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.4 tp -150.57 59.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 177.013 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.557 ' HB2' HG13 ' A' ' 4' ' ' VAL . 47.4 mt-10 -78.47 172.09 14.16 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.725 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -123.72 166.73 16.13 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 174.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 . . . . . 0 C--O 1.248 0.981 0 N-CA-C 104.756 -2.313 . . . . 0.0 104.756 171.578 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.911 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 pm0 -82.81 -154.75 0.14 Allowed 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.799 1.64 . . . . 0.0 111.339 -175.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.57 141.18 46.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.28 0 C-N-CA 124.082 0.953 . . . . 0.0 109.343 -174.324 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.6 p -104.96 127.01 59.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 C-N-CA 126.462 1.905 . . . . 0.0 110.663 -177.723 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -109.21 127.89 54.59 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 177.565 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -107.1 111.27 23.64 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 178.864 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.422 ' HG3' ' HB3' ' A' ' 43' ' ' ALA . 5.4 ptp -113.66 122.23 46.53 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.698 1.199 . . . . 0.0 109.152 179.477 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.486 ' NZ ' ' OE2' ' A' ' 42' ' ' GLU . 1.0 OUTLIER -74.46 130.85 40.4 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 174.44 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.6 m -116.15 153.7 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 178.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 54.3 mm-40 -117.08 146.85 42.86 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 176.259 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.72 -38.91 2.97 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.267 0.937 . . . . 0.0 113.077 170.756 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' MET . . . . . 0.465 ' CE ' HD13 ' A' ' 21' ' ' ILE . 34.0 mtt -62.72 137.06 58.17 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.457 1.129 . . . . 0.0 110.575 -174.989 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 30.5 m -143.4 -56.99 0.4 Allowed 'General case' 0 N--CA 1.452 -0.374 0 O-C-N 121.733 -0.605 . . . . 0.0 110.226 176.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 27.8 p -72.07 156.47 39.17 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 118.724 0.693 . . . . 0.0 110.098 -179.33 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -65.16 -18.71 65.53 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.295 177.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.1 m -64.54 -50.18 68.33 Favored 'General case' 0 N--CA 1.448 -0.549 0 O-C-N 121.422 -0.799 . . . . 0.0 110.665 -179.009 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 71.9 m -54.62 -57.85 9.81 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 118.787 0.721 . . . . 0.0 109.73 178.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 81.0 p -55.49 -55.31 33.25 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.539 -176.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 28.6 t -56.55 -45.89 80.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.961 0.905 . . . . 0.0 111.811 179.091 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 91.9 m -58.0 -49.48 76.71 Favored 'General case' 0 C--O 1.232 0.156 0 O-C-N 121.487 -0.758 . . . . 0.0 109.942 -179.492 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.465 HD13 ' CE ' ' A' ' 12' ' ' MET . 3.1 mt -61.14 -47.01 95.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 122.936 0.494 . . . . 0.0 109.912 176.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -51.56 -50.26 60.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.553 0.741 . . . . 0.0 109.551 178.527 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.86 -56.79 22.11 Favored Glycine 0 CA--C 1.529 0.966 0 C-N-CA 123.68 0.657 . . . . 0.0 111.817 173.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.0 tptt -60.63 -59.61 5.12 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 122.198 -0.589 . . . . 0.0 110.948 -171.856 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 34' ' ' ILE . 1.6 mp -67.58 -34.25 67.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 123.847 0.859 . . . . 0.0 109.954 -177.376 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -46.43 -33.79 6.12 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-O 119.808 -0.44 . . . . 0.0 112.58 168.804 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.2 ttmt -92.42 12.19 23.6 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 117.966 0.883 . . . . 0.0 112.353 -179.763 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.2 mt -66.61 151.24 47.71 Favored 'General case' 0 N--CA 1.453 -0.296 0 O-C-N 120.404 -1.435 . . . . 0.0 109.886 167.316 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -89.17 130.33 35.61 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 170.341 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.37 -0.88 29.49 Favored Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.557 1.075 . . . . 0.0 111.909 176.463 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.4 p -95.48 154.9 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 124.691 1.196 . . . . 0.0 109.658 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -122.1 -41.57 2.42 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 124.168 0.987 . . . . 0.0 110.055 179.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -150.66 164.37 36.26 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.603 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.461 HD12 HG22 ' A' ' 25' ' ' ILE . 10.5 tt -156.97 139.29 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 103.806 -2.665 . . . . 0.0 103.806 -172.899 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.1 mmtp -145.49 147.76 32.51 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 123.55 0.74 . . . . 0.0 110.027 172.067 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 49.8 t -137.32 140.76 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 119.863 1.211 . . . . 0.0 110.825 171.572 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.2 m -124.08 132.57 53.67 Favored 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.971 1.708 . . . . 0.0 110.569 -177.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -54.73 5.99 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.713 0.805 . . . . 0.0 112.151 176.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.61 -56.73 16.01 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 110.112 -166.195 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -88.22 11.58 16.08 Favored 'General case' 0 N--CA 1.448 -0.561 0 CA-C-N 114.228 -1.351 . . . . 0.0 110.845 -177.89 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 32.37 62.69 0.31 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 128.857 2.863 . . . . 0.0 113.042 -178.327 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.486 ' OE2' ' NZ ' ' A' ' 8' ' ' LYS . 3.8 tt0 -131.39 142.32 50.02 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.342 -175.227 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB3' ' HG3' ' A' ' 7' ' ' MET . . . -118.72 133.88 55.53 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.298 1.439 . . . . 0.0 108.659 175.71 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 91.3 m -109.94 117.18 33.1 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 129.518 3.127 . . . . 0.0 106.648 -178.46 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 4.6 mm -126.23 119.29 53.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 177.927 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 3.6 t -119.17 108.59 24.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 -168.029 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -144.14 164.45 30.65 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.192 0.52 . . . . 0.0 112.008 -165.356 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -89.31 108.58 25.45 Favored Pre-proline 0 CA--C 1.539 0.548 0 C-N-CA 125.714 1.606 . . . . 0.0 109.431 -174.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -72.2 73.14 2.69 Favored 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 123.02 2.48 . . . . 0.0 111.036 -176.726 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 5.3 m170 -168.22 -53.21 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.159 0 C-N-CA 126.413 1.885 . . . . 0.0 108.756 177.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.4 mt -72.67 -43.17 63.48 Favored 'General case' 0 C--N 1.338 0.077 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -175.621 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 tp -133.36 177.9 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -177.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 92.6 p -135.05 162.34 32.75 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 119.153 0.888 . . . . 0.0 110.215 -174.223 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 2.6 t -44.09 -46.44 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 C-N-CA 124.673 1.189 . . . . 0.0 110.995 169.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -61.14 -57.77 11.11 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-O 117.223 -1.37 . . . . 0.0 110.184 -174.719 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -38.57 -56.85 1.24 Allowed 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.763 1.625 . . . . 0.0 110.665 172.422 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' MET . . . . . . . . . . . . . 3.1 mtm -51.45 -63.01 1.27 Allowed 'General case' 0 N--CA 1.45 -0.47 0 O-C-N 122.163 -0.336 . . . . 0.0 111.57 175.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.04 -58.64 7.53 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 121.714 -0.616 . . . . 0.0 111.964 -177.443 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.5 tmtt? -36.88 -54.97 0.92 Allowed 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 125.844 1.658 . . . . 0.0 110.491 172.649 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -65.21 -41.8 94.13 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 119.094 -1.043 . . . . 0.0 113.388 176.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.5 mt -68.74 -61.76 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.174 -0.954 . . . . 0.0 109.98 -176.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -43.42 -40.96 4.0 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 118.606 -0.712 . . . . 0.0 111.957 169.553 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.15 -31.23 61.16 Favored 'General case' 0 C--N 1.345 0.376 0 CA-C-N 119.617 1.099 . . . . 0.0 113.222 178.836 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 12.8 mmt -56.82 -43.79 81.36 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.593 0.633 . . . . 0.0 110.777 171.801 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 136.02 -15.31 4.02 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 125.047 1.308 . . . . 0.0 111.287 -179.01 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.432 ' CE2' HD11 ' A' ' 21' ' ' ILE . 44.2 m-85 -80.89 116.89 65.41 Favored Pre-proline 0 N--CA 1.452 -0.35 0 CA-C-O 118.246 -0.883 . . . . 0.0 109.91 -173.221 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -67.9 140.04 49.27 Favored 'Trans proline' 0 N--CA 1.45 -1.045 0 N-CA-C 108.397 -1.424 . . . . 0.0 108.397 174.647 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -136.71 140.25 42.53 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.351 0.66 . . . . 0.0 110.48 -178.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -114.66 79.03 1.21 Allowed 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 123.939 0.896 . . . . 0.0 109.152 -178.543 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.0 p -62.39 105.01 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 C-N-CA 125.012 1.325 . . . . 0.0 109.691 169.796 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 31.5 pttt -152.98 54.72 0.77 Allowed 'General case' 0 N--CA 1.456 -0.143 0 CA-C-O 121.735 0.778 . . . . 0.0 112.42 176.282 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.74 132.7 8.67 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.252 -2.129 . . . . 0.0 105.252 -178.931 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.2 mp -130.15 70.59 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 175.684 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -83.81 175.81 9.37 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-O 121.288 0.565 . . . . 0.0 109.613 174.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -114.32 135.98 12.88 Favored Glycine 0 CA--C 1.527 0.785 0 N-CA-C 110.668 -0.973 . . . . 0.0 110.668 179.044 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 . . . . . 0 C--O 1.251 1.149 0 C-N-CA 125.476 1.51 . . . . 0.0 112.692 169.906 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_